-- phpMyAdmin SQL Dump
-- version 4.3.11
-- http://www.phpmyadmin.net
--
-- Host: 127.0.0.1
-- Generation Time: Jul 09, 2018 at 04:55 PM
-- Server version: 5.6.24
-- PHP Version: 5.6.8

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;

--
-- Database: `neurodb`
--

-- --------------------------------------------------------

--
-- Table structure for table `alldrug`
--

CREATE TABLE IF NOT EXISTS `alldrug` (
  `osr1` bigint(200) NOT NULL,
  `osr2` varchar(500) NOT NULL,
  `osr3` varchar(500) NOT NULL,
  `osr4` varchar(500) NOT NULL,
  `osr5` varchar(500) NOT NULL,
  `osr6` varchar(500) NOT NULL,
  `osr7` varchar(500) NOT NULL,
  `osr8` varchar(500) NOT NULL,
  `osr9` varchar(500) NOT NULL,
  `osr10` varchar(500) NOT NULL,
  `osr11` varchar(500) NOT NULL,
  `osr12` varchar(500) NOT NULL,
  `osr13` varchar(500) NOT NULL,
  `osr14` varchar(500) NOT NULL,
  `osr15` varchar(500) NOT NULL,
  `osr16` varchar(500) NOT NULL,
  `osr17` varchar(500) NOT NULL,
  `osr18` varchar(500) NOT NULL,
  `osr19` varchar(500) NOT NULL,
  `osr20` varchar(500) NOT NULL,
  `osr21` varchar(500) NOT NULL,
  `osr22` varchar(500) NOT NULL,
  `osr23` varchar(11) NOT NULL,
  `osr24` varchar(500) NOT NULL,
  `osr25` varchar(500) NOT NULL,
  `osr26` varchar(500) NOT NULL,
  `osr27` varchar(500) NOT NULL,
  `osr28` varchar(500) NOT NULL,
  `osr29` varchar(500) NOT NULL,
  `osr30` varchar(500) NOT NULL,
  `osr31` varchar(500) NOT NULL,
  `osr32` varchar(500) NOT NULL,
  `osr33` varchar(500) NOT NULL,
  `osr34` varchar(500) NOT NULL,
  `osr35` varchar(500) NOT NULL,
  `osr36` varchar(500) NOT NULL,
  `osr37` varchar(500) NOT NULL,
  `osr38` varchar(500) NOT NULL,
  `osr39` varchar(500) NOT NULL,
  `osr40` varchar(500) NOT NULL,
  `osr41` varchar(500) NOT NULL,
  `osr42` varchar(500) NOT NULL,
  `osr43` varchar(500) NOT NULL,
  `osr44` varchar(500) NOT NULL,
  `osr45` varchar(500) NOT NULL,
  `osr46` varchar(500) NOT NULL,
  `osr47` varchar(500) NOT NULL,
  `osr48` varchar(500) NOT NULL,
  `osr49` varchar(500) NOT NULL,
  `osr50` varchar(500) NOT NULL,
  `osr51` varchar(500) NOT NULL,
  `osr52` varchar(500) NOT NULL,
  `osr53` varchar(500) NOT NULL,
  `osr54` varchar(500) NOT NULL,
  `osr55` varchar(500) NOT NULL,
  `osr56` varchar(500) NOT NULL,
  `osr57` varchar(500) NOT NULL,
  `osr58` varchar(500) NOT NULL,
  `osr59` varchar(500) NOT NULL,
  `osr60` varchar(500) NOT NULL,
  `osr61` varchar(500) NOT NULL,
  `osr62` varchar(500) NOT NULL,
  `osr63` varchar(500) NOT NULL,
  `osr64` varchar(500) NOT NULL,
  `osr65` varchar(500) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=latin1;

--
-- Dumping data for table `alldrug`
--

INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(1, '1', 'Not Available', 'Cc1ccc(C)n1c2ccc(C(=O)O)c(O)c2', '4-(2,5-dimethylpyrrol-1-yl)-2-hydroxy-benzoic acid', 'CYAAFQwA^dwQSI^JFNt13yJB8cYmyZlXHiQoFkcpAPdGjU7WjUybUepbdTZRJ1qjeqMx^wdmIEr1Qqd0rTYX0B5fGnhcfuH^qr5r6hdriT4Iy5$9iBWGMbTnB6pfDAhAtcPYgT0QiNyUCdAjsZYJM2On9RqcqEo24pnriXTgyMq7gRRSO3YZQeKFsINmDjcUKO220FlX FHC8nImiFuMfLSJaUgSWeD96XooVZIX3HxmUtoQ0RK1md76daz7StWcATZYKo4C7q4lIKOicRjy7pQ3IVemdbbLBroQPxtkCmgiJlpxZ3tAmynoH5OkFzC1lRak2IWcNgmbLv5ZKwjoqTJivaZDnIu6YYiP4uVv0ErjdF5960ZqnKaMwd9OqhGcUMQRrxIH1fr0I8S6u UkkZYZjURK31vXaEkTVXo0dHolqeXvEmik6usO36dEoV94hdUPtf8629vqcXEK1JuVPpDcEf7Ktyq8jPkJiKgvYoFiFvyWM5', 'InChI=1S/C13H13NO3/c1-8-3-4-9(2)14(8)10-5-6-11(13(16)17)12(15)7-10/h3-7,15H,1-2H3,(H,16,17)', 'AuxInfo=1/1/N:3,4,15,14,6,5,10,13,12,8,7,9,1,11,2,16,17/E:(1,2)(3,4)(8,9)(16,17)/rA:17COCCCCCCCCNCCCCOO/rB:;;;;s5;s1d+5;d-6;s2s7;s8d+9;s8;s4s11;s3s11;d+12;d+13s14;s1;d1;/rC:10.9314,-3.5126,.0006;8.432 4,-5.0181,-.0016;8.2767,-9.8598,.0011;13.5264,-9.8692,-.0011;12.0483,-5.6556,.0017;12.0386,-7.1188,.0015;10.9058,-4.9784,.0006;10.8981,-7.8153,.0005;9.6407,-5.7058,-.0005;9.6394,-7.0367,-.0006;10.8983 ,-9.322,.0001;12.0476,-10.211,-.0005;9.7504,-10.2071,.0003;11.6289,-11.4745,-.0009;10.1651,-11.4', 'WAYCNXGAKFXIKA-UHFFFAOYSA-N', '1010:J177CVPU822Y1G2B1PE3CPNHGGTJ17', '[#6](=[#8])(-[#8])-[c](:[c](-[#8]):[c]:[c](-[n]1:[c](-[#6]):[c]:[c]:[c]1-[#6]):[c]2):[c]2', 'C(=O)(O)c(c(O)cc(n1c(C)ccc1C)c2)c2', '02.385', '2.385', '0', '0', 'TRUE', '0.2926\r\n-0.3601\r\n-2.88e-002\r\n-2.88e-002\r\n-4.47e-002\r\n-4.24e-002\r\n7.68e-002\r\n2.85e-002\r\n8.62e-002\r\n-1.24e-002\r\n-0.2224\r\n5.e-004\r\n5.e-004\r\n-4.66e-002\r\n-4.66e-002\r\n-0.3278\r\n-0.2608', '0', '0.904', 'C13H13NO3', '0231.09', '-3.22', '0231.247', '-3.7 -3.47 9.1', '1', '1', '1', '6', '11', '2', '17', '18', '6', '6', '004', '02', '13', '0', '2', '002', '0062.46', '243.02', 'Molecule has implicit hydrogens, 3D Descriptor calculation may not give useful results', '4.12466', '1.4137', '51.51', '23.41', '6.87617', '28.1', '913.854', '129.476', '184.19', '', 'C(/C2=C/C=C(N1/C(C)=C\\C=C1\\C)\\C=C2\\O)(O)=O', 'Cc1ccc(C)n1c2ccc(C(=O)O)c(O)c2', 'Compound_23', 'Not Available', 'Ephrin type-A receptor 4', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22922411', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(2, '71301474', '71301474', 'N\\C=C\\1/C(=N/CCN2CCN(CC2)c3ccc([123I])cc3F)/N=C(N)n4nc(nc14)c5occc5', '(7<I>Z</I>,8<I>E</I>)-8-(aminomethylene)-7-[2-[4-(2-fluoro-4-iodanyl-phenyl)piperazin-1-yl]ethylimino]-2-(2-furyl)-[1,2,4]triazolo[1,5-c]pyrimidin-5-amine', 'CYAAFQwArewQrYPB7RBng6B5HHuvIcgRdKniXs^cbrAyMgEQSAq9E$^NMivkeJ2fgfjCxe20LCdyjFDTdlgiDFovCn8^VcGRUwxw6Mwc8XbEUHFyWerB61HuULZvSBJpdzfePd3HpE2fn4eJQxEgv5UPAWFyklq20bJcLXfO0cZjfEyazt6TGF2O^6URvhXPoT4yhkW^ XyDu1QBXa3Xf8x6wnuYe9zozWSEJ5xjvLkskIfK92V$l3UkKfRkXe^lCAuIIA^LTz84O9kSFkp1j1NA252eOeU3mOb9GyS6IbSy8$io26vhVeiQIHaCPpkpb$9uo4^Y3BvLML$E00WYD8yJMu2MSeckiSNip^MUgqUsyE2^Tr90OXyP1DdVnf6KwvcdcAXANZfcnn$8K fyrW7PEicd0gi5shSl8SFeObDDkGPqjnaFsfT7s6f1GHFo7hAI$hviY5q2ZPpVZVI3$z3Z8tUdmXy0ry0pG0rjJ8X2IUxjlL', 'InChI=1S/C22H23FIN9O/c23-16-12-14(24)3-4-17(16)32-9-7-31(8-10-32)6-5-27-19-15(13-25)21-28-20(18-2-1-11-34-18)30-33(21)22(26)29-19/h1-4,11-13H,5-10,25H2,(H2,26,27,29)/b15-13+/i24-4', 'AuxInfo=1/1/N:33,32,23,21,19,17,13,14,16,15,34,22,29,25,26,20,18,31,24,30,27,28,2,1,12,11,6,9,8,10,4,5,7,3/E:(7,8)(9,10)/I:/E:m/rA:57I.i123FONNNNNNNNNCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:; ;;;;;;;s7;;;s4;s4;s5s14;s5s13;s4;s5;s6s17;s2d-18;s18;s20;d-21;d-6s8;s1d+22s23;s24;s7d-9s26;s7d-8s11;s12d-26;s9d-10;s3s30;d-31;s32;s3d-33;s14;s14;s13;s13;s15;s15;s16;s16;s17;s17;s19;s19;s21;s22;s23;s29 ;s11;s11;s12;s12;s32;s33;s34;/rC:11.3179,-1.7513,-.1945;6.6039,-.1794,-2.2624;-8.3229,-2.031,.06', 'AFYNYBQDRFWYTE-TZPOWQGUSA-N', '1010:2M4KFHCYV3JNRQPMXYT3B9M78SJQNJ', '[123#53]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])\\-[#7]=[#6](\\-[#6](=[#6](-[#1])/-[ #7](-[#1])-[#1])\\-[c](:[n]:[c](-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[o]3):[n]4):[n]45)/-[#7]=[#6]5-[#7](-[#1])-[#1]):[c](-[#1]):[c]1-[#9]', '[123I]c(c([H])c([H])c1N(C([H])([H])C2([H])[H])C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])\\N=C(\\C(=C([H])/N([H])[H])\\c(nc(c3c([H])c([H])c([H])o3)n4)n45)/N=C5N([H])[H])c([H])c1F', '01.838', '2.484', '0', '0', 'TRUE', '-4.42e-002\r\n-0.2052\r\n-0.3141\r\n-0.2989\r\n-0.27\r\n-0.2647\r\n-8.85e-002\r\n-0.2034\r\n-0.2103\r\n-0.1626\r\n-0.2751\r\n-0.3081\r\n1.14e-002\r\n1.14e-002\r\n1.59e-002\r\n1.59e-002\r\n1.8e-002\r\n5.36e-002\r\n5.41e-002\r\n0.1418\r\n-4.e-002\r\n-1.13e-002\r\n-4.71e-002\r\n0.1615\r\n1.6e-002\r\n6.85e-0', '0', '0.729', 'C22H23F[123I]N9O', '0571.107', '-5.974', '0571.382', '2.21 2.37 4.47 6.5 8.43 8.45', '5', '2', '3', '19', '16', '3', '34', '38', '30', '10', '010', '04', '23', '0', '5', '005', '0127.09', '488.48', '', '1.93916', '1.2915', '110.35', '58.73', '6.21195', '51.62', '6,922.37', '174.516', '367.69', '', '[123I]/C/5=C/C(F)=C(N4CCN(CC/N=C/3\\N=C(N)/N2/N=C(/C1=C/C=C\\O1)\\N=C2\\C3=C\\N)CC4)\\C=C5', 'NC=c4c(=NCCN2CCN(c1ccc([123I])cc1F)CC2)nc(N)n5nc(c3ccco3)nc45', '[123I]MNI-420', '2. 7-(2-(4-(2-Fluoro-4-[123I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine; MNI-420; (123I)MNI-420', 'Adenosine 2A receptors', '71301474', 'Phase I', 'Huntington Disease (HD)', '23970369', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(3, '716049', '716049', 'Clc1ccc2OC=C(C(=O)c2c1)c3nc4ccccc4[nH]3', '3-(1<I>H</I>-benzimidazol-2-yl)-6-chloro-chromen-4-one', 'CYAAFQwAtfwQnw4Eov6tQhDBO13ZMivf37LM5MS8Nnw6SftMISruCK^D4$Pb0z6Ys17tH694qxzDvcLWSx9D6Ca1W1fGvqwf6Kx5CwIHpoUX1QtLiVeDSghawp0c^8O$^80diAQCo1jPSTodGNlvn8WZcREyfOu0xzrHTsDMwPVtTdLxAxK8OYp$ahMPKsZRrOlZF^YX LSM6Fo22h32$L2mlLdQZec0bKacZqOQPESPN88MXMyGzMVUXY^wBe2DMdOw8FbsbIezxXG50jPBOVZI6vm1weML1fEUZ1Rgbwrq$q9UVhkdlhEhg8ftDwjPv1xZVfhKottSfXEtK1xBRfhJoJRd9q^6OGnuN2L381LRT5yosIqdopKXlXMzlj4ssBFjkJBPLZI2r2K$W qAdZkzrAbHxJjlwtHxlq1n5nZdKr6j3IeygA1^1A0lrC5d4NfqkgXrC9R1XOvuXnN3zF3TDyHFlCeB7^^LG9^sE2IGcKcKGK', 'InChI=1S/C16H9ClN2O2/c17-9-5-6-14-10(7-9)15(20)11(8-21-14)16-18-12-3-1-2-4-13(12)19-16/h1-8H,(H,18,19)', 'AuxInfo=1/1/N:18,20,14,16,21,17,15,13,19,9,7,8,10,12,11,6,1,4,5,3,2/E:(1,2)(3,4)(12,13)(18,19)/rA:30ClOONNCCCCCCCCCCCCCCCCHHHHHHHHH/rB:;;;;s4d-5;s6;s4;;s5s8;d3s7s9;s2d-9;s2d+7;d+8;s9;d+10;s12;s14;s1d+ 15;s16d-18;d-17s19;s4;s13;s14;s15;s16;s17;s18;s20;s21;/rC:-5.9107,2.1539,.2237;-1.9322,-2.1492,-.267;-.5845,1.6568,.3462;1.8671,.7333,-.3906;2.3181,-1.2828,.4295;1.3631,-.4658,.0361;-.0533,-.6379,-.00 79;3.2319,.6861,-.2648;-2.4198,.2088,.0543;3.4884,-.582,.249;-.9799,.5158,.1459;-2.822,-1.1119,-', 'RGRGDHLODJPCDR-UHFFFAOYSA-N', '1010:V8VS4J4WJUMQHPCMQYJSZ3DJZ5JNBR', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2-[#6](-[#6](=[#6](-[#1])-[#8]1)-[c]3:[n]:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1]):[c]4:[n]3-[#1])=[#8]):[c]2-[#1]', 'Clc(c([H])c([H])c1c2C(C(=C([H])O1)c3nc(c([H])c([H])c([H])c4[H])c4n3[H])=O)c2[H]', '03.453', '3.453', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3165\r\n-0.2883\r\n-0.2406\r\n-0.2343\r\n0.1238\r\n8.32e-002\r\n4.62e-002\r\n5.49e-002\r\n8.32e-002\r\n0.2004\r\n9.24e-002\r\n6.03e-002\r\n-4.17e-002\r\n-2.97e-002\r\n-3.48e-002\r\n-2.91e-002\r\n-6.06e-002\r\n4.14e-002\r\n-6.e-002\r\n-4.09e-002\r\n0.1358\r\n9.1e-002\r\n6.4e-002\r\n6.47', '0', '3.683', 'C16H9ClN2O2', '0296.035', '-4.557', '0296.708', '10.09', '3', '1', '2', '6', '16', '3', '21', '24', '12', '9', '004', '01', '9', '0', '4', '001', '0054.98', '263.8', '', '1.1912', '1.3126', '35.19', '21.22', '4.23204', '13.97', '1,071.11', '84.439', '208.2', '', 'Cl/C4=C([H])/C3=C(O/C([H])=C(/C2=N/C1=C([H])/C([H])=C([H])\\C([H])=C1\\N2[H])\\C3=O)\\C([H])=C4\\[H]', 'O=c3c(c2nc1ccccc1[nH]2)coc4ccc(Cl)cc34', '052C9', 'AC1LEPV7; HE190469; ST024603; AKOS030553058', 'Nuclear factor erythroid 2-related factor 2', '716049', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '18627324', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(4, '127912', '127912', 'Nc1ccccc1C(=O)NCCCCN2CCN(CC2)c3nsc4ccccc34', '2-amino-<I>N</I>-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]benzamide', 'CYAAFQwA6dwQYPLx7EM0zmtmUg41H8JpKfODj53UGgLi$qxTGsS3$FwgTTuSTeOUCmmWKVNGdUp94iLKoasC31pjqesTgpZ6KveRj9k5gn5qd$$R0xZ159X$Wv4vK4lo3^HLL39zAQw30747B7Mqw9RL3jCCYi3ZvZpiuzRZ58Av6HFQVyhLPbQH8TaViBfuRV7lRH9X wqOqXCBr51lfFiKdVc6mGbtwpGVWc45TjZuY3G5ta8A9hjnPcp7HzQl9hrmIXM4y03$ZMYlPyMMBzHvuG4q3rqNS9aYDDKk2ec1X13gHPoI97xsMtLatCLBPo^G1g9u0PeihMrgjiLTudOdwlN71eNuajomZQVuILGM6gHDHBdGsk$MHv7jCDga5LsC40qrnb8ttKPfe STw4iOTpEFHbYBZv1YmqyPQ9v6VzMK9KV05tNmn1PlW9cx2DRd^hkmqBUsPNdByheEDPQz2KNundEdUGXOkIMMAietndpb1R', 'InChI=1S/C22H27N5OS/c23-19-9-3-1-7-17(19)22(28)24-11-5-6-12-26-13-15-27(16-14-26)21-18-8-2-4-10-20(18)29-25-21/h1-4,7-10H,5-6,11-16,23H2,(H,24,28)', 'AuxInfo=1/1/N:28,21,29,22,15,13,26,19,27,20,17,12,8,9,10,11,24,16,25,18,14,23,7,6,5,3,4,2,1/E:(13,14)(15,16)/rA:56SONNNNNCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s1;;;s3;s3;s4s8;s4s9;s3 ;s12;s4d+5;s13;s14;s6s15;s1s16;d+16;d+18;s19;s20d-21;d2s6;s23;s7s24;d+24;d+25;s26;s27d-28;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s17;s17;s19;s6;s20;s21;s22;s26;s27;s28;s29;s7;s7;/rC:5.693 9,-.4053,1.8545;-4.0514,.639,1.9544;.3572,2.7265,-.5099;2.5856,1.2177,.4546;4.4889,.7297,1.8071;', 'GMDXHLCLNHCEIC-UHFFFAOYSA-N', '1010:6S4RZQ7AKZ6U1REYZG5EV8DAAVMD62', '[s]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c]2:[c](:[n]1)-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7] (-[#1])-[#6](-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#7](-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 's1c(c([H])c([H])c([H])c2[H])c2c(n1)N(C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(c4c([H])c([H])c([H])c([H])c4N([H])[H])=O)C([H])([H])C3([H])[H]', '03.453', '3.408', '0', '0', 'TRUE', '1.29e-002\r\n-0.2719\r\n-0.3008\r\n-0.2558\r\n-0.1987\r\n-0.3114\r\n-0.302\r\n1.14e-002\r\n1.14e-002\r\n1.73e-002\r\n1.73e-002\r\n-1.7e-003\r\n-3.9e-002\r\n0.1253\r\n-3.64e-002\r\n2.77e-002\r\n1.13e-002\r\n4.1e-002\r\n-5.06e-002\r\n-4.6e-002\r\n-6.15e-002\r\n-6.11e-002\r\n0.2445\r\n5.47e-002\r\n2.44e-002\r\n-4.81e-002\r\n-4.37e-002\r\n-6.14e-002\r\n-6.07e-002\r\n4.44e-002\r\n4.44e-002\r\n4.44e-002\r\n4.44e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n4.3e-002\r\n4.3e-002\r\n2.8e-002\r\n2.8e-002\r\n2.82e-002\r\n2.82e-002\r\n4.66e-002\r\n4.66e-002\r\n6.3e-002\r\n0.1496\r\n6.3', '0', '3.449', 'C22H27N5OS', '0409.194', '-5.231', '0409.548', '2.84 5.34', '2', '2', '1', '15', '16', '3', '29', '32', '31', '8', '006', '03', '27', '0', '4', '007', '0102.73', '422.24', '', '4.95386', '1.2792', '101.66', '43.1', '4.54646', '58.56', '1,771.40', '136.237', '329.96', '-178.85', 'S3/N=C(N2CCN(CCCCNC(=O)/C1=C/C=C\\C=C1\\N)CC2)\\C\\4=C\\C=C/C=C34', 'Nc1ccccc1C(=O)NCCCCN4CCN(c2nsc3ccccc23)CC4', '1192U90', 'LS-25359; L001475; CID127912; UNII-LLE3Y7VC87; HE314541', '5-hydroxytryptamine 2A receptor', '127912', 'Under Investigation', 'Schizophrenia', '8873106', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(5, '5', 'Not Available', 'COc1ccc(CCC(=O)Nc2cc(ccn2)c3nc(SC)[nH]c3c4ccc(F)cc4)c(OC)c1', '3-(2,4-dimethoxyphenyl)-<I>N</I>-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]propanamide', 'CYAAFQwASfwQafx26AJE5EqLlaKg7iMTq2EmX1ne6o^YCEXnYJkRiDScZsWW7pjQiHEsLIJNa$pi2cLRgUbi1OjjhEnL2H5gGwiMVEMdUiB$3BPC1gdt75XdzH^$XweNv61PgPXg4KgGt61edCftXDEAIS6BfikkUKnHTtNTjiKgD7JGfHfEB3fjWkDKRhbaGKGJfii6 oPl7JmKQpYk0WCaUrIUnKtjCqlliRGxGWVw8gSHl8CKFkpWULkOpZjyryhTUzLdSiVtwXk5OSAVOv0y83gX27ZxXlYCVJgIlUcZzOHQkec7ZxlRKzcBZ0c6ndFxRRaRgAYpxXc2TyFVwNmKbpKF7i7Jd0tBtWn6pkcZkpt7MjEaRuvWBFmUeFzD$UfTaMmKmGLqOeRb$ 3kG0I1INx5hxPpjYFqd8hQL2U9FDpcuOlsrXh8mAo5rbvMDREr2qQAqc9SXs5RNtxx35tWk2UgOZi5QVc7rcsNyrup0BX2tw', 'InChI=1S/C26H25FN4O3S/c1-33-20-10-6-16(21(15-20)34-2)7-11-23(32)29-22-14-18(12-13-28-22)25-24(30-26(31-25)35-3)17-4-8-19(27)9-5-17/h4-6,8-10,12-15H,7,11H2,1-3H3,(H,30,31)(H,28,29,32)', 'AuxInfo=1/1/N:33,34,29,23,24,8,14,25,26,10,15,3,5,4,13,9,22,2,27,12,11,6,16,18,17,21,30,7,1,20,19,35,31,32,28/E:(4,5)(8,9)/rA:35NCCCCCNCCCCCCCCCCCNNCCCCCCCSCFOOCCO/rB:;s2;d-2;d-3;s1s4;s5d+6;;s8;d-8;d- 9;s10;s11d-12;s9;s14;s1s15;s2;d+17;s17;s18;d-19s20;s18;s22;d+22;d-23;s24;s25d-26;s21;s28;s27;s12;s11;s31;s32;d16;/rC:12.1642,-5.6522,.0001;15.7691,-6.1508,.0001;15.8424,-7.6087,.0002;14.5689,-5.6208,0 ;14.7025,-8.3127,.0003;13.3746,-6.3824,.0001;13.4334,-7.6546,.0003;7.1416,-4.13,.0002;7.1511,-5.', 'GYQMPPCYKUSMTA-UHFFFAOYSA-N', '1010:TUWF483RVVEU86VKCX9ZSTYYX1V6XP', '[#7](-[#6](=[#8])-[#6]-[#6]-[c]1:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]:[c]1)-[c](:[n]:[c]:[c]2):[c]:[c]2-[c]3:[n]:[c](-[#16]-[#6]):[n]:[c]3-[c]4:[c]:[c]:[c](-[#9]):[c]:[c]4', 'N(C(=O)CCc1c(OC)cc(OC)cc1)c(ncc2)cc2c3nc(SC)[nH]c3c4ccc(F)cc4', '05.394', '5.394', '0', '0', 'TRUE', '-0.2701\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1242\r\n-0.2412\r\n-5.39e-002\r\n-1.7e-002\r\n-3.14e-002\r\n8.03e-002\r\n7.71e-002\r\n-1.2e-003\r\n-1.67e-002\r\n2.88e-002\r\n0.2173\r\n9.18e-002\r\n5.45e-002\r\n-0.2277\r\n-0.2351\r\n0.1447\r\n-4.9e-003\r\n-5.04e-002\r\n-5.04e-002\r\n-2.', '0', '5.464', 'C26H25FN4O3S', '0492.163', '-7.759', '0492.565', '5.44 7.35', '5', '2', '1', '14', '23', '4', '35', '38', '8', '12', '007', '02', '25', '0', '4', '009', '0114.43', '503.04', 'Molecule has implicit hydrogens, 3D Descriptor calculation may not give useful results', '5.03347', '1.4265', '88.06', '31.59', '7.86163', '56.47', '4,450.31', '163.162', '375.58', '180', 'N(/C/3=N/C=C\\C(\\C/2=C(/C/1=C/C=C(F)\\C=C1)\\N\\C(SC)=N2)=C3)C(CC/C/4=C(OC)/C=C(OC)\\C=C4)=O', 'COc4ccc(CCC(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)c(OC)c4', '11b', 'Not Available', 'protein kinase CK1 epsilon', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(6, '6', 'Not Available', 'COc1ccc(CCC(=O)Nc2cc(ccn2)c3nc(SC)[nH]c3c4ccc(F)cc4)c(OC)c1', '3-(2,4-dimethoxyphenyl)-<I>N</I>-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]propanamide', 'CYAAFQwAvdwQ9lRXE6R0Xk4zf5gyJGdAau9IzxqOP^ayl2mdgdSjH$lC0o3Y719hhwwHUHCiAftub3oHGqC5KzGcsOueMlZmDEnOGmjrtOWlUpc9RnagwEjVRoP^bOfEvDEALRyGf6lAFxrHr4yTLoCwUns5nX0yWOGrBPvq7DayL0qdMNpljwWd0vriFE9OlC2m3B3A 1dNxbI$niWz8IDVeZemOvzs4mvFomLZYfIXkKgtHbRnuDx8t8BQddx3Rz46tRQHWPc9b4pAbf8SP9hGdzfLDiXLQz1h0x2C4lN^OTgNXPMCosK$lsgxvszDOpDYYrfA3qOMvaH3S735NuULQxFrOJefN7R1g7tCwUjbUEx6jjgtWeuryEpb^P4WcqR1asExz4FL7Qorr $ST^oXHaJpvj0xBQ19xLqFYA8J$P7Uv7dMBF4FpfHPOzq^MOelwNzHt795R9nPv2I1TmL3tMrfuvfC17fV5$rRVT4WhgCgqA', 'InChI=1S/C26H25FN4O3S/c1-33-20-10-6-16(21(15-20)34-2)7-11-23(32)29-22-14-18(12-13-28-22)25-24(30-26(31-25)35-3)17-4-8-19(27)9-5-17/h4-6,8-10,12-15H,7,11H2,1-3H3,(H,30,31)(H,28,29,32)', 'AuxInfo=1/1/N:33,34,29,23,24,8,14,25,26,10,15,3,5,4,13,9,22,2,27,12,11,6,16,18,17,21,30,7,1,20,19,35,31,32,28/E:(4,5)(8,9)/rA:35NCCCCCNCCCCCCCCCCCNNCCCCCCCSCFOOCCO/rB:;s2;d-2;d-3;s1s4;s5d+6;;s8;d-8;d- 9;s10;s11d-12;s9;s14;s1s15;s2;d+17;s17;s18;d-19s20;s18;s22;d+22;d-23;s24;s25d-26;s21;s28;s27;s12;s11;s31;s32;d16;/rC:12.2905,-5.1524,0;14.4339,-5.5649,0;14.4339,-6.3899,0;13.7194,-5.1524,0;13.7194,-6. 8024,0;13.0049,-5.5649,0;13.0049,-6.3899,0;9.4326,-4.3274,0;9.4326,-5.1524,0;8.718,-3.9148,0;8.7', 'GYQMPPCYKUSMTA-UHFFFAOYSA-N', '1010:TUWF483RVVEU86VKCX9ZSTYYX1V6XP', '[#7](-[#6](=[#8])-[#6]-[#6]-[c]1:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]:[c]1)-[c](:[n]:[c]:[c]2):[c]:[c]2-[c]3:[n]:[c](-[#16]-[#6]):[n]:[c]3-[c]4:[c]:[c]:[c](-[#9]):[c]:[c]4', 'N(C(=O)CCc1c(OC)cc(OC)cc1)c(ncc2)cc2c3nc(SC)[nH]c3c4ccc(F)cc4', '05.394', '5.394', '0', '0', 'TRUE', '-0.2701\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1242\r\n-0.2412\r\n-5.39e-002\r\n-1.7e-002\r\n-3.14e-002\r\n8.03e-002\r\n7.71e-002\r\n-1.2e-003\r\n-1.67e-002\r\n2.88e-002\r\n0.2173\r\n9.18e-002\r\n5.45e-002\r\n-0.2277\r\n-0.2351\r\n0.1447\r\n-4.9e-003\r\n-5.04e-002\r\n-5.04e-002\r\n-2.', '0', '5.464', 'C26H25FN4O3S', '0492.163', '-7.759', '0492.565', '5.44 7.35', '5', '2', '1', '14', '23', '4', '35', '38', '8', '12', '007', '02', '25', '0', '4', '009', '0114.43', '503.04', '', '', '', '', '', '', '', '', '', '', '', 'N(/C/3=N/C=C\\C(\\C/2=C(/C/1=C/C=C(F)\\C=C1)\\N\\C(SC)=N2)=C3)C(CC/C/4=C(OC)/C=C(OC)\\C=C4)=O', 'COc4ccc(CCC(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)c(OC)c4', '11b', 'Not Available', 'Protein kinase C', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(7, '7', 'Not Available', 'COc1ccc(NC(=O)Nc2cc(ccn2)c3nc(SC)[nH]c3c4ccc(F)cc4)c(OC)c1', '1-(2,4-dimethoxyphenyl)-3-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]urea', 'CYAAFQwA2ewQePAeCqByP9rY4sT3L$7$4OGk8HvgNipnKvwY0NV$YvkgDSxOxUHUj7kUg7U$5X9RoILvb9n0YwDueHpVhVxyaypCAb8ttxG3ZFhEwMa6WA8FfygASRp^C8gwf8NACKKEe8KiRqGJgIDvCThe3A1puu9L3kNa98kOhzjacoXDTUZL9DTP5M3rP7ksuTfH vvdnklZkd3D4UFl5cHvpvMybw50Rj8yOLg8b5ScRvH1vX93LIZcef^Omr1zA^PXaJKCkelJlEm158YKVskkiXf^3lYRej29nD$PM758vq^$5P3jvir35sLZ^k0j^YLmY4s46zv5qWPoMlFzcTmPmgyAWW0n9PlB4Sf2Iq7qe86Dd1qibKWyTKvvTJF26MIfu6ZexPjrR 6IVUlMU0YqnqPQE6VPXITA4Qy8RPcu^CPT16HpwqgIZPnzrDy55aeUrT3bOXG8cRXqDpkjXGdnbf6^$Vzh5buhwTwXxnKIqt', 'InChI=1S/C24H22FN5O3S/c1-32-17-8-9-18(19(13-17)33-2)27-23(31)28-20-12-15(10-11-26-20)22-21(29-24(30-22)34-3)14-4-6-16(25)7-5-14/h4-13H,1-3H3,(H,29,30)(H2,26,27,28,31)', 'AuxInfo=1/1/N:10,11,32,26,27,28,29,3,1,14,16,15,6,25,13,30,5,2,4,17,21,20,19,24,33,18,7,12,23,22,34,8,9,31/E:(4,5)(6,7)/rA:34CCCCCCNOOCCNCCCCCNCCCNNCCCCCCCSCFO/rB:s1;d-1;d-2;s3;s4d-5;s2;s5;s4;s8;s9;;; s13;d-13;d-14;s12s15;s16d+17;s7s12;s13;d+20;s20;s21;d-22s23;s21;s25;d+25;d-26;s27;s28d-29;s24;s31;s30;d19;/rC:10.5044,-4.5948,0;9.7899,-5.0073,0;10.5044,-3.7698,0;9.0754,-4.5948,0;9.7899,-3.3573,0;9.0 754,-3.7698,0;9.7899,-5.8324,0;9.7899,-2.5323,0;8.3609,-5.0073,0;10.5044,-2.1198,0;8.3609,-5.832', 'AGRBOUQOWBWRQI-UHFFFAOYSA-N', '1010:CEMU4A23EX58D58SZAU4RSTT77UNBC', '[c]1:[c]:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]1-[#7]-[#6](=[#8])-[#7]-[c](:[n]:[c]:[c]2):[c]:[c]2-[c]3:[n]:[c](-[#16]-[#6]):[n]:[c]3-[c]4:[c]:[c]:[c](-[#9]):[c]:[c]4', 'c1cc(OC)cc(OC)c1NC(=O)Nc(ncc2)cc2c3nc(SC)[nH]c3c4ccc(F)cc4', '04.811', '4.811', '0', '0', 'TRUE', '-3.54e-002\r\n6.46e-002\r\n-2.98e-002\r\n9.85e-002\r\n7.73e-002\r\n5.e-004\r\n-0.2665\r\n-0.3493\r\n-0.3473\r\n4.22e-002\r\n4.23e-002\r\n-0.2534\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1256\r\n-0.2412\r\n0.3078\r\n9.18e-002\r\n5.46e-002\r\n-0.2276\r\n-0.2351\r\n0.1448\r\n-4.9e-003\r\n-5.', '0', '4.927', 'C24H22FN5O3S', '0479.143', '-6.993', '0479.527', '3.45 5.44 8.09', '5', '3', '1', '13', '23', '4', '34', '37', '8', '12', '008', '03', '22', '0', '4', '007', '0126.46', '481.64', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(OC)=C\\C(OC)=C1\\NC(N/C/4=N/C=C\\C(\\C/3=C(/C/2=C/C=C(F)\\C=C2)\\N\\C(SC)=N3)=C4)=O', 'COc4ccc(NC(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)c(OC)c4', '12a', 'Not Available', 'protein kinase CK1 epsilon', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(8, '8', 'Not Available', 'COc1ccc(NC(=O)Nc2cc(ccn2)c3nc(SC)[nH]c3c4ccc(F)cc4)c(OC)c1', '1-(2,4-dimethoxyphenyl)-3-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]urea', 'CYAAFQwA2ewQePAeCqByP9rY4sT3L$7$4OGk8HvgNipnKvwY0NV$YvkgDSxOxUHUj7kUg7U$5X9RoILvb9n0YwDueHpVhVxyaypCAb8ttxG3ZFhEwMa6WA8FfygASRp^C8gwf8NACKKEe8KiRqGJgIDvCThe3A1puu9L3kNa98kOhzjacoXDTUZL9DTP5M3rP7ksuTfH vvdnklZkd3D4UFl5cHvpvMybw50Rj8yOLg8b5ScRvH1vX93LIZcef^Omr1zA^PXaJKCkelJlEm158YKVskkiXf^3lYRej29nD$PM758vq^$5P3jvir35sLZ^k0j^YLmY4s46zv5qWPoMlFzcTmPmgyAWW0n9PlB4Sf2Iq7qe86Dd1qibKWyTKvvTJF26MIfu6ZexPjrR 6IVUlMU0YqnqPQE6VPXITA4Qy8RPcu^CPT16HpwqgIZPnzrDy55aeUrT3bOXG8cRXqDpkjXGdnbf6^$Vzh5buhwTwXxnKIqt', 'InChI=1S/C24H22FN5O3S/c1-32-17-8-9-18(19(13-17)33-2)27-23(31)28-20-12-15(10-11-26-20)22-21(29-24(30-22)34-3)14-4-6-16(25)7-5-14/h4-13H,1-3H3,(H,29,30)(H2,26,27,28,31)', 'AuxInfo=1/1/N:10,11,32,26,27,28,29,3,1,14,16,15,6,25,13,30,5,2,4,17,21,20,19,24,33,18,7,12,23,22,34,8,9,31/E:(4,5)(6,7)/rA:34CCCCCCNOOCCNCCCCCNCCCNNCCCCCCCSCFO/rB:s1;d-1;d-2;s3;s4d-5;s2;s5;s4;s8;s9;;; s13;d-13;d-14;s12s15;s16d+17;s7s12;s13;d+20;s20;s21;d-22s23;s21;s25;d+25;d-26;s27;s28d-29;s24;s31;s30;d19;/rC:10.5044,-4.5948,0;9.7899,-5.0073,0;10.5044,-3.7698,0;9.0754,-4.5948,0;9.7899,-3.3573,0;9.0 754,-3.7698,0;9.7899,-5.8324,0;9.7899,-2.5323,0;8.3609,-5.0073,0;10.5044,-2.1198,0;8.3609,-5.832', 'AGRBOUQOWBWRQI-UHFFFAOYSA-N', '1010:CEMU4A23EX58D58SZAU4RSTT77UNBC', '[c]1:[c]:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]1-[#7]-[#6](=[#8])-[#7]-[c](:[n]:[c]:[c]2):[c]:[c]2-[c]3:[n]:[c](-[#16]-[#6]):[n]:[c]3-[c]4:[c]:[c]:[c](-[#9]):[c]:[c]4', 'c1cc(OC)cc(OC)c1NC(=O)Nc(ncc2)cc2c3nc(SC)[nH]c3c4ccc(F)cc4', '04.811', '4.811', '0', '0', 'TRUE', '-3.54e-002\r\n6.46e-002\r\n-2.98e-002\r\n9.85e-002\r\n7.73e-002\r\n5.e-004\r\n-0.2665\r\n-0.3493\r\n-0.3473\r\n4.22e-002\r\n4.23e-002\r\n-0.2534\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1256\r\n-0.2412\r\n0.3078\r\n9.18e-002\r\n5.46e-002\r\n-0.2276\r\n-0.2351\r\n0.1448\r\n-4.9e-003\r\n-5.', '0', '4.927', 'C24H22FN5O3S', '0479.143', '-6.993', '0479.527', '3.45 5.44 8.09', '5', '3', '1', '13', '23', '4', '34', '37', '8', '12', '008', '03', '22', '0', '4', '007', '0126.46', '481.64', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(OC)=C\\C(OC)=C1\\NC(N/C/4=N/C=C\\C(\\C/3=C(/C/2=C/C=C(F)\\C=C2)\\N\\C(SC)=N3)=C4)=O', 'COc4ccc(NC(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)c(OC)c4', '12a', 'Not Available', 'Protein kinase C', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(9, '9', 'Not Available', 'Cc1ccc(COc2cccc3OC=CC(=O)c23)cc1', '5-(p-tolylmethoxy)chromen-4-one', 'CYAAFQwA4ewQvwp$z5$7aOL2sLshvgvHpOUB68SnbLB$lrkvBuD6OzBm5ilEw7AslNUJZuPrpptgVMtt4FWLhRIuhaR9SOphW9VYLSHgYaHAsloBjhSRQt$7ihfVFKjIUokIxiXA01lDIYPXwr0shPvCoug64TbgkqNPTwudl7FjK$csXX535tNfLOiHRe^HvrC0yVg8 39$9K2n6HVnjJr4H$ycsjJEp9b$3IEGLz7Q029tOKWkn0fv6Nof0iVY$RevGmDz^u67Re3k7f4X6dn3mMv9dfd5ARXcLtR$uBc2WeuSqVXdwJ6rAVIUBXB$rL69WXJ5qNHYqFQX5$E2WKm7YVg0Crs5FyegY9lk1B8qmCT4CfIWDYrIkiQq6rHgd^IXdOKN3v^GAcO^B Hk^h8G$9qB', 'InChI=1S/C17H14O3/c1-12-5-7-13(8-6-12)11-20-16-4-2-3-15-17(16)14(18)9-10-19-15/h2-10H,11H2,1H3', 'AuxInfo=1/0/N:20,13,14,11,4,5,2,3,16,18,7,6,1,15,12,9,10,19,17,8/E:(5,6)(7,8)/rA:20CCCCCCCOCCCCCCCCOCOC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;s8;s9;d+9;d-10;s11;s12d-13;s10;s15;s12;d-16s17;d15;s6;/rC:7.3733,-1 4.4742,0;6.9609,-15.1891,0;6.9609,-13.7593,0;6.1359,-15.1891,0;6.1359,-13.7593,0;5.7235,-14.4742,0;8.1925,-14.4742,0;8.6049,-15.1891,0;9.4299,-15.1891,0;9.8423,-15.893,0;9.8423,-14.4742,0;10.6671,-15. 893,0;10.6671,-14.4742,0;11.0795,-15.1891,0;9.4299,-16.6078,0;9.8423,-17.3228,0;11.0795,-16.6078', 'VQXIWEVLWUDWKJ-UHFFFAOYSA-N', '1010:4B3NHNR2CH67BCA9SS5N332RX11GKV', '[c]1(-[#6]-[#8]-[c]2:[c]:[c]:[c]:[c](-[#8]-[#6]=[#6]-[#6]3=[#8]):[c]23):[c]:[c]:[c](-[#6]):[c]:[c]1', 'c1(COc2cccc(OC=CC3=O)c23)ccc(C)cc1', '03.441', '3.441', '0', '0', 'TRUE', '-2.19e-002\r\n-5.65e-002\r\n-5.65e-002\r\n-5.9e-002\r\n-5.9e-002\r\n-5.11e-002\r\n7.83e-002\r\n-0.3406\r\n8.92e-002\r\n8.29e-002\r\n-3.09e-002\r\n9.49e-002\r\n-5.7e-002\r\n-3.04e-002\r\n0.1926\r\n9.6e-003\r\n-0.3172\r\n4.97e-002\r\n-0.289\r\n-3.98e-002', '0', '3.441', 'C17H14O3', '0266.094', '-4.484', '0266.291', '', '3', '0', '2', '8', '12', '2', '20', '22', '3', '8', '003', '00', '14', '0', '3', '003', '0035.53', '265.79', '', '', '', '', '', '', '', '', '', '', '', 'C\\3(/CO/C1=C/C=C\\C2=C1\\C(=O)\\C=C/O2)=C\\C=C(C)/C=C3', 'Cc3ccc(COc1cccc2occc(=O)c12)cc3', '13-27692996', 'Not Available', 'Amine oxidase [flavin-containing] B', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '27692996', 'Parkinson Disease(PARK)', 'PARK'),
(10, '10', 'Not Available', 'Cc1ccc(COc2cccc3OC=CC(=O)c23)cc1', '5-(p-tolylmethoxy)chromen-4-one', 'CYAAFQwA4ewQvwp$z5$7aOL2sLshvgvHpOUB68SnbLB$lrkvBuD6OzBm5ilEw7AslNUJZuPrpptgVMtt4FWLhRIuhaR9SOphW9VYLSHgYaHAsloBjhSRQt$7ihfVFKjIUokIxiXA01lDIYPXwr0shPvCoug64TbgkqNPTwudl7FjK$csXX535tNfLOiHRe^HvrC0yVg8 39$9K2n6HVnjJr4H$ycsjJEp9b$3IEGLz7Q029tOKWkn0fv6Nof0iVY$RevGmDz^u67Re3k7f4X6dn3mMv9dfd5ARXcLtR$uBc2WeuSqVXdwJ6rAVIUBXB$rL69WXJ5qNHYqFQX5$E2WKm7YVg0Crs5FyegY9lk1B8qmCT4CfIWDYrIkiQq6rHgd^IXdOKN3v^GAcO^B Hk^h8G$9qB', 'InChI=1S/C17H14O3/c1-12-5-7-13(8-6-12)11-20-16-4-2-3-15-17(16)14(18)9-10-19-15/h2-10H,11H2,1H3', 'AuxInfo=1/0/N:20,13,14,11,4,5,2,3,16,18,7,6,1,15,12,9,10,19,17,8/E:(5,6)(7,8)/rA:20CCCCCCCOCCCCCCCCOCOC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;s8;s9;d+9;d-10;s11;s12d-13;s10;s15;s12;d-16s17;d15;s6;/rC:7.3733,-1 4.4742,0;6.9609,-15.1891,0;6.9609,-13.7593,0;6.1359,-15.1891,0;6.1359,-13.7593,0;5.7235,-14.4742,0;8.1925,-14.4742,0;8.6049,-15.1891,0;9.4299,-15.1891,0;9.8423,-15.893,0;9.8423,-14.4742,0;10.6671,-15. 893,0;10.6671,-14.4742,0;11.0795,-15.1891,0;9.4299,-16.6078,0;9.8423,-17.3228,0;11.0795,-16.6078', 'VQXIWEVLWUDWKJ-UHFFFAOYSA-N', '1010:4B3NHNR2CH67BCA9SS5N332RX11GKV', '[c]1(-[#6]-[#8]-[c]2:[c]:[c]:[c]:[c](-[#8]-[#6]=[#6]-[#6]3=[#8]):[c]23):[c]:[c]:[c](-[#6]):[c]:[c]1', 'c1(COc2cccc(OC=CC3=O)c23)ccc(C)cc1', '03.441', '3.441', '0', '0', 'TRUE', '-2.19e-002\r\n-5.65e-002\r\n-5.65e-002\r\n-5.9e-002\r\n-5.9e-002\r\n-5.11e-002\r\n7.83e-002\r\n-0.3406\r\n8.92e-002\r\n8.29e-002\r\n-3.09e-002\r\n9.49e-002\r\n-5.7e-002\r\n-3.04e-002\r\n0.1926\r\n9.6e-003\r\n-0.3172\r\n4.97e-002\r\n-0.289\r\n-3.98e-002', '0', '3.441', 'C17H14O3', '0266.094', '-4.484', '0266.291', '', '3', '0', '2', '8', '12', '2', '20', '22', '3', '8', '003', '00', '14', '0', '3', '003', '0035.53', '265.79', '', '', '', '', '', '', '', '', '', '', '', 'C\\3(/CO/C1=C/C=C\\C2=C1\\C(=O)\\C=C/O2)=C\\C=C(C)/C=C3', 'Cc3ccc(COc1cccc2occc(=O)c12)cc3', '13-27692996', 'Not Available', 'Amine oxidase [flavin-containing] A', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '27692996', 'Parkinson Disease(PARK)', 'PARK'),
(11, '11', 'Not Available', 'Cc1cc(C)cc(COC(=O)CCCC(=O)OCCC[N+](C)(C)O)c1', '3-[5-[(3,5-dimethylphenyl)methoxy]-5-oxo-pentanoyl]oxypropyl-hydroxy-dimethyl-ammonium', 'CYAAFQwAMcwQYYh09B2NeosuYyBOZNg0EYk7dWmXqP4osIGTdrg74afE8S2kn^MUOLM5MLMAOXs0JArBHYhYuhJPS$TLz$yLzM0mXy5$^5WUQr9DrMItsr17cWeeIOU4s8Cq2lGIM^AASROqoZU$7Qwp8^HGofyRq3GJ33JFjSfet6Kz$x4Exc$WtLPOuPLfA6reXaRM I6rV1XqPuwrvFmQd9bLJOamEj4q0c3xWyOm92Wo^JE3XfMId091WZ9W3XX3razxp67sfdmr4fl1z$1g0d0X5dofrb0pRkrIdOuYVsbKMwr$t6IEKwtoz3yr28kGzcs853$tN^HK1Hunm9brGikr5dvElz3RRT71$yPc2xtAsRK5AdGA$H6UihTYhaZCctYfZDNh1DJRq sJZuRozUTw1QpKGGrDIR4aYpIqmXFIRtEUpDArJ4EcNEvgjhSCNiw2Dzai8PUoMwtg0tUrqfUhs4Avg9plv7ZOG7f5iP7^gH', 'InChI=1S/C19H30NO5/c1-15-11-16(2)13-17(12-15)14-25-19(22)8-5-7-18(21)24-10-6-9-20(3,4)23/h11-13,23H,5-10,14H2,1-4H3/q+1', 'AuxInfo=1/0/N:22,23,20,21,11,16,12,10,17,15,6,3,2,7,5,4,1,13,9,18,25,24,19,14,8/E:(1,2)(3,4)(12,13)(15,16)/CRV:20+1/rA:25CCCCCCCOCCCCCOCCCN+OCCCCOO/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;s8;s9;s10;s11;s12;s13;s 14;s15;s16;s17;s18;s18;s18;s5;s4;d9;d13;/rC:6.0593,-11.5038,0;6.0593,-12.3288,0;5.3449,-11.0913,0;5.3449,-12.7413,0;4.6304,-11.5038,0;4.6304,-12.3288,0;6.7738,-11.0913,0;7.4883,-11.5038,0;8.2027,-11.0 913,0;8.9172,-11.5038,0;9.6317,-11.0913,0;10.3462,-11.5038,0;11.0607,-11.0913,0;11.7752,-11.5038', 'KOTKMCZFYCLUGT-UHFFFAOYSA-N', '1010:RJASXAQGYKXHNHPVND9CE2J49Q4PZX', '[c]1(-[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#6](=[#8])-[#8]-[#6]-[#6]-[#6]-[#7+](-[#6])(-[#6])-[#8]):[c]:[c](-[#6]):[c]:[c](-[#6]):[c]1', 'c1(COC(=O)CCCC(=O)OCCC[N+](C)(C)O)cc(C)cc(C)c1', '03.201', '1.59', '0', '1', 'TRUE', '-2.12e-002\r\n-5.38e-002\r\n-5.38e-002\r\n-5.05e-002\r\n-5.05e-002\r\n-5.64e-002\r\n8.14e-002\r\n-0.3112\r\n0.2611\r\n3.42e-002\r\n-3.46e-002\r\n3.42e-002\r\n0.2608\r\n-0.3159\r\n5.97e-002\r\n4.9e-003\r\n6.14e-002\r\n0.2513\r\n-0.2603\r\n4.82e-002\r\n4.82e-002\r\n-3.98e-002\r\n-3.98e-002\r\n-0.2666\r\n', '0', '3.201', 'C19H30NO5', '0352.212', '-5.152', '0352.445', '', '4', '0', '2', '17', '06', '1', '25', '25', '7', '5', '006', '01', '30', '0', '1', '012', '0072.83', '415.91', '', '', '', '', '', '', '', '', '', '', '', 'C\\1(/COC(CCCC(OCCC[N+](O)(C)C)=O)=O)=C\\C(C)=C/C(C)=C1', 'Cc1cc(C)cc(COC(=O)CCCC(=O)OCCC[N+](C)(C)O)c1', '14-25772747', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '25772747', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(12, '12', 'Not Available', 'COc1ccc(c(OC)c1)c2cc(C(=O)Nc3cc(ccn3)c4nc(SC)[nH]c4c5ccc(F)cc5)n(C)c2', '4-(2,4-dimethoxyphenyl)-<I>N</I>-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]-1-methyl-pyrrole-2-carboxamide', 'CYAAFQwAifwQ2Rjvz9Wklht5pUl4tKmo1czicgjFizahmTv9IIgDIw3UFPN9Lw6fhIIIVU7Lw30ITaVWnp63CCbAxES9^2p5Ushdic1oROUQHU72kkOqCfeKP6B8forqYJEGep0CzpaM8B4nlTEymB^Xz6eD3d4qELgHJOmy1cuMRi$fvoeZ0bteBH3Xj38Cu6vH$744 RToAIv83F85Y7f$Hfjj8OPK4$7x45MN2fTk7y$UHlVOaLpav37AZTQOvd6pVzBMk1n1f59eMPUG5RuPUxdKj49s553WOY$pZnbFYEUM7Y8nVi7cIZWtqX8MZ1N35FqE8T1n5SL5HO8TfaSvXxzj5uHOZ82R9NS^fUrd$erQsTvi6mzdKsMcWF0mrnztRaGXJ4dd9$0Op ZCBIIx28B$ndhqvrujbGVJ9rSC0PgiL18NPh^GXggD4Dx4so866UzDDxjE3Z7Rtq9a2I5cJ8vurYPoKex57yAvQre9Tabyzz', 'InChI=1S/C29H26FN5O3S/c1-35-16-19(22-10-9-21(37-2)15-24(22)38-3)13-23(35)28(36)32-25-14-18(11-12-31-25)27-26(33-29(34-27)39-4)17-5-7-20(30)8-6-17/h5-16H,1-4H3,(H,33,34)(H,31,32,36)', 'AuxInfo=1/1/N:39,9,10,37,31,32,33,34,3,1,20,22,12,21,6,13,30,19,11,35,5,2,14,4,23,26,25,16,29,38,24,18,28,27,15,17,7,8,36/E:(5,6)(7,8)/rA:39CCCCCCOOCCCCCCNCONCCCCCNCCNNCCCCCCCSCFC/rB:s1;d-1;d-2;s3;s4d -5;s5;s4;s7;s8;s2;s11;d+11;d-12;s13s14;s14;d16;s16;;s19;d-19;d-20;s18s21;s22d+23;s19;d+25;s25;s26;d-27s28;s26;s30;d+30;d-31;s32;s33d-34;s29;s36;s35;s15;/rC:6.9259,-13.0733,0;6.2115,-13.4858,0;6.9259,- 12.2483,0;5.4969,-13.0733,0;6.2115,-11.8358,0;5.4969,-12.2483,0;6.2115,-11.0108,0;4.7825,-13.485', 'HAUMSGYLMPGOAZ-UHFFFAOYSA-N', '1010:H9GN9V9TC3RJDXKYP2DWEBS8R5KGJY', '[c]1:[c]:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]1-[c]2:[c]:[n](-[#6]):[c](-[#6](-[#7]-[c](:[n]:[c]:[c]3):[c]:[c]3-[c]4:[n]:[c](-[#16]-[#6]):[n]:[c]4-[c]5:[c]:[c]:[c](-[#9]):[c]:[c]5)=[#8]):[c]2', 'c1cc(OC)cc(OC)c1c2cn(C)c(C(Nc(ncc3)cc3c4nc(SC)[nH]c4c5ccc(F)cc5)=O)c2', '06.012', '6.012', '0', '0', 'TRUE', '-4.92e-002\r\n1.31e-002\r\n-3.1e-002\r\n8.5e-002\r\n7.71e-002\r\n-8.e-004\r\n-0.3493\r\n-0.3486\r\n4.22e-002\r\n4.22e-002\r\n-2.9e-003\r\n-2.93e-002\r\n-7.5e-003\r\n8.53e-002\r\n-0.2496\r\n0.2596\r\n-0.2704\r\n-0.2651\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1245\r\n-0.2412\r\n9.18e-002', '0', '6.043', 'C29H26FN5O3S', '0543.174', '-8.888', '0543.612', '0.24 5.44 6.78', '5', '2', '1', '14', '28', '5', '39', '43', '10', '14', '008', '02', '26', '0', '5', '008', '0119.36', '553.69', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(OC)=C\\C(OC)=C1\\C/5=C\\N(C)\\C(C(=O)N/C/4=N/C=C\\C(\\C/3=C(/C/2=C/C=C(F)\\C=C2)\\N\\C(SC)=N3)=C4)=C5', 'COc5ccc(c4cc(C(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)n(C)c4)c(OC)c5', '16b', 'Not Available', 'protein kinase CK1 epsilon', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(13, '13', 'Not Available', 'COc1ccc(c(OC)c1)c2cc(C(=O)Nc3cc(ccn3)c4nc(SC)[nH]c4c5ccc(F)cc5)n(C)c2', '4-(2,4-dimethoxyphenyl)-<I>N</I>-[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1<I>H</I>-imidazol-4-yl]-2-pyridyl]-1-methyl-pyrrole-2-carboxamide', 'CYAAFQwAifwQ2Rjvz9Wklht5pUl4tKmo1czicgjFizahmTv9IIgDIw3UFPN9Lw6fhIIIVU7Lw30ITaVWnp63CCbAxES9^2p5Ushdic1oROUQHU72kkOqCfeKP6B8forqYJEGep0CzpaM8B4nlTEymB^Xz6eD3d4qELgHJOmy1cuMRi$fvoeZ0bteBH3Xj38Cu6vH$744 RToAIv83F85Y7f$Hfjj8OPK4$7x45MN2fTk7y$UHlVOaLpav37AZTQOvd6pVzBMk1n1f59eMPUG5RuPUxdKj49s553WOY$pZnbFYEUM7Y8nVi7cIZWtqX8MZ1N35FqE8T1n5SL5HO8TfaSvXxzj5uHOZ82R9NS^fUrd$erQsTvi6mzdKsMcWF0mrnztRaGXJ4dd9$0Op ZCBIIx28B$ndhqvrujbGVJ9rSC0PgiL18NPh^GXggD4Dx4so866UzDDxjE3Z7Rtq9a2I5cJ8vurYPoKex57yAvQre9Tabyzz', 'InChI=1S/C29H26FN5O3S/c1-35-16-19(22-10-9-21(37-2)15-24(22)38-3)13-23(35)28(36)32-25-14-18(11-12-31-25)27-26(33-29(34-27)39-4)17-5-7-20(30)8-6-17/h5-16H,1-4H3,(H,33,34)(H,31,32,36)', 'AuxInfo=1/1/N:39,9,10,37,31,32,33,34,3,1,20,22,12,21,6,13,30,19,11,35,5,2,14,4,23,26,25,16,29,38,24,18,28,27,15,17,7,8,36/E:(5,6)(7,8)/rA:39CCCCCCOOCCCCCCNCONCCCCCNCCNNCCCCCCCSCFC/rB:s1;d-1;d-2;s3;s4d -5;s5;s4;s7;s8;s2;s11;d+11;d-12;s13s14;s14;d16;s16;;s19;d-19;d-20;s18s21;s22d+23;s19;d+25;s25;s26;d-27s28;s26;s30;d+30;d-31;s32;s33d-34;s29;s36;s35;s15;/rC:6.9259,-13.0733,0;6.2115,-13.4858,0;6.9259,- 12.2483,0;5.4969,-13.0733,0;6.2115,-11.8358,0;5.4969,-12.2483,0;6.2115,-11.0108,0;4.7825,-13.485', 'HAUMSGYLMPGOAZ-UHFFFAOYSA-N', '1010:H9GN9V9TC3RJDXKYP2DWEBS8R5KGJY', '[c]1:[c]:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]1-[c]2:[c]:[n](-[#6]):[c](-[#6](-[#7]-[c](:[n]:[c]:[c]3):[c]:[c]3-[c]4:[n]:[c](-[#16]-[#6]):[n]:[c]4-[c]5:[c]:[c]:[c](-[#9]):[c]:[c]5)=[#8]):[c]2', 'c1cc(OC)cc(OC)c1c2cn(C)c(C(Nc(ncc3)cc3c4nc(SC)[nH]c4c5ccc(F)cc5)=O)c2', '06.012', '6.012', '0', '0', 'TRUE', '-4.92e-002\r\n1.31e-002\r\n-3.1e-002\r\n8.5e-002\r\n7.71e-002\r\n-8.e-004\r\n-0.3493\r\n-0.3486\r\n4.22e-002\r\n4.22e-002\r\n-2.9e-003\r\n-2.93e-002\r\n-7.5e-003\r\n8.53e-002\r\n-0.2496\r\n0.2596\r\n-0.2704\r\n-0.2651\r\n6.8e-003\r\n-3.42e-002\r\n-1.2e-002\r\n2.97e-002\r\n0.1245\r\n-0.2412\r\n9.18e-002', '0', '6.043', 'C29H26FN5O3S', '0543.174', '-8.888', '0543.612', '0.24 5.44 6.78', '5', '2', '1', '14', '28', '5', '39', '43', '10', '14', '008', '02', '26', '0', '5', '008', '0119.36', '553.69', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(OC)=C\\C(OC)=C1\\C/5=C\\N(C)\\C(C(=O)N/C/4=N/C=C\\C(\\C/3=C(/C/2=C/C=C(F)\\C=C2)\\N\\C(SC)=N3)=C4)=C5', 'COc5ccc(c4cc(C(=O)Nc3cc(c1nc(SC)[nH]c1c2ccc(F)cc2)ccn3)n(C)c4)c(OC)c5', '16b', 'Not Available', 'Protein kinase C', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28338621', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(14, '14', 'Not Available', 'CC12CCC(O)CC1CCC3C2CCC4(C)C3CC=C4c5ccccc5', '10,13-dimethyl-17-phenyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1<I>H</I>-cyclopenta[a]phenanthren-3-ol', 'CYAAFQwA6cwQ7QfjoK4OxV3wXCJ3HiQnm8XX53AcoXcMON9M3uMcsA5V9VgCzuUi5AcNoOEsZBenIyxL2NLDSsIDmYFwaG2Mx6xSziyrj7yryAxc5yAulcrDTauIfDCAWh0N$0HClJYXdEk9KMLYUns5HX8yzQkFaVSzHROdILrPeoWQmjBJRVXkFYOpfMUcc8kWg51a FEv2zzV8OtMHRDe3Z9Sq8hzDHs1BvsqHxRccUioHIGLPz7oLqOFGjDuve8nTvoaUrzQkoXqoFQtTZK8mOaPvh77S89eH3r15efNybEdco2pPib1ia7Key74OO6vtMDq8eGU6L$Xy1WuzEKv^HjQp9dfdmMBaHPvr5tDL43pz709b^LLdb3fzcOq5CYLWVNxl0WOci$Gg ijiQ16nBPGX5Bi0KoMkaYJg46cNGK34mWXdtxdRAEfVAKybBKKYDBJbnBFLVBGrUAgLqdqYghKgsI1gisaQxrdgY^l7oR1lc', 'InChI=1S/C25H34O/c1-24-14-12-19(26)16-18(24)8-9-20-22-11-10-21(17-6-4-3-5-7-17)25(22,2)15-13-23(20)24/h3-7,10,18-20,22-23,26H,8-9,11-16H2,1-2H3', 'AuxInfo=1/0/N:25,24,3,1,5,2,6,17,16,8,10,21,13,20,12,22,4,19,23,14,7,11,15,18,9,26/E:(4,5)(6,7)/rA:26CCCCCCCCCCCCCCCCCCCCCCCCCO/rB:s1;d-1;d-2;s3;s4d-5;s4;d+7;s7;s8;s9s10;s9;s12;s11;s13s14;s14;s16;s15; s17s18;s18;s20;s19;s21s22;s9;s18;s23;/rC:12.9215,-6.3356,0;13.093,-7.1425,0;12.1369,-6.0806,0;12.4799,-7.6946,0;11.5237,-6.6326,0;11.6953,-7.4396,0;12.6514,-8.5015,0;13.4051,-8.8371,0;12.0994,-9.1147, 0;13.3188,-9.6576,0;12.5119,-9.8291,0;11.2744,-9.1147,0;10.8619,-9.8291,0;12.0994,-10.5436,0;11.', 'SINAMTXBCYKFDL-UHFFFAOYSA-N', '1010:4DFHYNJGMGD3KDZFKZYYJ5UKTFTFKY', '[c]1:[c]:[c]:[c]:[c](-[#6]2=[#6]-[#6]-[#6](-[#6]3-[#6](-[#6]4(-[#6])-[#6](-[#6]-[#6](-[#8])-[#6]-[#6]4)-[#6]-[#6]3)-[#6]-[#6]5)-[#6]25-[#6]):[c]1', 'c1cccc(C2=CCC(C3C(C4(C)C(CC(O)CC4)CC3)CC5)C25C)c1', '05.623', '5.623', '0', '0', 'TRUE', '-6.17e-002\r\n-5.47e-002\r\n-6.22e-002\r\n-2.22e-002\r\n-6.17e-002\r\n-5.47e-002\r\n-3.85e-002\r\n-7.98e-002\r\n-3.8e-003\r\n-3.05e-002\r\n-2.54e-002\r\n-4.32e-002\r\n-4.88e-002\r\n-3.41e-002\r\n-3.26e-002\r\n-4.96e-002\r\n-4.96e-002\r\n-2.65e-002\r\n-3.33e-002\r\n-4.49e-002\r\n-2.65e-002\r\n-2.3', '0', '5.623', 'C25H34O', '0350.261', '-7.583', '0350.537', '', '0', '1', '1', '23', '06', '1', '26', '30', '4', '4', '001', '01', '34', '0', '5', '001', '0020.23', '364.8', '', '', '', '', '', '', '', '', '', '', '', 'C/5=C/C=C\\C(\\C1=C\\CC2C1(C)CCC3C2CCC4C3(C)CCC(O)C4)=C5', 'CC34CCC2C(CCC1CC(O)CCC12C)C3C/C=C4/c5ccccc5', '17PA', 'Not Available', 'Gamma-aminobutyric acid receptor subunit alpha-1', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '26523675', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(15, '15', 'Not Available', 'Cc1c2cc[n+](C)cc2c(C)c3c4cc(O)ccc4[nH]c13', '2,5,11-trimethyl-6<I>H</I>-pyrido[4,3-b]carbazol-2-ium-9-ol', 'CYAAFQwARdwQpjk1jEO2hVJAsGRkQqMOoqu2kw39uGWgra6fyfudSvRqaCe1Sq8M5fXSeSIZR^2L^JuHUqB4R^Ajm3ak9PlpG8Y1x6BcdsbQMzBMwP0Lepbpgc5A6LMEm1VuR4nFPwFAlEDBy^PEAHFgNEv0DBhIO7B$$8BFU5L25koFSE86mLDKBiJ3LLMFaZRfayCW apGUqoJmMH8Z^X4gLI8wcq4SAelSZhtI8ADwict3iZ5J^yl^reB3J6oWOmMMs0SJNZWJE7YfJ$YKLZlyAFrPalWEHCEV3x5uhVGLqiQ0t4O0ZhtQdQKos4yinUDHScvaq7rVdYqbs0yixKROVvXtp6Rjwi9M0yJIlpEJBHJrePCXZzasAgV1uUKsHCQeN1tFsfOhuasJ YXRx7KG0aCOvFJR3ZTLtPbIGXCGkzy1FZF1SUurhA5gx0062FltLywGiyYgszzOtkmvg1XaBjaUAkYUuiz$uf1lmlSUmOEez', 'InChI=1S/C18H16N2O/c1-10-15-9-20(3)7-6-13(15)11(2)18-17(10)14-8-12(21)4-5-16(14)19-18/h4-9,21H,1-3H3/p+1', 'AuxInfo=1/5/N:21,14,20,19,17,13,16,15,12,10,7,18,8,9,6,11,4,5,2,3,1/rA:37ONN+CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;s2s4;;d+5;d-6s7;s4;d-4s6;s2d-9;d-3s6;s8;s7;s9;s3d-13;s11;s1d+15;d-17s18;s3;s10;s2; s13;s14;s14;s14;s15;s16;s17;s19;s20;s20;s20;s1;s21;s21;s21;/rC:.5504,-1.4095,-.023;4.6684,2.3166,.028;9.9425,-1.3204,-.0163;5.3576,.1441,-.0091;5.7963,1.4904,.0154;7.6854,-.5356,-.0171;7.0744,1.8408,. 0236;8.088,.7421,.0075;3.8652,.218,-.0062;6.2239,-.8796,-.029;3.5257,1.499,.0153;8.7001,-1.5942,', 'YZQRAQOSAPWELU-UHFFFAOYSA-O', '1010:QCG9ZT7S8PA1X1PRGJB16VA9G9HA9X', '[#8](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]1:[c]2:[c]3:[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n+]4-[#6](-[#1])(-[#1])-[#1]):[c](:[c]4):[c]2-[#6](-[#1])(-[#1])-[#1]):[n]3-[#1]):[ c]1-[#1]', 'O([H])c(c([H])c([H])c(c1c2c3c(C([H])([H])[H])c(c([H])c([H])[n+]4C([H])([H])[H])c(c4)c2C([H])([H])[H])n3[H])c1[H]', '04.566', '3.913', '0', '1', 'TRUE', '-0.3609\r\n-0.2577\r\n0.2907\r\n5.5e-003\r\n3.07e-002\r\n2.17e-002\r\n-2.41e-002\r\n-7.e-003\r\n4.4e-003\r\n-3.04e-002\r\n2.71e-002\r\n8.04e-002\r\n-1.77e-002\r\n-3.76e-002\r\n-2.26e-002\r\n7.27e-002\r\n-4.07e-002\r\n7.2e-002\r\n-3.05e-002\r\n6.22e-002\r\n-3.84e-002\r\n0.1342\r\n6.64e-002\r\n2.8e-002', '0', '3.692', 'C18H17N2O', '0277.134', '-6.093', '0277.34', '9.31 10.46', '0', '2', '0', '4', '20', '4', '21', '24', '20', '8', '003', '02', '17', '0', '4', '000', '0039.9', '287.96', 'Molecule has implicit hydrogens, 3D Descriptor calculation may not give useful results', '20.3719', '1.2763', '75.7', '23.47', '4.10117', '52.23', '763.474', '77.689', '226.37', '', 'O(/C4=C(H)/C2=C(N(H)/C/1=C(C(H)(H)H)/C3=C(\\C(C(H)(H)H)=C12)/C=[N+:3](C(H)(H)H)\\C(H)=C3\\H)\\C(H)=C4\\H)H', 'Cc3c1cc[n+](C)cc1c(C)c4c2cc(O)ccc2[nH]c34', '1d', '1d', 'd(CGG)n FMR1 (fragile X mental retardation 1)', 'Not Available', 'Under Investigation', 'Fragile X syndrome', '22948243', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(16, '16', 'Not Available', 'Cc1c2ccncc2c(C)c3c4ccccc4[nH]c13', '5,11-dimethyl-6<I>H</I>-pyrido[4,3-b]carbazole', 'CYAAFQwAmdwQtMcWTna7zjEHqKUu$CQI$LIIWNqME$rkYf0X756GrfjXKzWQ45IIkFl8M5emQubw22z1Aos$EdfcADaECBfwP2yfmH^49zJft9KfEWbTR0D5UKZJ3luy12KXLtB9NcfKpaScB1Nst1qVZvyu9GzTyFPpsU75vVtinxpneGPvu$qOLqJvT5YIIGsQLn$x rOmyb4EPPQgml7hVGBo24xGPVON6wm7JHDt0oIPzTR2rvMMLwLcF8edQrbLiIa$UPtyJo6XvA$yIVCu1t$0KEgSzvLCV6$RR^E131c11cBAfrd16wEV7Rl8m5t1Fp1Iksep9eOS6KRoZaH4QT1jNOX63tPSLcquPF^PiC$$MHAN6HoIdU13Vc^jeNmybl$uwF69H6OrY 9TBT4xFAUIDUNGJ4RmfG79pP9rTlXHpytZ^$peY79t9vcKDk80C9gnT8yOo7xzBgxXObHMk5MDxr6jpugznpejQNqdGjMLPs', 'InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3', 'AuxInfo=1/0/N:12,14,17,18,11,13,15,19,16,6,7,10,5,9,8,3,4,2,1/rA:33NNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH/rB:;;s1d-3;s3;s3;s4;s1d-5;d-6;d-7s9;s5;s6;s8;s7;s10;d-2s9;d-11;d-13s17;s2d-15;s1;s11;s12;s12;s12;s1 4;s14;s14;s15;s16;s17;s18;s19;s13;/rC:4.3651,1.7759,.0002;9.6725,-1.7849,-.0005;5.0822,-.3262,.0004;5.4854,.9286,.0001;3.5913,-.2929,.0007;6.0473,-1.4446,.0004;6.872,1.3032,-.0003;3.2284,.9744,.0006;7 .3627,-1.1175,0;7.7894,.313,-.0004;2.5922,-1.3576,.0011;5.555,-2.8869,.0008;1.8431,1.3897,.0008;', 'CTSPAMFJBXKSOY-UHFFFAOYSA-N', '1010:46KRRJ2Y21N4CPW8VSVVVPTD467D8A', '[n]1(-[#1]):[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c]2:[c]3:[c]1:[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n]4):[c](:[c]4-[#1]):[c]3-[#6](-[#1])(-[#1])-[#1]', 'n1([H])c(c([H])c([H])c([H])c2[H])c2c3c1c(C([H])([H])[H])c(c([H])c([H])n4)c(c4[H])c3C([H])([H])[H]', '04.053', '4.053', '0', '0', 'TRUE', '-0.2577\r\n-0.264\r\n5.4e-003\r\n3.07e-002\r\n1.8e-003\r\n-3.22e-002\r\n-2.42e-002\r\n2.69e-002\r\n3.9e-003\r\n-1.05e-002\r\n-5.27e-002\r\n-3.85e-002\r\n-4.33e-002\r\n-3.76e-002\r\n-3.57e-002\r\n3.49e-002\r\n-6.16e-002\r\n-6.07e-002\r\n2.74e-002\r\n0.1342\r\n6.29e-002\r\n2.8e-002\r\n2.8e-002\r\n2.8e-', '0', '3.265', 'C17H14N2', '0246.116', '-6.257', '0246.306', '6.35 10.46', '1', '1', '0', '2', '20', '4', '19', '22', '16', '8', '002', '01', '14', '0', '4', '000', '0028.68', '250.6', '', '1.12431', '1.2814', '75.36', '24.04', '3.62491', '51.32', '537.588', '44.207', '194.48', '', 'N1([H])/C3=C(\\C2=C1\\C([H])=C([H])/C([H])=C2/[H])/C(C([H])([H])[H])=C/4\\C(=C3\\C([H])([H])[H])\\C([H])=C([H])/N=C4/[H]', 'Cc3c1ccncc1c(C)c4c2ccccc2[nH]c34', '1f', '1f', 'd(CGG)n FMR1 (fragile X mental retardation 1)', 'Not Available', 'Under Investigation', 'Fragile X syndrome', '22948243', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(17, '17', 'Not Available', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '1OP-2198', 'Not Available', 'Potassium voltage-gated channel subfamily KQT member 1', 'Not Available', 'Under Investigation', 'Epilepsy', '28111749', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(18, '18', 'Not Available', 'CCCN(CC(=O)N(CCC)CC(=O)N(CC(=O)N)Cc1cn(CCCNC(=N)c2ccc(cc2)c3oc(cc3)c4ccc(cc4)C(=N)N)nn1)C(=O)CNCc5cn(CCCNC(=N)c6ccc(cc6)c7oc(cc7)c8ccc(cc8)C(=N)N)nn5', '<I>N</I>-[2-[[2-[(2-amino-2-oxo-ethyl)-[[1-[3-[[4-[5-(4-carbamimidoylphenyl)-2-furyl]benzenecarboximidoyl]amino]propyl]triazol-4-yl]methyl]amino]-2-oxo-ethyl]-propyl-amino]-2-oxo-ethyl]-2-[[1-[3-[[4-[ 5-(4-carbamimidoylphenyl)-2-furyl]benzenecarboximidoyl]amino]propyl]triazol-4-yl]methylamino]-<I>N</I>-propyl-acetamide', 'CYAAFQwA0cwQuW$WKKy^I9$AZ7elbPiE0R68kZfId6Ub^xQJW011VGf0VEhUmDKElf4OVHXD43LwLWqYF5xDl91rhVcyPwNWS9h^YXUEDhLizF8xImmd61XGM1bfX^$L^^WV39zzm6^vrvuWxqGtLSgNc71tP7epvuFs$f9z1Ks863k0q2ox7b44jaY7YxcUctWAnABf K1EfTISHVp019v^u1fsct0rIcqlvcPB2JVUJ4OOfxZWiqEPUgNutJWTaiI$4860wDti4RR8PP4VoFX^npBPn3sw7jimyMx35nshSflqIbllnkhMfD3SbdLd9N$5DOljrmrOt3F6ky^ef1qAPgrQdS1561g9vH2854NNysrYozPH65B^nqPbb0Tr3x7bssy9QHU$AzPtT mqPWrcztJ^VDQoFcucgrtu^qOfzT4NNT$05VfnScivr81IC8WM7zeE9lPaHud319VF2WRufjCVv$wVSl49VqnL0aNLn^Weg8', 'InChI=1S/C62H73N19O6/c1-3-29-77(56(83)34-70-33-49-36-80(75-73-49)31-5-27-71-61(68)47-19-11-43(12-20-47)53-25-23-51(86-53)41-7-15-45(16-8-41)59(64)65)39-57(84)78(30-4-2)40-58(85)79(38-55(63)82)35-50-37 -81(76-74-50)32-6-28-72-62(69)48-21-13-44(14-22-48)54-26-24-52(87-54)42-9-17-46(18-10-42)60(66)67/h7-26,36-37,70H,3-6,27-35,38-40H2,1-2H3,(H2,63,82)(H3,64,65)(H3,66,67)(H2,68,71)(H2,69,72)', 'AuxInfo=1/1/N:54,47,53,46,63,27,79,80,8,12,70,71,19,20,81,82,7,11,68,69,21,22,77,15,75,17,64,26,52,45,62,28,56,51,34,59,30,36,44,40,78,10,72,18,83,9,67,23,57,32,76,13,73,16,37,50,43,39,85,2,66,24,38,8 6,87,1,84,3,6,55,65,25,58,33,60,31,49,42,35,61,29,5,48,4,41,74,14/E:(7,8)(9,10)(11,12)(13,14)(15,16)(17,18)(19,20)(21,22)(64,65)(66,67)/rA:87NCNOONCCCCCCCOCCCCCCCCCCNCCCNCNCNCNCCNCCONCCCCCONCCCCCNCCNC NNCCCNCCCCCCCCOCCCCCCCCCNCNN/rB:s1;;;;;;s7;s2d+7;d-8;s9;s10d-11;s10;s13;d+13;s14;s15d-16;s16;s18', 'RDSJKXGFAMVXAU-UHFFFAOYSA-N', '1010:6A32PXMWTNGNX1ZJFC8SYMZ8EQDB1G', '[#7]-[#6](=[#7])-[c](:[c]:[c]:[c](-[c]1:[c]:[c]:[c](-[c]2:[c]:[c]:[c](-[#6](-[#7]-[#6]-[#6]-[#6]-[n]3:[n]:[n]:[c](-[#6]-[#7](-[#6](=[#8])-[#6]-[#7](-[#6]-[#6]-[#6])-[#6](=[#8])-[#6]-[#7](-[#6]-[#6]-[# 6])-[#6](=[#8])-[#6]-[#7]-[#6]-[c]4:[c]:[n](-[#6]-[#6]-[#6]-[#7]-[#6](-[c]5:[c]:[c]:[c](-[c]6:[c]:[c]:[c](-[c]7:[c]:[c]:[c](-[#6](=[#7])-[#7]):[c]:[c]7):[o]6):[c]:[c]5)=[#7]):[n]:[n]4)-[#6]-[#6](=[#8] )-[#7]):[c]3)=[#7]):[c]:[c]2):[o]1):[c]8):[c]8', 'NC(=N)c(ccc(c1ccc(c2ccc(C(NCCCn3nnc(CN(C(=O)CN(CCC)C(=O)CN(CCC)C(=O)CNCc4cn(CCCNC(c5ccc(c6ccc(c7ccc(C(=N)N)cc7)o6)cc5)=N)nn4)CC(=O)N)c3)=N)cc2)o1)c8)c8', '03.65', '3.65', '0', '0', 'TRUE', '-0.287\r\n0.1013\r\n-0.2891\r\n-0.2757\r\n-0.2761\r\n-0.2891\r\n-5.12e-002\r\n-5.17e-002\r\n1.04e-002\r\n5.3e-003\r\n-5.12e-002\r\n-5.17e-002\r\n8.93e-002\r\n-0.3092\r\n-2.8e-002\r\n8.93e-002\r\n-2.8e-002\r\n5.3e-003\r\n-5.17e-002\r\n-5.17e-002\r\n-5.12e-002\r\n-5.12e-002\r\n1.07e-002\r\n0.1041\r\n-0.2', '0', '2.937', 'C62H73N19O6', '1179.6', '-12.274', '1180.37', '0.66 4.07 7.44 11.13 11.13 11.49 11.49', '10', '6', '8', '42', '44', '8', '87', '94', '20', '28', '025', '13', '73', '0', '8', '034', '0375.24', '1,255.45', '', '', '', '', '', '', '', '', '', '', '', 'NC(/C/8=C/C=C(/C7=C/C=C(/C/6=C/C=C(C(=N)NCCCN/5/C=C(CN(CC(N)=O)C(CN(C(CN(C(CNC/C\\4=C/N(CCCNC(=N)/C/3=C/C=C(/C2=C/C=C(/C/1=C/C=C(C(N)=N)\\C=C1)\\O2)\\C=C3)/N=N4)=O)CCC)=O)CCC)=O)\\N=N5)\\C=C6)\\O7)\\C=C8)=N', 'CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)Cc4cn(CCCNC(=N)c3ccc(c2ccc(c1ccc(C(=N)N)cc1)o2)cc3)nn4)C(=O)CNCc8cn(CCCNC(=N)c7ccc(c6ccc(c5ccc(C(=N)N)cc5)o6)cc7)nn8', '2AU-2', 'Not Available', 'r(AUUCU)exp in ATXN10 gene', 'Not Available', 'Under Investigation', 'Spinocerebellar Ataxia 10', '27248057', 'Spinocerebellar Ataxia 10', 'SCA10');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(19, '19', 'Not Available', 'CC1c2cc[n+](CC3=CN(CCCN(CC(=O)N)C(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNCCCN4NNC(=C4)C[n+]5ccc6c(C)c7c8ccccc8[nH]c7c(C)c6c5)NN3)cc2C(C)c9c1[nH]c%10cc(O)ccc9%10', '<I>N</I>-[2-[[2-[[2-[[2-[[2-[(2-amino-2-oxo-ethyl)-[3-[5-[(8-hydroxy-5,11-dimethyl-6,11-dihydro-5<I>H</I>-pyrido[4,3-b]carbazol-2-ium-2-yl)methyl]-1,2-dihydrotriazol-3-yl]propyl]amino]-2-oxo-ethyl]ami no]-2-oxo-ethyl]amino]-2-oxo-ethyl]amino]-2-oxo-ethyl]amino]-2-oxo-ethyl]-2-[3-[5-[(5,11-dimethyl-10<I>H</I>-pyrido[3,4-b]carbazol-2-ium-2-yl)methyl]-1,2-dihydrotriazol-3-yl]propylamino]acetamide', 'CYAAFQwAQfwQ4r$hKCcao8AEUlpOJrFhaAR8ZT2SbpY7PMd3jL6oafmzFFB0txGT7s$8jlHnSiU9U0aSyuWqyG7NQwKKYZvEJ9r30kgxxKIhZB5GhH3q^glM5KH$HKMHkHn01^d7Hr6pzB5XcgjvqMpUcF^xhLgScio6PqJz^N6l^mDflnrSWir4uNBI78KuqYirT6Io zrB1dvnhwiZcHks8EKTqVkifxxtyEFaraoJuxYPlnps7Krakqzz$357G7fJuKDWej7cJSdly$iTgJ91KDsNVbwpvujA^t0Zcnr$StM1m4UUro4yqUzxduGjQ$4gKoKYFqx6X^wblxUznjzYZ3W1YSskPrmevd63uLs1DJxw6Bbum^K2VrjAkJuJ88q79AJu36fY4fE37 mKBUVT^THMpjWDcfOCUJBQ1owOvwxTL$bwdXdgmPkl6xPOnvS8hJHKAf1mbS6Prj3icP9pg50EhDR$ej9lKFlWhD9zH88rPP', 'InChI=1S/C60H72N18O8/c1-35-42-13-19-75(33-47(42)38(4)60-57(35)44-9-5-6-10-48(44)68-60)29-39-30-77(72-70-39)17-7-15-62-22-51(81)63-23-52(82)64-24-53(83)65-25-54(84)66-26-55(85)67-27-56(86)76(34-50(61)8 0)16-8-18-78-31-40(71-73-78)28-74-20-14-43-37(3)59-58(36(2)46(43)32-74)45-12-11-41(79)21-49(45)69-59/h5-6,9-14,19-21,30-33,36-37,62,69-73H,7-8,15-18,22-29,34H2,1-4H3,(H7-,61,63,64,65,66,67,79,80,81,82 ,83,84,85)/p+2', 'AuxInfo=1/6/N:79,23,22,1,86,84,61,31,85,83,18,17,73,8,60,32,62,30,71,9,19,54,51,48,45,43,38,24,68,64,27,5,70,34,77,11,13,75,66,25,20,74,6,82,14,4,72,81,15,35,53,50,47,44,41,37,78,10,12,76,36,55,52,49, 46,2,40,80,16,67,26,65,28,7,69,33,63,29,21,3,59,58,57,56,42,39/CRV:74+1,79-1/rA:86CNOCCCN+CCCCCCCCNCCCCOCCCCNCNNCCCNCCNCCONCOCCCNCCNCCNCCNOOOOCCCNCNCNCN+CCCCCCCCCCNCCCCCC/rB:;;;s4;d-4;d-5;s6;s7d-8;;s4 s10;d-10;s6s12;s10;d-14;s12s15;s14;d-17;s15;s18d-19;s20;s13;s11;s7;s24;s25;d+25;s26;s27s28;s29;s', 'RBDSYMJGWHMURA-UHFFFAOYSA-P', '1010:X36WRVWC39CPXMY8MADYDTVKJ5BPS8', '[#6]-[c]1:[c]2:[c](:[c](:[c]:[c]:[c]:[c]3):[c]3:[n]2):[c](-[#6]):[c](:[c]1:[c]4):[c]:[c]:[n+]4-[#6]-[#6](-[#7]-[#7]-[#7]5-[#6]-[#6]-[#6]-[#7]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](=[#8 ])-[#7]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#7](-[#6]-[#6](-[#7])=[#8])-[#6]-[#6]-[#6]-[#7](-[#7]-[#7]6)-[#6]=[#6]6-[#6]-[n+](:[c]:[c]:[c](-[#6](-[#6])-[c](:[n]:[c](:[c]:[c]( -[#8]):[c]:[c]7):[c]78):[c]89):[c]%10-[#6]9-[#6]):[c]%10)=[#6]5', 'Cc1c2c(c(cccc3)c3[nH]2)c(C)c(c1c4)cc[n+]4CC(NNN5CCCNCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N(CC(N)=O)CCCN(NN6)C=C6C[n+](ccc(C(C)c([nH]c(cc(O)cc7)c78)c89)c%10C9C)c%10)=C5', '-01.758', '-0.734', '6', '2', 'TRUE', '-3.75e-002\r\n-0.3052\r\n-0.2761\r\n-7.e-004\r\n7.67e-002\r\n-2.94e-002\r\n0.298\r\n-2.18e-002\r\n7.29e-002\r\n-1.71e-002\r\n1.16e-002\r\n7.6e-003\r\n1.72e-002\r\n-2.1e-003\r\n2.89e-002\r\n-0.2611\r\n-5.05e-002\r\n-3.14e-002\r\n-1.32e-002\r\n7.28e-002\r\n-0.3609\r\n-5.33e-002\r\n-5.41e-002\r\n0.1108\r', '0', '-2.868', 'C60H74N18O8', '1174.59', '-12.903', '1175.35', '-1.56 4.71 5.25 7.1 8.61 11.3', '7', '14', '9', '50', '36', '7', '86', '95', '16', '24', '026', '15', '74', '0', '10', '026', '0335.1', '1,180.58', '', '', '', '', '', '', '', '', '', '', '', 'C/C8=C/1N/C/%10=C(C1=C(C)\\C\\9=C\\C=[N+](C/C7=C/N(CCCNCC(NCC(NCC(NCC(NCC(NCC(N(CCCN6/C=C(C/[N+]/2=C/C3=C(\\C=C2)/C(C)/C4=C(C3C)/C/5=C(N4)/C=C(O)\\C=C5)\\NN6)CC(=O)N)=O)=O)=O)=O)=O)=O)NN7)/C=C89)/C=C\\C=C%10', 'Cc9c7c[n+](Cc6cn(CCCNCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N(CCCn5cc(C[n+]1ccc4c(c1)C(C)c2c([nH]c3cc(O)ccc23)C4C)[nH][nH]5)CC(N)=O)[nH][nH]6)ccc7c(C)c%10c8ccccc8[nH]c9%10', '2HE-5NMe', 'Not Available', 'd(CGG)n FMR1 (fragile X mental retardation 1)', 'Not Available', 'Under Investigation', 'Fragile X-Associated Tremor Ataxia Syndrome', '27276216', 'Fragile X-Associated Tremor Ataxia Syndrome', 'FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS'),
(20, '10017108', '10017108', 'O=C1NC(=S)CC[C@H]1N2C(=O)c3ccccc3C2=S', '2-[(3<I>R</I>)-2-oxo-6-thioxo-3-piperidyl]-3-thioxo-isoindolin-1-one', 'CYAAFQwA$ewQHjLmBtvDe0xGMKA8uU3eOdWZx79hZDoHDQ2yeJfeQeHyDG3zQGhirQaTTtaB36wtkIWKMDzbelGN4CUGxkSFesvdAIZd$HReE5tbSUefEkvtCAhd30PwjfuFdCv7OHTEutww6nVzu^mPh^VbOwihIF2XU6Bd5zbzcHGOIxKdeYFVCLSbFp4ImC1yfxgw ewrL9RUb3sZRWV2SX^5$r69CKPnECwOv8e9bbGns1FX9cfiHvRhYIq^taho26JZofggRM6IYeK25zJa85EiMWZlqk5sOlqaDt1qZ4hCzl3Gau7Zhetbm2LTK6WNs67F8setHNXqWvKSqEhOvs6ldnWCHqVDQcgnXsT$ETi5w531h8uoxVJKOGPPN6bN2XNIQtPKLxuGy kRvWls2MGx6uYP20syj7w4pk9gzrlXmJxQUaRhYVk$yUxzz7POkgnR6iovbsK5j9sGHmsvtKCjKinW5pvJj32Ge0xmCmtmX3', 'InChI=1S/C13H10N2O2S2/c16-11-9(5-6-10(18)14-11)15-12(17)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,18)/t9-/m1/s1', 'AuxInfo=1/1/N:19,18,17,16,8,9,14,13,7,15,10,12,11,6,5,3,4,2,1/it:im/rA:29SSOONNC.oCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s5;s7;s8;d3s6s7;d1s5;d4s5;s11;s12s13;d2s6s9;d+13;d+14;s16;s17d-18;s7;s8;s8;s9;s9;s6;s16 ;s17;s18;s19;/rC:-.8923,2.9983,.0239;5.6989,-.6284,-.1343;1.3332,-.0545,2.1522;-.0811,-1.9869,-.2462;-.0999,.3691,-.1293;3.2889,-.2792,.9629;1.3118,.6515,-.161;1.9543,.0962,-1.4241;3.4457,.3884,-1.406 8;1.9415,.0553,1.0877;-1.0827,1.3438,-.0502;-.6327,-.9039,-.1743;-2.3623,.6229,-.0438;-2.082,-.7', 'ZNXFEZJRALUZGZ-SECBINFHSA-N', '1010:MK5J3SQ1XV1WN4ZWTMEGU3F9Y1EN64', '[#16]=[#6]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#7]1-[#6@@](-[#1])(-[#6]3=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#16])=[#8]', 'S=C1c2c(c([H])c([H])c([H])c2[H])C(N1[C@@]([H])(C3=O)C([H])([H])C([H])([H])C(N3[H])=S)=O', '01.895', '1.895', '0', '0', 'TRUE', '-6.19e-002\r\n-6.79e-002\r\n-0.2752\r\n-0.2713\r\n-0.2453\r\n-0.2782\r\n0.1088\r\n-1.91e-002\r\n-1.7e-003\r\n0.2374\r\n0.1089\r\n0.2518\r\n1.98e-002\r\n4.76e-002\r\n7.38e-002\r\n-5.15e-002\r\n-4.9e-002\r\n-6.16e-002\r\n-6.15e-002\r\n6.11e-002\r\n2.95e-002\r\n2.95e-002\r\n3.39e-002\r\n3.39e-002\r\n0.156', '1', '1.895', 'C13H10N2O2S2', '0290.018', '-5.399', '0290.361', '12.2', '2', '1', '4', '11', '06', '1', '19', '21', '15', '7', '004', '01', '10', '0', '3', '001', '0113.58', '263.08', '', '3.37543', '1.3215', '46.76', '27.53', '3.5587', '19.23', '725.1', '218.652', '197.22', '-4.e-002 -2.95', 'S=C2N(C1([H])C([H])([H])C([H])([H])C(=S)N([H])C1=O)C(=O)/C/3=C([H])/C([H])=C([H])\\C([H])=C23', 'O=C1NC(=S)CCC1n3c(=O)c2ccccc2c3=S', '3,6''-dithiothalidomide', 'Not Available', 'TNF Alpha', '10017108', 'Termionated at Phase II/III', 'Alzheimer disease (AD)', '22632257', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(21, '10046873', '10046873', 'O=C1N(C(=O)c2cc(Nc3ccccc3)c(Nc4ccccc4)cc12)c5ccccc5', '5,6-dianilino-2-phenyl-isoindoline-1,3-dione', 'CYAAFQwAeewQhtmn7bKCeC94^IDof2vBO4OQLK69eZNimS4$2KqwHf2mPYPxwbbSEc2b3HH5BRVQ40BcYzo9NfZ7YaqFWXRlE6nNBw60q$MiK4ofYTtPAN5UJ4kE7^nDaa9rAEifCvBP6QaTg37NLplhNO429VSD4M8THbJej1iC8i$sRbOfpppBIHAegYFsBud6Ve75 tyqWmYk8IAfe84e0UzbbGTFeZRYv3yzTzoSt5JqqFHp582HLGjt8OhiqUk1fPyzTzXlildG9Lcpx4dH1Z2vMXJP6vxX4g14UcTOWsMtq^WM0HB58vmjvYBFC6f^z67unnjeU41tC^IkWu0fCmAvu1pBwbh64zvvP^ak$l4CKcDxMLXCeRiEyyUmZfVC4KDR2ZIIrjkV1 HiHRUP^hL0kCO1KdVILv8LLy$7Vc8un8SpWdl$9w5xuvM2IojSNa1ieWn0oHA4FN15ZZLV5MGH$Xj8buRf89pa$f4g338uu4', 'InChI=1S/C26H19N3O2/c30-25-21-16-23(27-18-10-4-1-5-11-18)24(28-19-12-6-2-7-13-19)17-22(21)26(31)29(25)20-14-8-3-9-15-20/h1-17,27-28H', 'AuxInfo=1/0/N:30,31,25,26,28,27,29,19,20,21,23,22,24,17,18,12,13,15,16,14,6,7,8,9,10,11,4,5,3,1,2/E:(1,2)(4,5,6,7)(8,9)(10,11,12,13)(14,15)(16,17)(18,19)(21,22)(23,24)(25,26)(27,28)(30,31)/rA:50OONNNC CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;;s6;s4;s5d-8;d1s3s6;d2s3s7;d-6s8;d-7s9;s3;s4;s5;d+14;s14;s17;d-18;d+15;d+16;s15;s16;d-19s20;s21;s22;d-23;d-24;d-26s28;d-27s29;s12;s13;s4;s5;s17;s18; s19;s20;s21;s22;s23;s24;s25;s26;s27;s28;s29;s30;s31;/rC:2.5594,-2.2796,.4825;2.5581,2.2812,-.482', 'LRCXLVSLCVACQP-UHFFFAOYSA-N', '1010:N1YJGG2WASMY4B3WRZDH5Z4543CDMA', '[#8]=[#6]1-[c]2:[c](:[c](-[#1]):[c](:[c](:[c]2-[#1])-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#7](-[#1])-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1])-[#6 ](-[#7]1-[c]5:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]5-[#1])=[#8]', 'O=C1c2c(c([H])c(c(c2[H])N([H])c3c([H])c([H])c([H])c([H])c3[H])N([H])c4c([H])c([H])c([H])c([H])c4[H])C(N1c5c([H])c([H])c([H])c([H])c5[H])=O', '05.539', '6.159', '0', '0', 'TRUE', '-0.2708\r\n-0.2708\r\n-0.2017\r\n-0.2577\r\n-0.2577\r\n5.23e-002\r\n5.23e-002\r\n3.82e-002\r\n3.82e-002\r\n0.2576\r\n0.2576\r\n-2.89e-002\r\n-2.89e-002\r\n4.39e-002\r\n1.89e-002\r\n1.89e-002\r\n-4.01e-002\r\n-4.01e-002\r\n-6.04e-002\r\n-6.04e-002\r\n-4.39e-002\r\n-4.39e-002\r\n-4.39e-002\r\n-4.39e-00', '0', '5.539', 'C26H19N3O2', '0405.148', '-6.785', '0405.448', '-4.27 -1.31 1.66', '2', '2', '2', '9', '24', '4', '31', '35', '24', '14', '005', '02', '19', '0', '5', '005', '0061.44', '383.45', '', '1.39384', '1.281', '135.7', '37.13', '5.14348', '98.57', '1,789.28', '90.924', '312.47', '179.83 179.82', 'O=C5N(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])C(=O)/C/4=C([H])/C(N(/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])[H])=C(N(/C3=C([H])/C([H])=C([H])\\C([H])=C3\\[H])[H])\\C([H])=C45', 'O=c4c3cc(Nc1ccccc1)c(Nc2ccccc2)cc3c(=O)n4c5ccccc5', '4,5-dianilinophthalimide', 'N-Phenyl-4,5-dianilinophthalimide; 2-Phenyl-5,6-bis-phenylamino-isoindole-1,3-dione', 'Glutamate receptor 1', '10046873', 'Under Investigation', 'Alzheimer disease (AD)', '15757396', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(22, '22', 'Not Available', 'CC(C)c1oc(nc1)C(=O)Nc2ccccc2', '5-isopropyl-<I>N</I>-phenyl-oxazole-2-carboxamide', 'CYAAFQwADfwQWmd0Iu^EcX0KTo2Zb10rNr2Of^2fzuniayfjO5l1rnTXTY4jxMen0mIjfFn4xF8aYhkvUT15Bromvy4QwoxivKFDMBr2SRk35rEW3ZJOXODIHEcmH^eeLIpobaJxkJ3QOXup6x$u2LIeTpI$3RxhCGXOnsAGFWjT1lz^5YPHypmdz43x^s3d67Tdm2f7 4cZNXHj3LQBXvm3m3m325t89xFKRzdl48K^rJjrp8seTZaMljbxCJ8n^g7ekXmAzY6Q^bHUXbIb4Ln2EyS8sQdxnpUOtz9mMrPBlULSKIqpjTsftLGDfOrGkWujg3J17rzm86qqT5jYOgq7KGqhKXgZozZxJSIcIw4$4RSHoe6kF8eO2PxDAxE^xLg^1gS77ZB', 'InChI=1S/C13H14N2O2/c1-9(2)11-8-14-13(17-11)12(16)15-10-6-4-3-5-7-10/h3-9H,1-2H3,(H,15,16)', 'AuxInfo=1/1/N:16,17,6,4,5,2,3,14,15,1,13,8,10,12,7,9,11/E:(1,2)(4,5)(6,7)/rA:17CCCCCCNCOCONCCCCC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;d8;s8;s10;d+10;s11;s12d-13;s13;s15;s15;/rC:7.3259,-7.2998,0;7.3259,-8.1248 ,0;6.6114,-6.8873,0;6.6114,-8.5373,0;5.8969,-7.2998,0;5.8969,-8.1248,0;8.0404,-6.8873,0;8.7549,-7.2998,0;9.4693,-6.8873,0;8.7549,-8.1248,0;9.4223,-8.6098,0;8.0874,-8.6098,0;9.1674,-9.3944,0;8.3424,-9. 3944,0;9.6523,-10.0619,0;10.4728,-9.9756,0;9.3168,-10.8155,0;', 'XOKRHZOIJIGPSA-UHFFFAOYSA-N', '1010:SPWJXKC2V43RGVACC5YXTWEH7E5Z5U', '[c]1(-[#7]-[#6](-[c]2:[n]:[c]:[c](-[#6](-[#6])-[#6]):[o]2)=[#8]):[c]:[c]:[c]:[c]:[c]1', 'c1(NC(c2ncc(C(C)C)o2)=O)ccccc1', '02.193', '2.193', '0', '0', 'TRUE', '3.29e-002\r\n-4.08e-002\r\n-4.08e-002\r\n-6.04e-002\r\n-6.04e-002\r\n-6.22e-002\r\n-0.2782\r\n0.2905\r\n-0.2673\r\n0.2365\r\n-0.29\r\n-0.2254\r\n8.23e-002\r\n5.69e-002\r\n1.9e-003\r\n-5.67e-002\r\n-5.67e-002', '0', '2.193', 'C13H14N2O2', '0230.106', '-3.576', '0230.262', '-3.24 0.9', '3', '1', '1', '6', '11', '2', '17', '18', '4', '6', '004', '01', '14', '0', '2', '003', '0055.13', '248.25', '', '', '', '', '', '', '', '', '', '', '', 'C\\2(/NC(=O)/C1=N/C=C(C(C)C)\\O1)=C\\C=C/C=C2', 'CC(C)c2cnc(C(=O)Nc1ccccc1)o2', '4m', 'Not Available', 'Survival Motor Neuron Protein', 'Not Available', 'Under Investigation', 'Spinal Muscular Atrophy Type I', '28481536', 'Spinal Muscular Atrophy Type I', 'SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA\nKENNEDY DISEASE; KD\nKENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY\nBULBOSPINAL MUSCULAR ATROPHY, X-LINKED\nBULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN; ; SMA1'),
(23, '23', 'Not Available', 'BrC1=C2[C@H]3CNC[C@H](C3)CN2C(=O)C=C1', '(9<I>S</I>,10<I>R</I>)-6-bromo-11,12-diazatricyclo[BLAH.BLAH.BLAH.BLAH]trideca-,6(8)-dien-7-one', 'CYAAFQwA4dwQkDMIdxkEJESkm0NnJ^bZD8YfoCnMPP9yNN^ttfNnW9vq59kfHrHy4kAolo4r1lWQ3sncQ4xSNO8bKQRVB2taIRBLifW6Rwi^amV4EN7zIbJuUWtEHrLYNtWVAkwPR3ltxARHtrqIjgbTfjEFxXh0eYs6F0Hb9Ia1EXoy^dwgs7vRK0W6DocDMnc3kpl$ Jki3AL27fpwKVgJK0o1$T48on6ddzqO9Ptz1u9PFRsuFDOuVF1mUGtWkyETmOXuA5tyY3zvoCko1CV9diWzZFkpu7ShVQWK7G5X1rTWthHQUcVaFqI1MQ4xR6uCF9uE3FSAZFdEtErCNgarocxFIij9VfoAjjHSd2XWJV6tLnMYDIQftKqMQXnnMQf4uC5ioLNCUdVlx U8CkIbYZiy0QkF9G9mZRLTx6LOH0dZ^kMGfQNxrvr3bmeFado8eX6VjrMyfg9ShFwwMUYfAX8wOX79kV9mZQf5zyaoGKrvtr', 'InChI=1S/C11H13BrN2O/c12-9-1-2-10(15)14-6-7-3-8(11(9)14)5-13-4-7/h1-2,7-8,13H,3-6H2/t7-,8+/m0/s1', 'AuxInfo=1/0/N:13,14,6,8,9,7,4,5,11,12,10,26,3,2,1/it:im/rA:27ONNC.oC.oCCCCCCCCCHHHHHHHHHHHBrH/rB:;;;;s4s5;s2s4;s3s4;s3s5;s2s5;d-10;d1s2;s11;s12d-13;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s3;s11;s13;/rC:2.0111, 2.029,.108;.2986,.4825,-.2286;-2.2777,-.1335,1.5703;-2.1461,1.1772,-.5635;-1.5457,-1.1973,-.5697;-2.2431,-.1063,-1.3784;-.6682,1.5705,-.435;-2.8279,.9847,.8053;-2.2628,-1.3707,.786;-.0826,-.8561,-.356 7;.8377,-1.8305,-.2737;1.6371,.8598,.0058;2.2178,-1.5209,-.031;2.633,-.2575,.1175;-2.674,1.9847,', 'QGUJDQNVLMZXLT-JGVFFNPUSA-N', '1010:KW17U7WW43SPAA77PJFBDX7XQRS7V2', '[#8]=[#6]1-[#6]=[#6](-[#1])-[#6](-[#35])=[#6](-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#7]2-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6]2(-[#1])-[#1])-[#6]3(-[#1])-[#1])-[#7]13', 'O=C1C=C([H])C(Br)=C([C@@]([H])(C([H])([H])N2[H])C([H])([H])[C@@]([H])(C2([H])[H])C3([H])[H])N13', '00.115', '0.115', '0', '0', 'TRUE', '-0.272\r\n-0.2701\r\n-0.3158\r\n-1.19e-002\r\n1.12e-002\r\n-3.83e-002\r\n2.34e-002\r\n-5.e-004\r\n3.3e-003\r\n3.13e-002\r\n3.54e-002\r\n0.2423\r\n-4.12e-002\r\n2.3e-003\r\n3.32e-002\r\n3.79e-002\r\n2.77e-002\r\n2.77e-002\r\n4.77e-002\r\n4.77e-002\r\n4.31e-002\r\n4.31e-002\r\n4.34e-002\r\n4.34e-002\r\n0', '0', '-0.564', 'C11H13BrN2O', '0268.021', '-1.73', '0269.138', '8.11', '1', '1', '3', '14', '00', '0', '15', '17', '14', '3', '003', '01', '13', '0', '3', '000', '0032.34', '210.75', 'Molecule has implicit hydrogens, 3D Descriptor calculation may not give useful results', '3.07258', '1.3182', '10.86', '4.19', '2.68463', '6.67', '382.039', '70.384', '174.24', '-0.3', 'O=C/3N/2C(H)(H)C1(H)C(H)(H)C(H)(C(H)(H)N(H)C1(H)H)C2=C(Br)\\C(H)=C3', 'O=c3ccc(Br)c2C1CNCC(C1)Cn23', '5-bromocytisine', 'Not Available', 'Neuronal acetylcholine receptor subunit alpha-4', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '18589414', 'Parkinson Disease(PARK)', 'PARK'),
(24, '24', 'Not Available', 'C\\C=C\\CCC(O)C1=C(C)C(=O)C(C)(O)C1O', '4,5-dihydroxy-3-[(<I>E</I>)-1-hydroxyhex-4-enyl]-2,5-dimethyl-cyclopent-2-en-1-one', 'CYAAFQwAMcwQtwoB2KRhYtO9TAzLVFthokg3D2VLubdue^$aSM1q^RW7xuP^8ly9A3p3vdgJVoX76mPbmWm$Hz4zZk0Wl74RUPfFWWeVzQFNXx9c69I0VtE5RsZ4lUTcsWSICfAAlUCQha4$eFRR8$Po5qccQDXcwTFk$dWE6JZNC1AXfqLm9bHZ$dmBrrYWKGypUEHq 5hLsItcrJsfuzh$ldrooYn4jkjy41LLz8k1KzMgjLevUPvYB6ScqZHc9ovcnHb$1P$bxe3lYHP^nR7eP0WCn3dNZDfDYbMfyRVPnPSGqrU9aV7cl$EvyPZ81i021aUk75NRQRfDBos5gOJ9M7UkManS1QfaSGqg9RvTQdniPQJhk0sI39OYBV5BNC4708WhG$ybAnf9H ^ZtteKQI$A', 'InChI=1S/C13H20O4/c1-4-5-6-7-9(14)10-8(2)11(15)13(3,17)12(10)16/h4-5,9,12,14,16-17H,6-7H2,1-3H3/b5-4+', 'AuxInfo=1/0/N:11,12,14,10,9,8,7,4,6,5,2,3,1,17,15,16,13/rA:17CCCCCCCCCCCCOCOOO/rB:s1;s1;s2;s3d-4;s5;s6;s7;s8;d+9;s10;s4;s1;s1;d2;s3;s6;/rC:7.4408,-10.1644,0;7.9258,-9.497,0;7.9258,-10.8319,0;8.7104,-9 .752,0;8.7104,-10.5769,0;9.3779,-11.0619,0;10.1315,-10.7263,0;10.799,-11.2112,0;11.5527,-10.8757,0;12.2201,-11.3606,0;12.9738,-11.025,0;9.3779,-9.267,0;6.7264,-9.752,0;6.7264,-10.5769,0;7.6708,-8.7124 ,0;7.6708,-11.6165,0;9.2916,-11.8823,0;', 'MDJUYTDLJQDSHN-SNAWJCMRSA-N', '1010:QNNVNWU9S1SH1RJFXPVQ36XERXFEDD', '[#6]1(-[#6])(-[#8])-[#6](-[#8])-[#6](-[#6](-[#8])-[#6]-[#6]\\-[#6]=[#6]\\-[#6])=[#6](-[#6])-[#6]1=[#8]', 'C1(C)(O)C(O)C(C(O)CC\\C=C\\C)=C(C)C1=O', '01.154', '1.154', '0', '0', 'TRUE', '0.1537\r\n0.1924\r\n0.114\r\n-4.e-004\r\n-3.6e-003\r\n7.85e-002\r\n-1.95e-002\r\n-3.23e-002\r\n-8.87e-002\r\n-9.17e-002\r\n-4.7e-002\r\n-3.6e-002\r\n-0.3789\r\n-2.56e-002\r\n-0.2912\r\n-0.3852\r\n-0.3887', '0', '1.154', 'C13H20O4', '0240.136', '-2.3', '0240.295', '', '1', '2', '3', '14', '00', '0', '17', '17', '7', '3', '004', '03', '20', '0', '1', '004', '0077.76', '272.96', '', '', '', '', '', '', '', '', '', '', '', 'C1(O)(C)C(=O)/C(C)=C(C(CC/C=C/C)O)\\C1O', 'C/C=C/CCC(O)/C1=C(C)/C(=O)C(C)(O)C1O', '5-Hydroxycyclopenicillone', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28825620', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(25, '1880', '1880', 'Oc1ccc2C(=O)C=C(Oc2c1O)c3ccccc3', '7,8-dihydroxy-2-phenyl-chromen-4-one', 'CYAAFQwATcwQ3aBwMRfGeeNiK$Pr3xA23lI0g$tZHua3J5hMfdN5O3bAnlf3XcJzN4rvtpWYEH3G7QP4Xk0hYzl9fEdKH99iRoqTrhYWiHiaNGwtrp9rXApwgLlx8sH9$5l7fDkENE6H7PHtz1sStyUBjtCf9c$cFZV4pdEt6c$UMjGeC4xVnUJdJip34pi$KHdrU30k DA96FR^sP$fMV04LQnMGtU1AeY1nVwUNqjjU5hFIr6c8RA1wPw8gdJDJrCG9^2jJQp9JdU2qq7LJNZc0AXFMQzvj1Ev^VgZbqrXGVbbIay9NKw69Wzgbm7os4IvsMoq9siTvYf9wVxzrHE6tY^usXJa9i$0Cqg5Vw7HZatsYqx5R82RZzZph8JGoltU7XOMa^NLWWLrq rS2WRYb0qjR5gvK1o7xVmJOiulnJxDnyW6X1mWb2eOHxEV3Lbrx1agL6ON2tye^gc$k9YBfe58IF5tFIatd4qXk9E9SUedxU', 'InChI=1S/C15H10O4/c16-11-7-6-10-12(17)8-13(19-15(10)14(11)18)9-4-2-1-3-5-9/h1-8,16,18H', 'AuxInfo=1/0/N:19,17,18,15,16,12,14,10,9,5,13,8,7,11,6,4,3,2,1/E:(2,3)(4,5)/rA:29OOOOCCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;s1d-5;s1;d3s5;s7;d-7s8;s2s6;s5;s4d-11;d-12s13;d+9;s9;s15;d-16;d-17s18;s10;s12;s14;s 15;s16;s17;s18;s19;s2;s4;/rC:.0531,.5691,.0328;-1.7445,2.5937,.1633;-1.1001,-3.3322,-.1882;-4.4597,2.0661,.1469;-1.7442,-1.0624,-.0555;-1.2811,.2501,.0205;.979,-.4602,-.0422;-.7647,-2.1576,-.1249;2.38 41,-.0064,-.0165;.6581,-1.7619,-.1118;-2.1892,1.3068,.0894;-3.1154,-1.3284,-.0639;-3.5596,1.0454', 'COCYGNDCWFKTMF-UHFFFAOYSA-N', '1010:7WGB3XVCPGBF1XH9HQ3UY6ATVRRTWK', '[#8]1-[#6](=[#6](-[#1])-[#6](-[c]2:[c]1:[c](:[c](:[c](-[#1]):[c]2-[#1])-[#8]-[#1])-[#8]-[#1])=[#8])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]', 'O1C(=C([H])C(c2c1c(c(c([H])c2[H])O[H])O[H])=O)c3c([H])c([H])c([H])c([H])c3[H]', '02.652', '2.652', '0', '0', 'TRUE', '-0.3061\r\n-0.3562\r\n-0.2891\r\n-0.3582\r\n5.56e-002\r\n0.1258\r\n9.32e-002\r\n0.1907\r\n5.4e-003\r\n1.76e-002\r\n0.1334\r\n-4.56e-002\r\n0.104\r\n-2.85e-002\r\n-5.24e-002\r\n-5.24e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-6.23e-002\r\n6.92e-002\r\n6.32e-002\r\n6.51e-002\r\n6.29e-002\r\n6.29e-002\r\n6.22e-', '0', '1.951', 'C15H10O4', '0254.058', '-2.754', '0254.237', '4.55 12.05', '2', '2', '2', '7', '12', '2', '19', '21', '14', '8', '004', '02', '10', '0', '3', '001', '0066.76', '235.17', '', '2.41079', '1.2856', '10.68', '-2.2', '3.74239', '12.88', '609.529', '137.962', '190.02', '', 'O1/C3=C(C(=O)/C([H])=C1/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])/C([H])=C([H])\\C(O[H])=C3\\O[H]', 'O=c2cc(c1ccccc1)oc3c(O)c(O)ccc23', '7,8-dihydroxyflavone', '8-DHF', 'Neurotrophic receptor tyrosine kinase 2', '1880', 'Under Investigation', 'Alzheimer disease (AD)', '21900882', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(26, '1880', '1880', 'Oc1ccc2C(=O)C=C(Oc2c1O)c3ccccc3', '7,8-dihydroxy-2-phenyl-chromen-4-one', 'CYAAFQwATcwQ3aBwMRfGeeNiK$Pr3xA23lI0g$tZHua3J5hMfdN5O3bAnlf3XcJzN4rvtpWYEH3G7QP4Xk0hYzl9fEdKH99iRoqTrhYWiHiaNGwtrp9rXApwgLlx8sH9$5l7fDkENE6H7PHtz1sStyUBjtCf9c$cFZV4pdEt6c$UMjGeC4xVnUJdJip34pi$KHdrU30k DA96FR^sP$fMV04LQnMGtU1AeY1nVwUNqjjU5hFIr6c8RA1wPw8gdJDJrCG9^2jJQp9JdU2qq7LJNZc0AXFMQzvj1Ev^VgZbqrXGVbbIay9NKw69Wzgbm7os4IvsMoq9siTvYf9wVxzrHE6tY^usXJa9i$0Cqg5Vw7HZatsYqx5R82RZzZph8JGoltU7XOMa^NLWWLrq rS2WRYb0qjR5gvK1o7xVmJOiulnJxDnyW6X1mWb2eOHxEV3Lbrx1agL6ON2tye^gc$k9YBfe58IF5tFIatd4qXk9E9SUedxU', 'InChI=1S/C15H10O4/c16-11-7-6-10-12(17)8-13(19-15(10)14(11)18)9-4-2-1-3-5-9/h1-8,16,18H', 'AuxInfo=1/0/N:19,17,18,15,16,12,14,10,9,5,13,8,7,11,6,4,3,2,1/E:(2,3)(4,5)/rA:29OOOOCCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;s1d-5;s1;d3s5;s7;d-7s8;s2s6;s5;s4d-11;d-12s13;d+9;s9;s15;d-16;d-17s18;s10;s12;s14;s 15;s16;s17;s18;s19;s2;s4;/rC:.0531,.5691,.0328;-1.7445,2.5937,.1633;-1.1001,-3.3322,-.1882;-4.4597,2.0661,.1469;-1.7442,-1.0624,-.0555;-1.2811,.2501,.0205;.979,-.4602,-.0422;-.7647,-2.1576,-.1249;2.38 41,-.0064,-.0165;.6581,-1.7619,-.1118;-2.1892,1.3068,.0894;-3.1154,-1.3284,-.0639;-3.5596,1.0454', 'COCYGNDCWFKTMF-UHFFFAOYSA-N', '1010:7WGB3XVCPGBF1XH9HQ3UY6ATVRRTWK', '[#8]1-[#6](=[#6](-[#1])-[#6](-[c]2:[c]1:[c](:[c](:[c](-[#1]):[c]2-[#1])-[#8]-[#1])-[#8]-[#1])=[#8])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]', 'O1C(=C([H])C(c2c1c(c(c([H])c2[H])O[H])O[H])=O)c3c([H])c([H])c([H])c([H])c3[H]', '02.652', '2.652', '0', '0', 'TRUE', '-0.3061\r\n-0.3562\r\n-0.2891\r\n-0.3582\r\n5.56e-002\r\n0.1258\r\n9.32e-002\r\n0.1907\r\n5.4e-003\r\n1.76e-002\r\n0.1334\r\n-4.56e-002\r\n0.104\r\n-2.85e-002\r\n-5.24e-002\r\n-5.24e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-6.23e-002\r\n6.92e-002\r\n6.32e-002\r\n6.51e-002\r\n6.29e-002\r\n6.29e-002\r\n6.22e-', '0', '1.951', 'C15H10O4', '0254.058', '-2.754', '0254.237', '4.55 12.05', '2', '2', '2', '7', '12', '2', '19', '21', '14', '8', '004', '02', '10', '0', '3', '001', '0066.76', '235.17', '', '2.41079', '1.2856', '10.68', '-2.2', '3.74239', '12.88', '609.529', '137.962', '190.02', '', 'O1/C3=C(C(=O)/C([H])=C1/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])/C([H])=C([H])\\C(O[H])=C3\\O[H]', 'O=c2cc(c1ccccc1)oc3c(O)c(O)ccc23', '7,8-dihydroxyflavone', '8-DHF', 'Neurotrophic receptor tyrosine kinase 2', '1880', 'Under Investigation', 'Huntington Disease (HD)', '23446639', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(27, '125663', '125663', 'Cc1c2ccncc2c(C)c3c4cccc(O)c4[nH]c13', '5,11-dimethyl-6<I>H</I>-pyrido[3,4-h]carbazol-7-ol', 'CYAAFQwAlcwQDoMXjtSrYefqubBsfced3ikX53A5mfwS61W1O1Keup7L^FHSGK4rQbr5iKDJYde6dGjd^m$9EjKrlZMoEGpsydvb^o$CFrfz$NQDtxsgH1hAk4kItXZKm91dh5nlYUeKKwN^C$3aoyNrsX5P$KZ1xn^pWEH48sJYNaJZzz79GfNNf$A7ZOJIayrR1BaE omsXefjWed05mJdxMUTt9zee97Fp7noWdaRqBqg$WyLRURf24I1r2El41zDAnuXV1a1nR$UqJJON2YihCB4qKxd83X2w7pe0Dfy$MNfpHSdMeqQ2GY6u3^TYKTeU8Y8C0Bazqdqqy9UIpKbZ4U5r5g$Bc5DmKu1nuiVeqBAl1PAm0yIHu8zeuGnhyjOBy5x2xX^^oTIP rWFzeICVAO19DMRy1gHjBb5kCe$caGPH4Vw5YCk847pIeSRbaqhP83fxnH4^AIjTEwDxrkchPFCQ9UzMhY1q6HO94SKeaA7$', 'InChI=1S/C17H14N2O/c1-9-13-8-18-7-6-11(13)10(2)16-15(9)12-4-3-5-14(20)17(12)19-16/h3-8,19-20H,1-2H3', 'AuxInfo=1/0/N:13,15,18,12,19,16,20,17,7,8,11,6,10,14,4,5,9,3,2,1/rA:34ONNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;s2d-4;s4;s4;s5;s2d-6;d-7;d-8s10;s6;s7;s1s9;s8;s11;d-3s10;d-12;d+14s18;s3d-16;s2;s12;s13;s 13;s13;s15;s15;s15;s16;s17;s18;s19;s20;s1;/rC:2.6048,1.8463,0;4.7149,1.2447,0;8.5644,-1.3998,0;5.2116,-.2885,0;5.5206,.6625,0;4.2175,-.286,0;5.8808,-1.0317,0;6.4988,.8704,0;3.9112,.6597,0;6.8589,-.823 8,0;7.1679,.1273,0;3.536,-1.0655,0;5.5717,-1.9827,0;2.902,.8915,0;6.8078,1.8215,0;8.1833,.3595,0', 'LMKVVMVYEHURBO-UHFFFAOYSA-N', '1010:RSDYYC9VUZ1KSDTH57YQMVF7T87PS4', '[#8](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#1]):[c](:[c]1:[c]2:[c]3:[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n]4):[c](:[c]4-[#1]):[c]2-[#6](-[#1])(-[#1])-[#1]):[n]3-[#1]', 'O([H])c(c([H])c([H])c1[H])c(c1c2c3c(C([H])([H])[H])c(c([H])c([H])n4)c(c4[H])c2C([H])([H])[H])n3[H]', '03.811', '3.811', '0', '0', 'TRUE', '-0.3592\r\n-0.2555\r\n-0.264\r\n5.5e-003\r\n3.08e-002\r\n4.4e-003\r\n-3.22e-002\r\n-2.42e-002\r\n5.73e-002\r\n3.9e-003\r\n-1.05e-002\r\n-5.26e-002\r\n-3.85e-002\r\n9.01e-002\r\n-3.76e-002\r\n-3.57e-002\r\n3.49e-002\r\n-5.9e-002\r\n-3.04e-002\r\n2.74e-002\r\n0.1343\r\n6.29e-002\r\n2.8e-002\r\n2.8e-002', '0', '2.978', 'C17H14N2O', '0262.111', '-5.514', '0262.306', '6.35 8.27 10.46', '1', '2', '0', '3', '20', '4', '20', '23', '17', '8', '003', '02', '14', '0', '4', '000', '0048.91', '261.9', '', '', '', '', '', '', '', '', '', '', '', 'O(/C1=C([H])/C([H])=C([H])\\C2=C1\\N([H])\\C3=C2\\C(C([H])([H])[H])=C\\4/C(=C3/C([H])([H])[H])/C([H])=C([H])\\N=C4\\[H])[H]', 'Cc3c1ccncc1c(C)c4c2cccc(O)c2[nH]c34', '7-hydroxyellipticine (1e)', 'Compound 1e_22948243', 'd(CGG)n FMR1 (fragile X mental retardation 1)', '125663', 'Under Investigation', 'Fragile X syndrome', '22948243', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(28, '1219', '1219', 'CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1', '(3<I>S</I>)-3-(dipropylamino)tetralin-6-ol', 'CYAAFQwATcwQLX8MarIs90G3w8XtYud669Q0uA46SVCr5HbmRp4hA097KkSKdJsjQwGtXsiYJ6NPbR5IIEUvXk7Wj3^fHjq4KdkdXIyfuGXPC1EWTzUnEbqVuLFn^D9fm9zPh5nlenvzC$BEn^Zp5vyQASfrf28QjsUf9MORlCE8kvnxBvyIEGMuX5lkRcknlDe4XNow 9BTVJdlSm0xyZEp0stXluoEOJ4tdIagX7iJi3anhVOr$zc35iLDlITfgqys^H3p5E3mUVxzy7A^IFHrnHCRqGawW413VJSAFeKnObTj$otqzGSUZAsuOy3bUU2B2MHvGofqg8efkO0roxgAPINqe$9ymG3oWhGeaUUxzLp$u0DFdXtzwpJUmm2n3MaxoWCpfr6AmnXNe 4Y4MxOU^45mOrrtXb7e97gMqhPxE^bTOLVHqvJwhDT^b$A8cnJ1Lwx7tlO3mc5LnWwSeyFUesSKOzrc5WoauDDW^K5pG8sXL', 'InChI=1S/C16H25NO/c1-3-9-17(10-4-2)15-7-5-13-6-8-16(18)12-14(13)11-15/h6,8,12,15,18H,3-5,7,9-11H2,1-2H3/t15-/m0/s1', 'AuxInfo=1/0/N:17,18,11,12,6,14,4,16,9,10,5,13,8,7,3,15,2,1/E:(1,2)(3,4)(9,10)/it:im/rA:43ONC.eCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;s3;s3;s4;s5;s6d-7;s2;s2;s9;s10;s7;s8;s1d+13;d-14s15;s11;s1 2;s3;s4;s4;s5;s5;s6;s6;s9;s9;s10;s10;s11;s11;s12;s12;s13;s14;s16;s17;s17;s17;s18;s18;s18;s1;/rC:4.625,.8734,-1.895;-2.283,-.0831,.4326;-.8664,-.0054,.7862;-.4338,-1.2841,1.5059;-.0114,.2031,-.4714;1.0 155,-1.1638,1.978;1.4679,.0464,-.214;1.9494,-.634,.9192;-2.5216,-1.2001,-.4809;-2.7295,1.1731,-.', 'BLYMJBIZMIGWFK-HNNXBMFYSA-N', '1010:YFY4Z9AQUJQ3U64VUSH1MR4Z2SE9MC', '[#8](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]1-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1] )(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]):[c]1-[#1]', 'O([H])c(c([H])c([H])c(c1C([H])([H])[C@@]2([H])N(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C2([H])[H])c1[H]', '04.287', '4.287', '0', '0', 'TRUE', '-0.3609\r\n-0.3001\r\n1.39e-002\r\n-3.32e-002\r\n-1.18e-002\r\n-2.62e-002\r\n-4.07e-002\r\n-4.45e-002\r\n-1.8e-003\r\n-1.8e-003\r\n-4.33e-002\r\n-4.33e-002\r\n-2.86e-002\r\n-5.62e-002\r\n7.15e-002\r\n-3.18e-002\r\n-6.42e-002\r\n-6.42e-002\r\n4.7e-002\r\n2.85e-002\r\n2.85e-002\r\n3.32e-002\r\n3.32e-', '1', '2.734', 'C16H25NO', '0247.194', '-3.966', '0247.376', '10.65 10.7', '0', '1', '0', '13', '06', '1', '18', '19', '28', '3', '002', '01', '25', '0', '2', '005', '0023.47', '285.37', '', '1.30632', '1.2517', '3.18', '-1.58', '3.71365', '4.76', '611.056', '59.333', '228.78', '', 'O(/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])C(C(C([H])([H])[H])([H])[H])([H])[H])([H])C1([H])[H])\\C([H])=C2\\[H])[H]', 'CCCN(CCC)C2CCc1ccc(O)cc1C2', '7-OH-DPAT', 'Not Available', 'D(3) dopamine receptor', '1219', 'Under Investigation', 'Parkinson Disease(PARK)', '17588764', 'Parkinson Disease(PARK)', 'PARK'),
(29, '178052', '178052', 'Cc1ncccc1OC[C@@H]2CCCN2', '2-methyl-3-[[(2<I>S</I>)-pyrrolidin-2-yl]methoxy]pyridine', 'CYAAFQwAxewQ042cTwa^iHIQf7aqA7sg06uqYjM8QrMK0Fg0Yz5H3RbV^D9Iq19VbeGWOUVLZzY1Milhg$LfeSWaeLXbcoB7x9DO220tuXjyGhLTCqrICbJRLhBUX3fgnf9FnUu7EDUAseyl2CNo5gV^y77181qyF3zKddus2SVhByFCPqDC8yalnwrDk75x6lRqiHyr KEvOswQrJSR^oeEt$Ylt6nVlkNNGph7VjaN4KWfmN2aSiBH8X3po88GkgERWkaVFOWDX3mI2rPc9WqWcinrWOvIxluAkpz2Jm3Ria9kue6YU2PwONJcFzQ$XrsOYTOfAd919kF0i5i1hQRw89W37nys1XgDe5tZVUqFv3O1yRML7jWnzliimdr2DOQ2bLXeMWvIz19zQ fo0RjdLGPUo4axOxuC9UdvJF$wBeJsKIPc2OMrMvsW1kaKfc35NYb17jBhmv3Ih3PmJb86sGhJquYWs9Xhb$LfXsSZzFIfTv', 'InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1', 'AuxInfo=1/0/N:12,6,13,5,11,14,7,8,10,4,9,3,2,1/it:im/rA:30ONNC.eCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;s2;s4;s5;s2s6;s1s4;s1;s3d+9;s9;s10;d-11;d-3s13;s4;s5;s5;s6;s6;s7;s7;s2;s8;s8;s11;s12;s12;s12;s13;s14;/rC :-.0608,.0935,.9538;3.4264,-1.022,.3627;-3.364,.7719,-.4496;2.3034,-.1226,.6688;2.3845,1.0238,-.3368;3.8215,.9746,-.8138;4.1009,-.5129,-.8315;.9595,-.8377,.6351;-1.2942,-.1186,.3908;-2.1408,.9301,.103 8;-1.7037,-1.4079,.1031;-1.7362,2.3363,.4016;-2.9557,-1.6109,-.4667;-3.7407,-.4978,-.7211;2.4628', 'YRVIKLBSVVNSHF-JTQLQIEISA-N', '1010:CVEKKF7QK7BN85XKYMTA1UGR963EJ7', '[#8](-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]1):[c]1-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#1]', 'O(c(c([H])c([H])c([H])n1)c1C([H])([H])[H])C([H])([H])[C@]2([H])C([H])([H])C([H])([H])C([H])([H])N2[H]', '01.038', '1.038', '0', '0', 'TRUE', '-0.3426\r\n-0.3117\r\n-0.2589\r\n3.07e-002\r\n-3.43e-002\r\n-3.91e-002\r\n-4.5e-003\r\n6.87e-002\r\n9.62e-002\r\n6.74e-002\r\n-2.84e-002\r\n-1.96e-002\r\n-4.12e-002\r\n2.72e-002\r\n4.88e-002\r\n2.83e-002\r\n2.83e-002\r\n2.8e-002\r\n2.8e-002\r\n4.27e-002\r\n4.27e-002\r\n0.1225\r\n5.88e-002\r\n5.88e-00', '1', '-0.182', 'C11H16N2O', '0192.126', '-2.45', '0192.258', '5.46 10.78', '2', '1', '0', '9', '06', '1', '14', '15', '18', '3', '003', '01', '16', '0', '2', '003', '0034.15', '210.49', '', '2.29699', '1.2567', '43.62', '13.35', '3.31478', '30.27', '372.966', '54.741', '166.69', '', 'O(C(C1([H])N([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])/C2=C(C([H])([H])[H])/N=C([H])\\C([H])=C2\\[H]', 'Cc1ncccc1OCC2CCCN2', 'ABT-089', 'Pozanicline; UNII-CL2002R563; CID178052; ZINC6562', 'Neuronal acetylcholine receptor subunit alpha-4', '178052', 'Terminated at Phase II', 'Alzheimer disease (AD)', '25973909', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(30, '178052', '178052', 'Cc1ncccc1OC[C@@H]2CCCN2', '2-methyl-3-[[(2<I>S</I>)-pyrrolidin-2-yl]methoxy]pyridine', 'CYAAFQwAxewQ042cTwa^iHIQf7aqA7sg06uqYjM8QrMK0Fg0Yz5H3RbV^D9Iq19VbeGWOUVLZzY1Milhg$LfeSWaeLXbcoB7x9DO220tuXjyGhLTCqrICbJRLhBUX3fgnf9FnUu7EDUAseyl2CNo5gV^y77181qyF3zKddus2SVhByFCPqDC8yalnwrDk75x6lRqiHyr KEvOswQrJSR^oeEt$Ylt6nVlkNNGph7VjaN4KWfmN2aSiBH8X3po88GkgERWkaVFOWDX3mI2rPc9WqWcinrWOvIxluAkpz2Jm3Ria9kue6YU2PwONJcFzQ$XrsOYTOfAd919kF0i5i1hQRw89W37nys1XgDe5tZVUqFv3O1yRML7jWnzliimdr2DOQ2bLXeMWvIz19zQ fo0RjdLGPUo4axOxuC9UdvJF$wBeJsKIPc2OMrMvsW1kaKfc35NYb17jBhmv3Ih3PmJb86sGhJquYWs9Xhb$LfXsSZzFIfTv', 'InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1', 'AuxInfo=1/0/N:12,6,13,5,11,14,7,8,10,4,9,3,2,1/it:im/rA:30ONNC.eCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;s2;s4;s5;s2s6;s1s4;s1;s3d+9;s9;s10;d-11;d-3s13;s4;s5;s5;s6;s6;s7;s7;s2;s8;s8;s11;s12;s12;s12;s13;s14;/rC :-.0608,.0935,.9538;3.4264,-1.022,.3627;-3.364,.7719,-.4496;2.3034,-.1226,.6688;2.3845,1.0238,-.3368;3.8215,.9746,-.8138;4.1009,-.5129,-.8315;.9595,-.8377,.6351;-1.2942,-.1186,.3908;-2.1408,.9301,.103 8;-1.7037,-1.4079,.1031;-1.7362,2.3363,.4016;-2.9557,-1.6109,-.4667;-3.7407,-.4978,-.7211;2.4628', 'YRVIKLBSVVNSHF-JTQLQIEISA-N', '1010:CVEKKF7QK7BN85XKYMTA1UGR963EJ7', '[#8](-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]1):[c]1-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#1]', 'O(c(c([H])c([H])c([H])n1)c1C([H])([H])[H])C([H])([H])[C@]2([H])C([H])([H])C([H])([H])C([H])([H])N2[H]', '01.038', '1.038', '0', '0', 'TRUE', '-0.3426\r\n-0.3117\r\n-0.2589\r\n3.07e-002\r\n-3.43e-002\r\n-3.91e-002\r\n-4.5e-003\r\n6.87e-002\r\n9.62e-002\r\n6.74e-002\r\n-2.84e-002\r\n-1.96e-002\r\n-4.12e-002\r\n2.72e-002\r\n4.88e-002\r\n2.83e-002\r\n2.83e-002\r\n2.8e-002\r\n2.8e-002\r\n4.27e-002\r\n4.27e-002\r\n0.1225\r\n5.88e-002\r\n5.88e-00', '1', '-0.182', 'C11H16N2O', '0192.126', '-2.45', '0192.258', '5.46 10.78', '2', '1', '0', '9', '06', '1', '14', '15', '18', '3', '003', '01', '16', '0', '2', '003', '0034.15', '210.49', '', '2.29699', '1.2567', '43.62', '13.35', '3.31478', '30.27', '372.966', '54.741', '166.69', '', 'O(C(C1([H])N([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])/C2=C(C([H])([H])[H])/N=C([H])\\C([H])=C2\\[H]', 'Cc1ncccc1OCC2CCCN2', 'ABT-089', 'Pozanicline; UNII-CL2002R563; CID178052; ZINC6562', 'Neuronal acetylcholine receptor subunit beta-2', '178052', 'Terminated at Phase II', 'Alzheimer disease (AD)', '25973909', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(31, '24987875', '24987875', 'C1C2C[C@H]3CN(C2)C[C@@H]1C3Oc4nnc(s4)c5ccccc5', '2-[[(14<I>R</I>,15<I>S</I>)-19-azatricyclo[BLAH.BLAH.BLAH.BLAH]decan-16-yl]oxy]-5-phenyl-1,3,4-thiadiazole', 'CYAAFQwAWewQsLe5LkN3MjNhokDMKK5R^YpIXgnxL1SteZUU6mk7FJPq7dHYdSKMmWPmmsmdhiDmbwZi73AIEjVJ0S4T6s9MFiXTtEwj7h9bNJoznsH9BbxNKolI49HH$$L^5rl1QAQSjUu^Makbu5z$3TFTAjdPvbZs4dYpgNl9F0X1ad9mQr4$byHpJKbcTTPI7Rg1 RhFvw1ZeOfSsQdKkoJ7MOsz8Xe2NnIkv0wxTKE$uqYYbF4VPOgsyTVOpQLVGfQHWWhq3NFR6Aq6WyjXjPubwK5EbwcQyIAWdu^pjiKIfMoppdyLnj7Y7aRczre1jDqmekButcQ0Y7A1px1wVBjn1nVfJqRWxu2S7K2cS1jSzlI^JC72r96dv$WrD8KiMPKW4zjCWImtG 4d^hTl2He4eUyYUU$aTRfK44n49QogO6w5FQxovEF3c5x^Zxrqo2D8O0rt2o6hoMn1x6RXeUPGRP8$MSw9m7RcdrEOWeWwje', 'InChI=1S/C17H19N3OS/c1-2-4-12(5-3-1)16-18-19-17(22-16)21-15-13-6-11-7-14(15)10-20(8-11)9-13/h1-5,11,13-15H,6-10H2/t11-,13-,14+,15+', 'AuxInfo=1/0/N:22,20,21,18,19,11,10,14,13,12,8,17,7,6,9,16,15,5,4,3,2,1/E:(2,3)(4,5)(6,7)(9,10)(13,14)/rA:41SONNNC.oC.eCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;s4;;;;s2s6s7;s6s8;s7s8;s3s6;s3s7;s3s8;s1s 2d-4;s1d-5;s16;d+17;s17;s18;d-19;d-20s21;s6;s7;s8;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s18;s19;s20;s21;s22;/rC:-1.6231,1.3227,-.0817;1.0355,.8777,.2164;4.441,.9941,-.9942;-.483,-.9075,.4598;-1.8 384,-1.1828,.4096;2.6154,-.702,-.8025;3.2774,.6591,1.1923;4.8252,-1.1017,.3084;2.0965,-.0303,.48', 'QZDCYUCETTWCMO-OFTMQHFLSA-N', '1010:KDNAJVNJX8TSNKYHYZBZKA2YP2ANSQ', '[s]1:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[n]:[n]:[c]1-[#8]-[#6]3(-[#1])-[#6@](-[#1])(-[#6]4(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#7]45)-[#6](-[ #1])(-[#1])-[#6@]3(-[#1])-[#6]5(-[#1])-[#1]', 's1c(c2c([H])c([H])c([H])c([H])c2[H])nnc1OC3([H])[C@]([H])(C4([H])[H])C([H])([H])C([H])(C([H])([H])N45)C([H])([H])[C@]3([H])C5([H])[H]', '02.756', '3.223', '0', '0', 'TRUE', '-2.01e-002\r\n-0.3185\r\n-0.3023\r\n-0.1161\r\n-0.1397\r\n-1.e-003\r\n-1.e-003\r\n-2.78e-002\r\n7.45e-002\r\n-4.27e-002\r\n-4.27e-002\r\n3.5e-003\r\n3.5e-003\r\n1.e-003\r\n0.2304\r\n0.1342\r\n9.e-003\r\n-5.22e-002\r\n-5.22e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-6.22e-002\r\n3.42e-002\r\n3.42e-002\r\n3.15', '1', '1.196', 'C17H19N3OS', '0313.125', '-3.53', '0313.417', '14.06', '3', '0', '0', '15', '11', '2', '22', '26', '21', '5', '004', '00', '19', '0', '6', '003', '0066.49', '287.27', '', '1.35599', '1.3142', '24.64', '9.38', '4.60211', '15.26', '1,160.08', '87.713', '246.61', '', 'S4/C(OC1([H])C2([H])C([H])([H])C3([H])C([H])([H])C1([H])C([H])([H])N(C2([H])[H])C3([H])[H])=N\\N=C4\\C5=C([H])\\C([H])=C([H])/C([H])=C5/[H]', 'c5ccc(c4nnc(O[C@@H]1[C@H]3C[C@H]2C[C@@H]1CN(C2)C3)s4)cc5', 'ABT-126', 'SCHEMBL878680', 'Neuronal acetylcholine receptor subunit alpha-4', '24987875', 'Terminated at Phase II', 'Alzheimer disease (AD)', '27756421', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(32, '24987875', '24987875', 'C1C2C[C@H]3CN(C2)C[C@@H]1C3Oc4nnc(s4)c5ccccc5', '2-[[(14<I>R</I>,15<I>S</I>)-19-azatricyclo[BLAH.BLAH.BLAH.BLAH]decan-16-yl]oxy]-5-phenyl-1,3,4-thiadiazole', 'CYAAFQwAWewQsLe5LkN3MjNhokDMKK5R^YpIXgnxL1SteZUU6mk7FJPq7dHYdSKMmWPmmsmdhiDmbwZi73AIEjVJ0S4T6s9MFiXTtEwj7h9bNJoznsH9BbxNKolI49HH$$L^5rl1QAQSjUu^Makbu5z$3TFTAjdPvbZs4dYpgNl9F0X1ad9mQr4$byHpJKbcTTPI7Rg1 RhFvw1ZeOfSsQdKkoJ7MOsz8Xe2NnIkv0wxTKE$uqYYbF4VPOgsyTVOpQLVGfQHWWhq3NFR6Aq6WyjXjPubwK5EbwcQyIAWdu^pjiKIfMoppdyLnj7Y7aRczre1jDqmekButcQ0Y7A1px1wVBjn1nVfJqRWxu2S7K2cS1jSzlI^JC72r96dv$WrD8KiMPKW4zjCWImtG 4d^hTl2He4eUyYUU$aTRfK44n49QogO6w5FQxovEF3c5x^Zxrqo2D8O0rt2o6hoMn1x6RXeUPGRP8$MSw9m7RcdrEOWeWwje', 'InChI=1S/C17H19N3OS/c1-2-4-12(5-3-1)16-18-19-17(22-16)21-15-13-6-11-7-14(15)10-20(8-11)9-13/h1-5,11,13-15H,6-10H2/t11-,13-,14+,15+', 'AuxInfo=1/0/N:22,20,21,18,19,11,10,14,13,12,8,17,7,6,9,16,15,5,4,3,2,1/E:(2,3)(4,5)(6,7)(9,10)(13,14)/rA:41SONNNC.oC.eCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;s4;;;;s2s6s7;s6s8;s7s8;s3s6;s3s7;s3s8;s1s 2d-4;s1d-5;s16;d+17;s17;s18;d-19;d-20s21;s6;s7;s8;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s18;s19;s20;s21;s22;/rC:-1.6231,1.3227,-.0817;1.0355,.8777,.2164;4.441,.9941,-.9942;-.483,-.9075,.4598;-1.8 384,-1.1828,.4096;2.6154,-.702,-.8025;3.2774,.6591,1.1923;4.8252,-1.1017,.3084;2.0965,-.0303,.48', 'QZDCYUCETTWCMO-OFTMQHFLSA-N', '1010:KDNAJVNJX8TSNKYHYZBZKA2YP2ANSQ', '[s]1:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[n]:[n]:[c]1-[#8]-[#6]3(-[#1])-[#6@](-[#1])(-[#6]4(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#7]45)-[#6](-[ #1])(-[#1])-[#6@]3(-[#1])-[#6]5(-[#1])-[#1]', 's1c(c2c([H])c([H])c([H])c([H])c2[H])nnc1OC3([H])[C@]([H])(C4([H])[H])C([H])([H])C([H])(C([H])([H])N45)C([H])([H])[C@]3([H])C5([H])[H]', '02.756', '3.223', '0', '0', 'TRUE', '-2.01e-002\r\n-0.3185\r\n-0.3023\r\n-0.1161\r\n-0.1397\r\n-1.e-003\r\n-1.e-003\r\n-2.78e-002\r\n7.45e-002\r\n-4.27e-002\r\n-4.27e-002\r\n3.5e-003\r\n3.5e-003\r\n1.e-003\r\n0.2304\r\n0.1342\r\n9.e-003\r\n-5.22e-002\r\n-5.22e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-6.22e-002\r\n3.42e-002\r\n3.42e-002\r\n3.15', '1', '1.196', 'C17H19N3OS', '0313.125', '-3.53', '0313.417', '14.06', '3', '0', '0', '15', '11', '2', '22', '26', '21', '5', '004', '00', '19', '0', '6', '003', '0066.49', '287.27', '', '1.35599', '1.3142', '24.64', '9.38', '4.60211', '15.26', '1,160.08', '87.713', '246.61', '', 'S4/C(OC1([H])C2([H])C([H])([H])C3([H])C([H])([H])C1([H])C([H])([H])N(C2([H])[H])C3([H])[H])=N\\N=C4\\C5=C([H])\\C([H])=C([H])/C([H])=C5/[H]', 'c5ccc(c4nnc(O[C@@H]1[C@H]3C[C@H]2C[C@@H]1CN(C2)C3)s4)cc5', 'ABT-126', 'SCHEMBL878680', 'Neuronal acetylcholine receptor subunit alpha-7', '24987875', 'Terminated at Phase II', 'Schizophrenia', '26940805', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(33, '71158', '71158', 'CC(=O)NCCCS(=O)(=O)O', '3-acetamidopropane-1-sulfonic acid', 'CYAAFQwAHfwQRzuFMY$vFKzuvPuvlCu1Z2AgjAdoiX1vq5^yoa9jfHV1E5Fzv$PL9ow08g$ozb$yMiMClm4Q3tJ3m32DQD^p^glCmIA8xXF$PS5SpMHGwMz4pDeARwTfZ8bANcZEGqa84WEtOurMRwLioEMvymn3stnsY3aE8NFfDhoyFeO4Vi8FhGeJ9FxJqEv50TDy OWIqs1EiJ3j4$qoSflTR8Y1559pI2YEtL6VKzIiN6B^6tvr7XzsdjYetnf4Uz$yMUhjKpvHixZd9KUq4IucsfonGeUOPX94M7u4dVH4zmx0l9QunEYMzmwVbzRc95d$8RP2D0yj2eai7P^dFiireYfF7rfkp$M$h^If8WPbyc6D9QzKpyMvPfr1qWuwi54yQvV63yZJV Oa18ZCxtjkdeS^ldeLaI6KzhnVp4tUXYrqtb69iVnnPsi4a52Na9pOu3D2Urdb$xwWlW82MkguFvLdB1H8rfnUYx7ubylL6K', 'InChI=1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10)', 'AuxInfo=1/1/N:11,7,9,8,10,6,5,2,3,4,1/E:(8,9,10)/CRV:11.6/rA:22SOOOONCCCCCHHHHHHHHHHH/rB:s1;d1;d1;;;;s1s7;s6s7;d5s6;s10;s7;s7;s8;s8;s9;s9;s6;s2;s11;s11;s11;/rC:2.5701,.2285,.1841;3.2889,1.048,-1.0293; 3.2902,-1.0132,.3996;2.3021,1.1495,1.2737;-3.1508,-.2624,1.2118;-1.9399,-.2494,-.7776;.1802,-1.0652,.1758;1.053,-.1264,-.646;-1.1283,-1.4086,-.5269;-2.8879,.229,.1173;-3.5777,1.4701,-.3824;.7235,-1.99 55,.3801;-.0332,-.6076,1.1498;1.3048,-.5899,-1.6056;.5551,.83,-.8324;-.93,-1.8842,-1.4933;-1.697', 'AFCGFAGUEYAMAO-UHFFFAOYSA-N', '1010:PXCECNNH8WFAZTMDTHVCRSTHDRT8Z2', '[#16](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])(=[#8])(=[#8])-[#8]-[#1]', 'S(C([H])([H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)(=O)(=O)O[H]', '-01.159', '-1.159', '0', '0', 'TRUE', '1.4874\r\n-0.5235\r\n-0.5636\r\n-0.5636\r\n-0.2781\r\n-0.3158\r\n-4.39e-002\r\n-1.51e-002\r\n9.8e-003\r\n0.2085\r\n1.26e-002\r\n2.7e-002\r\n2.7e-002\r\n1.67e-002\r\n1.67e-002\r\n4.66e-002\r\n4.66e-002\r\n0.1492\r\n0.156\r\n3.27e-002\r\n3.27e-002\r\n3.40999999999998e-002', '0', '-3.402', 'C5H11NO4S', '0181.041', '-0.643', '0181.21', '2.88', '1', '1', '3', '7', '00', '0', '11', '10', '15', '3', '005', '02', '11', '0', '0', '004', '0091.85', '188', '', '4.49077', '1.2743', '21.06', '0.6', '2.88885', '20.46', '310.124', '190.278', '129.31', '178.93', 'S(O[H])(=O)(=O)C(C(C(N(C(=O)C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H]', 'CC(=O)NCCCS(=O)(=O)O', 'Acamprosate', 'N-Acetylhomotaurine; Campral; UNII-N4K14YGM3J; N-(3-sulfopropyl)ethanimidic acid; Aotal', 'Gamma-aminobutyric acid receptor subunit alpha-1', '71158', 'Phase II/III', 'Fragile X Syndrome', '23436129', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(34, '1983', '1983', 'CC(=O)Nc1ccc(O)cc1', '<I>N</I>-(4-hydroxyphenyl)acetamide', 'CYAAFQwA6dwQYhvQLJZbMymma6YUjlgw85OmIuoyUEj^CGMh9VB3Zq1DUIkrqbia^Kc^5GfemUfBdTWkENjLMt^VqMZGJIbzHPRKlWSqKNd9KdhHnGZAmfx^qJ77NGervDGAZgK^gsoayYsckCgIGrB87ac4bj5oYsVQbjRGpfuXYOsyILfBeqgChDoeBZeZlhCJJzER CDY9zSc^dR0sKI6zH7KLhyz1CMqqcJhtea1T9ea1Mvoe3^ORK6l$aMFUoilenZq^VDpvwWl0voDszzTLHJ5zKhyHd9mfWlSe^dYS8lQmyDrHOVDzhQfZXwdWTv9mjsg6BElp8J51wDrbttErS0zeBzHmt9QVNmjCJkizs0HTKqIPVhue$KeovoH65gyRz7zHd^ZWnMY8 W1X1gIiPHna^prOfqcY2ilPXMcpPGt3x7xbu2nXm^rGUGD9DKAQca0SzmpKweS6zLBYusLqxUwwZ2i9zGCMTjLAep8Jqy3Yo', 'InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)', 'AuxInfo=1/1/N:11,5,6,7,8,10,4,9,3,2,1/E:(2,3)(4,5)/rA:20OONCCCCCCCCHHHHHHHHH/rB:;;s3;d+4;s4;s5;d-6;s1d+7s8;d2s3;s10;s5;s6;s3;s7;s8;s11;s11;s11;s1;/rC:3.8509,.4516,.0012;-2.5999,1.4041,-.0018;-1.5705,- .7171,.0001;-.2066,-.4231,-.0002;.2205,.9047,.0004;.7298,-1.457,-.0007;1.5841,1.1986,.0002;2.0933,-1.1629,-.0007;2.5204,.1648,-.0003;-2.6485,.1782,.0009;-3.9735,-.542,.001;-.4436,1.7577,.0012;.4113,-2 .4963,-.001;-1.801,-1.7086,.0001;1.9053,2.237,.0009;2.818,-1.9726,-.0008;-4.0655,-1.1463,-.9058;', 'RZVAJINKPMORJF-UHFFFAOYSA-N', '1010:JSFCFDECJVGWE856SQGQMNP8WNGK4M', '[#8](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c](-[#1]):[c]1-[#1]', 'O([H])c(c([H])c([H])c1N([H])C(C([H])([H])[H])=O)c([H])c1[H]', '00.708', '0.708', '0', '0', 'TRUE', '-0.361\r\n-0.2777\r\n-0.2857\r\n3.26e-002\r\n-3.82e-002\r\n-3.82e-002\r\n-3.03e-002\r\n-3.03e-002\r\n7.13e-002\r\n0.2128\r\n1.3e-002\r\n6.43e-002\r\n6.43e-002\r\n0.1556\r\n6.5e-002\r\n6.5e-002\r\n3.28e-002\r\n3.28e-002\r\n3.28e-002\r\n0.2191', '0', '0.705', 'C8H9NO2', '0151.063', '-1.385', '0151.163', '-0.57 9.5', '1', '2', '1', '4', '06', '1', '11', '11', '12', '4', '003', '02', '9', '0', '1', '001', '0049.33', '163.09', '', '2.37212', '1.2437', '6.92', '-0.53', '3.01383', '7.45', '232.01', '107.101', '119.7', '-180', 'O(/C1=C([H])/C([H])=C(N(C(=O)C([H])([H])[H])[H])\\C([H])=C1\\[H])[H]', 'CC(=O)Nc1ccc(O)cc1', 'Acetaminophen', 'Paracetamol; Tylenol; Naprinol; Fendon', 'Prostaglandin G/H synthase 2', '1983', 'Terminated at Phase IV', 'Migraine', '23633349', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(35, '1986', '1986', 'CC(=O)Nc1nnc(s1)S(=O)(=O)N', '<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide', 'CYAAFQwABcwQ9nm5agUtz3vZf7E36bfpC8Ye54gbeO92pZUrfR08sBle1zJXW^xXm2lF7OEzndCz7NTl5R5qczEqTutrpdHT3TFyfHZCKL4aWR6UK0CJmtTtM$lBP4OiwIxT7RtkmSIDD4Q9whml8aegBtjtHVJjSNZgEV65C80MLG8lv0Fh4TxkJnHmlYm8zu1jtwTr 84UJcCKkxM$ce6hbsZcKD84MmF8Z5SUzic45r7JchOMU6U1lmV4jVesnesJlKW^EsCtknXzBW5eL90whrTDpeARUzIRV57vjRtc32w7jbW17RZ$Rfm3B375J23yj$Qrba^61Xk4qoezai1UWBxj6snXm9288b9gSvylRu1O6zVib0S27Rzn055O0Ghlo7EVRsO^TLO^V f1HS6VPL65UrfWi4Lv1BaIlXuvyGne6epnrofDVq2IKiBce53FYXg$IEG8ObHAkqodAfImwB9EwdzSnWcDE3odaglC1BBA0u', 'InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)', 'AuxInfo=1/1/N:13,12,11,10,8,6,9,7,5,3,4,2,1/E:(10,11)/CRV:13.6/rA:19SSOOONNNNCCCCHHHHHH/rB:;d1;d1;;;;s1;s7;s1s2d+7;s2s6d-9;d5s6;s12;s6;s8;s8;s13;s13;s13;/rC:-3.0413,.1096,-.0849;-.3004,1.2561,-.0551;- 3.2804,1.4106,-.7138;-3.5976,-1.1019,-.6884;3.6277,-1.2076,.0479;2.273,.7117,-.0033;-.6907,-1.2763,-.0231;-3.6357,.2114,1.5313;.683,-1.1093,-.0015;-1.3219,-.122,-.0519;1.0438,.1727,-.0151;3.5294,.0106 ,.0277;4.7111,.9345,.0303;2.3074,1.7278,-.0193;-3.5872,-.6498,2.0909;-3.3608,1.0446,2.0673;4.740', 'BZKPWHYZMXOIDC-UHFFFAOYSA-N', '1010:3GCY54WAE8MJ3BX5WD8QQ4RQRGFTZE', '[#16](-[c]1:[n]:[n]:[c](-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[s]1)(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c1nnc(N([H])C(C([H])([H])[H])=O)s1)(N([H])[H])(=O)=O', '-01.329', '-0.579', '0', '0', 'TRUE', '1.442\r\n-4.94e-002\r\n-0.568\r\n-0.568\r\n-0.2777\r\n-0.2631\r\n-0.1601\r\n-0.3839\r\n-0.1281\r\n0.1103\r\n0.1855\r\n0.2143\r\n1.3e-002\r\n0.1577\r\n8.8e-002\r\n8.8e-002\r\n3.28e-002\r\n3.28e-002\r\n3.39000000000001e-002', '0', '-1.274', 'C4H6N4O3S2', '0221.988', '-1.038', '0222.245', '7.4', '5', '2', '3', '5', '05', '1', '13', '13', '11', '5', '007', '03', '6', '0', '1', '002', '0151.65', '205.44', '', '4.87619', '1.3536', '42.02', '13.87', '3.5067', '28.15', '429.136', '277.414', '143.71', '179.89', 'S(=O)(=O)(N([H])[H])/C1=N/N=C(N(C(=O)C([H])([H])[H])[H])\\S1', 'CC(=O)Nc1nnc(S(N)(=O)=O)s1', 'Acetazolamide', 'acetazolamide\nacetamox\nacetazolamid\ncidamex\nnephramide\nacetazolamide sodium', 'Carbonic anhydrase 1', '1986', 'Under Investigation', 'Mucopolysaccharidoses(MPS) hydrocephalus (Type I)', '28929292', 'Mucopolysaccharidoses(MPS) hydrocephalus (Type I)', 'MPS VI , MAROTEAUX-LAMY SYNDROME , ARYLSULFATASE B DEFICIENCY , ARSB DEFICIENCY , N-ACETYLGALACTOSAMINE-4-SULFATASE DEFICIENCY , MUCOPOLYSACCHARIDOSIS TYPE VI , MPS6'),
(36, '1986', '1986', 'CC(=O)Nc1nnc(s1)S(=O)(=O)N', '<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide', 'CYAAFQwABcwQ9nm5agUtz3vZf7E36bfpC8Ye54gbeO92pZUrfR08sBle1zJXW^xXm2lF7OEzndCz7NTl5R5qczEqTutrpdHT3TFyfHZCKL4aWR6UK0CJmtTtM$lBP4OiwIxT7RtkmSIDD4Q9whml8aegBtjtHVJjSNZgEV65C80MLG8lv0Fh4TxkJnHmlYm8zu1jtwTr 84UJcCKkxM$ce6hbsZcKD84MmF8Z5SUzic45r7JchOMU6U1lmV4jVesnesJlKW^EsCtknXzBW5eL90whrTDpeARUzIRV57vjRtc32w7jbW17RZ$Rfm3B375J23yj$Qrba^61Xk4qoezai1UWBxj6snXm9288b9gSvylRu1O6zVib0S27Rzn055O0Ghlo7EVRsO^TLO^V f1HS6VPL65UrfWi4Lv1BaIlXuvyGne6epnrofDVq2IKiBce53FYXg$IEG8ObHAkqodAfImwB9EwdzSnWcDE3odaglC1BBA0u', 'InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)', 'AuxInfo=1/1/N:13,12,11,10,8,6,9,7,5,3,4,2,1/E:(10,11)/CRV:13.6/rA:19SSOOONNNNCCCCHHHHHH/rB:;d1;d1;;;;s1;s7;s1s2d+7;s2s6d-9;d5s6;s12;s6;s8;s8;s13;s13;s13;/rC:-3.0413,.1096,-.0849;-.3004,1.2561,-.0551;- 3.2804,1.4106,-.7138;-3.5976,-1.1019,-.6884;3.6277,-1.2076,.0479;2.273,.7117,-.0033;-.6907,-1.2763,-.0231;-3.6357,.2114,1.5313;.683,-1.1093,-.0015;-1.3219,-.122,-.0519;1.0438,.1727,-.0151;3.5294,.0106 ,.0277;4.7111,.9345,.0303;2.3074,1.7278,-.0193;-3.5872,-.6498,2.0909;-3.3608,1.0446,2.0673;4.740', 'BZKPWHYZMXOIDC-UHFFFAOYSA-N', '1010:3GCY54WAE8MJ3BX5WD8QQ4RQRGFTZE', '[#16](-[c]1:[n]:[n]:[c](-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[s]1)(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c1nnc(N([H])C(C([H])([H])[H])=O)s1)(N([H])[H])(=O)=O', '-01.329', '-0.579', '0', '0', 'TRUE', '1.442\r\n-4.94e-002\r\n-0.568\r\n-0.568\r\n-0.2777\r\n-0.2631\r\n-0.1601\r\n-0.3839\r\n-0.1281\r\n0.1103\r\n0.1855\r\n0.2143\r\n1.3e-002\r\n0.1577\r\n8.8e-002\r\n8.8e-002\r\n3.28e-002\r\n3.28e-002\r\n3.39000000000001e-002', '0', '-1.274', 'C4H6N4O3S2', '0221.988', '-1.038', '0222.245', '7.4', '5', '2', '3', '5', '05', '1', '13', '13', '11', '5', '007', '03', '6', '0', '1', '002', '0151.65', '205.44', '', '4.87619', '1.3536', '42.02', '13.87', '3.5067', '28.15', '429.136', '277.414', '143.71', '179.89', 'S(=O)(=O)(N([H])[H])/C1=N/N=C(N(C(=O)C([H])([H])[H])[H])\\S1', 'CC(=O)Nc1nnc(S(N)(=O)=O)s1', 'Acetazolamide', 'acetazolamide\nacetamox\nacetazolamid\ncidamex\nnephramide\nacetazolamide sodium', 'Carbonic anhydrase 2', '1986', 'Under Investigation', 'Hypokalaemic Periodic Paralysis', '10976636', 'Hypokalaemic Periodic Paralysis', 'HYPP , ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA\nGAMSTORP DISEASE DDDDDSLNFLFNFDLNLNDSLNSLDN');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(37, '1986', '1986', 'CC(=O)Nc1nnc(s1)S(=O)(=O)N', '<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide', 'CYAAFQwABcwQ9nm5agUtz3vZf7E36bfpC8Ye54gbeO92pZUrfR08sBle1zJXW^xXm2lF7OEzndCz7NTl5R5qczEqTutrpdHT3TFyfHZCKL4aWR6UK0CJmtTtM$lBP4OiwIxT7RtkmSIDD4Q9whml8aegBtjtHVJjSNZgEV65C80MLG8lv0Fh4TxkJnHmlYm8zu1jtwTr 84UJcCKkxM$ce6hbsZcKD84MmF8Z5SUzic45r7JchOMU6U1lmV4jVesnesJlKW^EsCtknXzBW5eL90whrTDpeARUzIRV57vjRtc32w7jbW17RZ$Rfm3B375J23yj$Qrba^61Xk4qoezai1UWBxj6snXm9288b9gSvylRu1O6zVib0S27Rzn055O0Ghlo7EVRsO^TLO^V f1HS6VPL65UrfWi4Lv1BaIlXuvyGne6epnrofDVq2IKiBce53FYXg$IEG8ObHAkqodAfImwB9EwdzSnWcDE3odaglC1BBA0u', 'InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)', 'AuxInfo=1/1/N:13,12,11,10,8,6,9,7,5,3,4,2,1/E:(10,11)/CRV:13.6/rA:19SSOOONNNNCCCCHHHHHH/rB:;d1;d1;;;;s1;s7;s1s2d+7;s2s6d-9;d5s6;s12;s6;s8;s8;s13;s13;s13;/rC:-3.0413,.1096,-.0849;-.3004,1.2561,-.0551;- 3.2804,1.4106,-.7138;-3.5976,-1.1019,-.6884;3.6277,-1.2076,.0479;2.273,.7117,-.0033;-.6907,-1.2763,-.0231;-3.6357,.2114,1.5313;.683,-1.1093,-.0015;-1.3219,-.122,-.0519;1.0438,.1727,-.0151;3.5294,.0106 ,.0277;4.7111,.9345,.0303;2.3074,1.7278,-.0193;-3.5872,-.6498,2.0909;-3.3608,1.0446,2.0673;4.740', 'BZKPWHYZMXOIDC-UHFFFAOYSA-N', '1010:3GCY54WAE8MJ3BX5WD8QQ4RQRGFTZE', '[#16](-[c]1:[n]:[n]:[c](-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[s]1)(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c1nnc(N([H])C(C([H])([H])[H])=O)s1)(N([H])[H])(=O)=O', '-01.329', '-0.579', '0', '0', 'TRUE', '1.442\r\n-4.94e-002\r\n-0.568\r\n-0.568\r\n-0.2777\r\n-0.2631\r\n-0.1601\r\n-0.3839\r\n-0.1281\r\n0.1103\r\n0.1855\r\n0.2143\r\n1.3e-002\r\n0.1577\r\n8.8e-002\r\n8.8e-002\r\n3.28e-002\r\n3.28e-002\r\n3.39000000000001e-002', '0', '-1.274', 'C4H6N4O3S2', '0221.988', '-1.038', '0222.245', '7.4', '5', '2', '3', '5', '05', '1', '13', '13', '11', '5', '007', '03', '6', '0', '1', '002', '0151.65', '205.44', '', '4.87619', '1.3536', '42.02', '13.87', '3.5067', '28.15', '429.136', '277.414', '143.71', '179.89', 'S(=O)(=O)(N([H])[H])/C1=N/N=C(N(C(=O)C([H])([H])[H])[H])\\S1', 'CC(=O)Nc1nnc(S(N)(=O)=O)s1', 'Acetazolamide', 'acetazolamide\nacetamox\nacetazolamid\ncidamex\nnephramide\nacetazolamide sodium', 'Small conductance calcium-activated potassium channel protein 2', '1986', 'Under Investigation', 'Kleine-Levin Syndrome', '25317098', 'Kleine-Levin Syndrome', 'HYPP , ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA\nGAMSTORP DISEASE'),
(38, '1986', '1986', 'CC(=O)Nc1nnc(s1)S(=O)(=O)N', '<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide', 'CYAAFQwABcwQ9nm5agUtz3vZf7E36bfpC8Ye54gbeO92pZUrfR08sBle1zJXW^xXm2lF7OEzndCz7NTl5R5qczEqTutrpdHT3TFyfHZCKL4aWR6UK0CJmtTtM$lBP4OiwIxT7RtkmSIDD4Q9whml8aegBtjtHVJjSNZgEV65C80MLG8lv0Fh4TxkJnHmlYm8zu1jtwTr 84UJcCKkxM$ce6hbsZcKD84MmF8Z5SUzic45r7JchOMU6U1lmV4jVesnesJlKW^EsCtknXzBW5eL90whrTDpeARUzIRV57vjRtc32w7jbW17RZ$Rfm3B375J23yj$Qrba^61Xk4qoezai1UWBxj6snXm9288b9gSvylRu1O6zVib0S27Rzn055O0Ghlo7EVRsO^TLO^V f1HS6VPL65UrfWi4Lv1BaIlXuvyGne6epnrofDVq2IKiBce53FYXg$IEG8ObHAkqodAfImwB9EwdzSnWcDE3odaglC1BBA0u', 'InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)', 'AuxInfo=1/1/N:13,12,11,10,8,6,9,7,5,3,4,2,1/E:(10,11)/CRV:13.6/rA:19SSOOONNNNCCCCHHHHHH/rB:;d1;d1;;;;s1;s7;s1s2d+7;s2s6d-9;d5s6;s12;s6;s8;s8;s13;s13;s13;/rC:-3.0413,.1096,-.0849;-.3004,1.2561,-.0551;- 3.2804,1.4106,-.7138;-3.5976,-1.1019,-.6884;3.6277,-1.2076,.0479;2.273,.7117,-.0033;-.6907,-1.2763,-.0231;-3.6357,.2114,1.5313;.683,-1.1093,-.0015;-1.3219,-.122,-.0519;1.0438,.1727,-.0151;3.5294,.0106 ,.0277;4.7111,.9345,.0303;2.3074,1.7278,-.0193;-3.5872,-.6498,2.0909;-3.3608,1.0446,2.0673;4.740', 'BZKPWHYZMXOIDC-UHFFFAOYSA-N', '1010:3GCY54WAE8MJ3BX5WD8QQ4RQRGFTZE', '[#16](-[c]1:[n]:[n]:[c](-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[s]1)(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c1nnc(N([H])C(C([H])([H])[H])=O)s1)(N([H])[H])(=O)=O', '-01.329', '-0.579', '0', '0', 'TRUE', '1.442\r\n-4.94e-002\r\n-0.568\r\n-0.568\r\n-0.2777\r\n-0.2631\r\n-0.1601\r\n-0.3839\r\n-0.1281\r\n0.1103\r\n0.1855\r\n0.2143\r\n1.3e-002\r\n0.1577\r\n8.8e-002\r\n8.8e-002\r\n3.28e-002\r\n3.28e-002\r\n3.39000000000001e-002', '0', '-1.274', 'C4H6N4O3S2', '0221.988', '-1.038', '0222.245', '7.4', '5', '2', '3', '5', '05', '1', '13', '13', '11', '5', '007', '03', '6', '0', '1', '002', '0151.65', '205.44', '', '4.87619', '1.3536', '42.02', '13.87', '3.5067', '28.15', '429.136', '277.414', '143.71', '179.89', 'S(=O)(=O)(N([H])[H])/C1=N/N=C(N(C(=O)C([H])([H])[H])[H])\\S1', 'CC(=O)Nc1nnc(S(N)(=O)=O)s1', 'Acetazolamide', 'acetazolamide\nacetamox\nacetazolamid\ncidamex\nnephramide\nacetazolamide sodium', 'Carbonic anhydrase 1', '1986', 'Under Investigation', 'Mucopolysaccharidoses(MPS) hydrocephalus (Type IV )', '28929292', 'Mucopolysaccharidoses(MPS) hydrocephalus (Type IV )', 'HURLER SYNDROME , MUCOPOLYSACCHARIDOSIS TYPE IH , MPS1-H'),
(39, '1986', '1986', 'CC(=O)Nc1nnc(s1)S(=O)(=O)N', '<I>N</I>-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide', 'CYAAFQwABcwQ9nm5agUtz3vZf7E36bfpC8Ye54gbeO92pZUrfR08sBle1zJXW^xXm2lF7OEzndCz7NTl5R5qczEqTutrpdHT3TFyfHZCKL4aWR6UK0CJmtTtM$lBP4OiwIxT7RtkmSIDD4Q9whml8aegBtjtHVJjSNZgEV65C80MLG8lv0Fh4TxkJnHmlYm8zu1jtwTr 84UJcCKkxM$ce6hbsZcKD84MmF8Z5SUzic45r7JchOMU6U1lmV4jVesnesJlKW^EsCtknXzBW5eL90whrTDpeARUzIRV57vjRtc32w7jbW17RZ$Rfm3B375J23yj$Qrba^61Xk4qoezai1UWBxj6snXm9288b9gSvylRu1O6zVib0S27Rzn055O0Ghlo7EVRsO^TLO^V f1HS6VPL65UrfWi4Lv1BaIlXuvyGne6epnrofDVq2IKiBce53FYXg$IEG8ObHAkqodAfImwB9EwdzSnWcDE3odaglC1BBA0u', 'InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)', 'AuxInfo=1/1/N:13,12,11,10,8,6,9,7,5,3,4,2,1/E:(10,11)/CRV:13.6/rA:19SSOOONNNNCCCCHHHHHH/rB:;d1;d1;;;;s1;s7;s1s2d+7;s2s6d-9;d5s6;s12;s6;s8;s8;s13;s13;s13;/rC:-3.0413,.1096,-.0849;-.3004,1.2561,-.0551;- 3.2804,1.4106,-.7138;-3.5976,-1.1019,-.6884;3.6277,-1.2076,.0479;2.273,.7117,-.0033;-.6907,-1.2763,-.0231;-3.6357,.2114,1.5313;.683,-1.1093,-.0015;-1.3219,-.122,-.0519;1.0438,.1727,-.0151;3.5294,.0106 ,.0277;4.7111,.9345,.0303;2.3074,1.7278,-.0193;-3.5872,-.6498,2.0909;-3.3608,1.0446,2.0673;4.740', 'BZKPWHYZMXOIDC-UHFFFAOYSA-N', '1010:3GCY54WAE8MJ3BX5WD8QQ4RQRGFTZE', '[#16](-[c]1:[n]:[n]:[c](-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[s]1)(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c1nnc(N([H])C(C([H])([H])[H])=O)s1)(N([H])[H])(=O)=O', '-01.329', '-0.579', '0', '0', 'TRUE', '1.442\r\n-4.94e-002\r\n-0.568\r\n-0.568\r\n-0.2777\r\n-0.2631\r\n-0.1601\r\n-0.3839\r\n-0.1281\r\n0.1103\r\n0.1855\r\n0.2143\r\n1.3e-002\r\n0.1577\r\n8.8e-002\r\n8.8e-002\r\n3.28e-002\r\n3.28e-002\r\n3.39000000000001e-002', '0', '-1.274', 'C4H6N4O3S2', '0221.988', '-1.038', '0222.245', '7.4', '5', '2', '3', '5', '05', '1', '13', '13', '11', '5', '007', '03', '6', '0', '1', '002', '0151.65', '205.44', '', '4.87619', '1.3536', '42.02', '13.87', '3.5067', '28.15', '429.136', '277.414', '143.71', '179.89', 'S(=O)(=O)(N([H])[H])/C1=N/N=C(N(C(=O)C([H])([H])[H])[H])\\S1', 'CC(=O)Nc1nnc(S(N)(=O)=O)s1', 'Acetazolamide', 'acetazolamide\nacetamox\nacetazolamid\ncidamex\nnephramide\nacetazolamide sodium', 'Carbonic anhydrase 1', '1986', 'Under Investigation', 'Hyperkalaemic Periodic Paralysis', '18345024', 'Hyperkalaemic Periodic Paralysis', 'KLEINE-LEVIN HIBERNATION SYNDROME'),
(40, '7045767', '7045767', 'CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C', '(3<I>R</I>)-3-acetoxy-4-(trimethylammonio)butanoate', 'CYAAFQwAicwQM8zx3WnpHpq5htHNSiwOh78shupIcKIXZPPVZI^GSHvKyFXxvGWSlAeLm8bnyAwUEKBVQzDS1I6^btit9laHxP^evGOCS1Gf18x7irQMb9W$MwkY^UbKX^NrT39xAKwTwCU7qR2oce4JJA^4ULmd12C9HVJEXj6uLo9Wvg2FPoIQ8kqXIWN33RxWw9ir 4K$5dNsxdyKTSNEXTGSPIz7LUJjxrZWcIC$J4p99cULv9LAINpOZlH7HnTD9oebjBVUp^2mZeuaKZHGvyEMpjro9tSTisUKxHOYsj4G1oSvYUEUq8mXXpLyZ3BpzyqwtjrFrlomVgvWcGt0ooz7azSXTi21OD5N$H^rMzN0gwyx84N8xn5I^a7QrPcUHKX8Iqxxiv2Di Oqot^PqyvMzLtLFvpETvApuNhm3Wcwe$pb^I8eMEnJs8nQ9KPnrRoarTxFOfK1M9New7wEqyZOe3w2HNuD2ZwbunPYR55cPP', 'InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1', 'AuxInfo=1/0/N:14,8,9,10,11,6,13,7,12,5,4,2,3,1/E:(2,3,4)(12,13)/it:im/CRV:10+1,12-1/rA:31OO-OON+CC.eCCCCCCCHHHHHHHHHHHHHHHHH/rB:;;;;s5;s1s6;s5;s5;s5;s7;s2d3s11;s1d4;s13;s6;s6;s7;s8;s8;s8;s9;s9;s9;s10; s10;s10;s11;s11;s14;s14;s14;/r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r\n-0.6397\r\n-0.6397\r\n-0.267\r\n0.1389\r\n6.28e-002\r\n0.1057\r\n2.31e-002\r\n2.31e-002\r\n2.31e-002\r\n4.46e-002\r\n0.1885\r\n0.258\r\n2.21e-002\r\n7.1e-002\r\n7.1e-002\r\n6.52e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44', '1', '-2.909', 'C9H17NO4', '0203.116', '-2.238', '0203.236', '3.58', '2', '0', '2', '11', '00', '0', '14', '13', '23', '2', '005', '00', '17', '0', '0', '006', '0066.43', '264.55', '', '24.611', '1.2442', '22.83', '0.3', '2.88799', '22.53', '281.701', '109.289', '172.52', '', 'O(C(C([N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])([H])[H])(C(C([O-])=O)([H])[H])[H])C(=O)C([H])([H])[H]', 'CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C', 'Acetyl-l-carnitine', 'acetylcarnitine; ALCAR; Nicetile; CHEMBL1697733', 'Solute carrier family 22 member 5', '7045767', 'Phase II/III Completed', 'Carpal Tunnel Syndrome', '27079660', 'Carpal Tunnel Syndrome', 'CTS\nAMYOTROPHY, THENAR, OF CARPAL ORIGIN'),
(41, '5284513', '5284513', 'COc1cc(C)c(\\C=C\\C(=C\\C=C\\C(=C\\C(=O)O)\\C)\\C)c(C)c1C', '(2<I>E</I>,4<I>E</I>,6<I>E</I>,8<I>E</I>)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid', 'CYAAFQwA7cwQFB6QbWaCTEEvsJccWTCkymqBG6j1JbMQ9r$9jJWsd$de0EUKFbzqLRA8^hattqATYzn9j5Z6JNdj1Jg1LMTP9rCXTG9YtJSHvFC0bQU639u2$Cz696f7RHhPAYi^bfPyc19FKYMnrTmNbU4Y7LWBX28o5^6B2QqphbceKfxkMIPss5y58GG0jAW0w7HU yDnvvYCMg8MeoLcence7zp7DsGXRAxEes55TzEc4FD3K8ggqajn1UYUXriL3T4BTXPZ8sUwNxJXX17NVuz18RNuP5xjHZRnPdD16NUa1$CnI6TSgmFO5qJFEcJMCveYu$Va$xNuMRWNYq3VXs0Co0ii9vQd6tJde2OQqLxtrjS5ZfS9bzUu$HP4szsq2UbrF0v1a0s3I Xpzgi7DW8cVin310kQJzHOp$Vs5mxF9DpBkrGFf4Aw71ZkCa5St^44cSASZ1y1qe15J^zHKt$8tnkt^BpN3j3MUrz0JKbSnS', 'InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+', 'AuxInfo=1/1/N:17,22,13,10,12,16,19,18,20,14,11,23,9,15,21,7,4,6,5,8,24,2,3,1/E:(22,23)/rA:50OOOCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;d-4;s4;s5;s1d+6;d-7s8;s4;s5;s6;s7;d+11;s14;s1;s15;d +15;s18;d+19;s20;s21;d+21;s2d3s23;s9;s10;s10;s10;s11;s12;s12;s12;s13;s13;s13;s14;s16;s16;s16;s17;s17;s17;s18;s19;s20;s22;s22;s22;s23;s2;/rC:-6.8482,-.1375,-1.2911;8.6267,-.7398,-1.963;8.7198,-.0507,.2 063;-3.7119,-.9382,.4318;-3.0583,.2817,.3202;-4.9893,-1.0861,-.1089;-3.6584,1.3564,-.3223;-5.601', 'IHUNBGSDBOWDMA-AQFIFDHZSA-N', '1010:K1UAHDWNMAHZVB7Z4FEBY567UZW23N', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c]1\\-[#6](-[#1])=[#6](-[#1])\\-[#6](=[#6](-[#1])\\-[#6](-[#1])=[#6](-[#1])\\-[#6](=[#6](-[#1])\\-[#6](=[#8])-[#8]-[#1])\\-[#6]( -[#1])(-[#1])-[#1])\\-[#6](-[#1])(-[#1])-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c]1-[#6](-[#1])(-[#1])-[#1]', 'O(C([H])([H])[H])c(c([H])c(C([H])([H])[H])c1\\C([H])=C([H])\\C(=C([H])\\C([H])=C([H])\\C(=C([H])\\C(=O)O[H])\\C([H])([H])[H])\\C([H])([H])[H])c(C([H])([H])[H])c1C([H])([H])[H]', '05.665', '5.665', '0', '0', 'TRUE', '-0.3491\r\n-0.3284\r\n-0.2616\r\n-3.81e-002\r\n-1.94e-002\r\n-1.73e-002\r\n-4.1e-002\r\n7.8e-002\r\n-2.8e-002\r\n-3.89e-002\r\n-5.42e-002\r\n-3.69e-002\r\n-3.91e-002\r\n-5.88e-002\r\n-5.12e-002\r\n4.22e-002\r\n-3.98e-002\r\n-5.94e-002\r\n-6.18e-002\r\n-5.91e-002\r\n-4.51e-002\r\n-3.96e-002\r\n1.32e', '0', '4.195', 'C21H26O3', '0326.188', '-7.326', '0326.429', '3.8', '2', '0', '5', '13', '06', '1', '24', '24', '34', '8', '003', '01', '26', '0', '1', '006', '0046.53', '392.69', '', '1.47234', '1.2447', '62.71', '5.85', '5.47135', '56.86', '2,246.49', '106.792', '298.75', '', 'O(/C1=C(C([H])([H])[H])/C(C([H])([H])[H])=C(/C(=C(/C(C([H])([H])[H])=C(/C(=C(/C(C([H])([H])[H])=C(C(O[H])=O)\\[H])\\[H])[H])\\[H])\\[H])[H])\\C(C([H])([H])[H])=C1\\[H])C([H])([H])[H]', 'COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C', 'Acitretin', 'Etretin; Soriatane; Neotigason; Retinoid etretin; Isoetretin; RP17661', 'Retinoic acid receptor alpha', '5284513', 'Unknown', 'Alzheimer disease (AD)', '24608847', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(42, '42', 'Not Available', 'FC(F)(F)C1(CC1)c2ccc(CC(=O)NC3CCN(Cc4ccc(cc4)C#N)N3)cc2', '<I>N</I>-[1-[(4-cyanophenyl)methyl]pyrazolidin-3-yl]-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]acetamide', 'CYAAFQwAvdwQuTbx2V6I$4SMIQ$DnmQl2J3$U0Qm$3AyDAwkPEEdK2s4avf^yiDagg$Sw7tI0b04sg^0XvaCKnS27KFeseYn$YwzidFOrzCJeZpOO4joscXG0HuznfijS4H7V5uIwKZge^0cfZ0QLSQSkvvo^^s2RSQcLJpwKANkSyH1z5lkv7JDVhZcN0vr^6r7KxJC ^tilDTVAOw1QkrfJUKWEI4^O3k8HQQIO$aOeR8Mvz9FsXAZG505$ca0q5Vu0VeJGAf$rQUoq3^83mPnMDEtPkjQ$ZOH6631A0X9KMsCmXmlf5IegXG5VcZ253EDSJJyfEkvV^sJFJWmACw3qbSQS3o0P44W$J6ftj6oN$UHhv562NZFX06yKJY8b8qEeydhz4aVqqdFa 9$U7LPo$vytuMKlQ^Mbh3^CJnC8GgcOUIvNAspvrOy8t3gT45OPzcsRffnVGuirIpmAqoP0qiwSGQAO1xOmOVy2RVBrufLi7', 'InChI=1S/C23H23F3N4O/c24-23(25,26)22(10-11-22)19-7-5-16(6-8-19)13-21(31)28-20-9-12-30(29-20)15-18-3-1-17(14-27)2-4-18/h1-8,20,29H,9-13,15H2,(H,28,31)', 'AuxInfo=1/1/N:26,27,24,25,1,4,3,6,18,8,9,20,14,29,22,2,28,23,5,17,15,7,10,11,12,13,30,16,19,21,31/E:(1,2)(3,4)(5,6)(7,8)(10,11)(24,25,26)/rA:31CCCCCCCCCCFFFCCNCCNCNCCCCCCCCNO/rB:s1;d-1;d-2;s3;s4d-5;s5 ;s7;s7s8;s7;s10;s10;s10;s2;s14;s15;s16;s17;s17;s18;s19s20;s21;s22;s23;d+23;d-24;s25;s26d-27;s28;t29;d15;/rC:9.5243,-11.901,0;9.5243,-12.726,0;8.8099,-11.4885,0;8.8099,-13.1385,0;8.0954,-11.901,0;8.095 4,-12.726,0;7.381,-11.4885,0;6.556,-11.4885,0;6.9685,-10.774,0;8.206,-11.4885,0;8.206,-10.6635,0', 'SDXVQNIHBNLOIJ-UHFFFAOYSA-N', '1010:5U536BNFH1N8X1S81EH4XTPPSVGYQC', '[c]1:[c]:[c](-[#6]2(-[#6](-[#9])(-[#9])-[#9])-[#6]-[#6]2):[c]:[c]:[c]1-[#6]-[#6](=[#8])-[#7]-[#6]3-[#7]-[#7](-[#6]-[c]4:[c]:[c]:[c](-[#6]#[#7]):[c]:[c]4)-[#6]-[#6]3', 'c1cc(C2(C(F)(F)F)CC2)ccc1CC(=O)NC3NN(Cc4ccc(C#N)cc4)CC3', '03.539', '4.315', '2', '0', 'TRUE', '-5.83e-002\r\n-3.89e-002\r\n-5.79e-002\r\n-5.83e-002\r\n-3.29e-002\r\n-5.79e-002\r\n9.1e-002\r\n-3.36e-002\r\n-3.36e-002\r\n0.3979\r\n-0.1701\r\n-0.1701\r\n-0.1701\r\n4.95e-002\r\n0.2173\r\n-0.2985\r\n8.7e-002\r\n-5.8e-003\r\n-0.2348\r\n1.66e-002\r\n-0.2383\r\n3.82e-002\r\n-3.24e-002\r\n-5.64e-002\r\n-', '0', '3.539', 'C23H23F3N4O', '0428.182', '-6.161', '0428.45', '0.73', '1', '2', '1', '20', '12', '2', '31', '34', '8', '7', '005', '02', '23', '0', '4', '007', '0068.16', '418.93', '', '', '', '', '', '', '', '', '', '', '', 'C/2=C/C(C1(C(F)(F)F)CC1)=C\\C=C2\\CC(NC4CCN(C/C/3=C/C=C(C#N)\\C=C3)N4)=O', 'N#Cc4ccc(CN3CCC(NC(=O)Cc2ccc(C1(C(F)(F)F)CC1)cc2)N3)cc4', 'ACT-709478', 'Not Available', 'Voltage-dependent T-type calcium channel subunit alpha-1G', 'Not Available', 'Under Investigation', 'Epilepsy', '29116786', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(43, '10130337', '10130337', 'N[C@@H](COC(=O)N)Cc1ccccc1', '[(2<I>R</I>)-2-amino-3-phenyl-propyl] carbamate', 'CYAAFQwABcwQd5$BkjJHmrXD9Od4jvr6c3hy5TW3$L5A$rjHxFOPgie7DAMcnyZruxXwA^7El8onuo1nX5G5Tn4SZP186dN5miGrh$slSP$XZ7frweLvxLNg9D7K^sPcrMzHAgwfoFolmraxsOhxhpIoWqQEkUynv6hNHyFAtuWhhFGQeczqyKqrqGd6rILpvyyd741s 4hNVru4yZC9pN65BKwbNOGPJ7vfzWYvV2eTan8MGxYBZjHk0DfRXJZ2IV4$rVcjibvmlVsBxhrudUYUrtjWNjadd3mRt2nK45WBret39G2nGGFmilDHNzceiDil6hUxBXGPLkz79SJaS$gcZ7OFqjlw6sSg816Rh^41WQayEtPjXHFUW$nXmebjDoAAqVk0tZmneSiYe sT0OjbFFPPhhmazaspnGjf$WfTHTv2U0qI2E9U8Wy^0rD4eZ^KHhBjiBhH^804xJSzbiNYfBz^tKWOqWGH$mzn1$PkKi9ErG', 'InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1', 'AuxInfo=1/1/N:13,11,12,9,10,6,8,7,5,14,3,4,2,1/E:(2,3)(4,5)/it:im/rA:28OONNC.oCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;s3;s5;s6;s1s5;d+7;s7;s9;d-10;d-11s12;s1d2s4;s5;s6;s6;s8;s8;s3;s3;s9;s10;s11;s12;s13;s4;s4;/r C:2.1589,-.0881,-.2141;3.0035,1.5502,1.1651;1.4849,-2.8284,-.0871;3.6502,1.3931,-1.0358;.5538,-1.8024,.3928;-.4299,-1.4708,-.7491;-1.4884,-.455,-.3929;1.3727,-.5922,.8575;-2.6936,-.8874,.1377;-1.2358, .8916,-.6022;-3.6715,.051,.4671;-2.2137,1.83,-.2726;-3.4317,1.4096,.2622;2.9406,.9987,.0714;.000', 'UCTRAOBQFUDCSR-SECBINFHSA-N', '1010:7CU1DQUS9G48GYXTB5URQXZ7E9BTBU', '[#8](-[#6](-[#7](-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#1]', 'O(C(N([H])[H])=O)C([H])([H])[C@@]([H])(C([H])([H])c1c([H])c([H])c([H])c([H])c1[H])N([H])[H]', '00.915', '0.915', '0', '0', 'TRUE', '-0.299\r\n-0.2428\r\n-0.3255\r\n-0.3048\r\n3.24e-002\r\n-1.04e-002\r\n-4.64e-002\r\n7.34e-002\r\n-5.9e-002\r\n-5.9e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n0.3479\r\n4.9e-002\r\n3.32e-002\r\n3.32e-002\r\n5.9e-002\r\n5.9e-002\r\n0.1187\r\n0.1187\r\n6.25e-002\r\n6.25e-002\r\n6.22e-002\r\n6.22e-002', '1', '0.101', 'C10H14N2O2', '0194.106', '-2.275', '0194.23', '8.59', '2', '2', '1', '7', '06', '1', '14', '14', '17', '4', '004', '04', '14', '0', '1', '005', '0078.34', '215.38', '', '1.21859', '1.2421', '11.51', '3', '3.15022', '8.51', '339.321', '162.915', '157.43', '', 'O(C(C(N([H])[H])(C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])([H])[H])[H])([H])[H])C(=O)N([H])[H]', 'NC(=O)OCC(N)Cc1ccccc1', 'ADX-N05', 'UNII-939U7C91AI; O-Carbamoyl-(D)-phenylalaninol; ZINC34278783; JZP-110', 'Sodium-dependent noradrenaline transporter', '10130337', 'Phase III', 'Narcolepsy', '27166238', 'Narcolepsy', 'NARCOLEPTIC SYNDROME 1'),
(44, '10130337', '10130337', 'N[C@@H](COC(=O)N)Cc1ccccc1', '[(2<I>R</I>)-2-amino-3-phenyl-propyl] carbamate', 'CYAAFQwABcwQd5$BkjJHmrXD9Od4jvr6c3hy5TW3$L5A$rjHxFOPgie7DAMcnyZruxXwA^7El8onuo1nX5G5Tn4SZP186dN5miGrh$slSP$XZ7frweLvxLNg9D7K^sPcrMzHAgwfoFolmraxsOhxhpIoWqQEkUynv6hNHyFAtuWhhFGQeczqyKqrqGd6rILpvyyd741s 4hNVru4yZC9pN65BKwbNOGPJ7vfzWYvV2eTan8MGxYBZjHk0DfRXJZ2IV4$rVcjibvmlVsBxhrudUYUrtjWNjadd3mRt2nK45WBret39G2nGGFmilDHNzceiDil6hUxBXGPLkz79SJaS$gcZ7OFqjlw6sSg816Rh^41WQayEtPjXHFUW$nXmebjDoAAqVk0tZmneSiYe sT0OjbFFPPhhmazaspnGjf$WfTHTv2U0qI2E9U8Wy^0rD4eZ^KHhBjiBhH^804xJSzbiNYfBz^tKWOqWGH$mzn1$PkKi9ErG', 'InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1', 'AuxInfo=1/1/N:13,11,12,9,10,6,8,7,5,14,3,4,2,1/E:(2,3)(4,5)/it:im/rA:28OONNC.oCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;s3;s5;s6;s1s5;d+7;s7;s9;d-10;d-11s12;s1d2s4;s5;s6;s6;s8;s8;s3;s3;s9;s10;s11;s12;s13;s4;s4;/r C:2.1589,-.0881,-.2141;3.0035,1.5502,1.1651;1.4849,-2.8284,-.0871;3.6502,1.3931,-1.0358;.5538,-1.8024,.3928;-.4299,-1.4708,-.7491;-1.4884,-.455,-.3929;1.3727,-.5922,.8575;-2.6936,-.8874,.1377;-1.2358, .8916,-.6022;-3.6715,.051,.4671;-2.2137,1.83,-.2726;-3.4317,1.4096,.2622;2.9406,.9987,.0714;.000', 'UCTRAOBQFUDCSR-SECBINFHSA-N', '1010:7CU1DQUS9G48GYXTB5URQXZ7E9BTBU', '[#8](-[#6](-[#7](-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#1]', 'O(C(N([H])[H])=O)C([H])([H])[C@@]([H])(C([H])([H])c1c([H])c([H])c([H])c([H])c1[H])N([H])[H]', '00.915', '0.915', '0', '0', 'TRUE', '-0.299\r\n-0.2428\r\n-0.3255\r\n-0.3048\r\n3.24e-002\r\n-1.04e-002\r\n-4.64e-002\r\n7.34e-002\r\n-5.9e-002\r\n-5.9e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n0.3479\r\n4.9e-002\r\n3.32e-002\r\n3.32e-002\r\n5.9e-002\r\n5.9e-002\r\n0.1187\r\n0.1187\r\n6.25e-002\r\n6.25e-002\r\n6.22e-002\r\n6.22e-002', '1', '0.101', 'C10H14N2O2', '0194.106', '-2.275', '0194.23', '8.59', '2', '2', '1', '7', '06', '1', '14', '14', '17', '4', '004', '04', '14', '0', '1', '005', '0078.34', '215.38', '', '1.21859', '1.2421', '11.51', '3', '3.15022', '8.51', '339.321', '162.915', '157.43', '', 'O(C(C(N([H])[H])(C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])([H])[H])[H])([H])[H])C(=O)N([H])[H]', 'NC(=O)OCC(N)Cc1ccccc1', 'ADX-N05', 'UNII-939U7C91AI; O-Carbamoyl-(D)-phenylalaninol; ZINC34278783; JZP-110', 'Sodium-dependent dopamine transporter', '10130337', 'Phase III', 'Narcolepsy', '27166238', 'Narcolepsy', 'NARCOLEPTIC SYNDROME 1'),
(45, '45', 'Not Available', 'CCCCOc1cc(cc(OCCCC)c1O)C(C)(c2cc(OCCCC)c(O)c(OCCCC)c2)c3cc(OCCCC)c(O)c(OCCCC)c3', '4-[1,1-bis(3,5-dibutoxy-4-hydroxy-phenyl)ethyl]-2,6-dibutoxy-phenol', 'CYAAFQwAdfwQEUVoJ4FwPldp7UIdJ55cFTx3WPBo64EJuRRA$0uPcHGsgM$zW3giLcUkuxmUpL5PlwIyOAlwk^L$SS9Ci5q$eU0RX$paSPdbEmAqUmPLOEnG^dnuuniSALwFeqls^v6CXIoH$Xqz961B46L43Ne7USPPLjMaCXqPAx7W59ak$MF6UG0470XCfR17Q$IA qN^r4auNfMgxMDWmlJ5ySe003wJZZSpIv0Ce4gker3O570Mm984G2nhBUh^o8yGpfVigLg88fnEwJKoSvvDeI7pK0pDxxXQvU$SEql7seqwcjjuQ8efPA0Fp7zZOD^eAf0D^0N0rGgpXv5KvNzzpOi4mYI36L29zLjiVmfNiHqo^6YmPv^h3z5m8hNuW5sM4sefdJK1J vP3Vyrr76EOL9LtX4NcAMHK5keAnTgQ1EZPP^yFdij3^Oj6wN487O3KogZ$HE5LcecU7tfT7wY6G9vWxjWfr64dUziz92N6f', 'InChI=1S/C44H66O9/c1-8-14-20-48-35-26-32(27-36(41(35)45)49-21-15-9-2)44(7,33-28-37(50-22-16-10-3)42(46)38(29-33)51-23-17-11-4)34-30-39(52-24-18-12-5)43(47)40(31-34)53-25-19-13-6/h26-31,45-47H,8-25H2,1 -7H3', 'AuxInfo=1/0/N:33,37,41,45,49,53,20,32,36,40,44,48,52,31,35,39,43,47,51,30,34,38,42,46,50,12,11,14,18,4,1,13,16,2,10,9,15,19,6,3,8,17,5,7,28,24,22,27,29,25,26,23,21/E:(1,2,3,4,5,6)(8,9,10,11,12,13)(14, 15,16,17,18,19)(20,21,22,23,24,25)(26,27,28,29,30,31)(32,33,34)(35,36,37,38,39,40)(41,42,43)(45,46,47)(48,49,50,51,52,53)/rA:53CCCCCCCCCCCCCCCCCCCCOOOOOOOOOCCCCCCCCCCCCCCCCCCCCCCCC/rB:s1;d-1;d-2;s3;s4 d-5;s2;;s8;d-8;d-9;s10;s7s11d+12;;s14;s7d+14;d-15;s16;s17d-18;s7;s3;s5;s6;s17;s15;s19;s10;s8;s9;', 'FIGQQSJRICCLGT-UHFFFAOYSA-N', '1010:EUQJR4NJR341HK47XND9QZV29K6CX2', '[c]1:[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c](-[#8]):[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c]:[c]1-[#6](-[#6])(-[c](:[c]:[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c](-[#8]):[c]2-[#8]-[#6]-[#6]-[#6]-[#6]):[c]2)-[c](:[c]:[c] (-[#8]-[#6]-[#6]-[#6]-[#6]):[c]3-[#8]):[c]:[c]3-[#8]-[#6]-[#6]-[#6]-[#6]', 'c1c(OCCCC)c(O)c(OCCCC)cc1C(C)(c(cc(OCCCC)c(O)c2OCCCC)c2)c(cc(OCCCC)c3O)cc3OCCCC', '12.442', '12.442', '0', '0', 'TRUE', '-2.45e-002\r\n-2.79e-002\r\n0.1079\r\n-2.45e-002\r\n0.1324\r\n0.1079\r\n4.28e-002\r\n0.1324\r\n0.1079\r\n0.1079\r\n-2.45e-002\r\n-2.45e-002\r\n-2.79e-002\r\n-2.45e-002\r\n0.1079\r\n-2.79e-002\r\n0.1324\r\n-2.45e-002\r\n0.1079\r\n-4.73e-002\r\n-0.3433\r\n-0.3562\r\n-0.3433\r\n-0.3562\r\n-0.3433\r\n-0.3433', '0', '12.438', 'C44H66O9', '0738.471', '-11.486', '0738.989', '9.37 10.45 11.54', '6', '3', '0', '37', '18', '3', '53', '55', '12', '9', '009', '03', '66', '0', '3', '027', '0116.07', '832.51', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C(OCCCC)/C(O)=C(OCCCC)\\C=C1\\C(\\C\\2=C\\C(OCCCC)=C(O)/C(OCCCC)=C2)(\\C\\3=C\\C(OCCCC)=C(O)/C(OCCCC)=C3)C', 'CCCCOc3cc(C(C)(c1cc(OCCCC)c(O)c(OCCCC)c1)c2cc(OCCCC)c(O)c(OCCCC)c2)cc(OCCCC)c3O', 'AGS-499', 'Not Available', 'Telomerase', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22351600', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(46, '25243838', '25243838', 'Nc1ncnc(NCCc2cnc(NC(=O)Nc3cccc(c3)C(F)(F)F)s2)c1Br', '1-[5-[2-[(6-amino-5-bromo-pyrimidin-4-yl)amino]ethyl]thiazol-2-yl]-3-[3-(trifluoromethyl)phenyl]urea', 'CYAAFQwA4cwQS99J3twSZ18mlOgqdecgczQMJs8e3Q7AVdpoaMyKRnac45D9rAgOROEatn7M6OENhpuuolx0ZPzvytCbt8nmHrBbXRVFkI4DLY9TnY$9^9xQL$reaJCt^ziCuf$$C8S5fhLg1CnP27jxgIbqs2jjlLAaz^74uvn8YWUduH7KMX9cal^ex6lb6sO2VglV PcAkDBgKl3W$c3eaIIfc2v5eGPOzVvuxGjXUg58FkNl2YlX2NtSv879KGyOtF$Y5qG090m$izAo0C7tvVep8iU9BiGLwIXu2NQMv45dNteasam6yWqVUxvL8roDqxMlzIxzzNnsQG$6byMtTctPi$KYdyQ78CreYmzXT2i0i4r18pecbrDDVP4x0eeTx2SGVS^amojGV 0^2FP62yqPHq9eIjC8akwy77mjtoPHmqhWFzYnXPlcWDK9hAahvjNg^ezyV140oOaDzXx^Jw5Qd6ihIr$Xo$UPCy8JJIibQL', 'InChI=1S/C17H15BrF3N7OS/c18-12-13(22)25-8-26-14(12)23-5-4-11-7-24-16(30-11)28-15(29)27-10-3-1-2-9(6-10)17(19,20)21/h1-3,6-8H,4-5H2,(H3,22,23,25,26)(H2,24,27,28,29)', 'AuxInfo=1/1/N:27,25,23,14,15,22,17,30,21,20,16,26,29,19,24,18,28,1,3,4,5,13,7,8,12,11,10,9,6,2/E:(19,20,21)/rA:45BrSFFFONNNNNNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;s7s14;s2s14;s8d-16;s2d-8 s9;s7d+11;s10;;s20d-21;d+20;d6s9s10;s21;s1s19;s23d-25;s3s4s5s21;s12s13d+26;s11d-12;s14;s14;s15;s15;s7;s17;s22;s9;s10;s23;s25;s27;s30;s13;s13;/rC:-3.8539,2.3411,-1.184;-1.671,-1.4869,-1.5896;8.5867,1.7 013,-.003;7.6361,1.2165,-1.8913;6.9143,2.896,-.7134;1.9672,-1.9591,1.2981;-4.9487,-.5033,-.656;-', 'RLZZNXXMMUZRIT-UHFFFAOYSA-N', '1010:CZZSU9NP98B3NPTBGE467X413SP52M', '[#35]-[c](:[c](-[#7](-[#1])-[#1]):[n]:[c](-[#1]):[n]1):[c]1-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[c]2:[c](-[#1]):[n]:[c](-[#7](-[#1])-[#6](-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1 ]):[c](-[#6](-[#9])(-[#9])-[#9]):[c]3-[#1])=[#8]):[s]2', 'Brc(c(N([H])[H])nc([H])n1)c1N([H])C([H])([H])C([H])([H])c2c([H])nc(N([H])C(N([H])c3c([H])c([H])c([H])c(C(F)(F)F)c3[H])=O)s2', '03.482', '3.812', '0', '0', 'TRUE', '-4.39e-002\r\n-5.7e-002\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.2535\r\n-0.2716\r\n-0.2336\r\n-0.2476\r\n-0.2689\r\n-0.2237\r\n-0.224\r\n-0.2858\r\n-6.9e-003\r\n6.e-003\r\n1.22e-002\r\n3.96e-002\r\n0.1647\r\n0.1247\r\n3.45e-002\r\n5.73e-002\r\n-2.85e-002\r\n-4.07e-002\r\n0.3081\r\n-4.99e-002\r\n9.11e-002\r', '0', '3.695', 'C17H15BrF3N7OS', '0501.019', '-6.964', '0502.312', '-1 5.22 8.52', '4', '4', '1', '14', '17', '3', '30', '32', '23', '9', '008', '05', '15', '0', '3', '007', '0146.09', '430.76', '', '2.73268', '1.3106', '70.86', '32.37', '5.75395', '38.49', '3,359.37', '204.167', '317.96', '', 'Br/C1=C(N([H])[H])/N=C([H])\\N=C1\\N(C(C(/C3=C([H])/N=C(N(C(=O)N(/C2=C([H])/C([H])=C([H])\\C(C(F)(F)F)=C2\\[H])[H])[H])\\S3)([H])[H])([H])[H])[H]', 'Nc3ncnc(NCCc2cnc(NC(=O)Nc1cccc(C(F)(F)F)c1)s2)c3Br', 'AK7', 'Not Available', 'Sirtuin-2', '25243838', 'Under Investigation', 'Parkinson Disease(PARK)', '25608039', 'Parkinson Disease(PARK)', 'PARK'),
(47, '92786', '92786', 'CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C', '1-[(3<I>R</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17 -yl]ethanone', 'CYAAFQwAncwQ^b2mw4ylj6ujTIZYhnUkRvqAdmaEwZvyb$6vGDVFkpTWYRwTdWpcpbbY8D$f$P28w64c0RGBbtmZfvRIZ^0lpz4Uab2XHHR7MOpv83nh83T992f5VsCa^nhS^zP89ytfAUE^LfOEo7xhbofVxxEH84BMvgpahd5vKOvoeKuHJLAPia4t^71DlqZDarWv BK8z5vWVlwTqhbbXYIGAC66bVXY60PzlHOIPeiFE^8UEfyE7DG6$bIFT4Jfi1r1gf8zUrBGdIgUqzPSP70O$dzxZTJyhEdDzl^$t1XKAE9H7imi9g2POt0q4ra14KjHP2MOPe9wbRO4rRjKjHONHt3zkOGa8sVQaatq1n^Zbm5gntSbo7mGyqlXNTwHiEL^eOYuWR2qd 14zLrjN9jxNsrh7rUyUbWqYHocd1eOt$ULIHV^vMuuCI79ESVjCd$VEVPDmdLttq9gFHspQeie$gXKu8cYWAG2pn5tcbmnzn', 'InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1', 'AuxInfo=1/0/N:23,19,18,14,11,16,13,20,9,15,10,17,22,8,21,4,12,5,3,7,6,2,1/it:im/rA:57OOC.eC.oC.eC.oC.oC.eCCCC.oCCCCCCCCC.eCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s5;s3;s7;s3;s6s9;s4;s6;s5;s8s1 1;s7;s12s13;s8;s6;s7;s15;s1s17s20;d2s12;s22;s3;s4;s5;s8;s9;s9;s10;s10;s11;s11;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s18;s18;s18;s19;s19;s19;s20;s20;s21;s23;s23;s23;s1;/rC:-5.1964,-.3257,1.6786;5 .4994,-.2044,-.7145;-.7078,-.3685,.1656;.023,.9541,-.2359;1.4208,.9495,.3932;2.2848,-.2453,-.066', 'AURFZBICLPNKBZ-SYBPFIFISA-N', '1010:5B1M15CC613FAHYH654DG2D6YXCYC8', '[#8](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6@@]2(-[#1])-[#6@@](-[#6](-[#1])(-[#1])-[#1])(-[ #6@@](-[#1])(-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[#6@]34-[#1])-[#6@]14-[#6](-[#1])(-[#1])-[#1]', 'O([H])[C@]([H])(C([H])([H])C1([H])[H])C([H])([H])[C@]([H])(C([H])([H])C([H])([H])[C@@]([H])([C@@]2([H])[C@@](C([H])([H])[H])([C@@]([H])(C(C([H])([H])[H])=O)C([H])([H])C2([H])[H])C([H])([H])C3([H])[H]) [C@]34[H])[C@]14C([H])([H])[H]', '03.874', '3.874', '0', '0', 'TRUE', '-0.3931\r\n-0.2997\r\n-3.26e-002\r\n-3.47e-002\r\n-3.22e-002\r\n-1.98e-002\r\n-2.65e-002\r\n-3.33e-002\r\n-4.91e-002\r\n-4.66e-002\r\n-4.96e-002\r\n2.29e-002\r\n-4.9e-002\r\n-4.96e-002\r\n-4.49e-002\r\n-4.27e-002\r\n-2.37e-002\r\n-5.87e-002\r\n-5.91e-002\r\n-2.65e-002\r\n5.43e-002\r\n0.1329\r\n-5.4', '1', '3.874', 'C21H34O2', '0318.256', '-5.692', '0318.493', '', '1', '1', '1', '25', '00', '0', '23', '26', '39', '1', '002', '01', '34', '0', '4', '001', '0037.29', '341.56', '', '2.61753', '1.2789', '31.45', '15.64', '3.8937', '15.81', '958.335', '76.558', '290.17', '', 'O(C4([H])C([H])([H])C3([H])C(C([H])([H])[H])(C1([H])C([H])(C2([H])C(C([H])([H])[H])(C([H])([H])C1([H])[H])C(C(=O)C([H])([H])[H])([H])C([H])([H])C2([H])[H])C([H])([H])C3([H])[H])C([H])([H])C4([H])[H])[H]', 'CC(=O)C3CCC4C2CCC1CC(O)CCC1(C)C2CCC34C', 'Allopregnanolone', 'SGE-872; 3alpha-OH DHP; SAGE-547; Brexanolone; LS-118573', 'Gamma-aminobutyric acid type B receptor subunit 1', '92786', 'Phase II', 'Fragile X-Associated Tremor Ataxia Syndrome', '26308557', 'Fragile X-Associated Tremor Ataxia Syndrome', 'RAGILE X TREMOR/ATAXIA SYNDROME; FXTAS'),
(48, '92786', '92786', 'CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C', '1-[(3<I>R</I>,5<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>S</I>,13<I>S</I>,14<I>S</I>,17<I>S</I>)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1<I>H</I>-cyclopenta[a]phenanthren-17 -yl]ethanone', 'CYAAFQwAncwQ^b2mw4ylj6ujTIZYhnUkRvqAdmaEwZvyb$6vGDVFkpTWYRwTdWpcpbbY8D$f$P28w64c0RGBbtmZfvRIZ^0lpz4Uab2XHHR7MOpv83nh83T992f5VsCa^nhS^zP89ytfAUE^LfOEo7xhbofVxxEH84BMvgpahd5vKOvoeKuHJLAPia4t^71DlqZDarWv BK8z5vWVlwTqhbbXYIGAC66bVXY60PzlHOIPeiFE^8UEfyE7DG6$bIFT4Jfi1r1gf8zUrBGdIgUqzPSP70O$dzxZTJyhEdDzl^$t1XKAE9H7imi9g2POt0q4ra14KjHP2MOPe9wbRO4rRjKjHONHt3zkOGa8sVQaatq1n^Zbm5gntSbo7mGyqlXNTwHiEL^eOYuWR2qd 14zLrjN9jxNsrh7rUyUbWqYHocd1eOt$ULIHV^vMuuCI79ESVjCd$VEVPDmdLttq9gFHspQeie$gXKu8cYWAG2pn5tcbmnzn', 'InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1', 'AuxInfo=1/0/N:23,19,18,14,11,16,13,20,9,15,10,17,22,8,21,4,12,5,3,7,6,2,1/it:im/rA:57OOC.eC.oC.eC.oC.oC.eCCCC.oCCCCCCCCC.eCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s5;s3;s7;s3;s6s9;s4;s6;s5;s8s1 1;s7;s12s13;s8;s6;s7;s15;s1s17s20;d2s12;s22;s3;s4;s5;s8;s9;s9;s10;s10;s11;s11;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s18;s18;s18;s19;s19;s19;s20;s20;s21;s23;s23;s23;s1;/rC:-5.1964,-.3257,1.6786;5 .4994,-.2044,-.7145;-.7078,-.3685,.1656;.023,.9541,-.2359;1.4208,.9495,.3932;2.2848,-.2453,-.066', 'AURFZBICLPNKBZ-SYBPFIFISA-N', '1010:5B1M15CC613FAHYH654DG2D6YXCYC8', '[#8](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6@@]2(-[#1])-[#6@@](-[#6](-[#1])(-[#1])-[#1])(-[ #6@@](-[#1])(-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[#6@]34-[#1])-[#6@]14-[#6](-[#1])(-[#1])-[#1]', 'O([H])[C@]([H])(C([H])([H])C1([H])[H])C([H])([H])[C@]([H])(C([H])([H])C([H])([H])[C@@]([H])([C@@]2([H])[C@@](C([H])([H])[H])([C@@]([H])(C(C([H])([H])[H])=O)C([H])([H])C2([H])[H])C([H])([H])C3([H])[H]) [C@]34[H])[C@]14C([H])([H])[H]', '03.874', '3.874', '0', '0', 'TRUE', '-0.3931\r\n-0.2997\r\n-3.26e-002\r\n-3.47e-002\r\n-3.22e-002\r\n-1.98e-002\r\n-2.65e-002\r\n-3.33e-002\r\n-4.91e-002\r\n-4.66e-002\r\n-4.96e-002\r\n2.29e-002\r\n-4.9e-002\r\n-4.96e-002\r\n-4.49e-002\r\n-4.27e-002\r\n-2.37e-002\r\n-5.87e-002\r\n-5.91e-002\r\n-2.65e-002\r\n5.43e-002\r\n0.1329\r\n-5.4', '1', '3.874', 'C21H34O2', '0318.256', '-5.692', '0318.493', '', '1', '1', '1', '25', '00', '0', '23', '26', '39', '1', '002', '01', '34', '0', '4', '001', '0037.29', '341.56', '', '2.61753', '1.2789', '31.45', '15.64', '3.8937', '15.81', '958.335', '76.558', '290.17', '', 'O(C4([H])C([H])([H])C3([H])C(C([H])([H])[H])(C1([H])C([H])(C2([H])C(C([H])([H])[H])(C([H])([H])C1([H])[H])C(C(=O)C([H])([H])[H])([H])C([H])([H])C2([H])[H])C([H])([H])C3([H])[H])C([H])([H])C4([H])[H])[H]', 'CC(=O)C3CCC4C2CCC1CC(O)CCC1(C)C2CCC34C', 'Allopregnanolone', 'SGE-872; 3alpha-OH DHP; SAGE-547; Brexanolone; LS-118573', 'Gamma-aminobutyric acid type B receptor subunit 1', '92786', 'Phase II Completed', 'Epilepsy', '24944264', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(49, '123606', '123606', 'CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12', '<I>N</I>,<I>N</I>-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1<I>H</I>-indol-3-yl]ethanamine', 'CYAAFQwAmdwQZjBRRnJkKMRBrYq128UaRD17PM$kuyWhx6ldbcvXd1j9BniaC1UcNCHOlhn42hOK0RolMTk9aQ2SB^IK9BkYpoLgEsZIyw^bWf47Ru1rN5xw0mCvv6rtaLyJAQw3oH4jx4EkgCnVifuow54Etaf1F3czUJ867X9XhHOW9jbPwLfubSBUiT3K2PWy4PPu cGACB3tdKns5XrdnJffhPA7Bdci3n0ZwDxzDkHPvrcEIO19TdqtnCx$Nfl$h0HMClGBQyrb^QAE9gMFrdWkaAin35Vhrcp45OLOXNR$seJz^ropcTz8wedZjT1bjiLZDePTq3mbeLl6W^LDZ9n5SvusxyCbXV6Yhh6eaQ79dcBOQGVWa3sYbwH488aJtT6u72b$JMfpZ U69ZAizzi7dIvkBsq0fDsCpDu2Mn1cZIUeazefGTZBp4QyXTJmiax9mIi1OZHFbVdfYnH0Y4rqSPQVqa3dkuCyhnCPLZOFLj', 'InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3', 'AuxInfo=1/0/N:22,23,9,10,17,19,18,7,8,21,14,20,11,12,15,13,16,5,6,4,2,3,1/E:(1,2)(3,4)(8,9)(21,22)/CRV:23.6/rA:48SOONNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d1;d1;s1;;;s4;s4;s7;s8s9;s1;s11;;d+ 12s13;s13;s5d+13;s12;s15;s16d-17;s5d-15;s6s18;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s14;s18;s18;s17;s19;s20;s5;s21;s21;s22;s22;s22;s23;s23;s23;/rC:2.4729,.1518,-.9855;2.7432,-.9587,-1.8793;1.5146,1. 1823,-1.3389;3.9401,.8806,-.5372;-3.0381,-2.9373,-.0848;-4.2816,2.7863,-.0568;3.907,1.942,.5114;', 'WKEMJKQOLOHJLZ-UHFFFAOYSA-N', '1010:V2F94ZNZAPVBH7APRG7K486XHPQRYS', '[#16](-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c]2:[c](:[c](:[c](-[#1]):[n]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]1-[#1])(-[#7] 3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])(=[#8])=[#8]', 'S(C([H])([H])c1c([H])c([H])c2c(c(c([H])n2[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c1[H])(N3C([H])([H])C([H])([H])C([H])([H])C3([H])[H])(=O)=O', '02.103', '2.103', '0', '0', 'TRUE', '1.3698\r\n-0.5709\r\n-0.5709\r\n-0.3597\r\n-0.2646\r\n-0.3091\r\n-2.46e-002\r\n-2.46e-002\r\n-4.17e-002\r\n-4.17e-002\r\n-7.e-004\r\n-5.55e-002\r\n-2.9e-003\r\n-5.11e-002\r\n-2.71e-002\r\n2.6e-002\r\n-5.86e-002\r\n-1.35e-002\r\n-4.31e-002\r\n-1.45e-002\r\n1.6e-003\r\n-1.37e-002\r\n-1.37e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.07e-002\r\n2.07e-002\r\n6.32e-002\r\n3.29e-002\r\n3.29e-002\r\n6.25e-002\r\n6.39e-002\r\n7.56e-002\r\n0.1336\r\n4.33e-002\r\n4.33e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n', '0', '1.933', 'C17H25N3O2S', '0335.167', '-3.495', '0335.464', '-2.35 7.09', '2', '1', '2', '13', '10', '2', '23', '25', '30', '6', '005', '01', '25', '0', '3', '006', '0064.79', '354.87', '', '3.92569', '1.2801', '56.79', '37.66', '4.47697', '19.13', '1,084.13', '104.869', '269.94', '', 'S(=O)(=O)(N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C(/C3=C([H])/C2=C(N([H])/C([H])=C2/C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])\\C([H])=C3\\[H])([H])[H]', 'CN(C)CCc2c[nH]c3ccc(CS(=O)(=O)N1CCCC1)cc23', 'Almogran', 'Almotriptan; Axert; Almotrintan; AC1L3WYP; L000846', '5-hydroxytryptamine receptor 1D', '123606', 'FDA approved', 'Migraine', '11768838', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(50, '123607', '123607', 'CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12', '<I>N</I>,<I>N</I>-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1<I>H</I>-indol-3-yl]ethanamine', 'CYAAFQwAmdwQZjBRRnJkKMRBrYq128UaRD17PM$kuyWhx6ldbcvXd1j9BniaC1UcNCHOlhn42hOK0RolMTk9aQ2SB^IK9BkYpoLgEsZIyw^bWf47Ru1rN5xw0mCvv6rtaLyJAQw3oH4jx4EkgCnVifuow54Etaf1F3czUJ867X9XhHOW9jbPwLfubSBUiT3K2PWy4PPu cGACB3tdKns5XrdnJffhPA7Bdci3n0ZwDxzDkHPvrcEIO19TdqtnCx$Nfl$h0HMClGBQyrb^QAE9gMFrdWkaAin35Vhrcp45OLOXNR$seJz^ropcTz8wedZjT1bjiLZDePTq3mbeLl6W^LDZ9n5SvusxyCbXV6Yhh6eaQ79dcBOQGVWa3sYbwH488aJtT6u72b$JMfpZ U69ZAizzi7dIvkBsq0fDsCpDu2Mn1cZIUeazefGTZBp4QyXTJmiax9mIi1OZHFbVdfYnH0Y4rqSPQVqa3dkuCyhnCPLZOFLj', 'InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3', 'AuxInfo=1/0/N:22,23,9,10,17,19,18,7,8,21,14,20,11,12,15,13,16,5,6,4,2,3,1/E:(1,2)(3,4)(8,9)(21,22)/CRV:23.6/rA:48SOONNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d1;d1;s1;;;s4;s4;s7;s8s9;s1;s11;;d+ 12s13;s13;s5d+13;s12;s15;s16d-17;s5d-15;s6s18;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s14;s18;s18;s17;s19;s20;s5;s21;s21;s22;s22;s22;s23;s23;s23;/rC:2.4729,.1518,-.9855;2.7432,-.9587,-1.8793;1.5146,1. 1823,-1.3389;3.9401,.8806,-.5372;-3.0381,-2.9373,-.0848;-4.2816,2.7863,-.0568;3.907,1.942,.5114;', 'WKEMJKQOLOHJLZ-UHFFFAOYSA-N', '1010:V2F94ZNZAPVBH7APRG7K486XHPQRYS', '[#16](-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c]2:[c](:[c](:[c](-[#1]):[n]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]1-[#1])(-[#7] 3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])(=[#8])=[#8]', 'S(C([H])([H])c1c([H])c([H])c2c(c(c([H])n2[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c1[H])(N3C([H])([H])C([H])([H])C([H])([H])C3([H])[H])(=O)=O', '02.103', '2.103', '0', '0', 'TRUE', '1.3698\r\n-0.5709\r\n-0.5709\r\n-0.3597\r\n-0.2646\r\n-0.3091\r\n-2.46e-002\r\n-2.46e-002\r\n-4.17e-002\r\n-4.17e-002\r\n-7.e-004\r\n-5.55e-002\r\n-2.9e-003\r\n-5.11e-002\r\n-2.71e-002\r\n2.6e-002\r\n-5.86e-002\r\n-1.35e-002\r\n-4.31e-002\r\n-1.45e-002\r\n1.6e-003\r\n-1.37e-002\r\n-1.37e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.07e-002\r\n2.07e-002\r\n6.32e-002\r\n3.29e-002\r\n3.29e-002\r\n6.25e-002\r\n6.39e-002\r\n7.56e-002\r\n0.1336\r\n4.33e-002\r\n4.33e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n', '0', '1.933', 'C17H25N3O2S', '0335.167', '-3.495', '0335.464', '-2.35 7.09', '2', '1', '2', '13', '10', '2', '23', '25', '30', '6', '005', '01', '25', '0', '3', '006', '0064.79', '354.87', '', '3.92569', '1.2801', '56.79', '37.66', '4.47697', '19.13', '1,084.13', '104.869', '269.94', '', 'S(=O)(=O)(N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C(/C3=C([H])/C2=C(N([H])/C([H])=C2/C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])\\C([H])=C3\\[H])([H])[H]', 'CN(C)CCc2c[nH]c3ccc(CS(=O)(=O)N1CCCC1)cc23', 'almotriptan maleate', 'J-011571; S2096', '5-hydroxytryptamine receptor 1B', '123607', 'FDA approved', 'Migraine', '27503180', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(51, '123607', '123607', 'CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12', '<I>N</I>,<I>N</I>-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1<I>H</I>-indol-3-yl]ethanamine', 'CYAAFQwAmdwQZjBRRnJkKMRBrYq128UaRD17PM$kuyWhx6ldbcvXd1j9BniaC1UcNCHOlhn42hOK0RolMTk9aQ2SB^IK9BkYpoLgEsZIyw^bWf47Ru1rN5xw0mCvv6rtaLyJAQw3oH4jx4EkgCnVifuow54Etaf1F3czUJ867X9XhHOW9jbPwLfubSBUiT3K2PWy4PPu cGACB3tdKns5XrdnJffhPA7Bdci3n0ZwDxzDkHPvrcEIO19TdqtnCx$Nfl$h0HMClGBQyrb^QAE9gMFrdWkaAin35Vhrcp45OLOXNR$seJz^ropcTz8wedZjT1bjiLZDePTq3mbeLl6W^LDZ9n5SvusxyCbXV6Yhh6eaQ79dcBOQGVWa3sYbwH488aJtT6u72b$JMfpZ U69ZAizzi7dIvkBsq0fDsCpDu2Mn1cZIUeazefGTZBp4QyXTJmiax9mIi1OZHFbVdfYnH0Y4rqSPQVqa3dkuCyhnCPLZOFLj', 'InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3', 'AuxInfo=1/0/N:22,23,9,10,17,19,18,7,8,21,14,20,11,12,15,13,16,5,6,4,2,3,1/E:(1,2)(3,4)(8,9)(21,22)/CRV:23.6/rA:48SOONNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d1;d1;s1;;;s4;s4;s7;s8s9;s1;s11;;d+ 12s13;s13;s5d+13;s12;s15;s16d-17;s5d-15;s6s18;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s14;s18;s18;s17;s19;s20;s5;s21;s21;s22;s22;s22;s23;s23;s23;/rC:2.4729,.1518,-.9855;2.7432,-.9587,-1.8793;1.5146,1. 1823,-1.3389;3.9401,.8806,-.5372;-3.0381,-2.9373,-.0848;-4.2816,2.7863,-.0568;3.907,1.942,.5114;', 'WKEMJKQOLOHJLZ-UHFFFAOYSA-N', '1010:V2F94ZNZAPVBH7APRG7K486XHPQRYS', '[#16](-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c]2:[c](:[c](:[c](-[#1]):[n]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]1-[#1])(-[#7] 3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])(=[#8])=[#8]', 'S(C([H])([H])c1c([H])c([H])c2c(c(c([H])n2[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c1[H])(N3C([H])([H])C([H])([H])C([H])([H])C3([H])[H])(=O)=O', '02.103', '2.103', '0', '0', 'TRUE', '1.3698\r\n-0.5709\r\n-0.5709\r\n-0.3597\r\n-0.2646\r\n-0.3091\r\n-2.46e-002\r\n-2.46e-002\r\n-4.17e-002\r\n-4.17e-002\r\n-7.e-004\r\n-5.55e-002\r\n-2.9e-003\r\n-5.11e-002\r\n-2.71e-002\r\n2.6e-002\r\n-5.86e-002\r\n-1.35e-002\r\n-4.31e-002\r\n-1.45e-002\r\n1.6e-003\r\n-1.37e-002\r\n-1.37e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n4.05e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.07e-002\r\n2.07e-002\r\n6.32e-002\r\n3.29e-002\r\n3.29e-002\r\n6.25e-002\r\n6.39e-002\r\n7.56e-002\r\n0.1336\r\n4.33e-002\r\n4.33e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n3.93e-002\r\n', '0', '1.933', 'C17H25N3O2S', '0335.167', '-3.495', '0335.464', '-2.35 7.09', '2', '1', '2', '13', '10', '2', '23', '25', '30', '6', '005', '01', '25', '0', '3', '006', '0064.79', '354.87', '', '3.92569', '1.2801', '56.79', '37.66', '4.47697', '19.13', '1,084.13', '104.869', '269.94', '', 'S(=O)(=O)(N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C(/C3=C([H])/C2=C(N([H])/C([H])=C2/C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])\\C([H])=C3\\[H])([H])[H]', 'CN(C)CCc2c[nH]c3ccc(CS(=O)(=O)N1CCCC1)cc23', 'almotriptan maleate', 'J-011571; S2096', '5-hydroxytryptamine receptor 1D', '123607', 'FDA approved', 'Migraine', '27503180', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(52, '864', '864', 'OC(=O)CCCC[C@@H]1CCSS1', '5-[(3<I>R</I>)-dithiolan-3-yl]pentanoic acid', 'CYAAFQwADdwQBn6KNgWoeELa2fXgK9Djw5LmmsdE2YtNim$bnCNteZ7C8sNrDx2o5CTExWY2hzbNkW8npkXnlAGE0CC4a0P0yXKNA8agHoOOqPV7qkRw$QbzH4YCr^9jSLFlAKwTaLSrG3axzi7nbcNOAzK71WT6vcgEZq07F8wGlNuSwTbLRJhn1ZxhLp8wy9QUn9tT u5oXa1CalRLHufIG6fRm99AiBNSwMebaTlOqSPiGcSLuizO6ObW7k3QXgfeKu6c8m9yBtIqsyD5Actow2VpceJ9Q8lZmuGe5yqvNC21jLqM8BoRXKlk9TvGdalcOHZ3jK2Kz7mBUrrHLnP2mI8t1MUPsvMJqusefVoVhmMNjeXyz0eZ4o$M7dLcqsTH1OjPX9tycNLp3 IvjuiVvbcz4zARMFCLD3z^PbuCpYaloS2icPv1q93vUQhxIbm8T^INPvpeUrKbPoc5PG7gLeN4b5D3pPnrn5B1dWH84UIryr', 'InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1', 'AuxInfo=1/1/N:8,9,6,11,7,10,5,12,3,4,2,1/E:(9,10)/it:im/rA:26SSOOC.oCCCCCCCHHHHHHHHHHHHHH/rB:s1;;;s1;s5;s5;s6;s8;s2s7;s9;s3d4s11;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s3;/rC:2.587,-1.3583,-.3603; 4.6243,-1.1509,-.4692;-5.158,-.8719,.3044;-4.3517,.9806,-.7326;2.237,.2515,.4116;.8858,.783,-.0416;3.3868,1.1796,.0124;-.2865,-.1268,.3328;-1.6758,.3883,-.0538;4.7201,.4924,.2825;-2.8114,-.5299,.3968; -4.1579,-.0374,-.083;2.2352,.1111,1.4992;.7224,1.7676,.4153;.8798,.9477,-1.1272;3.3313,2.1143,.5', 'AGBQKNBQESQNJD-SSDOTTSWSA-N', '1010:MKUUMQFQQVRK8BSFBCSJH3K4QWZMFM', '[#16]1-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#16]1)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]', 'S1[C@@]([H])(C([H])([H])C([H])([H])S1)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H]', '02.258', '2.258', '0', '0', 'TRUE', '-9.07e-002\r\n-9.39e-002\r\n-0.3318\r\n-0.2669\r\n1.59e-002\r\n-4.05e-002\r\n-3.05e-002\r\n-5.18e-002\r\n-4.39e-002\r\n4.7e-003\r\n3.35e-002\r\n0.2581\r\n4.25e-002\r\n2.78e-002\r\n2.78e-002\r\n2.86e-002\r\n2.86e-002\r\n2.67e-002\r\n2.67e-002\r\n2.71e-002\r\n2.71e-002\r\n3.89e-002\r\n3.89e-002\r\n3.72', '1', '0.819', 'C8H14O2S2', '0206.044', '-2.816', '0206.326', '4.86', '1', '0', '1', '11', '00', '0', '12', '12', '16', '1', '002', '01', '14', '0', '1', '005', '0087.9', '209.1', '', '1.88666', '1.3144', '19.81', '10.74', '3.50672', '9.07', '618.958', '184.334', '166.35', '', 'S1SC([H])([H])C([H])([H])C1(C(C(C(C(C(O[H])=O)([H])[H])([H])[H])([H])[H])([H])[H])[H]', 'O=C(O)CCCCC1CCSS1', 'alpha Lipoic acid', 'dl-Thioctic acid; alpha-Lipoic acid; Lipothion; Thioctsan; Thioctansaeure', 'Sodium-dependent multivitamin transporter', '864', 'Phase II', 'Multiple Sclerosis', '23485514', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(53, '864', '864', 'OC(=O)CCCC[C@@H]1CCSS1', '5-[(3<I>R</I>)-dithiolan-3-yl]pentanoic acid', 'CYAAFQwADdwQBn6KNgWoeELa2fXgK9Djw5LmmsdE2YtNim$bnCNteZ7C8sNrDx2o5CTExWY2hzbNkW8npkXnlAGE0CC4a0P0yXKNA8agHoOOqPV7qkRw$QbzH4YCr^9jSLFlAKwTaLSrG3axzi7nbcNOAzK71WT6vcgEZq07F8wGlNuSwTbLRJhn1ZxhLp8wy9QUn9tT u5oXa1CalRLHufIG6fRm99AiBNSwMebaTlOqSPiGcSLuizO6ObW7k3QXgfeKu6c8m9yBtIqsyD5Actow2VpceJ9Q8lZmuGe5yqvNC21jLqM8BoRXKlk9TvGdalcOHZ3jK2Kz7mBUrrHLnP2mI8t1MUPsvMJqusefVoVhmMNjeXyz0eZ4o$M7dLcqsTH1OjPX9tycNLp3 IvjuiVvbcz4zARMFCLD3z^PbuCpYaloS2icPv1q93vUQhxIbm8T^INPvpeUrKbPoc5PG7gLeN4b5D3pPnrn5B1dWH84UIryr', 'InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1', 'AuxInfo=1/1/N:8,9,6,11,7,10,5,12,3,4,2,1/E:(9,10)/it:im/rA:26SSOOC.oCCCCCCCHHHHHHHHHHHHHH/rB:s1;;;s1;s5;s5;s6;s8;s2s7;s9;s3d4s11;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s3;/rC:2.587,-1.3583,-.3603; 4.6243,-1.1509,-.4692;-5.158,-.8719,.3044;-4.3517,.9806,-.7326;2.237,.2515,.4116;.8858,.783,-.0416;3.3868,1.1796,.0124;-.2865,-.1268,.3328;-1.6758,.3883,-.0538;4.7201,.4924,.2825;-2.8114,-.5299,.3968; -4.1579,-.0374,-.083;2.2352,.1111,1.4992;.7224,1.7676,.4153;.8798,.9477,-1.1272;3.3313,2.1143,.5', 'AGBQKNBQESQNJD-SSDOTTSWSA-N', '1010:MKUUMQFQQVRK8BSFBCSJH3K4QWZMFM', '[#16]1-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#16]1)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]', 'S1[C@@]([H])(C([H])([H])C([H])([H])S1)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H]', '02.258', '2.258', '0', '0', 'TRUE', '-9.07e-002\r\n-9.39e-002\r\n-0.3318\r\n-0.2669\r\n1.59e-002\r\n-4.05e-002\r\n-3.05e-002\r\n-5.18e-002\r\n-4.39e-002\r\n4.7e-003\r\n3.35e-002\r\n0.2581\r\n4.25e-002\r\n2.78e-002\r\n2.78e-002\r\n2.86e-002\r\n2.86e-002\r\n2.67e-002\r\n2.67e-002\r\n2.71e-002\r\n2.71e-002\r\n3.89e-002\r\n3.89e-002\r\n3.72', '1', '0.819', 'C8H14O2S2', '0206.044', '-2.816', '0206.326', '4.86', '1', '0', '1', '11', '00', '0', '12', '12', '16', '1', '002', '01', '14', '0', '1', '005', '0087.9', '209.1', '', '1.88666', '1.3144', '19.81', '10.74', '3.50672', '9.07', '618.958', '184.334', '166.35', '', 'S1SC([H])([H])C([H])([H])C1(C(C(C(C(C(O[H])=O)([H])[H])([H])[H])([H])[H])([H])[H])[H]', 'O=C(O)CCCCC1CCSS1', 'alpha Lipoic acid', 'dl-Thioctic acid; alpha-Lipoic acid; Lipothion; Thioctsan; Thioctansaeure', 'Sodium-dependent multivitamin transporter', '864', 'Phase II Completed', 'Carpal Tunnel Syndrome', '24563654', 'Carpal Tunnel Syndrome', 'CTS\nAMYOTROPHY, THENAR, OF CARPAL ORIGIN');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(54, '38853', '38853', 'C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O', '(2<I>S</I>)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid', 'CYAAFQwAmdwQgeePi3Pbu9EBuEgAqU$orTnQegopN^zkqWmtvMKBfob8H19PBa6cUgY2ocNc432OUOgmao1cq$QepZU7njg5Di$zP3E2ChrxZtis5J4oX1^whvPY89n9$5l7EDwEZIf$oo81X1RfhJMcW9WVhTpfRPuYuTn21PrORgVN8$CQKyrEgwCPnMoalLHrlyZS Y7lmhxgt3aY1qwLue$QgwCusJWsG$t21jqDDwCfqLHAwlKzlMnGo0kg2Sh2chyaYn1OEXEplgrcoZae11a1gy9yCSrNomj$iavaunkJ$nZI2hN6VfjaiDqx4VJDptNTK8$EpirjJe4kqXtmQaXvHA^EPpOIreei1irTz^MjM7cuZhhwzWFKeiVbNLoPudy5LFFNgZlOi vNtI475NDkDvBpFGLc9va5$LlYIzflp7^s7wH1uDNR879d$m5NDN1skiAOR9VaAnwvLWlWGZneDVKfmpt8doTOgbmJNr3Aev', 'InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1', 'AuxInfo=1/1/N:9,12,14,11,7,8,15,13,10,6,5,4,3,1,2/E:(14,15)/it:im/rA:28OOOONC.oCCCCCCCCCHHHHHHHHHHHHH/rB:;;;;s5;s6;s7;s6;s1d2s6;d+8;s8;s3s11;d-12;s4d-13s14;s7;s7;s9;s9;s9;s5;s5;s11;s12;s14;s1;s3;s4;/r C:-1.5314,1.0921,1.5978;-2.7621,1.9338,-.1006;2.7513,2.0227,-.4364;4.1025,-.138,.6718;-3.6209,-.6341,-.728;-2.3067,-.4643,-.0901;-1.2065,-.745,-1.1422;.2164,-.5791,-.6568;-2.257,-1.4665,1.0738;-2.2417 ,.9682,.4469;.8304,.6562,-.7726;.8746,-1.6662,-.1077;2.1429,.8091,-.3255;2.187,-1.5132,.3393;2.8', 'CJCSPKMFHVPWAR-JTQLQIEISA-N', '1010:FFGQUY1BBFRDXN1D9GVCSJ5J358CRM', '[#8](-[#1])-[#6](-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#1])-[#8]-[#1])-[#7](-[#1])-[#1])=[#8]', 'O([H])C([C@](C([H])([H])[H])(C([H])([H])c1c([H])c([H])c(c(c1[H])O[H])O[H])N([H])[H])=O', '-01.778', '0.701', '0', '0', 'TRUE', '-0.3303\r\n-0.2647\r\n-0.3582\r\n-0.3582\r\n-0.3169\r\n0.1036\r\n-3.e-004\r\n-4.29e-002\r\n-3.71e-002\r\n0.2784\r\n-2.61e-002\r\n-5.62e-002\r\n0.1014\r\n-2.92e-002\r\n0.1012\r\n3.4e-002\r\n3.4e-002\r\n2.54e-002\r\n2.54e-002\r\n2.54e-002\r\n0.1194\r\n0.1194\r\n6.54e-002\r\n6.26e-002\r\n6.51e-002\r\n0.2214', '1', '-1.761', 'C10H13NO4', '0211.084', '-1.426', '0211.215', '2.72 9.76 10.29 10.61', '1', '3', '1', '8', '06', '1', '15', '15', '19', '4', '005', '05', '13', '0', '1', '003', '0103.78', '227.05', '', '4.36509', '1.2489', '13.29', '3.7', '3.05415', '9.59', '355.905', '223.883', '167.38', '', 'O(C(=O)C(N([H])[H])(C(/C1=C([H])/C(O[H])=C(O[H])\\C([H])=C1\\[H])([H])[H])C([H])([H])[H])[H]', 'CC(N)(Cc1ccc(O)c(O)c1)C(=O)O', 'Alpha-Methyldopa', 'Aldomet; Dopamet; Baypresol; Presolisin; Sembrina; Becanta; Presinol', 'Alpha-2A adrenergic receptor', '38853', 'Under Investigation', 'Tardive Dyskinesia', '6789358', 'Tardive Dyskinesia', 'NA'),
(55, '14985', '14985', 'CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1', '(2<I>R</I>)-2,5,7,8-tetramethyl-2-[(4<I>R</I>,8<I>R</I>)-4,8,12-trimethyltridecyl]chroman-6-ol', 'CYAAFQwAKcwQMU0gm$CF4Gn0$CG7J4I7$ETFUk3XOTPS16oLXAPpj2ziUWp6xhgmE18Y5kwO$djWQwN2AaVj1moi9dXDHwwoQeMb6JLIVFH3XFkjXkg7rvMkLyRVwlyUjPM^Xv$^^tiW8CgE3KoO4dbC3QM$$P7Nk8GBbJvpOoSGz0XOncvOZtAfePRzX4C4rrm$U8pc Xor$L0V^nWeh60lMOvTfq3LhMOuJhNqVLvah1YeesWl33wiObMcpqMieiTu3SX1a19QqOCI$f23dBak8NuKligPfirdj959K0cT5MO$bzNS1KtbovubpUeSIE1aev1fNBSv^bKTmdkBq9AqN3KhdRGY4LDb4h1O4M84lmRiR54Qr7uWUrFUXZ2WWsNZs7yQuOeUDx9hQ hEryRRPPg4^yyhhI2xZTCqSuSJ3occYgf3PSNuLnTUMHIZ$SuyPHTPymDZwRNL0tcLkPi4l6p765nhaIgGRDnImPVEvhYTGD', 'InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1', 'AuxInfo=1/0/N:30,31,23,17,29,28,27,11,21,13,6,25,18,15,10,8,9,4,5,26,16,7,22,20,19,12,24,14,3,2,1/E:(1,2)/it:im/rA:81OOC.oCCCC.eCCCCCCCCC.eCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH HHHH/rB:;s1;s3;s3;s4;;s6s7;s5;s7;s3;s9;s10;s1s12;s13;s15;s7;s16;d+12;d+14;s18;s20;s16;s2s19d+22;s21;s25;s19;s20;s22;s26;s26;s4;s4;s5;s5;s6;s6;s7;s8;s8;s9;s9;s10;s10;s11;s11;s11;s13;s13;s15;s15;s16;s17 ;s17;s17;s18;s18;s21;s21;s23;s23;s23;s25;s25;s26;s27;s27;s27;s28;s28;s28;s29;s29;s29;s30;s30;s30', 'GVJHHUAWPYXKBD-IEOSBIPESA-N', '1010:P84UCC2X2AEKSEYY5HDX4K8GBYMTWT', '[#8]1-[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c]2-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]):[c]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]1(-[#6](-[#1])(-[#1])-[#1])-[#6](- [#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[ #1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#', 'O1c(c(C([H])([H])[H])c(C([H])([H])[H])c(c2C([H])([H])[H])O[H])c2C([H])([H])C([H])([H])[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[ C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H]', '10.44', '10.44', '0', '0', 'TRUE', '-0.3393\r\n-0.3604\r\n7.24e-002\r\n-2.36e-002\r\n-1.95e-002\r\n-5.03e-002\r\n-4.43e-002\r\n-5.06e-002\r\n-2.22e-002\r\n-5.07e-002\r\n-3.53e-002\r\n-1.18e-002\r\n-5.28e-002\r\n8.25e-002\r\n-5.07e-002\r\n-4.43e-002\r\n-6.26e-002\r\n-5.07e-002\r\n-1.5e-002\r\n-1.5e-002\r\n-5.28e-002\r\n-1.53e-002\r\n-', '1', '10.44', 'C29H50O2', '0430.381', '-10.821', '0430.706', '10.5', '1', '1', '0', '26', '06', '1', '31', '32', '59', '3', '002', '01', '50', '0', '2', '012', '0029.46', '526.25', '', '0.78542', '1.2485', '13.18', '-4.44', '4.44857', '17.62', '1,478.71', '35.57', '419.14', '', 'O1C(C(C(C(C(C(C(C(C(C(C(C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])/C/2=C(C([H])([H])[H])/C(O[H])=C(C([H])([H])[H])\\C(C([H])([H])[H])=C12', 'Cc2c(C)c1OC(C)(CCCC(C)CCCC(C)CCCC(C)C)CCc1c(C)c2O', 'Alpha-Tocopherol', 'VITAMIN E; Phytogermine; Eprolin; Syntopherol; Denamone; Viteolin; Profecundin', 'Nuclear receptor subfamily 1 group I member 2', '14985', 'Phase III', 'Fragile X Syndrome', '25187257', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(56, '14985', '14985', 'CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1', '(2<I>R</I>)-2,5,7,8-tetramethyl-2-[(4<I>R</I>,8<I>R</I>)-4,8,12-trimethyltridecyl]chroman-6-ol', 'CYAAFQwAKcwQMU0gm$CF4Gn0$CG7J4I7$ETFUk3XOTPS16oLXAPpj2ziUWp6xhgmE18Y5kwO$djWQwN2AaVj1moi9dXDHwwoQeMb6JLIVFH3XFkjXkg7rvMkLyRVwlyUjPM^Xv$^^tiW8CgE3KoO4dbC3QM$$P7Nk8GBbJvpOoSGz0XOncvOZtAfePRzX4C4rrm$U8pc Xor$L0V^nWeh60lMOvTfq3LhMOuJhNqVLvah1YeesWl33wiObMcpqMieiTu3SX1a19QqOCI$f23dBak8NuKligPfirdj959K0cT5MO$bzNS1KtbovubpUeSIE1aev1fNBSv^bKTmdkBq9AqN3KhdRGY4LDb4h1O4M84lmRiR54Qr7uWUrFUXZ2WWsNZs7yQuOeUDx9hQ hEryRRPPg4^yyhhI2xZTCqSuSJ3occYgf3PSNuLnTUMHIZ$SuyPHTPymDZwRNL0tcLkPi4l6p765nhaIgGRDnImPVEvhYTGD', 'InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1', 'AuxInfo=1/0/N:30,31,23,17,29,28,27,11,21,13,6,25,18,15,10,8,9,4,5,26,16,7,22,20,19,12,24,14,3,2,1/E:(1,2)/it:im/rA:81OOC.oCCCC.eCCCCCCCCC.eCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH HHHH/rB:;s1;s3;s3;s4;;s6s7;s5;s7;s3;s9;s10;s1s12;s13;s15;s7;s16;d+12;d+14;s18;s20;s16;s2s19d+22;s21;s25;s19;s20;s22;s26;s26;s4;s4;s5;s5;s6;s6;s7;s8;s8;s9;s9;s10;s10;s11;s11;s11;s13;s13;s15;s15;s16;s17 ;s17;s17;s18;s18;s21;s21;s23;s23;s23;s25;s25;s26;s27;s27;s27;s28;s28;s28;s29;s29;s29;s30;s30;s30', 'GVJHHUAWPYXKBD-IEOSBIPESA-N', '1010:P84UCC2X2AEKSEYY5HDX4K8GBYMTWT', '[#8]1-[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c]2-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]):[c]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]1(-[#6](-[#1])(-[#1])-[#1])-[#6](- [#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[ #1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#', 'O1c(c(C([H])([H])[H])c(C([H])([H])[H])c(c2C([H])([H])[H])O[H])c2C([H])([H])C([H])([H])[C@@]1(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[ C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H]', '10.44', '10.44', '0', '0', 'TRUE', '-0.3393\r\n-0.3604\r\n7.24e-002\r\n-2.36e-002\r\n-1.95e-002\r\n-5.03e-002\r\n-4.43e-002\r\n-5.06e-002\r\n-2.22e-002\r\n-5.07e-002\r\n-3.53e-002\r\n-1.18e-002\r\n-5.28e-002\r\n8.25e-002\r\n-5.07e-002\r\n-4.43e-002\r\n-6.26e-002\r\n-5.07e-002\r\n-1.5e-002\r\n-1.5e-002\r\n-5.28e-002\r\n-1.53e-002\r\n-', '1', '10.44', 'C29H50O2', '0430.381', '-10.821', '0430.706', '10.5', '1', '1', '0', '26', '06', '1', '31', '32', '59', '3', '002', '01', '50', '0', '2', '012', '0029.46', '526.25', '', '0.78542', '1.2485', '13.18', '-4.44', '4.44857', '17.62', '1,478.71', '35.57', '419.14', '', 'O1C(C(C(C(C(C(C(C(C(C(C(C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])/C/2=C(C([H])([H])[H])/C(O[H])=C(C([H])([H])[H])\\C(C([H])([H])[H])=C12', 'Cc2c(C)c1OC(C)(CCCC(C)CCCC(C)CCCC(C)C)CCc1c(C)c2O', 'Alpha-Tocopherol', 'VITAMIN E; Phytogermine; Eprolin; Syntopherol; Denamone; Viteolin; Profecundin', 'Nuclear receptor subfamily 1 group I member 2', '14985', 'Unknown', 'Alzheimer disease (AD)', '23583234', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(57, '5288674', '5288674', 'CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\\C(=C/C=C/[C@H](OC)[C@@H](OC(=O)N)\\C(=C/[C@H](C)[C@H]1O)\\C)\\C)C2=O', '[(3<I>R</I>,5<I>S</I>,6<I>R</I>,7<I>S</I>,8<I>Z</I>,10<I>S</I>,11<I>S</I>,12<I>E</I>,14<I>Z</I>)-21-[2-(dimethylamino)ethylamino]-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabi cyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate', 'CYAAFQwA6fwQd68DNf9XaArXI7^$Btih^ERGs128KdI^tAs42pkSq7y6RA7t7dfwV1tTZ9SqYxN5kf1D9p28bCYm26YZe0PgkrRWIqUcwXIJjezHwCXl^3nzf4q1zXu^qV3sDuVne8x4^89^2ffvAKwH$$NvIWG8Xs^4NQVv$SwhaTBWq227NIHGkGkXf54QQ3v0h8CS ceq4BRAvy6jp9RvPZvQwrfZZ^CDZ$csQGFXbF8d3WlZcNBaEwzezLdPfqbm0zry0uNv7mbvurTwBIAAt2pGd$0c5IGjfgetzPC0ZXq0Ep3V^zMlFpXYdHb3Bzvt9P6QXK$VacSf0hgeIvU$9oiak$zRuP0l5$c69fkae8hcWsGAduJBXlAu$1Uh7pK5DvFzT9MK^cLbK SXfU2wEGde2fzrb4V2XeKpUevnC119gyx7xDtfVGJ^0M2j$NZsz4SD9zyOtjHPTk6dQ1ZBp$Ky4I478oH^FJPs5imNs38mKH', 'InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H 2,33,41)(H,35,40)/b11-9+,19-10-,21-16-/t18-,20+,25+,26+,28-,30+/m1/s1', 'AuxInfo=1/1/N:19,44,22,29,42,43,40,27,36,41,34,33,35,18,14,21,32,15,39,17,23,20,30,31,28,13,24,16,26,25,37,38,12,9,10,11,6,2,5,7,8,4,1,3/E:(5,6)/it:im/rA:92OOOOOOOONNNNC.eCC.eC.eC.oCCCCCCCC.eCCC.oCCCC CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;s1;s13;s14;s2s13;s16;s15;s15;s18;s17;s17;d-21;s9d-20;s3s23;d5s20;s1;s4s25;s23;s10s26;d6s24;d+30s31;s9;s28;s11s33;d+34;d7s10;s 3d8s12;s37;s4;s36d-39;s11;s11;s39;s13;s14;s14;s15;s16;s17;s18;s18;s19;s19;s19;s21;s22;s22;s22;s2', 'KUFRQPKVAWMTJO-QZCVZMHSSA-N', '1010:3N1GQM3ZB4FSCSX8JBRXQZGC68M187', '[#8](-[#6](-[#1])(-[#1])-[#1])-[#6@](-[#1])(-[#6@@](-[#1])(-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])\\-[#6](-[#1])=[#6](\\-[#6](-[#1])(-[#1])-[#1])/-[#6@@](-[#1])(-[#6@](-[#1])(\\-[#6](-[#1])=[#6](-[#1])\\ -[#6](-[#1])=[#6](\\-[#6](-[#1])(-[#1])-[#1])/-[#6](-[#7]1-[#1])=[#8])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#7](-[#1])-[#1])=[#8])-[#8]-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[# 1])-[#6](-[#1])(-[#1])-[#6](-[#6](-[#6]1=[#6](-[#1])-[#6]2=[#8])=[#8])=[#6]2-[#7](-[#1])-[#6](-[', 'O(C([H])([H])[H])[C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])[H])\\C([H])=C(\\C([H])([H])[H])/[C@@]([H])([C@]([H])(\\C([H])=C([H])\\C([H])=C(\\C([H])([H])[H])/C(N1[H])=O)OC([H])([H])[H])OC(N([H])[H])=O)O[H] )C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C(C(C1=C([H])C2=O)=O)=C2N([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]', '02.046', '2.046', '0', '0', 'TRUE', '-0.3788\r\n-0.3899\r\n-0.2897\r\n-0.3743\r\n-0.2875\r\n-0.2881\r\n-0.272\r\n-0.2428\r\n-0.2838\r\n-0.2782\r\n-0.3082\r\n-0.3048\r\n8.38e-002\r\n-2.13e-002\r\n-3.75e-002\r\n8.61e-002\r\n2.8e-003\r\n-1.96e-002\r\n-6.21e-002\r\n2.35e-002\r\n-7.74e-002\r\n-5.65e-002\r\n-4.48e-002\r\n6.98e-002\r\n0.1193\r\n0.', '1', '1.975', 'C32H48N4O8', '0616.347', '-6.423', '0616.746', '5.51 6.63', '7', '4', '9', '36', '00', '0', '44', '45', '62', '9', '012', '05', '48', '0', '2', '008', '0169.52', '691.56', '', '4.76847', '1.2562', '81.27', '19.19', '5.24777', '62.08', '2,849.96', '217.071', '524.44', '-172.53', 'O(C1([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])/C2=C(N(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])/C(=O)/C([H])=C(N([H])C(=O)/C(C([H])([H])[H])=C([H])\\C([H])=C([H])\\C(OC([H])([H])[H])([H])C(OC(=O)N([H])[H])([H])C(C([H])([H])[H])=C([H])C(C([H])([H])[H])([H])C1(O[H])[H])\\C2=O)C([H])([H])[H]', 'CO[C@H]1/C=C/C=C(C)\\C(=O)Nc2cc(=O)c(NCCN(C)C)c(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(C)\\[C@@H]1OC(N)=O)c2=O', 'Alvespimycin', '17-DMAG; W-5374', 'Heat shock protein HSP 90-alpha', '5288674', 'Under Investigation', 'Parkinson Disease(PARK)', '24304935', 'Parkinson Disease(PARK)', 'PARK'),
(58, '58', 'Not Available', 'CC(O)C(N)C(=O)NCCCS(=O)(=O)O', '3-[(2-amino-3-hydroxy-butanoyl)amino]propane-1-sulfonic acid', 'CYAAFQwAtcwQHQrctzrQzzGh172z9cuBM7AKnZrvXcUgGzAgiQFeT9fBNjo9oRGkqgFNawM44nLTR7LA0$EQY^Q$e0nTYpq0lWh4VM1j3OGXcSZaDiFoq5rOVAfr3iMigYOPbSc1SAtYEe2lgbp9b6WHi6yWLpCxICrTOllluVDklkB480Qlh3SR48eOGKh5wfjmzLhM yqvhFXS9Fk3^8gaRe0Z5jX0cJOlyj^$IheUMXxYUzi8c$ULXLp568aamU4Wc7nr5SJB3$MdibO3j$h98fZHrYnKjpnSj2Rpx1pyY3pyY0p6Y2p6YpG4U1AWfxqJPr4hACEL43uyOAeQPnHX^532XfE^PqpI', 'InChI=1S/C7H16N2O5S/c1-5(10)6(8)7(11)9-3-2-4-15(12,13)14/h5-6,10H,2-4,8H2,1H3,(H,9,11)(H,12,13,14)', 'AuxInfo=1/1/N:1,7,6,8,2,3,4,14,5,13,15,10,11,12,9/E:(12,13,14)/CRV:15.6/rA:15CCCCNCCCSOOOONO/rB:s1;s2;s3;s4;s5;s6;s7;s8;d9;d9;s9;s2;s3;d4;/rC:2.7249,-5.2583,0;3.4394,-4.8458,0;4.1539,-5.2583,0;4.8684, -4.8458,0;5.5829,-5.2583,0;6.2974,-4.8458,0;7.0119,-5.2583,0;7.7263,-4.8458,0;8.4408,-5.2583,0;8.8533,-4.5438,0;8.0283,-5.9727,0;9.1553,-5.6708,0;3.4394,-4.0208,0;4.1539,-6.0833,0;4.8684,-4.0208,0;', 'JBYHTBYSVCMVSX-UHFFFAOYSA-N', '1010:KDMDC78WH1939RAHVNWENA4ZQ1UQCV', '[#6]-[#6](-[#8])-[#6](-[#7])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#16](-[#8])(=[#8])=[#8]', 'CC(O)C(N)C(=O)NCCCS(O)(=O)=O', '-02.148', '-2.148', '0', '0', 'TRUE', '-3.69e-002\r\n7.5e-002\r\n0.1079\r\n0.2312\r\n-0.3141\r\n9.9e-003\r\n-4.39e-002\r\n-1.51e-002\r\n1.4874\r\n-0.5636\r\n-0.5636\r\n-0.5235\r\n-0.3913\r\n-0.318\r\n-0.2758', '0', '-4.613', 'C7H16N2O5S', '0240.078', '-0.843', '0240.277', '2.88 7.3', '1', '3', '3', '11', '00', '0', '15', '14', '6', '3', '007', '05', '16', '0', '0', '006', '0138.1', '249.47', '', '', '', '', '', '', '', '', '', '', '', 'CC(C(C(NCCCS(=O)(=O)O)=O)N)O', 'CC(O)C(N)C(=O)NCCCS(=O)(=O)O', 'ALZ-801', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Phase II', 'Alzheimer disease (AD)', '29063518', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(59, '64150', '64150', 'NC12CC3CC(CC(C3)C1)C2', 'adamantan-1-amine', 'CYAAFQwA4dwQfrO51zD8WDRDu0XaeS0z9EZev1$SHmGYwz0DiuvUK^oEuXqjBdsxw0$UhbodzFGkTgCHy9Zvko^LtHlnphbfBZkBSqHPiCDg3unWyod9CAONO^PMh39xyW5FQPw51xmpWo8jCiz7Ee0l9YA8DHc$ZTbjfUCOhXZGLS8ytUzUdXVGE97Ksgor1$KPb08R fohH9vW1boGVpjl^dNowQrdjdpUNwrrrojGRrFq66NY5WgeZoprG4$3VanScqF5IGdR2Raef5a^U$iXu4l1UH$cUOY5g3PCiVcYiWSVbaPwhDrJkedytRK5aZWfusE6onqNvYupSv5Xehr34EdRh111TnFtxHV4kgMPnvG$8s4mx2pQ9gppHlPl$ceYlkylumN2vJVnW jTxeOpcz6Zt0o9af5g8KYP$NftU8XPGa08J7vw55eXb2KFtrRnR6ex0P45VNhXSuymJwUb^LX31veQOvxOPF$g1GSeN85i0p', 'InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-', 'AuxInfo=1/0/N:10,11,9,8,6,7,5,3,4,2,1/E:(1,2,3)(4,5,6)(7,8,9)/rA:28NCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:s1;;;;s2s3;s2s4;s2s5;s3s4;s3s5;s4s5;s3;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s1;s1;/rC:2.7385 ,.0003,-.0001;1.2768,-.0029,.0053;-.787,-.7575,-1.2444;-.7955,-.6961,1.2763;-.7876,1.4563,-.0372;.7526,-.7582,-1.2357;.7442,-.6971,1.278;.752,1.4502,-.0318;-1.3007,-1.4458,.0317;-1.2925,.6949,-1.2747; -1.3009,.756,1.2325;-1.1518,-1.2947,-2.1269;-1.1664,-1.1898,2.1814;-1.1529,2.4889,-.0635;1.1198,', 'DKNWSYNQZKUICI-CHIWXEEVSA-N', '1010:VW9AZ36Z19XE97G7NXPF24X6DTV7AM', '[#7](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6]3(-[#1])-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6]2(-[#1])-[#1]', 'N([H])([H])C12C([H])([H])C([H])(C([H])([H])C([H])(C3([H])[H])C1([H])[H])C([H])([H])C3([H])C2([H])[H]', '01.495', '1.495', '0', '0', 'TRUE', '-0.325\r\n1.64e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n3.03e-002\r\n3.03e-002\r\n3.03e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.71e-002\r\n2.71e-002\r\n2.71e-0', '0', '0.492', 'C10H17N', '0151.136', '-2.213', '0151.249', '10.63', '0', '1', '0', '13', '00', '0', '11', '13', '18', '0', '001', '02', '17', '0', '4', '000', '0026.02', '153.01', '', '0.80222', '1.2813', '-0.53', '-1.71', '2.39937', '1.18', '112.786', '50.406', '133.08', '', 'N(C12C([H])([H])C3([H])C([H])([H])C([H])(C1([H])[H])C([H])([H])C([H])(C2([H])[H])C3([H])[H])([H])[H]', 'N[C@@]23C[C@H]1C[C@@H](C[C@@H](C1)C2)C3', 'Amantadine', 'Symadine; Symmetrel; Endantadine; BIA4304', 'Glutamate receptor ionotropic, NMDA 3A', '64150', 'Phase II Completed', 'Huntington Disease (HD)', '12221159', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(60, '64150', '64150', 'NC12CC3CC(CC(C3)C1)C2', 'adamantan-1-amine', 'CYAAFQwA4dwQfrO51zD8WDRDu0XaeS0z9EZev1$SHmGYwz0DiuvUK^oEuXqjBdsxw0$UhbodzFGkTgCHy9Zvko^LtHlnphbfBZkBSqHPiCDg3unWyod9CAONO^PMh39xyW5FQPw51xmpWo8jCiz7Ee0l9YA8DHc$ZTbjfUCOhXZGLS8ytUzUdXVGE97Ksgor1$KPb08R fohH9vW1boGVpjl^dNowQrdjdpUNwrrrojGRrFq66NY5WgeZoprG4$3VanScqF5IGdR2Raef5a^U$iXu4l1UH$cUOY5g3PCiVcYiWSVbaPwhDrJkedytRK5aZWfusE6onqNvYupSv5Xehr34EdRh111TnFtxHV4kgMPnvG$8s4mx2pQ9gppHlPl$ceYlkylumN2vJVnW jTxeOpcz6Zt0o9af5g8KYP$NftU8XPGa08J7vw55eXb2KFtrRnR6ex0P45VNhXSuymJwUb^LX31veQOvxOPF$g1GSeN85i0p', 'InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-', 'AuxInfo=1/0/N:10,11,9,8,6,7,5,3,4,2,1/E:(1,2,3)(4,5,6)(7,8,9)/rA:28NCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:s1;;;;s2s3;s2s4;s2s5;s3s4;s3s5;s4s5;s3;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s1;s1;/rC:2.7385 ,.0003,-.0001;1.2768,-.0029,.0053;-.787,-.7575,-1.2444;-.7955,-.6961,1.2763;-.7876,1.4563,-.0372;.7526,-.7582,-1.2357;.7442,-.6971,1.278;.752,1.4502,-.0318;-1.3007,-1.4458,.0317;-1.2925,.6949,-1.2747; -1.3009,.756,1.2325;-1.1518,-1.2947,-2.1269;-1.1664,-1.1898,2.1814;-1.1529,2.4889,-.0635;1.1198,', 'DKNWSYNQZKUICI-CHIWXEEVSA-N', '1010:VW9AZ36Z19XE97G7NXPF24X6DTV7AM', '[#7](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6]3(-[#1])-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6]2(-[#1])-[#1]', 'N([H])([H])C12C([H])([H])C([H])(C([H])([H])C([H])(C3([H])[H])C1([H])[H])C([H])([H])C3([H])C2([H])[H]', '01.495', '1.495', '0', '0', 'TRUE', '-0.325\r\n1.64e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n3.03e-002\r\n3.03e-002\r\n3.03e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.71e-002\r\n2.71e-002\r\n2.71e-0', '0', '0.492', 'C10H17N', '0151.136', '-2.213', '0151.249', '10.63', '0', '1', '0', '13', '00', '0', '11', '13', '18', '0', '001', '02', '17', '0', '4', '000', '0026.02', '153.01', '', '0.80222', '1.2813', '-0.53', '-1.71', '2.39937', '1.18', '112.786', '50.406', '133.08', '', 'N(C12C([H])([H])C3([H])C([H])([H])C([H])(C1([H])[H])C([H])([H])C([H])(C2([H])[H])C3([H])[H])([H])[H]', 'N[C@@]23C[C@H]1C[C@@H](C[C@@H](C1)C2)C3', 'Amantadine', 'Symadine; Symmetrel; Endantadine; BIA4304', 'Glutamate receptor ionotropic, NMDA 3A', '64150', 'Terminated at Phase III', 'Schizophrenia', '20658059', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(61, '64150', '64150', 'NC12CC3CC(CC(C3)C1)C2', 'adamantan-1-amine', 'CYAAFQwA4dwQfrO51zD8WDRDu0XaeS0z9EZev1$SHmGYwz0DiuvUK^oEuXqjBdsxw0$UhbodzFGkTgCHy9Zvko^LtHlnphbfBZkBSqHPiCDg3unWyod9CAONO^PMh39xyW5FQPw51xmpWo8jCiz7Ee0l9YA8DHc$ZTbjfUCOhXZGLS8ytUzUdXVGE97Ksgor1$KPb08R fohH9vW1boGVpjl^dNowQrdjdpUNwrrrojGRrFq66NY5WgeZoprG4$3VanScqF5IGdR2Raef5a^U$iXu4l1UH$cUOY5g3PCiVcYiWSVbaPwhDrJkedytRK5aZWfusE6onqNvYupSv5Xehr34EdRh111TnFtxHV4kgMPnvG$8s4mx2pQ9gppHlPl$ceYlkylumN2vJVnW jTxeOpcz6Zt0o9af5g8KYP$NftU8XPGa08J7vw55eXb2KFtrRnR6ex0P45VNhXSuymJwUb^LX31veQOvxOPF$g1GSeN85i0p', 'InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-', 'AuxInfo=1/0/N:10,11,9,8,6,7,5,3,4,2,1/E:(1,2,3)(4,5,6)(7,8,9)/rA:28NCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:s1;;;;s2s3;s2s4;s2s5;s3s4;s3s5;s4s5;s3;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s1;s1;/rC:2.7385 ,.0003,-.0001;1.2768,-.0029,.0053;-.787,-.7575,-1.2444;-.7955,-.6961,1.2763;-.7876,1.4563,-.0372;.7526,-.7582,-1.2357;.7442,-.6971,1.278;.752,1.4502,-.0318;-1.3007,-1.4458,.0317;-1.2925,.6949,-1.2747; -1.3009,.756,1.2325;-1.1518,-1.2947,-2.1269;-1.1664,-1.1898,2.1814;-1.1529,2.4889,-.0635;1.1198,', 'DKNWSYNQZKUICI-CHIWXEEVSA-N', '1010:VW9AZ36Z19XE97G7NXPF24X6DTV7AM', '[#7](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6]3(-[#1])-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6]2(-[#1])-[#1]', 'N([H])([H])C12C([H])([H])C([H])(C([H])([H])C([H])(C3([H])[H])C1([H])[H])C([H])([H])C3([H])C2([H])[H]', '01.495', '1.495', '0', '0', 'TRUE', '-0.325\r\n1.64e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n3.03e-002\r\n3.03e-002\r\n3.03e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.71e-002\r\n2.71e-002\r\n2.71e-0', '0', '0.492', 'C10H17N', '0151.136', '-2.213', '0151.249', '10.63', '0', '1', '0', '13', '00', '0', '11', '13', '18', '0', '001', '02', '17', '0', '4', '000', '0026.02', '153.01', '', '0.80222', '1.2813', '-0.53', '-1.71', '2.39937', '1.18', '112.786', '50.406', '133.08', '', 'N(C12C([H])([H])C3([H])C([H])([H])C([H])(C1([H])[H])C([H])([H])C([H])(C2([H])[H])C3([H])[H])([H])[H]', 'N[C@@]23C[C@H]1C[C@@H](C[C@@H](C1)C2)C3', 'Amantadine', 'Symadine; Symmetrel; Endantadine; BIA4304', 'Glutamate receptor ionotropic, NMDA 3A', '64150', 'Terminated at phase III', 'Parkinson Disease(PARK)', '24610195', 'Parkinson Disease(PARK)', 'PARK'),
(62, '64150', '64150', 'NC12CC3CC(CC(C3)C1)C2', 'adamantan-1-amine', 'CYAAFQwA4dwQfrO51zD8WDRDu0XaeS0z9EZev1$SHmGYwz0DiuvUK^oEuXqjBdsxw0$UhbodzFGkTgCHy9Zvko^LtHlnphbfBZkBSqHPiCDg3unWyod9CAONO^PMh39xyW5FQPw51xmpWo8jCiz7Ee0l9YA8DHc$ZTbjfUCOhXZGLS8ytUzUdXVGE97Ksgor1$KPb08R fohH9vW1boGVpjl^dNowQrdjdpUNwrrrojGRrFq66NY5WgeZoprG4$3VanScqF5IGdR2Raef5a^U$iXu4l1UH$cUOY5g3PCiVcYiWSVbaPwhDrJkedytRK5aZWfusE6onqNvYupSv5Xehr34EdRh111TnFtxHV4kgMPnvG$8s4mx2pQ9gppHlPl$ceYlkylumN2vJVnW jTxeOpcz6Zt0o9af5g8KYP$NftU8XPGa08J7vw55eXb2KFtrRnR6ex0P45VNhXSuymJwUb^LX31veQOvxOPF$g1GSeN85i0p', 'InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-', 'AuxInfo=1/0/N:10,11,9,8,6,7,5,3,4,2,1/E:(1,2,3)(4,5,6)(7,8,9)/rA:28NCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:s1;;;;s2s3;s2s4;s2s5;s3s4;s3s5;s4s5;s3;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s1;s1;/rC:2.7385 ,.0003,-.0001;1.2768,-.0029,.0053;-.787,-.7575,-1.2444;-.7955,-.6961,1.2763;-.7876,1.4563,-.0372;.7526,-.7582,-1.2357;.7442,-.6971,1.278;.752,1.4502,-.0318;-1.3007,-1.4458,.0317;-1.2925,.6949,-1.2747; -1.3009,.756,1.2325;-1.1518,-1.2947,-2.1269;-1.1664,-1.1898,2.1814;-1.1529,2.4889,-.0635;1.1198,', 'DKNWSYNQZKUICI-CHIWXEEVSA-N', '1010:VW9AZ36Z19XE97G7NXPF24X6DTV7AM', '[#7](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6]3(-[#1])-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6]2(-[#1])-[#1]', 'N([H])([H])C12C([H])([H])C([H])(C([H])([H])C([H])(C3([H])[H])C1([H])[H])C([H])([H])C3([H])C2([H])[H]', '01.495', '1.495', '0', '0', 'TRUE', '-0.325\r\n1.64e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.91e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-3.22e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n3.03e-002\r\n3.03e-002\r\n3.03e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.87e-002\r\n2.71e-002\r\n2.71e-002\r\n2.71e-0', '0', '0.492', 'C10H17N', '0151.136', '-2.213', '0151.249', '10.63', '0', '1', '0', '13', '00', '0', '11', '13', '18', '0', '001', '02', '17', '0', '4', '000', '0026.02', '153.01', '', '0.80222', '1.2813', '-0.53', '-1.71', '2.39937', '1.18', '112.786', '50.406', '133.08', '', 'N(C12C([H])([H])C3([H])C([H])([H])C([H])(C1([H])[H])C([H])([H])C([H])(C2([H])[H])C3([H])[H])([H])[H]', 'N[C@@]23C[C@H]1C[C@@H](C[C@@H](C1)C2)C3', 'Amantadine Hydrochloride', 'Symmetrel; Amazolon; Influenol; Trivaline; Virofral', 'Glutamate receptor ionotropic, NMDA 3A', '64150', 'Phase III Completed', 'Dyskinesia with Parkinson''s Disease', '28833562', 'Dyskinesia with Parkinson''s Disease', 'PARK'),
(63, '2132', '2132', 'Nc1c(Br)cc(Br)cc1CNC2CCC(O)CC2', '4-[(2-amino-3,5-dibromo-phenyl)methylamino]cyclohexanol', 'CYAAFQwA3cwQXEEPVmrrR5GvMcTRZPyzxb6RU84RiFhO9BYKuU^SH3PDrjIHMj8gdXxiWS9VEWQhzNr4U8PehaMoXLlsTqwaoXUTbChTaKxV7IKx^LtOcxSTSd7CdjPYXu7jAQw7J3xzSoo5o92LefzIGG8v8SbTuNX^Q6hThFZy5M2IULeeb6tJoFju6Ihri^t7LTZD wLzlktGYOsKkEGPkewXr3UAeTN^MkPzHqWuDW9yEPnVkMHVVIDNeZu7y$Zy5Loi8YmDnvWQ5bQqolGaTZWgZJJberaZbNiicI5eH6$wK5X5ubcIiI2LmXK$5XJ0uOr6Pabv$ZqO3oE0F8BXF4i3mlLRqzpljOv5B4uUedc26RrYoI5srAl3WrZarhmTOnlJQbcoHMpKk CWKqLcUvktxjAR1Ftwv$Gpc9vsLVQ5Ln77VNVznRcrewKX85nl5xnzEfKeaMqtRW1m3WioaHgJrnrRmzALvu0saPuzna4iMa', 'InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2/t10-,11-', 'AuxInfo=1/0/N:7,8,9,10,15,18,12,13,17,6,11,16,14,2,1,5,4,3/E:(1,2)(3,4)/rA:36BrBrONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;;;s4;s6;s6;s7;s8;s3s9s10;s4;s12;s5d-13;s13;s1s14;s2d+15;d+16s17;s6;s7;s7;s8;s8; s9;s9;s10;s10;s11;s4;s12;s12;s3;s15;s18;s5;s5;/rC:4.9514,-2.2983,.1745;4.0284,3.2834,.4927;-6.3054,.2191,-.2053;-.728,-.29,.4438;1.8889,-2.33,-.5365;-2.1335,-.451,.0729;-2.9849,-.634,1.3349;-2.6143,.7 507,-.7504;-4.4678,-.7489,.9912;-4.0983,.6337,-1.0884;-4.9494,.4423,.1659;.0986,-.1042,-.7386;1.', 'JBDGDEWWOUBZPM-XYPYZODXSA-N', '1010:VKSK6DDSBJC17AV9BRYPNFTAP4NGJQ', '[#35]-[c](:[c](-[#1]):[c](:[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#8]-[#1])-[#35]):[c]1-[ #7](-[#1])-[#1]', 'Brc(c([H])c(c([H])c1C([H])([H])N([H])C2([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])[H])O[H])Br)c1N([H])[H]', '02.739', '2.739', '0', '0', 'TRUE', '-4.91e-002\r\n-5.08e-002\r\n-0.393\r\n-0.3098\r\n-0.3014\r\n7.3e-003\r\n-3.53e-002\r\n-3.53e-002\r\n-2.56e-002\r\n-2.56e-002\r\n5.42e-002\r\n2.24e-002\r\n-1.42e-002\r\n3.08e-002\r\n-4.19e-002\r\n3.66e-002\r\n1.9e-002\r\n-3.21e-002\r\n4.64e-002\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.', '0', '2.677', 'C13H18Br2N2O', '0375.979', '-5.214', '0378.103', '2.05 6.61', '0', '3', '0', '13', '06', '1', '18', '19', '23', '3', '003', '04', '18', '0', '2', '003', '0058.28', '287.52', '', '0.51334', '1.2955', '14.18', '8.24', '3.79024', '5.94', '1,401.28', '101.057', '229.46', '', 'Br/C2=C([H])/C(Br)=C([H])\\C(C(N(C1([H])C([H])([H])C([H])([H])C(O[H])([H])C([H])([H])C1([H])[H])[H])([H])[H])=C2\\N([H])[H]', 'Nc1c(Br)cc(Br)cc1CN[C@@H]2CC[C@@H](O)CC2', 'Ambroxol', 'Ambroxolum;', 'Sodium channel protein type 10 subunit alpha', '2132', 'Phase II', 'Parkinson Disease(PARK)', '24574503', 'Parkinson Disease(PARK)', 'PARK'),
(64, '64', 'Not Available', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'AMG 747', 'Not Available', 'Glycine transporter type-1', 'Not Available', 'Terminated at Phase II', 'Schizophrenia', '27789188', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(65, '9920716', '9920716', 'Nc1ccncc1N.OP(=O)(O)O', 'phosphoric acid;pyridine-3,4-diamine', 'CYAAFQwAkcwQgyHNO1fQsxZG6hmM73dpSZr1hhJpB2omDkGid$C5XPRmQEEtDxpT6SlRIm$kBAh3u3TylYtJGqCecoh4cT^LuDcMjoNpuLEOf8xoEae^BARpq5OoAQ4IEJ0nYo68krdv7p3EXWUny3A4JQs4KLhOLT3KcYfvxAbYG1MISxKXdmhcn4iyuvSlR5qbtI3m 69hezRt7mwqi1ZQuKmAwb4azcNm1nnCS3lq^v^FuD^rp3oX^42W^^7h9G2Vz33WubLZDb^MckuOXNaM56Xu3svO32dtHZIa19bL5ohWdJvOlj4MJrp^DY29f4T5UKMfeQbnMaJ632vOX7aUOGcFZjW43F5enW$CaEhpXAJkr5rDuihCAE$QWxD7qEgOB471uwyhKRJN1 eIAtRoHmNHiOTmQCvpmKXHT8jLu3URbtu8VUqymMbBGUAvAx4k$0xY8PqLw^o1sk', 'InChI=1S/C5H7N3.H3O4P/c6-4-1-2-8-3-5(4)7;1-5(2,3)4/h1-3H,7H2,(H2,6,8);(H3,1,2,3,4)', 'AuxInfo=1/1/N:11,13,12,9,10,6,8,7;2,3,4,5,1/E:;(1,2,3,4)/rA:23POOOONNNCCCCCHHHHHHHHHH/rB:s1;s1;s1;d1;;;;s6;s8d-9;s9;d-7s10;s7d-11;s11;s12;s13;s6;s6;s8;s8;s2;s3;s4;/rC:1.836,.866,0;2.702,1.366,0;.9699, .366,0;1.336,1.732,0;2.336,0,0;.5369,6.889,0;3.135,5.389,0;2.269,7.889,0;1.403,6.389,0;2.269,6.889,0;1.403,5.389,0;3.135,6.389,0;2.269,4.889,0;.866,5.079,0;3.672,6.699,0;2.269,4.269,0;0,6.579,0;.5369, 7.509,0;2.8059,8.199,0;1.732,8.199,0;3.2389,1.056,0;.433,.676,0;1.646,2.269,0;', 'KAICRBBQCRKMPO-UHFFFAOYSA-N', '1010:919ZHQCX18E29WR3HA28PUBJC7QX28', '[#15](=[#8])(-[#8]-[#1])(-[#8]-[#1])-[#8]-[#1].[#7](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[n]1):[c](:[c]1-[#1])-[#7](-[#1])-[#1]', 'P(=O)(O[H])(O[H])O[H].N([H])([H])c(c([H])c([H])n1)c(c1[H])N([H])[H]', '-01.283', '-0.814', '0', '0', 'TRUE', '0.4666\r\n-0.3028\r\n-0.3028\r\n-0.3028\r\n-0.2286\r\n-0.3012\r\n-0.263\r\n-0.3\r\n3.29e-002\r\n4.83e-002\r\n-2.45e-002\r\n4.61e-002\r\n2.84e-002\r\n6.55e-002\r\n8.56e-002\r\n8.39e-002\r\n0.1243\r\n0.1243\r\n0.1243\r\n0.1243\r\n0.2233\r\n0.2233\r\n0.2246', '0', '-2.653', 'C5H10N3O4P', '0207.041', '-0.619', '0207.124', '2.2 6.82 9.01 12.4', '1', '2', '1', '5', '06', '1', '13', '12', '15', '4', '007', '07', '10', '0', '1', '000', '0152.5', '213.79', '', '', '', '', '', '', '', '', '', '', '', 'P(O[H])(O[H])(O[H])=O.N(/C1=C(N([H])[H])/C([H])=N\\C([H])=C1\\[H])([H])[H]', 'O=P(O)(O)O.Nc1ccncc1N', 'Amifampridine Phosphate', '3,4-DAPP; 3,4-Diaminopyridine phosphate', 'Potassium voltage-gated channel subfamily A member 1', '9920716', 'Phase III Completed', 'Lambert-Eaton Myasthenic Syndrome', '20979551', 'Lambert-Eaton Myasthenic Syndrome', 'MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa, FORMERLY; CMS2A, FORMERLY\nCMS IIa, FORMERLY'),
(66, '2159', '2159', 'CCN1CCC[C@@H]1CNC(=O)c2cc(c(N)cc2OC)S(=O)(=O)CC', '4-amino-<I>N</I>-[[(2<I>R</I>)-1-ethylpyrrolidin-2-yl]methyl]-5-ethylsulfonyl-2-methoxy-benzamide', 'CYAAFQwAxewQwa7Q9s15wpDvs01QLiCXoaV3N2PykY^RZ6qZYofjRw1QFtju2^NcBzfGTsTegwFk$t2EWtA279KaKxSqhZcbkxGlNnKBsNjYzv8hRbBhkW6ZcJBn9j3ft63fPQftfCYAc$xT1r4Gqw8JB0pKChbmGap$L5ciwGNmteCjJYcTu7fK3X4rYlVAJVh28giJ lEm3cmX2lFcoFIXhDGs1nzm0q6SS84NHBGB1GHNmbI5SWlRSCDAzmCwLes3rN2hLoq1rFPVx$denNKzKYx0EW7yh7ZHDrVJnqNJ2wCfZfXqgBwi05dYzhhhhtSI5TlJ1E5cezqmT0IjNRRpS5t9S1UrmBy9irS9WHNY1GGrnnblMoaciZy$nERFY8UhLuimAra82khVG 23nVrlJBgEvvKK0FhKwp2WZu3V^$h$X1wDHt3TGBT3x6H1lemmYh7Rk5j2rvDMaj75UqN7Fj8d0gaswqvDkuH3ooW1emigyV', 'InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m1/s1', 'AuxInfo=1/1/N:15,24,25,14,23,11,10,12,19,22,13,9,17,21,20,18,16,8,7,6,2,4,5,3,1/E:(22,23)/it:im/CRV:25.6/rA:52SOOOONNNC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;d1;d1;;;;s6;s9;s10;s6s11;s7s9; s6;s14;d2s7;s16;s1;d+17s18;s3s17;s8d-18;d+20s21;s1;s23;s3;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s7;s15;s15;s15;s19;s22;s23;s23;s24;s24;s24;s8;s8;s25;s25;s25;/rC:-3.9148,-1.5454,.237;1.1816,1.5794 ,-1.4616;-.4349,3.2063,-.1724;-3.0904,-2.7035,-.0698;-4.6553,-1.4914,1.4882;4.9246,-.88,-.1001;1', 'NTJOBXMMWNYJFB-GFCCVEGCSA-N', '1010:TR4V1QYTS933BF3SMG4ZCMVSKFPXUG', '[#16](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])(-[c](:[c](:[c](-[#1]):[c](:[c]1-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[# 6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#1]):[c]1-[#1])(=[#8])=[#8]', 'S(C([H])([H])C([H])([H])[H])(c(c(c([H])c(c1C(N([H])C([H])([H])[C@@]2([H])C([H])([H])C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])[H])=O)OC([H])([H])[H])N([H])[H])c1[H])(=O)=O', '01.127', '1.127', '0', '0', 'TRUE', '1.2554\r\n-0.2719\r\n-0.3485\r\n-0.5781\r\n-0.5781\r\n-0.2991\r\n-0.3098\r\n-0.3037\r\n2.51e-002\r\n-3.49e-002\r\n-3.89e-002\r\n-1.5e-003\r\n2.69e-002\r\n-4.4e-003\r\n-5.25e-002\r\n0.2455\r\n6.61e-002\r\n-3.59e-002\r\n-5.6e-002\r\n8.85e-002\r\n3.8e-003\r\n-1.46e-002\r\n-3.8e-002\r\n-7.34e-002\r\n4.22e-002\r\n4.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.8e-002\r\n2.8e-002\r\n4.3e-002\r\n4.3e-002\r\n4.83e-002\r\n4.83e-002\r\n4.27e-002\r\n4.27e-002\r\n0.1497\r\n2.43e-002\r\n2.43e-002\r\n2.43e-002\r\n6.18e-002\r\n6.66e-002\r\n1.46e-002\r\n1.46e-002\r\n2.18e-002\r\n2.18e-002\r\n2.18e-002\r\n0.124', '1', '-0.158', 'C17H27N3O4S', '0369.172', '-2.884', '0369.479', '-1.31 8.99', '4', '2', '3', '17', '06', '1', '25', '26', '35', '6', '007', '03', '27', '0', '2', '007', '0110.11', '392.2', '', '1.64205', '1.2706', '84.07', '19.42', '4.83858', '64.65', '1,448.36', '154.934', '297.72', '-178.86', 'S(=O)(=O)(/C2=C(N([H])[H])/C([H])=C(OC([H])([H])[H])\\C(C(=O)N(C(C1([H])N(C(C([H])([H])[H])([H])[H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])[H])=C2\\[H])C(C([H])([H])[H])([H])[H]', 'CCN1CCC[C@@H]1CNC(=O)c2cc(S(=O)(=O)CC)c(N)cc2OC', 'Amisulpride', 'Aminosultopride; Solian; Deniban;Socian; DAN-2163', 'D(2) dopamine receptor', '2159', 'Terminated at Phase IV', 'Tardive Dyskinesia', '23440033', 'Tardive Dyskinesia', 'NA'),
(67, '2159', '2159', 'CCN1CCC[C@@H]1CNC(=O)c2cc(c(N)cc2OC)S(=O)(=O)CC', '4-amino-<I>N</I>-[[(2<I>R</I>)-1-ethylpyrrolidin-2-yl]methyl]-5-ethylsulfonyl-2-methoxy-benzamide', 'CYAAFQwAxewQwa7Q9s15wpDvs01QLiCXoaV3N2PykY^RZ6qZYofjRw1QFtju2^NcBzfGTsTegwFk$t2EWtA279KaKxSqhZcbkxGlNnKBsNjYzv8hRbBhkW6ZcJBn9j3ft63fPQftfCYAc$xT1r4Gqw8JB0pKChbmGap$L5ciwGNmteCjJYcTu7fK3X4rYlVAJVh28giJ lEm3cmX2lFcoFIXhDGs1nzm0q6SS84NHBGB1GHNmbI5SWlRSCDAzmCwLes3rN2hLoq1rFPVx$denNKzKYx0EW7yh7ZHDrVJnqNJ2wCfZfXqgBwi05dYzhhhhtSI5TlJ1E5cezqmT0IjNRRpS5t9S1UrmBy9irS9WHNY1GGrnnblMoaciZy$nERFY8UhLuimAra82khVG 23nVrlJBgEvvKK0FhKwp2WZu3V^$h$X1wDHt3TGBT3x6H1lemmYh7Rk5j2rvDMaj75UqN7Fj8d0gaswqvDkuH3ooW1emigyV', 'InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m1/s1', 'AuxInfo=1/1/N:15,24,25,14,23,11,10,12,19,22,13,9,17,21,20,18,16,8,7,6,2,4,5,3,1/E:(22,23)/it:im/CRV:25.6/rA:52SOOOONNNC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;d1;d1;;;;s6;s9;s10;s6s11;s7s9; s6;s14;d2s7;s16;s1;d+17s18;s3s17;s8d-18;d+20s21;s1;s23;s3;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s7;s15;s15;s15;s19;s22;s23;s23;s24;s24;s24;s8;s8;s25;s25;s25;/rC:-3.9148,-1.5454,.237;1.1816,1.5794 ,-1.4616;-.4349,3.2063,-.1724;-3.0904,-2.7035,-.0698;-4.6553,-1.4914,1.4882;4.9246,-.88,-.1001;1', 'NTJOBXMMWNYJFB-GFCCVEGCSA-N', '1010:TR4V1QYTS933BF3SMG4ZCMVSKFPXUG', '[#16](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])(-[c](:[c](:[c](-[#1]):[c](:[c]1-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[# 6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#1]):[c]1-[#1])(=[#8])=[#8]', 'S(C([H])([H])C([H])([H])[H])(c(c(c([H])c(c1C(N([H])C([H])([H])[C@@]2([H])C([H])([H])C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])[H])=O)OC([H])([H])[H])N([H])[H])c1[H])(=O)=O', '01.127', '1.127', '0', '0', 'TRUE', '1.2554\r\n-0.2719\r\n-0.3485\r\n-0.5781\r\n-0.5781\r\n-0.2991\r\n-0.3098\r\n-0.3037\r\n2.51e-002\r\n-3.49e-002\r\n-3.89e-002\r\n-1.5e-003\r\n2.69e-002\r\n-4.4e-003\r\n-5.25e-002\r\n0.2455\r\n6.61e-002\r\n-3.59e-002\r\n-5.6e-002\r\n8.85e-002\r\n3.8e-003\r\n-1.46e-002\r\n-3.8e-002\r\n-7.34e-002\r\n4.22e-002\r\n4.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.8e-002\r\n2.8e-002\r\n4.3e-002\r\n4.3e-002\r\n4.83e-002\r\n4.83e-002\r\n4.27e-002\r\n4.27e-002\r\n0.1497\r\n2.43e-002\r\n2.43e-002\r\n2.43e-002\r\n6.18e-002\r\n6.66e-002\r\n1.46e-002\r\n1.46e-002\r\n2.18e-002\r\n2.18e-002\r\n2.18e-002\r\n0.124', '1', '-0.158', 'C17H27N3O4S', '0369.172', '-2.884', '0369.479', '-1.31 8.99', '4', '2', '3', '17', '06', '1', '25', '26', '35', '6', '007', '03', '27', '0', '2', '007', '0110.11', '392.2', '', '1.64205', '1.2706', '84.07', '19.42', '4.83858', '64.65', '1,448.36', '154.934', '297.72', '-178.86', 'S(=O)(=O)(/C2=C(N([H])[H])/C([H])=C(OC([H])([H])[H])\\C(C(=O)N(C(C1([H])N(C(C([H])([H])[H])([H])[H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])[H])=C2\\[H])C(C([H])([H])[H])([H])[H]', 'CCN1CCC[C@@H]1CNC(=O)c2cc(S(=O)(=O)CC)c(N)cc2OC', 'Amisulpride', 'Aminosultopride; Solian; Deniban;Socian; DAN-2163', 'D(2) dopamine receptor', '2159', 'Terminated at Phase IV', 'Schizophrenia', '27020720', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(68, '2160', '2160', 'CN(C)CCC=C1c2ccccc2CCc3ccccc13', '3-(5,6-dihydrodibenzo[2,1-<I>b</I>:2'',1''-<I>f</I>][7]annulen-11-ylidene)-<I>N</I>,<I>N</I>-dimethyl-propan-1-amine', 'CYAAFQwADdwQQpRJ57zbZGOMdvUArvjpy7JG9gJbJuHZL9L5SVLrpLwQVV52x5nxM2z2Jh2dHB48w$loqERGV3Op7frbkIuTQ^fHNQJ26ecLHHOIusIeu0fm0WkI$jFFd^89E81yXeP0TdoQ4HbrAPIog^KtcxGUxepv$MfuWjG8A$OsQHzoObGeb5nXwCXeeUXmYBtH F^sBRcOeKUuIeotuonZWDOayHA96sR9RiW2Yxy7zz0xFmP8bUOVy8wzZGhkI6YeUVIn9ROu34xoKrwC2cf0FWZYekR2RsEPh0nNbdFY03m58Iqcg3wFTQh^^WV1nql7bPHmX5L1qkjH78gZd^0dkFEhoyo4jJr68aqzpXrPeqKvaLY$0GA6Huv6sIERO541WvYKyHgo0 VD6Dwx7ZGldTlDK5ERMHL5O2nqTlz1ZihxpwMd0j47rkQhNm7pKIvGSHMhcjj83Z$BpMOejqbd$hr4BBfqmdKZGfYKW9Mo8J', 'InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3', 'AuxInfo=1/0/N:20,21,16,17,18,19,10,11,12,13,14,9,2,3,15,5,6,7,8,4,1/E:(1,2)(3,4)(5,6)(8,9)(10,11)(13,14)(16,17)(18,19)/rA:44NCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;;s2;s3;s4s5;s4s6;d+4;s9; d+5;d+6;d+7;d+8;s1s10;s11;s12;s13d-16;s14d-17;s1;s1;s2;s2;s3;s3;s9;s10;s10;s11;s12;s13;s14;s15;s15;s16;s17;s18;s19;s20;s20;s20;s21;s21;s21;/rC:2.9255,-2.2076,-.6183;-1.8781,.8302,-1.7939;-.3777,1.0834 ,-1.9473;-.2112,-.2046,.6322;-2.3555,-.1607,-.7469;.1917,1.8189,-.7614;-1.6077,-.6335,.3543;.266', 'KRMDCWKBEZIMAB-UHFFFAOYSA-N', '1010:1TK4K1HGCH9PEVMEEXGPHZE9REH3ZQ', '[#7](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])\\-[#6](-[#1])=[#6](/-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1]):[c]1-[#6]2(-[#1])-[#1])\\-[c](:[c](-[ #1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c]3-[#6]2(-[#1])-[#1]', 'N(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])\\C([H])=C(/c(c([H])c([H])c([H])c1[H])c1C2([H])[H])\\c(c([H])c([H])c([H])c3[H])c3C2([H])[H]', '04.772', '4.772', '0', '0', 'TRUE', '-0.309\r\n-2.32e-002\r\n-2.32e-002\r\n-1.45e-002\r\n-3.98e-002\r\n-3.98e-002\r\n-1.49e-002\r\n-1.49e-002\r\n-7.48e-002\r\n-2.13e-002\r\n-5.84e-002\r\n-5.84e-002\r\n-5.41e-002\r\n-5.41e-002\r\n1.e-003\r\n-6.19e-002\r\n-6.19e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-1.37e-002\r\n-1.37e-002\r\n3.19e-002\r', '0', '3.336', 'C20H23N', '0277.183', '-5.956', '0277.403', '9.42', '0', '0', '1', '10', '12', '2', '21', '23', '25', '7', '001', '00', '23', '0', '3', '003', '0003.24', '312.18', '', '0.91598', '1.2655', '28.94', '19.21', '3.7259', '9.73', '594.332', '2.624', '244.55', '', 'N(C(C(/C(=C\\2/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C([H])([H])C([H])([H])/C/3=C([H])/C([H])=C([H])\\C([H])=C23)[H])([H])[H])([H])[H])(C([H])([H])[H])C([H])([H])[H]', 'CN(C)CC/C=C/2c1ccccc1CCc3ccccc23', 'Amitriptyline', 'Elavil; Damilen; Triptanol; Seroten; Proheptadiene', 'Sodium-dependent noradrenaline transporter', '2160', 'Terminated at Phase III', 'Migraine', '25410451', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(69, '2165', '2165', 'CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O', '4-[(7-chloro-4-quinolyl)amino]-2-(diethylaminomethyl)phenol', 'CYAAFQwAXdwQa5qjPxzG7fBMhAh0vGTr6hbsieyZuJ2o3NTsuOK3TcfpD3sKqds$h48w7LfL4dF4OoEm78mkaIntOC90uKPTIJTBp7C5Am0bWxc1D4$Le5bmRqWReUAKTc^PvUeE8CoA179XqRBAAF$7^t2NqFc487rU38y2jGJXTfrBU1xNbw4q$Blic8wLrw1HK^yd n0hA8VLVeD$erjJcP8Q6$PfC2AsTh2BH^urW3gBMWMIEtaMXrMCYxthILT8IOeylE8qDbpZPPgM4cYVLsrxHS$wFQfhHJXcd5WVgHZ1eAfT6cZFWjk$YTWtr0u8bX0kZm5JXa2j0^uVu4aWQKdy5Q9xoDozrccS4rLXar3JzvwJ8ky1dOrDpXeOu0RDjuG056NO0G9AC fvihKVt1ss6oYgHN93$o72DMDYO8S4vurg$pWx4j6nWv3bAr9XjCfpZwUGte$iu9d5AG0peUpUew9BNxeScB$tyMefs8zbSW', 'InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)', 'AuxInfo=1/1/N:13,14,8,9,24,15,21,17,20,23,10,22,6,7,25,11,18,16,19,12,1,5,4,3,2/E:(1,2)(3,4)/rA:47ClONNNCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3;s6;s3;s3;s7;s4d+10;s2d-7;s8;s9;s11;s4;s12d- 15;d+16;d-5s18;s16;s18;s19;s5d-20;d-21;s1d+22s24;s6;s6;s8;s8;s9;s9;s10;s13;s13;s13;s14;s14;s14;s4;s15;s17;s20;s21;s22;s2;s23;s24;/rC:-7.0142,.1866,1.3564;4.7936,-2.2774,.151;3.3773,1.534,.4275;-.6856, -1.4968,-.4065;-2.9557,1.9606,-1.1192;3.7064,.226,.9948;2.872,-.8691,.4169;3.5938,1.5324,-1.0185', 'OVCDSSHSILBFBN-UHFFFAOYSA-N', '1010:UX12PWKSNVWQE9GUTY9SU3481C8F1Y', '[#17]-[c](:[c](-[#1]):[c]1-[#1]):[c](-[#1]):[c]2:[c]1:[c](:[c](-[#1]):[c](-[#1]):[n]2)-[#7](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]3-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[ #1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]):[c]3-[#1]', 'Clc(c([H])c1[H])c([H])c2c1c(c([H])c([H])n2)N([H])c(c([H])c([H])c(c3C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])O[H])c3[H]', '04.76', '4.76', '0', '0', 'TRUE', '-8.43e-002\r\n-0.3606\r\n-0.2995\r\n-0.2584\r\n-0.2561\r\n2.59e-002\r\n-2.4e-003\r\n-4.4e-003\r\n-4.4e-003\r\n-3.68e-002\r\n1.94e-002\r\n7.59e-002\r\n-5.25e-002\r\n-5.25e-002\r\n-4.13e-002\r\n2.99e-002\r\n-3.02e-002\r\n1.85e-002\r\n7.32e-002\r\n-2.48e-002\r\n-4.98e-002\r\n-1.71e-002\r\n2.91e-002\r\n-', '0', '2.034', 'C20H22ClN3O', '0355.145', '-5.851', '0355.861', '4.51 5.62 9.41 10.03', '1', '2', '0', '10', '17', '3', '25', '27', '27', '8', '004', '02', '22', '0', '3', '006', '0048.39', '369.25', '', '2.54718', '1.271', '55.55', '7.22', '4.26531', '48.33', '1,419.53', '75', '285.03', '', 'Cl/C3=C([H])/C2=N/C([H])=C([H])\\C(N(/C1=C([H])/C(C(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])=C(O[H])\\C([H])=C1\\[H])[H])=C2\\C([H])=C3\\[H]', 'CCN(CC)Cc3cc(Nc1ccnc2cc(Cl)ccc12)ccc3O', 'amodiaquine', 'Camoquine; Flavoquine; Camochin; Miaquin; Sunoquine; Basoquin', 'Nuclear receptor subfamily 4 group A member 2', '2165', 'Under Investigation', 'Parkinson Disease(PARK)', '26124091', 'Parkinson Disease(PARK)', 'PARK'),
(70, '148184', '148184', 'O=C(N1CCCCC1)c2ccc3nccnc3c2', '1-piperidyl(quinoxalin-6-yl)methanone', 'CYAAFQwAFcwQ07hfV7kTFqKI$vRm4n7G5S6uxEzYgxfJ0PxHO8gujlj6v9lXwTEi$U0qosUvoW8do7ARrls5AXJg90diUni41xanNuxFl2luggPqu8W4cJcVCYJuz^7lV2aaAQwX86bcAZK4pdv3wYygtil9l9ul55NHQlItYzT7HHARBxqCwvbeAVsQYU4U9dVLxH$b t5i5gBKqErhr7ps6d0QkxBl2DMC8$41rpxzrxfdrxspAVj16ecjyqqWbqedqL2TDeZl4z84zJLomNOE069GnygN0Z0uG9wIFHW511CzmgaZ8Bzj1Cjf4F80Cg0dKWJ$PoveXKVTWdDaF5hVynLXreESVrVRcTsnKRlHXNowB9YQFzvA^Fxz7z6OzitzecvFtlcFcRa04 zVpmBX9u3PzWPiEdNzJDE5pV^d2LDIT37TqArhGHqSvM46YCtEUYed1XjqSr7b2gS0XibM4ITF4DpQ8D4lcltWd5$Rmus6nS', 'InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2', 'AuxInfo=1/0/N:5,6,7,13,16,18,17,8,9,12,11,15,14,10,4,3,2,1/E:(2,3)(8,9)/rA:33ONNNCCCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s2s6;s2s7;d1s2;s10;d+11;s11;d+3s12;d-4s14;d-13s15;s3;s4d-17;s5;s5;s6;s6;s7;s 7;s8;s8;s9;s9;s12;s13;s16;s17;s18;/rC:-1.6028,2.094,-1.3675;-2.4425,.4601,.079;2.706,-1.2317,-1.206;3.8849,.1419,.9019;-4.1809,-1.8085,.4858;-4.4998,-.7336,-.5538;-2.6766,-1.8957,.7442;-3.8835,.6074,- .1649;-2.0937,-.5298,1.0986;-1.4329,1.2055,-.534;-.0412,.9284,-.1568;.6925,-.0249,-.8554;.5423,1', 'ANDGGVOPIJEHOF-UHFFFAOYSA-N', '1010:3TFQHA5PF5PQG5SEDD25C724M59Z8P', '[#8]=[#6](-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c]2:[c]1-[#1]):[n]:[c](-[#1]):[c](-[#1]):[n]2)-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 'O=C(c1c([H])c([H])c(c2c1[H])nc([H])c([H])n2)N3C([H])([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H]', '01.625', '1.625', '0', '0', 'TRUE', '-0.2717\r\n-0.2979\r\n-0.253\r\n-0.253\r\n-5.04e-002\r\n-3.73e-002\r\n-3.73e-002\r\n1.43e-002\r\n1.43e-002\r\n0.2455\r\n3.95e-002\r\n-2.17e-002\r\n-4.74e-002\r\n8.94e-002\r\n8.86e-002\r\n-3.35e-002\r\n4.59e-002\r\n4.59e-002\r\n2.67e-002\r\n2.67e-002\r\n2.82e-002\r\n2.82e-002\r\n2.82e-002\r\n2.82e-002', '0', '1.625', 'C14H15N3O', '0241.122', '-3.042', '0241.288', '2.01', '3', '0', '1', '8', '11', '2', '18', '20', '17', '6', '004', '00', '15', '0', '3', '001', '0046.09', '251.01', '', '2.64214', '1.2752', '20.93', '14.06', '3.62949', '6.87', '552.134', '82.7', '193.79', '2.05', 'O=C(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])/C3=C([H])/C2=N/C([H])=C([H])\\N=C2\\C([H])=C3\\[H]', 'O=C(c2ccc1nccnc1c2)N3CCCCC3', 'Ampalex', 'CX-516; BDP-12; AC-001', 'Glutamate receptor 3', '148184', 'Phase II Completed', 'Fragile X Syndrome', '17069542', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(71, '3007', '3007', 'C[C@H](N)Cc1ccccc1', '(2<I>S</I>)-1-phenylpropan-2-amine', 'CYAAFQwApfwQHzCGlRo1L4wS2ToTpM0i^nSKxXTJ2wVP4yqzo2JfTS3YVZ8Fs1ehiA7yEXn1UK$6CPWehGhG$aayZD3Qyx775vIhN4qS$mD8LXVj5MK^exf^Dv7jEb0L$6heFFGy4lVvzmHqi9AAGAvKJTcPZN445ckgEdbcLEcJ8QFjG6Hjmnh6rtTEd25jZ7Zbu$z$ PuTCDOUR33vYARt851aWMT$awZao8smLhK61KgGo7JV1yBvsx7eMkLHk$LYtaXN5ec$sRO3DViMqR5hVHDt02MqKXV5xoTukLVN9XqpqTHhe3LLqgoSpvN4FziO8uFKSeOfaRikCW7pVvJi4nWpGj^Plpvec3WV6svCyP84Ce2QQuS8FW6GtPxzrpRVKZEjyeg1S7ZNv bzB5sxmlbZDRWwUeSuYeRSAxyx7lIPJJ2Ljpry97P80BcvnbWAypai083mJ8i0YzTnmXel3Plv2FLaSWsEUzY9aPe$kyF5FH', 'InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1', 'AuxInfo=1/0/N:5,10,8,9,6,7,3,2,4,1/E:(3,4)(5,6)/it:im/rA:23NC.oCCCCCCCCHHHHHHHHHHHHH/rB:s1;s2;s3;s2;d+4;s4;s6;d-7;d-8s9;s2;s3;s3;s5;s5;s5;s6;s7;s1;s1;s8;s9;s10;/rC:-3.5849,-.4599,.1218;-2.2239,-.1762, -.3436;-1.2222,-.4574,.7925;.2121,-.2349,.4021;-2.1745,1.2729,-.8278;.9484,-1.2846,-.1323;.7852,1.0179,.5809;2.2797,-1.0783,-.4941;2.1164,1.2243,.219;2.8637,.1762,-.3184;-2.0069,-.8349,-1.1935;-1.3381 ,-1.4935,1.1401;-1.458,.1652,1.6671;-1.2278,1.4959,-1.3291;-2.3048,1.98,-.0009;-2.9665,1.4674,-1', 'KWTSXDURSIMDCE-QMMMGPOBSA-N', '1010:Q9BE869DM4C25MB7SWHG5CG39SEQFV', '[#7](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1]', 'N([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])c1c([H])c([H])c([H])c([H])c1[H]', '01.634', '1.634', '0', '0', 'TRUE', '-0.3277\r\n5.1e-003\r\n-1.29e-002\r\n-4.65e-002\r\n-4.97e-002\r\n-5.9e-002\r\n-5.9e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.22e-002\r\n4.62e-002\r\n3.31e-002\r\n3.31e-002\r\n2.46e-002\r\n2.46e-002\r\n2.46e-002\r\n6.25e-002\r\n6.25e-002\r\n0.1186\r\n0.1186\r\n6.22e-002\r\n6.22e-002\r\n6.31000000000003e-', '1', '0.641', 'C9H13N', '0135.105', '-2.306', '0135.206', '9.91', '0', '1', '0', '4', '06', '1', '10', '10', '15', '3', '001', '02', '13', '0', '1', '002', '0026.02', '163.92', '', '0.67248', '1.2368', '5.64', '3.32', '2.78098', '2.32', '169.783', '58.575', '127.25', '', 'N(C(C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])([H])[H])(C([H])([H])[H])[H])([H])[H]', 'C[C@H](N)Cc1ccccc1', 'Amphetamine', 'Desoxynorephedrine; Adderall; Fenopromin; Mydrial; Simpatina; Finam', 'Sodium-dependent dopamine transporter', '3007', 'Phase IV', 'Attention Deficit Hyperactivity Disorder (ADHD)', '26844979', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(72, '44608289', '44608289', 'Brc1cccc(c1)c2cc([nH]n2)c3ccc4OCOc4c3', '5-(1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1<I>H</I>-pyrazole', 'CYAAFQwAofwQfzy4bjH2yOK7MgYLp3Kg4Cz4sQ^swQ^FVS81q3eG7dy5$Y8vXm4sFb6uzhyNzHC^6AtaVfcPEm9YfWnVKWeTcAc54exKFzxu^r6DIWKT9u^1WXBM0DuU35xOI87L^KMAtSNf^kUuAYW0wmB2Q1aQd0vPX1pzqOCd4$k33NQEYh9D3rcRaCvsrUXuYhgb p^wBxsuyeeIkjzmNI1aXEnf5IU5CXP4C2Qha4qMeqJM8E1GpDl8g$YFrFF3rJeMxEKfxyzrLeIHJDNccOIbQ9eRbxpB6zxTHAzso69aQdLZoMNEMVWtH2U^FVZpbjyq4hX29QZdwAcaIANvmmrbI0oyhmVGl$qgSTgn88mxEGjGOr5Yb94AXJ4qyRonzrWNYNVzG9KZF xw8fetY6r6Ud98cV3cKA2eDPYdJ3BFu3Krez$i50HFFt$GM7x3YEVNmyMoHHiVfNo79N2tWmyhUDYxibu23r^iN8xOH0BRDn', 'InChI=1S/C16H11BrN2O2/c17-12-3-1-2-10(6-12)13-8-14(19-18-13)11-4-5-15-16(7-11)21-9-20-15/h1-8H,9H2,(H,18,19)', 'AuxInfo=1/1/N:20,18,21,13,14,17,9,12,16,15,6,19,11,7,10,8,1,5,4,3,2/rA:32BrOONNCCCCCCCCCCCCCCCCHHHHHHHHHHH/rB:;;;s4;;s4s6;s2;d+6s8;s3d-8;d-5;d-7s11;s6;s10d-13;s11;s2s3;d+15;s15;s1s17;d-18;d+19s20;s9;s 12;s13;s14;s4;s16;s16;s17;s18;s20;s21;/rC:-5.7984,-2.8001,.066;5.2269,1.2303,-.3544;5.7898,-1.1016,-.1244;.0613,1.5717,.6612;-1.269,1.7632,.6531;1.8257,-.0632,.1168;.4449,.3489,.1943;4.129,.4504,-.157 8;2.8236,.8922,-.0905;4.4506,-.8811,-.0265;-1.7378,.6132,.1612;-.715,-.3053,-.1422;2.1542,-1.423', 'RCQIIBJSUWYYFU-UHFFFAOYSA-N', '1010:7J13X7WSHTV67EJRJ1S8JXV8U3G2ME', '[#35]-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[#1]):[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](:[c]3:[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#8]3):[n]4-[#1]):[n]4):[c]1-[#1]', 'Brc(c([H])c([H])c([H])c1c(c([H])c(c2c([H])c([H])c(c3c2[H])OC([H])([H])O3)n4[H])n4)c1[H]', '04.547', '4.547', '0', '0', 'TRUE', '-5.08e-002\r\n-0.316\r\n-0.316\r\n-0.1817\r\n-0.1969\r\n-3.e-003\r\n4.54e-002\r\n0.109\r\n-2.01e-002\r\n0.1084\r\n8.67e-002\r\n-1.41e-002\r\n-5.06e-002\r\n-2.84e-002\r\n2.6e-003\r\n0.1585\r\n-3.85e-002\r\n-5.27e-002\r\n1.81e-002\r\n-6.05e-002\r\n-4.8e-002\r\n6.58e-002\r\n6.63e-002\r\n6.3e-002\r\n6.51e-', '0', '4.547', 'C16H11BrN2O2', '0342', '-5.074', '0343.175', '2.23', '3', '1', '0', '7', '17', '3', '21', '24', '14', '8', '004', '01', '11', '0', '4', '002', '0047.14', '274.09', '', '1.01449', '1.3085', '43.19', '26.19', '4.44581', '17', '1,628.64', '98.082', '215.06', '', 'Br/C4=C([H])/C([H])=C([H])\\C(\\C3=N\\N([H])\\C(/C2=C([H])/C1=C(OC([H])([H])O1)\\C([H])=C2\\[H])=C3\\[H])=C4\\[H]', 'Brc4cccc(c3cc(c2ccc1OCOc1c2)[nH]n3)c4', 'Anle138b', 'CS-6522; HY-101855', 'Alpha-synuclein', '44608289', 'Under Investigation', 'Parkinson Disease(PARK)', '23604588', 'Parkinson Disease(PARK)', 'PARK'),
(73, '6440763', '6440763', 'O=C1Cc2c(N1)ccc3OC[C@H](CNCc4ccccc4)Oc23', '(2<I>S</I>)-2-[(benzylamino)methyl]-2,3,7,9-tetrahydro-[1,4]dioxino[2,3-e]indol-8-one', 'CYAAFQwAUdwQvmejTPTHX7zewb$PaqEFDIUBxn6IXMGsbcoxwmdnl7NpqtfNOqv3RynVipYgXu35FTuUAGxOH^8ujDS4$9a4oduebp3j6g7azIlAOTWYRaCx6DOl^v$wad98I87ST4IAEZSYHVs9UrEyI3jzTjF2dR99v2HH$5VArNBKpAAWNzT7nzCTCWeKW0NIv1Dx tKJvXo7n9JmoooVh8wSv6Jy9TVfxDTlLsHzHj9NP1jThHD^4TluZQLlGcQPW5eBO95jKYB3A0m8IiJaOKFXrqpDZ41tQEzzZlVl0nD1bspSXYxMPXWEvJMQR4y1f6Ne39jtKTsUq9aVdZdS5ISZpqxjx7A9VSD$DoODy9aBadOuJEn5xlp3$GJFIxT5lw^q7neNql4wo f18y44dyLGH7zHalNVa2H8$F80eWetgQ7IQg1I7TrODGH1FF^21oX4xjpechU8MScPGzhCUeB^4iTmHWm7pdOfoWjBQF97e1', 'InChI=1S/C18H18N2O3/c21-17-8-14-15(20-17)6-7-16-18(14)23-13(11-22-16)10-19-9-12-4-2-1-3-5-12/h1-7,13,19H,8-11H2,(H,20,21)/t13-/m0/s1', 'AuxInfo=1/1/N:23,21,22,19,20,15,14,13,17,10,9,18,6,7,12,11,16,8,5,4,3,2,1/E:(2,3)(4,5)/it:im/rA:41OOONNC.oCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;;;s1;;s1s7;s2s6;s5s6;s2d-8;s4d+7;s7;s11;s12d-14;d3s4s 13;s5;s17;d+18;s18;s19;d-20;d-21s22;s6;s9;s9;s10;s10;s13;s13;s14;s15;s4;s5;s17;s17;s19;s20;s21;s22;s23;/rC:1.2113,-.6229,.1936;.901,2.2363,-.0262;6.3234,-2.5104,.0429;5.8104,-.2258,-.1652;-2.461,-.352 7,.023;-.036,.0023,-.1388;3.5429,-.3003,.0124;2.2673,.2286,.0416;-.1115,1.3784,.5104;-1.1541,-.9', 'DYJIKHYBKVODAC-ZDUSSCGKSA-N', '1010:ZAXWZ25Z63GPPEQX3JFJT2HYFXG128', '[#8]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c]3:[c]2-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8])-[#8]-[#6](-[#1])(-[#1])-[#6@]1(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#1])(-[#1])-[c]4:[c](-[#1]):[c](- [#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1]', 'O1c2c(c([H])c([H])c3c2C([H])([H])C(N3[H])=O)OC([H])([H])[C@]1([H])C([H])([H])N([H])C([H])([H])c4c([H])c([H])c([H])c([H])c4[H]', '01.82', '1.82', '0', '0', 'TRUE', '-0.336\r\n-0.3406\r\n-0.277\r\n-0.2848\r\n-0.31\r\n0.1005\r\n1.55e-002\r\n0.1112\r\n8.14e-002\r\n2.47e-002\r\n0.1057\r\n3.89e-002\r\n5.44e-002\r\n-2.72e-002\r\n-3.77e-002\r\n0.2205\r\n2.06e-002\r\n-3.42e-002\r\n-5.78e-002\r\n-5.78e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n6.47e-002\r\n6.e-002\r\n6.', '1', '1.526', 'C18H18N2O3', '0310.132', '-3.696', '0310.347', '3.62 7.43', '3', '2', '1', '13', '12', '2', '23', '26', '20', '7', '005', '02', '18', '0', '4', '004', '0059.59', '294.82', '', '2.18944', '1.2801', '32.42', '22.95', '4.7552', '9.47', '1,489.28', '119.162', '240.09', '0.04', 'O2C(C(N(C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])([H])[H])[H])([H])[H])([H])C([H])([H])O/C4=C2/C3=C(N([H])C(=O)C3([H])[H])\\C([H])=C4\\[H]', 'O=C4Cc3c(ccc2OC[C@H](CNCc1ccccc1)Oc23)N4', 'Aplindore fumarate', 'Palindore Fumarate; DAB 452', 'D(2) dopamine receptor', '6440763', 'Under Investigation', 'Schizophrenia', '17056032', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(74, '6005', '6005', 'CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34', '(6<I>a</I><I>R</I>)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol', 'CYAAFQwA1fwQJdPKRS8ryCIAR8h37fbJ3pPIb$nLF8W2tQaLviqq7GEi6qE8rGd4kE1SG7CsS8Aq3SLB11xnjbLFYnUChVPVj5$OELZ07k4Jx18xEG2cSFITf8gxnf$^3Uu79CcA0q9IibsqzcTBH47pQXxWMMq8e$wEqZKbbcQngPesVifC2Lx9^sGSZ0axBgLyeLlq u5hZDyKr8I6hVHB7U6rVTj$aVoWHuV0hdccVjPKAj0jzDbMtoWlth$6YHVZyKD5mNwIsFNWOPuiwWW5Nsws3k^2czQM^lG21GjlM1C3pwe^15Be0WZzoXpOCg5mHgMfNBzb1yLrA2hNivW3KGeYuW77ScQvRN2rlkjBWEeciVZlNPYtar5^ucakHlp6NQTKfazjrHHAC mFrCSxqvN41V$JbGnllru2AbdVU8NSFd2d3o4nRfReg2UtTZSmGIfSk9CLBeC8cZY4BZ6TbTbDejKHD4TworL9WlBWz^TEZk', 'InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1', 'AuxInfo=1/0/N:13,18,14,15,16,20,9,8,6,7,11,10,4,19,5,12,17,3,2,1/it:im/rA:37OONC.eCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s4;d-5;s3;s7s8;s5;s6;s10d-11;s3;s7;d-10;s11;s1s12;d-14s15;s2d-17;d-16s19; s4;s6;s6;s8;s8;s9;s9;s13;s13;s13;s14;s15;s16;s18;s20;s1;s2;/rC:2.7577,-1.8892,.5407;4.8778,-.2391,.4097;-2.7275,1.6804,-.0774;-1.3737,1.1473,.2256;-1.2651,-.3657,.0082;-.2863,1.8505,-.6184;-2.4274,-1. 1613,-.0121;-3.7467,.8881,.6293;-3.7897,-.5308,.0701;.0162,-.9626,-.1079;1.0853,1.2772,-.3404;1.', 'VMWNQDUVQKEIOC-CYBMUJFWSA-N', '1010:MUGQPM8HG6AV5UKNKVCZAKHW1DD7PU', '[#8](-[#1])-[c](:[c](:[c](-[#1]):[c]1-[#1])-[#8]-[#1]):[c](:[c]1-[#6]2(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c](:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]4-[#6](-[#1])(-[#1])-[#1]) -[#6@@]24-[#1]', 'O([H])c(c(c([H])c1[H])O[H])c(c1C2([H])[H])c(c([H])c([H])c3[H])c(c3C([H])([H])C([H])([H])N4C([H])([H])[H])[C@@]24[H]', '03.116', '3.116', '0', '0', 'TRUE', '-0.3577\r\n-0.3582\r\n-0.2987\r\n3.94e-002\r\n-1.93e-002\r\n-7.3e-003\r\n-4.13e-002\r\n2.5e-003\r\n-1.47e-002\r\n-1.04e-002\r\n-3.55e-002\r\n1.8e-002\r\n-1.28e-002\r\n-5.86e-002\r\n-5.4e-002\r\n-5.56e-002\r\n0.1094\r\n-6.14e-002\r\n0.1019\r\n-2.91e-002\r\n5.21e-002\r\n3.35e-002\r\n3.35e-002\r\n4.33e-', '1', '2.524', 'C17H17NO2', '0267.126', '-3.107', '0267.322', '7.89 8.98 12.8', '0', '2', '0', '11', '12', '2', '20', '23', '20', '6', '003', '02', '17', '0', '4', '000', '0043.7', '260.94', '', '2.84795', '1.2855', '33.29', '9.52', '3.55108', '23.77', '562.859', '82.996', '216.43', '', 'O(/C1=C(O[H])/C([H])=C([H])\\C4=C1\\C2=C([H])\\C([H])=C([H])/C3=C2/C([H])(N(C([H])([H])[H])C([H])([H])C3([H])[H])C4([H])[H])[H]', 'CN2CCc3cccc4c1c(O)c(O)ccc1C[C@@H]2c34', 'Apomorphine', 'Apokyn; Uprima', 'D(2) dopamine receptor', '6005', 'Phase IV', 'Parkinson Disease(PARK)', '87620', 'Parkinson Disease(PARK)', 'PARK'),
(75, '107882', '107882', 'CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34', '(6<I>a</I><I>R</I>)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol', 'CYAAFQwA1fwQJdPKRS8ryCIAR8h37fbJ3pPIb$nLF8W2tQaLviqq7GEi6qE8rGd4kE1SG7CsS8Aq3SLB11xnjbLFYnUChVPVj5$OELZ07k4Jx18xEG2cSFITf8gxnf$^3Uu79CcA0q9IibsqzcTBH47pQXxWMMq8e$wEqZKbbcQngPesVifC2Lx9^sGSZ0axBgLyeLlq u5hZDyKr8I6hVHB7U6rVTj$aVoWHuV0hdccVjPKAj0jzDbMtoWlth$6YHVZyKD5mNwIsFNWOPuiwWW5Nsws3k^2czQM^lG21GjlM1C3pwe^15Be0WZzoXpOCg5mHgMfNBzb1yLrA2hNivW3KGeYuW77ScQvRN2rlkjBWEeciVZlNPYtar5^ucakHlp6NQTKfazjrHHAC mFrCSxqvN41V$JbGnllru2AbdVU8NSFd2d3o4nRfReg2UtTZSmGIfSk9CLBeC8cZY4BZ6TbTbDejKHD4TworL9WlBWz^TEZk', 'InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1', 'AuxInfo=1/0/N:13,18,14,15,16,20,9,8,6,7,11,10,4,19,5,12,17,3,2,1/it:im/rA:37OONC.eCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s4;d-5;s3;s7s8;s5;s6;s10d-11;s3;s7;d-10;s11;s1s12;d-14s15;s2d-17;d-16s19; s4;s6;s6;s8;s8;s9;s9;s13;s13;s13;s14;s15;s16;s18;s20;s1;s2;/rC:2.7577,-1.8892,.5407;4.8778,-.2391,.4097;-2.7275,1.6804,-.0774;-1.3737,1.1473,.2256;-1.2651,-.3657,.0082;-.2863,1.8505,-.6184;-2.4274,-1. 1613,-.0121;-3.7467,.8881,.6293;-3.7897,-.5308,.0701;.0162,-.9626,-.1079;1.0853,1.2772,-.3404;1.', 'VMWNQDUVQKEIOC-CYBMUJFWSA-N', '1010:MUGQPM8HG6AV5UKNKVCZAKHW1DD7PU', '[#8](-[#1])-[c](:[c](:[c](-[#1]):[c]1-[#1])-[#8]-[#1]):[c](:[c]1-[#6]2(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c](:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]4-[#6](-[#1])(-[#1])-[#1]) -[#6@@]24-[#1]', 'O([H])c(c(c([H])c1[H])O[H])c(c1C2([H])[H])c(c([H])c([H])c3[H])c(c3C([H])([H])C([H])([H])N4C([H])([H])[H])[C@@]24[H]', '03.116', '3.116', '0', '0', 'TRUE', '-0.3577\r\n-0.3582\r\n-0.2987\r\n3.94e-002\r\n-1.93e-002\r\n-7.3e-003\r\n-4.13e-002\r\n2.5e-003\r\n-1.47e-002\r\n-1.04e-002\r\n-3.55e-002\r\n1.8e-002\r\n-1.28e-002\r\n-5.86e-002\r\n-5.4e-002\r\n-5.56e-002\r\n0.1094\r\n-6.14e-002\r\n0.1019\r\n-2.91e-002\r\n5.21e-002\r\n3.35e-002\r\n3.35e-002\r\n4.33e-', '1', '2.524', 'C17H17NO2', '0267.126', '-3.107', '0267.322', '7.89 8.98 12.8', '0', '2', '0', '11', '12', '2', '20', '23', '20', '6', '003', '02', '17', '0', '4', '000', '0043.7', '260.94', '', '2.84795', '1.2855', '33.29', '9.52', '3.55108', '23.77', '562.859', '82.996', '216.43', '', 'O(/C1=C(O[H])/C([H])=C([H])\\C4=C1\\C2=C([H])\\C([H])=C([H])/C3=C2/C([H])(N(C([H])([H])[H])C([H])([H])C3([H])[H])C4([H])[H])[H]', 'CN2CCc3cccc4c1c(O)c(O)ccc1C[C@@H]2c34', 'Apomorphine?Hydrochloride', 'APL-130277; Apokyn', 'D(2) dopamine receptor', '107882', 'Phase II', 'Parkinson Disease(PARK)', '27430123', 'Parkinson Disease(PARK)', 'PARK'),
(76, '50914822', '50914822', 'Cc1ccc(cc1)c2ccc(O[C@H]3CN4CCC3CC4)cn2', '(3<I>R</I>)-3-[[6-(p-tolyl)-3-pyridyl]oxy]quinuclidine', 'CYAAFQwAJewQy5rWMnYKaot9xDArihY59R$4Ri5kllgre9sXLsT9D^7pQ6WiKDEJg3obEuyQMnqr0QTzS4zlR3pzGnrAyEGrJ09^xesKuy^Hs60NPsH4P^oHpExZBukUxPc8cr3^Lxfv7DBA6cwy7nJUaizeL6Eg8FaDEPTLBnOwb1KbWjKcMNctNcpygB^VtgTb5CIV gD9wAvvgNv2RERxZu4vtIRrdr8a^zAkDMmsCQcADrk4wxYZhRh89jUTVugq4CXAL5w2aNvhG1kEX1u6qH0j6MF8h517rUdkVnWx6ia1h4oZedY2Yx1Nduag1Yi4MZiALxGXXzJmCL6U1Oyf06I8Is6aLq7TyB7dt2p1GymUibIpIOSnbhUtc0G44tdsdoSXPFWVaj44K YW65SDEyD7nU8nVN1ySEVhfsiX0EZqGDMPdVenLgBkt4Myc0XMgAQZrFnWAxl$RwIJiSsqldn2h2amnSh1xzrZbENo0P$qO3', 'InChI=1S/C19H22N2O/c1-14-2-4-15(5-3-14)18-7-6-17(12-20-18)22-19-13-21-10-8-16(19)9-11-21/h2-7,12,16,19H,8-11,13H2,1H3/t19-/m0/s1', 'AuxInfo=1/0/N:22,20,21,17,18,12,14,6,7,9,10,13,8,19,16,4,11,15,5,3,2,1/E:(2,3)(4,5)(8,9)(10,11)/it:im/rA:44ONNCC.oCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s1s4;s4;s4;s2s5;s2s6;s2s7;s1;s11;s3d+11; d-12;d-3s14;s15;d+16;s16;;s17d-19;d-18s19;s19;s4;s5;s7;s6;s6;s7;s8;s8;s10;s10;s9;s9;s12;s13;s14;s17;s18;s20;s21;s22;s22;s22;/rC:-2.1533,.8405,.361;-5.3368,-.5573,.8664;1.3581,1.15,-.616;-3.8889,.1136, -1.1844;-3.005,-.2481,.023;-4.7555,-1.1133,-1.5021;-4.8362,1.2558,-.7775;-3.9005,-.5891,1.2277;-', 'NPDLTEZXGWRMLQ-IBGZPJMESA-N', '1010:8MM8BWYDCA4X1734HG2QH9DM22ECFQ', '[#8](-[c](:[c]1-[#1]):[c](-[#1]):[c](-[#1]):[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]2-[#1]):[n]1)-[#6@@](-[#1])(-[#6]3(-[#1])-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])- [#6](-[#1])(-[#1])-[#7]34)-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]', 'O(c(c1[H])c([H])c([H])c(c2c([H])c([H])c(C([H])([H])[H])c([H])c2[H])n1)[C@@]([H])(C3([H])[H])C([H])(C([H])([H])C([H])([H])N34)C([H])([H])C4([H])[H]', '03.632', '3.632', '0', '0', 'TRUE', '-0.3396\r\n-0.3007\r\n-0.2535\r\n-1.08e-002\r\n7.98e-002\r\n-3.5e-002\r\n-3.5e-002\r\n2.53e-002\r\n-1.4e-003\r\n-1.4e-003\r\n9.37e-002\r\n-2.81e-002\r\n5.78e-002\r\n-3.32e-002\r\n7.03e-002\r\n1.e-004\r\n-5.26e-002\r\n-5.26e-002\r\n-5.11e-002\r\n-5.87e-002\r\n-5.87e-002\r\n-3.98e-002\r\n3.3e-002\r\n6.', '1', '3.632', 'C19H22N2O', '0294.173', '-4.407', '0294.391', '3.29 3.7', '2', '0', '0', '13', '12', '2', '22', '25', '25', '6', '003', '00', '22', '0', '5', '003', '0025.36', '302.53', '', '2.12869', '1.2782', '66.9', '18.11', '4.93273', '48.79', '1,290.64', '31.8', '250.73', '', 'O(C1([H])C2([H])C([H])([H])C([H])([H])N(C1([H])[H])C([H])([H])C2([H])[H])/C4=C([H])/N=C(/C3=C([H])/C([H])=C(C([H])([H])[H])\\C([H])=C3\\[H])\\C([H])=C4\\[H]', 'Cc4ccc(c3ccc(O[C@H]1C[N@]2CC[C@@H]1CC2)cn3)cc4', 'AQW051', 'GTPL7371', 'Neuronal acetylcholine receptor subunit alpha-7', '50914822', 'Phase II Completed', 'Parkinson Disease(PARK)', '26990766', 'Parkinson Disease(PARK)', 'PARK'),
(77, '448014', '448014', 'COc1ccc(CNC(=O)Nc2ncc(s2)[N+](=O)[O-])cc1', '1-[(4-methoxyphenyl)methyl]-3-(5-nitrothiazol-2-yl)urea', 'CYAAFQwAEfwQ0xSBSRiBO2C0LkK3bSyrEzeNIZCpI$1WkIeVf6j2622XdaylPbxPJ^0m98mAeBt8LUimWUst2KWC6nLssERPWl4QnKfVYaGA$uzuvVK6cqwqXds^^2yaSDACxzjvSLq5xBrTE7Y9hWVDhRJfFBH3nC3tU3QoNPojv^EL6x1JdUTAa86JbSY7nVR85v5m VfC8gaGYOtT4M40JTRUaWsRd67rB736SC2qHjg7$v5CBYi75HjYM1RZCRhB41yxVXcK7DjKtjNgAGkdxgHHXG3kQ7TTScH3PNM$8$ZGnrTDquARh6c$zTNAaQkhG6pj9Ci^XWw44RwvO91BV7OTAqjo4UdAnuO5nFXXwlbZyDpnzcZHaKKOMYA4CJhgXGzlROsC4LZSn pZtorwU4RtnrguO3ElamBPmcsba0wWLOSGw1nUwp$cey9aZrgw88XJY6EKJX9u4JBPp7kz9SB3YfCr9AAZGZLkdjnllLTNCi', 'InChI=1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17)', 'AuxInfo=1/1/N:21,12,13,15,16,11,20,10,14,19,17,18,6,8,7,9,3,4,5,2,1/E:(2,3)(4,5)(18,19)/CRV:16.5/rA:33SOOO-ONNNN+CCCCCCCCCCCCHHHHHHHHHHHH/rB:;;;;;;;s4d5;;s6s10;d+10;s10;s2;s12d+14;d-13s14;d3s6s7;s1s7d -8;s1s9;s8d-19;s2;s11;s11;s12;s13;s6;s15;s16;s7;s20;s21;s21;s21;/rC:-3.7454,-.397,1.155;5.8772,1.815,.665;-.0565,-.7958,-1.635;-6.7667,1.496,-.3587;-6.4612,.5576,1.607;.7758,-1.9077,.2103;-1.3523,-1.0 535,.3115;-2.7957,.1689,-1.1818;-6.0391,.8564,.4534;3.0728,-1.152,-.0843;2.0652,-2.2177,-.3533;3', 'YAEMHJKFIIIULI-UHFFFAOYSA-N', '1010:9Y8PF2ZUH2Z823F41RQEXYR1ACA8JR', '[s]1:[c](:[c](-[#1]):[n]:[c]1-[#7](-[#1])-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#7+](=[#8])-[#8-]', 's1c(c([H])nc1N([H])C(N([H])C([H])([H])c2c([H])c([H])c(c([H])c2[H])OC([H])([H])[H])=O)[N+](=O)[O-]', '01.529', '2.137', '0', '0', 'TRUE', '-7.5e-003\r\n-0.3494\r\n-0.2539\r\n-0.4298\r\n-0.4298\r\n-0.2949\r\n-0.2478\r\n-0.2293\r\n0.5798\r\n-3.07e-002\r\n3.78e-002\r\n-5.49e-002\r\n-5.49e-002\r\n7.45e-002\r\n-3.15e-002\r\n-3.15e-002\r\n0.304\r\n0.1685\r\n0.2322\r\n8.61e-002\r\n4.22e-002\r\n5.18e-002\r\n5.18e-002\r\n6.27e-002\r\n6.27e-002\r\n0.', '0', '1.645', 'C12H12N4O4S', '0308.058', '-3.751', '0308.313', '7.3', '3', '2', '2', '9', '11', '2', '21', '22', '17', '7', '008', '02', '12', '0', '2', '005', '0137.31', '308.4', '', '3.50759', '1.2898', '34.43', '12.99', '4.53612', '21.44', '1,378.41', '230.087', '222.94', '', 'S2/C(N(C(=O)N(C(/C1=C([H])/C([H])=C(OC([H])([H])[H])\\C([H])=C1\\[H])([H])[H])[H])[H])=N\\C([H])=C2\\N(=O)=O', 'COc2ccc(CNC(=O)Nc1ncc(N(=O)=O)s1)cc2', 'AR-A014418', 'GSK-3 inhibitor VIII', 'Glycogen synthase kinase-3 beta', '448014', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '17433298', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(78, '448014', '448014', 'COc1ccc(CNC(=O)Nc2ncc(s2)[N+](=O)[O-])cc1', '1-[(4-methoxyphenyl)methyl]-3-(5-nitrothiazol-2-yl)urea', 'CYAAFQwAEfwQ0xSBSRiBO2C0LkK3bSyrEzeNIZCpI$1WkIeVf6j2622XdaylPbxPJ^0m98mAeBt8LUimWUst2KWC6nLssERPWl4QnKfVYaGA$uzuvVK6cqwqXds^^2yaSDACxzjvSLq5xBrTE7Y9hWVDhRJfFBH3nC3tU3QoNPojv^EL6x1JdUTAa86JbSY7nVR85v5m VfC8gaGYOtT4M40JTRUaWsRd67rB736SC2qHjg7$v5CBYi75HjYM1RZCRhB41yxVXcK7DjKtjNgAGkdxgHHXG3kQ7TTScH3PNM$8$ZGnrTDquARh6c$zTNAaQkhG6pj9Ci^XWw44RwvO91BV7OTAqjo4UdAnuO5nFXXwlbZyDpnzcZHaKKOMYA4CJhgXGzlROsC4LZSn pZtorwU4RtnrguO3ElamBPmcsba0wWLOSGw1nUwp$cey9aZrgw88XJY6EKJX9u4JBPp7kz9SB3YfCr9AAZGZLkdjnllLTNCi', 'InChI=1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17)', 'AuxInfo=1/1/N:21,12,13,15,16,11,20,10,14,19,17,18,6,8,7,9,3,4,5,2,1/E:(2,3)(4,5)(18,19)/CRV:16.5/rA:33SOOO-ONNNN+CCCCCCCCCCCCHHHHHHHHHHHH/rB:;;;;;;;s4d5;;s6s10;d+10;s10;s2;s12d+14;d-13s14;d3s6s7;s1s7d -8;s1s9;s8d-19;s2;s11;s11;s12;s13;s6;s15;s16;s7;s20;s21;s21;s21;/rC:-3.7454,-.397,1.155;5.8772,1.815,.665;-.0565,-.7958,-1.635;-6.7667,1.496,-.3587;-6.4612,.5576,1.607;.7758,-1.9077,.2103;-1.3523,-1.0 535,.3115;-2.7957,.1689,-1.1818;-6.0391,.8564,.4534;3.0728,-1.152,-.0843;2.0652,-2.2177,-.3533;3', 'YAEMHJKFIIIULI-UHFFFAOYSA-N', '1010:9Y8PF2ZUH2Z823F41RQEXYR1ACA8JR', '[s]1:[c](:[c](-[#1]):[n]:[c]1-[#7](-[#1])-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#7+](=[#8])-[#8-]', 's1c(c([H])nc1N([H])C(N([H])C([H])([H])c2c([H])c([H])c(c([H])c2[H])OC([H])([H])[H])=O)[N+](=O)[O-]', '01.529', '2.137', '0', '0', 'TRUE', '-7.5e-003\r\n-0.3494\r\n-0.2539\r\n-0.4298\r\n-0.4298\r\n-0.2949\r\n-0.2478\r\n-0.2293\r\n0.5798\r\n-3.07e-002\r\n3.78e-002\r\n-5.49e-002\r\n-5.49e-002\r\n7.45e-002\r\n-3.15e-002\r\n-3.15e-002\r\n0.304\r\n0.1685\r\n0.2322\r\n8.61e-002\r\n4.22e-002\r\n5.18e-002\r\n5.18e-002\r\n6.27e-002\r\n6.27e-002\r\n0.', '0', '1.645', 'C12H12N4O4S', '0308.058', '-3.751', '0308.313', '7.3', '3', '2', '2', '9', '11', '2', '21', '22', '17', '7', '008', '02', '12', '0', '2', '005', '0137.31', '308.4', '', '3.50759', '1.2898', '34.43', '12.99', '4.53612', '21.44', '1,378.41', '230.087', '222.94', '', 'S2/C(N(C(=O)N(C(/C1=C([H])/C([H])=C(OC([H])([H])[H])\\C([H])=C1\\[H])([H])[H])[H])[H])=N\\C([H])=C2\\N(=O)=O', 'COc2ccc(CNC(=O)Nc1ncc(N(=O)=O)s1)cc2', 'AR-A014418', 'GSK-3 inhibitor VIII', 'Glycogen synthase kinase-3 beta', '448014', 'Under Investigation', 'Alzheimer disease (AD)', '12928438', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(79, '44602', '44602', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', '(3<I>R</I>)-4-amino-3-(4-chlorophenyl)butanoic acid', 'CYAAFQwAsdwQYfqTZKbZiOKDkYHfvqZIk75mL$qUWaScPey5Qwaa3mjfMmbvM3ftS$uS$WUztNsU49JwEecZOrrAzv15Qtr^Y5$yZNqgrSu5ZAOUvU4laVPSbtPSibP4^tX783L3ICAJkIP$GW5Ws9T^HCM3cJeRM$vnv2NFKYA0GwqMPNMr5rVW$5gVQnPGmUmhgvG3 6iqJGEv$a3LR122EGskWe7FqMyn17derA1sgkgVZ5WuYu3CrOGXMYFWjmzaFdSzPTkdMWFkidRvFVLbBFdzDo5qTEI8Mo^7FsJ4EtCjW1Dm1Q09C05q2dVfT15MHmEbzWe5AcuSvGHt8ITz8cB74fGY6y13tmfYFl^Uwp9ZIg9TTI4nS$dmJnvaVsRMbsCG1X5lUlFYn N28VsymR$5KsKHBvY1kXIGiUuybyuFYdTTQf2LN6Dqf$jP0HTuJnY0tZXLO8IG95qvvB40nkPmq08OIUjbu54WDuHabN0KkP', 'InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1', 'AuxInfo=1/1/N:9,10,12,13,7,8,6,5,14,11,1,4,2,3/E:(1,2)(3,4)(13,14)/it:im/rA:26ClOONC.eCCCCCCCCCHHHHHHHHHHHH/rB:;;;;s5;s5;s4s5;d+6;s6;s2d3s7;s9;d-10;s1d+12s13;s5;s7;s7;s8;s8;s9;s10;s4;s4;s12;s13;s2;/rC :-4.5471,.3709,.2493;2.0604,2.7036,.6347;1.5418,1.8843,-1.4166;3.0229,-2.5587,.3169;1.3178,-.8064,-.2448;-.173,-.5085,-.1186;2.148,.3419,.3728;1.6139,-2.188,.3841;-1.0317,-1.0017,-1.077;-.6107,.2451,. 949;1.8915,1.6947,-.26;-2.3947,-.7281,-.9621;-1.9736,.5187,1.064;-2.8656,.0321,.1084;1.5659,-.84', 'KPYSYYIEGFHWSV-QMMMGPOBSA-N', '1010:HEW6U8A4KMBQDRNZ4RMVN1YWU8XAG2', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1[C@]([H])(C([H])([H])N([H])[H])C([H])([H])C(=O)O[H])c([H])c1[H]', '-01.06', '1.419', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3318\r\n-0.2668\r\n-0.3299\r\n5.4e-003\r\n-4.31e-002\r\n4.15e-002\r\n-3.e-004\r\n-5.73e-002\r\n-5.73e-002\r\n0.2588\r\n-4.33e-002\r\n-4.33e-002\r\n4.05e-002\r\n3.7e-002\r\n3.79e-002\r\n3.79e-002\r\n4.31e-002\r\n4.31e-002\r\n6.26e-002\r\n6.26e-002\r\n0.1184\r\n0.1184\r\n6.38e-002\r\n6.3', '1', '-0.978', 'C10H12ClNO2', '0213.056', '-2.901', '0213.661', '1.07 9.02', '1', '1', '1', '7', '06', '1', '14', '14', '16', '4', '003', '03', '12', '0', '1', '004', '0063.31', '217.71', '', '1.79944', '1.2722', '11.18', '1.49', '2.95185', '9.69', '404.282', '150.729', '167.04', '', 'Cl/C1=C([H])/C([H])=C(C(C(C(O[H])=O)([H])[H])(C(N([H])[H])([H])[H])[H])\\C([H])=C1\\[H]', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', 'Arbaclofen', 'd-Baclofen; STX-209; 2C0', 'Gamma-aminobutyric acid type B receptor subunit 1', '44602', 'Phase III', 'Multiple Sclerosis', '25278123', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(80, '44602', '44602', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', '(3<I>R</I>)-4-amino-3-(4-chlorophenyl)butanoic acid', 'CYAAFQwAsdwQYfqTZKbZiOKDkYHfvqZIk75mL$qUWaScPey5Qwaa3mjfMmbvM3ftS$uS$WUztNsU49JwEecZOrrAzv15Qtr^Y5$yZNqgrSu5ZAOUvU4laVPSbtPSibP4^tX783L3ICAJkIP$GW5Ws9T^HCM3cJeRM$vnv2NFKYA0GwqMPNMr5rVW$5gVQnPGmUmhgvG3 6iqJGEv$a3LR122EGskWe7FqMyn17derA1sgkgVZ5WuYu3CrOGXMYFWjmzaFdSzPTkdMWFkidRvFVLbBFdzDo5qTEI8Mo^7FsJ4EtCjW1Dm1Q09C05q2dVfT15MHmEbzWe5AcuSvGHt8ITz8cB74fGY6y13tmfYFl^Uwp9ZIg9TTI4nS$dmJnvaVsRMbsCG1X5lUlFYn N28VsymR$5KsKHBvY1kXIGiUuybyuFYdTTQf2LN6Dqf$jP0HTuJnY0tZXLO8IG95qvvB40nkPmq08OIUjbu54WDuHabN0KkP', 'InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1', 'AuxInfo=1/1/N:9,10,12,13,7,8,6,5,14,11,1,4,2,3/E:(1,2)(3,4)(13,14)/it:im/rA:26ClOONC.eCCCCCCCCCHHHHHHHHHHHH/rB:;;;;s5;s5;s4s5;d+6;s6;s2d3s7;s9;d-10;s1d+12s13;s5;s7;s7;s8;s8;s9;s10;s4;s4;s12;s13;s2;/rC :-4.5471,.3709,.2493;2.0604,2.7036,.6347;1.5418,1.8843,-1.4166;3.0229,-2.5587,.3169;1.3178,-.8064,-.2448;-.173,-.5085,-.1186;2.148,.3419,.3728;1.6139,-2.188,.3841;-1.0317,-1.0017,-1.077;-.6107,.2451,. 949;1.8915,1.6947,-.26;-2.3947,-.7281,-.9621;-1.9736,.5187,1.064;-2.8656,.0321,.1084;1.5659,-.84', 'KPYSYYIEGFHWSV-QMMMGPOBSA-N', '1010:HEW6U8A4KMBQDRNZ4RMVN1YWU8XAG2', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1[C@]([H])(C([H])([H])N([H])[H])C([H])([H])C(=O)O[H])c([H])c1[H]', '-01.06', '1.419', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3318\r\n-0.2668\r\n-0.3299\r\n5.4e-003\r\n-4.31e-002\r\n4.15e-002\r\n-3.e-004\r\n-5.73e-002\r\n-5.73e-002\r\n0.2588\r\n-4.33e-002\r\n-4.33e-002\r\n4.05e-002\r\n3.7e-002\r\n3.79e-002\r\n3.79e-002\r\n4.31e-002\r\n4.31e-002\r\n6.26e-002\r\n6.26e-002\r\n0.1184\r\n0.1184\r\n6.38e-002\r\n6.3', '1', '-0.978', 'C10H12ClNO2', '0213.056', '-2.901', '0213.661', '1.07 9.02', '1', '1', '1', '7', '06', '1', '14', '14', '16', '4', '003', '03', '12', '0', '1', '004', '0063.31', '217.71', '', '1.79944', '1.2722', '11.18', '1.49', '2.95185', '9.69', '404.282', '150.729', '167.04', '', 'Cl/C1=C([H])/C([H])=C(C(C(C(O[H])=O)([H])[H])(C(N([H])[H])([H])[H])[H])\\C([H])=C1\\[H]', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', 'Arbaclofen', 'STX209; GTPL1064', 'Gamma-aminobutyric acid type B receptor subunit 1', '44602', 'Phase III Completed', 'Fragile X Syndrome', '22993294', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(81, '44602', '44602', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', '(3<I>R</I>)-4-amino-3-(4-chlorophenyl)butanoic acid', 'CYAAFQwAsdwQYfqTZKbZiOKDkYHfvqZIk75mL$qUWaScPey5Qwaa3mjfMmbvM3ftS$uS$WUztNsU49JwEecZOrrAzv15Qtr^Y5$yZNqgrSu5ZAOUvU4laVPSbtPSibP4^tX783L3ICAJkIP$GW5Ws9T^HCM3cJeRM$vnv2NFKYA0GwqMPNMr5rVW$5gVQnPGmUmhgvG3 6iqJGEv$a3LR122EGskWe7FqMyn17derA1sgkgVZ5WuYu3CrOGXMYFWjmzaFdSzPTkdMWFkidRvFVLbBFdzDo5qTEI8Mo^7FsJ4EtCjW1Dm1Q09C05q2dVfT15MHmEbzWe5AcuSvGHt8ITz8cB74fGY6y13tmfYFl^Uwp9ZIg9TTI4nS$dmJnvaVsRMbsCG1X5lUlFYn N28VsymR$5KsKHBvY1kXIGiUuybyuFYdTTQf2LN6Dqf$jP0HTuJnY0tZXLO8IG95qvvB40nkPmq08OIUjbu54WDuHabN0KkP', 'InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1', 'AuxInfo=1/1/N:9,10,12,13,7,8,6,5,14,11,1,4,2,3/E:(1,2)(3,4)(13,14)/it:im/rA:26ClOONC.eCCCCCCCCCHHHHHHHHHHHH/rB:;;;;s5;s5;s4s5;d+6;s6;s2d3s7;s9;d-10;s1d+12s13;s5;s7;s7;s8;s8;s9;s10;s4;s4;s12;s13;s2;/rC :-4.5471,.3709,.2493;2.0604,2.7036,.6347;1.5418,1.8843,-1.4166;3.0229,-2.5587,.3169;1.3178,-.8064,-.2448;-.173,-.5085,-.1186;2.148,.3419,.3728;1.6139,-2.188,.3841;-1.0317,-1.0017,-1.077;-.6107,.2451,. 949;1.8915,1.6947,-.26;-2.3947,-.7281,-.9621;-1.9736,.5187,1.064;-2.8656,.0321,.1084;1.5659,-.84', 'KPYSYYIEGFHWSV-QMMMGPOBSA-N', '1010:HEW6U8A4KMBQDRNZ4RMVN1YWU8XAG2', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1[C@]([H])(C([H])([H])N([H])[H])C([H])([H])C(=O)O[H])c([H])c1[H]', '-01.06', '1.419', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3318\r\n-0.2668\r\n-0.3299\r\n5.4e-003\r\n-4.31e-002\r\n4.15e-002\r\n-3.e-004\r\n-5.73e-002\r\n-5.73e-002\r\n0.2588\r\n-4.33e-002\r\n-4.33e-002\r\n4.05e-002\r\n3.7e-002\r\n3.79e-002\r\n3.79e-002\r\n4.31e-002\r\n4.31e-002\r\n6.26e-002\r\n6.26e-002\r\n0.1184\r\n0.1184\r\n6.38e-002\r\n6.3', '1', '-0.978', 'C10H12ClNO2', '0213.056', '-2.901', '0213.661', '1.07 9.02', '1', '1', '1', '7', '06', '1', '14', '14', '16', '4', '003', '03', '12', '0', '1', '004', '0063.31', '217.71', '', '1.79944', '1.2722', '11.18', '1.49', '2.95185', '9.69', '404.282', '150.729', '167.04', '', 'Cl/C1=C([H])/C([H])=C(C(C(C(O[H])=O)([H])[H])(C(N([H])[H])([H])[H])[H])\\C([H])=C1\\[H]', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', 'Arbaclofen', 'STX209; GTPL1064', 'Gamma-aminobutyric acid type B receptor subunit 2', '44602', 'Terminated at Phase III', 'Fragile X Syndrome', '22993294', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(82, '9568077', '9568077', 'O[C@@H](CO\\N=C(/Cl)\\c1ccc[n+]([O-])c1)CN2CCCCC2', '(3<I>Z</I>)-<I>N</I>-[(2<I>R</I>)-2-hydroxy-3-(1-piperidyl)propoxy]-1-oxido-pyridin-1-ium-3-carboximidoyl chloride', 'CYAAFQwAicwQ8FGT7X6MF9lWktdD6GyR34kWWLjl0NEKfhu^GobOjZNGQ$FtitDAjkjpG9k3OKOy^lbjIWhmVOtCXke6Nyjxa$DkwaQ$Pako9iPkwhmxfc8Ki8snKRIWP0fgn^^9L39zAKwTe9FOVvKcH^tagRVjakD7^fdlHX0BIqdF30evgyIbbUQfyPoSwxVrb9FE wEj8Q1Tjuvh1qeTRF0H63O0WL8ScXNg12O$nAHNgbgUoEr2KVue5jZzDUvdzqacC7iuaXpW4EOexF0kSHIm4eNvjP2zthxqzP5K65JGtrYevIVyWwpNHA4EKHVR1LsjDmwUbF$wgZWcYv$IADtryYQW4cdH5t6TDE^0gAOyMNsPqV21xF0nZHMDJogfXELKvnmQu010f 0Jg4ZaMLiTHYwVPrFsWo3tBtcKNZDtGJn1TLj3LZHOAemlQmtE4jI9rnSQN48Z5pntn1qOS4TPRir6Iznoc8hnFrGYEM7Gmr', 'InChI=1S/C14H20ClN3O3/c15-14(12-5-4-8-18(20)9-12)16-21-11-13(19)10-17-6-2-1-3-7-17/h4-5,8-9,13,19H,1-3,6-7,10-11H2/b16-14-/t13-/m1/s1', 'AuxInfo=1/0/N:12,10,11,20,19,8,9,21,18,13,15,17,14,16,1,6,5,7,2,4,3/E:(2,3)(6,7)/it:im/CRV:18.5/rA:41ClOOO-NNN+CCCCCCC.oCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3;s4;s5;s5;s8;s9;s10s11;s5;s2s13;s3s14;s1d-6 ;s16;s7d+17;s17;d-19;d+7s20;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s15;s15;s2;s18;s19;s20;s21;/rC:-1.5585,1.264,-1.9182;2.2397,3.3106,.147;.3175,1.3032,.0636;-6.2519,-.7198,-1.3415;3.5192,-.1 447,-.2723;-.8362,.692,.567;-5.3033,-.6459,-.4948;3.9875,-.8641,-1.4651;4.5205,-.1897,.8025;4.29', 'SGEIEGAXKLMUIZ-XUVDNFPMSA-N', '1010:W8PPQY5ZJWJFX2WFN1NH5RNC47SNB2', '[#17]\\-[#6](\\-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n+]1-[#8-]):[c]1-[#1])=[#7]/-[#8]-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1 ])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#8]-[#1]', 'Cl\\C(\\c(c([H])c([H])c([H])[n+]1[O-])c1[H])=N/OC([H])([H])[C@@]([H])(C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H])O[H]', '00.693', '0.879', '0', '0', 'TRUE', '-5.9e-002\r\n-0.3893\r\n-0.248\r\n-1.0638\r\n-0.3007\r\n-0.1213\r\n0.5033\r\n-1.8e-003\r\n-1.8e-003\r\n-4.04e-002\r\n-4.04e-002\r\n-5.09e-002\r\n2.66e-002\r\n9.26e-002\r\n0.1043\r\n0.1667\r\n5.45e-002\r\n0.1328\r\n-4.49e-002\r\n-2.1e-002\r\n0.1224\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n2.79e-', '1', '-0.841', 'C14H20ClN3O3', '0313.119', '-3.491', '0313.78', '4.79 10.13', '2', '1', '1', '15', '06', '1', '21', '22', '24', '4', '006', '01', '20', '0', '2', '006', '0070.52', '321.66', '', '9.96336', '1.2778', '5.25', '-3.09', '4.38667', '8.34', '1,143.24', '108.348', '244.21', '', 'Cl/C(=N\\OC(C(O[H])(C(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])[H])([H])[H])/C2=C([H])/N(=O)=C([H])\\C([H])=C2\\[H]', 'O=n2cccc(/C(Cl)=N/OC[C@H](O)CN1CCCCC1)c2', 'Arimoclomol', 'API0007198', 'Superoxide Dismutase 1', '9568077', 'Phase II/III', 'Amyotrophic Lateral Sclerosis (ALS)', '23978556', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(83, '9568077', '9568077', 'O[C@@H](CO\\N=C(/Cl)\\c1ccc[n+]([O-])c1)CN2CCCCC2', '(3<I>Z</I>)-<I>N</I>-[(2<I>R</I>)-2-hydroxy-3-(1-piperidyl)propoxy]-1-oxido-pyridin-1-ium-3-carboximidoyl chloride', 'CYAAFQwAicwQ8FGT7X6MF9lWktdD6GyR34kWWLjl0NEKfhu^GobOjZNGQ$FtitDAjkjpG9k3OKOy^lbjIWhmVOtCXke6Nyjxa$DkwaQ$Pako9iPkwhmxfc8Ki8snKRIWP0fgn^^9L39zAKwTe9FOVvKcH^tagRVjakD7^fdlHX0BIqdF30evgyIbbUQfyPoSwxVrb9FE wEj8Q1Tjuvh1qeTRF0H63O0WL8ScXNg12O$nAHNgbgUoEr2KVue5jZzDUvdzqacC7iuaXpW4EOexF0kSHIm4eNvjP2zthxqzP5K65JGtrYevIVyWwpNHA4EKHVR1LsjDmwUbF$wgZWcYv$IADtryYQW4cdH5t6TDE^0gAOyMNsPqV21xF0nZHMDJogfXELKvnmQu010f 0Jg4ZaMLiTHYwVPrFsWo3tBtcKNZDtGJn1TLj3LZHOAemlQmtE4jI9rnSQN48Z5pntn1qOS4TPRir6Iznoc8hnFrGYEM7Gmr', 'InChI=1S/C14H20ClN3O3/c15-14(12-5-4-8-18(20)9-12)16-21-11-13(19)10-17-6-2-1-3-7-17/h4-5,8-9,13,19H,1-3,6-7,10-11H2/b16-14-/t13-/m1/s1', 'AuxInfo=1/0/N:12,10,11,20,19,8,9,21,18,13,15,17,14,16,1,6,5,7,2,4,3/E:(2,3)(6,7)/it:im/CRV:18.5/rA:41ClOOO-NNN+CCCCCCC.oCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3;s4;s5;s5;s8;s9;s10s11;s5;s2s13;s3s14;s1d-6 ;s16;s7d+17;s17;d-19;d+7s20;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s15;s15;s2;s18;s19;s20;s21;/rC:-1.5585,1.264,-1.9182;2.2397,3.3106,.147;.3175,1.3032,.0636;-6.2519,-.7198,-1.3415;3.5192,-.1 447,-.2723;-.8362,.692,.567;-5.3033,-.6459,-.4948;3.9875,-.8641,-1.4651;4.5205,-.1897,.8025;4.29', 'SGEIEGAXKLMUIZ-XUVDNFPMSA-N', '1010:W8PPQY5ZJWJFX2WFN1NH5RNC47SNB2', '[#17]\\-[#6](\\-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n+]1-[#8-]):[c]1-[#1])=[#7]/-[#8]-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1 ])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#8]-[#1]', 'Cl\\C(\\c(c([H])c([H])c([H])[n+]1[O-])c1[H])=N/OC([H])([H])[C@@]([H])(C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H])O[H]', '00.693', '0.879', '0', '0', 'TRUE', '-5.9e-002\r\n-0.3893\r\n-0.248\r\n-1.0638\r\n-0.3007\r\n-0.1213\r\n0.5033\r\n-1.8e-003\r\n-1.8e-003\r\n-4.04e-002\r\n-4.04e-002\r\n-5.09e-002\r\n2.66e-002\r\n9.26e-002\r\n0.1043\r\n0.1667\r\n5.45e-002\r\n0.1328\r\n-4.49e-002\r\n-2.1e-002\r\n0.1224\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n2.79e-', '1', '-0.841', 'C14H20ClN3O3', '0313.119', '-3.491', '0313.78', '4.79 10.13', '2', '1', '1', '15', '06', '1', '21', '22', '24', '4', '006', '01', '20', '0', '2', '006', '0070.52', '321.66', '', '9.96336', '1.2778', '5.25', '-3.09', '4.38667', '8.34', '1,143.24', '108.348', '244.21', '', 'Cl/C(=N\\OC(C(O[H])(C(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])[H])([H])[H])/C2=C([H])/N(=O)=C([H])\\C([H])=C2\\[H]', 'O=n2cccc(/C(Cl)=N/OC[C@H](O)CN1CCCCC1)c2', 'Arimoclomol', 'API0007198', 'Heat shock protein 70', '9568077', 'Phase II/III', 'Niemann-Pick Disease Type C', '27605553', 'Niemann-Pick Disease Type C', 'NIEMANN-PICK DISEASE, TYPE C1; NPC; Niemann Pick disease\nNIEMANN-PICK DISEASE WITH CHOLESTEROL ESTERIFICATION BLOCK\nNIEMANN-PICK DISEASE, SUBACUTE JUVENILE FORM\nNIEMANN-PICK DISEASE, CHRONIC NEURONOPATHIC FORM\nNIEMANN-PICK DISEASE WITHOUT SPHINGOMYELINASE DEFICIENCY\nNEUROVISCERAL STORAGE DISEASE WITH VERTICAL SUPRANUCLEAR OPHTHALMOPLEGIA'),
(84, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', 'D(2) dopamine receptor', '60795', 'FDA approved', 'Bipolar disorder', '22540407', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(85, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', '5-hydroxytryptamine receptor 2A', '60795', 'FDA approved', 'Bipolar disorder', '22540407', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(86, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', '5-hydroxytryptamine receptor 2A', '60795', 'Clinical Trail Completed', 'Trichotillomania', '21694623', 'Trichotillomania', 'TTM'),
(87, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', 'D(2) dopamine receptor', '60795', 'Phase II Completed', 'Fragile X syndrome', '21318565', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(88, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', 'D(2) dopamine receptor', '60795', 'Phase IV', 'Alzheimer disease (AD)', '23350964', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(89, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', 'D(2) dopamine receptor', '60795', 'Terminated at Phase III', 'Schizophrenia', '25556976', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(90, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', 'D(2) dopamine receptor', '60795', 'Under Investigation', 'Delayed Sleep Phase Syndrome', '24992089', 'Delayed Sleep Phase Syndrome', 'DSPD'),
(91, '60795', '60795', 'Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl', '7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1<I>H</I>-quinolin-2-one', 'CYAAFQwAlcwQP4AQ^R1epeyDbtUJP01Hz3KEu5xtKAGmRRgZLCVM6UQxYIpFaeHbGT3tebcTPEfJi1WNWS3h1T3N0ickC6ZazYJSBXPES2QZvJ09YGuO9XevtgWvsXqBXs^^vVeEcDoAV7zXkSwCLfcP9gbmquww8nvW$92og^4bXcsAH5yD0xDGpjHPRJ1^QwL6LbMw UFWH3gi^x1$Le6AMV$6hPxbHhkAdGeb9UZHMf9CEe55d7WEWnD1NJPmzeZH$DuQ8riXblJCM0WvqUd5xL6qjfJnoR5bZx^pP0neu6n8W0HtSVlM5$dY12haGVLxekxznamKsR$FR86pODtgFiL8tRdxQth^fQFcUrNwljHwXZc2gfP1MDpRIKI7F9$yBo^cEGDXUaT3R RR5KGBfw55NwwHv5F$yWjuQqj581Gj3Eom9FzPXP1JvO^Oljk8iUQEajMgK2y7zKSyM8cMPvi7hVHQb8wIvuAl3H8$JGW^Cr', 'InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)', 'AuxInfo=1/1/N:13,15,24,27,18,28,20,29,25,12,8,9,10,11,16,26,19,22,23,21,14,30,17,2,1,7,5,6,4,3/E:(11,12)(13,14)/rA:57ClClOONNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5;s5;s6s8;s6s 9;s5;s12;s6;s13;s3s15;s1d-14;s14;;s19;s7d-19;s3;s2s17;d-18;s20;s21d+22;d+23s24;s19;s22d-28;d4s7s25;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s18;s20;s20;s25;s25;s24;s26;s28;s27;s29;s 7;/rC:-7.0404,1.8323,-1.0756;-10.0814,.8103,-1.1816;3.545,.9401,-.8962;10.3931,.9898,.9896;-2.42', 'CEUORZQYGODEFX-UHFFFAOYSA-N', '1010:UMNR4PR37VNFGZB915EB4RH1C94QU1', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[c](:[c](-[#1]) :[c]3-[#1]):[c](-[#1]):[c]4:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#7]4-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc(c([H])c3[H])c([H])c4c3C([H])([H])C([H])([H])C(N4[H])=O)C([H])([H])C2([H])[H])Cl', '04.998', '4.998', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.3461\r\n-0.2774\r\n-0.3008\r\n-0.2712\r\n-0.2851\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.83e-002\r\n3.77e-002\r\n-2.79e-002\r\n5.33e-002\r\n7.73e-002\r\n-4.24e-002\r\n-2.59e-002\r\n-1.75e-002\r\n3.82e-002\r\n7.68e-002\r\n6.08e-002\r\n-5.91e', '0', '4.632', 'C23H27Cl2N3O2', '0447.148', '-6.146', '0448.385', '3.69 5.5 7.55', '2', '1', '1', '20', '12', '2', '30', '33', '32', '7', '005', '01', '27', '0', '4', '007', '0044.81', '436.41', '', '5.01187', '1.2906', '94.02', '14.71', '6.33974', '79.31', '4,847.18', '89.463', '348.48', '-9.09', 'Cl/C4=C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C2=C([H])/C1=C(C([H])([H])C([H])([H])C(=O)N1[H])\\C([H])=C2\\[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])/C([H])=C([H])\\C([H])=C4\\Cl', 'O=C4CCc3ccc(OCCCCN2CCN(c1cccc(Cl)c1Cl)CC2)cc3N4', 'Aripiprazole', 'Abilify; Discmelt; OPC 31; Pripiprazole; Aripiprex', '5-hydroxytryptamine receptor 2A', '60795', 'Under Investigation', 'Delayed Sleep Phase Syndrome', '24992089', 'Delayed Sleep Phase Syndrome', 'DSPD'),
(92, '9690109', '9690109', 'NC(=O)C[S@@](=O)C(c1ccccc1)c2ccccc2', '2-[(R)-benzhydrylsulfinyl]acetamide', 'CYAAFQwAKcwQhOxdSvQnAZTtQcJgNw9udyOHJOWabpsZldS2VBxEw2xBJdN72jzIKvH8tlyEPReC9XwZTCnXc^0gFGTv$bXv1ecRI2$l^RKiXDcZUvrTSJcBBuEWjX840G^9vos17DoAzBmjDrYIS52E$cWbNbUwWybu$Xc1j1h5J151jX9WnwvT$ZFTPOBlCd7wA129 M^k2PtCgVaiN10mbv0DreZ1t9wrTj82LMG^QcB4q5xpvmUFuFxj7j4c1wbr1U8j4E2^8Nr3GtSAuazjrjHCWMCuVrSyyGi$vOXcV5z$YqQWYXrR9b1Knmt2G4xMQ8cY9G3m6gES2F2PWArVN5sY3sLPcT$uUx3Fx5tI7FWq98bNnj4q4Smg9PXCG^Ui6GSi3RNK1noJp 99w8ZBh5rR27HMEY8fNhVFDhSimA2b9kj9Vwf5JljyarpHz4Rdch^aap6MIKtXwDM$j2JtvMyIHhXNkWdY134ZIxQSgVXFY$', 'InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)/t19-/m1/s1', 'AuxInfo=1/1/N:17,18,13,15,14,16,9,11,10,12,8,6,7,19,5,4,3,2,1/E:(1,2)(3,4,5,6)(7,8,9,10)(12,13)/it:im/rA:34S.oOONCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:d1;;;s1;s5;s5;s1;d+6;d+7;s6;s7;s9;s10;d-11;d-12;d-13s 15;d-14s16;d3s4s8;s5;s8;s8;s9;s10;s11;s12;s13;s14;s15;s16;s17;s18;s4;s4;/rC:.8422,-1.476,-.2983;.6385,-2.756,.4326;3.845,-1.6025,-1.3301;4.3254,-1.9701,.8869;-.289,-.248,.5013;-1.7323,-.5155,.2359;.14 68,1.1871,.2097;2.35,-.703,.3249;-2.6751,-.318,1.2447;.6836,1.9358,1.2331;-2.139,-.9634,-1.0207;', 'YFGHCGITMMYXAQ-LJQANCHMSA-N', '1010:EHTH3ZA5ZE5N2AM46PW1YY8MM5CPEW', '[#16@](-[#6](-[#1])(-[#1])-[#6](-[#7](-[#1])-[#1])=[#8])(-[#6](-[#1])(-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])=[#8]', '[S@](C([H])([H])C(N([H])[H])=O)(C([H])(c1c([H])c([H])c([H])c([H])c1[H])c2c([H])c([H])c([H])c([H])c2[H])=O', '01.733', '1.733', '0', '0', 'TRUE', '0.7763\r\n-0.6198\r\n-0.2795\r\n-0.3303\r\n-1.13e-002\r\n-5.31e-002\r\n-5.31e-002\r\n3.9e-003\r\n-5.98e-002\r\n-5.98e-002\r\n-5.98e-002\r\n-5.98e-002\r\n-6.21e-002\r\n-6.21e-002\r\n-6.21e-002\r\n-6.21e-002\r\n-6.23e-002\r\n-6.23e-002\r\n0.1965\r\n2.49e-002\r\n2.11e-002\r\n2.11e-002\r\n6.25e-002\r\n6.25e-002\r\n6.25e-002\r\n6.25e-002\r\n6.22e-002\r\n6.22e-002\r\n6.22e-002\r\n6.22e-002\r\n6.22e-002\r\n6.22e-002\r\n0.1454\r\n0.1469', '1', '1.733', 'C15H15NO2S', '0273.082', '-4.344', '0273.35', '8.99', '2', '1', '2', '6', '12', '2', '19', '20', '19', '8', '003', '02', '15', '0', '2', '005', '0079.37', '278.44', '', '3.622', '1.29', '21.78', '3.73', '3.60318', '18.05', '565.919', '149.954', '214.71', '', 'S(=O)(C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])(\\C2=C([H])\\C([H])=C([H])/C([H])=C2/[H])[H])C(C(=O)N([H])[H])([H])[H]', 'NC(=O)CS(=O)C(c1ccccc1)c2ccccc2', 'Armodafinil', 'Nuvigil; (R)-Modafinil', 'Sodium-dependent dopamine transporter', '9690109', 'Phase III Completed', 'Narcolepsy', '20957845', 'Narcolepsy', 'NARCOLEPTIC SYNDROME 1'),
(93, '25183127', '25183127', 'COc1ccc(\\C=C\\C(=O)C(CC2CCC2)C(=O)\\C=C\\c3ccc(OC)c(OC)c3)cc1OC', '(1<I>E</I>,6<I>E</I>)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)hepta-1,6-diene-3,5-dione', 'CYAAFQwAoewQBbsISLiWZ2Q5iyA8Ewyz4DcWFHYJueuXpVuN4f1LvE8y2GVl6hA5ugX6ACklJNYme$IylkaBl4VMa^BIpx6HBgfDDktZZQnEwCXhVSsR$^zRZnv$1rJz2Du1Fp^9buPRXDCAw9ytNOCuAwzJiyH5oy9wmHd^rFs4FRHed8WmKaeQPgob7ch3NqLBYAXF 1$8oPxSoC$TP368unzN4ODrC^0zTHjI13y92MG^QzONcO9Ajs^hHycq3Tdsuwd^LvwLHYAmcY4Jlf$pteUCPRzXeUZ0wZ^8J1dOZPhRs6kFnmlfXvshbpC99jW8J6TzgB9wGw75pjBCjeXXGhANeEli5vSBI8$$CT6O61J6hyLubj9CjxpqzrFR60JUODM60N7bbqAR3 $7gvmvEreFgh6E3bx4ADgL^3jB5AkcpVFJgKedKtjOsVTSjsNkzSTS989B0gEVg6hJU8DO50yr0pmADOeq3jnbKzns7wN^8L', 'InChI=1S/C28H32O6/c1-31-25-14-10-20(17-27(25)33-3)8-12-23(29)22(16-19-6-5-7-19)24(30)13-9-21-11-15-26(32-2)28(18-21)34-4/h8-15,17-19,22H,5-7,16H2,1-4H3/b12-8+,13-9+', 'AuxInfo=1/0/N:33,34,31,32,10,8,9,17,18,23,24,15,16,27,28,11,21,22,7,19,20,12,13,14,29,30,25,26,1,2,5,6,3,4/E:(1,2)(3,4)(6,7)(8,9)(10,11)(12,13)(14,15)(17,18)(20,21)(23,24)(25,26)(27,28)(29,30)(31,32)( 33,34)/rA:66OOOOOOCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s7;s8s9;s7;s11;d1s12;d2s12;s13;s14;d+15;d+16;s17;s18;d+19;d+20;s19;s20;s3s21;s4s22;d-23;d-24;s5d-25s27;s6d-26 s28;s3;s4;s5;s6;s7;s8;s8;s9;s9;s10;s10;s11;s11;s12;s15;s16;s17;s18;s21;s22;s23;s24;s27;s28;s31;s', 'PJOSHEDKRPRCAE-QHKWOANTSA-N', '1010:56WKCECSTMDQCWAKBD6T5B89NZ4APH', '[#8]=[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]2:[c](- [#1]):[c](-[#1]):[c](:[c](:[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 'O=C(\\C([H])=C([H])\\c1c([H])c([H])c(c(c1[H])OC([H])([H])[H])OC([H])([H])[H])C([H])(C(\\C([H])=C([H])\\c2c([H])c([H])c(c(c2[H])OC([H])([H])[H])OC([H])([H])[H])=O)C([H])([H])C3([H])C([H])([H])C([H])([H])C3 ([H])[H]', '05.716', '5.716', '0', '0', 'TRUE', '-0.294\r\n-0.294\r\n-0.3466\r\n-0.3466\r\n-0.3467\r\n-0.3467\r\n-4.03e-002\r\n-5.04e-002\r\n-5.04e-002\r\n-5.28e-002\r\n-3.3e-002\r\n8.46e-002\r\n0.166\r\n0.166\r\n-1.77e-002\r\n-1.77e-002\r\n-5.14e-002\r\n-5.14e-002\r\n-2.28e-002\r\n-2.28e-002\r\n-2.19e-002\r\n-2.19e-002\r\n-5.22e-002\r\n-5.22e-002\r', '0', '5.716', 'C28H32O6', '0464.22', '-7.962', '0464.55', '5.81', '6', '0', '4', '20', '12', '2', '34', '36', '40', '10', '006', '00', '32', '0', '3', '012', '0071.06', '499.21', '', '2.664', '1.2678', '48.57', '26.85', '5.96407', '21.72', '3,174.54', '123.86', '392.73', '', 'O=C(C(C(C1([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])(C(=O)/C(=C(/C2=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C2\\[H])\\[H])[H])[H])/C(=C(/C3=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C3\\[H])\\[H])[H]', 'COc3ccc(/C=C/C(=O)C(CC1CCC1)C(=O)/C=C/c2ccc(OC)c(OC)c2)cc3OC', 'ASC-JM17 Curcumin Analog', 'ASC-JM17', 'Nuclear factor erythroid 2-related factor 2', '25183127', 'Under Investigation', 'Spinal Muscular Atrophy Type I', '26962150', 'Spinal Muscular Atrophy Type I', 'SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA\nKENNEDY DISEASE; KD\nKENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY\nBULBOSPINAL MUSCULAR ATROPHY, X-LINKED\nBULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN; ; SMA1'),
(94, '25183127', '25183127', 'COc1ccc(\\C=C\\C(=O)C(CC2CCC2)C(=O)\\C=C\\c3ccc(OC)c(OC)c3)cc1OC', '(1<I>E</I>,6<I>E</I>)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)hepta-1,6-diene-3,5-dione', 'CYAAFQwAoewQBbsISLiWZ2Q5iyA8Ewyz4DcWFHYJueuXpVuN4f1LvE8y2GVl6hA5ugX6ACklJNYme$IylkaBl4VMa^BIpx6HBgfDDktZZQnEwCXhVSsR$^zRZnv$1rJz2Du1Fp^9buPRXDCAw9ytNOCuAwzJiyH5oy9wmHd^rFs4FRHed8WmKaeQPgob7ch3NqLBYAXF 1$8oPxSoC$TP368unzN4ODrC^0zTHjI13y92MG^QzONcO9Ajs^hHycq3Tdsuwd^LvwLHYAmcY4Jlf$pteUCPRzXeUZ0wZ^8J1dOZPhRs6kFnmlfXvshbpC99jW8J6TzgB9wGw75pjBCjeXXGhANeEli5vSBI8$$CT6O61J6hyLubj9CjxpqzrFR60JUODM60N7bbqAR3 $7gvmvEreFgh6E3bx4ADgL^3jB5AkcpVFJgKedKtjOsVTSjsNkzSTS989B0gEVg6hJU8DO50yr0pmADOeq3jnbKzns7wN^8L', 'InChI=1S/C28H32O6/c1-31-25-14-10-20(17-27(25)33-3)8-12-23(29)22(16-19-6-5-7-19)24(30)13-9-21-11-15-26(32-2)28(18-21)34-4/h8-15,17-19,22H,5-7,16H2,1-4H3/b12-8+,13-9+', 'AuxInfo=1/0/N:33,34,31,32,10,8,9,17,18,23,24,15,16,27,28,11,21,22,7,19,20,12,13,14,29,30,25,26,1,2,5,6,3,4/E:(1,2)(3,4)(6,7)(8,9)(10,11)(12,13)(14,15)(17,18)(20,21)(23,24)(25,26)(27,28)(29,30)(31,32)( 33,34)/rA:66OOOOOOCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s7;s8s9;s7;s11;d1s12;d2s12;s13;s14;d+15;d+16;s17;s18;d+19;d+20;s19;s20;s3s21;s4s22;d-23;d-24;s5d-25s27;s6d-26 s28;s3;s4;s5;s6;s7;s8;s8;s9;s9;s10;s10;s11;s11;s12;s15;s16;s17;s18;s21;s22;s23;s24;s27;s28;s31;s', 'PJOSHEDKRPRCAE-QHKWOANTSA-N', '1010:56WKCECSTMDQCWAKBD6T5B89NZ4APH', '[#8]=[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]2:[c](- [#1]):[c](-[#1]):[c](:[c](:[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 'O=C(\\C([H])=C([H])\\c1c([H])c([H])c(c(c1[H])OC([H])([H])[H])OC([H])([H])[H])C([H])(C(\\C([H])=C([H])\\c2c([H])c([H])c(c(c2[H])OC([H])([H])[H])OC([H])([H])[H])=O)C([H])([H])C3([H])C([H])([H])C([H])([H])C3 ([H])[H]', '05.716', '5.716', '0', '0', 'TRUE', '-0.294\r\n-0.294\r\n-0.3466\r\n-0.3466\r\n-0.3467\r\n-0.3467\r\n-4.03e-002\r\n-5.04e-002\r\n-5.04e-002\r\n-5.28e-002\r\n-3.3e-002\r\n8.46e-002\r\n0.166\r\n0.166\r\n-1.77e-002\r\n-1.77e-002\r\n-5.14e-002\r\n-5.14e-002\r\n-2.28e-002\r\n-2.28e-002\r\n-2.19e-002\r\n-2.19e-002\r\n-5.22e-002\r\n-5.22e-002\r', '0', '5.716', 'C28H32O6', '0464.22', '-7.962', '0464.55', '5.81', '6', '0', '4', '20', '12', '2', '34', '36', '40', '10', '006', '00', '32', '0', '3', '012', '0071.06', '499.21', '', '2.664', '1.2678', '48.57', '26.85', '5.96407', '21.72', '3,174.54', '123.86', '392.73', '', 'O=C(C(C(C1([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])(C(=O)/C(=C(/C2=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C2\\[H])\\[H])[H])[H])/C(=C(/C3=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C3\\[H])\\[H])[H]', 'COc3ccc(/C=C/C(=O)C(CC1CCC1)C(=O)/C=C/c2ccc(OC)c(OC)c2)cc3OC', 'ASC-JM17 Curcumin Analog', 'ASC-JM17', 'heat shock transcription factor 1', '25183127', 'Under Investigation', 'Spinal Muscular Atrophy Type I', '26962150', 'Spinal Muscular Atrophy Type I', 'SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA\nKENNEDY DISEASE; KD\nKENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY\nBULBOSPINAL MUSCULAR ATROPHY, X-LINKED\nBULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN; ; SMA1'),
(95, '25183127', '25183127', 'COc1ccc(\\C=C\\C(=O)C(CC2CCC2)C(=O)\\C=C\\c3ccc(OC)c(OC)c3)cc1OC', '(1<I>E</I>,6<I>E</I>)-4-(cyclobutylmethyl)-1,7-bis(3,4-dimethoxyphenyl)hepta-1,6-diene-3,5-dione', 'CYAAFQwAoewQBbsISLiWZ2Q5iyA8Ewyz4DcWFHYJueuXpVuN4f1LvE8y2GVl6hA5ugX6ACklJNYme$IylkaBl4VMa^BIpx6HBgfDDktZZQnEwCXhVSsR$^zRZnv$1rJz2Du1Fp^9buPRXDCAw9ytNOCuAwzJiyH5oy9wmHd^rFs4FRHed8WmKaeQPgob7ch3NqLBYAXF 1$8oPxSoC$TP368unzN4ODrC^0zTHjI13y92MG^QzONcO9Ajs^hHycq3Tdsuwd^LvwLHYAmcY4Jlf$pteUCPRzXeUZ0wZ^8J1dOZPhRs6kFnmlfXvshbpC99jW8J6TzgB9wGw75pjBCjeXXGhANeEli5vSBI8$$CT6O61J6hyLubj9CjxpqzrFR60JUODM60N7bbqAR3 $7gvmvEreFgh6E3bx4ADgL^3jB5AkcpVFJgKedKtjOsVTSjsNkzSTS989B0gEVg6hJU8DO50yr0pmADOeq3jnbKzns7wN^8L', 'InChI=1S/C28H32O6/c1-31-25-14-10-20(17-27(25)33-3)8-12-23(29)22(16-19-6-5-7-19)24(30)13-9-21-11-15-26(32-2)28(18-21)34-4/h8-15,17-19,22H,5-7,16H2,1-4H3/b12-8+,13-9+', 'AuxInfo=1/0/N:33,34,31,32,10,8,9,17,18,23,24,15,16,27,28,11,21,22,7,19,20,12,13,14,29,30,25,26,1,2,5,6,3,4/E:(1,2)(3,4)(6,7)(8,9)(10,11)(12,13)(14,15)(17,18)(20,21)(23,24)(25,26)(27,28)(29,30)(31,32)( 33,34)/rA:66OOOOOOCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s7;s8s9;s7;s11;d1s12;d2s12;s13;s14;d+15;d+16;s17;s18;d+19;d+20;s19;s20;s3s21;s4s22;d-23;d-24;s5d-25s27;s6d-26 s28;s3;s4;s5;s6;s7;s8;s8;s9;s9;s10;s10;s11;s11;s12;s15;s16;s17;s18;s21;s22;s23;s24;s27;s28;s31;s', 'PJOSHEDKRPRCAE-QHKWOANTSA-N', '1010:56WKCECSTMDQCWAKBD6T5B89NZ4APH', '[#8]=[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]2:[c](- [#1]):[c](-[#1]):[c](:[c](:[c]2-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 'O=C(\\C([H])=C([H])\\c1c([H])c([H])c(c(c1[H])OC([H])([H])[H])OC([H])([H])[H])C([H])(C(\\C([H])=C([H])\\c2c([H])c([H])c(c(c2[H])OC([H])([H])[H])OC([H])([H])[H])=O)C([H])([H])C3([H])C([H])([H])C([H])([H])C3 ([H])[H]', '05.716', '5.716', '0', '0', 'TRUE', '-0.294\r\n-0.294\r\n-0.3466\r\n-0.3466\r\n-0.3467\r\n-0.3467\r\n-4.03e-002\r\n-5.04e-002\r\n-5.04e-002\r\n-5.28e-002\r\n-3.3e-002\r\n8.46e-002\r\n0.166\r\n0.166\r\n-1.77e-002\r\n-1.77e-002\r\n-5.14e-002\r\n-5.14e-002\r\n-2.28e-002\r\n-2.28e-002\r\n-2.19e-002\r\n-2.19e-002\r\n-5.22e-002\r\n-5.22e-002\r', '0', '5.716', 'C28H32O6', '0464.22', '-7.962', '0464.55', '5.81', '6', '0', '4', '20', '12', '2', '34', '36', '40', '10', '006', '00', '32', '0', '3', '012', '0071.06', '499.21', '', '2.664', '1.2678', '48.57', '26.85', '5.96407', '21.72', '3,174.54', '123.86', '392.73', '', 'O=C(C(C(C1([H])C([H])([H])C([H])([H])C1([H])[H])([H])[H])(C(=O)/C(=C(/C2=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C2\\[H])\\[H])[H])[H])/C(=C(/C3=C([H])/C(OC([H])([H])[H])=C(OC([H])([H])[H])\\C([H])=C3\\[H])\\[H])[H]', 'COc3ccc(/C=C/C(=O)C(CC1CCC1)C(=O)/C=C/c2ccc(OC)c(OC)c2)cc3OC', 'ASC-JM17 Curcumin Analog', 'ASC-JM17', 'nuclear respiratory factor 1', '25183127', 'Under Investigation', 'Spinal Muscular Atrophy Type I', '26962150', 'Spinal Muscular Atrophy Type I', 'SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA\nKENNEDY DISEASE; KD\nKENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY\nBULBOSPINAL MUSCULAR ATROPHY, X-LINKED\nBULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN; ; SMA1'),
(96, '54670067', '54670067', 'OC[C@H](O)[C@H]1OC(=O)C(=C1O)O', '(2<I>R</I>)-2-[(1<I>S</I>)-1,2-dihydroxyethyl]-3,4-dihydroxy-2<I>H</I>-furan-5-one', 'CYAAFQwAUfwQoi1uq4tRdahP8cWtC2MZdGTtu11YYiPAHQiXOCdvhSM00GeZT5JyTEle1$D76YCKFXGszQono9$jslih2scuGt$r3t2erOGVtK2MYPjgWobvUGvg^BHeMf8XC8iygUHgYCM2CiP3rJ0GJ2a89KP11oIRcyCvLDlXGbNC9$8E3uryGYM0I9NG8ZeRSkHv 7Z5GsASQzpmZA6tPLJCCDaVb$A61zAH8L19wWa9G7DZ$1sNzteOrYpmGXuSX0K3pj7Aj13NqShJLA8eNhBPzDgOzNXcI9oFg9Dq$jnFja2ltBYERZQVpa2XfoP16p27xHY9c88oYcuvrFxjxI$^suOLorOxdDoFpR1wSz^SKb1A3hEl116u5M^$iHy1yEpFmseOSij7V 5NPz36hAzMzlUvndoGbhr80OmtfHebi2gZE2z33iOgc9w4atfOx5uVaIOX^9IKPW79RKzTZlWfGcxs^6bpX6Zx^eDixOWCuT', 'InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1', 'AuxInfo=1/0/N:10,8,9,11,7,12,4,2,3,5,6,1/it:im/rA:20OOOOOOC.oC.oCCCCHHHHHHHH/rB:;;;;;s1;s2s7;s3s7;s4s8;s5d-9;s1d6s11;s7;s8;s10;s10;s2;s3;s4;s5;/r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r\n-0.3875\r\n-0.3597\r\n-0.3936\r\n-0.3538\r\n-0.2582\r\n0.1443\r\n0.1101\r\n0.1173\r\n7.21e-002\r\n0.1738\r\n0.3191\r\n7.13e-002\r\n6.57e-002\r\n5.91e-002\r\n5.91e-002\r\n0.2106\r\n0.2179\r\n0.2101\r\n0.2195', '1', '-2.411', 'C6H8O6', '0176.032', '-0.08', '0176.124', '4.17 11.56', '2', '4', '2', '10', '00', '0', '12', '12', '13', '2', '006', '04', '8', '0', '1', '002', '0107.22', '165.6', '', '4.01321', '1.2593', '31.12', '17.54', '2.6091', '13.58', '216.435', '248.336', '128.62', '', 'O1C(C(O[H])(C(O[H])([H])[H])[H])([H])/C(O[H])=C(O[H])\\C1=O', 'O=C1O[C@H]([C@@H](O)CO)/C(O)=C1/O', 'Ascorbic acid', 'vitamin C; Ascoltin; Cevitamic acid; Laroscorbine; Viforcit', 'Prolyl 4-hydroxylase subunit alpha-1', '54670067', 'Phase II/III Completed', 'Charcot Marie Tooth disease (CMT)', '26662471', 'Charcot Marie Tooth disease (CMT)', 'CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB; CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE B\nDI-CMTB; CMTDI1'),
(97, '54670067', '54670067', 'OC[C@H](O)[C@H]1OC(=O)C(=C1O)O', '(2<I>R</I>)-2-[(1<I>S</I>)-1,2-dihydroxyethyl]-3,4-dihydroxy-2<I>H</I>-furan-5-one', 'CYAAFQwAUfwQoi1uq4tRdahP8cWtC2MZdGTtu11YYiPAHQiXOCdvhSM00GeZT5JyTEle1$D76YCKFXGszQono9$jslih2scuGt$r3t2erOGVtK2MYPjgWobvUGvg^BHeMf8XC8iygUHgYCM2CiP3rJ0GJ2a89KP11oIRcyCvLDlXGbNC9$8E3uryGYM0I9NG8ZeRSkHv 7Z5GsASQzpmZA6tPLJCCDaVb$A61zAH8L19wWa9G7DZ$1sNzteOrYpmGXuSX0K3pj7Aj13NqShJLA8eNhBPzDgOzNXcI9oFg9Dq$jnFja2ltBYERZQVpa2XfoP16p27xHY9c88oYcuvrFxjxI$^suOLorOxdDoFpR1wSz^SKb1A3hEl116u5M^$iHy1yEpFmseOSij7V 5NPz36hAzMzlUvndoGbhr80OmtfHebi2gZE2z33iOgc9w4atfOx5uVaIOX^9IKPW79RKzTZlWfGcxs^6bpX6Zx^eDixOWCuT', 'InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1', 'AuxInfo=1/0/N:10,8,9,11,7,12,4,2,3,5,6,1/it:im/rA:20OOOOOOC.oC.oCCCCHHHHHHHH/rB:;;;;;s1;s2s7;s3s7;s4s8;s5d-9;s1d6s11;s7;s8;s10;s10;s2;s3;s4;s5;/r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r\n-0.3875\r\n-0.3597\r\n-0.3936\r\n-0.3538\r\n-0.2582\r\n0.1443\r\n0.1101\r\n0.1173\r\n7.21e-002\r\n0.1738\r\n0.3191\r\n7.13e-002\r\n6.57e-002\r\n5.91e-002\r\n5.91e-002\r\n0.2106\r\n0.2179\r\n0.2101\r\n0.2195', '1', '-2.411', 'C6H8O6', '0176.032', '-0.08', '0176.124', '4.17 11.56', '2', '4', '2', '10', '00', '0', '12', '12', '13', '2', '006', '04', '8', '0', '1', '002', '0107.22', '165.6', '', '4.01321', '1.2593', '31.12', '17.54', '2.6091', '13.58', '216.435', '248.336', '128.62', '', 'O1C(C(O[H])(C(O[H])([H])[H])[H])([H])/C(O[H])=C(O[H])\\C1=O', 'O=C1O[C@H]([C@@H](O)CO)/C(O)=C1/O', 'Ascorbic acid', 'vitamin C; Ascoltin; Cevitamic acid; Laroscorbine; Viforcit', 'Egl nine homolog 2', '54670067', 'Phase III', 'Fragile X Syndrome', '25187257', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(98, '98', 'Not Available', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', '', 'ASO7', 'Not Available', 'Ataxin-2', 'Not Available', 'Under Investigation', 'Spinocerebellar Ataxia 2', '28405024', 'Spinocerebellar Ataxia 2', 'SPINOCEREBELLAR ATROPHY II\nOLIVOPONTOCEREBELLAR ATROPHY, HOLGUIN TYPE\nOLIVOPONTOCEREBELLAR ATROPHY II; OPCA2\nSPINOCEREBELLAR ATAXIA, CUBAN TYPE\nCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS\nWADIA-SWAMI SYNDROME\nSPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM'),
(99, '2244', '2244', 'CC(=O)Oc1ccccc1C(=O)O', '2-acetoxybenzoic acid', 'CYAAFQwAwcwQQn2SDLVi4lftE7L4Z2mTV40eD4rskBJPjSiNQUqZTfjAowmhPCaXu1C8PuweSGNQ30Evk8xhuri$0gg1^r2yo3MT0Fs^JjflsmkTunyav6IW7FewohInAkwvwFoleYWJqyaEZWhAfUbBHIZrsOx7GRZPhuKRZ2Ne3kpw9OkcygOe72bl4mnn9PumHFUF i7qBStf6ty1Fc3BeBIxKP^pbsRLvimaFz9gF88ETcVhKMpbXLSePXorXhUp6RglJXtUZbhpHxXQ6GcA9zoc^Kn$1l9kOq3nEiWwA6GupfYU8ibnYHQft31dMNr^28YEXeVz6WHWl7iY19dmXKuuqqwWprN6M6tPcEPY639hyFVHmXI5cYplnbkb6olbzEXuzZX94e9hZ bsx8TAIhws^L5gqCCh9y9zVZJkVNRfvdf7^4SnXJ7t7wnZjz5jtxu^Vy9eLSNMVpzsHnyvjZ6CncAZR^1Eg2gOAxtD$BIrQh', 'InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)', 'AuxInfo=1/1/N:13,10,9,8,7,12,6,5,11,4,2,3,1/E:(11,12)/rA:21OOOOCCCCCCCCCHHHHHHHH/rB:;;;s1;s5;d+5;d-6;s7;s8d-9;s2d3s6;s1d4;s12;s7;s8;s9;s10;s13;s13;s13;s2;/rC:1.2333,.554,.7792;-.6952,-2.7148,-.7502;.7 958,-2.1843,.8685;1.7813,.8105,-1.4821;-.0857,.6088,.4403;-.7927,-.5515,.1244;-.7288,1.8464,.4133;-2.1426,-.4741,-.2184;-2.0787,1.9238,.0706;-2.7855,.7636,-.2453;-.1409,-1.8536,.1477;2.1094,.6715,-.31 13;3.5305,.5996,.1635;-.1851,2.7545,.6593;-2.7247,-1.3605,-.4564;-2.5797,2.8872,.0506;-3.8374,.8', 'BSYNRYMUTXBXSQ-UHFFFAOYSA-N', '1010:32MVJNA7DGT3SP2EZZYFGRUP37EUP5', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#8])-[#8]-[#1]', 'O(C(C([H])([H])[H])=O)c1c([H])c([H])c([H])c([H])c1C(=O)O[H]', '01.227', '1.227', '0', '0', 'TRUE', '-0.2776\r\n-0.3278\r\n-0.2608\r\n-0.2666\r\n9.86e-002\r\n7.76e-002\r\n-3.03e-002\r\n-4.62e-002\r\n-5.96e-002\r\n-6.13e-002\r\n0.2927\r\n0.2627\r\n2.25e-002\r\n6.5e-002\r\n6.32e-002\r\n6.23e-002\r\n6.22e-002\r\n3.36e-002\r\n3.36e-002\r\n3.36e-002\r\n0.2226', '0', '-0.245', 'C9H8O4', '0180.042', '-1.889', '0180.157', '3.48', '3', '0', '2', '5', '06', '1', '13', '13', '12', '5', '004', '01', '8', '0', '1', '003', '0063.6', '185.08', '', '0.9424', '1.2624', '53.36', '16.6', '2.943', '36.76', '211.707', '125.026', '138.91', '', 'O(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C(O[H])=O)C(=O)C([H])([H])[H]', 'CC(=O)Oc1ccccc1C(=O)O', 'Aspirin', 'ACETYLSALICYLIC ACID; Ecotrin; Polopiryna; Micristin; Saletin', 'Prostaglandin G/H synthase 2', '2244', 'Early Phase I Completed', 'Multiple Sclerosis', '26123634', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(100, '2244', '2244', 'CC(=O)Oc1ccccc1C(=O)O', '2-acetoxybenzoic acid', 'CYAAFQwAwcwQQn2SDLVi4lftE7L4Z2mTV40eD4rskBJPjSiNQUqZTfjAowmhPCaXu1C8PuweSGNQ30Evk8xhuri$0gg1^r2yo3MT0Fs^JjflsmkTunyav6IW7FewohInAkwvwFoleYWJqyaEZWhAfUbBHIZrsOx7GRZPhuKRZ2Ne3kpw9OkcygOe72bl4mnn9PumHFUF i7qBStf6ty1Fc3BeBIxKP^pbsRLvimaFz9gF88ETcVhKMpbXLSePXorXhUp6RglJXtUZbhpHxXQ6GcA9zoc^Kn$1l9kOq3nEiWwA6GupfYU8ibnYHQft31dMNr^28YEXeVz6WHWl7iY19dmXKuuqqwWprN6M6tPcEPY639hyFVHmXI5cYplnbkb6olbzEXuzZX94e9hZ bsx8TAIhws^L5gqCCh9y9zVZJkVNRfvdf7^4SnXJ7t7wnZjz5jtxu^Vy9eLSNMVpzsHnyvjZ6CncAZR^1Eg2gOAxtD$BIrQh', 'InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)', 'AuxInfo=1/1/N:13,10,9,8,7,12,6,5,11,4,2,3,1/E:(11,12)/rA:21OOOOCCCCCCCCCHHHHHHHH/rB:;;;s1;s5;d+5;d-6;s7;s8d-9;s2d3s6;s1d4;s12;s7;s8;s9;s10;s13;s13;s13;s2;/rC:1.2333,.554,.7792;-.6952,-2.7148,-.7502;.7 958,-2.1843,.8685;1.7813,.8105,-1.4821;-.0857,.6088,.4403;-.7927,-.5515,.1244;-.7288,1.8464,.4133;-2.1426,-.4741,-.2184;-2.0787,1.9238,.0706;-2.7855,.7636,-.2453;-.1409,-1.8536,.1477;2.1094,.6715,-.31 13;3.5305,.5996,.1635;-.1851,2.7545,.6593;-2.7247,-1.3605,-.4564;-2.5797,2.8872,.0506;-3.8374,.8', 'BSYNRYMUTXBXSQ-UHFFFAOYSA-N', '1010:32MVJNA7DGT3SP2EZZYFGRUP37EUP5', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#8])-[#8]-[#1]', 'O(C(C([H])([H])[H])=O)c1c([H])c([H])c([H])c([H])c1C(=O)O[H]', '01.227', '1.227', '0', '0', 'TRUE', '-0.2776\r\n-0.3278\r\n-0.2608\r\n-0.2666\r\n9.86e-002\r\n7.76e-002\r\n-3.03e-002\r\n-4.62e-002\r\n-5.96e-002\r\n-6.13e-002\r\n0.2927\r\n0.2627\r\n2.25e-002\r\n6.5e-002\r\n6.32e-002\r\n6.23e-002\r\n6.22e-002\r\n3.36e-002\r\n3.36e-002\r\n3.36e-002\r\n0.2226', '0', '-0.245', 'C9H8O4', '0180.042', '-1.889', '0180.157', '3.48', '3', '0', '2', '5', '06', '1', '13', '13', '12', '5', '004', '01', '8', '0', '1', '003', '0063.6', '185.08', '', '0.9424', '1.2624', '53.36', '16.6', '2.943', '36.76', '211.707', '125.026', '138.91', '', 'O(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C(O[H])=O)C(=O)C([H])([H])[H]', 'CC(=O)Oc1ccccc1C(=O)O', 'Aspirin', 'ACETYLSALICYLIC ACID; Ecotrin; Polopiryna; Micristin; Saletin', 'Prostaglandin G/H synthase 1', '2244', 'Early Phase I Completed', 'Multiple Sclerosis', '26123634', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(101, '2244', '2244', 'CC(=O)Oc1ccccc1C(=O)O', '2-acetoxybenzoic acid', 'CYAAFQwAwcwQQn2SDLVi4lftE7L4Z2mTV40eD4rskBJPjSiNQUqZTfjAowmhPCaXu1C8PuweSGNQ30Evk8xhuri$0gg1^r2yo3MT0Fs^JjflsmkTunyav6IW7FewohInAkwvwFoleYWJqyaEZWhAfUbBHIZrsOx7GRZPhuKRZ2Ne3kpw9OkcygOe72bl4mnn9PumHFUF i7qBStf6ty1Fc3BeBIxKP^pbsRLvimaFz9gF88ETcVhKMpbXLSePXorXhUp6RglJXtUZbhpHxXQ6GcA9zoc^Kn$1l9kOq3nEiWwA6GupfYU8ibnYHQft31dMNr^28YEXeVz6WHWl7iY19dmXKuuqqwWprN6M6tPcEPY639hyFVHmXI5cYplnbkb6olbzEXuzZX94e9hZ bsx8TAIhws^L5gqCCh9y9zVZJkVNRfvdf7^4SnXJ7t7wnZjz5jtxu^Vy9eLSNMVpzsHnyvjZ6CncAZR^1Eg2gOAxtD$BIrQh', 'InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)', 'AuxInfo=1/1/N:13,10,9,8,7,12,6,5,11,4,2,3,1/E:(11,12)/rA:21OOOOCCCCCCCCCHHHHHHHH/rB:;;;s1;s5;d+5;d-6;s7;s8d-9;s2d3s6;s1d4;s12;s7;s8;s9;s10;s13;s13;s13;s2;/rC:1.2333,.554,.7792;-.6952,-2.7148,-.7502;.7 958,-2.1843,.8685;1.7813,.8105,-1.4821;-.0857,.6088,.4403;-.7927,-.5515,.1244;-.7288,1.8464,.4133;-2.1426,-.4741,-.2184;-2.0787,1.9238,.0706;-2.7855,.7636,-.2453;-.1409,-1.8536,.1477;2.1094,.6715,-.31 13;3.5305,.5996,.1635;-.1851,2.7545,.6593;-2.7247,-1.3605,-.4564;-2.5797,2.8872,.0506;-3.8374,.8', 'BSYNRYMUTXBXSQ-UHFFFAOYSA-N', '1010:32MVJNA7DGT3SP2EZZYFGRUP37EUP5', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#8])-[#8]-[#1]', 'O(C(C([H])([H])[H])=O)c1c([H])c([H])c([H])c([H])c1C(=O)O[H]', '01.227', '1.227', '0', '0', 'TRUE', '-0.2776\r\n-0.3278\r\n-0.2608\r\n-0.2666\r\n9.86e-002\r\n7.76e-002\r\n-3.03e-002\r\n-4.62e-002\r\n-5.96e-002\r\n-6.13e-002\r\n0.2927\r\n0.2627\r\n2.25e-002\r\n6.5e-002\r\n6.32e-002\r\n6.23e-002\r\n6.22e-002\r\n3.36e-002\r\n3.36e-002\r\n3.36e-002\r\n0.2226', '0', '-0.245', 'C9H8O4', '0180.042', '-1.889', '0180.157', '3.48', '3', '0', '2', '5', '06', '1', '13', '13', '12', '5', '004', '01', '8', '0', '1', '003', '0063.6', '185.08', '', '0.9424', '1.2624', '53.36', '16.6', '2.943', '36.76', '211.707', '125.026', '138.91', '', 'O(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C(O[H])=O)C(=O)C([H])([H])[H]', 'CC(=O)Oc1ccccc1C(=O)O', 'Aspirin', 'ACETYLSALICYLIC ACID; Ecotrin; Polopiryna; Micristin; Saletin', 'Prostaglandin G/H synthase 2', '2244', 'Terminated at Phase IV', 'Migraine', '23633350', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(102, '2244', '2244', 'CC(=O)Oc1ccccc1C(=O)O', '2-acetoxybenzoic acid', 'CYAAFQwAwcwQQn2SDLVi4lftE7L4Z2mTV40eD4rskBJPjSiNQUqZTfjAowmhPCaXu1C8PuweSGNQ30Evk8xhuri$0gg1^r2yo3MT0Fs^JjflsmkTunyav6IW7FewohInAkwvwFoleYWJqyaEZWhAfUbBHIZrsOx7GRZPhuKRZ2Ne3kpw9OkcygOe72bl4mnn9PumHFUF i7qBStf6ty1Fc3BeBIxKP^pbsRLvimaFz9gF88ETcVhKMpbXLSePXorXhUp6RglJXtUZbhpHxXQ6GcA9zoc^Kn$1l9kOq3nEiWwA6GupfYU8ibnYHQft31dMNr^28YEXeVz6WHWl7iY19dmXKuuqqwWprN6M6tPcEPY639hyFVHmXI5cYplnbkb6olbzEXuzZX94e9hZ bsx8TAIhws^L5gqCCh9y9zVZJkVNRfvdf7^4SnXJ7t7wnZjz5jtxu^Vy9eLSNMVpzsHnyvjZ6CncAZR^1Eg2gOAxtD$BIrQh', 'InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)', 'AuxInfo=1/1/N:13,10,9,8,7,12,6,5,11,4,2,3,1/E:(11,12)/rA:21OOOOCCCCCCCCCHHHHHHHH/rB:;;;s1;s5;d+5;d-6;s7;s8d-9;s2d3s6;s1d4;s12;s7;s8;s9;s10;s13;s13;s13;s2;/rC:1.2333,.554,.7792;-.6952,-2.7148,-.7502;.7 958,-2.1843,.8685;1.7813,.8105,-1.4821;-.0857,.6088,.4403;-.7927,-.5515,.1244;-.7288,1.8464,.4133;-2.1426,-.4741,-.2184;-2.0787,1.9238,.0706;-2.7855,.7636,-.2453;-.1409,-1.8536,.1477;2.1094,.6715,-.31 13;3.5305,.5996,.1635;-.1851,2.7545,.6593;-2.7247,-1.3605,-.4564;-2.5797,2.8872,.0506;-3.8374,.8', 'BSYNRYMUTXBXSQ-UHFFFAOYSA-N', '1010:32MVJNA7DGT3SP2EZZYFGRUP37EUP5', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#8])-[#8]-[#1]', 'O(C(C([H])([H])[H])=O)c1c([H])c([H])c([H])c([H])c1C(=O)O[H]', '01.227', '1.227', '0', '0', 'TRUE', '-0.2776\r\n-0.3278\r\n-0.2608\r\n-0.2666\r\n9.86e-002\r\n7.76e-002\r\n-3.03e-002\r\n-4.62e-002\r\n-5.96e-002\r\n-6.13e-002\r\n0.2927\r\n0.2627\r\n2.25e-002\r\n6.5e-002\r\n6.32e-002\r\n6.23e-002\r\n6.22e-002\r\n3.36e-002\r\n3.36e-002\r\n3.36e-002\r\n0.2226', '0', '-0.245', 'C9H8O4', '0180.042', '-1.889', '0180.157', '3.48', '3', '0', '2', '5', '06', '1', '13', '13', '12', '5', '004', '01', '8', '0', '1', '003', '0063.6', '185.08', '', '0.9424', '1.2624', '53.36', '16.6', '2.943', '36.76', '211.707', '125.026', '138.91', '', 'O(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C(O[H])=O)C(=O)C([H])([H])[H]', 'CC(=O)Oc1ccccc1C(=O)O', 'Aspirin', 'ACETYLSALICYLIC ACID; Ecotrin; Polopiryna; Micristin; Saletin', 'Prostaglandin G/H synthase 1', '2244', 'Terminated at Phase IV', 'Migraine', '23633350', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(103, '54841', '54841', 'CNCC[C@@H](Oc1ccccc1C)c2ccccc2', '(3<I>R</I>)-<I>N</I>-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine', 'CYAAFQwAAewQaAAiipYrvhClgVrkI5OlI6B0Bj0ysmT9vkMsoLAmB2IV7R$sJrBYjvhW1XbTH98G8TH3k7tU3aDJz$8p5IAc5N6VUQvGGnh$eHzzGN7^L4j5QJ81^3tS^hjw$ZlZV3KYLt84IQU3nJ^wlwSP1KvxBqIR1j7KvSm1LEBsjsMD5PEoVXsckgYjtRDL160B HgCfMyTJ8Y8IADb5yB0qwsGIx55YaVlScxmMvW3khfMdWwkBg2mVbNYUuvRlzaTBD0rlFWIoWLLBOCUZEYCiZGSYrWHrTtIdRYA60n1W8fpXwOXGISlEY0suEwn1rfPspey0AmZkMBu3OQgOj9ea4TFz^chP3kdBqml4kJuQWiOTZk^zYRUUcd87Vcoajr7JhUthk26d L^KfnqyGZopJoaSpPps6MJ2OoQQTubHmHb$bx$0QpiaBeLJHuor1vTG1Mv848mlryb446daqc5Qz$o1hNUb3VAd7MX6Y3RKj', 'InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1', 'AuxInfo=1/0/N:17,15,14,11,12,19,18,16,8,9,13,4,6,10,5,7,3,2,1/E:(4,5)(9,10)/it:im/rA:40ONC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;s1;s3;s3;s2s4;s1;d+5;s5;s7;s8;d-9;d+7;d-11s12;s2;d-10;s10;s13;s16d -18;s3;s4;s4;s6;s6;s8;s9;s2;s11;s12;s13;s14;s15;s15;s15;s16;s17;s17;s17;s18;s19;/rC:-.7732,-.0006,-.8342;2.6557,3.3471,.0161;.3337,.2985,.0188;.9347,1.6516,-.3951;1.3075,-.854,-.0603;2.1439,2.0518,.45 07;-1.9952,-.1129,-.2317;1.4124,-1.5731,-1.2397;2.0769,-1.1691,1.0478;-3.0444,.7281,-.5941;2.311', 'VHGCDTVCOLNTBX-QGZVFWFLSA-N', '1010:VUQCCP6KMC6WAM9QJ2GNFQRE8F6R1M', '[#8](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[#1])-[#6@@](-[#1])(-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[# 7](-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O(c1c([H])c([H])c([H])c([H])c1C([H])([H])[H])[C@@]([H])(c2c([H])c([H])c([H])c([H])c2[H])C([H])([H])C([H])([H])N([H])C([H])([H])[H]', '03.577', '3.577', '0', '0', 'TRUE', '-0.3378\r\n-0.3197\r\n9.04e-002\r\n-9.4e-003\r\n-1.88e-002\r\n-2.4e-003\r\n7.87e-002\r\n-5.65e-002\r\n-5.65e-002\r\n-2.08e-002\r\n-6.19e-002\r\n-6.19e-002\r\n-3.15e-002\r\n-6.23e-002\r\n-1.65e-002\r\n-5.68e-002\r\n-3.72e-002\r\n-5.97e-002\r\n-6.18e-002\r\n6.6e-002\r\n3.09e-002\r\n3.09e-002\r\n4.28e', '1', '2.424', 'C17H21NO', '0255.162', '-5.059', '0255.355', '9.3', '1', '1', '0', '8', '12', '2', '19', '20', '24', '6', '002', '01', '21', '0', '2', '006', '0021.26', '288.28', '', '2.38431', '1.2523', '40.39', '2.47', '3.83017', '37.92', '604.866', '28.79', '226.37', '', 'O(C(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])[H])/C2=C([H])/C([H])=C([H])\\C([H])=C2\\C([H])([H])[H]', 'CNCCC(Oc1ccccc1C)c2ccccc2', 'Atomoxetine', 'Tomoxetine; Strattera; Tomoxetinum', 'Sodium-dependent noradrenaline transporter', '54841', 'Phase II', 'Multiple Sclerosis', '19957206', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(104, '54841', '54841', 'CNCC[C@@H](Oc1ccccc1C)c2ccccc2', '(3<I>R</I>)-<I>N</I>-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine', 'CYAAFQwAAewQaAAiipYrvhClgVrkI5OlI6B0Bj0ysmT9vkMsoLAmB2IV7R$sJrBYjvhW1XbTH98G8TH3k7tU3aDJz$8p5IAc5N6VUQvGGnh$eHzzGN7^L4j5QJ81^3tS^hjw$ZlZV3KYLt84IQU3nJ^wlwSP1KvxBqIR1j7KvSm1LEBsjsMD5PEoVXsckgYjtRDL160B HgCfMyTJ8Y8IADb5yB0qwsGIx55YaVlScxmMvW3khfMdWwkBg2mVbNYUuvRlzaTBD0rlFWIoWLLBOCUZEYCiZGSYrWHrTtIdRYA60n1W8fpXwOXGISlEY0suEwn1rfPspey0AmZkMBu3OQgOj9ea4TFz^chP3kdBqml4kJuQWiOTZk^zYRUUcd87Vcoajr7JhUthk26d L^KfnqyGZopJoaSpPps6MJ2OoQQTubHmHb$bx$0QpiaBeLJHuor1vTG1Mv848mlryb446daqc5Qz$o1hNUb3VAd7MX6Y3RKj', 'InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1', 'AuxInfo=1/0/N:17,15,14,11,12,19,18,16,8,9,13,4,6,10,5,7,3,2,1/E:(4,5)(9,10)/it:im/rA:40ONC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;s1;s3;s3;s2s4;s1;d+5;s5;s7;s8;d-9;d+7;d-11s12;s2;d-10;s10;s13;s16d -18;s3;s4;s4;s6;s6;s8;s9;s2;s11;s12;s13;s14;s15;s15;s15;s16;s17;s17;s17;s18;s19;/rC:-.7732,-.0006,-.8342;2.6557,3.3471,.0161;.3337,.2985,.0188;.9347,1.6516,-.3951;1.3075,-.854,-.0603;2.1439,2.0518,.45 07;-1.9952,-.1129,-.2317;1.4124,-1.5731,-1.2397;2.0769,-1.1691,1.0478;-3.0444,.7281,-.5941;2.311', 'VHGCDTVCOLNTBX-QGZVFWFLSA-N', '1010:VUQCCP6KMC6WAM9QJ2GNFQRE8F6R1M', '[#8](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[#1])-[#6@@](-[#1])(-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[# 7](-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O(c1c([H])c([H])c([H])c([H])c1C([H])([H])[H])[C@@]([H])(c2c([H])c([H])c([H])c([H])c2[H])C([H])([H])C([H])([H])N([H])C([H])([H])[H]', '03.577', '3.577', '0', '0', 'TRUE', '-0.3378\r\n-0.3197\r\n9.04e-002\r\n-9.4e-003\r\n-1.88e-002\r\n-2.4e-003\r\n7.87e-002\r\n-5.65e-002\r\n-5.65e-002\r\n-2.08e-002\r\n-6.19e-002\r\n-6.19e-002\r\n-3.15e-002\r\n-6.23e-002\r\n-1.65e-002\r\n-5.68e-002\r\n-3.72e-002\r\n-5.97e-002\r\n-6.18e-002\r\n6.6e-002\r\n3.09e-002\r\n3.09e-002\r\n4.28e', '1', '2.424', 'C17H21NO', '0255.162', '-5.059', '0255.355', '9.3', '1', '1', '0', '8', '12', '2', '19', '20', '24', '6', '002', '01', '21', '0', '2', '006', '0021.26', '288.28', '', '2.38431', '1.2523', '40.39', '2.47', '3.83017', '37.92', '604.866', '28.79', '226.37', '', 'O(C(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])[H])/C2=C([H])/C([H])=C([H])\\C([H])=C2\\C([H])([H])[H]', 'CNCCC(Oc1ccccc1C)c2ccccc2', 'Atomoxetine', 'Tomoxetine; Strattera; Tomoxetinum', 'Sodium-dependent noradrenaline transporter', '54841', 'Phase II Completed', 'Huntington Disease (HD)', '19745649', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(105, '54841', '54841', 'CNCC[C@@H](Oc1ccccc1C)c2ccccc2', '(3<I>R</I>)-<I>N</I>-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine', 'CYAAFQwAAewQaAAiipYrvhClgVrkI5OlI6B0Bj0ysmT9vkMsoLAmB2IV7R$sJrBYjvhW1XbTH98G8TH3k7tU3aDJz$8p5IAc5N6VUQvGGnh$eHzzGN7^L4j5QJ81^3tS^hjw$ZlZV3KYLt84IQU3nJ^wlwSP1KvxBqIR1j7KvSm1LEBsjsMD5PEoVXsckgYjtRDL160B HgCfMyTJ8Y8IADb5yB0qwsGIx55YaVlScxmMvW3khfMdWwkBg2mVbNYUuvRlzaTBD0rlFWIoWLLBOCUZEYCiZGSYrWHrTtIdRYA60n1W8fpXwOXGISlEY0suEwn1rfPspey0AmZkMBu3OQgOj9ea4TFz^chP3kdBqml4kJuQWiOTZk^zYRUUcd87Vcoajr7JhUthk26d L^KfnqyGZopJoaSpPps6MJ2OoQQTubHmHb$bx$0QpiaBeLJHuor1vTG1Mv848mlryb446daqc5Qz$o1hNUb3VAd7MX6Y3RKj', 'InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1', 'AuxInfo=1/0/N:17,15,14,11,12,19,18,16,8,9,13,4,6,10,5,7,3,2,1/E:(4,5)(9,10)/it:im/rA:40ONC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;s1;s3;s3;s2s4;s1;d+5;s5;s7;s8;d-9;d+7;d-11s12;s2;d-10;s10;s13;s16d -18;s3;s4;s4;s6;s6;s8;s9;s2;s11;s12;s13;s14;s15;s15;s15;s16;s17;s17;s17;s18;s19;/rC:-.7732,-.0006,-.8342;2.6557,3.3471,.0161;.3337,.2985,.0188;.9347,1.6516,-.3951;1.3075,-.854,-.0603;2.1439,2.0518,.45 07;-1.9952,-.1129,-.2317;1.4124,-1.5731,-1.2397;2.0769,-1.1691,1.0478;-3.0444,.7281,-.5941;2.311', 'VHGCDTVCOLNTBX-QGZVFWFLSA-N', '1010:VUQCCP6KMC6WAM9QJ2GNFQRE8F6R1M', '[#8](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[#1])-[#6@@](-[#1])(-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[# 7](-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O(c1c([H])c([H])c([H])c([H])c1C([H])([H])[H])[C@@]([H])(c2c([H])c([H])c([H])c([H])c2[H])C([H])([H])C([H])([H])N([H])C([H])([H])[H]', '03.577', '3.577', '0', '0', 'TRUE', '-0.3378\r\n-0.3197\r\n9.04e-002\r\n-9.4e-003\r\n-1.88e-002\r\n-2.4e-003\r\n7.87e-002\r\n-5.65e-002\r\n-5.65e-002\r\n-2.08e-002\r\n-6.19e-002\r\n-6.19e-002\r\n-3.15e-002\r\n-6.23e-002\r\n-1.65e-002\r\n-5.68e-002\r\n-3.72e-002\r\n-5.97e-002\r\n-6.18e-002\r\n6.6e-002\r\n3.09e-002\r\n3.09e-002\r\n4.28e', '1', '2.424', 'C17H21NO', '0255.162', '-5.059', '0255.355', '9.3', '1', '1', '0', '8', '12', '2', '19', '20', '24', '6', '002', '01', '21', '0', '2', '006', '0021.26', '288.28', '', '2.38431', '1.2523', '40.39', '2.47', '3.83017', '37.92', '604.866', '28.79', '226.37', '', 'O(C(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\[H])[H])/C2=C([H])/C([H])=C([H])\\C([H])=C2\\C([H])([H])[H]', 'CNCCC(Oc1ccccc1C)c2ccccc2', 'Atomoxetine', 'Tomoxetine; Strattera; Tomoxetinum', 'Sodium-dependent noradrenaline transporter', '54841', 'Terminated at Phase IV', 'Attention Deficit Hyperactivity Disorder (ADHD)', '28657141', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD'),
(106, '60823', '60823', 'CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)O', '(3<I>R</I>,5<I>R</I>)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid', 'CYAAFQwA4fwQgdCU9dUJiVhNgnVz3w6PkQrvJMLDPpzkV40jrbQ56j7Wa7qNU2TeMp9S6M0DMt2rtg$mq$N6b2vhKTNXzrgf88cF$9dvXOiESXTxcC09jWfYX^6LQVfoS74P^H0^5q^^nE^$eJllJGfDeKDh90LjTYZf4jfGugR5d2huaXA5ZyzV7aMlesgUt39vIzI5 xhHeeijq^oDo57D7pxGLqB5VnuwWdXNW0uwnp4T3ZMGPmw6TS05uh^3davWx12YFyt7DOKgEiJ6pU^Su7yne7dxxwDMCJL6BkRySyt7T$BlmlgSrrnb^9Nd8bZ53yQfow3jI6RDBXVg2VkBqjniQ4rSnx66wjQ0Kl8iPHFR^^9AfW3SUoOEt70jMB3vPyAQabEUeqZ$T 41xuCRf0kaHlXQP^GCl2oYlOiJPYsDra5jrIoULMxmq6Dbqytt9tJIXTM4pzwCtivJ2kIIVsQXZOX^NZZfhMEwZ7aUwkpIds', 'InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,4 0)/t26-,27-/m1/s1', 'AuxInfo=1/1/N:19,20,36,41,31,32,39,40,27,28,37,38,25,26,29,30,13,10,17,24,12,21,18,33,34,16,22,35,15,14,9,11,23,1,8,7,2,3,5,6,4/E:(1,2)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)(39,40)/it:im/rA:76FOOOOONNC CCCCCCC.oCCCCCC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s7;s7;s7;s9;s10;d-9;d-11s14;s2s13;s16;s11;s12;s12;s15;s3s17;d4s8s14;s22;d+18;s18;d+21;s21;s25;d-26;s27;d-28;s1d+29s30; s8;s5d6s24;d-31s32;d+34;s34;s37;d-38;d-39s40;s10;s10;s12;s13;s13;s16;s17;s17;s19;s19;s19;s20;s20', 'XUKUURHRXDUEBC-KAYWLYCHSA-N', '1010:9XN3VWEJU5Y3TNAC2XU96CBPKFSPRJ', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c](-[#6](-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])=[#8]):[c]4 -[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[n]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1])-[#8] -[#1])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1c(c(c2c([H])c([H])c([H])c([H])c2[H])c(C(N([H])c3c([H])c([H])c([H])c([H])c3[H])=O)c4C([H])(C([H])([H])[H])C([H])([H])[H])n4C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[C@]([H])(C([H])([ H])C(=O)O[H])O[H])O[H])c([H])c1[H]', '05.555', '5.555', '0', '0', 'TRUE', '-0.207\r\n-0.393\r\n-0.3925\r\n-0.2715\r\n-0.3317\r\n-0.2668\r\n-0.2464\r\n-0.2813\r\n1.45e-002\r\n1.03e-002\r\n3.75e-002\r\n-1.06e-002\r\n-1.33e-002\r\n6.14e-002\r\n1.46e-002\r\n5.77e-002\r\n-3.e-004\r\n-6.3e-003\r\n-5.77e-002\r\n-5.77e-002\r\n-1.6e-002\r\n6.57e-002\r\n0.2491\r\n5.96e-002\r\n-5.05e-00', '1', '1.605', 'C33H35FN2O5', '0558.253', '-8.841', '0558.64', '0.42 4.48 10.25', '2', '3', '2', '19', '23', '4', '41', '44', '46', '13', '007', '04', '35', '0', '4', '012', '0111.79', '571.25', '', '3.22903', '1.268', '82.19', '51.17', '5.11935', '31.02', '2,769.86', '184.877', '446.92', '178.19', 'F/C4=C([H])/C([H])=C(/C3=C(C1=C([H])/C([H])=C([H])\\C([H])=C1[H])/C(C(=O)N(/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])[H])=C(C(C([H])([H])[H])(C([H])([H])[H])[H])\\N3C(C(C(O[H])(C(C(O[H])(C(C(O[H])=O)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])\\C([H])=C4\\[H]', 'CC(C)c4c(C(=O)Nc1ccccc1)c(c2ccccc2)c(c3ccc(F)cc3)n4CC[C@@H](O)C[C@@H](O)CC(=O)O', 'Atorvastatin', 'Tozalip; Lipitor; Vastina; Sincol; Lipinon; Ator', '3-hydroxy-3-methylglutaryl-coenzyme A reductase', '60823', 'Phase II', 'Multiple Sclerosis', '24497963', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(107, '60823', '60823', 'CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)O', '(3<I>R</I>,5<I>R</I>)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid', 'CYAAFQwA4fwQgdCU9dUJiVhNgnVz3w6PkQrvJMLDPpzkV40jrbQ56j7Wa7qNU2TeMp9S6M0DMt2rtg$mq$N6b2vhKTNXzrgf88cF$9dvXOiESXTxcC09jWfYX^6LQVfoS74P^H0^5q^^nE^$eJllJGfDeKDh90LjTYZf4jfGugR5d2huaXA5ZyzV7aMlesgUt39vIzI5 xhHeeijq^oDo57D7pxGLqB5VnuwWdXNW0uwnp4T3ZMGPmw6TS05uh^3davWx12YFyt7DOKgEiJ6pU^Su7yne7dxxwDMCJL6BkRySyt7T$BlmlgSrrnb^9Nd8bZ53yQfow3jI6RDBXVg2VkBqjniQ4rSnx66wjQ0Kl8iPHFR^^9AfW3SUoOEt70jMB3vPyAQabEUeqZ$T 41xuCRf0kaHlXQP^GCl2oYlOiJPYsDra5jrIoULMxmq6Dbqytt9tJIXTM4pzwCtivJ2kIIVsQXZOX^NZZfhMEwZ7aUwkpIds', 'InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,4 0)/t26-,27-/m1/s1', 'AuxInfo=1/1/N:19,20,36,41,31,32,39,40,27,28,37,38,25,26,29,30,13,10,17,24,12,21,18,33,34,16,22,35,15,14,9,11,23,1,8,7,2,3,5,6,4/E:(1,2)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)(39,40)/it:im/rA:76FOOOOONNC CCCCCCC.oCCCCCC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s7;s7;s7;s9;s10;d-9;d-11s14;s2s13;s16;s11;s12;s12;s15;s3s17;d4s8s14;s22;d+18;s18;d+21;s21;s25;d-26;s27;d-28;s1d+29s30; s8;s5d6s24;d-31s32;d+34;s34;s37;d-38;d-39s40;s10;s10;s12;s13;s13;s16;s17;s17;s19;s19;s19;s20;s20', 'XUKUURHRXDUEBC-KAYWLYCHSA-N', '1010:9XN3VWEJU5Y3TNAC2XU96CBPKFSPRJ', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c](-[#6](-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])=[#8]):[c]4 -[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[n]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1])-[#8] -[#1])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1c(c(c2c([H])c([H])c([H])c([H])c2[H])c(C(N([H])c3c([H])c([H])c([H])c([H])c3[H])=O)c4C([H])(C([H])([H])[H])C([H])([H])[H])n4C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[C@]([H])(C([H])([ H])C(=O)O[H])O[H])O[H])c([H])c1[H]', '05.555', '5.555', '0', '0', 'TRUE', '-0.207\r\n-0.393\r\n-0.3925\r\n-0.2715\r\n-0.3317\r\n-0.2668\r\n-0.2464\r\n-0.2813\r\n1.45e-002\r\n1.03e-002\r\n3.75e-002\r\n-1.06e-002\r\n-1.33e-002\r\n6.14e-002\r\n1.46e-002\r\n5.77e-002\r\n-3.e-004\r\n-6.3e-003\r\n-5.77e-002\r\n-5.77e-002\r\n-1.6e-002\r\n6.57e-002\r\n0.2491\r\n5.96e-002\r\n-5.05e-00', '1', '1.605', 'C33H35FN2O5', '0558.253', '-8.841', '0558.64', '0.42 4.48 10.25', '2', '3', '2', '19', '23', '4', '41', '44', '46', '13', '007', '04', '35', '0', '4', '012', '0111.79', '571.25', '', '3.22903', '1.268', '82.19', '51.17', '5.11935', '31.02', '2,769.86', '184.877', '446.92', '178.19', 'F/C4=C([H])/C([H])=C(/C3=C(C1=C([H])/C([H])=C([H])\\C([H])=C1[H])/C(C(=O)N(/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])[H])=C(C(C([H])([H])[H])(C([H])([H])[H])[H])\\N3C(C(C(O[H])(C(C(O[H])(C(C(O[H])=O)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])\\C([H])=C4\\[H]', 'CC(C)c4c(C(=O)Nc1ccccc1)c(c2ccccc2)c(c3ccc(F)cc3)n4CC[C@@H](O)C[C@@H](O)CC(=O)O', 'Atorvastatin', 'Tozalip; Lipitor; Vastina; Sincol; Lipinon; Ator', '3-hydroxy-3-methylglutaryl-coenzyme A reductase', '60823', 'Phase III Completed', 'Alzheimer disease (AD)', '15883262', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(108, '16240819', '16240819', 'C1CN2C=C(SC2=N1)c3ccc(cc3)c4ccccc4', '2-(4-phenylphenyl)-5,6-dihydroimidazo[2,1-b]thiazole', 'CYAAFQwAxfwQoi1aA7OxrGxdDWmm9QtH5yFTeaqCgo^PNqTNuULCnIeKlW8zujDDniXZAJdIOqUVROYa27dhm3SLTS$Z^22U9IcRijpgHBNTG5Av71Pe3^$M4KlwLLQl1H35Pts37DoAAdlzvIu2sWNWge^bWiqAsI39pmj3HpGZ1wM1ljeO0Web7EgNLCK^C$LbrY4Q x37Jrsg9gn$u5vHwWJnskFWFQi2IP3gfnQAn2XywQzxlq8YxjsuQjqiynzgDFd9Cfgd4WPEEMn^2ZbTR73re6PXE4$Zorh8lrNLYifRm42ZUNfKul9yM4DaRvXDxa^8oM6vxHKO5aTZV8NO8tanHaM$YTA^$DQf5cMnOsv9alXmGPDY8GQFnCHuxgdHPZyM8a7SHHIXj THPfz2tamkjSDNfcNIXupSFcPPtLz2^L72jyKvrF4ImO38sz2Lh8AIyYV8Iz^ljvQD3ujKHbC4goV56Z55MF70hF4jQ76lKx', 'InChI=1S/C17H14N2S/c1-2-4-13(5-3-1)14-6-8-15(9-7-14)16-12-19-11-10-18-17(19)20-16/h1-9,12H,10-11H2', 'AuxInfo=1/0/N:20,18,19,16,17,13,14,11,12,5,4,8,15,10,9,7,6,3,2,1/E:(2,3)(4,5)(6,7)(8,9)/rA:34SNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH/rB:;;s2;s3s4;s1s2d+3;s1;s2d-7;s7;;d+9;s9;d-10s11;s10d-12;s10;d+15;s15;s1 6;d-17;d-18s19;s4;s4;s5;s5;s8;s11;s12;s13;s14;s16;s17;s18;s19;s20;/rC:3.012,-1.5669,.0055;4.2656,.6685,.0009;5.7406,-1.0944,-.013;5.4973,1.3865,-.0089;6.5105,.207,-.0171;4.5145,-.668,-.0029;2.1079,-.0 354,.017;2.945,1.023,.0093;.6437,-.0233,.0118;-2.1606,.0004,.0034;-.0578,1.0225,-.6051;-.0789,-1', 'PRAINSWTJUJHAV-UHFFFAOYSA-N', '1010:FA2YJQB9WP78G84U34JHVWKAF2JR9T', '[#16]1-[#6](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c](-[#1]):[c]2-[#1])=[#6](-[#1])-[#7]4-[#6]1=[#7]-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]', 'S1C(c2c([H])c([H])c(c3c([H])c([H])c([H])c([H])c3[H])c([H])c2[H])=C([H])N4C1=NC([H])([H])C4([H])[H]', '03.348', '3.348', '0', '0', 'TRUE', '-5.63e-002\r\n-0.2274\r\n-0.2654\r\n2.92e-002\r\n5.49e-002\r\n0.1468\r\n3.31e-002\r\n1.4e-003\r\n-1.06e-002\r\n-1.84e-002\r\n-5.32e-002\r\n-5.32e-002\r\n-5.38e-002\r\n-5.38e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-6.17e-002\r\n-6.23e-002\r\n4.58e-002\r\n4.58e-002\r\n5.29e-00', '0', '3.28', 'C17H14N2S', '0278.088', '-4.411', '0278.371', '1.72 7.73', '1', '0', '2', '9', '12', '2', '20', '23', '16', '8', '002', '00', '14', '0', '4', '002', '0040.9', '267.99', '', '2.64448', '1.3054', '64.24', '37.73', '4.68321', '26.51', '1,119.13', '66.96', '221.57', '', 'S2/C1=N/C([H])([H])C([H])([H])N1/C([H])=C2/C4=C([H])/C([H])=C(/C3=C([H])/C([H])=C([H])\\C([H])=C3\\[H])\\C([H])=C4\\[H]', 'c4ccc(c3ccc(c2cn1CCN=c1s2)cc3)cc4', 'AUTEN-99', 'autophagy enhancer-99', 'Autophagy', '16240819', 'Under Investigation', 'Parkinson Disease(PARK)', '28790323', 'Parkinson Disease(PARK)', 'PARK'),
(109, '46883536', '46883536', 'NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3', '(2<I>R</I>)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide', 'CYAAFQwAgewQOOrnywcXR0sojLroK0SOPCVYeOPVZn6zpSPbDVSAMr2tcnoJqLBZvQsYAPEn$vq0crtEX1$2TWkmPxJQPBtrphfQdFnBjYtHI0LPMFhB1onPcbax^wuGP^P3aLyJAQw3kF4r868kC42S4nnYosBBlvPWxQ1xw9Jexf$UmFetOJDqYGKst^KtNOrwegNb Y7oED5zpbbPibdalv4KyyCcejg28u9VT17LvtyDNMVYkD2bfDjn3U58ljjqW8QB9P6K8aQkNnYJv55T7trgQPuzz4lLAneoTe8gDB62boYzREQopX34xw4gMo08LnEVF$ur4kUC9TpgqmgmYlb^tmNjzgwGqrTryj7Hq61dNiEPaOsC19wvyoREej8Z5ZtbT$ubwNrN^ 2p6jG55Lp53zRv8RzhTcDXCxPRTELJA5fXj59yeuSJGOVJvl88OATdXzs62CA$0Rvcw9WFy83jl$HJD6zNPk11$4iLNkfWub', 'InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1', 'AuxInfo=1/1/N:28,24,30,31,25,26,16,18,27,17,34,29,20,32,21,23,15,19,33,22,1,6,3,4,5,12,13,14,11,9,7,8,10,2/E:(3,4)(5,6)(23,24,25)(31,32)/it:im/CRV:34.6/rA:51ClSFFFFOOOONNNNC.oCCCCCCCCCCCCCCCCCCCHHHHHH HHHHHHHHHHH/rB:;;;;;d2;d2;;;s2;;;s10;s11;s15;s11;s16;d9s12s15;s17;s2;s3s4s5s18;s6d-20;s20;d+21;s21;s23;d-24;d-27s28;s25;d-26;s1d+30s31;s13d-14s29;s10d-13;s15;s16;s16;s17;s17;s18;s18;s24;s25;s26;s12;s1 2;s27;s28;s30;s31;s34;/rC:4.4633,3.4047,-.0507;-1.5837,1.7154,.1474;-7.2753,-1.8116,-.7109;-5.94', 'XEAOPVUAMONVLA-QGZVFWFLSA-N', '1010:WHGHP2QG22GBMF93UERP774V2QF7R7', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#16](-[#7](-[#6](-[#1])(-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](-[c](:[n]3):[n]:[c](-[#1]):[o]3):[c](-[#1]):[c]2-[#9])-[#6@@](-[#1])(-[#6](-[#7](-[#1])-[#1])=[#8]) -[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#9])(-[#9])-[#9])(=[#8])=[#8]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1S(N(C([H])([H])c2c([H])c([H])c(c(n3)nc([H])o3)c([H])c2F)[C@@]([H])(C(N([H])[H])=O)C([H])([H])C([H])([H])C(F)(F)F)(=O)=O)c([H])c1[H]', '03.364', '3.364', '0', '0', 'TRUE', '-8.44e-002\r\n1.418\r\n-0.1712\r\n-0.1712\r\n-0.1712\r\n-0.2067\r\n-0.5684\r\n-0.5684\r\n-0.2763\r\n-0.1997\r\n-0.3428\r\n-0.3279\r\n-0.2067\r\n-0.1068\r\n6.62e-002\r\n-2.24e-002\r\n5.e-003\r\n4.53e-002\r\n0.224\r\n-5.e-004\r\n-4.14e-002\r\n0.3887\r\n0.1278\r\n-5.42e-002\r\n-7.03e-002\r\n-7.03e-002\r\n-1.4', '1', '3.364', 'C20H17ClF4N4O4S', '0520.06', '-7.101', '0520.885', '', '6', '1', '3', '16', '17', '3', '34', '36', '28', '11', '008', '02', '17', '0', '3', '010', '0127.77', '474.81', '', '6.6648', '1.321', '55.08', '19.9', '4.31745', '35.18', '2,218.14', '180.951', '349.51', '', 'Cl/C3=C([H])/C([H])=C(S(=O)(=O)N(C(C(C(C(F)(F)F)([H])[H])([H])[H])(C(=O)N([H])[H])[H])C(/C2=C(F)/C([H])=C(/C\\1=N/O/C([H])=N1)\\C([H])=C2\\[H])([H])[H])\\C([H])=C3\\[H]', 'NC(=O)[C@@H](CCC(F)(F)F)N(Cc2ccc(c1ncon1)cc2F)S(=O)(=O)c3ccc(Cl)cc3', 'Avagacestat', 'BMS-708163', 'Gamma-secretase', '46883536', 'Terminated at Phase II', 'Alzheimer disease (AD)', '28065657', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(110, '110', 'Not Available', 'CSc1nn2c(C)cc(C)cc2c1S(=O)(=O)c3ccccc3', '3-(benzenesulfonyl)-5,7-dimethyl-2-methylsulfanyl-pyrazolo[1,5-a]pyridine', 'CYAAFQwAlewQxnXvvYGpSpb9hMQ3J73wSGC2DmlVzsj71CJ7e7UNXkLBaKW7zIZT17KshOvnVjd63yWnO9gBN2gfUmOgQwZMAaZisKfBR4tCwvK9vwoequ18M$pCekKiy2Ai3l29cakiAxa5Ei1kFj6FacUTJ98sIBPTZ0xIVjqdMs4zxiS^UjutQLPMg30DXWDK97AH VRE0qX3WuFk4fnL9WV2Erz9$d$k3J0BNzPoxVvWE2VXqWPLrvp9uDkAYqjWHuu1gPnOOrn9dLPmAjcURrcZXeAtR^aF5KNLrAu^oM0FNjh$^m3x0Itvpl^87EgsP$KzJOX2jwyGbnmzoGLFXZM3hevJ9HgQa5k17h$jN95enwv^^ctdgwbMxeeJWvUZJ2t1ArEIX8bwu QYmQBkrCEf939mUlIIAyyi6CdNAPcfRAfJmaZs0YNIbruwEuT6jByMxCtHY20qAbt3inJtMaZptBHb3Mg0W4L$fMGAfV5oH8', 'InChI=1S/C16H16N2O2S2/c1-11-9-12(2)18-14(10-11)15(16(17-18)21-3)22(19,20)13-7-5-4-6-8-13/h4-10H,1-3H3', 'AuxInfo=1/0/N:20,19,18,3,1,5,2,6,16,13,14,15,4,10,8,9,11,12,21,22,17,7/E:(5,6)(7,8)(19,20)/CRV:22.6/rA:22CCCCCCSCCCNNCCCCSCCCOO/rB:s1;d-1;d-2;s3;s4d-5;s4;s7;s8;d+8;d-9;s10s11;s10;d-13;s12;s14d-15;s9;s 17;s15;s14;d7;d7;/rC:12.0255,-7.8432,0;12.197,-8.6501,0;11.2409,-7.5882,0;11.5839,-9.2021,0;10.6278,-8.1402,0;10.7993,-8.9472,0;11.7555,-10.0091,0;10.9485,-10.1807,0;10.6129,-10.9343,0;10.3354,-9.6286 ,0;9.7925,-10.8481,0;9.6209,-10.0411,0;10.3354,-8.8036,0;9.6209,-8.3911,0;8.9064,-9.6286,0;8.906', 'ATGJFIRCLJXYCM-UHFFFAOYSA-N', '1010:2YBANN5CZ3Q6N7AXGP212SAMGU7H1X', '[c]1:[c]:[c]:[c]:[c](-[#16](=[#8])(=[#8])-[c]2:[c]3:[n](:[c](-[#6]):[c]:[c](-[#6]):[c]3):[n]:[c]2-[#16]-[#6]):[c]1', 'c1cccc(S(=O)(=O)c2c3n(c(C)cc(C)c3)nc2SC)c1', '04.01', '4.01', '0', '0', 'TRUE', '-6.36e-002\r\n-7.26e-002\r\n-6.24e-002\r\n-5.12e-002\r\n-6.36e-002\r\n-7.26e-002\r\n1.3102\r\n2.8e-003\r\n0.1027\r\n3.71e-002\r\n-0.1845\r\n-0.1432\r\n-4.e-002\r\n-4.82e-002\r\n1.93e-002\r\n-4.32e-002\r\n-0.1099\r\n-1.22e-002\r\n-2.72e-002\r\n-3.97e-002\r\n-0.5756\r\n-0.5756', '0', '4.01', 'C16H16N2O2S2', '0332.065', '-4.526', '0332.44', '-2.34', '3', '0', '2', '6', '16', '3', '22', '24', '6', '9', '004', '00', '16', '0', '3', '003', '0085.12', '325.04', '', '', '', '', '', '', '', '', '', '', '', 'C/3=C/C=C\\C(S(/C2=C/1\\C=C(C)/C=C(C)\\N1/N=C2/SC)(=O)=O)=C3', 'CSc2nn1c(C)cc(C)cc1c2S(=O)(=O)c3ccccc3', 'AVN-211', 'Not Available', '5-hydroxytryptamine receptor 6', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '26886442', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(111, '111', 'Not Available', 'CNc1nn2c3CCN(C)Cc3cnc2c1S(=O)(=O)c4ccccc4', '3-(benzenesulfonyl)-<I>N</I>,7-dimethyl-8,9-dihydro-6<I>H</I>-pyrazolo[BLAH]pyrido[BLAH]pyrimidin-2-amine', 'CYAAFQwAGcwQLBL3VSuAK6aqSIHqDBou0olUQPIr$m$lNSdL7zdREal146heg1upYKOKvzcqA^89oAvNz5DL9VEmEec2SeL$dBFkNIG23n58BMqsuSHN9q7AjihrAcSeyuImGDMLzGKPPDrLTB2ZOzMF^9I1m6dcuv3jqNH0mtQ1Uwmj5cvi3UwbL7G3^NcoydL1br$f 6FMcrfNDiB32cD5A6v7zj5e35tb9WgwfaN5g7K5n19QMAov2MHWimbYAEm2hEz740iDUGlpjbM2c3^eViy^mbssQ5$$oTZ54vjFiHGQW9gmfrvcU4MM2vB5LYBw73xOdtcZ6nzgCZ6ulZf5cNU8T6Bc^bebyyzT^Q6TjN0cq$sfVcdrXeDN04r4HBeQMt$8rOu5yswes 89CXVIVCmlAf4WSIw6lCLSEUNFNaWJExCCVgLi4qrmOqFJ9G6G$ZAJpCfHj63FSumgrbLNYV1keONEVZwLHCHAjIUa0GY15g', 'InChI=1S/C17H19N5O2S/c1-18-16-15(25(23,24)13-6-4-3-5-7-13)17-19-10-12-11-21(2)9-8-14(12)22(17)20-16/h3-7,10H,8-9,11H2,1-2H3,(H,18,20)', 'AuxInfo=1/1/N:25,15,22,20,21,18,19,7,8,4,9,6,17,5,11,12,1,14,2,13,10,3,23,24,16/E:(4,5)(6,7)(23,24)/CRV:25.6/rA:25CNNCCCCCCNCCNNCSCCCCCCOOC/rB:s1;s1;d-2;s3;s4d-5;s5;s7;s6;s8s9;d+1;s11;s3d-12;s12;s10;s 11;s16;s17;d+17;d-18;s19;s20d-21;d16;d16;s14;/rC:9.5605,-13.3754,0;9.5605,-14.2004,0;8.8461,-12.9629,0;8.8461,-14.6129,0;8.1315,-13.3754,0;8.1315,-14.2004,0;7.4171,-12.9629,0;6.7026,-13.3754,0;7.4171, -14.6129,0;6.7026,-14.2004,0;10.1736,-12.8234,0;9.8381,-12.0697,0;9.0176,-12.156,0;10.2506,-11.3', 'OSHBEPOEBKFEEK-UHFFFAOYSA-N', '1010:BKF3E4QECTWS6UPRTMN2A25F921FC9', '[c]12:[n](:[n]:[c](-[#7]-[#6]):[c]1-[#16](=[#8])(=[#8])-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]4:[c](-[#6]-[#7](-[#6])-[#6]-[#6]4):[c]:[n]2', 'c12n(nc(NC)c1S(=O)(=O)c3ccccc3)c4c(CN(C)CC4)cn2', '01.843', '2.105', '0', '0', 'TRUE', '0.1256\r\n-0.2434\r\n-0.1237\r\n3.45e-002\r\n3.12e-002\r\n8.e-004\r\n-2.1e-003\r\n3.3e-003\r\n2.59e-002\r\n-0.3016\r\n2.62e-002\r\n0.1137\r\n-0.1778\r\n-0.2761\r\n-1.3e-002\r\n1.3124\r\n-5.12e-002\r\n-7.26e-002\r\n-7.26e-002\r\n-6.36e-002\r\n-6.36e-002\r\n-6.24e-002\r\n-0.5756\r\n-0.5756\r\n-1.02e-002', '0', '1.843', 'C17H19N5O2S', '0357.126', '-2.721', '0357.43', '1.9 2.47', '4', '1', '2', '10', '16', '3', '25', '28', '5', '9', '007', '01', '19', '0', '4', '003', '0087.97', '349.13', '', '', '', '', '', '', '', '', '', '', '', 'C/2/3=C(S(/C/1=C/C=C\\C=C1)(=O)=O)/C(NC)=N\\N2/C4=C(\\C=N3)/CN(C)CC4', 'CNc3nn2c1CCN(C)Cc1cnc2c3S(=O)(=O)c4ccccc4', 'AVN-322', 'Not Available', '5-hydroxytryptamine receptor 6', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '27829340', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(112, '25052519', '25052519', '[2H]C([2H])([2H])Oc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C([2H])([2H])[2H])c2c1', '(19<I>S</I>,20<I>S</I>,21<I>S</I>)-16-(trideuteriomethoxy)-24-(trideuteriomethyl)-24-azatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]heptadeca-6,8(16),17-triene', 'CYAAFQwAYcwQZaLvnJPqAP$xcizthRBa0G802p4ZaCP4y$IdeGQFbFXCXiUzr1xUVsvY5qX7nIZgfxgHOpzhLHByHXYSFR^jm^uXNZN5wqN4PqHDu3Ymjn^yze$jpZBixDcp^f8huf$6C8S5fhDghIrX$3NtI2ogZ$TtvdZKYvbp2UYetqtEzdTBCNRyrXuItOIz0bbh $Ang^hSVSXFl3YQedC2rYNUWsN89zsu$7EItmSsZZ8Ttrv7xj3ND0fLEHRmj23DxzZCdHdFi1EphecHiVatEwU5FV5G5NKXPtq8d9ybLZZuTSCXCVSo^36B$E8cSgaxNsfA9284KuVudUBZRvBMYdQq^xvXPczuhQE03Ul37FJKPW6uvpCqChUevNfUlevWJKrsKM0yC w$ULW4LZ4etDYGDvMz49KMHiune0Cp4rCVyVznTmqfRn7zTk$e4yD8R3NnH3B1PMhNRH$uqbk52l2^1IPlu597O2IjN8UXnb', 'InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1/i1D3,2D3', 'AuxInfo=1/0/N:16,20,13,12,8,17,19,7,6,11,10,15,14,18,4,9,5,3,2,1/it:im/rA:45ONC.eC.eC.oCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH.i2H.i2H.i2HHH.i2H.i2H.i2/rB:;;s3;s2s4;s3;s3;s4;s3;s5;s2s6;s7;s8s12;d-9s10;s9;s2 ;s14;s1d+15;d-17s18;s1;s4;s5;s6;s6;s7;s7;s8;s8;s10;s10;s11;s11;s12;s12;s13;s13;s15;s16;s16;s16;s17;s19;s20;s20;s20;/rC:-4.108,-.2235,-.7753;2.2425,1.794,-.4244;.8251,-.7101,-.716;1.9607,-.6,.3375;2.09 91,.8856,.7391;1.238,.1277,-1.9691;.691,-2.2049,-1.1216;1.7713,-1.5501,1.5388;-.4791,-.0924,-.16', 'MKXZASYAUGDDCJ-QNNIAVNKSA-N', '1010:GGYCJ4K1FU7UQWP22F4P9Q4QPSD2F1', '[#8](-[#6](-[2#1])(-[2#1])-[2#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6@@]1(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6@@]23- [#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]1-[#6](-[2#1])(-[2#1])-[2#1]):[c]34):[c]4-[#1]', 'O(C([2H])([2H])[2H])c(c([H])c([H])c(C([H])([H])[C@@]1([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C2([H])[H])[C@@]23C([H])([H])C([H])([H])N1C([2H])([2H])[2H])c34)c4[H]', '03.674', '3.674', '0', '0', 'TRUE', '-0.3493\r\n-0.3027\r\n1.2e-003\r\n-1.57e-002\r\n1.69e-002\r\n-3.03e-002\r\n-4.32e-002\r\n-4.81e-002\r\n-3.56e-002\r\n-1.16e-002\r\n-1.e-003\r\n-5.25e-002\r\n-5.3e-002\r\n-4.25e-002\r\n-2.78e-002\r\n-1.31e-002\r\n-5.61e-002\r\n7.48e-002\r\n-3.16e-002\r\n4.22e-002\r\n3.27e-002\r\n4.73e-002\r\n2.88e-0', '1', '2.808', 'C18H19D6NO', '0277.231', '-3.138', '0277.434', '8.3', '1', '0', '0', '17', '06', '1', '20', '23', '25', '3', '002', '00', '25', '0', '4', '003', '0012.47', '275.54', '', '', '1.2803', '23.57', '13.9', '', '9.67', '', '22.759', '231.86', '', 'O(/C4=C([H])/C1=C(C([H])([H])C2([H])N(C([2H])([2H])[2H])C([H])([H])C([H])([H])C13C2([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])\\C([H])=C4\\[H])C([2H])([2H])[2H]', 'COc4ccc3C[C@H]2[C@H]1CCCC[C@@]1(CCN2C)c3c4', 'AVP-786', 'D6-Dextromethorphan', 'Neuronal acetylcholine receptor subunit alpha-2', '25052519', 'Phase III', 'Alzheimer disease (AD)', '27936965', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(113, '9916632', '9916632', 'COc1ccc2C[C@@H]3[C@H]4CCCC[C@]4(CCN3C)c2c1.COc5ccc6nccc([C@H](O)[C@H]7CC8CCN7C[C@@H]8C=C)c6c5', '(15<I>S</I>,16<I>S</I>,17<I>S</I>)-12-methoxy-18-methyl-18-azatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]heptadeca-2,4(12),13-triene;(<I>S</I>)-(6-methoxy-4-quinolyl)-[(2<I>R</I>,5<I>R</I>)-5-vinylquinuclidi n-2-yl]methanol', 'CYAAFQwAwcwQXd4rt3kw2kVPGxhOq91bQU4ZDuKbq$W3T$dyW6qkoo7LfzFrAPWY$JNNgFiVSXbMU1rNqZCCX8sM8nF9LCjbisDBK5gEsUetJxJWaXZrPxX^fd48k9oHSxMlfcuyu$PnWn^nzh5PyzpfE48RwVYf^Lrrp78XpS3zKXOOjWSkOAwLl3gM5iC42trnFJCG YyncrkGSqgpOvKnb9w1upTKUNL3AcFJZrxaOfOUk9tX^EtsttMO29vNvK3QPGyCcGR2DOmx10Bkz95jhi$ghi$O3ntLwgwgRtHLeReytUyBnZ$9hyREtVha5$aD8Vy9NusLiyX6hCtTFuik1WElbmkfqeCpD1YWSifL1^lDCisLXBiHN^PGXukJQFyQzpnjY8reOHjdk 1sldHjSW8Z2hCb9vH2CHLbJQvr4hOpv$VvkXIfgbkivwY5dskoh8574AjuzFKm7dTSZO9R3oWCU5P4AUJmXXfzcJ3feJ8MuX', 'InChI=1S/C20H24N2O2.C18H25NO/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h3-6,8,11,13-14,19-20,23H,1,7,9- 10,12H2,2H3;6-7,12,15,17H,3-5,8-11H2,1-2H3/t13-,14?,19+,20-;15-,17+,18+/m01/s1', 'AuxInfo=1/0/N:34,44,32,43,41,36,26,40,28,25,39,27,24,21,42,33,35,38,23,31,6,5,2,3;20,37,17,16,12,22,30,11,10,15,14,19,18,29,8,13,9,7,4,1/it:2im/rA:93OOONNNC.oC.eC.eCCCCCCCCCCCCCC.oC.oCCCCCCC.oCCCCCCCC CCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s4s8;s7;N7;s8;s7;s9;s4s10;s11;s12s16;d-13s14;s13;s4;;s18;s5;s21;s21s23;s21;s5s24;s5s26;s1d+19;d-22s29;n2s23;P24;s31;d-32;d+33;s33;s1; d-6s35;s35;s6d-36;s38;s3d+39;d-41s42;s3;N8;N9;s10;s10;s11;s11;s12;s12;s14;s14;s15;s15;s16;s16;s1', 'UZBODILCSLUHQR-JLMRSGIVSA-N', '1010:TYF8THTBG3YYV9CT9T96RW18HHPUT7', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6@]1(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6@]23-[#6]( -[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#1]):[c]34):[c]4-[#1].[#8](-[#1])-[#6@@](-[#1])(-[c](:[c](-[#1]):[c](-[#1]):[n]5):[c]6:[c]5:[c](-[#1]):[c](-[#1]):[c](:[c]6-[#1])-[#8]-[#6](- [#1])(-[#1])-[#1])-[#6@@]7(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])', 'O(C([H])([H])[H])c(c([H])c([H])c(C([H])([H])[C@]1([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C2([H])[H])[C@]23C([H])([H])C([H])([H])N1C([H])([H])[H])c34)c4[H].O([H])[C@@]([H])(c(c([H])c([H])n5)c6 c5c([H])c([H])c(c6[H])OC([H])([H])[H])[C@@]7([H])C([H])([H])C([H])(C([H])([H])C([H])([H])N78)[C@@]([H])(C([H])=C([H])[H])C8([H])[H]', '06.408', '2.733', '0', '0', 'TRUE', '-0.3493\r\n-0.3867\r\n-0.3493\r\n-0.3027\r\n-0.2969\r\n-0.2562\r\n1.2e-003\r\n-1.57e-002\r\n1.69e-002\r\n-3.03e-002\r\n-4.32e-002\r\n-4.81e-002\r\n-3.56e-002\r\n-1.16e-002\r\n-1.e-003\r\n-5.25e-002\r\n-5.3e-002\r\n-4.25e-002\r\n-2.78e-002\r\n-1.31e-002\r\n-3.11e-002\r\n-5.61e-002\r\n4.01e-002\r\n-7.9', '1', '4.16', 'C38H49N3O3', '0595.377', '-9.98', '0595.814', '4.36 8.05 8.3', '3', '1', '1', '32', '17', '3', '44', '50', '55', '9', '006', '01', '49', '0', '9', '005', '0058.06', '619.37', '', '', '', '', '', '', '', '', '', '', '', 'O(/C4=C([H])/C1=C(C([H])([H])[C@]2([H])N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]13[C@]2([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])\\C([H])=C4\\[H])C([H])([H])[H].O([C@]([C@]1([H])N2C([H])([H])[C@@](/C(=C([H])/[H])[H])([H])C([H])(C1([H])[H])C([H])([H])C2([H])[H])(/C3=C\\4/C(=N\\C([H])=C3\\[H])/C([H])=C([H])\\C(OC([H])([H])[H])=C4\\[H])[H])[H]', 'COc4ccc3C[C@@H]2[C@H]1CCCC[C@]1(CCN2C)c3c4.C=C[C@H]1CN2CCC1C[C@@H]2C(O)c3ccnc4ccc(OC)cc34', 'AVP-923', 'Dextromethorphan and quinidine mixture; Zenvia; Neurodex', 'Glutamate receptor ionotropic, kainate 1', '9916632', 'Phase III Completed', 'Parkinson Disease(PARK)', '28370447', 'Parkinson Disease(PARK)', 'PARK'),
(114, '9916632', '9916632', 'COc1ccc2C[C@@H]3[C@H]4CCCC[C@]4(CCN3C)c2c1.COc5ccc6nccc([C@H](O)[C@H]7CC8CCN7C[C@@H]8C=C)c6c5', '(15<I>S</I>,16<I>S</I>,17<I>S</I>)-12-methoxy-18-methyl-18-azatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]heptadeca-2,4(12),13-triene;(<I>S</I>)-(6-methoxy-4-quinolyl)-[(2<I>R</I>,5<I>R</I>)-5-vinylquinuclidi n-2-yl]methanol', 'CYAAFQwAwcwQXd4rt3kw2kVPGxhOq91bQU4ZDuKbq$W3T$dyW6qkoo7LfzFrAPWY$JNNgFiVSXbMU1rNqZCCX8sM8nF9LCjbisDBK5gEsUetJxJWaXZrPxX^fd48k9oHSxMlfcuyu$PnWn^nzh5PyzpfE48RwVYf^Lrrp78XpS3zKXOOjWSkOAwLl3gM5iC42trnFJCG YyncrkGSqgpOvKnb9w1upTKUNL3AcFJZrxaOfOUk9tX^EtsttMO29vNvK3QPGyCcGR2DOmx10Bkz95jhi$ghi$O3ntLwgwgRtHLeReytUyBnZ$9hyREtVha5$aD8Vy9NusLiyX6hCtTFuik1WElbmkfqeCpD1YWSifL1^lDCisLXBiHN^PGXukJQFyQzpnjY8reOHjdk 1sldHjSW8Z2hCb9vH2CHLbJQvr4hOpv$VvkXIfgbkivwY5dskoh8574AjuzFKm7dTSZO9R3oWCU5P4AUJmXXfzcJ3feJ8MuX', 'InChI=1S/C20H24N2O2.C18H25NO/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h3-6,8,11,13-14,19-20,23H,1,7,9- 10,12H2,2H3;6-7,12,15,17H,3-5,8-11H2,1-2H3/t13-,14?,19+,20-;15-,17+,18+/m01/s1', 'AuxInfo=1/0/N:34,44,32,43,41,36,26,40,28,25,39,27,24,21,42,33,35,38,23,31,6,5,2,3;20,37,17,16,12,22,30,11,10,15,14,19,18,29,8,13,9,7,4,1/it:2im/rA:93OOONNNC.oC.eC.eCCCCCCCCCCCCCC.oC.oCCCCCCC.oCCCCCCCC CCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s4s8;s7;N7;s8;s7;s9;s4s10;s11;s12s16;d-13s14;s13;s4;;s18;s5;s21;s21s23;s21;s5s24;s5s26;s1d+19;d-22s29;n2s23;P24;s31;d-32;d+33;s33;s1; d-6s35;s35;s6d-36;s38;s3d+39;d-41s42;s3;N8;N9;s10;s10;s11;s11;s12;s12;s14;s14;s15;s15;s16;s16;s1', 'UZBODILCSLUHQR-JLMRSGIVSA-N', '1010:TYF8THTBG3YYV9CT9T96RW18HHPUT7', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6@]1(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6@]23-[#6]( -[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#1]):[c]34):[c]4-[#1].[#8](-[#1])-[#6@@](-[#1])(-[c](:[c](-[#1]):[c](-[#1]):[n]5):[c]6:[c]5:[c](-[#1]):[c](-[#1]):[c](:[c]6-[#1])-[#8]-[#6](- [#1])(-[#1])-[#1])-[#6@@]7(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])', 'O(C([H])([H])[H])c(c([H])c([H])c(C([H])([H])[C@]1([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])C2([H])[H])[C@]23C([H])([H])C([H])([H])N1C([H])([H])[H])c34)c4[H].O([H])[C@@]([H])(c(c([H])c([H])n5)c6 c5c([H])c([H])c(c6[H])OC([H])([H])[H])[C@@]7([H])C([H])([H])C([H])(C([H])([H])C([H])([H])N78)[C@@]([H])(C([H])=C([H])[H])C8([H])[H]', '06.408', '2.733', '0', '0', 'TRUE', '-0.3493\r\n-0.3867\r\n-0.3493\r\n-0.3027\r\n-0.2969\r\n-0.2562\r\n1.2e-003\r\n-1.57e-002\r\n1.69e-002\r\n-3.03e-002\r\n-4.32e-002\r\n-4.81e-002\r\n-3.56e-002\r\n-1.16e-002\r\n-1.e-003\r\n-5.25e-002\r\n-5.3e-002\r\n-4.25e-002\r\n-2.78e-002\r\n-1.31e-002\r\n-3.11e-002\r\n-5.61e-002\r\n4.01e-002\r\n-7.9', '1', '4.16', 'C38H49N3O3', '0595.377', '-9.98', '0595.814', '4.36 8.05 8.3', '3', '1', '1', '32', '17', '3', '44', '50', '55', '9', '006', '01', '49', '0', '9', '005', '0058.06', '619.37', '', '', '', '', '', '', '', '', '', '', '', 'O(/C4=C([H])/C1=C(C([H])([H])[C@]2([H])N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]13[C@]2([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])\\C([H])=C4\\[H])C([H])([H])[H].O([C@]([C@]1([H])N2C([H])([H])[C@@](/C(=C([H])/[H])[H])([H])C([H])(C1([H])[H])C([H])([H])C2([H])[H])(/C3=C\\4/C(=N\\C([H])=C3\\[H])/C([H])=C([H])\\C(OC([H])([H])[H])=C4\\[H])[H])[H]', 'COc4ccc3C[C@@H]2[C@H]1CCCC[C@]1(CCN2C)c3c4.C=C[C@H]1CN2CCC1C[C@@H]2C(O)c3ccnc4ccc(OC)cc34', 'AVP-923', 'Dextromethorphan and quinidine mixture; Zenvia; Neurodex', 'Sigma non-opioid intracellular receptor 1', '9916632', 'Phase III Completed', 'Parkinson Disease(PARK)', '28370447', 'Parkinson Disease(PARK)', 'PARK'),
(115, '9794392', '9794392', 'C1CN2CCC1[C@@]3(C2)Cc4cccnc4O3', '(2<I>R</I>)-spiro[3<I>H</I>-furo[2,3-b]pyridine-2,3''-quinuclidine]', 'CYAAFQwAfewQhdcllz5hDoxwU8NAefIXyhSfP4t2kLzc9x$nSDUD9Tw65riH8picq9XjHf^B7lyVDZGuYsoUQxGLaFgLC1x5WORbCzWol0qfT3ntvF5FVAT9AXqrjPc85G^^Nl^efDHAMyWEEurrzh6Gj^FCrsFT3p0P$OfsIZq0A1i3FoblyfYVKFvOkSI8gU0aaEQ^ xhnXPllV$^RraLsQVyDo6U3MD6WhIP4Wwu9qD^jYY3mhZ$AJEMi0tNXMTfeUqOpUCsQdh5WsyjrzuftakShXhx58GGf4z0iA9$KIVX1WQ4xVVl58YkXPbzs09MyZc5mG2MXHXEfdxRrXrtlaIESKBCOfzbkSAvYwF5xVywwDnvmbX0J1cRsnctfMnv1KdhbkZwbejo1n h6ypnvVVaKkx$v$cxcvov0SGx091ezstuUOtrwnWxlwrs3mxoOcyjK89TGC2lRLlEAW5v5xVzxdl5ImvfrbmHXYljCt4z7RM', 'InChI=1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1', 'AuxInfo=1/0/N:15,14,7,8,16,9,10,11,6,12,5,13,4,3,2,1/E:(3,4)(6,7)/it:im/rA:32ONNC.oCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;s1;s4;s2s4;s5;s5;s2s7;s2s8;s4;s11;s1s3d-12;s12;d-14;d-3s15;s5;s6;s6;s7;s7;s8;s8;s9; s9;s10;s10;s11;s11;s14;s15;s16;/rC:.3196,1.0693,-.3677;-2.6129,.0662,1.259;2.6424,1.4403,-.0181;-.5363,-.0962,-.157;-1.7077,-.0361,-1.1717;-1.1322,-.0036,1.2796;-2.6668,-1.2048,-.8931;-2.5048,1.2604,- .9301;-3.1407,-1.1295,.5669;-3.0233,1.2755,.5155;.3404,-1.3591,-.3569;1.6731,-.7771,-.104;1.6064', 'OCKIPDMKGPYYJS-ZDUSSCGKSA-N', '1010:1X54RCY9C3QDNWJDPB4D63F6HBTMNM', '[#8]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]2)-[#6](-[#1])(-[#1])-[#6@]1(-[#6]3(-[#1])-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]34)-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]', 'O1c2c(c([H])c([H])c([H])n2)C([H])([H])[C@]1(C3([H])[H])C([H])(C([H])([H])C([H])([H])N34)C([H])([H])C4([H])[H]', '01.669', '1.669', '0', '0', 'TRUE', '-0.3204\r\n-0.3004\r\n-0.2325\r\n9.63e-002\r\n-7.6e-003\r\n2.86e-002\r\n-3.47e-002\r\n-3.47e-002\r\n-1.4e-003\r\n-1.4e-003\r\n7.8e-003\r\n4.8e-003\r\n0.1704\r\n-5.32e-002\r\n-4.34e-002\r\n2.98e-002\r\n3.33e-002\r\n4.6e-002\r\n4.6e-002\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n4.3e-002\r\n4', '1', '0.537', 'C13H16N2O', '0216.126', '-1.92', '0216.279', '7.09 8.78', '2', '0', '0', '13', '06', '1', '16', '19', '16', '3', '003', '00', '16', '0', '5', '000', '0025.36', '210.73', '', '3.4976', '1.2949', '35.14', '28.73', '3.15342', '6.41', '354.585', '44.852', '175.95', '', 'O(/C4=C([H])/C1=C(C([H])([H])[C@]2([H])N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]13[C@]2([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])\\C([H])=C4\\[H])C([H])([H])[H].O([C@]([C@]1([H])N2C([H])([H])[C@@](/C(=C([H])/[H])[H])([H])C([H])(C1([H])[H])C([H])([H])C2([H])[H])(/C3=C\\4/C(=N\\C([H])=C3\\[H])/C([H])=C([H])\\C(OC([H])([H])[H])=C4\\[H])[H])[H]', 'COc4ccc3C[C@@H]2[C@H]1CCCC[C@@]1(CCN2C)c3c4.C=C[C@H]1CN2CCC1C[C@@H]2C(O)c3ccnc4ccc(OC)cc34', 'AZD0328', 'AK318437', 'Neuronal acetylcholine receptor subunit alpha-7', '9794392', 'Terminated at Phase II', 'Schizophrenia', '21550383', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(116, '25262792', '25262792', 'CNC(=O)c1cccc(c1)c2ccc3c(nc(nc3n2)N4CCOC[C@@H]4C)N5CCOC[C@@H]5C', '3-[2,4-bis[(3<I>S</I>)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-<I>N</I>-methyl-benzamide', 'CYAAFQwAFewQvx^cw7Usc^LGt3JYwmoeGv3viqHhpnpKfwhwRudaa0ORKVDtZjHAqFM4NbKCo2PE9Tntv0oZxHJLLGe^MoESM7C4kqFrOtQ8Xccc$bl2Zu1Ny7^HTWheK4lY49Hn^8r^yXbrAHwJ^Q76FDhqH2i4fJ2EmHSwr4nVpV8w5cwpS6Lt7y0AjGYXDPeOP0l7 5u6U7z12g9gC^cKlpipOmW^x4B5QksI3u6rW7yhdJcsUhXKRjuVGd0xp76k3UVk7w1xhhz^2HkZgdqsHCEXp3HG82FnxRGF56epk2efxyn4QGbm3RmR6Qxj9$aEzyzXT6X6FlyVqxsmoFRkz4FG1rqBdFlKy37fvm3BDd65oHZVkPFlLyc2nzKrH3FlO8yZqxnjRHdYa kR9YTyExbbwLIGY^yVZjPGet1kIYgSWdKWkfSsWNa7niRRfRvxIgM3P13S2g8WxEkAIv0SyRNc$xKBbZAkqL72qImU8Pz8zg', 'InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1', 'AuxInfo=1/1/N:20,22,34,31,29,32,24,25,12,15,17,19,28,13,16,10,11,27,30,21,26,23,14,33,18,9,8,7,6,4,5,3,1,2/it:im/rA:64OOONNNNNNC.oC.oCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;s4 ;s5;s4;s1s10;s4d+6;s5;s2s11;s1s12;s5s6d+7;s2s15;s10;s14;s11;s7s8d-21;s21;d-24;d-8s25;s26;d+27;s27;s28;d-29;d-30s31;d3s9s30;s9;s10;s11;s12;s12;s13;s13;s15;s15;s16;s16;s17;s17;s19;s19;s20;s20;s20;s22;s2 2;s22;s24;s25;s28;s29;s31;s32;s9;s34;s34;s34;/rC:3.7422,-4.8211,-.4686;5.2809,4.0651,.9831;-7.65', 'JUSFANSTBFGBAF-IRXDYDNUSA-N', '1010:ZT6TJGA88TXAC2Q2PFFUR518537QNW', '[#8]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]3-[#1]):[n]4):[c]4 :[n]:[c](:[n]2)-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]5)-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6]5(-[#1])-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6]1(-[#1])-[#1]', 'O1C([H])([H])C([H])([H])N(c2c(c([H])c([H])c(c3c([H])c([H])c([H])c(C(N([H])C([H])([H])[H])=O)c3[H])n4)c4nc(n2)N(C([H])([H])C([H])([H])O5)[C@@]([H])(C([H])([H])[H])C5([H])[H])[C@@]([H])(C([H])([H])[H])C 1([H])[H]', '03.103', '3.364', '0', '0', 'TRUE', '-0.3785\r\n-0.3785\r\n-0.272\r\n-0.2513\r\n-0.2356\r\n-0.2053\r\n-0.1977\r\n-0.2279\r\n-0.3145\r\n3.64e-002\r\n3.79e-002\r\n2.84e-002\r\n6.23e-002\r\n0.1231\r\n2.98e-002\r\n6.24e-002\r\n5.98e-002\r\n0.2067\r\n5.99e-002\r\n-4.69e-002\r\n5.66e-002\r\n-4.68e-002\r\n0.166\r\n-4.58e-002\r\n-3.49e-002\r\n7.28e', '1', '3.101', 'C25H30N6O3', '0462.238', '-4.164', '0462.544', '3.82 5.03', '6', '1', '1', '20', '17', '3', '34', '38', '37', '9', '009', '01', '30', '0', '5', '004', '0092.71', '480.6', '', '3.91861', '1.2749', '104.6', '30', '5.30769', '74.6', '2,352.22', '118.629', '372.84', '-178.9', 'O5C([H])([H])C(C([H])([H])[H])([H])N(/C2=N/C(N1C(C([H])([H])[H])([H])C([H])([H])OC([H])([H])C1([H])[H])=N\\C\\4=C2\\C([H])=C([H])/C(/C3=C([H])/C(C(=O)N(C([H])([H])[H])[H])=C([H])\\C([H])=C3\\[H])=N4)C([H])([H])C5([H])[H]', 'CNC(=O)c5cccc(c4ccc3c(N1CCOCC1C)nc(N2CCOCC2C)nc3n4)c5', 'AZD2014', 'Vistusertib', 'Serine/threonine-protein kinase mTOR', '25262792', 'Phase II', 'Neurofibromatosis Type 1', '26219339', 'Neurofibromatosis Type 1', 'NEUROFIBROMATOSIS, CENTRAL TYPE\nACOUSTIC SCHWANNOMAS, BILATERAL\nBILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF\nACOUSTIC NEURINOMA, BILATERAL; CAN'),
(117, '57404290', '57404290', 'COC1CCC2(CC1)Cc3ccc(cc3[C@@]24N=C(C)C(=N4)N)c5cncc(c5)C#CC', 'methoxy-methyl-(5-prop-1-ynyl-3-pyridyl)dispiro[BLAH]amine', 'CYAAFQwAcewQ5DrUXulOlCMd951$CazDljAEotKyR^GSpBMZloeXK6Z1QpB9Pi2alwQGb^TmG$XI4d419zTicH6qQ0FiLEbx2Y09n7S3WKvuoQW^ixnarfZf$$7j8WkXCcJK88z5^^7^83L39DQRUnvfxC0QBG$f$SDbKnNVQV270KPv7TvqQhJeEq^^JJ6o0af$w46E GKO7H8ijO2NwMme33iA$dMzJJXvpoS$VvZNr4EE0oBO$NuvvH39u2WRGwO6Mrc0A$55X6w7QhUpTBTQ7ps7LnWX2WEqHKsMDbnHQLf$gma4MMcEULtGV6q8fqW120n2UU3UGHkW9Mv8BsgeKiC1IN21p6Hny0HcdbQ$6kwxnZOZzImfO^eXVDSmzbBVxxTiaxGftRqZN R0tnRi6Niy$PWCk^wBTeOes6FtPt1paGPdUJW9NhIq23LSFPOfjq2jF$HPKfYnHjOLVVC1m7Nw3ebZ$WWVWh3CnWPb0IZPqb', 'InChI=1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22-,25-,26-/m0/s1', 'AuxInfo=1/1/N:31,22,23,30,29,21,17,13,12,8,9,25,16,10,28,26,18,27,20,14,24,15,11,19,6,7,4,5,2,3,1/E:(8,9)(10,11)/it:22-,25-,26+/iN:31,22,23,30,29,21,17,12,13,9,8,25,16,10,28,26,18,27,20,14,24,15,11,19 ,6,7,4,5,2,3,1/rA:59ONNNNCC.eCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s2s3s6;s6;s6;s6;s7;s9;s8;s10d-11;s1s12s13;s11;s14;d-2;d+3s4s18;d-16;d-17s20;s18;s1;s20;s24;s5d+24;d-25;d-5s27; s27;t29;s30;s8;s8;s9;s9;s10;s10;s13;s12;s12;s13;s15;s16;s17;s21;s22;s22;s22;s23;s23;s23;s4;s4;s2', 'WKDNQONLGXOZRG-HRNNMHKYSA-N', '1010:7YZ7EKT9XGGWUBVCB23FRS2WPXZ445', '[#8](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[c](:[c]3-[#1]):[c](-[ #1]):[c](-[#6]#[#6]-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[n]3):[c]4-[#1]):[c]4-[#6@]25-[#7]=[#6](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#7]5)-[#7](-[#1])-[#1]', 'O(C([H])([H])[H])C([H])(C([H])([H])C1([H])[H])C([H])([H])C([H])([H])C12C([H])([H])c(c([H])c([H])c(c(c3[H])c([H])c(C#CC([H])([H])[H])c([H])n3)c4[H])c4[C@]25N=C(C(C([H])([H])[H])=N5)N([H])[H]', '03.882', '3.882', '0', '0', 'TRUE', '-0.3814\r\n-0.2517\r\n-0.237\r\n-0.2857\r\n-0.2628\r\n2.45e-002\r\n0.1836\r\n-4.03e-002\r\n-4.03e-002\r\n-1.72e-002\r\n5.8e-003\r\n-2.61e-002\r\n-2.61e-002\r\n-3.97e-002\r\n5.72e-002\r\n-4.65e-002\r\n-5.8e-002\r\n7.13e-002\r\n0.1216\r\n-1.64e-002\r\n-5.41e-002\r\n-1.94e-002\r\n3.58e-002\r\n1.2e-003\r\n', '1', '3.728', 'C26H28N4O', '0412.226', '-8.653', '0412.527', '4.62 7.45 8', '4', '1', '2', '20', '12', '2', '31', '35', '33', '8', '005', '02', '28', '0', '5', '003', '0072.86', '437.03', '', '3.32212', '1.2812', '51.82', '37.27', '5.05535', '14.55', '1,866.90', '117.158', '344.37', '', 'O(C5([H])C([H])([H])C([H])([H])C2(C/1(/N=C(C([H])([H])[H])\\C(N([H])[H])=N1)\\C4=C(C2([H])[H])\\C([H])=C([H])/C(/C3=C([H])/N=C([H])\\C(C#CC([H])([H])[H])=C3\\[H])=C4/[H])C([H])([H])C5([H])[H])C([H])([H])[H]', 'CC#Cc5cncc(c4ccc3C[C@]1(CC[C@@H](OC)CC1)[C@]/2(/N=C(C)\\C(N)=N2)c3c4)c5', 'AZD-3293', 'AZD3293', 'BACE1 (beta-secretase)', '57404290', 'Phase II/III', 'Alzheimer disease (AD)', '27418961', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(118, '67979346', '67979346', 'COC1CCC2(CC1)Cc3ccc(cc3[C@@]24N=C(C)C(=N4)N)c5cncc(c5)C#CC', 'methoxy-methyl-(5-prop-1-ynyl-3-pyridyl)dispiro[BLAH]amine', 'CYAAFQwAcewQ5DrUXulOlCMd951$CazDFx4hxgXIyl0qbecD^YprXBCsxcm2zqtteFQAF79e6m193bLwNjkVHhLXVbhRbBoEBGHvOkY8vaVByz$FC44bR3v^re91leBi5ruU^78D39z7h93LuXTr980l0rCpAizLXeMD5nlKKyQvy65VP8rS2nwh698rUiJM780bD7aI o7mLaJP$jcbYjwzdtLsPHyYy5^TKMxhiG0vaDigHN7xrx97d4s^t2J4o2RhZKHc1fd6ljzsrmmKV1DUnK52yh3tdqS9IrJ5wtzbxlPfwTPUGGMiyp7GZ3l0Tea0OPPoS2QMaQqnvCyJzCIjzazXROSVcL8q0H9Fpkj^3emGQJTEz6S6hCV3$GwyGjIl2N$aihz6jsTPj Birjh1fDvW^FHkJa9rUV3FAyDByvk7atwnI6ti^2DBkh6hatPy4o38MZIysej2hhvZnUjz9EyA9aSaxXBmWWJ4Q3NsLPFdxZ', 'InChI=1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22-,25-,26-/m0/s1', 'AuxInfo=1/1/N:31,22,23,30,29,21,17,13,12,8,9,25,16,10,28,26,18,27,20,14,24,15,11,19,6,7,4,5,2,3,1/E:(8,9)(10,11)/it:22-,25-,26+/iN:31,22,23,30,29,21,17,12,13,9,8,25,16,10,28,26,18,27,20,14,24,15,11,19 ,6,7,4,5,2,3,1/rA:59ONNNNCC.eCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s2s3s6;s6;s6;s6;s7;s9;s8;s10d-11;s1s12s13;s11;s14;d-2;d+3s4s18;d-16;d-17s20;s18;s1;s20;s24;s5d+24;d-25;d-5s27; s27;t29;s30;s8;s8;s9;s9;s10;s10;s13;s12;s12;s13;s15;s16;s17;s21;s22;s22;s22;s23;s23;s23;s4;s4;s2', 'WKDNQONLGXOZRG-HRNNMHKYSA-N', '1010:7YZ7EKT9XGGWUBVCB23FRS2WPXZ445', '[#8](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]12-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[c](:[c]3-[#1]):[c](-[ #1]):[c](-[#6]#[#6]-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[n]3):[c]4-[#1]):[c]4-[#6@]25-[#7]=[#6](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#7]5)-[#7](-[#1])-[#1]', 'O(C([H])([H])[H])C([H])(C([H])([H])C1([H])[H])C([H])([H])C([H])([H])C12C([H])([H])c(c([H])c([H])c(c(c3[H])c([H])c(C#CC([H])([H])[H])c([H])n3)c4[H])c4[C@]25N=C(C(C([H])([H])[H])=N5)N([H])[H]', '03.882', '3.882', '0', '0', 'TRUE', '-0.3814\r\n-0.2517\r\n-0.237\r\n-0.2857\r\n-0.2628\r\n2.45e-002\r\n0.1836\r\n-4.03e-002\r\n-4.03e-002\r\n-1.72e-002\r\n5.8e-003\r\n-2.61e-002\r\n-2.61e-002\r\n-3.97e-002\r\n5.72e-002\r\n-4.65e-002\r\n-5.8e-002\r\n7.13e-002\r\n0.1216\r\n-1.64e-002\r\n-5.41e-002\r\n-1.94e-002\r\n3.58e-002\r\n1.2e-003\r\n', '1', '3.728', 'C26H28N4O', '0412.226', '-8.653', '0412.527', '4.62 7.45 8', '4', '1', '2', '20', '12', '2', '31', '35', '33', '8', '005', '02', '28', '0', '5', '003', '0072.86', '437.03', '', '3.32212', '1.2812', '51.82', '37.27', '5.05535', '14.55', '1,866.90', '117.158', '344.37', '', 'O(C5([H])C([H])([H])C([H])([H])C2(C/1(/N=C(C([H])([H])[H])\\C(N([H])[H])=N1)\\C4=C(C2([H])[H])\\C([H])=C([H])/C(/C3=C([H])/N=C([H])\\C(C#CC([H])([H])[H])=C3\\[H])=C4/[H])C([H])([H])C5([H])[H])C([H])([H])[H]', 'CC#Cc5cncc(c4ccc3C[C@]1(CC[C@@H](OC)CC1)[C@]/2(/N=C(C)\\C(N)=N2)c3c4)c5', 'AZD3293 (Lanabecestat, LY3314814)', 'Lanabecestat; LY3314814;', 'BACE1 (beta-secretase)', '67979346', 'Phase III', 'Alzheimer disease (AD)', '27767991', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(119, '60210951', '60210951', 'N[C@H]1N[C@@](c2cccc(c2)c3cncnc3)(c4ccnc(c4)C(F)F)c5cccc(F)c15', '(1<I>S</I>,3<I>S</I>)-3-[2-(difluoromethyl)-4-pyridyl]-7-fluoro-3-(3-pyrimidin-5-ylphenyl)isoindolin-1-amine', 'CYAAFQwA6cwQBFBArtYkjGjzXHOVqEcECs$AzksEbaKoy^iDcFEy1xCy3ZLpODy4AifEStv5dLNSSMk0dmFit0Ik7$NHp7AP2gEHqoBESV06JnJ1Fam9vE56ye1rTxEnfcuyv^fnts2T50c^3e15qAB74^ZpN4CM$c3hJdDPhf6vePuoUBJd7ci76jFVUw3ix11YbBLf We^9qV8wBH9xB3XmpuT4XaI1G8kWqGOi71XOAQu4eZTqoZFl1iCxLrIyei7hITP^IvMX6W$o7Pg$GptqeqivL54Bn0RlfMYRUD3mWoOoV89FHNQycVUrprSY2S71B5LYlXcpx3sY2SrWibW$52lKO4wq0rvJvtazP9TQ69KZ8JRzfbDXohc$1gD6OJT43VtmX1KXnkMZ zg^GFXWyRGZyTRlSohROir78eDL9WP^uwpXuFYecs7$9BOYR4dyn5wvpWY^D7IXNT$46PFde3bV$1mb4zHlaiTrY5kJwF3m8', 'InChI=1S/C24H18F3N5/c25-19-6-2-5-18-21(19)23(28)32-24(18,17-7-8-31-20(10-17)22(26)27)16-4-1-3-14(9-16)15-11-29-13-30-12-15/h1-13,22-23,32H,28H2/t23-,24-/m0/s1', 'AuxInfo=1/0/N:24,21,26,18,15,22,20,27,17,19,30,31,32,23,28,13,14,10,16,25,12,29,11,9,1,2,3,5,7,8,6,4/E:(11,12)(26,27)(29,30)/it:im/rA:50FFFNNNNNC.eCC.oCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;;;;; ;s4;s9;s4s5;d-10s11;s9;s9;s10;s1s12;s13;d+13;d+14;s14;d-15;d+16s21;d-17;s18;d-6s19;s23d-24;s6d-20;s23;s2s3s25;d-7s28;s8d+28;s7d-8;s11;s4;s15;s17;s5;s5;s18;s19;s20;s21;s22;s24;s26;s27;s29;s30;s31;s32;/ rC:5.3177,2.5279,-.6093;-1.1382,-5.4323,.7524;-2.2657,-3.6358,1.2026;1.3819,.8877,-1.644;3.2799,', 'QXKYWSDUVAJHNZ-ZEQRLZLVSA-N', '1010:7Z2W5S6Q8ND6Y999AN1YTP8N89RHK3', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#1]):[c](-[#6@@](-[#1])(-[#7](-[#1])-[#1])-[#7]2-[#1]):[c]1-[#6@@]2(-[c](:[c](-[#1]):[c](-[#1]):[n]3):[c](-[#1]):[c]3-[#6](-[#1])(-[#9])-[#9])-[c]4:[c](-[#1]):[c] (-[#1]):[c](-[#1]):[c](-[c](:[c](-[#1]):[n]:[c](-[#1]):[n]5):[c]5-[#1]):[c]4-[#1]', 'Fc(c([H])c([H])c1[H])c([C@@]([H])(N([H])[H])N2[H])c1[C@@]2(c(c([H])c([H])n3)c([H])c3C([H])(F)F)c4c([H])c([H])c([H])c(c(c([H])nc([H])n5)c5[H])c4[H]', '03.22', '3.22', '0', '0', 'TRUE', '-0.2066\r\n-0.2033\r\n-0.2033\r\n-0.2809\r\n-0.312\r\n-0.2553\r\n-0.2442\r\n-0.2442\r\n9.68e-002\r\n-9.9e-003\r\n8.54e-002\r\n2.47e-002\r\n-1.83e-002\r\n-1.54e-002\r\n-5.59e-002\r\n0.1291\r\n-4.85e-002\r\n-5.65e-002\r\n-2.9e-002\r\n-3.81e-002\r\n-5.9e-002\r\n-2.59e-002\r\n-1.5e-002\r\n-6.13e-002\r\n0.1', '1', '3.213', 'C24H18F3N5', '0433.151', '-8.016', '0433.428', '0.26 0.91 2.21 5.65', '3', '2', '0', '12', '24', '4', '32', '36', '25', '12', '005', '03', '18', '0', '5', '004', '0076.72', '409.73', '', '4.36859', '1.2976', '48.44', '18.17', '4.21706', '30.27', '1,499.78', '134.918', '315.9', '', 'Cl/C\\4=C(C(O[H])([H])[H])/N(C(/C3=C([H])/C([H])=C(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C/2=N\\N([H])\\N=N2)\\C([H])=C3\\[H])([H])[H])/C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])=N4', 'N[C@H]5N[C@@](c2cccc(c1cncnc1)c2)(c3ccnc(C(F)F)c3)c4cccc(F)c45', 'AZD-3839', '4b05; 32D; GTPL6931', 'BACE1 (beta-secretase)', '60210951', 'Terminated at Preclincal trail', 'Alzheimer disease (AD)', '23048024', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(120, '17757205', '17757205', 'CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O', '[(2<I>R</I>)-2-(8-carboxyoctanoyloxy)-3-hexadecoxy-propyl] 2-(trimethylammonio)ethyl phosphate', 'CYAAFQwA9dwQ9iZFjC41MNX8ol^6WN6mCIEKIV$XiM2RAJK3ydzYloZ$0txgghiyuoE9^Bc7lN2VIHrtC8UMuCFM7x1gQAg6JNytBI9RrcNCSIL^B$rc^8L0jfov887kJAgHQSokY8jxHd9PfLMR0XaOihI6pkUKFPR4YyjSopeKE$nCwLWTgJLJ8xj7u1f5iUTejDd4 ezBm3sn0POx7NhwIXdqn$s5Y1SmaX55^d$9pVHxxeko$UiEpnbqytsAz6VsY4MQ6qbt1I7VpEnes9p$Hlh32YWJ6rv$aqD^CdO74ic8NjyWuWCv4n6rX9my9ijn$MSYY5lOusK08eZamXVavBrubI5ZhornG51l$8^CkVrn7VP90pn8c4o^w4ebm73MPeNnS081ZvNuC RX9HM^6CXtH^$8yH76tdivneQeba^Fn9tKeecDlf^2CutpP57LXUs^Gu7WDP9l3fN2l5rwlfVeqve6^syr5mOeUelxeX8X5U', 'InChI=1S/C33H66NO9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-23-27-40-29-31(30-42-44(38,39)41-28-26-34(2,3)4)43-33(37)25-22-19-17-18-21-24-32(35)36/h31H,5-30H2,1-4H3,(H-,35,36,38,39)/t31-/m1/s1', 'AuxInfo=1/2/N:39,26,27,28,31,25,22,20,18,16,14,12,13,15,17,19,35,37,34,21,41,36,24,43,40,23,30,29,33,38,32,44,42,11,9,10,8,6,7,2,3,5,4,1/E:(2,3,4)(35,36)(38,39)/it:im/CRV:34+1,38-1/rA:110POOOOO-OOOON+ CCCCCCCCCCCCCCCCCCCCC.oCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;s1;;s1;s1;d1;;;;;;s12;s12;s13;s14;s15;s16;s17;s18;s19;s20;s11;s21;s22;s11;s11;s11;s3s23;s2s24; s25;p4;s2s32;;s34;s34;s35;s5s32;s31;s36;s37;s4d8s40;s41;s9d10s43;s12;s12;s13;s13;s14;s14;s15;s15', 'ZDFOCDTXDPKJKA-WJOKGBTCSA-N', '1010:UMC9XD9VW4DFSSP27J6PT145QUDTX7', '[#15](=[#8])(-[#8-])(-[#8]-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[ #6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]- [#6](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[', 'P(=O)([O-])(OC([H])([H])[C@@]([H])(C([H])([H])OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H] )C([H])([H])C([H])([H])[H])OC(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H])=O)OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]', '05.586', '6.73', '0', '0', 'TRUE', '0.3932\r\n-0.3787\r\n-0.2984\r\n-0.3078\r\n-0.2993\r\n-0.5973\r\n-0.5973\r\n-0.2666\r\n-0.3318\r\n-0.2669\r\n0.1387\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.33e-002\r\n-5.34e-002\r\n-5.12e-002\r\n-5.34e-002\r\n5.94e-002\r\n-2.96e-002\r\n-5.36e-002\r\n2.31e-002\r\n2.31e-002\r\n2.31e-002\r\n8.81e-002\r\n4.67e-002\r\n-5.62e-002\r\n0.1143\r\n7.57e-002\r\n-5.28e-002\r\n-5.33e-002\r\n-4.4e-002\r\n-5.28e-002\r\n8.6e-002\r\n-6.54e-002\r\n3.37e-002\r\n-4.4e-002\r\n0.2612\r\n3.35e-002\r\n0.2581\r\n2.66e-002\r\n2.66e-002\r\n2.66e-002\r', '1', '4.81', 'C33H66NO9P', '0651.448', '-10.565', '0651.852', '4.72 6.57', '6', '0', '3', '40', '00', '0', '44', '43', '74', '3', '010', '01', '66', '0', '0', '034', '0141.23', '769.16', '', '', '', '', '', '', '', '', '', '', '', 'P(OC(C([N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])(OC([C@](OC(=O)C(C(C(C(C(C(C(C(O[H])=O)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])(C(OC(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([O-])=O', 'CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O', 'Azelaoyl PAF', 'hexadecyl azelaoyl phosphatidylcholine', 'Peroxisome proliferator-activated receptor gamma', '17757205', 'Under Investigation', 'Friedreich''s Ataxia', '19104905', 'Friedreich''s Ataxia', 'FRDA1\nFA; Friedreich Ataxia'),
(121, '11180124', '11180124', 'CCCCc1nc(cn1c2ccc(Oc3ccc(Cl)cc3)cc2)c4ccc(OCCCN(CC)CC)cc4', '3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]imidazol-4-yl]phenoxy]-<I>N</I>,<I>N</I>-diethyl-propan-1-amine', 'CYAAFQwAxdwQ6BX48MOmK$H6wezKecA7X^HRagCOIw7Y4UFzH2giYZeEJYSxXyKqSe5QmZBhuwqfmm5$7EHX0ed8DItou0JT81PQsRiiwUs8vyplMS9Gy$4OXiu^i98zLxsW^3eg3PX$K8u8$GHAGzFIrHvTNy1Gf5omV2KRe8^ndv7h027NzfvKgdaYelR^Xqh2HX5f Vjsr25NpHJU98eyHZznVXsWfxTro9qktiCf7$$sFi7^7MuCrYAErp$yxuFck5^51yeTHrhk4xJE^1uNebX8SMYIiQKGMfWps4h79dlemI3bZc$lZb33Wo^fRi6jz^$RVGNkoLKL$s2EuWRrZHT^61ZMdSVPHwhMd^BhnLM^$GtkKjby0eIBrfbtdeXpZNbMDn1IaIv7L xotPVWF^mxO9ToPdLRutsLdB7ANurEqbXZHGDGcyhysmlPuHgw7LxtV5LzLtf5pFPrm^OM9TXsfIvpGF8WzfB5FTHcYxH4te', 'InChI=1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3', 'AuxInfo=1/0/N:23,20,21,16,12,13,11,10,8,24,25,36,37,26,27,28,29,34,35,30,31,7,15,17,19,38,18,22,33,32,14,9,1,6,4,5,2,3/E:(2,3)(5,6)(10,11)(12,13)(14,15)(16,17)(18,19)(20,21)/rA:76ClOONNNCCCCCCCCCCCCCC CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s4;;s5d-6s8;s7;s8;s4;s4;s6;s2s10;s11;s5d-14;s5;s14;s12;s13;s2;s16;d+19;s19;d+18;s18;d+22s24;s22d-25;s26;d-27;s3d+30s31;s3;d+33;s33;s34; d-35;s1d+36s37;s7;s7;s8;s8;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s17;s20;s20;s20;s21;s', 'KJNNWYBAOPXVJY-UHFFFAOYSA-N', '1010:RG92UEBNJ2Z88ZXQFJ7XE93RAHSBZP', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#8]-[c](:[c](-[#1]):[c](-[#1]):[c]2-[n]3:[c](-[#1]):[c](-[c]4:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]4-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[n]:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c] (-[#1]):[c]2-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1Oc(c([H])c([H])c2n3c([H])c(c4c([H])c([H])c(c([H])c4[H])OC([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])nc3C([H])([H])C([H])([H])C([H])([H])C([ H])([H])[H])c([H])c2[H])c([H])c1[H]', '08.393', '8.393', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3461\r\n-0.3105\r\n-0.3038\r\n-0.2066\r\n-0.2391\r\n3.e-004\r\n9.e-004\r\n9.38e-002\r\n-1.63e-002\r\n-4.7e-002\r\n-4.7e-003\r\n-4.7e-003\r\n8.32e-002\r\n5.45e-002\r\n-5.58e-002\r\n1.76e-002\r\n2.73e-002\r\n1.3e-003\r\n-5.25e-002\r\n-5.25e-002\r\n7.49e-002\r\n-6.54e-002\r\n-5.02e-002\r', '0', '6.854', 'C32H38ClN3O2', '0531.265', '-10.538', '0532.116', '5.39 10.31', '3', '0', '0', '18', '23', '4', '38', '41', '45', '11', '005', '00', '38', '0', '4', '014', '0039.52', '570.11', '', '1.35972', '1.2664', '91.66', '25.64', '6.63783', '66.02', '5,178.32', '41.847', '443.15', '', 'Cl/C4=C([H])/C([H])=C(O/C3=C([H])/C([H])=C(N2/C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])=N\\C(\\C1=C([H])\\C([H])=C(OC(C(C(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/C([H])=C1/[H])=C2\\[H])\\C([H])=C3\\[H])\\C([H])=C4\\[H]', 'CCCCc2nc(c1ccc(OCCCN(CC)CC)cc1)cn2c4ccc(Oc3ccc(Cl)cc3)cc4', 'Azeliragon', 'PF-04494700; LPU25F15UQ;', 'Amyloid beta A4 protein', '11180124', 'Phase III', 'Alzheimer disease (AD)', '28720101', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(122, '11180124', '11180124', 'CCCCc1nc(cn1c2ccc(Oc3ccc(Cl)cc3)cc2)c4ccc(OCCCN(CC)CC)cc4', '3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]imidazol-4-yl]phenoxy]-<I>N</I>,<I>N</I>-diethyl-propan-1-amine', 'CYAAFQwAxdwQ6BX48MOmK$H6wezKecA7X^HRagCOIw7Y4UFzH2giYZeEJYSxXyKqSe5QmZBhuwqfmm5$7EHX0ed8DItou0JT81PQsRiiwUs8vyplMS9Gy$4OXiu^i98zLxsW^3eg3PX$K8u8$GHAGzFIrHvTNy1Gf5omV2KRe8^ndv7h027NzfvKgdaYelR^Xqh2HX5f Vjsr25NpHJU98eyHZznVXsWfxTro9qktiCf7$$sFi7^7MuCrYAErp$yxuFck5^51yeTHrhk4xJE^1uNebX8SMYIiQKGMfWps4h79dlemI3bZc$lZb33Wo^fRi6jz^$RVGNkoLKL$s2EuWRrZHT^61ZMdSVPHwhMd^BhnLM^$GtkKjby0eIBrfbtdeXpZNbMDn1IaIv7L xotPVWF^mxO9ToPdLRutsLdB7ANurEqbXZHGDGcyhysmlPuHgw7LxtV5LzLtf5pFPrm^OM9TXsfIvpGF8WzfB5FTHcYxH4te', 'InChI=1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3', 'AuxInfo=1/0/N:23,20,21,16,12,13,11,10,8,24,25,36,37,26,27,28,29,34,35,30,31,7,15,17,19,38,18,22,33,32,14,9,1,6,4,5,2,3/E:(2,3)(5,6)(10,11)(12,13)(14,15)(16,17)(18,19)(20,21)/rA:76ClOONNNCCCCCCCCCCCCCC CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s4;;s5d-6s8;s7;s8;s4;s4;s6;s2s10;s11;s5d-14;s5;s14;s12;s13;s2;s16;d+19;s19;d+18;s18;d+22s24;s22d-25;s26;d-27;s3d+30s31;s3;d+33;s33;s34; d-35;s1d+36s37;s7;s7;s8;s8;s10;s10;s11;s11;s12;s12;s13;s13;s15;s15;s16;s16;s17;s20;s20;s20;s21;s', 'KJNNWYBAOPXVJY-UHFFFAOYSA-N', '1010:RG92UEBNJ2Z88ZXQFJ7XE93RAHSBZP', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#8]-[c](:[c](-[#1]):[c](-[#1]):[c]2-[n]3:[c](-[#1]):[c](-[c]4:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]4-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[n]:[c]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c] (-[#1]):[c]2-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1Oc(c([H])c([H])c2n3c([H])c(c4c([H])c([H])c(c([H])c4[H])OC([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])nc3C([H])([H])C([H])([H])C([H])([H])C([ H])([H])[H])c([H])c2[H])c([H])c1[H]', '08.393', '8.393', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3461\r\n-0.3105\r\n-0.3038\r\n-0.2066\r\n-0.2391\r\n3.e-004\r\n9.e-004\r\n9.38e-002\r\n-1.63e-002\r\n-4.7e-002\r\n-4.7e-003\r\n-4.7e-003\r\n8.32e-002\r\n5.45e-002\r\n-5.58e-002\r\n1.76e-002\r\n2.73e-002\r\n1.3e-003\r\n-5.25e-002\r\n-5.25e-002\r\n7.49e-002\r\n-6.54e-002\r\n-5.02e-002\r', '0', '6.854', 'C32H38ClN3O2', '0531.265', '-10.538', '0532.116', '5.39 10.31', '3', '0', '0', '18', '23', '4', '38', '41', '45', '11', '005', '00', '38', '0', '4', '014', '0039.52', '570.11', '', '1.35972', '1.2664', '91.66', '25.64', '6.63783', '66.02', '5,178.32', '41.847', '443.15', '', 'Cl/C4=C([H])/C([H])=C(O/C3=C([H])/C([H])=C(N2/C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])=N\\C(\\C1=C([H])\\C([H])=C(OC(C(C(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/C([H])=C1/[H])=C2\\[H])\\C([H])=C3\\[H])\\C([H])=C4\\[H]', 'CCCCc2nc(c1ccc(OCCCN(CC)CC)cc1)cn2c4ccc(Oc3ccc(Cl)cc3)cc4', 'Azeliragon', 'TTP488; CS-5117', 'Receptor for advanced glycation end products (RAGE)', '11180124', 'Phase III', 'Alzheimer disease (AD)', '24423155', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(123, '71062059', '71062059', 'COc1ccc(cc1)c2ccccc2N3CCN(C[C@@H](O)COc4cnccn4)CC3', '(2<I>R</I>)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-pyrazin-2-yloxy-propan-2-ol', 'CYAAFQwA1dwQ3J556PnzJz8Nfcfha$fBLD3HAewFszoaJiJ1IWgjJW03nHznsqPqTSLD$3ftML6rqhHy2itS20k7vw8ZkLD9c4xCUZvXF3MvUGuDpbrL^9AgS2beUSm1^QvEv^P7106TA0U^TfP4i81JJecBdSa2CIF4k$HTtHdQiJI945E3PkSgDOxOS31hgV1iWmC8 5nt7PliaKirPT5YqDro5kTrDnXH9Rs4wQwJdiwPKs3TiB$FXNEuy$RMP47kqXsCtCr$equrLZcszHkG6kH6FCLZcnIiN^ikJaqP7ZCrFQVcDnSiK1aVXZlIOsWJ2g05pHhKSrBvpdvvnT9rzX6OkiuGPV^3M0xnncUTUSg6JXeUGjSO8lSxqOOC4AjBvTdYHgPMz4$oZ 5QiR$9ydoz0BX1cyh7VkCsj1$QLtWK3Yi1jCiaxZz5DylIffc6V8obRt1pWVnyGgwHSnX0Didg4g585Cuat8wb44Ztl8C7zT', 'InChI=1S/C24H28N4O3/c1-30-21-8-6-19(7-9-21)22-4-2-3-5-23(22)28-14-12-27(13-15-28)17-20(29)18-31-24-16-25-10-11-26-24/h2-11,16,20,29H,12-15,17-18H2,1H3/t20-/m1/s1', 'AuxInfo=1/0/N:30,21,20,19,17,22,23,24,25,31,29,8,9,11,10,28,12,16,18,14,27,15,13,26,7,6,4,5,1,3,2/E:(6,7)(8,9)(12,13)(14,15)/it:im/rA:59OOONNNNCCCCCCC.oCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB :;;;;;;s4;s4;s5s9;s5s8;s4;s5;s1s12;s13;s2s14;d+13;s15;d-15;s17;s19d-20;d+18;s18;s22;d-23;s2d+6;s3d+24s25;d-7s26;s6;s3;s7d-29;s9;s9;s8;s8;s10;s10;s11;s11;s12;s12;s14;s16;s16;s17;s19;s1;s20;s21;s22;s23; s24;s25;s28;s29;s30;s30;s30;s31;/rC:-3.4481,-3.3364,-.5201;-5.0863,-1.0653,-.646;5.354,-3.518,.5', 'ATGGHACHMARXLW-HXUWFJFHSA-N', '1010:JYRJHSYYQHAT7BFSGTM8GP9WW6YUCD', '[#8](-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[c]1:[c](-[#1]):[n]:[c](-[#1]):[c](-[#1]):[n]1)-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[c]3:[c](-[#1]):[c](-[#1]):[c](- [#1]):[c](-[#1]):[c]3-[c]4:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]4-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]', 'O([H])[C@@]([H])(C([H])([H])Oc1c([H])nc([H])c([H])n1)C([H])([H])N2C([H])([H])C([H])([H])N(c3c([H])c([H])c([H])c([H])c3c4c([H])c([H])c(c([H])c4[H])OC([H])([H])[H])C([H])([H])C2([H])[H]', '02.81', '2.81', '0', '0', 'TRUE', '-0.3894\r\n-0.3253\r\n-0.3494\r\n-0.2981\r\n-0.2719\r\n-0.2298\r\n-0.2587\r\n1.15e-002\r\n1.15e-002\r\n1.59e-002\r\n1.59e-002\r\n2.67e-002\r\n2.52e-002\r\n9.06e-002\r\n-2.e-004\r\n8.23e-002\r\n-4.34e-002\r\n-1.66e-002\r\n-5.28e-002\r\n-6.07e-002\r\n-6.16e-002\r\n-5.18e-002\r\n-5.18e-002\r\n-3.12e-002', '1', '2.81', 'C24H28N4O3', '0420.216', '-4.366', '0420.504', '-0.47 1.81 4.07', '4', '1', '0', '16', '18', '3', '31', '34', '33', '9', '007', '01', '28', '0', '4', '008', '0070.95', '444.88', '', '2.60704', '1.2687', '96.72', '30.4', '5.05704', '66.32', '2,276.98', '113.662', '339.56', '', 'O(C(C(N3C([H])([H])C([H])([H])N(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C2=C([H])C([H])=C(OC([H])([H])[H])C([H])=C2[H])C([H])([H])C3([H])[H])([H])[H])(C(O/C4=N/C([H])=C([H])\\N=C4\\[H])([H])[H])[H])[H]', 'COc4ccc(c1ccccc1N3CCN(C[C@@H](O)COc2cnccn2)CC3)cc4', 'BA-10', 'SCHEMBL14060827', '5-hydroxytryptamine receptor 7', '71062059', 'Under Investigation', 'Fragile X Syndrome', '25814945', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(124, '2284', '2284', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', '(3<I>R</I>)-4-amino-3-(4-chlorophenyl)butanoic acid', 'CYAAFQwAUewQX8oO766qtJ9T7KF^^IYfhKpqwSzCKkm1d3XItZJgBUVMPLnDawEMGd4ryaDfnQKEBlVFXqKmZKy3QhmdSiepAizd$xzFw4p5TImBxyrUlaZ^vtOUF3eg$ff75vHuQAQRJVe$Kri1suT^jAKrWFvIG9jnr4ciDJEtCEpHjZ0Z9KfsYgHnvrX9JkpH46h9 2YrCFg38rquIqbNtQpgkOzbsbJe9Ec^rLH0q6TCi5dpPn0DxZEl1BTlRh$LKTGZ6sF6Mz27qd1NY59JIobMuiSLPmkRHiFPN0DmTrCGjVNy1hnHmtL4G2ctT7dhIOtG6cpAmveGJCNvPyfUFSVFW3EZH$sq4$68VnfYFx^aor1zQAnXNwqPlRn3Odv1Vsa09M6RjXrcV gfW2rvrtXNiCMjvGQV54gSi8gZGe55JiAeW3bQdoIx7588aDD$mceCyRCnbf7vOx7SZoJPdVprA8cfj0b8MIpas0hpHjnzVq', 'InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1', 'AuxInfo=1/1/N:9,10,12,13,7,8,6,5,14,11,1,4,2,3/E:(1,2)(3,4)(13,14)/it:im/rA:26ClOONC.eCCCCCCCCCHHHHHHHHHHHH/rB:;;;;s5;s5;s4s5;d+6;s6;s2d3s7;s9;d-10;s1d+12s13;s5;s7;s7;s8;s8;s9;s10;s4;s4;s12;s13;s2;/rC :-4.5473,.3707,.2496;2.0613,2.7033,.6348;1.5426,1.8841,-1.4166;3.0222,-2.5594,.3171;1.3176,-.8066,-.2448;-.173,-.5082,-.1187;2.1482,.3415,.3729;1.6133,-2.1882,.3842;-1.0319,-1.0015,-1.077;-.6108,.2456 ,.9489;1.8921,1.6944,-.2599;-2.3948,-.7277,-.9623;-1.9738,.5194,1.0639;-2.8658,.0326,.1082;1.565', 'KPYSYYIEGFHWSV-QMMMGPOBSA-N', '1010:HEW6U8A4KMBQDRNZ4RMVN1YWU8XAG2', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1[C@]([H])(C([H])([H])N([H])[H])C([H])([H])C(=O)O[H])c([H])c1[H]', '-01.06', '1.419', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3318\r\n-0.2668\r\n-0.3299\r\n5.4e-003\r\n-4.31e-002\r\n4.15e-002\r\n-3.e-004\r\n-5.73e-002\r\n-5.73e-002\r\n0.2588\r\n-4.33e-002\r\n-4.33e-002\r\n4.05e-002\r\n3.7e-002\r\n3.79e-002\r\n3.79e-002\r\n4.31e-002\r\n4.31e-002\r\n6.26e-002\r\n6.26e-002\r\n0.1184\r\n0.1184\r\n6.38e-002\r\n6.3', '1', '-0.978', 'C10H12ClNO2', '0213.056', '-2.901', '0213.661', '1.07 9.02', '1', '1', '1', '7', '06', '1', '14', '14', '16', '4', '003', '03', '12', '0', '1', '004', '0063.31', '217.71', '', '1.51063', '1.2722', '11.42', '2.23', '2.91844', '9.19', '403.592', '147.815', '167.38', '', 'Cl/C1=C([H])/C([H])=C(C(C(C(O[H])=O)([H])[H])(C(N([H])[H])([H])[H])[H])\\C([H])=C1\\[H]', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', 'Baclofen', 'Arbaclofen; STX209; Tocris-0796; BG0394', 'Gamma-aminobutyric acid type B receptor subunit 1', '2284', 'Phase II Completed', 'Multiple Sclerosis', '26922704', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(125, '2284', '2284', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', '(3<I>R</I>)-4-amino-3-(4-chlorophenyl)butanoic acid', 'CYAAFQwAUewQX8oO766qtJ9T7KF^^IYfhKpqwSzCKkm1d3XItZJgBUVMPLnDawEMGd4ryaDfnQKEBlVFXqKmZKy3QhmdSiepAizd$xzFw4p5TImBxyrUlaZ^vtOUF3eg$ff75vHuQAQRJVe$Kri1suT^jAKrWFvIG9jnr4ciDJEtCEpHjZ0Z9KfsYgHnvrX9JkpH46h9 2YrCFg38rquIqbNtQpgkOzbsbJe9Ec^rLH0q6TCi5dpPn0DxZEl1BTlRh$LKTGZ6sF6Mz27qd1NY59JIobMuiSLPmkRHiFPN0DmTrCGjVNy1hnHmtL4G2ctT7dhIOtG6cpAmveGJCNvPyfUFSVFW3EZH$sq4$68VnfYFx^aor1zQAnXNwqPlRn3Odv1Vsa09M6RjXrcV gfW2rvrtXNiCMjvGQV54gSi8gZGe55JiAeW3bQdoIx7588aDD$mceCyRCnbf7vOx7SZoJPdVprA8cfj0b8MIpas0hpHjnzVq', 'InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1', 'AuxInfo=1/1/N:9,10,12,13,7,8,6,5,14,11,1,4,2,3/E:(1,2)(3,4)(13,14)/it:im/rA:26ClOONC.eCCCCCCCCCHHHHHHHHHHHH/rB:;;;;s5;s5;s4s5;d+6;s6;s2d3s7;s9;d-10;s1d+12s13;s5;s7;s7;s8;s8;s9;s10;s4;s4;s12;s13;s2;/rC :-4.5473,.3707,.2496;2.0613,2.7033,.6348;1.5426,1.8841,-1.4166;3.0222,-2.5594,.3171;1.3176,-.8066,-.2448;-.173,-.5082,-.1187;2.1482,.3415,.3729;1.6133,-2.1882,.3842;-1.0319,-1.0015,-1.077;-.6108,.2456 ,.9489;1.8921,1.6944,-.2599;-2.3948,-.7277,-.9623;-1.9738,.5194,1.0639;-2.8658,.0326,.1082;1.565', 'KPYSYYIEGFHWSV-QMMMGPOBSA-N', '1010:HEW6U8A4KMBQDRNZ4RMVN1YWU8XAG2', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1[C@]([H])(C([H])([H])N([H])[H])C([H])([H])C(=O)O[H])c([H])c1[H]', '-01.06', '1.419', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3318\r\n-0.2668\r\n-0.3299\r\n5.4e-003\r\n-4.31e-002\r\n4.15e-002\r\n-3.e-004\r\n-5.73e-002\r\n-5.73e-002\r\n0.2588\r\n-4.33e-002\r\n-4.33e-002\r\n4.05e-002\r\n3.7e-002\r\n3.79e-002\r\n3.79e-002\r\n4.31e-002\r\n4.31e-002\r\n6.26e-002\r\n6.26e-002\r\n0.1184\r\n0.1184\r\n6.38e-002\r\n6.3', '1', '-0.978', 'C10H12ClNO2', '0213.056', '-2.901', '0213.661', '1.07 9.02', '1', '1', '1', '7', '06', '1', '14', '14', '16', '4', '003', '03', '12', '0', '1', '004', '0063.31', '217.71', '', '1.51063', '1.2722', '11.42', '2.23', '2.91844', '9.19', '403.592', '147.815', '167.38', '', 'Cl/C1=C([H])/C([H])=C(C(C(C(O[H])=O)([H])[H])(C(N([H])[H])([H])[H])[H])\\C([H])=C1\\[H]', 'NC[C@H](CC(=O)O)c1ccc(Cl)cc1', 'Baclofen', 'Arbaclofen; STX209; Tocris-0796; BG0394', 'Gamma-aminobutyric acid type B receptor subunit 1', '2284', 'Under Investigation', 'Tardive Dyskinesia', '11816865', 'Tardive Dyskinesia', 'NA'),
(126, '46848915', '46848915', 'COC1=CN(N=C(C1=O)c2ccnn2c3ccccc3)c4ccc(cc4F)n5cccn5', '1-(2-fluoro-4-pyrazol-1-yl-phenyl)-5-methoxy-3-(2-phenylpyrazol-3-yl)pyridazin-4-one', 'CYAAFQwA7cwQFB6QbWaCRwMvVAmLSj6idaY1WdCc$j^395u1y$Dqs2cIwdxArWQ7dVPdRM9kstGNPA74n$YXa3Zo$xUNFsrOaH3ZXz2cHExK8CZjLYvF8$7hi2kXGcbK1^9t7TERgDwk8ISNNPDqgnUlhFMW$htJzPnbG3Hw8VzwwgPrrshdwoDOu^9tY4DOjl9x0Dwh uLduyHOs7EBDFrTWJkIX782tYZ4nsMS60vHHvfZHktMteKiZDy67mi7bvv1hfDQpHOGf8xuQgDhcHd0GYW9HoVlSDP75UXb0mxyddKLAx5wjPMj6ZBqZBSyFeNt92P0ZyLYyywk7eY2hyy1dduAOntXVStin5FX3LboLRZCZzPXrX2B4HvjmqEA3swMUJ7zDTxavZt9n TPRcM7xZPOZI^Y1OOGsOoI3ahU3Q1H12$e2wnV0gKacXymhifsT1k$dZVet6LqPoc$EipE2I97TDXHrg^XapWFHl9bGHz$kk', 'InChI=1S/C23H17FN6O2/c1-32-21-15-29(19-9-8-17(14-18(19)24)28-13-5-11-25-28)27-22(23(21)31)20-10-12-26-30(20)16-6-3-2-4-7-16/h2-15H,1H3', 'AuxInfo=1/0/N:32,29,27,28,30,24,25,22,20,18,31,23,26,21,14,15,17,19,12,10,16,11,13,1,9,8,6,7,4,5,3,2/E:(3,4)(6,7)/rA:49FOONNNNNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:;;;;s4;;s5;s7;s5;d+6s10;s4;d 3s11;s4;s5;s2s13d+14;s7;d-10;s1d-12;s12;d+17s19;s17d-20;d-8s18;d+15;s15;s7;s24;d-25;d-27s28;d-26;d-9s30;s2;s14;s18;s20;s21;s22;s23;s24;s25;s26;s27;s28;s29;s30;s31;s32;s32;s32;/rC:1.2732,1.6491,.6641;- 1.8598,-3.6386,-.7033;-3.3153,-1.4007,-1.578;.4466,-.7729,-.4643;-3.5946,1.6219,-.3897;-.3574,.3', 'KVHRYLNQDWXAGI-UHFFFAOYSA-N', '1010:H6QKZR76B753KKB7MA33KUCKGSGWQY', '[#9]-[c]1:[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7]2-[#6](-[#1])=[#6](-[#6](-[#6](-[c](:[c](-[#1]):[c](-[#1]):[n]3):[n]3-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1])=[#7]2)=[#8])- [#8]-[#6](-[#1])(-[#1])-[#1])-[n]5:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]5', 'Fc1c([H])c(c([H])c([H])c1N2C([H])=C(C(C(c(c([H])c([H])n3)n3c4c([H])c([H])c([H])c([H])c4[H])=N2)=O)OC([H])([H])[H])n5c([H])c([H])c([H])n5', '03.983', '3.857', '1', '0', 'TRUE', '-0.2051\r\n-0.3443\r\n-0.2844\r\n-0.1395\r\n-0.1363\r\n-0.1842\r\n-0.1459\r\n-0.1977\r\n-0.1984\r\n7.74e-002\r\n0.1489\r\n7.99e-002\r\n0.2378\r\n4.3e-002\r\n4.47e-002\r\n0.1375\r\n4.7e-002\r\n-1.96e-002\r\n0.1447\r\n-3.71e-002\r\n-4.1e-003\r\n-3.99e-002\r\n4.4e-002\r\n-4.18e-002\r\n-4.18e-002\r\n9.9e-003', '0', '3.983', 'C23H17FN6O2', '0428.14', '-6.411', '0428.418', '0.17 0.44 0.75', '5', '0', '3', '11', '22', '4', '32', '36', '24', '13', '008', '00', '17', '0', '5', '005', '0077.54', '410.84', '', '6.47437', '1.2878', '88.24', '46.6', '4.98164', '41.64', '1,891.01', '94.352', '317.61', '', 'F/C5=C(N3/N=C(/C1=C([H])/C([H])=N\\N1\\C2=C([H])\\C([H])=C([H])/C([H])=C2/[H])\\C(=O)\\C(OC([H])([H])[H])=C3\\[H])/C([H])=C([H])\\C(N4/N=C([H])\\C([H])=C4\\[H])=C5\\[H]', 'COc5cn(c2ccc(n1cccn1)cc2F)nc(c3ccnn3c4ccccc4)c5=O', 'Balipodect', 'TAK-063', 'Phosphodiesterase 10A (PDE10A)', '46848915', 'Phase II', 'Schizophrenia', '26849714', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(127, '11438771', '11438771', 'Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1c3ccc(F)cc3', '2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethyl-imidazol-4-yl]ethynyl]pyridine', 'CYAAFQwAfewQj37C83yAjD3tYYpN2SxTKbqp1HVIi0MGvOp5M7cwpDoTon9qu0z^olcw57qsCamBWeAkeEHqVt4ZljI6QMGrwA84uH1Bz3y9A1WBgPAce2PabNBW6DnS39TPI8zT$IMAWoWP77mMDHBmwYPMKBwR7$7LlOecKkhm0Ml9F0GL2zSWTUqPYJzjKabsUr60 IgyVZue6Fn5BNcMq3j9d4lqS00T42DwGeZKaI8zhf282dqwlt4zRSDFgHm5yptYWuU1XqRWZ84qXFyuzoky$PEO1451ix^Wb$npSvCIS^Ii^1L91ej6q9ldby$4yfJnAdxUmdhjq5KReZAN83v3i2rITr^8HxYF7DVZ6^2SpFlpkK4nhAaOMKpj96zjFRpv1uTVbLcZL wOzTVfuWzMq6pTLzMGzFKo2pCJyo7pvuq7ChA2wQr$1wdZD3vGlHDwp2hm^mQMnbdeGPaMUfIUsCX1Z16eIFGcGXrFjpG55F', 'InChI=1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3', 'AuxInfo=1/0/N:10,11,18,14,15,12,13,17,21,23,20,6,7,19,16,8,9,22,1,2,5,4,3/E:(4,5)(6,7)/rA:36ClFNNNCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH/rB:;;;;s3;s3d-4;s3;s4d-6;s6;s7;d+8;s8;s12;d-13;s2d+14s15;s9;t17;s18;d+ 19;s19;s1d+5s20;s5d-21;s10;s10;s10;s11;s11;s11;s12;s13;s14;s15;s20;s21;s23;/rC:-7.4283,1.1136,-1.4382;7.3051,-1.1815,-.4851;2.0858,.4762,.141;.3482,1.8151,.5571;-6.8001,-.8697,.1082;.957,-.2901,-.0214 ;1.6586,1.7355,.4895;3.3953,.0607,-.0156;-.0953,.5555,.2403;.9965,-1.7169,-.3994;2.6013,2.8451,.', 'UPZWINBEAHDTLA-UHFFFAOYSA-N', '1010:49HKQ2BRBRB856TXWSS457B348K6Z9', '[#17]-[c]1:[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n]1)-[#6]#[#6]-[c](:[c]2-[#6](-[#1])(-[#1])-[#1]):[n]:[c](-[#6](-[#1])(-[#1])-[#1]):[n]2-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]3-[#1])-[#9]', 'Clc1c([H])c(c([H])c([H])n1)C#Cc(c2C([H])([H])[H])nc(C([H])([H])[H])n2c3c([H])c([H])c(c([H])c3[H])F', '04.371', '4.371', '0', '0', 'TRUE', '-6.23e-002\r\n-0.207\r\n-0.2033\r\n-0.2306\r\n-0.2445\r\n3.63e-002\r\n9.17e-002\r\n2.77e-002\r\n0.1289\r\n-2.59e-002\r\n-1.08e-002\r\n-4.04e-002\r\n-4.04e-002\r\n-2.48e-002\r\n-2.48e-002\r\n0.1228\r\n-4.e-002\r\n-5.98e-002\r\n2.95e-002\r\n-9.e-003\r\n-2.8e-002\r\n0.1297\r\n2.98e-002\r\n2.91e-002\r\n2.9', '0', '4.602', 'C18H13ClFN3', '0325.078', '-7.175', '0325.767', '1.49 10.06', '2', '0', '0', '7', '17', '3', '23', '25', '19', '8', '003', '00', '13', '0', '3', '003', '0030.71', '328.79', '', '1.51897', '1.291', '43.79', '36.11', '4.64037', '7.68', '1,817.88', '43.306', '249.36', '', 'Cl/C3=N/C([H])=C([H])\\C(C#C/C\\2=C(C([H])([H])[H])/N(/C1=C([H])/C([H])=C(F)\\C([H])=C1\\[H])/C(C([H])([H])[H])=N2)=C3\\[H]', 'Cc2nc(C#Cc1ccnc(Cl)c1)c(C)n2c3ccc(F)cc3', 'Basimglurant', 'RO4917523, RG7090', 'Metabotropic glutamate receptor 5', '11438771', 'Under Investigation', 'Fragile X Syndrome', '25665805', 'Fragile X Syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(128, '11269353', '11269353', 'OC[C@@H](NS(=O)(=O)c1ccc(Cl)s1)C(C(F)(F)F)C(F)(F)F', '5-chloro-<I>N</I>-[(1<I>S</I>)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]thiophene-2-sulfonamide', 'CYAAFQwAucwQzS8H05OXmdRgSTVxznNp^tW60ZQ52V19MEl70$YUyGIxerQtZ8jyGeHLeAgS0^tI6F9wjpb55L63UP2aY4$f0^EpMEyYle26n^Zva1KJnGOSwU76MeL9ff^FuP$$BcR5vwJQhK7Dn7e80idDpC7WPmCNEPy7NNsz3rLjHKYgRhHPXeZBoFvM2c8UaWBv 3sQdL8KJr6^L4RDx7iFSAsZR6kPUjh384pjkz0EQ2WrnsIu8e1Ra8g5r2jWpuNCxa0amZ8qSTOjNs61ceZUDpa$gTddAFjKvWsxWQDduD6PI990M6cB64t8NzHFg^U1jv1D5kUBWVo6Oex7TBT7CZzyaxs6RXn5yTWU1KIacEbnYzvcj0Nny$iSzL2w58UbWVWnlI7pp qWTLnyTVDHDpoJ7xzTrjLagosdkYPIcFJHAPlTVDZMYkFXOfAtJhICtV3ukUCBvuxaTGq1akhGWx59JqMxWbSZ89sgHjHroe', 'InChI=1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m1/s1', 'AuxInfo=1/0/N:21,20,16,14,22,19,15,17,18,1,4,5,6,7,8,9,13,10,11,12,3,2/E:(8,9)(11,12,13,14,15,16)(19,20)/it:im/CRV:22.6/rA:30ClSSFFFFFFOOONC.eCCCCCCCCHHHHHHHH/rB:;;;;;;;;;d2;d2;s2;s13;s14;s10s14;s4s5s 6s15;s7s8s9s15;s2s3;d+19;s20;s1s3d+21;s14;s15;s13;s16;s16;s10;s20;s21;/rC:-4.173,3.0376,.6484;-1.4726,-2.0313,.3533;-2.6918,.5087,1.1295;1.5232,.1215,2.4002;3.3245,.0286,1.1788;2.4265,1.9516,1.6299;2. 2385,2.5714,-.7774;3.158,.7089,-1.4359;1.1988,1.2942,-2.198;1.6926,-3.0879,-1.0165;-2.138,-2.504', 'PSXOKXJMVRSARX-SCSAIBSYSA-N', '1010:ZFFXM8CAGGJQD6G37XAK3V1Z2VPK85', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#16](-[#7](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[#1])-[#6](-[#1])(-[#6](-[#9])(-[#9])-[#9])-[#6](-[#9])(-[#9])-[#9])(=[#8])=[#8]):[s]1', 'Clc(c([H])c([H])c1S(N([H])[C@]([H])(C([H])([H])O[H])C([H])(C(F)(F)F)C(F)(F)F)(=O)=O)s1', '02.275', '2.739', '0', '0', 'TRUE', '-7.65e-002\r\n1.422\r\n-9.66e-002\r\n-0.1704\r\n-0.1704\r\n-0.1704\r\n-0.1704\r\n-0.1704\r\n-0.1704\r\n-0.3949\r\n-0.5684\r\n-0.5684\r\n-0.3653\r\n2.93e-002\r\n0.1652\r\n5.71e-002\r\n0.4015\r\n0.4015\r\n-2.6e-003\r\n-6.31e-002\r\n-3.75e-002\r\n7.64e-002\r\n4.74e-002\r\n5.08e-002\r\n9.14e-002\r\n5.79e-002', '1', '2.275', 'C9H8ClF6NO3S2', '0390.954', '-5.996', '0391.738', '10.41', '2', '2', '2', '15', '05', '1', '22', '22', '18', '4', '004', '02', '8', '0', '1', '007', '0103.01', '325.81', '', '2.46768', '1.3793', '55.11', '16.61', '3.14888', '38.5', '843.298', '139.898', '236.66', '', 'Cl/C1=C([H])/C([H])=C(S(=O)(=O)N(C(C(C(F)(F)F)(C(F)(F)F)[H])(C(O[H])([H])[H])[H])[H])\\S1', 'O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1', 'Begacestat (GSI-953)', 'GSI-953; GTPL6979', 'Gamma-secretase', '11269353', 'Failed at Phase I', 'Alzheimer disease (AD)', '19671883', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(129, '3032771', '3032771', 'C\\C(=C(/CCOP(=O)(O)O)\\SC(=O)c1ccccc1)\\N(Cc2cnc(C)nc2N)C=O', '<I>S</I>-[(<I>Z</I>)-2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-1-(2-phosphonooxyethyl)prop-1-enyl] benzenecarbothioate', 'CYAAFQwA1cwQSSCAbVruQYNBQ14B1E4IheexiXb^gdSJ1oXMPHr1cXSw2AKrJ8q6JyL75CzlVdpcXmp7JHB$QLXEDOKELF5WeaXIF1mpJz8wEiLtd0FwPwc^9q3fRpkieUQLHf^ffvc3vCABQBuj$7f4YgzFn5IrL3ZlWIz19wznyhIENqZBuAaFn8c5a^4jPcAwgrOF pETV4xzfVzQ8orrz6AIafJm1wD^uzrDQq^m9F7rP4h1IA5Rp$Mbl4BzrrIMbL7wTAiu$s2mRbJGY1oReXs0tSNbgECEPI7j9pOeN45oG7HsxJRu8peI6JZlLqgVh$wjrmpJ16UtNmBj$ImX2HOoQURG0rYKQoe$rWmvqjOL0v$tr168qI6jnoBYKoet1Rzrrvx4GH1pX GXOPj$wK9r5j54ihkYewQ59ayBczpjnH2S$hquoxaNHzZJihOe0sF7TrPcZk8opbtWraemTeduUafNbz338aeyIeXng$1lz2', 'InChI=1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13-', 'AuxInfo=1/1/N:19,26,31,29,30,27,28,16,18,22,14,21,13,24,25,17,15,20,23,12,11,10,9,4,5,6,7,8,3,2,1/E:(4,5)(6,7)(26,27,28)/rA:54SPOOOOOONNNNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;;;s2;s2;d2;; ;;;s9;s9;s1d-13;s15;s14;s3s16;s13;d+10s12s17;d4s9;s11d+17;s1d5;s10d-11;s23;s24;d+25;s25;s27;d-28;d-29s30;s14;s14;s16;s16;s18;s18;s19;s19;s19;s21;s22;s12;s12;s26;s26;s26;s27;s28;s29;s30;s31;s6;s7;/rC:. 543,-.3086,.6393;5.1022,.5188,-.0594;3.6709,.0506,-.6484;-.158,2.7015,3.1709;-1.1222,-1.1599,-1.', 'BTNNPSLJPBRMLZ-LGMDPLHJSA-N', '1010:T6C4AB9FH9GC861383D137KARKP5KY', '[#16](-[#6](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])=[#8])\\-[#6](\\-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#15](=[#8])(-[#8]-[#1])-[#8]-[#1])=[#6](\\-[#6](-[#1])(-[#1])-[#1])/-[ #7](-[#6](-[#1])=[#8])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[n]:[c](-[#6](-[#1])(-[#1])-[#1]):[n]2):[c]2-[#7](-[#1])-[#1]', 'S(C(c1c([H])c([H])c([H])c([H])c1[H])=O)\\C(\\C([H])([H])C([H])([H])OP(=O)(O[H])O[H])=C(\\C([H])([H])[H])/N(C([H])=O)C([H])([H])c(c([H])nc(C([H])([H])[H])n2)c2N([H])[H]', '00.648', '0.835', '0', '0', 'TRUE', '-4.95e-002\r\n0.4691\r\n-0.2868\r\n-0.2809\r\n-0.2812\r\n-0.3027\r\n-0.3027\r\n-0.2284\r\n-0.2729\r\n-0.2218\r\n-0.2412\r\n-0.2866\r\n1.95e-002\r\n4.84e-002\r\n1.24e-002\r\n4.4e-003\r\n2.48e-002\r\n6.31e-002\r\n-2.54e-002\r\n0.1111\r\n0.2057\r\n3.69e-002\r\n0.2233\r\n0.1265\r\n2.9e-002\r\n-4.3e-003\r\n-5.0', '0', '-1.05', 'C19H23N4O6PS', '0466.108', '-3.148', '0466.448', '2.6 7.38 7.6', '5', '1', '4', '16', '12', '2', '31', '32', '32', '10', '010', '04', '23', '0', '2', '010', '0191.05', '473.72', '', '4.98253', '1.2913', '71.24', '14.67', '4.35676', '56.57', '1,507.95', '271.45', '346.77', '', 'S(/C(=C(N(C(/C1=C([H])/N=C(C([H])([H])[H])\\N=C1\\N([H])[H])([H])[H])C(=O)[H])/C([H])([H])[H])C(C(OP(O[H])(O[H])=O)([H])[H])([H])[H])C(=O)/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H]', 'C/C(=C(CCOP(=O)(O)O)/SC(=O)c1ccccc1)N(C=O)Cc2cnc(C)nc2N', 'Benfotiamine', 'Benphothiamine; Betivina; Biotamin; Nitanevril; Tabiomyl; Vitanevril; milgamma', 'Amyloid beta A4 protein', '3032771', 'Phase II', 'Alzheimer disease (AD)', '20385653', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(130, '2353', '2353', 'COc1ccc2cc3c4cc5OCOc5cc4CC[n+]3cc2c1OC', '12,19-dimethoxy-21,22-dioxa-20-azoniapentacyclo[BLAH.BLAH.BLAH.BLAH.BLAH.BLAH]henicosa-2,4(11),5(13),6(14),7(18),12(19),15,17(20)-octaene', 'CYAAFQwA0cwQtVYhUvtDB14Q1$HAyT$FoOGVLBT87BJdDq^23NgnekczH$bHPE4eWYlsRXQtsWEscA2jMUc9RLkgc9wu^kFbYXLw^BQ4JyhDU9rhjp5WlEjAyTpt9sn80bdtOPXH$8pbSXA666Eu2miMCm^b$DJL43tTfmo59NuQrsCwAdrSxrbpY9lE3QrMhgFuh4xd n055jX1lM2sHU3w4z5syqVVVgd49NEHGrr3a2pHP6WzWFH$onvGXJVVi8c9HFpC40cig6BBFn3I35RqtmVA12BRha5lH$a4izDjwvcCq4J1AvpRExrLiYVtWVzfJF^Wm7^VX6llx9CgRN4^Me5xTdTMKOqoA7QMPVR8c$3uMJskMHB8fnhdXud$IawUQyJJPFsm5nAty 4RhN^9wpR6iPdjeJXe^Ndyw2TVTcBOE6iBMs05xe6gcqf1TJWrX1gmchjXwKvsHm84ePYyrbcIiklDq$TlutfG17L9qYcgZw', 'InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1', 'AuxInfo=1/0/N:25,24,20,23,7,6,12,15,16,11,22,14,9,10,13,8,21,17,18,19,5,4,3,1,2/CRV:21+1/rA:43OOOON+CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;;;s5;s6;d-5;s7;s8s9;s5;s8;d-11;d-12s13;d+9;d+10;s1s15;s2 s16d-17;s3s13;s14;s4d-19;s1s2;d-20s21;s3;s4;s6;s6;s7;s7;s11;s12;s15;s16;s20;s22;s22;s23;s24;s24;s24;s25;s25;s25;/rC:-6.1547,.0362,-.1051;-5.0317,-2.0625,.2639;4.2801,1.461,.324;5.7974,-.7744,-.1678;.0 959,1.2172,.2729;-.673,2.4499,.5795;-1.885,2.5374,-.3278;-.536,.0317,.0321;-2.6986,1.2841,-.1679', 'YBHILYKTIRIUTE-UHFFFAOYSA-N', '1010:1NKSCRX8RKABTP4JSVBFS8CV1PDUUU', '[#8]1-[#6](-[#1])(-[#1])-[#8]-[c](:[c]1:[c]2-[#1]):[c](-[#1]):[c](:[c]2-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[c](:[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[c](:[c]4-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[# 6](-[#1])(-[#1])-[#1]):[c]4:[c]5-[#1]):[n+]35', 'O1C([H])([H])Oc(c1c2[H])c([H])c(c2C([H])([H])C3([H])[H])c(c([H])c(c([H])c([H])c(c4OC([H])([H])[H])OC([H])([H])[H])c4c5[H])[n+]35', '03.962', '3.446', '0', '1', 'TRUE', '-0.316\r\n-0.316\r\n-0.3458\r\n-0.3466\r\n0.2991\r\n7.79e-002\r\n8.2e-003\r\n0.1188\r\n-3.04e-002\r\n2.44e-002\r\n8.35e-002\r\n-9.5e-003\r\n5.08e-002\r\n-8.3e-003\r\n-2.49e-002\r\n-1.75e-002\r\n0.1086\r\n0.1091\r\n0.1159\r\n-5.14e-002\r\n0.1055\r\n0.1585\r\n-2.85e-002\r\n4.23e-002\r\n4.23e-002\r\n7.25e-0', '0', '3.962', 'C20H18NO4', '0336.124', '-5.151', '0336.361', '', '4', '0', '0', '12', '17', '3', '25', '29', '20', '8', '005', '00', '18', '0', '5', '002', '0040.8', '325.21', '', '5.70155', '1.2872', '101.02', '40.03', '4.53729', '60.99', '1,311.66', '72.448', '262.73', '', 'O1/C3=C(OC1([H])[H])/C([H])=C\\2/C4=[N+](C([H])([H])C([H])([H])C2=C3\\[H])/C([H])=C/5\\C(=C4\\[H])\\C([H])=C([H])/C(OC([H])([H])[H])=C5/OC([H])([H])[H]', 'COc5ccc4cc3c2cc1OCOc1cc2CC[n+]3cc4c5OC', 'Berberine', 'Umbellatine; Berberin; Majarine; Umbellatin; Thalsine', 'd(CAG)n huntingtin', '2353', 'Under Investigation', 'Huntington Disease (HD)', '26225560', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(131, '156328', '156328', 'Fc1ccc(CC2CCN(CC[S@](=O)c3ccc4NC(=O)Oc4c3)CC2)cc1', '6-[(S)-2-[4-[(4-fluorophenyl)methyl]-1-piperidyl]ethylsulfinyl]-3<I>H</I>-1,3-benzoxazol-2-one', 'CYAAFQwA7cwQn1agntM2hluzr5GWe9C5xbTpnBsfDmqUwIhXgX8uzMHRHfqiy4Ph06L3IVXzGhTqcRlHLdawBuSG^Thi4KATdG^m1jWO8rAb8hNJ4eaEe9rKoGbRHLAlf^4F7N9$T83L$TMAV4s88QGSur8pqNxByD$ZhwavsfnxK1aK3hzb$c4SFEmn^2iV3v5lVVtT 0ZzMUMvsnL^8Vd6kuzHDeGMIoDQOqPryeWn30o26RAWeLmc$E5$ZwrRedAOyxFoKGbb$jD7MOxKX^YeDhDFkctSynFUTkzal34xMbLvpVd0kWdGpnItwnj2zbWScCVoq8AJY5h1EZmAWU2wUFUA11fObRKp7ynWoeeDAQqGhO05q4sv3Cr9QxU7GvyMwVwZMqrddarK0 VV3TDfhUJiGUOWzhTNTbhM11hGOaV5ZJq6Z9mhVgX3nS2sSRVyuzCzwz5utkmGtUiE7t8WmiawOszU8reMza$dmC7TsrV7Tu', 'InChI=1S/C21H23FN2O3S/c22-17-3-1-15(2-4-17)13-16-7-9-24(10-8-16)11-12-28(26)18-5-6-19-20(14-18)27-21(25)23-19/h1-6,14,16H,7-13H2,(H,23,25)/t28-/m0/s1', 'AuxInfo=1/1/N:17,18,20,21,24,27,9,10,11,12,14,16,13,23,15,8,22,19,26,25,28,2,7,6,5,3,4,1/E:(1,2)(3,4)(7,8)(9,10)/it:im/rA:51S.oFOOONNCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:;d1;;;;;;s8;s8;s6s9 ;s6s10;s8;s6;s13;s1s14;d+15;s15;s1;s17;d-18;s2d+20s21;d+19;s19;s4s23;s7d-25;d-24s26;s4d5s7;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s16;s16;s17;s18;s20;s21;s23;s24;s27;s7;/rC:-3.0244,2.388,.93 03;7.4971,-3.4909,1.0355;-2.8554,2.0926,2.3868;-5.4608,-2.2419,.9005;-6.8895,-3.8562,.0626;.8822', 'FCBQJNCAKZSIAH-NDEPHWFRSA-N', '1010:RTZ58X2UQP1CMK8CKQYR71K258JA9Z', '[#16@](-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c]2:[c]1-[#1])-[#7](-[#1])-[#6](=[#8])-[#8]2)(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1] )-[c]4:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]4-[#1])-[#9])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])=[#8]', '[S@](c1c([H])c([H])c(c2c1[H])N([H])C(=O)O2)(C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])C([H])(C([H])([H])c4c([H])c([H])c(c([H])c4[H])F)C([H])([H])C3([H])[H])=O', '03.771', '3.771', '0', '0', 'TRUE', '0.8039\r\n-0.207\r\n-0.6144\r\n-0.2604\r\n-0.2417\r\n-0.3046\r\n-0.2582\r\n-3.5e-002\r\n-3.72e-002\r\n-3.72e-002\r\n-1.7e-003\r\n-1.7e-003\r\n-2.5e-002\r\n-1.28e-002\r\n-4.76e-002\r\n-5.81e-002\r\n-5.62e-002\r\n-5.62e-002\r\n-8.95e-002\r\n-2.61e-002\r\n-2.61e-002\r\n0.1227\r\n-4.28e-002\r\n-7.39e-002\r\n0.107\r\n6.56e-002\r\n-3.94e-002\r\n0.3602\r\n3.06e-002\r\n2.82e-002\r\n2.82e-002\r\n2.82e-002\r\n2.82e-002\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n4.3e-002\r\n3.18e-002\r\n3.18e-002\r\n4.17e-002\r\n4.17e-002\r\n1.29e-002\r\n1.29e-002\r\n6.26e-002\r\n6.26e-002\r\n6.53e-002\r\n6.53e-002\r\n', '1', '2.227', 'C21H23FN2O3S', '0402.141', '-5.286', '0402.482', '7.23 10.63', '3', '1', '2', '17', '12', '2', '28', '31', '28', '8', '005', '01', '23', '0', '4', '006', '0077.85', '384.74', '', '8.22314', '1.2973', '33.04', '19.76', '5.13828', '13.28', '2,539.54', '162.561', '303.21', '', 'S(=O)(C(C(N2C([H])([H])C([H])([H])C(C(/C1=C([H])/C([H])=C(F)\\C([H])=C1\\[H])([H])[H])([H])C([H])([H])C2([H])[H])([H])[H])([H])[H])/C4=C([H])/C3=C(N([H])C(=O)O3)\\C([H])=C4\\[H]', 'O=c4[nH]c3ccc(S(=O)CCN2CCC(Cc1ccc(F)cc1)CC2)cc3o4', 'Besonprodil', 'CI-1041; PD196860; SCH-58261', 'Glutamate receptor ionotropic, NMDA 2B', '156328', 'Under Investigation', 'Parkinson Disease(PARK)', '16739115', 'Parkinson Disease(PARK)', 'PARK'),
(132, '9782', '9782', 'C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO', '(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>S</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phen anthren-3-one', 'CYAAFQwABdwQz2WkRrB16EP7vNb4pH^JBBCNdT$jrs1koojDPapcDHABjq6YZZzMkpoSG^WzisZdvbx6WZqJaBE1$Og6O$lSwAP2OMYcKRpBoSRQP1cIhnv3H94zMoV0^lhS^xP$9ydfA0E^WgO8qKiHOkQ^xXLRUPaHZsk8urjLm7YnHMgggzn3vUFv4yyfoVBOdwxT ^ELWMeWvucfF3qzBAVc44gzn9mFtww$4emRRmJWr3JsSeGLXv0ws$^JUKMrwxHHbeyKqFLoXNNQcqwHqmr8digTHeqTrlULXr3wCudoccJ$derXoy2kb7fnPIzZYSz1ljv0OYbErbw5fklzxlSCH^0FjcMBieQANAVUXperG7wsiQcXWW1JltQPkHDHjHBfcbyjNEURX w^xUUq2IXfV^6Lwsd4A4F4U192JC171s2w5Rrm1aEqyaacbjUhHKEZPSGzK^X3g6MhxcM^HdHtVqOuzxPN0Ia3jZrEnmu2z2', 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1', 'AuxInfo=1/0/N:22,23,18,19,17,27,24,12,25,13,26,14,20,28,9,8,15,21,16,7,10,11,1,5,6,3,4,2/it:im/rA:57FOOOOOC.eC.oC.eC.eC.eCCC.oC.oC.eCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s8;s1s9;s2s7;s 8;s7;s11s12;s3s10s13;s10;s9;s7;s17;s16s19;d4s11;s14;s16;s16;d-20;s5s21;d-24;d6s25s27;s8;s9;s12;s12;s13;s13;s14;s15;s17;s17;s18;s18;s18;s19;s19;s22;s22;s22;s23;s23;s23;s2;s24;s3;s25;s26;s26;s27;s5;/rC: 1.4455,.1156,1.3147;-2.8941,.0989,1.9879;.4081,2.1711,-1.4455;-4.1938,1.6051,-.5867;-6.6514,.671', 'UREBDLICKHMUKA-DVTGEIKXSA-N', '1010:JU2HGHNTPRNUHT87Z5TZ9KUKD8TR81', '[#9]-[#6@](-[#6@]1(-[#6](-[#1])(-[#1])-[#1])-[#6](=[#6](-[#1])-[#6](-[#6](-[#1])=[#6]1-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])(-[#6@](-[#1])(-[#6]3(-[#1])-[#1])-[#8]-[#1])-[#6@]2(-[#1])-[#6@ ](-[#1])(-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6@@]4(-[#6](-[#6](-[#1])(-[#1])-[#8]-[#1])=[#8])-[#8]-[#1])-[#6@]34-[#6](-[#1])(-[#1])-[#1]', 'F[C@]([C@]1(C([H])([H])[H])C(=C([H])C(C([H])=C1[H])=O)C([H])([H])C2([H])[H])([C@]([H])(C3([H])[H])O[H])[C@]2([H])[C@]([H])(C([H])([H])[C@]([H])(C([H])([H])[H])[C@@]4(C(C([H])([H])O[H])=O)O[H])[C@]34C( [H])([H])[H]', '01.708', '1.708', '0', '0', 'TRUE', '-0.2394\r\n-0.3811\r\n-0.3897\r\n-0.2938\r\n-0.3885\r\n-0.29\r\n9.5e-003\r\n-2.63e-002\r\n4.e-004\r\n0.1517\r\n0.1332\r\n-4.37e-002\r\n-1.49e-002\r\n-7.2e-003\r\n9.01e-002\r\n4.41e-002\r\n-4.32e-002\r\n-5.61e-002\r\n-3.02e-002\r\n-5.34e-002\r\n0.1899\r\n-5.93e-002\r\n-4.91e-002\r\n-6.75e-002\r\n-1.45e-', '1', '1.708', 'C22H29FO5', '0392.2', '-3.784', '0392.461', '', '2', '2', '4', '27', '00', '0', '28', '31', '38', '4', '005', '03', '29', '0', '4', '002', '0094.83', '394.35', '', '2.1701', '1.2908', '68.5', '40.26', '3.95606', '28.24', '1,257.60', '173.181', '317.27', '', 'FC23C([H])(C1([H])C(C([H])([H])[H])(C(O[H])(C(=O)C(O[H])([H])[H])C(C([H])([H])[H])([H])C1([H])[H])C([H])([H])C2(O[H])[H])C([H])([H])C([H])([H])/C4=C([H])/C(=O)/C([H])=C([H])\\C34C([H])([H])[H]', 'C[C@H]4C[C@H]3[C@@H]2CC/C1=C/C(=O)/C=C\\[C@]1(C)[C@@]2(F)[C@@H](O)C[C@]3(C)[C@@]4(O)C(=O)CO', 'Betamethasone', 'Flubenisolone; Celestone; Rinderon; Betacortril; Cellestoderm; Betadexamethasone', 'Glucocorticoid receptor', '9782', 'Phase III Completed', 'Carpal Tunnel Syndrome', '28035909', 'Carpal Tunnel Syndrome', 'CTS\nAMYOTROPHY, THENAR, OF CARPAL ORIGIN'),
(133, '82146', '82146', 'Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)O)C(C)(C)CCC2(C)C', '4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid', 'CYAAFQwA6fwQZwasAAzl2855X4$xSjRBbD1sUZWkmO3f0E8pGEjG58Xq63zQ7PyzmArXekGw$tX7hwXykcm03U^G6spf4m7BHFp6SIdijjaxxTZxujHxrv$5aSV1wtmW9f3$7TERgDwi9CZNyzZ0$uw4$i6ganBgG027A^8FBzXbLC1mjb9ZCvfwUS2b7rdeRwZotrBj PtzpkVsUCphnHBUR5ln3bVnGDGM0vHL5LeFPRrdewYUdHZq$jb1bPucy5VhXr7M0PBjqnBQNYvLB1f5kMCvCjQMUO^tAeuLBpsFKTl$d0Ryz5PwrKUK4kle9gbqxpf6kkH^HPJZCWEdvh79TmkbargT4ixgy68wzdyermHiye^kjU2B$OY$a7^6SsuuzfcUV99zrMzv7 X83L0rrbEaGOuasMLV8BlH4xnfLf6Zz$dm2kKDssfezjw4w8iw6qr5gjT384v00qbaNf9Ra3btS3zmcvHNU0LGmp6ny1vf5k', 'InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)', 'AuxInfo=1/1/N:18,20,11,12,9,10,21,22,23,24,6,5,14,13,16,17,19,25,15,8,7,26,4,3,1,2/E:(3,4)(5,6)(7,8)(9,10)(25,26)/rA:54OOCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s3;s4s5;s3;s4d-7;s3; s3;s4;s4;s7;s8;d-13;d-14s15;s15;s16;s17;d-17;d+19;s19;s21;d-22;d-23s24;s1d2s25;s5;s5;s6;s6;s9;s9;s9;s10;s10;s10;s11;s11;s11;s12;s12;s12;s13;s14;s18;s18;s18;s20;s20;s21;s22;s23;s24;s1;/rC:6.1672,-1.922 2,-1.033;6.6076,.2152,-1.6689;-3.1314,-1.8872,.3159;-4.2164,.6104,-1.0813;-4.6109,-1.6924,-.0837', 'NAVMQTYZDKMPEU-UHFFFAOYSA-N', '1010:ET5RBNQUA6G14YZYC8QPEKJTRGUUQK', '[#8](-[#1])-[#6](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#6](-[#1])-[#1])-[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]2-[#6]3(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[ #1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c]2-[#1]):[c](-[#1]):[c]1-[#1])=[#8]', 'O([H])C(c(c([H])c([H])c1C(=C([H])[H])c(c(C([H])([H])[H])c([H])c(c2C3(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C3([H])[H])c2[H])c([H])c1[H])=O', '06.405', '6.405', '0', '0', 'TRUE', '-0.3279\r\n-0.2609\r\n-1.e-002\r\n-1.01e-002\r\n-4.33e-002\r\n-4.33e-002\r\n-3.8e-002\r\n-3.83e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.01e-002\r\n-5.47e-002\r\n-1.52e-002\r\n-4.3e-002\r\n-1.81e-002\r\n-3.92e-002\r\n-1.84e-002\r\n-9.06e-002\r\n-5.36e-002\r\n-5.36e-002\r\n-', '0', '4.952', 'C24H28O2', '0348.209', '-8.567', '0348.478', '4.63', '1', '0', '2', '14', '12', '2', '26', '28', '37', '8', '002', '01', '28', '0', '3', '003', '0037.29', '401.48', '', '1.35802', '1.2671', '38.68', '14.68', '4.37717', '24', '1,316.99', '92.22', '305.26', '', 'O(C(=O)/C3=C([H])/C([H])=C(/C(/C2=C([H])/C1=C(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])\\C([H])=C2\\C([H])([H])[H])=C([H])\\[H])\\C([H])=C3\\[H])[H]', 'C=C(c1ccc(C(=O)O)cc1)c2cc3c(cc2C)C(C)(C)CCC3(C)C', 'Bexarotene', 'Targretin; bexarotenum; Targret; AK-64115; LG 1069', 'Retinoic acid receptor RXR-alpha', '82146', 'Terminated at Phase III', 'Schizophrenia', '24434091', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(134, '82146', '82146', 'Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)O)C(C)(C)CCC2(C)C', '4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid', 'CYAAFQwA6fwQZwasAAzl2855X4$xSjRBbD1sUZWkmO3f0E8pGEjG58Xq63zQ7PyzmArXekGw$tX7hwXykcm03U^G6spf4m7BHFp6SIdijjaxxTZxujHxrv$5aSV1wtmW9f3$7TERgDwi9CZNyzZ0$uw4$i6ganBgG027A^8FBzXbLC1mjb9ZCvfwUS2b7rdeRwZotrBj PtzpkVsUCphnHBUR5ln3bVnGDGM0vHL5LeFPRrdewYUdHZq$jb1bPucy5VhXr7M0PBjqnBQNYvLB1f5kMCvCjQMUO^tAeuLBpsFKTl$d0Ryz5PwrKUK4kle9gbqxpf6kkH^HPJZCWEdvh79TmkbargT4ixgy68wzdyermHiye^kjU2B$OY$a7^6SsuuzfcUV99zrMzv7 X83L0rrbEaGOuasMLV8BlH4xnfLf6Zz$dm2kKDssfezjw4w8iw6qr5gjT384v00qbaNf9Ra3btS3zmcvHNU0LGmp6ny1vf5k', 'InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)', 'AuxInfo=1/1/N:18,20,11,12,9,10,21,22,23,24,6,5,14,13,16,17,19,25,15,8,7,26,4,3,1,2/E:(3,4)(5,6)(7,8)(9,10)(25,26)/rA:54OOCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s3;s4s5;s3;s4d-7;s3; s3;s4;s4;s7;s8;d-13;d-14s15;s15;s16;s17;d-17;d+19;s19;s21;d-22;d-23s24;s1d2s25;s5;s5;s6;s6;s9;s9;s9;s10;s10;s10;s11;s11;s11;s12;s12;s12;s13;s14;s18;s18;s18;s20;s20;s21;s22;s23;s24;s1;/rC:6.1672,-1.922 2,-1.033;6.6076,.2152,-1.6689;-3.1314,-1.8872,.3159;-4.2164,.6104,-1.0813;-4.6109,-1.6924,-.0837', 'NAVMQTYZDKMPEU-UHFFFAOYSA-N', '1010:ET5RBNQUA6G14YZYC8QPEKJTRGUUQK', '[#8](-[#1])-[#6](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#6](-[#1])-[#1])-[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]2-[#6]3(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[ #1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c]2-[#1]):[c](-[#1]):[c]1-[#1])=[#8]', 'O([H])C(c(c([H])c([H])c1C(=C([H])[H])c(c(C([H])([H])[H])c([H])c(c2C3(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C3([H])[H])c2[H])c([H])c1[H])=O', '06.405', '6.405', '0', '0', 'TRUE', '-0.3279\r\n-0.2609\r\n-1.e-002\r\n-1.01e-002\r\n-4.33e-002\r\n-4.33e-002\r\n-3.8e-002\r\n-3.83e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.01e-002\r\n-5.47e-002\r\n-1.52e-002\r\n-4.3e-002\r\n-1.81e-002\r\n-3.92e-002\r\n-1.84e-002\r\n-9.06e-002\r\n-5.36e-002\r\n-5.36e-002\r\n-', '0', '4.952', 'C24H28O2', '0348.209', '-8.567', '0348.478', '4.63', '1', '0', '2', '14', '12', '2', '26', '28', '37', '8', '002', '01', '28', '0', '3', '003', '0037.29', '401.48', '', '1.35802', '1.2671', '38.68', '14.68', '4.37717', '24', '1,316.99', '92.22', '305.26', '', 'O(C(=O)/C3=C([H])/C([H])=C(/C(/C2=C([H])/C1=C(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])\\C([H])=C2\\C([H])([H])[H])=C([H])\\[H])\\C([H])=C3\\[H])[H]', 'C=C(c1ccc(C(=O)O)cc1)c2cc3c(cc2C)C(C)(C)CCC3(C)C', 'Bexarotene', 'Targretin; bexarotenum; Targret; AK-64115; LG 1069', 'Retinoic acid receptor RXR-gamma', '82146', 'Terminated at Phase III', 'Schizophrenia', '24434091', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(135, '82146', '82146', 'Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)O)C(C)(C)CCC2(C)C', '4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid', 'CYAAFQwA6fwQZwasAAzl2855X4$xSjRBbD1sUZWkmO3f0E8pGEjG58Xq63zQ7PyzmArXekGw$tX7hwXykcm03U^G6spf4m7BHFp6SIdijjaxxTZxujHxrv$5aSV1wtmW9f3$7TERgDwi9CZNyzZ0$uw4$i6ganBgG027A^8FBzXbLC1mjb9ZCvfwUS2b7rdeRwZotrBj PtzpkVsUCphnHBUR5ln3bVnGDGM0vHL5LeFPRrdewYUdHZq$jb1bPucy5VhXr7M0PBjqnBQNYvLB1f5kMCvCjQMUO^tAeuLBpsFKTl$d0Ryz5PwrKUK4kle9gbqxpf6kkH^HPJZCWEdvh79TmkbargT4ixgy68wzdyermHiye^kjU2B$OY$a7^6SsuuzfcUV99zrMzv7 X83L0rrbEaGOuasMLV8BlH4xnfLf6Zz$dm2kKDssfezjw4w8iw6qr5gjT384v00qbaNf9Ra3btS3zmcvHNU0LGmp6ny1vf5k', 'InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)', 'AuxInfo=1/1/N:18,20,11,12,9,10,21,22,23,24,6,5,14,13,16,17,19,25,15,8,7,26,4,3,1,2/E:(3,4)(5,6)(7,8)(9,10)(25,26)/rA:54OOCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s3;s4s5;s3;s4d-7;s3; s3;s4;s4;s7;s8;d-13;d-14s15;s15;s16;s17;d-17;d+19;s19;s21;d-22;d-23s24;s1d2s25;s5;s5;s6;s6;s9;s9;s9;s10;s10;s10;s11;s11;s11;s12;s12;s12;s13;s14;s18;s18;s18;s20;s20;s21;s22;s23;s24;s1;/rC:6.1672,-1.922 2,-1.033;6.6076,.2152,-1.6689;-3.1314,-1.8872,.3159;-4.2164,.6104,-1.0813;-4.6109,-1.6924,-.0837', 'NAVMQTYZDKMPEU-UHFFFAOYSA-N', '1010:ET5RBNQUA6G14YZYC8QPEKJTRGUUQK', '[#8](-[#1])-[#6](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#6](-[#1])-[#1])-[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]2-[#6]3(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[ #1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c]2-[#1]):[c](-[#1]):[c]1-[#1])=[#8]', 'O([H])C(c(c([H])c([H])c1C(=C([H])[H])c(c(C([H])([H])[H])c([H])c(c2C3(C([H])([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C3([H])[H])c2[H])c([H])c1[H])=O', '06.405', '6.405', '0', '0', 'TRUE', '-0.3279\r\n-0.2609\r\n-1.e-002\r\n-1.01e-002\r\n-4.33e-002\r\n-4.33e-002\r\n-3.8e-002\r\n-3.83e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-5.01e-002\r\n-5.47e-002\r\n-1.52e-002\r\n-4.3e-002\r\n-1.81e-002\r\n-3.92e-002\r\n-1.84e-002\r\n-9.06e-002\r\n-5.36e-002\r\n-5.36e-002\r\n-', '0', '4.952', 'C24H28O2', '0348.209', '-8.567', '0348.478', '4.63', '1', '0', '2', '14', '12', '2', '26', '28', '37', '8', '002', '01', '28', '0', '3', '003', '0037.29', '401.48', '', '1.35802', '1.2671', '38.68', '14.68', '4.37717', '24', '1,316.99', '92.22', '305.26', '', 'O(C(=O)/C3=C([H])/C([H])=C(/C(/C2=C([H])/C1=C(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])\\C([H])=C2\\C([H])([H])[H])=C([H])\\[H])\\C([H])=C3\\[H])[H]', 'C=C(c1ccc(C(=O)O)cc1)c2cc3c(cc2C)C(C)(C)CCC3(C)C', 'Bexarotene', 'Targretin; bexarotenum; Targret; AK-64115; LG 1069', 'Retinoic acid receptor RXR-Beta', '82146', 'Terminated at Phase III', 'Schizophrenia', '24434091', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(136, '39042', '39042', 'CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O', '2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid', 'CYAAFQwAjfwQvzZIcIJ1fhwImJyHUkU06qzFFPn2KhqjY6go0Zb9PNP$9ewBPlP6sqYsxKsPrAkeLjgjS7V3dH8tu1mMTSwF$CMw6VpUQeQgFJm5A4F3P^ceWF5ZBuERz^7yl7$5AHwOpCycRIszllEvVEBpGjAqvPd5kjXe1EXvftpdmhRgWxGpX6i^FYFvEdUE1FR1 nHJRnLJ8iIjLmKCrZ$8kXZZ$poLuqgYjMvfKtz$EDdknbh681oKsNUHmvTxYHad5sC8kT18CJl5HlTX$C08CEVhOcwetbN7WtxpXq0mwZTAagn5Br9QnJb6cpg7BePbjHJ8$Jfbtlq$FIQdZv0z$MBn$kluF1Pys89ixKmKsO5yrYRw8WyPTjU7hDze6zvJYCaCYx8Vt zljyR8JyvAjQg0Ydnz18lNUTr^FIcOvN3wgWZDxTrek01uFBAEGOQdRONetuILV6Cyyni0vk5xqu7sr6fmWA9K^iqI93bSKM', 'InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)', 'AuxInfo=1/1/N:12,13,14,15,21,22,23,24,16,17,8,10,9,20,25,11,19,18,7,1,6,5,3,4,2/E:(1,2)(3,4)(5,6)(7,8)(9,10)(23,24)/rA:45ClOOOONCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s2;;s8;s6s8;s2;s7;s7;d+9 ;s9;d+11s14;s11d-15;s3d4s7;d5s6;s19;d+20;s20;s21;d-22;s1d+23s24;s8;s8;s10;s10;s12;s12;s12;s13;s13;s13;s14;s15;s16;s17;s6;s21;s22;s3;s23;s24;/rC:4.9343,-4.3123,.1083;-3.8398,.023,.6388;-5.4111,-2.9116, -.6908;-5.9944,-1.4486,.9333;3.9862,2.2639,.4175;2.1081,1.685,-.8145;-3.924,-1.0596,-.2884;.6406', 'IIBYAHWJQTYFKB-UHFFFAOYSA-N', '1010:D931UDVSXVKY6EV7EHZ73XP812RYM3', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]2-[#1])-[#8]-[#6](-[#6](=[#8])-[#8]-[#1])(-[#6](-[#1])(-[#1] )-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1C(N([H])C([H])([H])C([H])([H])c2c([H])c([H])c(c([H])c2[H])OC(C(=O)O[H])(C([H])([H])[H])C([H])([H])[H])=O)c([H])c1[H]', '03.868', '3.868', '0', '0', 'TRUE', '-8.44e-002\r\n-0.3298\r\n-0.3295\r\n-0.2634\r\n-0.272\r\n-0.3111\r\n0.1541\r\n-1.22e-002\r\n-4.63e-002\r\n1.53e-002\r\n7.64e-002\r\n-2.58e-002\r\n-2.58e-002\r\n-5.64e-002\r\n-5.64e-002\r\n-3.15e-002\r\n-3.15e-002\r\n0.2906\r\n0.2429\r\n3.71e-002\r\n-4.83e-002\r\n-4.83e-002\r\n-4.28e-002\r\n-4.28e-002', '0', '2.397', 'C19H20ClNO4', '0361.108', '-5.877', '0361.819', '3.86', '3', '1', '2', '12', '12', '2', '25', '26', '27', '8', '005', '02', '20', '0', '2', '007', '0075.63', '371.82', '', '3.12743', '1.2736', '61.33', '6.63', '4.24871', '54.7', '1,500.02', '140.261', '282.28', '-178.85', 'Cl/C2=C([H])/C([H])=C(C(=O)N(C(C(/C1=C([H])/C([H])=C(OC(C([H])([H])[H])(C([H])([H])[H])C(O[H])=O)\\C([H])=C1\\[H])([H])[H])([H])[H])[H])\\C([H])=C2\\[H]', 'CC(C)(Oc2ccc(CCNC(=O)c1ccc(Cl)cc1)cc2)C(=O)O', 'Bezafibrate', 'Bezalip; Cedur; Sklerofibrat; Difaterol; Solibay; Eulitop', 'Peroxisome proliferator-activated receptor alpha (PPAR-alpha)', '39042', 'Clinical Trail Completed', 'Adrenoleukodystrophy', '22447153', 'Adrenoleukodystrophy', 'ADDISON DISEASE AND CEREBRAL SCLEROSIS\nSIEMERLING-CREUTZFELDT DISEASE\nBRONZE SCHILDER DISEASE\nMELANODERMIC LEUKODYSTROPHY'),
(137, '73755047', '73755047', 'COc1ccc(nc1)c2ccc(OC[C@@H]3C[C@H](O[C@H]3C)C(=O)NS(=O)(=O)c4ccccc4C)cc2', '(2<I>S</I>,4<I>S</I>,5<I>S</I>)-4-[[4-(5-methoxy-2-pyridyl)phenoxy]methyl]-5-methyl-<I>N</I>-(o-tolylsulfonyl)tetrahydrofuran-2-carboxamide', 'CYAAFQwANfwQ2x3dTqwvm4yyQOa0BMo1ZBEStAfDgzJE^d^90XTkLAML29$WLGpHHtSG5eppYC$kY52ZSbQXcBPKfhFRDBrrS9RFA5KVtFreBK6mH5MQ^kJl6Rv^iNeFcqgV$j3f9$3vXI^9rBcA61DILyebdwxNn1YsDBGeK9lK5hDmUQFfZWBjoyOQ$zFD$jHWCpLj KFKWDaFNgb^hw9VuNk$g7Dv2IOgx1dOeryXxI8cFKBJ6617mPiLktLwMq2fNebPbS$d3i0ThDGLrsfXzhFS8eHJWSMDK5JfkHeWtCmje0o9xB0gVfzjHmp3ajFd6^MzPaVwaPnif90sV0BDdzqZjRxq2PUWxkuX7fc6AxbRob^Ie9PJ37VJbkSJ8NbqZb8^VYxxDgNXM 5gxa6fNAe2OtrMVEmTHTY7l6w73sAiK5hVtGZwu5tzjkG4ce2WFdej8NTDtKMdvnOS8u2DpD3BAQW37ewyL1ddJZftpUlk9j', 'InChI=1S/C26H28N2O6S/c1-17-6-4-5-7-25(17)35(30,31)28-26(29)24-14-20(18(2)34-24)16-33-21-10-8-19(9-11-21)23-13-12-22(32-3)15-27-23/h4-13,15,18,20,24H,14,16H2,1-3H3,(H,28,29)/t18-,20-,24-/m0/s1', 'AuxInfo=1/1/N:27,15,35,29,28,26,22,23,24,19,20,32,31,12,33,14,21,11,25,10,17,34,30,13,18,16,9,8,4,5,6,7,3,2,1/E:(8,9)(10,11)(30,31)/it:im/CRV:35.6/rA:63SOOOOOONNC.eC.oCC.eCCCCCCCCCCCCCCCCCCCCCCHHHHHHH HHHHHHHHHHHHHHHHHHHHH/rB:;;;d1;d1;;s1;;;s2s10;s10;s2s12;s3s10;s11;d4s8s13;s3;s1;d+17;s17;s18;d+18;s19;d-20;d-23s24;d-21;s21;s22;s26d-28;d+9s25;s30;d-31;s9;s7s32d+33;s7;s10;s11;s12;s12;s13;s14;s14;s15; s15;s15;s8;s19;s20;s22;s23;s24;s26;s27;s27;s27;s28;s29;s31;s32;s33;s35;s35;s35;/rC:5.9783,-.9118', 'BGXAOTTWXYPIQN-WXVUKLJWSA-N', '1010:7TH75X9HYE8TS97NBFQXB7YGSGSZD9', '[#16](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[#1])(-[#7](-[#1])-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[c]2:[c](-[#1]):[c](-[# 1]):[c](-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[n]3)-[#8]-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]2-[#1])-[#6@]4(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]4)=[#8])(=[#8])=[#8]', 'S(c1c([H])c([H])c([H])c([H])c1C([H])([H])[H])(N([H])C([C@]([H])(C([H])([H])[C@@]([H])(C([H])([H])Oc2c([H])c([H])c(c3c([H])c([H])c(c([H])n3)OC([H])([H])[H])c([H])c2[H])[C@]4([H])C([H])([H])[H])O4)=O)(= O)=O', '03.772', '3.772', '0', '0', 'TRUE', '1.4542\r\n-0.3654\r\n-0.3458\r\n-0.2777\r\n-0.5663\r\n-0.5663\r\n-0.3478\r\n-0.3801\r\n-0.2536\r\n1.17e-002\r\n6.08e-002\r\n-1.04e-002\r\n0.1317\r\n5.86e-002\r\n-3.83e-002\r\n0.2153\r\n7.49e-002\r\n-3.57e-002\r\n-3.12e-002\r\n-3.12e-002\r\n-6.03e-002\r\n-7.12e-002\r\n-5.03e-002\r\n-5.03e-002\r\n2.e-004\r\n-6.06e-002\r\n-4.1e-002\r\n-6.35e-002\r\n-6.21e-002\r\n7.03e-002\r\n-3.32e-002\r\n-2.81e-002\r\n5.78e-002\r\n9.28e-002\r\n4.22e-002\r\n3.54e-002\r\n6.04e-002\r\n3.03e-002\r\n3.03e-002\r\n7.04e-002\r\n5.76e-002\r\n5.76e-002\r\n2.56e-002\r\n2.56e-002\r\n2.56e-002\r\n0.1134\r\n6.5e-002\r\n', '1', '4.236', 'C26H28N2O6S', '0496.167', '-6.94', '0496.575', '1.97 8.04', '7', '1', '3', '17', '18', '3', '35', '38', '37', '12', '008', '01', '28', '0', '4', '008', '0112.2', '487.4', '', '5.63696', '1.2879', '76.36', '19.87', '5.73815', '56.49', '3,483.64', '157.39', '384.15', '', 'S(=O)(=O)(N(C(=O)C3([H])OC(C([H])([H])[H])([H])C(C(O/C2=C([H])/C([H])=C(/C1=N/C([H])=C(OC([H])([H])[H])\\C([H])=C1\\[H])\\C([H])=C2\\[H])([H])[H])([H])C3([H])[H])[H])/C4=C([H])/C([H])=C([H])\\C([H])=C4\\C([H])([H])[H]', 'COc4ccc(c3ccc(OC[C@@H]2C[C@@H](C(=O)NS(=O)(=O)c1ccccc1C)O[C@H]2C)cc3)nc4', 'BGC20-1531', 'GTPL3380;', 'Prostaglandin E2 receptor EP4 subtype', '73755047', 'Withdrawn at Phase II', 'Migraine', '19154437', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(138, '138', 'Not Available', 'Cc1ccc2nc(sc2c1)c3ccc(NCCOCCOCCOCCO)cc3', '2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]ethanol', 'CYAAFQwAydwQXGUy^45iBvc7qEPaDvcyMCCihdn53ggJBUii8RwMmnngRsD0EqGRAxfMpzDp3y6N$Tp1LUW4Iu6TZ2RBrVAHnD$ja3AJn$RV^bwgkgIqIkofxALfswsZxuVIitDALeOFqC60g7lBkDv$S55CFll98dp452REqL^ht5gvcKLt^z8ZP3l9FixSfWL37Tdt P1rT2fJ0CdR2XxNX0kP0pMX9Hmn9GckzPTbuXwee5L9510JCJ6zKftrb0My5S2NFkCzj^CE99$2mzM6Hf7ndPz7wvlAIdOo9yyIY2tP9T2^5by5deZ08W9wd9m$$EatSjzb2o8YveaH0Ddm33l38zBqv5xbi6AvXg43Fct$zezn0p^cnczGXA9mPzHmiXUd^Cf2VKI$V viomhaiYifDiW2ymFeyrqK5eUlImpKScpDhBKgalTGScYNrYitciskft1SsdPlqO0UyUaBoE5XUHi02r0wo$tAsI3GBQijy8', 'InChI=1S/C22H28N2O4S/c1-17-2-7-20-21(16-17)29-22(24-20)18-3-5-19(6-4-18)23-8-10-26-12-14-28-15-13-27-11-9-25/h2-7,16,23,25H,8-15H2,1H3', 'AuxInfo=1/0/N:29,6,11,12,13,14,4,17,27,18,26,20,24,21,23,3,5,10,15,2,1,8,16,9,28,19,25,22,7/E:(3,4)(5,6)/rA:29CCCCCCSCNCCCCCCNCCOCCOCCOCCOC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;s2d-8;s8;s10;d+10;d-11;s12;s13d -14;s15;s16;s17;s18;s19;s20;s21;s22;s23;s24;s25;s26;s27;s5;/rC:8.2393,-12.945,0;8.6518,-13.6595,0;7.4143,-12.945,0;8.2393,-14.3739,0;7.0018,-13.6595,0;7.4143,-14.3739,0;8.7914,-12.3319,0;9.545,-12.667 5,0;9.4588,-13.4879,0;10.2595,-12.255,0;10.2595,-11.43,0;10.974,-12.6675,0;10.974,-11.0174,0;11.', 'OMNADQKBOIYQPW-UHFFFAOYSA-N', '1010:ZVXKW3VDBDTQRVD76HS22P4N96UGPS', '[c]12:[c](:[n]:[c](-[c]3:[c]:[c]:[c](-[#7]-[#6]-[#6]-[#8]-[#6]-[#6]-[#8]-[#6]-[#6]-[#8]-[#6]-[#6]-[#8]):[c]:[c]3):[s]1):[c]:[c]:[c](-[#6]):[c]2', 'c12c(nc(c3ccc(NCCOCCOCCOCCO)cc3)s1)ccc(C)c2', '03.201', '3.247', '0', '0', 'TRUE', '3.97e-002\r\n7.83e-002\r\n-4.31e-002\r\n-3.5e-002\r\n-4.99e-002\r\n-5.71e-002\r\n-6.73e-002\r\n0.1088\r\n-0.2399\r\n7.1e-003\r\n-5.07e-002\r\n-5.07e-002\r\n-4.36e-002\r\n-4.36e-002\r\n1.46e-002\r\n-0.2864\r\n2.35e-002\r\n5.95e-002\r\n-0.3777\r\n7.01e-002\r\n7.01e-002\r\n-0.3767\r\n7.01e-002\r\n7.01e-002\r\n-0.3767\r\n6.98e-002\r\n6.65e-002\r\n-0.394\r\n-3.98e-002', '0', '3.2', 'C22H28N2O4S', '0416.177', '-6.678', '0416.534', '3.03 4.85', '4', '2', '0', '15', '16', '3', '29', '31', '3', '7', '006', '02', '28', '0', '3', '013', '0101.08', '441', '', '', '', '', '', '', '', '', '', '', '', '', '', 'BI 425809', 'Not Available', 'Glycine transporter type-1', 'Not Available', 'Suspended at Phase II', 'Schizophrenia', '29076028', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(139, '208951', '208951', 'O=C1Nc2cccc(N3CCN(Cc4cccc(c4)c5ccccc5)CC3)c2O1', '7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3<I>H</I>-1,3-benzoxazol-2-one', 'CYAAFQwADdwQymVY^hcam9iF0Hpga^zZw$0FIcqFDRThUSARG5c37wl59EK$G54cRp0FP7Kqbzvit3EYIwhe4RU4Hx$Ok3C3kzhprOyPnXXnOVhMiFd6C6CIUQbR72Pu12qfC8g8jsLwawtPDIexabsjOUwVyftEHmxZe45T7UcTe7xrPZAy55TrmIYokhHMqKfd5JP1 jO81xOsYtIwC$WzVt7Tfkipm1R0V9Qq8XEGeGrGQjZeAxKVZXLH^n11iZ4vHXla4He2wwi3HNJG7uNWZ941TYYjGAJ0uJsx4XMo27om1w^zdycKCnlgc0pnn76EockgHVVryFquebAmCnp8qOoXP^JCKhEP6xpponaKs7KEgrpd3jrSOh0hmkLv758aSrgyjFptee3ik NtK059lZQskx8wmvcBLcO9cA7pG1dTFHN^3hPfAnv$aYKzJ9bED4G6pD7$0gzcUoZWoSGS3ZNfYnZROezKblLDXRZZ8n0yWy', 'InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)', 'AuxInfo=1/1/N:29,27,28,21,18,17,25,26,23,19,14,6,7,8,9,16,10,12,24,20,15,11,13,22,5,3,4,2,1/E:(2,3)(7,8)(12,13)(14,15)/rA:52OONNNCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3;s3;s4s6;s4s7; s3;s4;s10;s1s11;d+11;s5d-13;d+12;s12;s14;s15d-18;s16;d-17;s1d2s5;d-20s21;s20;d+24;s24;s25;d-26;d-27s28;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s14;s16;s17;s18;s19;s5;s21;s23;s25;s26;s27;s28;s29;/rC:4.8793,-.9 463,.3586;6.9658,-1.8937,.6716;-.275,-1.3717,.6151;2.1292,.0509,.0192;6.7575,.3331,.0159;-.0051,', 'CYGODHVAJQTCBG-UHFFFAOYSA-N', '1010:QXSEQGW4FSVYFDYPYZ2ACP7RJ3V7QH', '[#8]1-[#6](-[#7](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[c]5:[c](-[#1]):[c](- [#1]):[c](-[#1]):[c](-[#1]):[c]5-[#1]):[c]4-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c]12)=[#8]', 'O1C(N([H])c(c([H])c([H])c([H])c2N(C([H])([H])C([H])([H])N3C([H])([H])c4c([H])c([H])c([H])c(c5c([H])c([H])c([H])c([H])c5[H])c4[H])C([H])([H])C3([H])[H])c12)=O', '04.561', '4.561', '0', '0', 'TRUE', '-0.2587\r\n-0.2417\r\n-0.2966\r\n-0.2702\r\n-0.2581\r\n1.17e-002\r\n1.17e-002\r\n1.59e-002\r\n1.59e-002\r\n2.34e-002\r\n5.07e-002\r\n-3.34e-002\r\n0.1265\r\n-4.12e-002\r\n6.74e-002\r\n-4.99e-002\r\n-5.77e-002\r\n-5.87e-002\r\n-3.79e-002\r\n-1.81e-002\r\n-6.14e-002\r\n0.3603\r\n-5.44e-002\r\n-1.84e-00', '0', '4.58', 'C24H23N3O2', '0385.179', '-5.069', '0385.458', '2.61 3.2 8.85', '2', '1', '1', '14', '18', '3', '29', '33', '27', '10', '005', '01', '23', '0', '5', '004', '0044.81', '378.46', '', '3.21177', '1.279', '82.33', '23.96', '4.89212', '58.37', '1,987.70', '94.012', '306.64', '', 'O1/C2=C(N([H])C1=O)/C([H])=C([H])\\C([H])=C2\\N5C([H])([H])C([H])([H])N(C(/C4=C([H])/C(/C3=C([H])/C([H])=C([H])\\C([H])=C3\\[H])=C([H])\\C([H])=C4\\[H])([H])[H])C([H])([H])C5([H])[H]', 'O=c5[nH]c4cccc(N3CCN(Cc2cccc(c1ccccc1)c2)CC3)c4o5', 'Bifeprunox', 'Bifeprunoxum; L001659; A822533', 'D(2) dopamine receptor', '208951', 'Terminated at Phase III', 'Schizophrenia', '18597078', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(140, '71587645', '71587645', 'CC(C)c1ccc(NC(=O)Oc2ccc3N[C@H]4NCC[C@@]4(C)c3c2)cc1', '[(3<I>a</I><I>R</I>,8<I>b</I><I>S</I>)-8<I>b</I>-methyl-2,3,3<I>a</I>,4-tetrahydro-1<I>H</I>-pyrrolo[2,3-b]indol-7-yl] <I>N</I>-(4-isopropylphenyl)carbamate', 'CYAAFQwA3cwQp2NRIQU6dXOODP3eTbqQlDfY41Km9ZTuI2tkjyi2i$wjEVW2lkNvAwp9^QUYE54q8U33MZFZgPrwQfC6XUxiwYtk$XK2cearFNNF8GDr39e9qwSU1Dcp^f9had9$Q8^K9TMAOEg8zDrU6eIhs6f15rmCLqrWA760czUokC4TZTV^uP86g3xgbduLbyBP T3Vps6rWwqndjad10vQGmD2G4t7Dpyl1kN08I63TnQv8zn1hlpawR4oH5N24wFrSpTBcFS8dYmo$DlLaytzzVuNkE2RPBkJR31ZQ$sjLkmJtZikwktWKJHP8xl62qe69VMwIprdftAcgfpQuBOon$7uM9oHwSjW4ihCZHlW7iNxBYMxtjBXlgMv31r90pj3bJWjG4jtV AefRx9zQMjcR3yWT5W9aaA0MuuvmZn8340LOTcPCj7ji9rhlKksxDNbAuKalNuzD5bvntekF67ZAn7TFmueIUYjxdfmkbQvS', 'InChI=1S/C21H25N3O2/c1-13(2)14-4-6-15(7-5-14)23-20(25)26-16-8-9-18-17(12-16)21(3)10-11-22-19(21)24-18/h4-9,12-13,19,22,24H,10-11H2,1-3H3,(H,23,25)/t19-,21+/m1/s1', 'AuxInfo=1/1/N:25,26,11,21,22,23,24,16,14,8,10,13,18,19,20,15,9,12,7,17,6,3,5,4,2,1/E:(1,2)(4,5)(6,7)/it:im/rA:51OONNNC.eC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s3s4s6;s6;s6;s3s8;s6;s4d -9;s9;s12;s1d+13;d-14s15;s1d2s5;;s18;s5;d+19;s19;d+20s21;s20d-22;s18;s18;s7;s8;s8;s10;s10;s3;s4;s11;s11;s11;s13;s14;s16;s18;s5;s21;s22;s25;s25;s25;s26;s26;s26;s23;s24;/rC:-.2506,-1.5867,-.7415;.5323,. 0125,.7387;-6.0884,1.8196,.7957;-5.3679,-.634,1.0668;1.9852,-1.1138,-.7114;-4.6698,.7397,-.8179;', 'ZIGIADNCAWZUAB-CTNGQTDRSA-N', '1010:NXQ8ND6KJEXK3JHEHRHHVS7FYDDRVH', '[#8](-[#6](-[#7](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]1-[#1])=[#8])-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#6@](-[#6](-[#1 ])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#1])-[#6@]34-[#1])-[#7]4-[#1]):[c]2-[#1]', 'O(C(N([H])c(c([H])c([H])c1C([H])(C([H])([H])[H])C([H])([H])[H])c([H])c1[H])=O)c(c([H])c([H])c(c2[C@](C([H])([H])[H])(C([H])([H])C([H])([H])N3[H])[C@]34[H])N4[H])c2[H]', '04.231', '4.231', '0', '0', 'TRUE', '-0.2623\r\n-0.2417\r\n-0.3009\r\n-0.2718\r\n-0.2607\r\n2.41e-002\r\n7.1e-002\r\n-2.83e-002\r\n-1.85e-002\r\n-2.5e-003\r\n-5.27e-002\r\n1.99e-002\r\n-2.56e-002\r\n-4.13e-002\r\n8.73e-002\r\n-2.95e-002\r\n0.36\r\n-2.19e-002\r\n-4.54e-002\r\n3.46e-002\r\n-5.7e-002\r\n-5.7e-002\r\n-4.04e-002\r\n-4.04e-00', '1', '3.104', 'C21H25N3O2', '0351.195', '-5.441', '0351.442', '1.26 4.1 9.16', '2', '3', '1', '16', '12', '2', '26', '29', '30', '7', '005', '03', '25', '0', '4', '004', '0062.39', '358.53', '', '1.38675', '1.2708', '117.41', '61.71', '5.56227', '55.7', '1,884.09', '117.562', '292.57', '', 'O(/C3=C([H])/C2=C(N([H])C1([H])N([H])C([H])([H])C([H])([H])C12C([H])([H])[H])\\C([H])=C3\\[H])C(=O)N(/C4=C([H])/C([H])=C(C(C([H])([H])[H])(C([H])([H])[H])[H])\\C([H])=C4\\[H])[H]', 'CC(C)c4ccc(NC(=O)Oc3ccc2N[C@H]1NCC[C@@]1(C)c2c3)cc4', 'Bisnorcymserine', 'Not Available', 'Butyrylcholinesterase', '71587645', 'Phase I', 'Alzheimer disease (AD)', '16988481', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(141, '11203271', '11203271', 'NCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1', '2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl 4-aminobutanoate', 'CYAAFQwAacwQHMDGQb$hSY7PSKFYc002Y6gnj^ROFKaXuyYQkUVbyrG0tTawzkzyl1$Ww3WEabinlFsFQeUC1AJvhB4rYNvfUJGz7prIhb$Wfd4i3S0gl^GTPPu$xc1rla$K^JPw7l7^AsY$RUN4szCHHu55j^GNcY9ufc6yTW$4RcwZoH3n5tDATE871K^l3xL36C6O KfajTOfj^tCa6xLrMCBouCypeITPPwoICSuXnvWFEGY0j4LPf5CM0hn12PBm4g3TL65YB3ug9qyi5Sem8VHYP2mII$Oe0W0RDUVkTtSwL45eQFyhRQ8^XMVByfuBpMeak7nZyMCKnQLuz40Lrq3zf3RQtPSAIdEPAoR^7$iZvsiVKAuzpKuMir4j$^aDhEN5FqrOkK6h lz1Dq$SG4vGDRlI4YIt6zR8PFkNqGX^HuH4JeWzqj4CHSg6v7pnzu16zoDXdPkNz9npV4hdJKBje8Wldonb5HxO^J5ekyl5H', 'InChI=1S/C25H33ClN4O2S/c26-20-8-9-24-22(19-20)30(21-5-1-2-6-23(21)33-24)12-4-11-28-13-15-29(16-14-28)17-18-32-25(31)7-3-10-27/h1-2,5-6,8-9,19H,3-4,7,10-18,27H2', 'AuxInfo=1/0/N:28,30,32,14,23,25,31,29,24,33,13,16,9,10,11,12,15,17,22,27,19,18,21,20,26,1,8,5,6,7,4,3,2/E:(13,14)(15,16)/rA:66ClSOONNNNCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;; ;;;;s5;s5;s6s9;s6s10;s5;s13;s6;s7s14;s3s15;s7;s7;s2d-18;s2s19;s18;d+19;s20;d+21;s3d4;s1d+22;s23;d-24s27;s25d-28;s26;s31;s8s32;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s22; s23;s24;s25;s28;s29;s30;s31;s31;s32;s32;s33;s33;s8;s8;/rC:.3439,3.4898,.8891;6.223,2.0698,-.8494', 'BABFYCSPNDKXRI-UHFFFAOYSA-N', '1010:5DVVF2FFM4HRJ7TNUK6S77UASYPHTH', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2-[#7](-[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#16]1)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]4-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#6](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]):[c]2-[#1]', 'Clc(c([H])c([H])c1c2N(c3c(c([H])c([H])c([H])c3[H])S1)C([H])([H])C([H])([H])C([H])([H])N4C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])OC(C([H])([H])C([H])([H])C([H])([H])N([H])[H])=O)C([H])([H])C4([H] )[H])c2[H]', '04.144', '4.144', '0', '0', 'TRUE', '-8.43e-002\r\n-8.68e-002\r\n-0.3147\r\n-0.2667\r\n-0.3008\r\n-0.2985\r\n-0.2429\r\n-0.3305\r\n1.1e-002\r\n1.1e-002\r\n1.1e-002\r\n1.1e-002\r\n-6.e-004\r\n-2.68e-002\r\n2.24e-002\r\n9.3e-003\r\n6.9e-002\r\n3.72e-002\r\n3.58e-002\r\n3.08e-002\r\n3.07e-002\r\n-2.38e-002\r\n-4.25e-002\r\n-4.52e-002\r\n-4.6', '0', '0.766', 'C25H33ClN4O2S', '0488.201', '-5.445', '0489.073', '5.38 8.06 9.71 10.51', '2', '1', '1', '23', '12', '2', '33', '36', '37', '7', '006', '02', '33', '0', '4', '011', '0087.34', '498.88', '', '1.66543', '1.2875', '40.35', '3.65', '6.19686', '36.7', '3,775.69', '153.083', '387.24', '', 'Cl/C4=C([H])/C2=C(S/C1=C([H])/C([H])=C([H])\\C([H])=C1\\N2C(C(C(N3C([H])([H])C([H])([H])N(C(C(OC(=O)C(C(C(N([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])([H])[H])([H])[H])([H])[H])\\C([H])=C4\\[H]', 'NCCCC(=O)OCCN4CCN(CCCn3c1ccccc1sc2ccc(Cl)cc23)CC4', 'BL-1020', 'Perphenazine GABA ester', 'D(2) dopamine receptor', '11203271', 'Phase II Completed', 'Schizophrenia', '20047163', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(142, '125564', '125564', 'CCN1CCN(CC1)c2cc(c3CCCCCCc3n2)c4ccc(F)cc4', '2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine', 'CYAAFQwA5ewQnudFF6nbBV8tUO6b5nASbwESpW1chz55n3zsVSDU0CvgTqwy1$uC19ht1dN^IgM6yvsCPqIftz$rQZOv3gqjtiNT5wkCc1WSatVzb7V2rPvKbSd1zvWQK2^3PYPirBcAFI7R3xom5HIpsNh5ZnvwOYz1Px77ClCtB$GjTYfwR7U$Ze72DsxpWhfxcyW2 4VGQrDm8^lXXZu5hhrz9384KirDRG1wxrnMB$pdAEK^eecYVlrEqPFQIsymnPNkIgg44ZjQ9Z6pVgoSndqMULFc58ETFjU77zQtgHVo0jfeWJQu3eUlM4^MhhMj8LGMpfmBISEeuo72HxFPVIFPQrlM5nlGvE0xGhsfOeLLAw21aImiKLFXV6xyRDGBZ8Qxp9zI9n9aT lY0Q8BaKdEZhXrOXvuU3pr7QL3CyPsigy7c8Lup6it$PnK0moT88PZNTflh45Ykf6W$AHpO01WvH2h5b0p3H6nR1peuqaq7N', 'InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3', 'AuxInfo=1/0/N:22,19,15,17,13,16,10,14,23,24,25,26,7,8,5,6,20,21,27,9,18,11,12,1,4,3,2/E:(9,10)(11,12)(13,14)(15,16)/rA:57FNNNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s2;s3s5;s3s6 ;;s9;s4d+9;s2d+4;s10;s11;s13;s14;s15s16;s9;s3;s12d-18;s18;s19;d+21;s21;s23;d-24;s1d+25s26;s5;s5;s6;s6;s7;s7;s8;s8;s10;s10;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s19;s19;s20;s22;s22;s22;s23;s24;s25;s2 6;/rC:4.9164,4.2591,-.4364;-2.5109,-.0306,.0517;-5.3029,.5366,-.153;-.8853,-1.6678,.573;-3.112,1', 'XVGOZDAJGBALKS-UHFFFAOYSA-N', '1010:DU8EDF85TFRFW1PF45H1UBHF53SMBC', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[#1]):[c](:[n]2)-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c]4 :[c]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1c(c([H])c(n2)N3C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C3([H])[H])c4c2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])c([H])c1[H]', '05.843', '5.843', '0', '0', 'TRUE', '-0.207\r\n-0.2569\r\n-0.301\r\n-0.241\r\n1.73e-002\r\n1.73e-002\r\n1.14e-002\r\n1.14e-002\r\n-1.85e-002\r\n-2.55e-002\r\n4.61e-002\r\n0.109\r\n-4.92e-002\r\n-1.01e-002\r\n-5.3e-002\r\n-4.78e-002\r\n-5.3e-002\r\n-1.02e-002\r\n-4.6e-003\r\n-1.68e-002\r\n-1.78e-002\r\n-5.25e-002\r\n-5.15e-002\r\n-5.15e-', '0', '4.661', 'C23H30FN3', '0367.242', '-6.176', '0367.503', '3.63 8.78', '1', '0', '0', '18', '12', '2', '27', '30', '34', '6', '003', '00', '30', '0', '4', '003', '0019.37', '392.86', '', '0.50958', '1.271', '71.47', '26.81', '4.66008', '44.66', '1,394.12', '10.061', '318.64', '', 'F/C4=C([H])/C([H])=C(/C2=C([H])/C(N1C([H])([H])C([H])([H])N(C(C([H])([H])[H])([H])[H])C([H])([H])C1([H])[H])=N\\C3=C2\\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])\\C([H])=C4\\[H]', 'CCN4CCN(c3cc(c1ccc(F)cc1)c2CCCCCCc2n3)CC4', 'Blonanserin', 'Lonasen; P111009', 'D(2) dopamine receptor', '125564', 'Phase III Completed', 'Schizophrenia', '26343601', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(143, '58075317', '58075317', 'CNc1nc(Nc2ccc(c(OC)c2)n3cnc(C)n3)nc4[C@H](CCc14)c5ccc(F)cc5', '(7<I>R</I>)-7-(4-fluorophenyl)-<I>N</I>2-[3-methoxy-4-(3-methyl-1,2,4-triazol-1-yl)phenyl]-<I>N</I>4-methyl-6,7-dihydro-5<I>H</I>-cyclopenta[d]pyrimidine-2,4-diamine', 'CYAAFQwAdfwQt2lYfUBoyo8gYo0tPW$4InB5Q0c6jFbvLCVjugAUDnvQ5ZGo$PChJ7f7UWerHzVxtXPdqkwY6ltXRAsEqktMcwMoMs2qT6jwRI79OqBSn9sEKsSEzTdpvaxOXu7jrh1787ZfpUxAk^hFcbAwoC3VPXZOojZZ89Av0LJmUh3E^Z90Vd0qnLP5wtiw2rCi M3TVV0IsyX7chXeb9JVgDqFrMeCt4PPuYIEElZonuxjGvsDQGlKf04xw5xuvvuxaQFwxh66xl6ZePtjpQfhD6MUwDE8Vzrb8HJPN80zpGEIy910DO849hFoMMH^TV98X8XbbSZfUHFbLc2mBRjRALdfQTmp54dwJK0dz46Dl82$gcSLyeeZsYjcGvHRraqDP7xgmmcK7 Img$45NrDJIxk0cMR56qPtDsBgCcWh0jUGgZ$wzbPqDuCIIXrZvZLqHekX2Aj^QBP610ts$A^jgDrNDEpBT0ujwDqI19CIyP', 'InChI=1S/C24H24FN7O/c1-14-27-13-32(31-14)20-11-8-17(12-21(20)33-3)28-24-29-22-18(15-4-6-16(25)7-5-15)9-10-19(22)23(26-2)30-24/h4-8,11-13,18H,9-10H2,1-3H3,(H2,26,28,29,30)/t18-/m1/s1', 'AuxInfo=1/1/N:33,23,32,17,18,20,21,26,11,12,29,25,30,31,15,22,24,10,14,28,27,13,16,19,1,5,9,6,3,4,8,7,2/E:(4,5)(6,7)/it:im/rA:57FONNNNNNNC.eCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7; ;;s10;s11;s3s10;s12d+13;s10;d+4s5s14;d+15;s15;d-3s4s6;s17;d-18;s1d+20s21;s5;s6;d+24;s24;s2s25;s7d-27;d-26s28;s7d-9;d-8s9;s2;s31;s10;s11;s11;s12;s12;s17;s18;s5;s20;s21;s6;s23;s23;s23;s25;s26;s29;s30;s3 2;s32;s32;s33;s33;s33;/rC:3.2623,-5.2814,-1.6793;-4.7635,2.0768,-.0624;1.5662,.7728,.4407;2.2509', 'NDVMOVOEROCRIO-GOSISDBHSA-N', '1010:BU7QVT2S3UKQPJW449784XTTJT3JVH', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@]2(-[#1])-[c]3:[c](:[c](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#1]):[n]:[c](-[#7](-[#1])-[c]4:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]4-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1] )-[n]5:[c](-[#1]):[n]:[c](-[#6](-[#1])(-[#1])-[#1]):[n]5):[n]3)-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1[C@]2([H])c3c(c(N([H])C([H])([H])[H])nc(N([H])c4c([H])c([H])c(c(c4[H])OC([H])([H])[H])n5c([H])nc(C([H])([H])[H])n5)n3)C([H])([H])C2([H])[H])c([H])c1[H]', '04.716', '4.716', '0', '0', 'TRUE', '-0.207\r\n-0.3476\r\n-0.2219\r\n-0.2059\r\n-0.2758\r\n-0.2264\r\n-0.1231\r\n-0.1734\r\n-0.2262\r\n2.71e-002\r\n-3.65e-002\r\n-2.2e-002\r\n5.77e-002\r\n1.13e-002\r\n-3.87e-002\r\n0.1136\r\n-5.55e-002\r\n-5.55e-002\r\n0.2062\r\n-2.61e-002\r\n-2.61e-002\r\n0.1227\r\n-1.02e-002\r\n2.41e-002\r\n-1.17e-002\r\n', '1', '4.191', 'C24H24FN7O', '0445.203', '-6.882', '0445.492', '3.77 8.12', '5', '2', '0', '14', '23', '4', '33', '37', '31', '11', '008', '02', '24', '0', '5', '006', '0089.78', '448.1', '', '4.24004', '1.2768', '96.24', '50.86', '5.29322', '45.38', '2,217.49', '100.309', '351.23', '', 'F/C5=C([H])/C([H])=C(C1([H])C([H])([H])C([H])([H])/C4=C1/N=C(N(/C3=C([H])/C(OC([H])([H])[H])=C(N2/N=C(C([H])([H])[H])\\N=C2\\[H])\\C([H])=C3\\[H])[H])\\N=C4\\N(C([H])([H])[H])[H])\\C([H])=C5\\[H]', 'CNc3nc(Nc2ccc(n1cnc(C)n1)c(OC)c2)nc4c3CC[C@@H]4c5ccc(F)cc5', 'BMS-932481', 'Not Available', 'Gamma-secretase', '58075317', 'Under Investigation', 'Alzheimer disease (AD)', '27189973', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(144, '4035309', '4035309', 'CC12CCC(O)CC1=CCC3C2CCC4(C)C3CCC45CO5', '10,13-dimethylspiro[1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,2''-oxirane]-3-ol', 'CYAAFQwAZcwQF8q3Y9m$oQWpAyC4p5dJpWmYw^mEVoVrn65ZqA8iKdGvP36YOwqkqm$GZvpjBKpEurFO64x6O$GzdMOQU9JPN5AJ$HkBX4AO$4lFPl577fekWgQvqLV0tHo9cr3$Ezfv9tuW0QbRUC6gQ41J^y6mmVS1Wl^adCh9wR9Z4mzHNnnjHuIe9Z7C9deRJROe 5t1Y7BCtwEfHdyG1lKYfdJeTlrDvVnfX86Xa4TFqx01HO0bhUzpE1ZQAZW49Cq7J8snwfeQk9m^BV^aVzeRjenZTvdojrvF12OT4XwoOxF1$FU40sGWHrp72ZOTw9fL$RfttHaFYF9pYc0Waaz5zIIqPPlMOPpTz$YS3RH^E9Neig5ziF3H64xJh371nOD$isp9w7vFx UoXhxQMY7Txz4Lp^s4JMtXLquoqus4xI9qi7Gm5TbKa8n3Hgkgdu6Fsn626Z0TjziJbJn6tlvAt8qrzgTYsYf5w^n9jwrecH', 'InChI=1S/C20H30O2/c1-18-8-5-14(21)11-13(18)3-4-15-16(18)6-9-19(2)17(15)7-10-20(19)12-22-20/h3,14-17,21H,4-12H2,1-2H3', 'AuxInfo=1/0/N:19,14,18,15,21,12,10,17,8,9,20,11,16,22,6,7,5,13,3,4,2,1/rA:52OOCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s1s3;s3;s5;s6;s3;s4;s5s9;s1s4;s7s8;s7;s3;s6;s13;s13;s15d-16;s13;s1 6;s17;s2s20s21;s5;s6;s7;s8;s8;s9;s9;s10;s10;s12;s12;s11;s11;s14;s14;s14;s15;s15;s17;s17;s18;s19;s19;s19;s20;s20;s21;s21;s22;s2;/r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r\n-0.3928\r\n1.9e-003\r\n9.72e-002\r\n-2.97e-002\r\n-3.08e-002\r\n-2.89e-002\r\n-4.45e-002\r\n-2.08e-002\r\n-4.67e-002\r\n7.71e-002\r\n-4.87e-002\r\n-8.4e-003\r\n-5.66e-002\r\n-3.14e-002\r\n-6.54e-002\r\n-4.14e-002\r\n-8.44e-002\r\n-5.56e-002\r\n-5.3e-003\r\n-2.59e-002\r\n5.77e-002\r\n3.12e', '1', '3.321', 'C20H30O2', '0302.225', '-5.115', '0302.451', '', '1', '1', '1', '25', '00', '0', '22', '26', '33', '1', '002', '01', '30', '0', '5', '000', '0032.76', '311.56', '', '', '', '', '', '', '', '', '', '', '', 'O5C4(C1(C([H])([H])[H])C([H])(C2([H])C([H])(C([H])([H])C1([H])[H])C3(C([H])([H])[H])/C(=C([H])\\C2([H])[H])C([H])([H])C(O[H])([H])C([H])([H])C3([H])[H])C([H])([H])C4([H])[H])C5([H])[H]', 'CC/12CCC(O)CC1=C\\CC3C2CCC4(C)C3CCC45CO5', 'BNN-20', 'AC1N1S76', 'Neurotrophic receptor tyrosine kinase 2', '4035309', 'Under Investigation', 'Parkinson Disease(PARK)', '28461162', 'Parkinson Disease(PARK)', 'PARK'),
(145, '387447', '387447', 'CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O', '[(1<I>R</I>)-3-methyl-1-[[(2<I>S</I>)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid', 'CYAAFQwAedwQ$9umgiN8mVdHWmnWTeanaxqTtW8Sqnjbyy64St9SD4O0hUa2wcFBe5EoEbaAOIGGqaGPykIJDwkQQMambWUAG2XO33yNhJm8MuNDiNAUBc4RQMkA99DA2qPcCQ5p7l8PIx4PZhCXkDfK$hYXnqnY$6xqxwSwlgd8VmmpzFJXSAnX59aBIlf2FbMNTzlb 6d^8v0yrRySO8xj5VcOPQr4lH7bYnAEPWhbn^25lP2yzR7IXtp$HfULe1y75PVXp$zMd2eIu7Z7h33la4rd9d1eMy7$n979mo2xRzfwW^11R99rNHb6fb2TXaN9y$vvb$9DsK^OU8F6XHfOP^4HvttD0q^1Bi$eG^azv$5^uLbu2eFGzwiRls1b49BZ9xaOvL^8EhpU$ lf^E39J255cm0ceUjceLP7xpiz1eudiUmHEdHKSucGvQNV9pLxz8j7DIFvYoJd^rcWuiXG5JfOCfHPy$q5Ku1tXJnfizv509', 'InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1', 'AuxInfo=1/1/N:15,16,23,21,22,18,19,27,26,9,14,25,10,17,12,24,11,13,20,28,8,7,6,5,1,4,2,3/E:(1,2)(4,5)(6,7)(27,28)/it:im/rA:53OOOONNNNCCC.eC.oCCCCCCCCCCCCCCCBHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;s9;p5s 9;p6;d1s5s12;s12;s10;s10;s14;d+17;s17;d4s6;s18;d-19;d-21s22;d+7s20;d-8s24;s7;s8d-26;s2s3s11;s9;s9;s10;s11;s12;s5;s14;s14;s15;s15;s15;s16;s16;s16;s6;s18;s19;s2;s3;s21;s22;s23;s25;s26;s27;/rC:4.5981,-.5 6,0;3.732,2.94,0;5.4641,2.94,0;8.0622,-1.56,0;5.4641,.94,0;7.1962,-.06,0;9.7942,-.56,0;9.7942,1.', 'GXJABQQUPOEUTA-RDJZCZTQSA-N', '1010:RZ4QESDRR5FB3EG476VRMW2W3DA422', '[#8]=[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#6](-[c]2:[c](-[#1]):[n]:[c](-[#1]):[c](-[#1]):[n]2)=[#8])-[#7](-[#1])-[#6@](-[#1]) (-[#5](-[#8]-[#1])-[#8]-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@]([H])(C([H])([H])c1c([H])c([H])c([H])c([H])c1[H])N([H])C(c2c([H])nc([H])c([H])n2)=O)N([H])[C@]([H])(B(O[H])O[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H]', '02.183', '2.588', '0', '0', 'TRUE', '-0.2756\r\n-0.2546\r\n-0.2546\r\n-0.2701\r\n-0.3091\r\n-0.298\r\n-0.2481\r\n-0.2607\r\n-3.06e-002\r\n-4.53e-002\r\n4.1e-002\r\n0.1035\r\n0.2327\r\n-5.e-004\r\n-6.28e-002\r\n-6.28e-002\r\n-4.57e-002\r\n-5.9e-002\r\n-5.9e-002\r\n0.2637\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n0.1436\r\n5.79e-002\r\n4.6e-', '1', '2.177', 'C19H25BN4O4', '0384.197', '-4.604', '0384.237', '-7.e-002 8.97 11.51', '4', '2', '2', '15', '12', '2', '28', '29', '32', '8', '008', '04', '25', '0', '2', '009', '0124.44', '418.11', '', '', '', '', '', '', '', '', '', '', '', 'O=C(N([C@@](C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])(B(O[H])O[H])[H])[H])[C@@](N(C(=O)/C1=N/C([H])=C([H])\\N=C1\\[H])[H])(C(/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])([H])[H])[H]', 'CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c2cnccn2)B(O)O', 'Bortezomib', 'DPBA; Velcade; MLN-341; LDP 341; S1013', 'Proteasome subunit beta type-5', '387447', 'Phase II', 'Myasthenia Gravis', '28966662', 'Myasthenia Gravis', 'MG'),
(146, '387447', '387447', 'CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O', '[(1<I>R</I>)-3-methyl-1-[[(2<I>S</I>)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid', 'CYAAFQwAedwQ$9umgiN8mVdHWmnWTeanaxqTtW8Sqnjbyy64St9SD4O0hUa2wcFBe5EoEbaAOIGGqaGPykIJDwkQQMambWUAG2XO33yNhJm8MuNDiNAUBc4RQMkA99DA2qPcCQ5p7l8PIx4PZhCXkDfK$hYXnqnY$6xqxwSwlgd8VmmpzFJXSAnX59aBIlf2FbMNTzlb 6d^8v0yrRySO8xj5VcOPQr4lH7bYnAEPWhbn^25lP2yzR7IXtp$HfULe1y75PVXp$zMd2eIu7Z7h33la4rd9d1eMy7$n979mo2xRzfwW^11R99rNHb6fb2TXaN9y$vvb$9DsK^OU8F6XHfOP^4HvttD0q^1Bi$eG^azv$5^uLbu2eFGzwiRls1b49BZ9xaOvL^8EhpU$ lf^E39J255cm0ceUjceLP7xpiz1eudiUmHEdHKSucGvQNV9pLxz8j7DIFvYoJd^rcWuiXG5JfOCfHPy$q5Ku1tXJnfizv509', 'InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1', 'AuxInfo=1/1/N:15,16,23,21,22,18,19,27,26,9,14,25,10,17,12,24,11,13,20,28,8,7,6,5,1,4,2,3/E:(1,2)(4,5)(6,7)(27,28)/it:im/rA:53OOOONNNNCCC.eC.oCCCCCCCCCCCCCCCBHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;s9;p5s 9;p6;d1s5s12;s12;s10;s10;s14;d+17;s17;d4s6;s18;d-19;d-21s22;d+7s20;d-8s24;s7;s8d-26;s2s3s11;s9;s9;s10;s11;s12;s5;s14;s14;s15;s15;s15;s16;s16;s16;s6;s18;s19;s2;s3;s21;s22;s23;s25;s26;s27;/rC:4.5981,-.5 6,0;3.732,2.94,0;5.4641,2.94,0;8.0622,-1.56,0;5.4641,.94,0;7.1962,-.06,0;9.7942,-.56,0;9.7942,1.', 'GXJABQQUPOEUTA-RDJZCZTQSA-N', '1010:RZ4QESDRR5FB3EG476VRMW2W3DA422', '[#8]=[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#6](-[c]2:[c](-[#1]):[n]:[c](-[#1]):[c](-[#1]):[n]2)=[#8])-[#7](-[#1])-[#6@](-[#1]) (-[#5](-[#8]-[#1])-[#8]-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@]([H])(C([H])([H])c1c([H])c([H])c([H])c([H])c1[H])N([H])C(c2c([H])nc([H])c([H])n2)=O)N([H])[C@]([H])(B(O[H])O[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H]', '02.183', '2.588', '0', '0', 'TRUE', '-0.2756\r\n-0.2546\r\n-0.2546\r\n-0.2701\r\n-0.3091\r\n-0.298\r\n-0.2481\r\n-0.2607\r\n-3.06e-002\r\n-4.53e-002\r\n4.1e-002\r\n0.1035\r\n0.2327\r\n-5.e-004\r\n-6.28e-002\r\n-6.28e-002\r\n-4.57e-002\r\n-5.9e-002\r\n-5.9e-002\r\n0.2637\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n0.1436\r\n5.79e-002\r\n4.6e-', '1', '2.177', 'C19H25BN4O4', '0384.197', '-4.604', '0384.237', '-7.e-002 8.97 11.51', '4', '2', '2', '15', '12', '2', '28', '29', '32', '8', '008', '04', '25', '0', '2', '009', '0124.44', '418.11', '', '', '', '', '', '', '', '', '', '', '', 'O=C(N([C@@](C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])(B(O[H])O[H])[H])[H])[C@@](N(C(=O)/C1=N/C([H])=C([H])\\N=C1\\[H])[H])(C(/C2=C([H])/C([H])=C([H])\\C([H])=C2\\[H])([H])[H])[H]', 'CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c2cnccn2)B(O)O', 'Bortezomib', 'DPBA; Velcade; MLN-341; LDP 341; S1013', 'Proteasome subunit beta type-1', '387447', 'Phase II', 'Myasthenia Gravis', '28966662', 'Myasthenia Gravis', 'MG'),
(147, '3038495', '3038495', 'COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2', '<I>N</I>-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]naphthalene-2-carboxamide', 'CYAAFQwAydwQLvRms4L8fSSi$BXwBF^VE0uFGsQvhtWCPrirS^v0m6^SpTJx0uYG3zRMUkraNcs34N6hRS1cqqr6AnSn2tSUAXafz5q6S6x6Hm71nF4gPPaSRd1rlqCLfnO13P38Wfj8n8lWHA3^8sy6x6HIHQA$ybdEHmxeT8$OmxuHVX4YBhj6hbWYMhTFPeAifFmG JPc1dyHvoQXeS5OQr6xQX0k6phlXsSW47DNjpCe2PoG0tGkDO3c6OICilrItvU9lGWGx7WVPkco7y$yKzXV4tJlVJDJrOs3d4o0Ij0jWBs^j8wKC7vDi68TeyDJUvMDhBDPvXvG21QWeOGy6w96KTPI1LjymhEDWMYv79cIyMO^Vmr^oqz69$sSeV6pK2ln7v29xWhnG bsl2xBs9Eu4yDrYv3qiCbGJrRwD7xFZw4o8IX1Ei16hnI0VjZ56bnr3IqKUouk4k2C4vos$xrLrOWCJo156mpw6ipakQiKD0', 'InChI=1S/C26H31N3O2/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30)', 'AuxInfo=1/1/N:22,31,30,18,19,13,11,29,28,16,17,27,25,14,10,6,7,8,9,23,26,24,21,12,15,20,5,3,4,2,1/E:(16,17)(18,19)/rA:62OONNNCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3;s3;s4s6 ;s4s7;s3;s10;s4;s11;s5s13;s1s12;d+12;d+15;s16;s17d-18;d2s5;s20;s1;d+21;s23;s21;s24;d-25s26;d+24;d-26;s28;s29d-30;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s13;s13;s14;s14;s16;s5;s17;s18;s19;s22;s22;s22; s23;s25;s27;s28;s29;s30;s31;/rC:3.9917,2.1111,-1.332;-2.4977,-2.207,2.3;1.7534,-2.3832,-.9379;3.', 'MNHDKMDLOJSCGN-UHFFFAOYSA-N', '1010:C1ZBX65DE371HTGKVV5FTN7N4V813D', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[# 1])(-[#1])-[#7](-[#1])-[#6](-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1]):[c]4:[c]3-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]', 'O(C([H])([H])[H])c1c([H])c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(c3c([H])c([H])c(c([H])c([H])c([H])c4[H])c4c3[H])=O)C([H])([H])C2([H])[H]', '04.34', '4.34', '0', '0', 'TRUE', '-0.3477\r\n-0.272\r\n-0.3008\r\n-0.2703\r\n-0.3114\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n-1.7e-003\r\n-3.9e-002\r\n4.8e-002\r\n-3.64e-002\r\n1.13e-002\r\n9.26e-002\r\n-4.14e-002\r\n-3.02e-002\r\n-6.05e-002\r\n-5.96e-002\r\n0.2429\r\n3.76e-002\r\n4.22e-002\r\n-4.19e-002\r\n-1.77e-002\r', '0', '4.12', 'C26H31N3O2', '0417.242', '-6.081', '0417.543', '5.38 7.23', '2', '1', '1', '16', '17', '3', '31', '34', '35', '9', '005', '01', '31', '0', '4', '008', '0044.81', '445.07', '', '2.48641', '1.2658', '54.77', '9.5', '5.038', '45.27', '2,000.71', '50.893', '341.62', '-178.86', 'O(/C1=C([H])/C([H])=C([H])\\C([H])=C1\\N4C([H])([H])C([H])([H])N(C(C(C(C(N(C(=O)/C3=C([H])/C2=C([H])/C([H])=C([H])\\C([H])=C2\\C([H])=C3\\[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C4([H])[H])C([H])([H])[H]', 'COc1ccccc1N4CCN(CCCCNC(=O)c3ccc2ccccc2c3)CC4', 'BP-897', 'Lopac-B-9308; LP00165; B 9308', 'D(3) dopamine receptor', '3038495', 'Under Investigation', 'Parkinson Disease(PARK)', '15226382', 'Parkinson Disease(PARK)', 'PARK'),
(148, '9554198', '9554198', 'CO\\N=C\\[C@H]1[C@H]2CC[C@@H](C[C@@H]1c3ccc(Cl)c(Cl)c3)N2C', '(<I>E</I>)-1-[(1<I>S</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>)-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-4-yl]-<I>N</I>-methoxy-methanimine', 'CYAAFQwA5fwQjIkT76RxhyY6nD8QYmeP^5UVPxMtlxl93XG0h0QxgfOLQJzz7svS8cz2PH6cxlQnU45XBqRh3x2izmnN$8OvWANZoGSKoWWWr0y6sWOt$Jnh5XO$FJILYTBu^D3^613ffU$7PCgA59xLaI2Mxi7TtNRxKXBrR$1ppfuY1ptJWFMPkFXBY2og5Hecqi4d tK5ukPYdyPbS4l5dBVHtArLizNi1KD97kL71tk6IQoiIc90BzrswHK0tp6mq3tFldUWfDwRxDNUFUX$Fm76L1EqiCejB0FsJHmVYrzMbgV3dU02UrOATx0Z8V^P6cYQwXhrbGOcGnZ7lFmNTD03HuJ7px7d3oTI3EpVlkPOu8$cXuHY4a5x8uKbRaCuonx7THi8s2X6Y z92J0eTzoWLgxTr1pna4jdtWdLdF^doL9qVFwp68rdXTshc5yLLjB6nxG6bZN8kED3edZ9x9KcLIieeKnDHpMbaVyGlUsawD', 'InChI=1S/C16H20Cl2N2O/c1-20-11-4-6-16(20)13(9-19-21-2)12(8-11)10-3-5-14(17)15(18)7-10/h3,5,7,9,11-13,16H,4,6,8H2,1-2H3/b19-9+/t11-,12+,13+,16+/m0/s1', 'AuxInfo=1/0/N:14,21,17,12,19,11,16,10,15,13,7,9,8,20,18,6,2,1,5,4,3/it:im/rA:41ClClONNC.eC.oC.eC.oCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;s3;s4;s4;s6;s8;s7s9;s6;s7s11;s9;s4;d+5s8;d+13;s13;s1s16;d-17;s2 d-18s19;s3;s6;s7;s8;s9;s10;s10;s11;s11;s12;s12;s14;s14;s14;s15;s16;s17;s19;s21;s21;s21;/rC:-3.6232,-1.3632,-2.357;-5.4595,-.7411,.2331;.1155,3.896,.2486;2.941,-1.0369,-.9908;.2478,2.7023,-.4741;2.7421 ,.2965,-.3891;2.7071,-1.9453,.1469;1.2084,.4785,-.267;.5582,-.6067,.6305;1.1803,-2.0007,.3619;3.', 'NRLIFEGHTNUYFL-QJDHNRDASA-N', '1010:3KV9Z7RFHCHQC6EQN8X5KVU2G3SSPW', '[#17]-[c](:[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6@]23-[#1])-[#6@@]3(-[#1])\\-[#6](-[#1] )=[#7]\\-[#8]-[#6](-[#1])(-[#1])-[#1])-[#17]):[c]1-[#1]', 'Clc(c(c([H])c([H])c1[C@@]([H])(C([H])([H])[C@]([H])(C([H])([H])C2([H])[H])N(C([H])([H])[H])[C@]23[H])[C@@]3([H])\\C([H])=N\\OC([H])([H])[H])Cl)c1[H]', '03.816', '4.003', '0', '0', 'TRUE', '-8.27e-002\r\n-8.28e-002\r\n-0.2558\r\n-0.2998\r\n-0.1473\r\n1.8e-002\r\n1.02e-002\r\n1.9e-002\r\n-5.3e-003\r\n-3.e-002\r\n-3.54e-002\r\n-3.61e-002\r\n-4.26e-002\r\n-1.28e-002\r\n3.71e-002\r\n-3.85e-002\r\n-5.72e-002\r\n5.94e-002\r\n-4.18e-002\r\n5.92e-002\r\n6.61e-002\r\n4.74e-002\r\n4.67e-002\r\n3.', '1', '2.255', 'C16H20Cl2N2O', '0326.095', '-5.054', '0327.249', '4.59 12.2', '2', '0', '1', '16', '06', '1', '21', '23', '25', '4', '003', '00', '20', '0', '3', '003', '0024.83', '316.54', '', '2.71099', '1.3036', '37.05', '23.44', '3.65272', '13.61', '896.506', '35.846', '254.84', '', 'Cl/C3=C(Cl)/C([H])=C([H])\\C(C1([H])C(/C(=N/OC([H])([H])[H])[H])([H])C2([H])N(C([H])([H])[H])C([H])(C1([H])[H])C([H])([H])C2([H])[H])=C3\\[H]', 'CO/N=C/[C@@H]2[C@@H](c1ccc(Cl)c(Cl)c1)C[C@@H]3CC[C@H]2N3C', 'Brasofensine', 'NS2214; BMS 204756', 'D(2) dopamine receptor', '9554198', 'Under Investigation', 'Parkinson Disease(PARK)', '11847938', 'Parkinson Disease(PARK)', 'PARK'),
(149, '11978813', '11978813', 'O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1', '7-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butoxy]-1<I>H</I>-quinolin-2-one', 'CYAAFQwALcwQCduU6Q^tg3oP8a^P5SPbXpVWXru4ejULP^GkPXFnollQ4CK$oUaV66OqYmzhBFgXwXpeAt$zcHhM$sqVtHWasvwtPAMR3BdZXRpVjsHw^9hjK2beUlqe^ziCad9$R83KOxLAtjFddAC3N2aTqb6JZsV5vvzmzeYz1g1wJM^4AC2DNfs8cMyeOCa1HLSV OchvX14b0liXPgJoNp1ea90B1J^0hnc5YBe4KLVJ7B3J$5N8eqHiK39CPVH44b^H2YIIcqIeLkl^55XDKcq$5ZFM9sNnPJcbKwhnRXnME510PZgjHguXVMGCeIdS1jWUWUE413DCDn2c0S1AU9$BbJzAOqB19B3JNok8GjdrtoljBD9n6a^n6KpGalHAtEqFYsjDZ9ub Wz18r8pttItz2w6UtVSSOO4j5hnqld5ryr9IFcU4czY9d4aTTefs9f1fLHaV5520fm54PsQergClqXJjX5qfQFKs1bZ1095h', 'InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)', 'AuxInfo=1/1/N:12,14,20,16,21,28,29,26,31,19,11,7,8,9,10,17,22,24,27,23,15,25,13,18,30,6,4,5,3,2,1/E:(12,13)(14,15)/rA:58SOONNNCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s4;s4;s5s7;s5 s8;s4;s11;s5;s12;d+13;s13;s2s14;s1s15;s15;d-16;d+18s20;s1d-19;s2;d+23;s6s24;s23;d+25;d-26s27;s27;d3s6;d-29s30;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s14;s14;s16;s17;s17;s19;s20;s21;s22;s24;s26;s28; s6;s29;s31;/rC:9.7662,.9579,.3268;-3.838,.773,1.03;-10.6706,1.2281,-.8993;2.1478,.5675,-.4995;4.', 'ZKIAIYBUSXZPLP-UHFFFAOYSA-N', '1010:3ZEHPFS4WRTWWS9X6AU6NEJAFCZMGG', '[s]1:[c](-[#1]):[c](-[#1]):[c]2:[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1]) -[#8]-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])=[#6](-[#1])-[#6](-[#7]5-[#1])=[#8]):[c]5:[c]4-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 's1c([H])c([H])c2c1c([H])c([H])c([H])c2N(C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc4c([H])c([H])c(C([H])=C([H])C(N5[H])=O)c5c4[H])C([H])([H])C3([H])[H]', '04.508', '4.28', '0', '0', 'TRUE', '-9.74e-002\r\n-0.3461\r\n-0.2723\r\n-0.3008\r\n-0.2719\r\n-0.2812\r\n1.13e-002\r\n1.13e-002\r\n1.58e-002\r\n1.58e-002\r\n-1.7e-003\r\n-3.83e-002\r\n2.57e-002\r\n-2.79e-002\r\n7.e-003\r\n-4.34e-002\r\n5.33e-002\r\n2.04e-002\r\n-4.56e-002\r\n-5.96e-002\r\n-4.76e-002\r\n-2.35e-002\r\n7.68e-002\r\n-9.7e-', '0', '4.501', 'C25H27N3O2S', '0433.182', '-6.685', '0433.566', '-0.49 2.25 5.58', '2', '1', '2', '17', '16', '3', '31', '35', '30', '9', '005', '01', '27', '0', '5', '007', '0073.05', '430.13', '', '3.15802', '1.2891', '78.45', '23.29', '6.34802', '55.16', '4,732.65', '144.07', '342.31', '0.03', 'S5/C4=C([H])/C([H])=C([H])\\C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C1=C([H])/C2=C(\\C([H])=C1\\[H])/C([H])=C([H])\\C(=O)N2[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])=C4\\C([H])=C5\\[H]', 'O=c5ccc4ccc(OCCCCN3CCN(c1cccc2sccc12)CC3)cc4[nH]5', 'Brexpiprazole', 'Rexulti; GTPL7672; CS-2108; BC600277', '5-hydroxytryptamine receptor 1A', '11978813', 'Phase III', 'Schizophrenia', '25882325', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(150, '11978813', '11978813', 'O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1', '7-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butoxy]-1<I>H</I>-quinolin-2-one', 'CYAAFQwALcwQCduU6Q^tg3oP8a^P5SPbXpVWXru4ejULP^GkPXFnollQ4CK$oUaV66OqYmzhBFgXwXpeAt$zcHhM$sqVtHWasvwtPAMR3BdZXRpVjsHw^9hjK2beUlqe^ziCad9$R83KOxLAtjFddAC3N2aTqb6JZsV5vvzmzeYz1g1wJM^4AC2DNfs8cMyeOCa1HLSV OchvX14b0liXPgJoNp1ea90B1J^0hnc5YBe4KLVJ7B3J$5N8eqHiK39CPVH44b^H2YIIcqIeLkl^55XDKcq$5ZFM9sNnPJcbKwhnRXnME510PZgjHguXVMGCeIdS1jWUWUE413DCDn2c0S1AU9$BbJzAOqB19B3JNok8GjdrtoljBD9n6a^n6KpGalHAtEqFYsjDZ9ub Wz18r8pttItz2w6UtVSSOO4j5hnqld5ryr9IFcU4czY9d4aTTefs9f1fLHaV5520fm54PsQergClqXJjX5qfQFKs1bZ1095h', 'InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)', 'AuxInfo=1/1/N:12,14,20,16,21,28,29,26,31,19,11,7,8,9,10,17,22,24,27,23,15,25,13,18,30,6,4,5,3,2,1/E:(12,13)(14,15)/rA:58SOONNNCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s4;s4;s5s7;s5 s8;s4;s11;s5;s12;d+13;s13;s2s14;s1s15;s15;d-16;d+18s20;s1d-19;s2;d+23;s6s24;s23;d+25;d-26s27;s27;d3s6;d-29s30;s7;s7;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s14;s14;s16;s17;s17;s19;s20;s21;s22;s24;s26;s28; s6;s29;s31;/rC:9.7662,.9579,.3268;-3.838,.773,1.03;-10.6706,1.2281,-.8993;2.1478,.5675,-.4995;4.', 'ZKIAIYBUSXZPLP-UHFFFAOYSA-N', '1010:3ZEHPFS4WRTWWS9X6AU6NEJAFCZMGG', '[s]1:[c](-[#1]):[c](-[#1]):[c]2:[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1]) -[#8]-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])=[#6](-[#1])-[#6](-[#7]5-[#1])=[#8]):[c]5:[c]4-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 's1c([H])c([H])c2c1c([H])c([H])c([H])c2N(C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])C([H])([H])C([H])([H])Oc4c([H])c([H])c(C([H])=C([H])C(N5[H])=O)c5c4[H])C([H])([H])C3([H])[H]', '04.508', '4.28', '0', '0', 'TRUE', '-9.74e-002\r\n-0.3461\r\n-0.2723\r\n-0.3008\r\n-0.2719\r\n-0.2812\r\n1.13e-002\r\n1.13e-002\r\n1.58e-002\r\n1.58e-002\r\n-1.7e-003\r\n-3.83e-002\r\n2.57e-002\r\n-2.79e-002\r\n7.e-003\r\n-4.34e-002\r\n5.33e-002\r\n2.04e-002\r\n-4.56e-002\r\n-5.96e-002\r\n-4.76e-002\r\n-2.35e-002\r\n7.68e-002\r\n-9.7e-', '0', '4.501', 'C25H27N3O2S', '0433.182', '-6.685', '0433.566', '-0.49 2.25 5.58', '2', '1', '2', '17', '16', '3', '31', '35', '30', '9', '005', '01', '27', '0', '5', '007', '0073.05', '430.13', '', '3.15802', '1.2891', '78.45', '23.29', '6.34802', '55.16', '4,732.65', '144.07', '342.31', '0.03', 'S5/C4=C([H])/C([H])=C([H])\\C(N3C([H])([H])C([H])([H])N(C(C(C(C(O/C1=C([H])/C2=C(\\C([H])=C1\\[H])/C([H])=C([H])\\C(=O)N2[H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C3([H])[H])=C4\\C([H])=C5\\[H]', 'O=c5ccc4ccc(OCCCCN3CCN(c1cccc2sccc12)CC3)cc4[nH]5', 'Brexpiprazole', 'Rexulti; GTPL7672; CS-2108; BC600277', '5-hydroxytryptamine receptor 1A', '11978813', 'Phase III Completed', 'Alzheimer disease (AD)', '28300462', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(151, '9837243', '9837243', 'CCC[C@H]1CN([C@@H](CC)C(=O)N)C(=O)C1', '(2<I>S</I>)-2-[(4<I>R</I>)-2-oxo-4-propyl-pyrrolidin-1-yl]butanamide', 'CYAAFQwAUdwQ$t8$Ecvd2uVNsOqslS2gi5twTeEUv5H9WSZD7dF8YxCX02XY5mZKxjJHEg82g2VFD8ZNtH6$hLhqe2v6wJdhjORmZQv$L9mjKGl7eWL0f^TCbV47YXx^^j7f35zPI8zL$KCAGGOP^3nJmbbiF0Hqrp1mZsW5j5eKLJ6tV94j84xQVGqdws5BVhVwBQul XTZobeYmdT^IbspADgT2hTHTExdFVIFzI8IsyDLdlwaqwGjndEXNG56KOPcGmz0ZaQhRyxqaS0fT84SdJBg3a6ixRiV486yk9MlXfIbFyrx52V7fXX3DaEtGzVaZVrn7lgF0JLU^lRg68kSr0fKR1GStKAL9hMuvbEL1csTDrbklzUXu82RBVAi2cpKIgFw8gZyOb$Eu rOLU7py5XgqlfIFF5NWEhmXmdkjnZYBdACBP090KXIG8^Gz251LFt$cWQttUJjmarDz4mOuyg0PmQlOyLUqDnazj2LRfGtkD', 'InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1', 'AuxInfo=1/1/N:14,15,11,12,8,7,6,5,9,10,13,4,3,1,2/it:im/rA:35OONNC.eCCCC.eCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3s5;s5;s5;s3;d1s3s7;s8;s9;d2s4s9;s11;s12;s5;s6;s6;s7;s7;s8;s8;s9;s11;s11;s12;s12;s14;s14;s1 4;s15;s15;s15;s4;s4;/r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r\n-0.2758\r\n-0.2897\r\n-0.3276\r\n-1.7e-002\r\n1.82e-002\r\n2.88e-002\r\n-4.88e-002\r\n0.1015\r\n0.2152\r\n-5.59e-002\r\n-2.85e-002\r\n0.2297\r\n-6.54e-002\r\n-6.32e-002\r\n3.23e-002\r\n4.72e-002\r\n4.72e-002\r\n3.67e-002\r\n3.67e-002\r\n2.69e-002\r\n2.69e-002\r\n6.06e-002\r\n2.63e-002\r\n2.6', '1', '0.928', 'C11H20N2O2', '0212.152', '-1.756', '0212.289', '', '2', '1', '2', '13', '00', '0', '15', '15', '25', '2', '004', '02', '20', '0', '1', '005', '0063.4', '247.84', '', '2.6459', '1.2448', '27.43', '17.55', '3.29087', '9.88', '367.383', '128.931', '188.3', '174.87', 'O=C1N(C(C(C([H])([H])[H])([H])[H])(C(=O)N([H])[H])[H])C([H])([H])C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])C1([H])[H]', 'CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1', 'Brivaracetam', 'Briviact; Rikelta; GTPL9041; CS-3418', 'Sodium channel protein type 1 subunit alpha', '9837243', 'Phase III', 'Epilepsy', '24446953', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(152, '31101', '31101', 'CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C', '(6<I>a</I><I>R</I>,9<I>R</I>)-<I>N</I>-[(2<I>R</I>,5<I>S</I>,10<I>a</I><I>S</I>,10<I>b</I><I>S</I>)-10<I>b</I>-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10<I>a</I>-tetrahydro-5<I>H</I>-oxazolo[B LAH]pyrrolo[BLAH]pyrazin-2-yl]-5-bromo-7-methyl-6,6<I>a</I>,8,9-tetrahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide', 'CYAAFQwA1cwQavpIlJm1sR3wqe9NGoM3OgVu6^tAtJUpUQ00QbnUue$ukbnfo29^^F0Ty9Wsf1jft3GiNs6EepocsY7jHPlAjBTkz^nhsvL6C^k98$7W99B1K2rfWF^U^3jS^nfwtuW^x$Tlqrv1m8IywHPRR4QCO4^hG7mD^dc5uoohjnw9^oEtTdYrFEfh3jH1In3W ZUTmZCtW0MxxccaguKYHwnRqeAK99oh0oye5YXHbcQQVsKk$iTuPhEIlxB5nQcN$csrNNQr$VQyaAfxxLXuwHeiK1QqqhO5pwHk7DSp^oa1or$5QDzI6XFC40DE6lIuOkbzbbugI^dIn1KJ2fmuKTndGi^hLNInmkaEcnWOxPOlMyF28yojzrPiUHOtwDrP88TybPxop hLJn$nkF$sB$PqK0qlLqJbp5moP7JWwaLWHMQ58Z6yyGbla4Gp6oBAdPZkFh$0qD$fUd83JuvYMRIj0K6kzTtUDiIVxUXT3b', 'InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12 ,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1', 'AuxInfo=1/1/N:30,31,24,25,38,43,18,41,42,15,17,21,33,34,29,23,22,27,35,32,36,39,28,14,12,37,40,26,20,19,16,13,1,11,9,10,8,7,6,5,4,3,2/E:(1,2)(3,4)/it:im/rA:83BrOOOOONNNNNC.oC.oC.oCC.eCCCCCCCCCCC.eC.eC CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;s8;s2s3s7s12;s7;s12;s2s9;s8;s15s17;d4s7s16;d5s8s14;s14;s16;s21;s22;s22;d6s9;s26;s10;s10s27;s23;s23;s28;s27d-32;s28;s32;s34;d-35s36;s 10;s11s37;s1s11d-36;s35;d+39;d-41s42;s12;s14;s15;s15;s17;s17;s18;s18;s21;s21;s22;s9;s3;s23;s24;s', 'OZVBMTJYIDMWIL-AYFBDAFISA-N', '1010:2AB95RFBGJ6M3H3D8FSQ1FS27H1CFB', '[#35]-[c](:[c](:[c](:[c]1:[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c]2-[#6](=[#6](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#1])-[#6](-[#7](-[#1])-[#6@@](-[#6](-[#1])(-[#6](-[#1])(-[# 1])-[#1])-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#7]4-[#6@@]5(-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]6(-[#1])-[#1])-[#7]6-[#6](-[#6@]4(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[ #1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#8]-[#1])=[#8])-[#8]5)=[#8])-[#6@]37-[#1])-[#6]7(-[#1', 'Brc(c(c(c1c([H])c([H])c2[H])c2C(=C([H])[C@]([H])(C([H])([H])N3C([H])([H])[H])C(N([H])[C@@](C([H])(C([H])([H])[H])C([H])([H])[H])(C(N4[C@@]5([C@]([H])(C([H])([H])C([H])([H])C6([H])[H])N6C([C@]4([H])C([ H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)O[H])=O)O5)=O)[C@]37[H])C7([H])[H])n1[H]', '04.363', '4.363', '0', '0', 'TRUE', '-3.71e-002\r\n-0.2985\r\n-0.3488\r\n-0.2719\r\n-0.2753\r\n-0.2769\r\n-0.2326\r\n-0.2899\r\n-0.2788\r\n-0.298\r\n-0.2523\r\n9.83e-002\r\n0.2668\r\n0.1078\r\n-2.59e-002\r\n0.2193\r\n1.48e-002\r\n-3.53e-002\r\n0.2706\r\n0.2356\r\n-2.31e-002\r\n8.6e-003\r\n-4.49e-002\r\n-5.79e-002\r\n-5.79e-002\r\n0.2224\r\n6.', '1', '4.126', 'C32H40BrN5O5', '0653.221', '-5.726', '0654.594', '-2.4 7.28', '4', '2', '4', '35', '10', '2', '43', '49', '51', '8', '010', '03', '40', '0', '7', '005', '0118.2', '593.67', '', '1.31548', '1.2914', '188.26', '71.52', '5.38754', '116.74', '4,671.60', '114.529', '485.68', '179.45 -175.59 178.93', 'Br/C7=C/5C([H])([H])C4([H])N(C([H])([H])[H])C([H])([H])C(C(=O)N(C3(C(C([H])([H])[H])(C([H])([H])[H])[H])OC1(O[H])N(C(C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])C(=O)N2C1([H])C([H])([H])C([H])([H])C2([H])[H])C3=O)[H])([H])/C([H])=C4/C6=C5/C(=C([H])\\C([H])=C6\\[H])N7[H]', 'CC(C)C[C@H]6C(=O)N1CCC[C@H]1[C@]7(O)O[C@](NC(=O)[C@@H]3/C=C\\2c4cccc5[nH]c(Br)c(C[C@H]2N(C)C3)c45)(C(C)C)C(=O)N67', 'Bromocriptine', 'Bromoergocriptine; Bromocriptina; Parlodel; Ergoset; Apo-Bromocriptine', 'D(2) dopamine receptor', '31101', 'FDA approved', 'Parkinson Disease(PARK)', '24169242', 'Parkinson Disease(PARK)', 'PARK'),
(153, '31101', '31101', 'CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C', '(6<I>a</I><I>R</I>,9<I>R</I>)-<I>N</I>-[(2<I>R</I>,5<I>S</I>,10<I>a</I><I>S</I>,10<I>b</I><I>S</I>)-10<I>b</I>-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10<I>a</I>-tetrahydro-5<I>H</I>-oxazolo[B LAH]pyrrolo[BLAH]pyrazin-2-yl]-5-bromo-7-methyl-6,6<I>a</I>,8,9-tetrahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carboxamide', 'CYAAFQwA1cwQavpIlJm1sR3wqe9NGoM3OgVu6^tAtJUpUQ00QbnUue$ukbnfo29^^F0Ty9Wsf1jft3GiNs6EepocsY7jHPlAjBTkz^nhsvL6C^k98$7W99B1K2rfWF^U^3jS^nfwtuW^x$Tlqrv1m8IywHPRR4QCO4^hG7mD^dc5uoohjnw9^oEtTdYrFEfh3jH1In3W ZUTmZCtW0MxxccaguKYHwnRqeAK99oh0oye5YXHbcQQVsKk$iTuPhEIlxB5nQcN$csrNNQr$VQyaAfxxLXuwHeiK1QqqhO5pwHk7DSp^oa1or$5QDzI6XFC40DE6lIuOkbzbbugI^dIn1KJ2fmuKTndGi^hLNInmkaEcnWOxPOlMyF28yojzrPiUHOtwDrP88TybPxop hLJn$nkF$sB$PqK0qlLqJbp5moP7JWwaLWHMQ58Z6yyGbla4Gp6oBAdPZkFh$0qD$fUd83JuvYMRIj0K6kzTtUDiIVxUXT3b', 'InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12 ,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1', 'AuxInfo=1/1/N:30,31,24,25,38,43,18,41,42,15,17,21,33,34,29,23,22,27,35,32,36,39,28,14,12,37,40,26,20,19,16,13,1,11,9,10,8,7,6,5,4,3,2/E:(1,2)(3,4)/it:im/rA:83BrOOOOONNNNNC.oC.oC.oCC.eCCCCCCCCCCC.eC.eC CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;s8;s2s3s7s12;s7;s12;s2s9;s8;s15s17;d4s7s16;d5s8s14;s14;s16;s21;s22;s22;d6s9;s26;s10;s10s27;s23;s23;s28;s27d-32;s28;s32;s34;d-35s36;s 10;s11s37;s1s11d-36;s35;d+39;d-41s42;s12;s14;s15;s15;s17;s17;s18;s18;s21;s21;s22;s9;s3;s23;s24;s', 'OZVBMTJYIDMWIL-AYFBDAFISA-N', '1010:2AB95RFBGJ6M3H3D8FSQ1FS27H1CFB', '[#35]-[c](:[c](:[c](:[c]1:[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c]2-[#6](=[#6](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#1])-[#6](-[#7](-[#1])-[#6@@](-[#6](-[#1])(-[#6](-[#1])(-[# 1])-[#1])-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#7]4-[#6@@]5(-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]6(-[#1])-[#1])-[#7]6-[#6](-[#6@]4(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[ #1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#8]-[#1])=[#8])-[#8]5)=[#8])-[#6@]37-[#1])-[#6]7(-[#1', 'Brc(c(c(c1c([H])c([H])c2[H])c2C(=C([H])[C@]([H])(C([H])([H])N3C([H])([H])[H])C(N([H])[C@@](C([H])(C([H])([H])[H])C([H])([H])[H])(C(N4[C@@]5([C@]([H])(C([H])([H])C([H])([H])C6([H])[H])N6C([C@]4([H])C([ H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)O[H])=O)O5)=O)[C@]37[H])C7([H])[H])n1[H]', '04.363', '4.363', '0', '0', 'TRUE', '-3.71e-002\r\n-0.2985\r\n-0.3488\r\n-0.2719\r\n-0.2753\r\n-0.2769\r\n-0.2326\r\n-0.2899\r\n-0.2788\r\n-0.298\r\n-0.2523\r\n9.83e-002\r\n0.2668\r\n0.1078\r\n-2.59e-002\r\n0.2193\r\n1.48e-002\r\n-3.53e-002\r\n0.2706\r\n0.2356\r\n-2.31e-002\r\n8.6e-003\r\n-4.49e-002\r\n-5.79e-002\r\n-5.79e-002\r\n0.2224\r\n6.', '1', '4.126', 'C32H40BrN5O5', '0653.221', '-5.726', '0654.594', '-2.4 7.28', '4', '2', '4', '35', '10', '2', '43', '49', '51', '8', '010', '03', '40', '0', '7', '005', '0118.2', '593.67', '', '1.31548', '1.2914', '188.26', '71.52', '5.38754', '116.74', '4,671.60', '114.529', '485.68', '179.45 -175.59 178.93', 'Br/C7=C/5C([H])([H])C4([H])N(C([H])([H])[H])C([H])([H])C(C(=O)N(C3(C(C([H])([H])[H])(C([H])([H])[H])[H])OC1(O[H])N(C(C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])C(=O)N2C1([H])C([H])([H])C([H])([H])C2([H])[H])C3=O)[H])([H])/C([H])=C4/C6=C5/C(=C([H])\\C([H])=C6\\[H])N7[H]', 'CC(C)C[C@H]6C(=O)N1CCC[C@H]1[C@]7(O)O[C@](NC(=O)[C@@H]3/C=C\\2c4cccc5[nH]c(Br)c(C[C@H]2N(C)C3)c45)(C(C)C)C(=O)N67', 'Bromocriptine', 'Bromoergocriptine; Bromocriptina; Parlodel; Ergoset; Apo-Bromocriptine', 'D(2) dopamine receptor', '31101', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '21867702', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(154, '22524140', '22524140', 'CCC\\C=C\\C=C\\C(=O)O[C@H]1\\C(=C\\C(=O)OC)\\C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(=O)C)C(C)(C)[C@](O)(C[C@@H]4C\\C(=C\\C(=O)OC)\\C[C@@H](O4)\\C=C/C(C)(C)[C@]1(O)O2)O3)[C@@H](C)O', '[(17<I>Z</I>,27<I>R</I>,28<I>R</I>,29<I>S</I>,30<I>R</I>,31<I>S</I>,32<I>S</I>,33<I>R</I>,34<I>S</I>,35<I>Z</I>,36<I>E</I>,45<I>S</I>,46<I>S</I>)-31-acetoxy-28,45,46-trihydroxy-30-[(1<I>R</I>)-1-hydro xyethyl]-35,36-bis(2-methoxy-2-oxo-ethylidene)-43,43,44,44-tetramethyl-37-oxo-56,57,58,59-tetraoxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]nonacos-17-en-34-yl] (2<I>E</I>,4<I>E</I>)-octa-2,4-dienoate', 'CYAAFQwAacwQoQ4cxdZ2B7gNYq96eqIHXyR8DnbJ$5k^hXkemF^WdUFkcIQzfxD7D3jCS48Gf7ZxEM3QHLYxMvNyCCAE8xScXRjmgoIhAa2AiOd7Ns8d$^3EvMPD^lXfE70J4RYOzPq^XV^^^1wabjBpoHy8osakAzvPiQ8h4tb7GSD4XJ03VqccQJ5ouOylVnM5MN3g O4UTe2Swl4Bny1mcigU853r7nqESJEOHc7rSc8apVnMrOc4JQFff$4qzRLZPi^EYnW4$omjPkbvVTCB75^y0$dDqzNS4H5G11LHZNTcJH$oaHVhGghujeyjy9TJsYVJuzc5cvc9YxebFV^fdwJDexLC5c9b5HOe1eS67hIt$d4Jpi8^pak7d^$cZj^xHzVudn7sem4wS e$hXPP8YfGXs7lfaMPveek8coJ3nfFlsDNe1Ui^HeJnOjv2H9cXQz4jUzqLBevC0e6wQL7bHnoaWN6$tf0r3sDL^$$8Ew9yq', 'InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5) 47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16-,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1', 'AuxInfo=1/0/N:64,53,49,44,45,24,25,57,59,63,62,61,60,58,56,38,39,32,28,47,41,51,27,36,43,21,23,50,40,31,42,29,30,37,22,26,46,20,54,52,55,48,35,33,18,19,34,12,10,6,16,14,17,11,2,7,13,15,3,4,9,8,1,5/E:( 4,5)(6,7)/it:im/rA:132OOOOOOOOOOOOOOOOOCC.oC.oCC.eCCCC.oCCC.oC.oCCCC.eC.oCC.eCCCCCCCCC.oCCCC.eCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;s1n 2s18;p3s18;s20;s1s21;s19;s18;s18;s4s23;s22;s26;p6s27;s4;s28;s30s31;;s5n7s33;p8s34;s29;s5;s30;s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r\n-0.3648\r\n-0.312\r\n-0.3701\r\n-0.3429\r\n-0.3925\r\n-0.3625\r\n-0.299\r\n-0.3098\r\n-0.267\r\n-0.2665\r\n-0.3907\r\n-0.316\r\n-0.2614\r\n-0.316\r\n-0.2614\r\n-0.2614\r\n4.55e-002\r\n0.1754\r\n7.98e-002\r\n1.3e-003\r\n6.59e-002\r\n2.85e-002\r\n-5.23e-002\r\n-5.23e-002\r\n6.71e-002\r\n2.e-004\r\n-', '1', '4.253', 'C47H68O17', '0904.446', '-7.948', '0905.033', '', '13', '2', '10', '57', '00', '0', '64', '67', '86', '10', '017', '04', '68', '0', '4', '013', '0240.1', '962.97', '', '', '', '', '', '', '', '', '', '', '', 'O1[C@]2(O[H])C(C([H])([H])[H])(C([H])([H])[H])[C@](OC(=O)C([H])([H])[H])([H])C([H])([H])[C@@]1([H])C([H])([H])[C@](O[H])([H])C([H])([H])C(=O)O[C@]([C@](O[H])(C([H])([H])[H])[H])([H])C([H])([H])[C@@]4([H])O[C@@](O[H])(C(C([H])([H])[H])(C([H])([H])[H])/C([H])=C([H])\\[C@]3([H])O[C@]([H])(C2([H])[H])C([H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C3([H])[H])[C@](OC(=O)/C(=C(/C(=C(C(C(C([H])([H])[H])([H])[H])([H])[H])\\[H])[H])\\[H])[H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C4([H])[H]', 'CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H](C(C)O)OC(=O)C[C@H](O)C[C@@H]4C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]3C/C(=C/C(=O)OC)C[C@H](/C=C\\C(C)(C)[C@]1(O)O2)O3)O4', 'Bryostatin 1', 'BRYOSTATIN', 'Protein kinase C', '22524140', 'Unknown', 'Alzheimer disease (AD)', '25523423', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(155, '22524140', '22524140', 'CCC\\C=C\\C=C\\C(=O)O[C@H]1\\C(=C\\C(=O)OC)\\C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(=O)C)C(C)(C)[C@](O)(C[C@@H]4C\\C(=C\\C(=O)OC)\\C[C@@H](O4)\\C=C/C(C)(C)[C@]1(O)O2)O3)[C@@H](C)O', '[(17<I>Z</I>,27<I>R</I>,28<I>R</I>,29<I>S</I>,30<I>R</I>,31<I>S</I>,32<I>S</I>,33<I>R</I>,34<I>S</I>,35<I>Z</I>,36<I>E</I>,45<I>S</I>,46<I>S</I>)-31-acetoxy-28,45,46-trihydroxy-30-[(1<I>R</I>)-1-hydro xyethyl]-35,36-bis(2-methoxy-2-oxo-ethylidene)-43,43,44,44-tetramethyl-37-oxo-56,57,58,59-tetraoxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]nonacos-17-en-34-yl] (2<I>E</I>,4<I>E</I>)-octa-2,4-dienoate', 'CYAAFQwAacwQoQ4cxdZ2B7gNYq96eqIHXyR8DnbJ$5k^hXkemF^WdUFkcIQzfxD7D3jCS48Gf7ZxEM3QHLYxMvNyCCAE8xScXRjmgoIhAa2AiOd7Ns8d$^3EvMPD^lXfE70J4RYOzPq^XV^^^1wabjBpoHy8osakAzvPiQ8h4tb7GSD4XJ03VqccQJ5ouOylVnM5MN3g O4UTe2Swl4Bny1mcigU853r7nqESJEOHc7rSc8apVnMrOc4JQFff$4qzRLZPi^EYnW4$omjPkbvVTCB75^y0$dDqzNS4H5G11LHZNTcJH$oaHVhGghujeyjy9TJsYVJuzc5cvc9YxebFV^fdwJDexLC5c9b5HOe1eS67hIt$d4Jpi8^pak7d^$cZj^xHzVudn7sem4wS e$hXPP8YfGXs7lfaMPveek8coJ3nfFlsDNe1Ui^HeJnOjv2H9cXQz4jUzqLBevC0e6wQL7bHnoaWN6$tf0r3sDL^$$8Ew9yq', 'InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5) 47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16-,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1', 'AuxInfo=1/0/N:64,53,49,44,45,24,25,57,59,63,62,61,60,58,56,38,39,32,28,47,41,51,27,36,43,21,23,50,40,31,42,29,30,37,22,26,46,20,54,52,55,48,35,33,18,19,34,12,10,6,16,14,17,11,2,7,13,15,3,4,9,8,1,5/E:( 4,5)(6,7)/it:im/rA:132OOOOOOOOOOOOOOOOOCC.oC.oCC.eCCCC.oCCC.oC.oCCCC.eC.oCC.eCCCCCCCCC.oCCCC.eCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;s1n 2s18;p3s18;s20;s1s21;s19;s18;s18;s4s23;s22;s26;p6s27;s4;s28;s30s31;;s5n7s33;p8s34;s29;s5;s30;s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r\n-0.3648\r\n-0.312\r\n-0.3701\r\n-0.3429\r\n-0.3925\r\n-0.3625\r\n-0.299\r\n-0.3098\r\n-0.267\r\n-0.2665\r\n-0.3907\r\n-0.316\r\n-0.2614\r\n-0.316\r\n-0.2614\r\n-0.2614\r\n4.55e-002\r\n0.1754\r\n7.98e-002\r\n1.3e-003\r\n6.59e-002\r\n2.85e-002\r\n-5.23e-002\r\n-5.23e-002\r\n6.71e-002\r\n2.e-004\r\n-', '1', '4.253', 'C47H68O17', '0904.446', '-7.948', '0905.033', '', '13', '2', '10', '57', '00', '0', '64', '67', '86', '10', '017', '04', '68', '0', '4', '013', '0240.1', '962.97', '', '', '', '', '', '', '', '', '', '', '', 'O1[C@]2(O[H])C(C([H])([H])[H])(C([H])([H])[H])[C@](OC(=O)C([H])([H])[H])([H])C([H])([H])[C@@]1([H])C([H])([H])[C@](O[H])([H])C([H])([H])C(=O)O[C@]([C@](O[H])(C([H])([H])[H])[H])([H])C([H])([H])[C@@]4([H])O[C@@](O[H])(C(C([H])([H])[H])(C([H])([H])[H])/C([H])=C([H])\\[C@]3([H])O[C@]([H])(C2([H])[H])C([H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C3([H])[H])[C@](OC(=O)/C(=C(/C(=C(C(C(C([H])([H])[H])([H])[H])([H])[H])\\[H])[H])\\[H])[H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C4([H])[H]', 'CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H](C(C)O)OC(=O)C[C@H](O)C[C@@H]4C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]3C/C(=C/C(=O)OC)C[C@H](/C=C\\C(C)(C)[C@]1(O)O2)O3)O4', 'Bryostatin 1', 'BRYOSTATIN', 'Protein kinase C', '22524140', 'Under Investigation', 'Fragile X syndrome', '26941170', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(156, '5280757', '5280757', 'CCC\\C=C\\C=C\\C(=O)O[C@H]1\\C(=C\\C(=O)OC)\\C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(=O)C)C(C)(C)[C@](O)(C[C@@H]4C\\C(=C\\C(=O)OC)\\C[C@@H](O4)\\C=C\\C(C)(C)[C@]1(O)O2)O3)[C@@H](C)O', '[(17<I>E</I>,27<I>R</I>,28<I>R</I>,29<I>S</I>,30<I>R</I>,31<I>S</I>,32<I>S</I>,33<I>R</I>,34<I>S</I>,35<I>Z</I>,36<I>E</I>,45<I>S</I>,46<I>S</I>)-31-acetoxy-28,45,46-trihydroxy-30-[(1<I>R</I>)-1-hydro xyethyl]-35,36-bis(2-methoxy-2-oxo-ethylidene)-43,43,44,44-tetramethyl-37-oxo-56,57,58,59-tetraoxatetracyclo[BLAH.BLAH.BLAH.BLAH.BLAH]nonacos-17-en-34-yl] (2<I>E</I>,4<I>E</I>)-octa-2,4-dienoate', 'CYAAFQwAhcwQB8x^O60uPzZkXrSnG3QTLg3E0SZwIjNJ1xKIIIhaex3zLGwciER0Gt1lpcH$c1TWZo41NNkKHrPjdyrsg^^hM251uubuF1aejdR4X$KJ2s^YrTu^BZc7tRKOfM$oP^^HKL1vQcr9i0a0FM42vc4widZYH5Xup50OrN3$54kKylaN8dIvpoHfjZ3ViTeP LGori$8rvMN1NdEtlmM70KWXuclJpwY5ssjNUhfWV2zXTLP63Viq7mjfdbs9ZnLR3H9yp2$ivEMylVS7CTe9zJjXXs8kPTm$7GGi6B5NpGmfeS9p96LSSvHTckL9hiM77FQ2fd0AeopLfJiV8jHax^ZhxhWVua2KyqwXTikrrhyoy7vnd$KwlHofcUa4^wDTZqLni81T dy$Jnx2ZPvWUyXEiegO$jvUWGLZn5r7lS9YkrZVo^mzDMbk65imQXv2V5AQ5mHZUBz8kvrT51oaf6$w19oycEO5^oPH4cVf$', 'InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5) 47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16+,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1', 'AuxInfo=1/0/N:64,53,49,44,45,24,25,57,59,63,62,61,60,58,56,38,39,32,28,47,41,51,27,36,43,21,23,50,40,31,42,29,30,37,22,26,46,20,54,52,55,48,35,33,18,19,34,12,10,6,16,14,17,11,2,7,13,15,3,4,9,8,1,5/E:( 4,5)(6,7)/it:im/rA:132OOOOOOOOOOOOOOOOOCC.oC.oCC.eCCCC.oCCC.oC.oCCCC.eC.oCC.eCCCCCCCCC.oCCCC.eCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;s1n 2s18;p3s18;s20;s1s21;s19;s18;s18;s4s23;s22;s26;n6s27;s4;s28;s30s31;;s5n7s33;p8s34;s29;s5;s30;s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r\n-0.3648\r\n-0.312\r\n-0.3701\r\n-0.3429\r\n-0.3925\r\n-0.3625\r\n-0.299\r\n-0.3098\r\n-0.267\r\n-0.2665\r\n-0.3907\r\n-0.316\r\n-0.2614\r\n-0.316\r\n-0.2614\r\n-0.2614\r\n4.55e-002\r\n0.1754\r\n7.98e-002\r\n1.3e-003\r\n6.59e-002\r\n2.85e-002\r\n-5.23e-002\r\n-5.23e-002\r\n6.71e-002\r\n2.e-004\r\n-', '1', '4.253', 'C47H68O17', '0904.446', '-7.948', '0905.033', '', '13', '2', '10', '57', '00', '0', '64', '67', '86', '10', '017', '04', '68', '0', '4', '013', '0240.1', '962.97', '', '', '', '', '', '', '', '', '', '', '', 'O1[C@]2(O[H])C(C([H])([H])[H])(C([H])([H])[H])[C@](OC(=O)C([H])([H])[H])([H])C([H])([H])[C@@]1([H])C([H])([H])[C@](O[H])([H])C([H])([H])C(=O)O[C@]([C@](O[H])(C([H])([H])[H])[H])([H])C([H])([H])[C@@]4([H])O[C@@](O[H])(C(C([H])([H])[H])(C([H])([H])[H])/C([H])=C([H])\\[C@]3([H])O[C@]([H])(C2([H])[H])C([H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C3([H])[H])[C@](OC(=O)/C(=C(/C(=C(C(C(C([H])([H])[H])([H])[H])([H])[H])\\[H])[H])\\[H])[H])([H])/C(=C(C(OC([H])([H])[H])=O)\\[H])C4([H])[H]', 'CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H](C(C)O)OC(=O)C[C@H](O)C[C@@H]4C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]3C/C(=C/C(=O)OC)C[C@H](/C=C\\C(C)(C)[C@]1(O)O2)O3)O4', 'Bryostatin 1', 'BRYOSTATIN', 'Protein kinase C', '5280757', 'Phase II', 'Alzheimer disease (AD)', '25523423', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(157, '16040694', '16040694', 'Cc1ccc2nc(sc2c1)c3ccc(NCCOCCOCCOCCO)cc3', '2-[2-[2-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]ethoxy]ethoxy]ethoxy]ethanol', 'CYAAFQwATcwQTm5WoMkB5mh81NucYcK9rAj^fNleOKfp3gv3bmRclmk1goCmzLlUlvftM5T3Rmcvw9m4S0ep9o$RwSvj3urP4Mp6^G7WBOxlOcsn5GHtX6L3PHa9Rc1rlKeL3ZPw9ydfAUI^5rD8VPxRUhPeqo2jc0R^l7CZbmxWT8$OA7yHPURf97KQoyRHfos1d86O jRGLlAal8TxDDMpz^BlKZNqwBz98ecnRpSlHBdijPkKbDmuQUTzhEN81JAu6v6Yxw^6GhVdUBAF8q7tRedDTrOFxEojP1pJxyHKNv4x6GVtsBt5IEGf1sLXNrhNvjYneUjgdxMIr49NNbCGf3uSeFPArpn3HMDPQ4Q$y8oin9KReheumCWpOx3bo6VKr5laC0XpvDPoz qUeq5bKV67tD6wuQNzrnGSGew47zdQH$44eSI7^OyA0C1dE^yPT6Ww7eSHZe4Y8p17z914dtv57HsvOUj79H31QF8shQpbCw', 'InChI=1S/C22H28N2O4S/c1-17-2-7-20-21(16-17)29-22(24-20)18-3-5-19(6-4-18)23-8-10-26-12-14-28-15-13-27-11-9-25/h2-7,16,23,25H,8-15H2,1H3', 'AuxInfo=1/0/N:27,24,15,16,17,18,23,8,29,11,28,19,26,22,25,20,21,9,10,14,13,12,6,7,5,2,4,3,1/E:(3,4)(5,6)/rA:57SOOOONNCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s6;;s6;s2s8;s1d-7s9;s1; s7d-13;d+9;s9;d+10s15;s10d-16;s2;s13;d-20;s3s19;s14;s21d-23;s3;s4s25;s21;s4;s5s28;s8;s8;s11;s11;s6;s15;s16;s17;s18;s19;s19;s20;s22;s22;s23;s24;s25;s25;s26;s26;s27;s27;s27;s28;s28;s29;s29;s5;/rC:3.6577 ,-1.1875,.3895;-4.9504,2.0241,-.2786;-6.4538,-.3061,-.0709;-5.0103,-2.6869,-.3483;-2.3131,-2.522', 'OMNADQKBOIYQPW-UHFFFAOYSA-N', '1010:ZVXKW3VDBDTQRVD76HS22P4N96UGPS', '[s]1:[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c]2-[#1]):[n]:[c]1-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]3-[#1])-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#6] (-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#8]-[#1]', 's1c2c(c([H])c([H])c(C([H])([H])[H])c2[H])nc1c3c([H])c([H])c(c([H])c3[H])N([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])O[H]', '03.201', '3.247', '0', '0', 'TRUE', '-6.73e-002\r\n-0.3777\r\n-0.3767\r\n-0.3767\r\n-0.394\r\n-0.2864\r\n-0.2399\r\n2.35e-002\r\n7.1e-003\r\n1.46e-002\r\n5.95e-002\r\n0.1088\r\n3.97e-002\r\n7.83e-002\r\n-5.07e-002\r\n-5.07e-002\r\n-4.36e-002\r\n-4.36e-002\r\n7.01e-002\r\n-4.31e-002\r\n-4.99e-002\r\n7.01e-002\r\n-3.5e-002\r\n-5.71e-002\r\n', '0', '3.2', 'C22H28N2O4S', '0416.177', '-6.678', '0416.534', '3.03 4.85', '4', '2', '0', '15', '16', '3', '29', '31', '31', '7', '006', '02', '28', '0', '3', '013', '0101.08', '441', '', '2.31589', '1.273', '33.46', '17.19', '5.92316', '16.27', '2,653.50', '98.6', '339.56', '', 'S2/C(/C1=C([H])/C([H])=C(N(C(C(OC(C(OC(C(OC(C(O[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])\\C([H])=C1\\[H])=N\\C3=C2\\C([H])=C(C([H])([H])[H])/C([H])=C3/[H]', 'Cc3ccc2nc(c1ccc(NCCOCCOCCOCCO)cc1)sc2c3', 'BTA-EG4', 'SCHEMBL15043913', 'Amyloid beta A4 protein', '16040694', 'Under Investigation', 'Alzheimer disease (AD)', '24316432', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(158, '68778', '68778', 'CC(C)(C)N1CCC(CC1)(c2ccccc2)c3ccccc3', '1-tert-butyl-4,4-diphenyl-piperidine', 'CYAAFQwAkdwQHu954Q2xP86duIvRBjXN2d5WIwrpIED0fdshUoHSdIGRZF4PZIJu8QKw2tjdNuhAL8vGlJA2FKR1bPVgs3WgJeKIMMh60gZgSNDOwz6gVoX4QJij$3tSicizY9ly938aPMR52LqFq7YHt2uiJVpHSf^y6^7N0azNoYk^tjnMNef7rm59MXFPyobNdCsO DFxhbQ4LOMx7rUOcn6wDBdZqxiUj4xjQzLa1QvOVxTzyDPqy8m$8OqKD9qGP3Uu6hGbM9AmgTTp5O$wKumHgQD9h7x9gPcZO99aQVm0B2fRW9$4Ot6a9NjjCDpOCiC4DVU2RD$3a9wNbnXyDkKhrIIwItaPvsFC4woyIPGNgonHUtkd1x71Do3XUSwc$jUts6h4XqOz1 Dtj3QJCugq^u49NZdWk1vyu6LMOPH66wHPpr69hXhuvN95DDf8QFsbFmu^cFBB^yKPvNC5^yImeh3GvXhj^XRV5e0dfDEe3U', 'InChI=1S/C21H27N/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13H,14-17H2,1-3H3', 'AuxInfo=1/0/N:10,11,12,21,22,17,19,18,20,13,15,14,16,3,4,5,6,8,9,7,2,1/E:(1,2,3)(4,5)(6,7,8,9)(10,11,12,13)(14,15)(16,17)(18,19)/rA:49NCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;s2;s1s3;s 1s4;s1;s2;s2;s7;s7;s7;d+8;d+9;s8;s9;s13;s14;d-15;d-16;d-17s19;d-18s20;s3;s3;s4;s4;s5;s5;s6;s6;s10;s10;s10;s11;s11;s11;s12;s12;s12;s13;s14;s15;s16;s17;s18;s19;s20;s21;s22;/rC:-2.4533,1.0862,.0436;.4727 ,.3255,.0255;-.3462,.7869,1.2811;-.2997,.9549,-1.1864;-1.8362,.4363,1.2019;-1.8079,.6609,-1.2002', 'QIHLUZAFSSMXHQ-UHFFFAOYSA-N', '1010:5KBDVXHQSXXYU9NN8QNFV3746CKA3X', '[#7]1(-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])(-[c]3:[ c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1]', 'N1(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(c2c([H])c([H])c([H])c([H])c2[H])(c3c([H])c([H])c([H])c([H])c3[H])C([H])([H])C1([H])[H]', '04.691', '4.691', '0', '0', 'TRUE', '-0.2983\r\n2.27e-002\r\n-2.65e-002\r\n-2.65e-002\r\n-2.e-004\r\n-2.e-004\r\n1.25e-002\r\n-3.73e-002\r\n-3.73e-002\r\n-4.72e-002\r\n-4.72e-002\r\n-4.72e-002\r\n-5.81e-002\r\n-5.81e-002\r\n-5.81e-002\r\n-5.81e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.22e-002\r\n-6.22e-002\r\n2.91', '0', '3.141', 'C21H27N', '0293.214', '-6.43', '0293.446', '10.55', '0', '0', '0', '12', '12', '2', '22', '24', '32', '6', '001', '00', '27', '0', '3', '003', '0003.24', '342.24', '', '0.78', '1.2649', '1.15', '-3.12', '3.78622', '4.27', '692.042', '2.187', '267.53', '', 'N3(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C(C1=C([H])C([H])=C([H])C([H])=C1[H])(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C3([H])[H]', 'CC(C)(C)N3CCC(c1ccccc1)(c2ccccc2)CC3', 'Budipine', 'Budipinum; AN-2326; M128', 'Glutamate receptor ionotropic, NMDA 2A', '68778', 'Under Investigation', 'Parkinson Disease(PARK)', '15936515', 'Parkinson Disease(PARK)', 'PARK'),
(159, '159', 'Not Available', 'CCCCNc1cc(CNc2ccccc2)cc(c1Oc3ccccc3)S(=O)(=O)N', '5-(anilinomethyl)-3-(butylamino)-2-phenoxy-benzenesulfonamide', 'CYAAFQwAzewQMxqQd8Y1zUEl30ioyOyxHu10Wp4hJmRHH931IYSHZiAgk^EhGPfNC9fjWAu^g^AhsHXP72E1y$RgB^8UE3^K8z29cH0TnVCpZBI2nFva6CLyjVh5GdHhe0HRz1ACEZn0jroxjCEpTIMLXcI5CiuOHgYiIENdBp^rD6AN$8LZpzOimUnOL46uvJmRVN^d 81sum3iWz^nadqWXh3sdM6L$duPXu43lEv$VahNi0r79p448lX816Sdei$VRvm1Zj^9mW9vT37m636cpsdQN$dPrKy99OcmbMoByfDCd2sDrm05pd3E428D1sjjnpz66pzarq1JI3DDPx1no5e$9w^lPY4hec2v9HMv5Z^ovfx4TvUtzKa2Prk6^61thvld3a46qlNQq A$A0TA3MfAYmmEFyDkzA6R2XRX4CAwaXpEZYOoKosmQzBslzkGDVAKpsyCA^ikUASAxJilcOQsiIWxsijpnbuDIn4cs0mXmA', 'InChI=1S/C23H27N3O3S/c1-2-3-14-25-21-15-18(17-26-19-10-6-4-7-11-19)16-22(30(24,27)28)23(21)29-20-12-8-5-9-13-20/h4-13,15-16,25-26H,2-3,14,17H2,1H3,(H2,24,27,28)', 'AuxInfo=1/1/N:22,21,20,30,19,28,29,17,18,26,27,15,16,1,7,4,23,6,25,14,5,2,3,9,12,24,10,11,13,8/E:(6,7)(8,9)(10,11)(12,13)(27,28)/CRV:30.6/rA:30CCCCCCCSNOONOCCCCCCCCCCNCCCCCC/rB:;s2;d-2;d-3;s4;s5d-6;s2 ;s8;d8;d8;s1s5;s3;s13;s14;d+14;d-15;s16;s17d-18;s1;s20;s21;s6;s23;s24;s25;d+25;d-26;s27;s28d-29;/rC:10.2232,-11.3752,0;10.2232,-8.9002,0;10.2232,-9.7252,0;9.5087,-8.4877,0;9.5087,-10.1377,0;8.7943,-8. 9002,0;8.7943,-9.7252,0;10.9377,-8.4877,0;11.3502,-9.2022,0;10.5252,-7.7732,0;11.6521,-8.0752,0;', 'YFQFGDKUFNMHSK-UHFFFAOYSA-N', '1010:BQCSE8TNF5MRHU6ADXARMJC8F9Y852', '[#6](-[#6]-[#6]-[#6])-[#7]-[c](:[c]:[c](-[#6]-[#7]-[c]1:[c]:[c]:[c]:[c]:[c]1):[c]:[c]2-[#16](=[#8])(=[#8])-[#7]):[c]2-[#8]-[c]3:[c]:[c]:[c]:[c]:[c]3', 'C(CCC)Nc(cc(CNc1ccccc1)cc2S(=O)(=O)N)c2Oc3ccccc3', '04.625', '4.625', '0', '0', 'TRUE', '0\r\n-8.8e-003\r\n9.06e-002\r\n-6.45e-002\r\n4.48e-002\r\n-3.33e-002\r\n-3.72e-002\r\n1.414\r\n-0.3846\r\n-0.5685\r\n-0.5685\r\n-0.2866\r\n-0.3101\r\n8.2e-002\r\n-3.13e-002\r\n-3.13e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002\r\n-4.06e-002\r\n-5.5e-002\r\n-6.54e-002\r\n2.5e-002\r\n-0.2843\r\n1.47e-002\r\n-4.43e-002\r\n-4.43e-002\r\n-6.07e-002\r\n-6.07e-002\r\n-6.22e-002', '0', '4.625', 'C23H27N3O3S', '0425.177', '-6.613', '0425.544', '3.57 4.04 10.14', '3', '3', '2', '12', '18', '3', '30', '32', '6', '11', '006', '04', '27', '0', '3', '010', '0101.83', '428.31', '', '', '', '', '', '', '', '', '', '', '', 'C(N/C/3=C(O/C/1=C/C=C\\C=C1)/C(S(N)(=O)=O)=C\\C(CN/C/2=C/C=C\\C=C2)=C3)CCC', 'CCCCNc2cc(CNc1ccccc1)cc(S(N)(=O)=O)c2Oc3ccccc3', 'BUM13', 'Not Available', 'Solute carrier family 12 member 4', 'Not Available', 'Under Investigation', 'Epilepsy', '27088517', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(160, '2471', '2471', 'CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O', '3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid', 'CYAAFQwACewQQnzjCZehnRHMB8fT9DrXkwKy^XJTiIVrII9xdCWQfKvlV7hNHJBqO9AbTawmem2hOuO9CeDJl0fMxTFMwO2rO47YZ7H3d$CiJV4aNN6YiQtocpgWn6s^$ZVtEBAEHlHfKP8WqXwYgNTtrQyEIo83wmn32naAV4WFe5wGyf8cjqc9b3RDjwNzs4mCeeHC sxMbE81IniM6SyPRJX1L6IghIjGthM^XT8$mZDI2r88BFWf3BKjFN^CVUoyxylPU$u6rr2$1oQm29OWRMpU8NHVrsXYVl2wgy^LvmsKewgSdrwKgG3vV2O36cqvmqaMRKLtk546M1GUD08Bn6OPuaMmv3zSlxHRj28krjmWcG96DVdwg5QvXimf7hY1jsIY^NZNtPTwH EjWBvKrotdEPUq3hlNYOqWjfrqeUHkNgr3dMYXrR$aZh5^scihVUYtdrS0fIJssF15SqIUywNsfuPYKCH1p6jnwGsyEyqgvc', 'InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)', 'AuxInfo=1/1/N:18,14,10,25,23,24,21,22,9,15,17,16,19,11,13,12,20,8,7,5,6,3,4,2,1/E:(5,6)(7,8)(20,21)(22,23)/CRV:25.6/rA:45SOOOOONNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;d1;d1;;;;s1;s7;s9;s7;s2d-11;s 1s12;s10;s11;d-15;d+13s16;s14;s2;s5d6s16;d+19;s19;s21;d-22;d-23s24;s9;s9;s10;s10;s7;s14;s14;s15;s17;s18;s18;s18;s8;s8;s21;s22;s23;s24;s25;s5;/rC:-2.9153,-2.0685,.4127;-.0266,-1.5191,.9881;-2.1819,-2.9 156,1.341;-4.3337,-1.8196,.6223;-2.1685,4.1406,-.6;-4.1378,3.0338,-.8521;1.274,.9498,.8192;-2.68', 'MAEIEVLCKWDQJH-UHFFFAOYSA-N', '1010:E9K1TPK556ZX177VSUGAZSJBQC25JK', '[#16](-[c](:[c](-[#1]):[c](-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]1-[#8]-[c]2:[c](-[#1]):[c](-[#1]):[c ](-[#1]):[c](-[#1]):[c]2-[#1])(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c(c([H])c(C(=O)O[H])c([H])c1N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c1Oc2c([H])c([H])c([H])c([H])c2[H])(N([H])[H])(=O)=O', '02.862', '2.862', '0', '0', 'TRUE', '1.4141\r\n-0.3101\r\n-0.5685\r\n-0.5685\r\n-0.3279\r\n-0.2609\r\n-0.2866\r\n-0.3846\r\n0\r\n-4.06e-002\r\n4.53e-002\r\n9.06e-002\r\n-8.3e-003\r\n-5.5e-002\r\n-2.83e-002\r\n4.72e-002\r\n-5.56e-002\r\n-6.54e-002\r\n8.2e-002\r\n0.29\r\n-3.13e-002\r\n-3.13e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002\r\n4.31e-002\r\n4.31e-002\r\n2.79e-002\r\n2.79e-002\r\n0.1281\r\n2.64e-002\r\n2.64e-002\r\n6.48e-002\r\n6.18e-002\r\n2.3e-002\r\n2.3e-002\r\n2.3e-002\r\n8.8e-002\r\n8.8e-002\r\n6.5e-002\r\n6.5e-002\r\n6.23e-002\r\n6.23e-002\r\n6.22e-002\r\n0.223900000000001', '0', '1.404', 'C17H20N2O5S', '0364.109', '-4.355', '0364.416', '1.8 4.5 10.06', '4', '2', '3', '11', '12', '2', '25', '26', '27', '9', '007', '04', '20', '0', '2', '008', '0127.1', '358.86', '', '4.66346', '1.2789', '88.93', '27.65', '4.07403', '61.28', '1,030.94', '224.754', '272.34', '', 'S(=O)(=O)(N([H])[H])/C1=C([H])/C(C(O[H])=O)=C([H])\\C(N(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])[H])=C1\\O\\C2=C([H])\\C([H])=C([H])C([H])=C2[H]', 'CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc2ccccc2', 'Bumetanide', 'PF-1593; Bumex; Fordiuran; Lunetoron; Segurex; Aquazone; Cambiex; Diurama; Lixil', 'Solute carrier family 12 member 4', '2471', 'Phase I', 'Epilepsy', '27088517', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(161, '2471', '2471', 'CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O', '3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid', 'CYAAFQwACewQQnzjCZehnRHMB8fT9DrXkwKy^XJTiIVrII9xdCWQfKvlV7hNHJBqO9AbTawmem2hOuO9CeDJl0fMxTFMwO2rO47YZ7H3d$CiJV4aNN6YiQtocpgWn6s^$ZVtEBAEHlHfKP8WqXwYgNTtrQyEIo83wmn32naAV4WFe5wGyf8cjqc9b3RDjwNzs4mCeeHC sxMbE81IniM6SyPRJX1L6IghIjGthM^XT8$mZDI2r88BFWf3BKjFN^CVUoyxylPU$u6rr2$1oQm29OWRMpU8NHVrsXYVl2wgy^LvmsKewgSdrwKgG3vV2O36cqvmqaMRKLtk546M1GUD08Bn6OPuaMmv3zSlxHRj28krjmWcG96DVdwg5QvXimf7hY1jsIY^NZNtPTwH EjWBvKrotdEPUq3hlNYOqWjfrqeUHkNgr3dMYXrR$aZh5^scihVUYtdrS0fIJssF15SqIUywNsfuPYKCH1p6jnwGsyEyqgvc', 'InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)', 'AuxInfo=1/1/N:18,14,10,25,23,24,21,22,9,15,17,16,19,11,13,12,20,8,7,5,6,3,4,2,1/E:(5,6)(7,8)(20,21)(22,23)/CRV:25.6/rA:45SOOOOONNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;d1;d1;;;;s1;s7;s9;s7;s2d-11;s 1s12;s10;s11;d-15;d+13s16;s14;s2;s5d6s16;d+19;s19;s21;d-22;d-23s24;s9;s9;s10;s10;s7;s14;s14;s15;s17;s18;s18;s18;s8;s8;s21;s22;s23;s24;s25;s5;/rC:-2.9153,-2.0685,.4127;-.0266,-1.5191,.9881;-2.1819,-2.9 156,1.341;-4.3337,-1.8196,.6223;-2.1685,4.1406,-.6;-4.1378,3.0338,-.8521;1.274,.9498,.8192;-2.68', 'MAEIEVLCKWDQJH-UHFFFAOYSA-N', '1010:E9K1TPK556ZX177VSUGAZSJBQC25JK', '[#16](-[c](:[c](-[#1]):[c](-[#6](=[#8])-[#8]-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]1-[#8]-[c]2:[c](-[#1]):[c](-[#1]):[c ](-[#1]):[c](-[#1]):[c]2-[#1])(-[#7](-[#1])-[#1])(=[#8])=[#8]', 'S(c(c([H])c(C(=O)O[H])c([H])c1N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c1Oc2c([H])c([H])c([H])c([H])c2[H])(N([H])[H])(=O)=O', '02.862', '2.862', '0', '0', 'TRUE', '1.4141\r\n-0.3101\r\n-0.5685\r\n-0.5685\r\n-0.3279\r\n-0.2609\r\n-0.2866\r\n-0.3846\r\n0\r\n-4.06e-002\r\n4.53e-002\r\n9.06e-002\r\n-8.3e-003\r\n-5.5e-002\r\n-2.83e-002\r\n4.72e-002\r\n-5.56e-002\r\n-6.54e-002\r\n8.2e-002\r\n0.29\r\n-3.13e-002\r\n-3.13e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002\r\n4.31e-002\r\n4.31e-002\r\n2.79e-002\r\n2.79e-002\r\n0.1281\r\n2.64e-002\r\n2.64e-002\r\n6.48e-002\r\n6.18e-002\r\n2.3e-002\r\n2.3e-002\r\n2.3e-002\r\n8.8e-002\r\n8.8e-002\r\n6.5e-002\r\n6.5e-002\r\n6.23e-002\r\n6.23e-002\r\n6.22e-002\r\n0.223900000000001', '0', '1.404', 'C17H20N2O5S', '0364.109', '-4.355', '0364.416', '1.8 4.5 10.06', '4', '2', '3', '11', '12', '2', '25', '26', '27', '9', '007', '04', '20', '0', '2', '008', '0127.1', '358.86', '', '4.66346', '1.2789', '88.93', '27.65', '4.07403', '61.28', '1,030.94', '224.754', '272.34', '', 'S(=O)(=O)(N([H])[H])/C1=C([H])/C(C(O[H])=O)=C([H])\\C(N(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])[H])=C1\\O\\C2=C([H])\\C([H])=C([H])C([H])=C2[H]', 'CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc2ccccc2', 'Bumetanide', 'PF-1593; Bumex; Fordiuran; Lunetoron; Segurex; Aquazone; Cambiex; Diurama; Lixil', 'Solute carrier family 12 member 1', '2471', 'Phase II', 'Hypokalemic Periodic Paralysis', '23427324', 'Hypokalemic Periodic Paralysis', 'HYPP , ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA\nGAMSTORP DISEASE DDDDDSLNFLFNFDLNLNDSLNSLDN'),
(162, '2474', '2474', 'CCCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C', '(2<I>S</I>)-1-butyl-<I>N</I>-(2,6-dimethylphenyl)piperidine-2-carboxamide', 'CYAAFQwAzdwQgCmH2O^dbdvg6OeTueOqI2D5Y3gWdj45BIYKpKSRyIBlzqoZfpKANpBBgwqQh1y2mH0An2iajNL4^TUn7NVWn9vuVL8dbUs7cSJa6FECE3F7SV4Se$gxH^$vXtc34CoAB7zXSDWAv9x^f7NywBB8X$XKkLeYIHc0qCfdvtBYLXNSXU4lclwdUl6xjG$8 y7nVBEuPcTXzaYDQyaHP5tn8u^rSKHOw0xyZS6GN5Xp$yPnuvBB$qqGmN^IJjmc7o31A4pFz1WjbHIsKS30e1qwrVtC9xtndUPOq8GGD6TeUZuewcmsdeM1SmSxbK87d2eU1zGCRyqoyKx68cpQHHIN16vHSW3XDjonpK3nT699mqyJItKnwboEmt7jOq4VRFrHpdZ4s 8SwXKX9$AEHnw55ze$0qeyLRqAt95erZD4c0nTLp3NLrXjHitp$hZAEK4wYFD8IdRW6DIrzFlZIgf1q478qwU8Fp3ml0XTr9', 'InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)/t16-/m0/s1', 'AuxInfo=1/1/N:14,19,20,12,11,7,8,21,17,18,5,9,6,15,16,4,13,10,3,2,1/E:(2,3)(9,10)(14,15)/it:im/rA:49ONNC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s2;s4;s2;s5;s6s7;s2;d1s3s4;s9;s11;s3;s12;d+ 13;s13;s15;d-16;s15;s16;d-17s18;s4;s5;s5;s6;s6;s7;s7;s8;s8;s9;s9;s11;s11;s12;s12;s3;s14;s14;s14;s17;s18;s19;s19;s19;s20;s20;s20;s21;/rC:-.0084,.0139,1.4094;-2.3135,.5416,.1259;1.2097,.4589,-.5539;-1.0 687,1.1382,-.3928;-.973,2.6364,-.0733;-3.4961,1.2544,-.3898;-2.1942,3.3965,-.571;-3.464,2.7426,-', 'LEBVLXFERQHONN-INIZCTEOSA-N', '1010:1BHDN57ZYCPU3WYRRBV5C7PHS28DN7', '[#8]=[#6](-[#6@]1(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1]) -[c]2:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])N([H])c2c(C([H])([H])[H])c([H])c([H])c([H])c2C([H])([H])[H]', '04.31', '4.31', '0', '0', 'TRUE', '-0.2755\r\n-0.2922\r\n-0.2836\r\n8.73e-002\r\n-2.87e-002\r\n-1.1e-003\r\n-5.01e-002\r\n-4.04e-002\r\n-1.1e-003\r\n0.2333\r\n-4.07e-002\r\n-5.5e-002\r\n3.83e-002\r\n-6.54e-002\r\n-2.95e-002\r\n-2.95e-002\r\n-5.75e-002\r\n-5.75e-002\r\n-3.8e-002\r\n-3.8e-002\r\n-6.16e-002\r\n5.68e-002\r\n2.87e-002\r\n2', '1', '3.508', 'C18H28N2O', '0288.22', '-4.615', '0288.428', '2.82 8.21', '1', '1', '1', '15', '06', '1', '21', '22', '33', '4', '003', '01', '28', '0', '2', '005', '0032.34', '333.94', '', '3.19597', '1.251', '26.42', '12.46', '4.14502', '13.96', '820.157', '35.948', '260.67', '-180', 'O=C(N(/C1=C(C([H])([H])[H])/C([H])=C([H])\\C([H])=C1\\C([H])([H])[H])[H])C2([H])N(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H]', 'CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C', 'Bupivacaine', 'Marcaine; Carbostesin; Anekain; Sensorcaine; Win 11318', 'Prostaglandin G/H synthase 2', '2474', 'Phase IV', 'Migraine', '25828648', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(163, '2474', '2474', 'CCCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C', '(2<I>S</I>)-1-butyl-<I>N</I>-(2,6-dimethylphenyl)piperidine-2-carboxamide', 'CYAAFQwAzdwQgCmH2O^dbdvg6OeTueOqI2D5Y3gWdj45BIYKpKSRyIBlzqoZfpKANpBBgwqQh1y2mH0An2iajNL4^TUn7NVWn9vuVL8dbUs7cSJa6FECE3F7SV4Se$gxH^$vXtc34CoAB7zXSDWAv9x^f7NywBB8X$XKkLeYIHc0qCfdvtBYLXNSXU4lclwdUl6xjG$8 y7nVBEuPcTXzaYDQyaHP5tn8u^rSKHOw0xyZS6GN5Xp$yPnuvBB$qqGmN^IJjmc7o31A4pFz1WjbHIsKS30e1qwrVtC9xtndUPOq8GGD6TeUZuewcmsdeM1SmSxbK87d2eU1zGCRyqoyKx68cpQHHIN16vHSW3XDjonpK3nT699mqyJItKnwboEmt7jOq4VRFrHpdZ4s 8SwXKX9$AEHnw55ze$0qeyLRqAt95erZD4c0nTLp3NLrXjHitp$hZAEK4wYFD8IdRW6DIrzFlZIgf1q478qwU8Fp3ml0XTr9', 'InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)/t16-/m0/s1', 'AuxInfo=1/1/N:14,19,20,12,11,7,8,21,17,18,5,9,6,15,16,4,13,10,3,2,1/E:(2,3)(9,10)(14,15)/it:im/rA:49ONNC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s2;s4;s2;s5;s6s7;s2;d1s3s4;s9;s11;s3;s12;d+ 13;s13;s15;d-16;s15;s16;d-17s18;s4;s5;s5;s6;s6;s7;s7;s8;s8;s9;s9;s11;s11;s12;s12;s3;s14;s14;s14;s17;s18;s19;s19;s19;s20;s20;s20;s21;/rC:-.0084,.0139,1.4094;-2.3135,.5416,.1259;1.2097,.4589,-.5539;-1.0 687,1.1382,-.3928;-.973,2.6364,-.0733;-3.4961,1.2544,-.3898;-2.1942,3.3965,-.571;-3.464,2.7426,-', 'LEBVLXFERQHONN-INIZCTEOSA-N', '1010:1BHDN57ZYCPU3WYRRBV5C7PHS28DN7', '[#8]=[#6](-[#6@]1(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1]) -[c]2:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])N([H])c2c(C([H])([H])[H])c([H])c([H])c([H])c2C([H])([H])[H]', '04.31', '4.31', '0', '0', 'TRUE', '-0.2755\r\n-0.2922\r\n-0.2836\r\n8.73e-002\r\n-2.87e-002\r\n-1.1e-003\r\n-5.01e-002\r\n-4.04e-002\r\n-1.1e-003\r\n0.2333\r\n-4.07e-002\r\n-5.5e-002\r\n3.83e-002\r\n-6.54e-002\r\n-2.95e-002\r\n-2.95e-002\r\n-5.75e-002\r\n-5.75e-002\r\n-3.8e-002\r\n-3.8e-002\r\n-6.16e-002\r\n5.68e-002\r\n2.87e-002\r\n2', '1', '3.508', 'C18H28N2O', '0288.22', '-4.615', '0288.428', '2.82 8.21', '1', '1', '1', '15', '06', '1', '21', '22', '33', '4', '003', '01', '28', '0', '2', '005', '0032.34', '333.94', '', '3.19597', '1.251', '26.42', '12.46', '4.14502', '13.96', '820.157', '35.948', '260.67', '-180', 'O=C(N(/C1=C(C([H])([H])[H])/C([H])=C([H])\\C([H])=C1\\C([H])([H])[H])[H])C2([H])N(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H]', 'CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C', 'Bupivacaine', 'Marcaine; Carbostesin; Anekain; Sensorcaine; Win 11318', 'Prostaglandin G/H synthase 2', '2474', 'Phase IV Completed', 'Carpal Tunnel Syndrome', '28396759', 'Carpal Tunnel Syndrome', 'CTS\nAMYOTROPHY, THENAR, OF CARPAL ORIGIN'),
(164, '444', '444', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', '(2<I>S</I>)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one', 'CYAAFQwAIdwQBqMZCbL4$EVbkp5AAKkOWAWceDSWQ0Mr6alEkdpZaRh^WMWlnJI6cwjUEfg27c$tsCTW6xnAJxsKk49IwvvhjFPTpwXuNnkWF422Xg5Qt78p8CXTexPelm5jAQwHe$p7ieIepZv2oy1tOGc79kDihk$^1$iGmNePM1ZpV8es$K5gHlopFB7OqBLFlean dqHWjybeVeYCZQ8q9QjUczzz0vYkZkFeYVgYo49TtqYc3rU1aDoVJT5V5it16JVVtaFRJsbUazTrQn6SqT2oXBaOQU$N9YVurEnKqQ8C1w6AYWWNJsVrJh2a$tGqReRzKc4uPEn188eGtgQUgb$CugXg2^4COoGXBT7DdX7aXUDeNoaHrHYz3^qWJElTQzc^GdogJ75d r$IyKBfa9fXKwrGhQVrcknLnmnH9bpStx^xf3RkiuiAm3$DPBQtQAuv2weMvszLrwGv$Pgr6896AEmf4fJHocUZMBPaOJ7RP', 'InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m0/s1', 'AuxInfo=1/0/N:9,6,7,8,15,13,16,12,5,11,14,10,4,1,3,2/E:(2,3,4)/it:im/rA:34ClONCC.eCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s4;s4;s4;s5;d2s5;s10;d+11;s11;s1s12;d-13;d+14s15;s3;s5;s6;s6;s6;s7;s7;s7;s8;s 8;s8;s9;s9;s9;s12;s13;s15;s16;/rC:-3.0766,2.9472,-.1114;.1193,-2.2961,.7907;2.0392,-.0989,.6779;3.1953,.6385,.1576;1.1375,-.463,-.4018;3.6897,1.6008,1.2429;4.2967,-.3668,-.1952;2.778,1.423,-1.0918;1.8 685,-1.3505,-1.4006;-.0339,-1.2181,.2169;-1.4113,-.6518,.1141;-1.5603,.7148,.0585;-2.4784,-1.519', 'SNPPWIUOZRMYNY-VIFPVBQESA-N', '1010:916M4ZB2WN5ETGDGW9X8FXMH9EUWDH', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]1-[ #1]', 'Clc(c([H])c([H])c([H])c1C([C@]([H])(C([H])([H])[H])N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)c1[H]', '03.119', '3.12', '0', '0', 'TRUE', '-8.44e-002\r\n-0.2924\r\n-0.3027\r\n1.03e-002\r\n6.83e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.23e-002\r\n0.179\r\n2.06e-002\r\n-3.27e-002\r\n-5.13e-002\r\n4.12e-002\r\n-6.01e-002\r\n-4.35e-002\r\n0.1234\r\n5.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48', '1', '2.156', 'C13H18ClNO', '0239.108', '-4.36', '0239.741', '8.65', '1', '1', '1', '9', '06', '1', '16', '16', '24', '4', '002', '01', '18', '0', '1', '004', '0029.1', '275.72', '', '2.40123', '1.2629', '37.52', '9.38', '3.43075', '28.14', '530.24', '44.612', '200.65', '', 'Cl/C1=C([H])/C([H])=C([H])\\C(C(=O)C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])=C1\\[H]', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', 'Bupropion', 'Amfebutamone; Wellbutrin; Elontril; Wellbatrin; Zyban; AC1L198Y', 'Sodium-dependent dopamine transporter', '444', 'FDA approved', 'Attention Deficit Hyperactivity Disorder (ADHD)', '22176279', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD'),
(165, '444', '444', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', '(2<I>S</I>)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one', 'CYAAFQwAIdwQBqMZCbL4$EVbkp5AAKkOWAWceDSWQ0Mr6alEkdpZaRh^WMWlnJI6cwjUEfg27c$tsCTW6xnAJxsKk49IwvvhjFPTpwXuNnkWF422Xg5Qt78p8CXTexPelm5jAQwHe$p7ieIepZv2oy1tOGc79kDihk$^1$iGmNePM1ZpV8es$K5gHlopFB7OqBLFlean dqHWjybeVeYCZQ8q9QjUczzz0vYkZkFeYVgYo49TtqYc3rU1aDoVJT5V5it16JVVtaFRJsbUazTrQn6SqT2oXBaOQU$N9YVurEnKqQ8C1w6AYWWNJsVrJh2a$tGqReRzKc4uPEn188eGtgQUgb$CugXg2^4COoGXBT7DdX7aXUDeNoaHrHYz3^qWJElTQzc^GdogJ75d r$IyKBfa9fXKwrGhQVrcknLnmnH9bpStx^xf3RkiuiAm3$DPBQtQAuv2weMvszLrwGv$Pgr6896AEmf4fJHocUZMBPaOJ7RP', 'InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m0/s1', 'AuxInfo=1/0/N:9,6,7,8,15,13,16,12,5,11,14,10,4,1,3,2/E:(2,3,4)/it:im/rA:34ClONCC.eCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s4;s4;s4;s5;d2s5;s10;d+11;s11;s1s12;d-13;d+14s15;s3;s5;s6;s6;s6;s7;s7;s7;s8;s 8;s8;s9;s9;s9;s12;s13;s15;s16;/rC:-3.0766,2.9472,-.1114;.1193,-2.2961,.7907;2.0392,-.0989,.6779;3.1953,.6385,.1576;1.1375,-.463,-.4018;3.6897,1.6008,1.2429;4.2967,-.3668,-.1952;2.778,1.423,-1.0918;1.8 685,-1.3505,-1.4006;-.0339,-1.2181,.2169;-1.4113,-.6518,.1141;-1.5603,.7148,.0585;-2.4784,-1.519', 'SNPPWIUOZRMYNY-VIFPVBQESA-N', '1010:916M4ZB2WN5ETGDGW9X8FXMH9EUWDH', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]1-[ #1]', 'Clc(c([H])c([H])c([H])c1C([C@]([H])(C([H])([H])[H])N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)c1[H]', '03.119', '3.12', '0', '0', 'TRUE', '-8.44e-002\r\n-0.2924\r\n-0.3027\r\n1.03e-002\r\n6.83e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.23e-002\r\n0.179\r\n2.06e-002\r\n-3.27e-002\r\n-5.13e-002\r\n4.12e-002\r\n-6.01e-002\r\n-4.35e-002\r\n0.1234\r\n5.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48', '1', '2.156', 'C13H18ClNO', '0239.108', '-4.36', '0239.741', '8.65', '1', '1', '1', '9', '06', '1', '16', '16', '24', '4', '002', '01', '18', '0', '1', '004', '0029.1', '275.72', '', '2.40123', '1.2629', '37.52', '9.38', '3.43075', '28.14', '530.24', '44.612', '200.65', '', 'Cl/C1=C([H])/C([H])=C([H])\\C(C(=O)C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])=C1\\[H]', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', 'Bupropion', 'Amfebutamone; Wellbutrin; Elontril; Wellbatrin; Zyban; AC1L198Y', 'Sodium-dependent noradrenaline transporter', '444', 'FDA approved', 'Attention Deficit Hyperactivity Disorder (ADHD)', '22176279', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD'),
(166, '444', '444', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', '(2<I>S</I>)-2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one', 'CYAAFQwAIdwQBqMZCbL4$EVbkp5AAKkOWAWceDSWQ0Mr6alEkdpZaRh^WMWlnJI6cwjUEfg27c$tsCTW6xnAJxsKk49IwvvhjFPTpwXuNnkWF422Xg5Qt78p8CXTexPelm5jAQwHe$p7ieIepZv2oy1tOGc79kDihk$^1$iGmNePM1ZpV8es$K5gHlopFB7OqBLFlean dqHWjybeVeYCZQ8q9QjUczzz0vYkZkFeYVgYo49TtqYc3rU1aDoVJT5V5it16JVVtaFRJsbUazTrQn6SqT2oXBaOQU$N9YVurEnKqQ8C1w6AYWWNJsVrJh2a$tGqReRzKc4uPEn188eGtgQUgb$CugXg2^4COoGXBT7DdX7aXUDeNoaHrHYz3^qWJElTQzc^GdogJ75d r$IyKBfa9fXKwrGhQVrcknLnmnH9bpStx^xf3RkiuiAm3$DPBQtQAuv2weMvszLrwGv$Pgr6896AEmf4fJHocUZMBPaOJ7RP', 'InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m0/s1', 'AuxInfo=1/0/N:9,6,7,8,15,13,16,12,5,11,14,10,4,1,3,2/E:(2,3,4)/it:im/rA:34ClONCC.eCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s4;s4;s4;s5;d2s5;s10;d+11;s11;s1s12;d-13;d+14s15;s3;s5;s6;s6;s6;s7;s7;s7;s8;s 8;s8;s9;s9;s9;s12;s13;s15;s16;/rC:-3.0766,2.9472,-.1114;.1193,-2.2961,.7907;2.0392,-.0989,.6779;3.1953,.6385,.1576;1.1375,-.463,-.4018;3.6897,1.6008,1.2429;4.2967,-.3668,-.1952;2.778,1.423,-1.0918;1.8 685,-1.3505,-1.4006;-.0339,-1.2181,.2169;-1.4113,-.6518,.1141;-1.5603,.7148,.0585;-2.4784,-1.519', 'SNPPWIUOZRMYNY-VIFPVBQESA-N', '1010:916M4ZB2WN5ETGDGW9X8FXMH9EUWDH', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]1-[ #1]', 'Clc(c([H])c([H])c([H])c1C([C@]([H])(C([H])([H])[H])N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)c1[H]', '03.119', '3.12', '0', '0', 'TRUE', '-8.44e-002\r\n-0.2924\r\n-0.3027\r\n1.03e-002\r\n6.83e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-4.23e-002\r\n0.179\r\n2.06e-002\r\n-3.27e-002\r\n-5.13e-002\r\n4.12e-002\r\n-6.01e-002\r\n-4.35e-002\r\n0.1234\r\n5.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48e-002\r\n2.48', '1', '2.156', 'C13H18ClNO', '0239.108', '-4.36', '0239.741', '8.65', '1', '1', '1', '9', '06', '1', '16', '16', '24', '4', '002', '01', '18', '0', '1', '004', '0029.1', '275.72', '', '2.40123', '1.2629', '37.52', '9.38', '3.43075', '28.14', '530.24', '44.612', '200.65', '', 'Cl/C1=C([H])/C([H])=C([H])\\C(C(=O)C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])=C1\\[H]', 'C[C@H](NC(C)(C)C)C(=O)c1cccc(Cl)c1', 'Bupropion', 'Amfebutamone; Wellbutrin; Elontril; Wellbatrin; Zyban; AC1L198Y', 'Sodium-dependent dopamine transporter', '444', 'Phase II', 'Huntington Disease (HD)', '28323838', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(167, '36431', '36431', 'O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4', '8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione', 'CYAAFQwAfdwQfVy^4duMzub$T$p$gT9rGtogrQX1ieT7FTnbcnE9FNOE$E0HyIUI^ANSl96nWvhC85QHAdOIGlhTnQSiXDzGt4f^V72Guj1hviI9tsTO86Lc8WkXlyCNP^nLl7$51y6T87tvx17ilF8XFMHW8Ta1hbsVDnF5$kFsraXMcVx9PpF56NlXVp$8sSXDKTEk XU415SgVv2ljZrf1xFAOTa8x4txCKOv2mObyd96OHCl3IR09iS44T7M8tdNizoA7NvXDeZD1LfRaBvxOrj3iyEI429plNplnMowKV^yI84OvaxUvoOoZg5ZenP5liLDywQOa1RjT2lX38oetzjHrC^E9n0Z1bj$ll5xqMQ7syRSLgQF8gr8qAnRWGXNybhz4Lidd83Mp TefNZK0RSSSD9cUGLWs42dGgWDWg75QzrVUYJr7y^4123DW08v^rhkF5jHV76NvtOYoDqploh8TqhxuPuL3jvSv4rns4tRUf', 'InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2', 'AuxInfo=1/0/N:11,12,19,18,28,9,10,26,27,20,17,21,22,23,24,13,14,15,16,25,8,6,7,4,5,3,1,2/E:(1,2)(6,7)(8,9)(12,13)(14,15)(16,17)(18,19)(22,23)(27,28)/rA:59OONNNNNCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH HHHHHHHHHHHHH/rB:;;;;;;;s8;s8;s9;s10s11;s8;s8;d1s3s13;d2s3s14;s3;s17;s18;s4s19;s4;s4;s5s21;s5s22;s5d+6s7;s6;d-7;d-26s27;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s17;s17;s18;s18;s19;s19;s20;s20;s2 1;s21;s22;s22;s23;s23;s24;s24;s26;s27;s28;/rC:3.4964,1.8204,1.1085;3.8622,-2.1009,-1.397;3.6732,', 'QWCRAEMEVRGPNT-UHFFFAOYSA-N', '1010:49RWQB44BHB82RVAFRB7177P3BM5NN', '[#8]=[#6]1-[#6](-[#1])(-[#1])-[#6]2(-[#6](-[#1])(-[#1])-[#6](-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[c]4:[ n]:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]4)-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]', 'O=C1C([H])([H])C2(C([H])([H])C(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])N(c4nc([H])c([H])c([H])n4)C([H])([H])C3([H])[H])=O)C([H])([H])C([H])([H])C([H])([H])C2([H])[H]', '02.021', '2.545', '0', '0', 'TRUE', '-0.277\r\n-0.277\r\n-0.2419\r\n-0.3008\r\n-0.2405\r\n-0.2265\r\n-0.2265\r\n-1.26e-002\r\n-4.67e-002\r\n-4.67e-002\r\n-5.28e-002\r\n-5.28e-002\r\n3.11e-002\r\n3.11e-002\r\n0.2212\r\n0.2212\r\n2.2e-002\r\n-3.56e-002\r\n-3.9e-002\r\n-1.7e-003\r\n1.15e-002\r\n1.15e-002\r\n1.87e-002\r\n1.87e-002\r\n0.2027\r\n', '0', '0.504', 'C21H31N5O2', '0385.248', '-2.879', '0385.503', '5.68 9.86', '4', '0', '2', '23', '06', '1', '28', '31', '35', '5', '007', '00', '31', '0', '4', '006', '0069.64', '415.5', '', '1.7378', '1.2739', '40.87', '21.48', '5.99372', '19.39', '3,005.10', '103.488', '322.07', '-179.62 -179.24', 'O=C4N(C(C(C(C(N2C([H])([H])C([H])([H])N(/C/1=N/C([H])=C([H])\\C([H])=N1)C([H])([H])C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=O)C([H])([H])C3(C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C4([H])[H]', 'O=C2CC1(CCCC1)CC(=O)N2CCCCN4CCN(c3ncccn3)CC4', 'Buspirone hydrochloride', 'Buspar; Narol; Ansitec; Anxinil; Effiplen; Censpar; Kallmiren; Mabuson', '5-hydroxytryptamine receptor 1A', '36431', 'Phase II', 'Parkinson Disease(PARK)', '2873889', 'Parkinson Disease(PARK)', 'PARK'),
(168, '36431', '36431', 'O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4', '8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione', 'CYAAFQwAfdwQfVy^4duMzub$T$p$gT9rGtogrQX1ieT7FTnbcnE9FNOE$E0HyIUI^ANSl96nWvhC85QHAdOIGlhTnQSiXDzGt4f^V72Guj1hviI9tsTO86Lc8WkXlyCNP^nLl7$51y6T87tvx17ilF8XFMHW8Ta1hbsVDnF5$kFsraXMcVx9PpF56NlXVp$8sSXDKTEk XU415SgVv2ljZrf1xFAOTa8x4txCKOv2mObyd96OHCl3IR09iS44T7M8tdNizoA7NvXDeZD1LfRaBvxOrj3iyEI429plNplnMowKV^yI84OvaxUvoOoZg5ZenP5liLDywQOa1RjT2lX38oetzjHrC^E9n0Z1bj$ll5xqMQ7syRSLgQF8gr8qAnRWGXNybhz4Lidd83Mp TefNZK0RSSSD9cUGLWs42dGgWDWg75QzrVUYJr7y^4123DW08v^rhkF5jHV76NvtOYoDqploh8TqhxuPuL3jvSv4rns4tRUf', 'InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2', 'AuxInfo=1/0/N:11,12,19,18,28,9,10,26,27,20,17,21,22,23,24,13,14,15,16,25,8,6,7,4,5,3,1,2/E:(1,2)(6,7)(8,9)(12,13)(14,15)(16,17)(18,19)(22,23)(27,28)/rA:59OONNNNNCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH HHHHHHHHHHHHH/rB:;;;;;;;s8;s8;s9;s10s11;s8;s8;d1s3s13;d2s3s14;s3;s17;s18;s4s19;s4;s4;s5s21;s5s22;s5d+6s7;s6;d-7;d-26s27;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s17;s17;s18;s18;s19;s19;s20;s20;s2 1;s21;s22;s22;s23;s23;s24;s24;s26;s27;s28;/rC:3.4964,1.8204,1.1085;3.8622,-2.1009,-1.397;3.6732,', 'QWCRAEMEVRGPNT-UHFFFAOYSA-N', '1010:49RWQB44BHB82RVAFRB7177P3BM5NN', '[#8]=[#6]1-[#6](-[#1])(-[#1])-[#6]2(-[#6](-[#1])(-[#1])-[#6](-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[c]4:[ n]:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]4)-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]', 'O=C1C([H])([H])C2(C([H])([H])C(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])N3C([H])([H])C([H])([H])N(c4nc([H])c([H])c([H])n4)C([H])([H])C3([H])[H])=O)C([H])([H])C([H])([H])C([H])([H])C2([H])[H]', '02.021', '2.545', '0', '0', 'TRUE', '-0.277\r\n-0.277\r\n-0.2419\r\n-0.3008\r\n-0.2405\r\n-0.2265\r\n-0.2265\r\n-1.26e-002\r\n-4.67e-002\r\n-4.67e-002\r\n-5.28e-002\r\n-5.28e-002\r\n3.11e-002\r\n3.11e-002\r\n0.2212\r\n0.2212\r\n2.2e-002\r\n-3.56e-002\r\n-3.9e-002\r\n-1.7e-003\r\n1.15e-002\r\n1.15e-002\r\n1.87e-002\r\n1.87e-002\r\n0.2027\r\n', '0', '0.504', 'C21H31N5O2', '0385.248', '-2.879', '0385.503', '5.68 9.86', '4', '0', '2', '23', '06', '1', '28', '31', '35', '5', '007', '00', '31', '0', '4', '006', '0069.64', '415.5', '', '1.7378', '1.2739', '40.87', '21.48', '5.99372', '19.39', '3,005.10', '103.488', '322.07', '-179.62 -179.24', 'O=C4N(C(C(C(C(N2C([H])([H])C([H])([H])N(/C/1=N/C([H])=C([H])\\C([H])=N1)C([H])([H])C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=O)C([H])([H])C3(C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C4([H])[H]', 'O=C2CC1(CCCC1)CC(=O)N2CCCCN4CCN(c3ncccn3)CC4', 'Buspirone hydrochloride', 'Buspar; Narol; Ansitec; Anxinil; Effiplen; Censpar; Kallmiren; Mabuson', 'D(2) dopamine receptor', '36431', 'Phase II', 'Parkinson Disease(PARK)', '2873889', 'Parkinson Disease(PARK)', 'PARK');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(169, '54746', '54746', 'CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1', '(6<I>a</I><I>R</I>,9<I>R</I>,10<I>a</I><I>R</I>)-7-allyl-<I>N</I>-[3-(dimethylamino)propyl]-<I>N</I>-(ethylcarbamoyl)-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carbox amide', 'CYAAFQwAdewQOURgLhJ7^zUCs52Mk4Qg893oEx5a3eVwlKd4Hu9KztOlXHDKSQkRDwpz1ulgzmzUyoRgL3piZZoM5ZqDXsJbJCgniLwKS530n5q7K15Z8f8pXfe8wh66O4DVw7Pu^^n$43P3gAwif$h9SRF6x^8babCryCnV^yBsF39HrOEsUVQfx91Swafrs9yCKudF gGhTncgZxLfirUbbXWxZPZh9cPaA0S^iqNzie1eR6zA0wHtyneYafVRwQ9AR$sjL$oZopqc77VqBrTRU6LTkG^hFuV8WSr8Bxx6VH^q7GbJoh$uosm8EDZy7R4yTDmdeR2zz6BWFog4JVaqev2z70aJjA^NdMlv7^4fEV7jHi5$LRR5j9RzW61w8YKdc2EMgtzDIBWkW NNbufkpyTDsMK$sjAZnlu2tC29GizKrcEcb9Fsildda17aJ1zIspjpfcP2CoTZKUkkuZMSdZ3$Ddt0EK4W9Ds9RRVo75HUfT', 'InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1', 'AuxInfo=1/1/N:28,33,31,32,24,30,23,27,20,22,17,29,25,10,12,21,13,16,11,14,8,19,9,15,18,26,6,4,7,3,5,1,2/E:(3,4)/it:im/rA:70OONNNNNC.oC.eCC.oCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/ rB:;;;;;;;s3s8;s8;s10;s9;s3s11;s8;d-14;s12s15;s3;d1s5s11;s4s15;s14;s4d+16;d+19;d-20s22;s17;s5;d2s5s6;s25;d+24;s7s27;s6;s7;s7;s30;s8;s9;s10;s10;s11;s12;s12;s13;s13;s17;s17;s20;s21;s4;s22;s23;s24;s25;s2 5;s27;s27;s28;s28;s29;s29;s6;s30;s30;s31;s31;s31;s32;s32;s32;s33;s33;s33;/rC:-2.6269,1.7846,.343', 'KORNTPPJEAJQIU-KJXAQDMKSA-N', '1010:TRKY3R33TBR9XB5RRH5U7T7UCEREBC', '[#8]=[#6](-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6@@]1(-[#1])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[n]3-[#1]):[c](: [c]3:[c](-[#1]):[c](-[#1]):[c]4-[#1]):[c]24)-[#7](-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1]) -[#1])-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@@]([H])(C([H])([H])N1C([H])([H])C([H])=C([H])[H])C([H])([H])[C@@]2([H])[C@@]1([H])C([H])([H])c(c([H])n3[H])c(c3c([H])c([H])c4[H])c24)N(C(N([H])C([H])([H])C([H])([H])[H])=O)C([H])([H])C([H])([H] )C([H])([H])N(C([H])([H])[H])C([H])([H])[H]', '03.036', '3.56', '0', '0', 'TRUE', '-0.2766\r\n-0.2537\r\n-0.2951\r\n-0.2646\r\n-0.2252\r\n-0.2991\r\n-0.3094\r\n1.2e-003\r\n2.09e-002\r\n-3.21e-002\r\n4.98e-002\r\n-1.e-002\r\n1.02e-002\r\n-3.42e-002\r\n4.e-004\r\n-2.65e-002\r\n1.63e-002\r\n0.2263\r\n2.63e-002\r\n-5.8e-002\r\n-1.45e-002\r\n-4.33e-002\r\n-6.04e-002\r\n-7.78e-002\r\n2.48e', '1', '1.418', 'C26H37N5O2', '0451.295', '-4.601', '0451.604', '-2.4 6.96 9.67', '2', '2', '3', '23', '10', '2', '33', '36', '43', '7', '007', '02', '37', '0', '4', '008', '0071.67', '495.18', '', '1.28952', '1.2651', '65.86', '34.32', '4.77526', '31.54', '1,742.76', '88.637', '376.95', '-30.29', 'O=C(N(C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N(C(C([H])([H])[H])([H])[H])[H])C1([H])C([H])([H])C/2([H])C([H])(N(C(/C(=C([H])\\[H])[H])([H])[H])C1([H])[H])C([H])([H])/C3=C([H])/N([H])/C/4=C([H])/C([H])=C([H])\\C2=C34', 'C=CCN2C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]1c3cccc4[nH]cc(C[C@H]12)c34', 'Cabergoline', 'Dostinex; Cabergolinum; Cabaser; Galastop; Sogilen; CG-101', 'D(2) dopamine receptor', '54746', 'Terminated at Phase IV', 'Parkinson Disease(PARK)', '21908226', 'Parkinson Disease(PARK)', 'PARK'),
(170, '54746', '54746', 'CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1', '(6<I>a</I><I>R</I>,9<I>R</I>,10<I>a</I><I>R</I>)-7-allyl-<I>N</I>-[3-(dimethylamino)propyl]-<I>N</I>-(ethylcarbamoyl)-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydro-4<I>H</I>-indolo[4,3-fg]quinoline-9-carbox amide', 'CYAAFQwAdewQOURgLhJ7^zUCs52Mk4Qg893oEx5a3eVwlKd4Hu9KztOlXHDKSQkRDwpz1ulgzmzUyoRgL3piZZoM5ZqDXsJbJCgniLwKS530n5q7K15Z8f8pXfe8wh66O4DVw7Pu^^n$43P3gAwif$h9SRF6x^8babCryCnV^yBsF39HrOEsUVQfx91Swafrs9yCKudF gGhTncgZxLfirUbbXWxZPZh9cPaA0S^iqNzie1eR6zA0wHtyneYafVRwQ9AR$sjL$oZopqc77VqBrTRU6LTkG^hFuV8WSr8Bxx6VH^q7GbJoh$uosm8EDZy7R4yTDmdeR2zz6BWFog4JVaqev2z70aJjA^NdMlv7^4fEV7jHi5$LRR5j9RzW61w8YKdc2EMgtzDIBWkW NNbufkpyTDsMK$sjAZnlu2tC29GizKrcEcb9Fsildda17aJ1zIspjpfcP2CoTZKUkkuZMSdZ3$Ddt0EK4W9Ds9RRVo75HUfT', 'InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1', 'AuxInfo=1/1/N:28,33,31,32,24,30,23,27,20,22,17,29,25,10,12,21,13,16,11,14,8,19,9,15,18,26,6,4,7,3,5,1,2/E:(3,4)/it:im/rA:70OONNNNNC.oC.eCC.oCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/ rB:;;;;;;;s3s8;s8;s10;s9;s3s11;s8;d-14;s12s15;s3;d1s5s11;s4s15;s14;s4d+16;d+19;d-20s22;s17;s5;d2s5s6;s25;d+24;s7s27;s6;s7;s7;s30;s8;s9;s10;s10;s11;s12;s12;s13;s13;s17;s17;s20;s21;s4;s22;s23;s24;s25;s2 5;s27;s27;s28;s28;s29;s29;s6;s30;s30;s31;s31;s31;s32;s32;s32;s33;s33;s33;/rC:-2.6269,1.7846,.343', 'KORNTPPJEAJQIU-KJXAQDMKSA-N', '1010:TRKY3R33TBR9XB5RRH5U7T7UCEREBC', '[#8]=[#6](-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6@@]1(-[#1])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[n]3-[#1]):[c](: [c]3:[c](-[#1]):[c](-[#1]):[c]4-[#1]):[c]24)-[#7](-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1]) -[#1])-[#6](-[#1])(-[#1])-[#1]', 'O=C([C@@]([H])(C([H])([H])N1C([H])([H])C([H])=C([H])[H])C([H])([H])[C@@]2([H])[C@@]1([H])C([H])([H])c(c([H])n3[H])c(c3c([H])c([H])c4[H])c24)N(C(N([H])C([H])([H])C([H])([H])[H])=O)C([H])([H])C([H])([H] )C([H])([H])N(C([H])([H])[H])C([H])([H])[H]', '03.036', '3.56', '0', '0', 'TRUE', '-0.2766\r\n-0.2537\r\n-0.2951\r\n-0.2646\r\n-0.2252\r\n-0.2991\r\n-0.3094\r\n1.2e-003\r\n2.09e-002\r\n-3.21e-002\r\n4.98e-002\r\n-1.e-002\r\n1.02e-002\r\n-3.42e-002\r\n4.e-004\r\n-2.65e-002\r\n1.63e-002\r\n0.2263\r\n2.63e-002\r\n-5.8e-002\r\n-1.45e-002\r\n-4.33e-002\r\n-6.04e-002\r\n-7.78e-002\r\n2.48e', '1', '1.418', 'C26H37N5O2', '0451.295', '-4.601', '0451.604', '-2.4 6.96 9.67', '2', '2', '3', '23', '10', '2', '33', '36', '43', '7', '007', '02', '37', '0', '4', '008', '0071.67', '495.18', '', '1.28952', '1.2651', '65.86', '34.32', '4.77526', '31.54', '1,742.76', '88.637', '376.95', '-30.29', 'O=C(N(C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N(C(C([H])([H])[H])([H])[H])[H])C1([H])C([H])([H])C/2([H])C([H])(N(C(/C(=C([H])\\[H])[H])([H])[H])C1([H])[H])C([H])([H])/C3=C([H])/N([H])/C/4=C([H])/C([H])=C([H])\\C2=C34', 'C=CCN2C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]1c3cccc4[nH]cc(C[C@H]12)c34', 'Cabergoline', 'Dostinex; Cabergolinum; Cabaser; Galastop; Sogilen; CG-101', '5-hydroxytryptamine receptor 2B', '54746', 'Terminated at Phase IV', 'Parkinson Disease(PARK)', '21908226', 'Parkinson Disease(PARK)', 'PARK'),
(171, '25102847', '25102847', 'COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c2cc1OC', '<I>N</I>1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-<I>N</I>1''-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide', 'CYAAFQwAhcwQI7brcYwh4bIDPrzwV748lu1guhQUTMUsIwVOMzBDfLkeUD0BGiV5kynxR8xnRwcjt^jp4RyHBUMRU7E1QwObD2uFtM5JjhuczU7PBhOY$^xqn4H90k8K4zfpu^zuh6vn8PDn2d40tfFiwj^3jwrWFGp89ovWTceDpc0Rp0vJ6lbHlj09eaEM485PWoVP b$UG$8dnZOM5hEMbWcuiWv0TCI4sVMPXi^4V8eElP$kWr^hXAvmhx7RcACDSq^ZUd8hVq2DauQ4rr9wTXPtXS^Yts5ItbslkWr13kfZFzLF0m^FmAL5ctEaaFyhnO^IPE0blSXojHXxxP5Ztm$YsUMSgUPevOdAW$9sqKucKmP6ovJm063crFjHj2$VooKqOnlT1ibba KvEsIDebefMmdZicpZYceoBFNubNKZFepOe2P5xVPSSXKnpmYfs2tyeeHRIkTxvzz74H1UFG8ADlPJPpbGS9l23RSXaRl^be', 'InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)', 'AuxInfo=1/1/N:36,37,23,24,19,20,17,18,21,22,30,11,12,35,31,32,26,16,15,25,28,29,27,33,34,14,13,10,1,9,8,7,3,2,5,6,4/E:(3,4)(5,6)(7,8)(9,10)(12,13)/rA:61FOOOOONNNCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH HHHHHHHHHHHHH/rB:;;;;;;;;;s10;s10s11;d2s7s10;d3s8s10;s7;s8;d+15;s15;d+16;s16;s17;d-18;s19;d-20;s4d+21s22;s1d+23s24;s4;d+27;d-9s28;s27;s28;s29;s5d+31;s6d+32s33;s9d-30;s5;s6;s11;s11;s12;s12;s7;s8;s17;s1 8;s19;s20;s21;s22;s23;s24;s31;s30;s32;s35;s36;s36;s36;s37;s37;s37;/rC:-8.4975,-3.9719,.0428;-2.1', 'ONIQOQHATWINJY-UHFFFAOYSA-N', '1010:5MTH1TU846UK2RUDEA42NYZYRM5ZB8', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[#6](-[#6]2(-[#6](-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]3-[#1])-[#8]-[c](:[c](-[#1]):[c](-[#1]):[n]4):[c]5:[c]4:[c](-[#1]):[c](:[c ](:[c]5-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])=[#8]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1N([H])C(C2(C(N([H])c3c([H])c([H])c(c([H])c3[H])Oc(c([H])c([H])n4)c5c4c([H])c(c(c5[H])OC([H])([H])[H])OC([H])([H])[H])=O)C([H])([H])C2([H])[H])=O)c([H])c1[H]', '04.342', '4.342', '0', '0', 'TRUE', '-0.207\r\n-0.2761\r\n-0.2761\r\n-0.3097\r\n-0.3466\r\n-0.3466\r\n-0.2845\r\n-0.2845\r\n-0.256\r\n0.124\r\n-2.87e-002\r\n-2.87e-002\r\n0.2314\r\n0.2314\r\n3.26e-002\r\n3.26e-002\r\n-3.82e-002\r\n-3.82e-002\r\n-3.79e-002\r\n-3.79e-002\r\n-2.94e-002\r\n-2.94e-002\r\n-2.45e-002\r\n-2.45e-002\r\n8.21e-002\r\n', '0', '4.524', 'C28H24FN3O5', '0501.17', '-7.432', '0501.506', '1.6 1.77 7.09', '6', '2', '2', '16', '23', '4', '37', '41', '32', '13', '008', '02', '24', '0', '5', '008', '0098.78', '487.34', '', '1.58753', '1.2791', '182.75', '55.14', '6.10106', '127.61', '3,790.43', '120.671', '384.15', '179.99 -180', 'F/C5=C([H])/C([H])=C(N(C(=O)C4(C(=O)N(/C3=C([H])/C([H])=C(O/C1=C\\2/C(=N\\C([H])=C1\\[H])/C([H])=C(OC([H])([H])[H])\\C(OC([H])([H])[H])=C2\\[H])\\C([H])=C3\\[H])[H])C([H])([H])C4([H])[H])[H])\\C([H])=C5\\[H]', 'COc5cc4nccc(Oc3ccc(NC(=O)C2(C(=O)Nc1ccc(F)cc1)CC2)cc3)c4cc5OC', 'Cabozantinib', 'Cometriq; XL 184; BMS907351; EX-A075; CS-0278', 'Vascular endothelial growth factor receptor 2', '25102847', 'Phase II Completed', 'Neurofibromatosis Type 2', '28775147', 'Neurofibromatosis Type 2', 'NEUROFIBROMATOSIS, CENTRAL TYPE\nACOUSTIC SCHWANNOMAS, BILATERAL\nBILATERAL ACOUSTIC NEUROFIBROMATOSIS; BANF\nACOUSTIC NEURINOMA, BILATERAL; CAN'),
(172, '56603756', '56603756', 'COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O[C@@H]4O[C@H](O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2', '5-hydroxy-2-(4-methoxyphenyl)-7-[(2<I>R</I>,3<I>R</I>,4<I>S</I>,5<I>S</I>,6<I>S</I>)-3,4,5,6-tetrahydroxytetrahydropyran-2-yl]oxy-chromen-4-one', 'CYAAFQwAHfwQqxgTGsVOHXymEBIUHpEqUfg2N4qtABPJp5EN1$30c2RLFPj4naZXqGRSmSrdXadmL7Umxa7r65y7HYU2AeLcKYb8w41TrnO8XSlwJiafTjfyTt3$tqCbfsew^6vvRHhfAQi^2vPSadQweE^tGSyDgTQ$W3fvivopgLckvSSfe4wkubCHO88OpL6ZGWQx 48wvDrvQk5xnd9lWnZKSdWqVAd0JUyjBCGaH5I00459Yf9FlnIpXIVKojXHhQcXjk3rM1FTsDBOQsxxBG1Wq8wFw7mETsp8P8oJdT7cwilgFhl95G3HGah8h4DbEM$yMrFtU0qI97H3il0ZqhNfpPha5IgzGELHq94Pxv8$GAn67ZitObn7BD7G4ML$hGAW8bOZ1G$cf zD9smHGHWOSav9^Z6hJbz7tXyqfyy1bcKUDUMoKY8QVoZfTWJmdejKTgiPeAYTXC2OMeO96Y84FpnQNDl19TD2pdGFfei3zN', 'InChI=1S/C21H20O10/c1-28-10-4-2-9(3-5-10)14-8-13(23)16-12(22)6-11(7-15(16)30-14)29-21-19(26)17(24)18(25)20(27)31-21/h2-8,17-22,24-27H,1H3/t17-,18-,19+,20-,21+/m0/s1', 'AuxInfo=1/0/N:31,26,27,28,29,18,17,24,25,30,16,21,22,23,19,20,11,13,12,15,14,8,9,3,5,4,6,10,2,7,1/E:(2,3)(4,5)/it:im/rA:51OOOOOOOOOOC.oC.oC.eC.eC.oCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;s3;s 4s11;s5s11;s1s2s12;s1s6s13;s2;s16;d+16;s7d+17;s19;s8s18d+20;d9s20;s7;s22d-23;s23;d+25;s25;s26;d-27;s10d+28s29;s10;s11;s12;s13;s14;s15;s3;s4;s5;s6;s17;s18;s24;s8;s26;s27;s28;s29;s31;s31;s31;/rC:-3.1686 ,1.123,1.0078;-3.2506,-1.1825,.6477;-6.7322,1.74,-.9488;-5.265,-.7424,-1.3552;-4.9099,3.9541,-.5', 'WRIWBZLJIGBNSQ-JRSUCEMESA-N', '1010:SESR6ZPNVJMGHM21WY71AN3FG6FKKC', '[#8]1-[#6@@](-[#1])(-[#6@](-[#1])(-[#6@@](-[#1])(-[#6@](-[#1])(-[#6@]1(-[#1])-[#8]-[c]2:[c](-[#1]):[c](:[c](-[#6](-[#6](-[#1])=[#6](-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]3-[#1])-[#8]-[#6](-[# 1])(-[#1])-[#1])-[#8]4)=[#8]):[c]4:[c]2-[#1])-[#8]-[#1])-[#8]-[#1])-[#8]-[#1])-[#8]-[#1])-[#8]-[#1]', 'O1[C@@]([H])([C@]([H])([C@@]([H])([C@]([H])([C@]1([H])Oc2c([H])c(c(C(C([H])=C(c3c([H])c([H])c(c([H])c3[H])OC([H])([H])[H])O4)=O)c4c2[H])O[H])O[H])O[H])O[H])O[H]', '00.877', '0.877', '0', '0', 'TRUE', '-0.3179\r\n-0.3132\r\n-0.3873\r\n-0.385\r\n-0.385\r\n-0.3657\r\n-0.3087\r\n-0.36\r\n-0.289\r\n-0.3494\r\n0.1157\r\n0.1338\r\n0.1332\r\n0.1946\r\n0.1862\r\n8.37e-002\r\n2.e-004\r\n-6.e-004\r\n9.84e-002\r\n8.29e-002\r\n8.77e-002\r\n0.1932\r\n9.31e-002\r\n1.77e-002\r\n5.6e-003\r\n-4.98e-002\r\n-4.98e-002\r\n-3.', '1', '0.258', 'C21H20O10', '0432.106', '-3.022', '0432.377', '6.14', '5', '4', '2', '20', '12', '2', '31', '34', '29', '8', '010', '05', '20', '0', '4', '004', '0155.13', '396.57', '', '4.06887', '1.2841', '51.36', '-3.02', '5.08805', '54.38', '2,064.27', '312.894', '316.24', '', 'O4C(O/C1=C([H])/C(O[H])=C/3\\C(=C1\\[H])O/C(/C2=C([H])/C([H])=C(OC([H])([H])[H])\\C([H])=C2\\[H])=C([H])\\C3=O)([H])C(O[H])([H])C(O[H])([H])C(O[H])([H])C4(O[H])[H]', 'COc4ccc(c3cc(=O)c2c(O)cc(O[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)cc2o3)cc4', 'Calpastatin', 'DNC000381', 'Nuclear factor erythroid 2-related factor 2', '56603756', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '26756888', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(173, '2541', '2541', 'CCOc1nc2cccc(C(=O)O)c2n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5', '2-ethoxy-3-[[4-[2-(2<I>H</I>-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid', 'CYAAFQwAyewQoONTILplK3XtdOiYQ$Y$FEaJnj5ec7vEuzhBY08PdwbIxa6VCfhicrZRNW4JRWtOpKJquamggm92zXgNEtjfqLwOywpg0kpWtKsGRb8aiW$PYRRt$1r^yXbrAHwL6MysMWmW68wj5HNv5eQBal^YpIvhXf4BGcoV^D3spOkwO2l$nPmDkXY8U6jlreZY 4hG12s2M3gIfW9FLa5TOlPNB2DA8Y5rOy5GlQw3HLzAkz7jA9uLg2ILy6NiqSPjg1MEOEUe2EcUzRwJw2WNoUH6yNcJzRxJYnv7EDeUg1Elln9xElTmJ$u393eKaaaIqKiv6uQOhSU7FHRb0jOTTbrr58gwazjDNapUjTSGUbQ0Ijq9tz1yPe38kseZyJv4nAyGsLMJc nheXc55wOWU^y9mn5hpIY2KUdHBzNVE7caat6D2mq7dNic4JPiI0vJbHuweVkmz1fnhrYRH6DrhxFncs8RWEeHvcvCXyaa9n', 'InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)', 'AuxInfo=1/1/N:33,27,30,32,24,28,29,22,19,16,17,20,21,10,12,18,23,25,15,13,11,31,26,14,5,6,7,8,9,4,2,3,1/E:(10,11)(12,13)(26,27)(28,29)(31,32)/rA:53OOONNNNNNCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH /rB:;;;;;;s6;d-7s8;s4;s4;s10;s5s11;s1s4d+5;d+11;d+12;s12;;d+13;s16d-18;d-17s18;s15;s18;s19d-22;s23;s2d3s15;s1;d+23;d-25;s28;d-6s7s25;s29d-30;s27;s10;s10;s16;s17;s19;s20;s21;s22;s24;s27;s27;s28;s29;s30 ;s32;s33;s33;s33;s2;s8;/rC:2.9731,-2.8921,-.2881;.8797,2.3343,1.5278;2.6383,2.1286,2.953;2.7292,', 'HTQMVQVXFRQIKW-UHFFFAOYSA-N', '1010:35TXU3V8G25583WPPX9734X56XNB46', '[#8](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[c](:[n]:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](=[#8])-[#8]-[#1]):[c]12):[n]2-[#6](-[#1])(-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[c]4:[c](-[# 1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[c](:[n]:[n]:[n]5-[#1]):[n]5):[c](-[#1]):[c]3-[#1]', 'O(C([H])([H])C([H])([H])[H])c(nc(c([H])c([H])c([H])c1C(=O)O[H])c12)n2C([H])([H])c3c([H])c([H])c(c4c([H])c([H])c([H])c([H])c4c(nnn5[H])n5)c([H])c3[H]', '04.626', '4.626', '0', '0', 'TRUE', '-0.32\r\n-0.3279\r\n-0.2609\r\n-0.201\r\n-0.2119\r\n-0.1563\r\n-0.1139\r\n-8.24e-002\r\n-7.41e-002\r\n3.66e-002\r\n6.45e-002\r\n-3.3e-002\r\n8.64e-002\r\n0.2252\r\n6.75e-002\r\n-5.71e-002\r\n-5.71e-002\r\n-1.77e-002\r\n-3.46e-002\r\n-5.41e-002\r\n-5.41e-002\r\n-4.71e-002\r\n-7.3e-003\r\n-5.92e-002\r\n3', '0', '3.16', 'C24H20N6O3', '0440.16', '-6.534', '0440.454', '4.16 5.3', '6', '1', '1', '9', '27', '5', '33', '37', '26', '13', '009', '02', '20', '0', '5', '007', '0118.8', '430.56', '', '0.98547', '1.2809', '100.05', '83.28', '4.55522', '16.77', '1,542.69', '181.037', '332.02', '', 'O(/C2=N/C1=C([H])/C([H])=C([H])\\C(C(O[H])=O)=C1\\N2C(/C5=C([H])/C([H])=C(/C3=C([H])/C([H])=C([H])\\C([H])=C3\\C/4=N\\N([H])\\N=N4)\\C([H])=C5\\[H])([H])[H])C(C([H])([H])[H])([H])[H]', 'CCOc2nc1cccc(C(=O)O)c1n2Cc5ccc(c3ccccc3c4nn[nH]n4)cc5', 'Candesartan', 'Blopress; Ratacand; CV11974; KS-5003; AC-203; LS-32740', 'Type-1 angiotensin II receptor', '2541', 'Phase II', 'Alzheimer disease (AD)', '26822027', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(174, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase I', 'Epilepsy', '24854329', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(175, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase II', 'Parkinson Disease(PARK)', '25237116', 'Parkinson Disease(PARK)', 'PARK'),
(176, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase II Completed', 'Huntington Disease (HD)', '27159993', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(177, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase III', 'Myoclonic Epilepsy (Dravet Syndrome)', '28538134', 'Myoclonic Epilepsy (Dravet Syndrome)', 'EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6; SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI'),
(178, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase III', 'Tuberous Sclerosis', '27696387', 'Tuberous Sclerosis', 'TUBEROUS SCLEROSIS COMPLEX; TSC\nTUBEROSE SCLEROSIS; TS'),
(179, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase III', 'Infantile Spasms', '25935511', 'Infantile Spasms', 'EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1, ISSX1\nWEST SYNDROME, X-LINKED\nOHTAHARA SYNDROME, X-LINKED\nINFANTILE EPILEPTIC-DYSKINETIC ENCEPHALOPATHY\nXMESID'),
(180, '644019', '644019', 'CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol', 'CYAAFQwA8dwQBYfn1B6hYfa7KXlaKIbxoBbVGSNTNXpK1MIfeS9n88bkapBOo77a0JvKGkf0Xd7$7h8J$YZ68KZUkN9tvLU9ZrVVwVUgbmAvWGaUvkNSv^8xuE1dAXqKnfY$Xf$^^tiWEDgEzIf$BXBHPow$HDFqkWlyD3CfYJPRKMftcziHiro$Kv9mAOw4w9nTYUFK AX8Zl9iyfSXlMBfoIipM0Ouj^jeoDF5nwkH2PRTAcnwMe5yZRpxAmqRKfdnHLGRevaSkLzQozCXlgq7FLGrtWZDZr4CDh$wjldoVl6kY7qIjHi63Cwmjjpee979RR5tgWPlOtwrzK7KvYNTJoKdpeGMGM6zFKfclfKVwuGvIxl4T7MH6zI98KvNVro$6U7FZ$cYW07tU GZZhWWLniZvlPtThfPbCjkCwrRka3pQ341sXYxXkVTljAW^DDt7s23dq8eLnXgOlRT^vPTGybZTP0oXebQfsi3byrAabq64z', 'InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1', 'AuxInfo=1/0/N:23,19,14,13,22,21,20,18,6,5,7,16,17,10,9,15,3,4,11,12,8,1,2/E:(12,13)(19,20)(22,23)/it:im/rA:53OOC.eC.eCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s4;s6d-7;s3;s1d- 8;s2s8;s9;s10;;s11d-15;d+12s15;s15;d+10;s18;s20;s21;s22;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s21;s21;s1;s2;s22;s22;s23;s23;s23;/rC:-.8107,-1.0808,-1.7544;-.3557 ,1.3439,2.3576;-3.002,.528,-.4606;-2.0824,-.1171,.6145;-4.4373,.0054,-.324;-4.4902,-1.5161,-.477', 'QHMBSVQNZZTUGM-ZWKOTPCHSA-N', '1010:12TM92UQBCVF9DM1WKWND57CPPFDP3', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(- [#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '06.613', '6.613', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n1.95e-002\r\n-7.67e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.77e-002\r\n-9.99e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.5', '1', '6.591', 'C21H30O2', '0314.225', '-5.834', '0314.462', '8.58 11.78', '0', '2', '2', '16', '06', '1', '23', '24', '37', '5', '002', '02', '30', '0', '2', '006', '0040.46', '358.83', '', '1.09136', '1.2524', '48.91', '10.47', '4.79197', '38.44', '1,156.08', '64.402', '289.14', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCCCC)cc2O', 'Cannabidiol', 'CBD; Epidiolex; cannabidiolum; ZYN002; GWP42003-P', 'Cannabinoid receptor 1', '644019', 'Phase III Completed', 'Multiple Sclerosis-Related Resistant Spasticity', '27732980', 'Multiple Sclerosis-Related Resistant Spasticity', 'DISSEMINATED SCLEROSIS'),
(181, '11601669', '11601669', 'CCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C(=C)C)c(O)c1', '2-[(1<I>R</I>,6<I>R</I>)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-propyl-benzene-1,3-diol', 'CYAAFQwA1cwQ6$YmQhhXMnq46k5nLTNZzasLlKxHIXyVK8dgDrKEaInf0zM7CtDBqd53^o3iStA0tLjZWxMUdiEc5gmawktQPuYuQOgvWMvVUVWwqVRD6pv3iEbF4SRr6Dv^c^^fNxfv2DBAOOR5OXtywQ39lb1nW9wEHJ^4S6S6XL4BI3RKFcqqUROHCy7HGO6RZSb^ N^0JSxPvtkinrRlNC8YTpMO1Y^v6taBRidme$l$IdqFjPehNLTwDRiqq64RdHO5wq^8hd4VoA8ZOHNp26l5hWVzPQkR645DiFtz5hUz792BYzjtdOTxAmtC7pj15MffGzQQxc36ehlT^2Me3hdq6kKQEx1kdVsyjpvep9Aprda6VUj6RBe3KiTvNo6drSF8gqrzjtcbZ EpzPCUdM^mtb2NsVSGx4Y7mp6kYll7LszS41$I2f1hq6c856m6SU00sMaPy8obt4UT$MfUhYmrdma^4TV6qr6PzccB^Ur8Jf', 'InChI=1S/C19H26O2/c1-5-6-14-10-17(20)19(18(21)11-14)16-9-13(4)7-8-15(16)12(2)3/h9-11,15-16,20-21H,2,5-8H2,1,3-4H3/t15-,16+/m0/s1', 'AuxInfo=1/0/N:21,18,14,13,20,19,6,5,7,16,17,10,8,15,3,4,11,12,9,1,2/E:(10,11)(17,18)(20,21)/it:im/rA:47OOC.eC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s3;s5;s4;s6d-7;s4;s3;s1d-9;s2s9;s8;s1 0;;s11d-15;d+12s15;d+10;s15;s19;s20;s3;s4;s5;s5;s6;s6;s7;s13;s13;s13;s14;s14;s14;s16;s17;s18;s18;s19;s19;s20;s20;s1;s2;s21;s21;s21;/rC:-.5357,2.3348,-1.3673;-.0418,-2.1366,.2925;1.8281,.8796,.6779;1.2 555,.2402,-.6169;2.1859,-.1824,1.7285;3.1078,-1.2827,1.193;1.9348,-1.0557,-1.0008;2.7769,-1.7364', 'REOZWEGFPHTFEI-JKSUJKDBSA-N', '1010:HWC8X4GRNCWWHY2QP3MVWXEN5FWQHZ', '[#8](-[#1])-[c]1:[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](:[c]1-[#6@]2(-[#1])-[#6](-[#1])=[#6](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#1])-[#6@@]2(-[#1])-[#6](=[#6](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1]', 'O([H])c1c([H])c(C([H])([H])C([H])([H])C([H])([H])[H])c([H])c(c1[C@]2([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(=C([H])[H])C([H])([H])[H])O[H]', '05.701', '5.701', '0', '0', 'TRUE', '-0.3605\r\n-0.3605\r\n-1.e-002\r\n1.37e-002\r\n-4.21e-002\r\n-3.17e-002\r\n-7.73e-002\r\n-7.67e-002\r\n1.95e-002\r\n-7.65e-002\r\n7.79e-002\r\n7.79e-002\r\n-4.4e-002\r\n-4.39e-002\r\n-4.29e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-9.99e-002\r\n-2.8e-002\r\n-5.21e-002\r\n-6.51e-002\r\n3.58e-002\r\n4.03e-', '1', '5.18', 'C19H26O2', '0286.193', '-4.85', '0286.409', '6.57 9.77', '0', '2', '2', '14', '06', '1', '21', '22', '33', '5', '002', '02', '26', '0', '2', '004', '0040.46', '323.99', '', '1.66947', '1.254', '38.43', '12.97', '4.16411', '25.46', '755.903', '64.518', '260.67', '', 'O(/C2=C(C1([H])C(/C(C([H])([H])[H])=C([H])\\[H])([H])C([H])([H])C([H])([H])/C(C([H])([H])[H])=C1/[H])/C(O[H])=C([H])\\C(C(C(C([H])([H])[H])([H])[H])([H])[H])=C2\\[H])[H]', 'C=C(C)[C@@H]1CC/C(C)=C\\[C@H]1c2c(O)cc(CCC)cc2O', 'Cannabidivarin', 'GWP42006; CBDV; CTK4F3282', 'transient receptor potential vanilloid 1 (TRPV1)', '11601669', 'Phase II', 'Epilepsy', '25029033', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(182, '16394575', '16394575', 'CCCCCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@H]45)[C@@H]3CC=C2C1', '[(20''<I>R</I>,21<I>S</I>,22<I>S</I>,23<I>S</I>,24<I>S</I>,25<I>S</I>,26<I>S</I>,27<I>R</I>,30<I>R</I>,31<I>S</I>,32<I>R</I>)-20'',21,30,31-tetramethylspiro[35-oxapentacyclo[BLAH.BLAH.BLAH.BLAH.BLAH.BLA H]icos-15(28)-ene-32,2''-tetrahydropyran]-22-yl] hexanoate', 'CYAAFQwA7fwQOJ4ptsIa^0$xUrkliYvrfME^klImfw2BWV$t99HZwV9hA4NQyJAsYuDYkxof8KiYL2IrOrvy92DMy2WRFJdCW5rVsl0LnIJhUyidnqMaPc9q^1XfL28L1nycnfA^Pe^^^c5uaYNsXs89bQYO69a9v0MOyHoQqkxa9kjTGjNXGWZacMRXPoC5HKSuhU^Q 410BxnCfR^1U0W0Q$W4fo3ma876EPcBfhc^Id94FUiiFTr8HOVexhUcJhVRyqYI3BzNu$0x56Mra9XFJ7Lj$^4E$3l8B4rOVM3vEI6jN08OLMSvoDjewcI$dtgShllm4POYRDMabQDHYaS0oiXQc7786K1GOS4Z3FHErgWEfkXeP1MLCA78ormWyfNW7y8ywU3tTNSrZ 7EK8prKNoxFZizo5rx9J5NM28R9B8gjxvQS^SzAn5uxBHlDFpd^Ca04d4b3Si6k425BrQH44zol0VnRas5rGzqsczgrYKJmN', 'InChI=1S/C33H52O4/c1-6-7-8-9-29(34)36-24-13-15-31(4)23(18-24)10-11-25-26(31)14-16-32(5)27(25)19-28-30(32)22(3)33(37-28)17-12-21(2)20-35-33/h10,21-22,24-28,30H,6-9,11-20H2,1-5H3/t21-,22+,24+,25-,26+,27 +,28+,30+,31+,32+,33-/m1/s1', 'AuxInfo=1/0/N:37,31,21,24,17,36,35,34,33,23,18,28,26,14,20,12,22,25,11,30,29,13,19,27,8,10,6,9,32,7,15,5,16,4,2,3,1/it:im/rA:89OOOOC.eC.oC.oC.eC.oC.oCCC.eCC.oC.eCCCCCCCCCCC.oCC.oCCCCCCCCHHHHHHHHHHHHHH HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s6;s1s7;s8;s6s9;s5;s7;s10s12;s10;s1s2s13;s5;s8;s15;s15;s13;s16;s18d-19;s15;s19;s20;s3s25s26;s22;s28;s2s29;s29;s3d4;s32;s33;s34;s35;s36;s6;s7;s8;s9;s 10;s11;s11;s12;s12;s13;s14;s14;s17;s17;s17;s18;s18;s20;s20;s21;s21;s21;s22;s22;s23;s24;s24;s24;s', 'VMOZFSWFUBLCNN-AAPULDEBSA-N', '1010:8DPPATDXB3ED2KDF9PX5SAY5H4K394', '[#8]1-[#6@]2(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#8]2)-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6@@]3(-[#1])-[#6@]1(-[#1])-[#6](-[#1])(- [#1])-[#6@@](-[#1])(-[#6@@]4(-[#1])-[#6@@](-[#1])(-[#6@]5(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6]5(-[#1])-[#1])-[#8]-[#6](-[#6](-[#1])(-[#1])-[#6](-[#1 ])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])=[#6](-[#1])-[#6]4', 'O1[C@]2(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C([H])([H])O2)[C@@]([H])(C([H])([H])[H])[C@@]3([H])[C@]1([H])C([H])([H])[C@@]([H])([C@@]4([H])[C@@]([H])([C@]5(C([H])([H])[H])C(C([H])([H])[C@]( [H])(C([H])([H])C5([H])[H])OC(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=O)=C([H])C4([H])[H])C([H])([H])C6([H])[H])[C@@]36C([H])([H])[H]', '07.048', '7.048', '0', '0', 'TRUE', '-0.3461\r\n-0.3494\r\n-0.3124\r\n-0.2666\r\n-2.36e-002\r\n-2.98e-002\r\n-1.5e-003\r\n-3.09e-002\r\n6.5e-002\r\n-2.89e-002\r\n-2.27e-002\r\n-4.69e-002\r\n1.59e-002\r\n-4.88e-002\r\n-8.4e-003\r\n0.171\r\n-5.9e-002\r\n-3.14e-002\r\n-6.54e-002\r\n-4.14e-002\r\n-5.7e-002\r\n2.e-003\r\n-8.44e-002\r\n-5.56e', '1', '7.048', 'C33H52O4', '0512.387', '-8.933', '0512.764', '', '4', '0', '2', '40', '00', '0', '37', '42', '58', '2', '004', '00', '52', '0', '6', '006', '0044.76', '538.71', '', '1.29358', '1.2794', '105.67', '61.35', '6.90814', '44.32', '4,847.78', '46.287', '460.3', '', 'O5C4([H])C([H])(C1(C([H])([H])[H])C([H])(C2([H])C([H])(C([H])([H])C1([H])[H])C3(C([H])([H])[H])/C(=C([H])\\C2([H])[H])C([H])([H])C(OC(=O)C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])C([H])([H])C3([H])[H])C4([H])[H])C(C([H])([H])[H])([H])C56OC([H])([H])C(C([H])([H])[H])([H])C([H])([H])C6([H])[H]', 'CCCCCC(=O)O[C@H]6CC[C@@]1(C)/C(=C\\C[C@@H]2[C@@H]1CC[C@@]5(C)[C@H]2C[C@@H]4O[C@]3(CC[C@@H](C)CO3)[C@@H](C)[C@@H]45)C6', 'Caprospinol', 'SP-233; Diosgenin caproate', 'Amyloid beta A4 protein', '16394575', 'Under Investigation', 'Alzheimer disease (AD)', '21623958', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(183, '44093', '44093', 'C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O', '(2<I>S</I>)-1-[(2<I>S</I>)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid', 'CYAAFQwAtcwQ5lC9h$oPk5UuJj0Yn^1dFBZtj$mfxZVsrDmMwrAPXXuLsG24CZCV8uJPBRt^$Hd48DXU0etRgkRBvkBzf6lPqqLWrtge38GW2yvjPfibI7ZPB9y67H2$uzzfQ4nn$TMAHRM91psRy4QHGq^pRr3h6pJ9DasihZ^ICY$jwaHN2qvWdIB8dSixlK25ii18 HUoxH1qlr1cVkyTD59NZdOQUBIwuG6b0eZJTs7lVjIcpjwuifkwcdXqPDUkiKzYsoLcYlncHyND3aZ$GOkY$eWIFfRzGPXLef2DDXpXMLnRjetqxnxkMhMncpBg1qe9zoYfA$H6WKnolCr3^nf7MjypMnrLrLBv5h9^hakBXq2OCHSdAcYlQkDoLIUPf5w4supmUYrVx Ln$rmNnztd6GzMkw84eInihPz9se1Cp8KwD76h5Z5^uPVfoYWvbyeffVOafOesvqxj7ZMfgq5M^skh1lPV15zHbV0TpQokbv', 'InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1', 'AuxInfo=1/1/N:14,8,7,9,13,11,6,10,12,5,2,3,4,1/E:(12,13)/it:im/rA:29SOOONC.eCCCCC.eCCCHHHHHHHHHHHHHHH/rB:;;;;s5;s6;s7;s5s8;d2s5;s10;s3d4s6;s1s11;s11;s6;s7;s7;s8;s8;s9;s9;s11;s13;s13;s14;s14;s14;s3;s1; /rC:-3.5125,.2892,1.7967;-.9991,1.5602,.2378;2.8324,1.9486,.3425;2.0858,.7789,-1.4659;.2193,-.4047,.1328;1.4263,.1139,.7629;2.2349,-1.1252,1.1294;1.8157,-2.147,.0754;.345,-1.8319,-.1516;-.9306,.3558,- .0124;-2.1401,-.3862,-.5226;2.1306,.9563,-.2577;-3.4278,.2636,-.0218;-2.0798,-.3717,-2.0455;1.15', 'FAKRSMQSSFJEIM-RQJHMYQMSA-N', '1010:VWW4XKBXDVFDSSJKC3MJH6UZVQ8BPY', '[#16](-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#7]1-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@@]1(-[#1])-[#6](=[#8])-[#8]-[#1])=[#8]', 'S([H])C([H])([H])[C@@]([H])(C([H])([H])[H])C(N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(=O)O[H])=O', '00.667', '0.667', '0', '0', 'TRUE', '-0.1786\r\n-0.2772\r\n-0.3303\r\n-0.2647\r\n-0.2889\r\n0.1111\r\n-2.33e-002\r\n-3.5e-002\r\n1.5e-002\r\n0.2185\r\n4.19e-002\r\n0.279\r\n1.3e-003\r\n-5.31e-002\r\n6.15e-002\r\n2.91e-002\r\n2.91e-002\r\n2.83e-002\r\n2.83e-002\r\n4.69e-002\r\n4.69e-002\r\n4.06e-002\r\n3.85e-002\r\n3.85e-002\r\n2.38e-002\r\n', '1', '-0.804', 'C9H15NO3S', '0217.077', '-0.312', '0217.285', '3.7 9.8', '2', '0', '2', '12', '00', '0', '14', '14', '20', '2', '004', '01', '15', '0', '1', '003', '0096.4', '233.82', '', '3.64759', '1.2799', '30.55', '14.88', '2.98658', '15.67', '340.452', '180.511', '175.27', '-0.52', 'S(C(C(C(=O)N1C(C(O[H])=O)([H])C([H])([H])C([H])([H])C1([H])[H])(C([H])([H])[H])[H])([H])[H])[H]', 'C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O', 'Captopril', 'Capoten; Captopryl; Lopirin; Tensoprel; Dilabar; Tenosbon; Hypertil; Garranil', 'Angiotensin-converting enzyme', '44093', 'Under Investigation', 'Wilson Disease', '14703896', 'Wilson Disease', 'WND; WD\nHEPATOLENTICULAR DEGENERATION');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(184, '2554', '2554', 'NC(=O)N1c2ccccc2C=Cc3ccccc13', 'benzo[b][1]benzazepine-11-carboxamide', 'CYAAFQwA0ewQrZiCKjTDnAe65dFcVkzAAVX2YplezjrDk$CR5K3TaxNMdbHwItTo2wtkNm0cCPf6y5iKE5sX4ycjS5yodCpF6sooSy24BosADRb2WqIyTJhu7DnSz4xuI87SGaPAsAI805k12nFGcMxwlObRHk67d2^7jD3RNGVwj8LpvvUZe4xd6hBa7wYl4B1zeln4 uWoQla1hYB6nm9dTkLUPdMSwmwFvpsunR0uY0vEU4iUIYki6I8MB19oBjMo19415GWhHddhM8um6HPoIViHO60zZCzIUqL^PjeyHeOrYMg68OIkHIpvnC37FlVFEHE9qM^JZIcloi^4oTE81fV74dxI4FKTmLm9f8lXmoSOsvorilZZb5Nc7cbMWnHmK$6aM5GJ8Q$nh EpXwriaqeZsXpbbPE10jPUXgsbFs0vQnnqb$pLmvTndd4JjK7Nsw1x^7hNj1KcK6HGta65qi99oBvuV8rTvfeObwxW2fkTXn', 'InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)', 'AuxInfo=1/1/N:17,18,15,16,12,13,10,11,8,9,6,7,4,5,14,3,2,1/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)/rA:30ONNCCCCCCCCCCCCCCCHHHHHHHHHHHH/rB:;;s2;s2;s4;s5;s6;s7d-8;d+4;d+5;d-6;d-7;d1s2s3;s10;s11;s12d- 15;s13d-16;s8;s9;s10;s11;s12;s13;s15;s16;s17;s18;s3;s3;/rC:1.0649,2.9296,-.7569;-.0003,.8924,-.2539;-1.1919,2.8293,-.9143;1.215,.1984,.0798;-1.2113,.1925,.0767;1.5118,-1.0876,-.4121;-1.509,-1.092,-.41 35;.6693,-1.8018,-1.3758;-.6674,-1.8031,-1.3783;2.1492,.8267,.9279;-2.1272,.8106,.953;2.7308,-1.', 'FFGPTBGBLSHEPO-UHFFFAOYSA-N', '1010:AVMR5U643QMJAWX1P6EZ39GJ44M3Q6', '[#8]=[#6](-[#7](-[#1])-[#1])-[#7]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])=[#6](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c]13', 'O=C(N([H])[H])N1c2c(c([H])c([H])c([H])c2[H])C([H])=C([H])c(c([H])c([H])c([H])c3[H])c13', '02.679', '2.679', '0', '0', 'TRUE', '-0.2536\r\n-0.2233\r\n-0.3123\r\n4.93e-002\r\n4.93e-002\r\n-3.6e-003\r\n-3.6e-003\r\n-5.25e-002\r\n-5.25e-002\r\n-3.95e-002\r\n-3.95e-002\r\n-5.31e-002\r\n-5.31e-002\r\n0.3068\r\n-6.04e-002\r\n-6.04e-002\r\n-6.16e-002\r\n-6.16e-002\r\n6.29e-002\r\n6.29e-002\r\n6.42e-002\r\n6.42e-002\r\n6.29e-002\r\n6', '0', '2.679', 'C15H12N2O', '0236.095', '-3.754', '0236.269', '2.63', '1', '1', '2', '6', '12', '2', '18', '20', '14', '8', '003', '02', '12', '0', '3', '000', '0046.33', '235.28', '', '2.35658', '1.2775', '30.77', '22.04', '3.30483', '8.73', '380.387', '89.869', '180.76', '', 'O=C(N2/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C([H])=C([H])/C/3=C([H])/C([H])=C([H])\\C([H])=C23)N([H])[H]', 'NC(=O)n3c1ccccc1ccc2ccccc23', 'Carbamazepine', 'Tegretol; Finlepsin; Epitol; Carbatrol; Equetro; Neurotol; Timonil; Biston', 'Sodium channel protein type 5 subunit alpha', '2554', 'FDA approved', 'Bipolar disorder', '17190529', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(185, '2554', '2554', 'NC(=O)N1c2ccccc2C=Cc3ccccc13', 'benzo[b][1]benzazepine-11-carboxamide', 'CYAAFQwA0ewQrZiCKjTDnAe65dFcVkzAAVX2YplezjrDk$CR5K3TaxNMdbHwItTo2wtkNm0cCPf6y5iKE5sX4ycjS5yodCpF6sooSy24BosADRb2WqIyTJhu7DnSz4xuI87SGaPAsAI805k12nFGcMxwlObRHk67d2^7jD3RNGVwj8LpvvUZe4xd6hBa7wYl4B1zeln4 uWoQla1hYB6nm9dTkLUPdMSwmwFvpsunR0uY0vEU4iUIYki6I8MB19oBjMo19415GWhHddhM8um6HPoIViHO60zZCzIUqL^PjeyHeOrYMg68OIkHIpvnC37FlVFEHE9qM^JZIcloi^4oTE81fV74dxI4FKTmLm9f8lXmoSOsvorilZZb5Nc7cbMWnHmK$6aM5GJ8Q$nh EpXwriaqeZsXpbbPE10jPUXgsbFs0vQnnqb$pLmvTndd4JjK7Nsw1x^7hNj1KcK6HGta65qi99oBvuV8rTvfeObwxW2fkTXn', 'InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)', 'AuxInfo=1/1/N:17,18,15,16,12,13,10,11,8,9,6,7,4,5,14,3,2,1/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)/rA:30ONNCCCCCCCCCCCCCCCHHHHHHHHHHHH/rB:;;s2;s2;s4;s5;s6;s7d-8;d+4;d+5;d-6;d-7;d1s2s3;s10;s11;s12d- 15;s13d-16;s8;s9;s10;s11;s12;s13;s15;s16;s17;s18;s3;s3;/rC:1.0649,2.9296,-.7569;-.0003,.8924,-.2539;-1.1919,2.8293,-.9143;1.215,.1984,.0798;-1.2113,.1925,.0767;1.5118,-1.0876,-.4121;-1.509,-1.092,-.41 35;.6693,-1.8018,-1.3758;-.6674,-1.8031,-1.3783;2.1492,.8267,.9279;-2.1272,.8106,.953;2.7308,-1.', 'FFGPTBGBLSHEPO-UHFFFAOYSA-N', '1010:AVMR5U643QMJAWX1P6EZ39GJ44M3Q6', '[#8]=[#6](-[#7](-[#1])-[#1])-[#7]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])=[#6](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c]13', 'O=C(N([H])[H])N1c2c(c([H])c([H])c([H])c2[H])C([H])=C([H])c(c([H])c([H])c([H])c3[H])c13', '02.679', '2.679', '0', '0', 'TRUE', '-0.2536\r\n-0.2233\r\n-0.3123\r\n4.93e-002\r\n4.93e-002\r\n-3.6e-003\r\n-3.6e-003\r\n-5.25e-002\r\n-5.25e-002\r\n-3.95e-002\r\n-3.95e-002\r\n-5.31e-002\r\n-5.31e-002\r\n0.3068\r\n-6.04e-002\r\n-6.04e-002\r\n-6.16e-002\r\n-6.16e-002\r\n6.29e-002\r\n6.29e-002\r\n6.42e-002\r\n6.42e-002\r\n6.29e-002\r\n6', '0', '2.679', 'C15H12N2O', '0236.095', '-3.754', '0236.269', '2.63', '1', '1', '2', '6', '12', '2', '18', '20', '14', '8', '003', '02', '12', '0', '3', '000', '0046.33', '235.28', '', '2.35658', '1.2775', '30.77', '22.04', '3.30483', '8.73', '380.387', '89.869', '180.76', '', 'O=C(N2/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C([H])=C([H])/C/3=C([H])/C([H])=C([H])\\C([H])=C23)N([H])[H]', 'NC(=O)n3c1ccccc1ccc2ccccc23', 'Carbamazepine', 'Tegretol; Finlepsin; Epitol; Carbatrol; Equetro; Neurotol; Timonil; Biston', 'Sodium channel protein type 5 subunit alpha', '2554', 'FDA approved', 'Epilepsy', '4052718', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(186, '2554', '2554', 'NC(=O)N1c2ccccc2C=Cc3ccccc13', 'benzo[b][1]benzazepine-11-carboxamide', 'CYAAFQwA0ewQrZiCKjTDnAe65dFcVkzAAVX2YplezjrDk$CR5K3TaxNMdbHwItTo2wtkNm0cCPf6y5iKE5sX4ycjS5yodCpF6sooSy24BosADRb2WqIyTJhu7DnSz4xuI87SGaPAsAI805k12nFGcMxwlObRHk67d2^7jD3RNGVwj8LpvvUZe4xd6hBa7wYl4B1zeln4 uWoQla1hYB6nm9dTkLUPdMSwmwFvpsunR0uY0vEU4iUIYki6I8MB19oBjMo19415GWhHddhM8um6HPoIViHO60zZCzIUqL^PjeyHeOrYMg68OIkHIpvnC37FlVFEHE9qM^JZIcloi^4oTE81fV74dxI4FKTmLm9f8lXmoSOsvorilZZb5Nc7cbMWnHmK$6aM5GJ8Q$nh EpXwriaqeZsXpbbPE10jPUXgsbFs0vQnnqb$pLmvTndd4JjK7Nsw1x^7hNj1KcK6HGta65qi99oBvuV8rTvfeObwxW2fkTXn', 'InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)', 'AuxInfo=1/1/N:17,18,15,16,12,13,10,11,8,9,6,7,4,5,14,3,2,1/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)/rA:30ONNCCCCCCCCCCCCCCCHHHHHHHHHHHH/rB:;;s2;s2;s4;s5;s6;s7d-8;d+4;d+5;d-6;d-7;d1s2s3;s10;s11;s12d- 15;s13d-16;s8;s9;s10;s11;s12;s13;s15;s16;s17;s18;s3;s3;/rC:1.0649,2.9296,-.7569;-.0003,.8924,-.2539;-1.1919,2.8293,-.9143;1.215,.1984,.0798;-1.2113,.1925,.0767;1.5118,-1.0876,-.4121;-1.509,-1.092,-.41 35;.6693,-1.8018,-1.3758;-.6674,-1.8031,-1.3783;2.1492,.8267,.9279;-2.1272,.8106,.953;2.7308,-1.', 'FFGPTBGBLSHEPO-UHFFFAOYSA-N', '1010:AVMR5U643QMJAWX1P6EZ39GJ44M3Q6', '[#8]=[#6](-[#7](-[#1])-[#1])-[#7]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])=[#6](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c]13', 'O=C(N([H])[H])N1c2c(c([H])c([H])c([H])c2[H])C([H])=C([H])c(c([H])c([H])c([H])c3[H])c13', '02.679', '2.679', '0', '0', 'TRUE', '-0.2536\r\n-0.2233\r\n-0.3123\r\n4.93e-002\r\n4.93e-002\r\n-3.6e-003\r\n-3.6e-003\r\n-5.25e-002\r\n-5.25e-002\r\n-3.95e-002\r\n-3.95e-002\r\n-5.31e-002\r\n-5.31e-002\r\n0.3068\r\n-6.04e-002\r\n-6.04e-002\r\n-6.16e-002\r\n-6.16e-002\r\n6.29e-002\r\n6.29e-002\r\n6.42e-002\r\n6.42e-002\r\n6.29e-002\r\n6', '0', '2.679', 'C15H12N2O', '0236.095', '-3.754', '0236.269', '2.63', '1', '1', '2', '6', '12', '2', '18', '20', '14', '8', '003', '02', '12', '0', '3', '000', '0046.33', '235.28', '', '2.35658', '1.2775', '30.77', '22.04', '3.30483', '8.73', '380.387', '89.869', '180.76', '', 'O=C(N2/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C([H])=C([H])/C/3=C([H])/C([H])=C([H])\\C([H])=C23)N([H])[H]', 'NC(=O)n3c1ccccc1ccc2ccccc23', 'Carbamazepine', 'Tegretol; Finlepsin; Epitol; Carbatrol; Equetro; Neurotol; Timonil; Biston', 'Sodium channel protein type 5 subunit alpha', '2554', 'Phase III', 'Alzheimer disease (AD)', '11739066', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(187, '2554', '2554', 'NC(=O)N1c2ccccc2C=Cc3ccccc13', 'benzo[b][1]benzazepine-11-carboxamide', 'CYAAFQwA0ewQrZiCKjTDnAe65dFcVkzAAVX2YplezjrDk$CR5K3TaxNMdbHwItTo2wtkNm0cCPf6y5iKE5sX4ycjS5yodCpF6sooSy24BosADRb2WqIyTJhu7DnSz4xuI87SGaPAsAI805k12nFGcMxwlObRHk67d2^7jD3RNGVwj8LpvvUZe4xd6hBa7wYl4B1zeln4 uWoQla1hYB6nm9dTkLUPdMSwmwFvpsunR0uY0vEU4iUIYki6I8MB19oBjMo19415GWhHddhM8um6HPoIViHO60zZCzIUqL^PjeyHeOrYMg68OIkHIpvnC37FlVFEHE9qM^JZIcloi^4oTE81fV74dxI4FKTmLm9f8lXmoSOsvorilZZb5Nc7cbMWnHmK$6aM5GJ8Q$nh EpXwriaqeZsXpbbPE10jPUXgsbFs0vQnnqb$pLmvTndd4JjK7Nsw1x^7hNj1KcK6HGta65qi99oBvuV8rTvfeObwxW2fkTXn', 'InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)', 'AuxInfo=1/1/N:17,18,15,16,12,13,10,11,8,9,6,7,4,5,14,3,2,1/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)/rA:30ONNCCCCCCCCCCCCCCCHHHHHHHHHHHH/rB:;;s2;s2;s4;s5;s6;s7d-8;d+4;d+5;d-6;d-7;d1s2s3;s10;s11;s12d- 15;s13d-16;s8;s9;s10;s11;s12;s13;s15;s16;s17;s18;s3;s3;/rC:1.0649,2.9296,-.7569;-.0003,.8924,-.2539;-1.1919,2.8293,-.9143;1.215,.1984,.0798;-1.2113,.1925,.0767;1.5118,-1.0876,-.4121;-1.509,-1.092,-.41 35;.6693,-1.8018,-1.3758;-.6674,-1.8031,-1.3783;2.1492,.8267,.9279;-2.1272,.8106,.953;2.7308,-1.', 'FFGPTBGBLSHEPO-UHFFFAOYSA-N', '1010:AVMR5U643QMJAWX1P6EZ39GJ44M3Q6', '[#8]=[#6](-[#7](-[#1])-[#1])-[#7]1-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1])-[#6](-[#1])=[#6](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[c]13', 'O=C(N([H])[H])N1c2c(c([H])c([H])c([H])c2[H])C([H])=C([H])c(c([H])c([H])c([H])c3[H])c13', '02.679', '2.679', '0', '0', 'TRUE', '-0.2536\r\n-0.2233\r\n-0.3123\r\n4.93e-002\r\n4.93e-002\r\n-3.6e-003\r\n-3.6e-003\r\n-5.25e-002\r\n-5.25e-002\r\n-3.95e-002\r\n-3.95e-002\r\n-5.31e-002\r\n-5.31e-002\r\n0.3068\r\n-6.04e-002\r\n-6.04e-002\r\n-6.16e-002\r\n-6.16e-002\r\n6.29e-002\r\n6.29e-002\r\n6.42e-002\r\n6.42e-002\r\n6.29e-002\r\n6', '0', '2.679', 'C15H12N2O', '0236.095', '-3.754', '0236.269', '2.63', '1', '1', '2', '6', '12', '2', '18', '20', '14', '8', '003', '02', '12', '0', '3', '000', '0046.33', '235.28', '', '2.35658', '1.2775', '30.77', '22.04', '3.30483', '8.73', '380.387', '89.869', '180.76', '', 'O=C(N2/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C([H])=C([H])/C/3=C([H])/C([H])=C([H])\\C([H])=C23)N([H])[H]', 'NC(=O)n3c1ccccc1ccc2ccccc23', 'Carbamazepine', 'Tegretol; Finlepsin; Epitol; Carbatrol; Equetro; Neurotol; Timonil; Biston', 'Sodium channel protein type 1 subunit alpha', '2554', 'Under Investigation', 'Myoclonic Epilepsy (Dravet Syndrome)', '26076853', 'Myoclonic Epilepsy (Dravet Syndrome)', 'EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6; SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI'),
(188, '636403', '636403', 'CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(=O)O)OC(=O)CCC(=O)O', '(2<I>S</I>,4<I>a</I><I>S</I>,6<I>a</I><I>R</I>,6<I>a</I><I>S</I>,6<I>b</I><I>R</I>,8<I>a</I><I>R</I>,10<I>S</I>,12<I>a</I><I>S</I>,14<I>b</I><I>R</I>)-10-(3-carboxypropanoyloxy)-2,4<I>a</I>,6<I>a</I>, 6<I>b</I>,9,9,12<I>a</I>-heptamethyl-13-oxo-3,4,5,6,6<I>a</I>,7,8,8<I>a</I>,10,11,12,14<I>b</I>-dodecahydro-1<I>H</I>-picene-2-carboxylic acid', 'CYAAFQwAZewQzYoZijGUY5xDRF7400mMenLpYpFQ9vZkkQv9M^Bi3zhClmb2usrtsgMLozqmHxlW6lH2VnXbSMEXm$tUWTz8BY3TFutnNY2MKR4sXGKQ5uWdlzvP40b^l$qFHmPw7^^5l7$4AKwLq749a1QYAmPfqpzoO0w^lb2hOKz9^$BezXdgA2RKD0lYWS1DHx9h dw0Ozxlh3OkqTBtiK6hrxrsebzVgfPBkBqe7^KtZMEU4m4kPl^9EJhFPK5XuPhA2rP9qTDVeZYlrZDQcw620zrS08pCe^GhxtURUJV5Pv0cL8w24e4pGjQihr6HYr^pR1HIwjWP5UP9fwmaADBO6iI$JoPmOZCZGmb^M0p$nkhuzqSXO$yUVzVfUHG$OLygod8mWyUnu 0HkbRcWILYtb86^Lba8DbacTGa9eHOOSSzJXZDCzzyXaJn8snBVwJzM94XTHScnD2IUds0AJeGcG19Ur5AC$M3evP30OrlMe', 'InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/ t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1', 'AuxInfo=1/1/N:33,34,35,36,25,27,23,40,39,14,26,20,13,30,32,21,19,28,29,16,17,22,12,24,41,38,10,37,15,18,31,9,11,8,2,6,7,5,3,4,1/E:(1,2)(36,37)(39,40)/it:im/rA:91OOOOOOOC.oC.oC.eC.eC.eCCCCC.eC.eCCCCCC. oCCCCCCC.eCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;s8s9;s8;s9;s8;s12s13;s12;s11;s16;s17;s11;s9;s18s19;d2s10;s8;s1s15;s9;s20s24;s11;d-16s22;s17;s18;s29;s30s31;s15;s15;s18 ;s31;s3d4s31;s1d5;s38;s39;s6d7s40;s10;s12;s13;s13;s14;s14;s17;s19;s19;s20;s20;s21;s21;s23;s23;s2', 'OBZHEBDUNPOCJG-WBXJDKIVSA-N', '1010:SE3Y9ZQFZB91PPT3EW5EBESZ8Y9VJN', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1])=[#8])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6@](-[#1] )(-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#6@@]1(-[#6](-[#1])(-[#1])-[#1])-[#6@@](-[#1])(-[#6](-[#6](-[#1])=[#6](-[#6@@]3(-[#1])-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])- [#6@@](-[#6](=[#8])-[#8]-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6]3(-[#1])-[#1])-[#6](-[#1])(-[#1])-[', 'O(C(C([H])([H])C([H])([H])C(=O)O[H])=O)[C@@]([H])(C([H])([H])C1([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(C([H])([H])C2([H])[H])[C@@]1(C([H])([H])[H])[C@@]([H])(C(C([H])=C([C@@]3([H])[C@](C([ H])([H])[H])(C([H])([H])C([H])([H])[C@@](C(=O)O[H])(C([H])([H])[H])C3([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])=O)[C@@]25C([H])([H])[H]', '05.88', '5.88', '0', '0', 'TRUE', '-0.3121\r\n-0.2945\r\n-0.3314\r\n-0.2662\r\n-0.2666\r\n-0.3318\r\n-0.2669\r\n-1.29e-002\r\n-1.85e-002\r\n3.35e-002\r\n-4.8e-003\r\n-2.77e-002\r\n-4.6e-002\r\n-4.88e-002\r\n-5.1e-003\r\n-5.66e-002\r\n-1.29e-002\r\n-2.59e-002\r\n-4.3e-002\r\n-4.44e-002\r\n-4.65e-002\r\n0.1593\r\n-5.81e-002\r\n7.26e-002', '1', '2.998', 'C34H50O7', '0570.356', '-8.745', '0570.757', '4.18 5.09', '5', '0', '5', '40', '00', '0', '41', '45', '63', '5', '007', '02', '50', '0', '5', '006', '0117.97', '629.3', '', '4.30292', '1.2836', '89.57', '42.07', '5.38516', '47.5', '3,519.16', '214.87', '487.05', '', 'O(C5([H])C(C([H])([H])[H])(C([H])([H])[H])C4([H])C(C([H])([H])[H])(C1([H])C(C([H])([H])[H])(C2(C([H])([H])[H])/C(=C([H])\\C1=O)C3([H])C(C([H])([H])[H])(C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C(O[H])=O)C3([H])[H])C([H])([H])C4([H])[H])C([H])([H])C5([H])[H])C(=O)C(C(C(O[H])=O)([H])[H])([H])[H]', 'CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]5(C)[C@@H]2C(=O)/C=C\\4[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]45C', 'Carbenoxolone', 'Biogastrone; Bioral; CBO; AB1009515', 'heat shock transcription factor 1', '636403', 'Under Investigation', 'Parkinson Disease(PARK)', '24946750', 'Parkinson Disease(PARK)', 'PARK'),
(189, '34359', '34359', 'C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O', '(2<I>S</I>)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid', 'CYAAFQwA4ewQsp4$qOJ^BwHpph^oTQ11GNcIQTdlECRgVlk82KvkzRH4GOyS3l2gn1WvUrNEg$qwqPVdfnIzgWO2JGo6I8o$HoQqAbzXoSWv9SBQoV8E^NkYxh3yP55$836aIAgIJI^^3K2VX9h^jxKZQZSpRcpvRPuYSzkKCQbr^ZPms6BEw^6E04qC3RjoBwDGVMen hkdW6SQrrCQZ0Wd9M^6LPZg0HWauyXceiIPvNvlH0YCeHFq45$cbFDiDWPewD$KeuwHs0S2uPY4L90Arme9YGiebPfqxTZvMpROwPoUR455AYcQPoAWlo224vRVBQCFvreXzDh96bqKMc1o9aNNB1V2KLHpZ6cTnrFJHancFx7WCKetox3hkwVnmdYPNeZzTBMFxs4hH eYG1YiwruNjSPeg6e1PxlhyLGbgfZmdGbc9yOt2jXDhAOSD1jyMx0zCmy5FnMU4Tz4M^uysFZcuO^RDcL^2vsUoesa6$4MvM', 'InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1', 'AuxInfo=1/1/N:10,13,15,12,8,9,16,14,11,7,6,5,4,3,1,2/E:(15,16)/it:im/rA:30OOOONNC.oCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;;s5;s5;s7;s8;s7;s1d2s7;d+9;s9;s3s12;d-13;s4d-14s15;s8;s8;s10;s10;s10;s5;s12;s13;s15;s6; s6;s1;s3;s4;/rC:-1.2387,1.1316,1.574;-2.4324,2.0075,-.1335;3.0852,1.988,-.405;4.38,-.2057,.7057;-3.3349,-.539,-.7861;-4.3376,-.2742,.1887;-2.0251,-.3993,-.1321;-.9186,-.6959,-1.1731;.5016,-.5612,-.670 3;-2.009,-1.4089,1.0263;-1.9378,1.0285,.4142;1.1415,.6621,-.7716;1.1316,-1.6644,-.1202;2.4514,.7', 'TZFNLOMSOLWIDK-JTQLQIEISA-N', '1010:ZY2Z7K6Y45NP459W3NZU76FSA32K5J', '[#8](-[#1])-[#6](-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#1])-[#8]-[#1])-[#7](-[#1])-[#7](-[#1])-[#1])=[#8]', 'O([H])C([C@](C([H])([H])[H])(C([H])([H])c1c([H])c([H])c(c(c1[H])O[H])O[H])N([H])N([H])[H])=O', '00.364', '0.752', '1', '0', 'TRUE', '-0.3303\r\n-0.2646\r\n-0.3582\r\n-0.3582\r\n-0.2444\r\n-0.2705\r\n0.1185\r\n1.2e-003\r\n-4.28e-002\r\n-3.56e-002\r\n0.2799\r\n-2.61e-002\r\n-5.62e-002\r\n0.1014\r\n-2.92e-002\r\n0.1012\r\n3.41e-002\r\n3.41e-002\r\n2.55e-002\r\n2.55e-002\r\n2.55e-002\r\n0.1422\r\n6.54e-002\r\n6.26e-002\r\n6.51e-002\r\n0.1', '1', '-1.112', 'C10H14N2O4', '0226.095', '-1.337', '0226.229', '4.8 4.83 10.29 10.61', '1', '4', '1', '9', '06', '1', '16', '16', '20', '4', '006', '06', '14', '0', '1', '004', '0115.81', '239.08', '', '2.90541', '1.247', '15', '2.99', '3.20583', '12.01', '427.15', '242.927', '176.64', '', 'O(C5([H])C(C([H])([H])[H])(C([H])([H])[H])C4([H])C(C([H])([H])[H])(C1([H])C(C([H])([H])[H])(C2(C([H])([H])[H])/C(=C([H])\\C1=O)C3([H])C(C([H])([H])[H])(C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C(O[H])=O)C3([H])[H])C([H])([H])C4([H])[H])C([H])([H])C5([H])[H])C(=O)C(C(C(O[H])=O)([H])[H])([H])[H]', 'C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O', 'Carbidopa', 'Lodosyn; Carbidopum; Atamet; C-DOPA', 'DOPA decarboxylase', '34359', 'FDA approved', 'Parkinson Disease(PARK)', '26777085', 'Parkinson Disease(PARK)', 'PARK'),
(190, '34359', '34359', 'C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O', '(2<I>S</I>)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methyl-propanoic acid', 'CYAAFQwA4ewQsp4$qOJ^BwHpph^oTQ11GNcIQTdlECRgVlk82KvkzRH4GOyS3l2gn1WvUrNEg$qwqPVdfnIzgWO2JGo6I8o$HoQqAbzXoSWv9SBQoV8E^NkYxh3yP55$836aIAgIJI^^3K2VX9h^jxKZQZSpRcpvRPuYSzkKCQbr^ZPms6BEw^6E04qC3RjoBwDGVMen hkdW6SQrrCQZ0Wd9M^6LPZg0HWauyXceiIPvNvlH0YCeHFq45$cbFDiDWPewD$KeuwHs0S2uPY4L90Arme9YGiebPfqxTZvMpROwPoUR455AYcQPoAWlo224vRVBQCFvreXzDh96bqKMc1o9aNNB1V2KLHpZ6cTnrFJHancFx7WCKetox3hkwVnmdYPNeZzTBMFxs4hH eYG1YiwruNjSPeg6e1PxlhyLGbgfZmdGbc9yOt2jXDhAOSD1jyMx0zCmy5FnMU4Tz4M^uysFZcuO^RDcL^2vsUoesa6$4MvM', 'InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1', 'AuxInfo=1/1/N:10,13,15,12,8,9,16,14,11,7,6,5,4,3,1,2/E:(15,16)/it:im/rA:30OOOONNC.oCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;;s5;s5;s7;s8;s7;s1d2s7;d+9;s9;s3s12;d-13;s4d-14s15;s8;s8;s10;s10;s10;s5;s12;s13;s15;s6; s6;s1;s3;s4;/rC:-1.2387,1.1316,1.574;-2.4324,2.0075,-.1335;3.0852,1.988,-.405;4.38,-.2057,.7057;-3.3349,-.539,-.7861;-4.3376,-.2742,.1887;-2.0251,-.3993,-.1321;-.9186,-.6959,-1.1731;.5016,-.5612,-.670 3;-2.009,-1.4089,1.0263;-1.9378,1.0285,.4142;1.1415,.6621,-.7716;1.1316,-1.6644,-.1202;2.4514,.7', 'TZFNLOMSOLWIDK-JTQLQIEISA-N', '1010:ZY2Z7K6Y45NP459W3NZU76FSA32K5J', '[#8](-[#1])-[#6](-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#1])-[#8]-[#1])-[#7](-[#1])-[#7](-[#1])-[#1])=[#8]', 'O([H])C([C@](C([H])([H])[H])(C([H])([H])c1c([H])c([H])c(c(c1[H])O[H])O[H])N([H])N([H])[H])=O', '00.364', '0.752', '1', '0', 'TRUE', '-0.3303\r\n-0.2646\r\n-0.3582\r\n-0.3582\r\n-0.2444\r\n-0.2705\r\n0.1185\r\n1.2e-003\r\n-4.28e-002\r\n-3.56e-002\r\n0.2799\r\n-2.61e-002\r\n-5.62e-002\r\n0.1014\r\n-2.92e-002\r\n0.1012\r\n3.41e-002\r\n3.41e-002\r\n2.55e-002\r\n2.55e-002\r\n2.55e-002\r\n0.1422\r\n6.54e-002\r\n6.26e-002\r\n6.51e-002\r\n0.1', '1', '-1.112', 'C10H14N2O4', '0226.095', '-1.337', '0226.229', '4.8 4.83 10.29 10.61', '1', '4', '1', '9', '06', '1', '16', '16', '20', '4', '006', '06', '14', '0', '1', '004', '0115.81', '239.08', '', '2.90541', '1.247', '15', '2.99', '3.20583', '12.01', '427.15', '242.927', '176.64', '', 'OC(=O)C(NN)(C/C/1=C/C(O)=C(O)\\C=C1)C', 'C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O', 'Carbidopa', 'Lodosyn; Carbidopum; Atamet; C-DOPA', 'DOPA decarboxylase', '34359', 'Phase III Completed', 'Familial Dysautonomia (FD)', '23553478', 'Familial Dysautonomia (FD)', 'NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3; HSAN III; RILEY-DAY SYNDROME; DYS; FD'),
(191, '498142', '498142', 'OC(=O)C1(CCC1)C(=O)O', 'cyclobutane-1,1-dicarboxylic acid', 'CYAAFQwA4dwQz$c8xXzvaACNj4zOlgdEqMMlbpeESfyHgygTyyyysOszXhtaKWB^JftkTOvNFrWqNGI$Uyjxv42klyT523egsnU1ip7MRtpBvwybw9HtPcfs$iPcBnpjEZ0XFM81rQzNbS0eR8uKYbM0g4VBktGxGBbzwHrFmGuHxbjoz0mdXVkDjGNb82cEI92ClFpK ETxO6dOXxEFulgYiz5De^6Q5HDT4UH9pW2KWHL3si2Or8M5UcSaZdoimPDr7OePPJEhpn98B7LMEsUpeUH7uzNvnnnYoWGcWphbVuLmee6b^0vEMyrd7lqmjz^kASJEfaGiUkPCP3femevk0OZXpfb6vjTVefDbJnvkf64qvTj38LdsoTIJ43mLkh41OEhIxHKH0u7z$ 2K7$K1Be517taL13zeN37ol1Wsq9Lal23yjjff7ZnQKANDPYfCaD0wNouBEH$TAtJtN9jA6cMEAsQ3Vp0A0BB6jAFQjjA4$3', 'InChI=1S/C6H8O4/c7-4(8)6(5(9)10)2-1-3-6/h1-3H2,(H,7,8)(H,9,10)', 'AuxInfo=1/1/N:8,6,7,9,10,5,1,3,2,4/E:(2,3)(4,5)(7,8,9,10)/gE:(1,2)/rA:18OOOOC.oCCCCCHHHHHHHH/rB:;;;;s5;s5;s6s7;s1d3s5;s2d4s5;s6;s6;s7;s7;s8;s8;s1;s2;/rC:-.0993,-1.7723,1.2084;-1.9905,1.0032,.7479;1.26 92,-1.8706,-.6119;-2.0174,-.2992,-1.1225;.1394,.2492,-.0528;.9559,1.028,-1.1052;.7201,1.2151,1.0008;1.9097,1.4251,.041;.519,-1.2458,.1231;-1.4061,.2672,-.2288;.4224,1.8762,-1.5513;1.4143,.4472,-1.9102 ;.9834,.7821,1.9702;.1523,2.1367,1.1745;2.7372,.7233,.1961;2.31,2.4409,-.0052;.1276,-2.718,1.336', 'CCQPAEQGAVNNIA-UHFFFAOYSA-N', '1010:5DGTWP7EN4PF3UXPA3W6XHRZFZSKE2', '[#8](-[#1])-[#6](-[#6@@]1(-[#6](=[#8])-[#8]-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1])=[#8]', 'O([H])C([C@@]1(C(=O)O[H])C([H])([H])C([H])([H])C1([H])[H])=O', '00.57', '0.57', '0', '0', 'TRUE', '-0.3309\r\n-0.3309\r\n-0.2656\r\n-0.2656\r\n0.1412\r\n-2.85e-002\r\n-2.85e-002\r\n-5.02e-002\r\n0.2745\r\n0.2745\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.83e-002\r\n2.67e-002\r\n2.67e-002\r\n0.2214\r\n0.222', '0', '-2.201', 'C6H8O4', '0144.042', '-0.692', '0144.125', '2.5 5.65', '2', '0', '2', '8', '00', '0', '10', '10', '12', '2', '004', '02', '8', '0', '1', '002', '0074.59', '143.98', '', '1.93086', '1.2758', '42.1', '27.21', '2.29671', '14.89', '114.909', '170.453', '114.21', '', 'OC(=O)C1(C(O)=O)CCC1', 'O=C(O)C1(C(=O)O)CCC1', 'Carboplatin', 'Cbdca, Paraplatin; Ercar; JM 8', 'DNA', '498142', 'Phase I Completed', 'Neurofibromatosis Type 1', '27061921', 'Neurofibromatosis Type 1', 'NEUROFIBROMATOSIS, PERIPHERAL TYPE\nVON RECKLINGHAUSEN DISEASE'),
(192, '11154555', '11154555', 'CN(C)C(=O)NC1CCC(CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1', '3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea', 'CYAAFQwAocwQnH28LBvtwdhZjWw91PviwTsuhWEsU9GWBhDvSAdCrpN9wtmBrtJOIFffqdSsnse4g7s8kMfGOSq3U0IZocIViMTFJ0UBQ3q6j3Ssrm4Yxzvk3f^5MCJZlLoUqx^^vker^AgA651nt3aZus4$2LLAheJB0rfW$$xsqUee9Ir7gVU4MnH2vsBhAua5FUhh p2Pyx^jFsr1eiUQ4yVR8vGWp2qPaeJJ8JMXNtBmHHy57vvBKxcVxV6^g8VkMzTLYl6DPLJO3RmFeisE8u84BRqYy239LKIL3pRvlFHf5kBnn6WVSyxd5Yh3OvqDWKsIZwyS5SQ^8$5eYHxQWwTnvkoM559ZEjMSoybnK4lDlqQjWdoqXCBv9NEVz1JR0cPkNr4VeHEJg vVx33z4Jb1Nfq4RF7bZyI80OG5lTy5Pj$0eR8eiq7i98^KNYEJpieITh1msf4hjV5yBbeCfAQ57RMbpRsG2QThteru39fX3s', 'InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)/t16-,17+', 'AuxInfo=1/1/N:24,25,27,28,23,10,9,13,12,14,15,16,17,18,19,8,11,26,21,22,20,2,1,5,7,4,6,3/E:(1,2)(6,7)(8,9)(12,13)(14,15)/rA:60ClClONNNNCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s 8;s8;s5;s9s11;s10s11;s8;s4s14;s4;s4;s6s16;s6s17;d3s5s7;s6;s1d-21;s21;s7;s7;s2s22;d-23;d+26s27;s8;s9;s9;s10;s10;s11;s12;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s5;s18;s18;s19;s19;s23;s24;s24;s24;s2 5;s25;s25;s27;s28;/rC:-5.759,-2.0026,-.6166;-8.8555,-1.2061,-.3321;7.8056,-.5007,-.9861;-1.0447,', 'KPWSJANDNDDRMB-CALCHBBNSA-N', '1010:5BU3WG65EB7RQK15XDBDZHVSK6JAAH', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[#7](-[#1])-[#6](-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C3([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C3([H])[H])N([H])C(N(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C2([H])[H])Cl', '04.552', '4.552', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.2541\r\n-0.3008\r\n-0.2964\r\n-0.2712\r\n-0.2921\r\n-4.01e-002\r\n-4.87e-002\r\n-4.87e-002\r\n2.39e-002\r\n-3.44e-002\r\n-3.44e-002\r\n-3.76e-002\r\n-1.5e-003\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n0.3002\r\n3.77e-002\r\n7.73e-002\r\n-4.24e-002\r\n3.8e-00', '0', '4.461', 'C21H32Cl2N4O', '0426.195', '-5.133', '0427.411', '3.69 6.78', '1', '1', '1', '23', '06', '1', '28', '30', '39', '4', '005', '01', '32', '0', '3', '005', '0038.82', '447.5', '', '3.51564', '1.2784', '86.37', '12.85', '5.527', '73.52', '3,404.36', '39.951', '350.2', '', 'Cl/C3=C(N2C([H])([H])C([H])([H])N(C(C(C1([H])C([H])([H])C([H])([H])C(N(C(=O)N(C([H])([H])[H])C([H])([H])[H])[H])([H])C([H])([H])C1([H])[H])([H])[H])([H])[H])C([H])([H])C2([H])[H])/C([H])=C([H])\\C([H])=C3\\Cl', 'CN(C)C(=O)N[C@@H]3CC[C@H](CCN2CCN(c1cccc(Cl)c1Cl)CC2)CC3', 'Cariprazine', 'RGH-188; Vraylar; MP 214', 'D(3) dopamine receptor', '11154555', 'Phase III Completed', 'Bipolar disorder', '29017067', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(193, '11154555', '11154555', 'CN(C)C(=O)NC1CCC(CCN2CCN(CC2)c3cccc(Cl)c3Cl)CC1', '3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea', 'CYAAFQwAocwQnH28LBvtwdhZjWw91PviwTsuhWEsU9GWBhDvSAdCrpN9wtmBrtJOIFffqdSsnse4g7s8kMfGOSq3U0IZocIViMTFJ0UBQ3q6j3Ssrm4Yxzvk3f^5MCJZlLoUqx^^vker^AgA651nt3aZus4$2LLAheJB0rfW$$xsqUee9Ir7gVU4MnH2vsBhAua5FUhh p2Pyx^jFsr1eiUQ4yVR8vGWp2qPaeJJ8JMXNtBmHHy57vvBKxcVxV6^g8VkMzTLYl6DPLJO3RmFeisE8u84BRqYy239LKIL3pRvlFHf5kBnn6WVSyxd5Yh3OvqDWKsIZwyS5SQ^8$5eYHxQWwTnvkoM559ZEjMSoybnK4lDlqQjWdoqXCBv9NEVz1JR0cPkNr4VeHEJg vVx33z4Jb1Nfq4RF7bZyI80OG5lTy5Pj$0eR8eiq7i98^KNYEJpieITh1msf4hjV5yBbeCfAQ57RMbpRsG2QThteru39fX3s', 'InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)/t16-,17+', 'AuxInfo=1/1/N:24,25,27,28,23,10,9,13,12,14,15,16,17,18,19,8,11,26,21,22,20,2,1,5,7,4,6,3/E:(1,2)(6,7)(8,9)(12,13)(14,15)/rA:60ClClONNNNCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s 8;s8;s5;s9s11;s10s11;s8;s4s14;s4;s4;s6s16;s6s17;d3s5s7;s6;s1d-21;s21;s7;s7;s2s22;d-23;d+26s27;s8;s9;s9;s10;s10;s11;s12;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s5;s18;s18;s19;s19;s23;s24;s24;s24;s2 5;s25;s25;s27;s28;/rC:-5.759,-2.0026,-.6166;-8.8555,-1.2061,-.3321;7.8056,-.5007,-.9861;-1.0447,', 'KPWSJANDNDDRMB-CALCHBBNSA-N', '1010:5BU3WG65EB7RQK15XDBDZHVSK6JAAH', '[#17]-[c]1:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[ #1])(-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[#7](-[#1])-[#6](-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#17]', 'Clc1c(c([H])c([H])c([H])c1N(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C3([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C3([H])[H])N([H])C(N(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C2([H])[H])Cl', '04.552', '4.552', '0', '0', 'TRUE', '-8.1e-002\r\n-8.27e-002\r\n-0.2541\r\n-0.3008\r\n-0.2964\r\n-0.2712\r\n-0.2921\r\n-4.01e-002\r\n-4.87e-002\r\n-4.87e-002\r\n2.39e-002\r\n-3.44e-002\r\n-3.44e-002\r\n-3.76e-002\r\n-1.5e-003\r\n1.13e-002\r\n1.13e-002\r\n1.59e-002\r\n1.59e-002\r\n0.3002\r\n3.77e-002\r\n7.73e-002\r\n-4.24e-002\r\n3.8e-00', '0', '4.461', 'C21H32Cl2N4O', '0426.195', '-5.133', '0427.411', '3.69 6.78', '1', '1', '1', '23', '06', '1', '28', '30', '39', '4', '005', '01', '32', '0', '3', '005', '0038.82', '447.5', '', '3.51564', '1.2784', '86.37', '12.85', '5.527', '73.52', '3,404.36', '39.951', '350.2', '', 'Cl/C3=C(N2C([H])([H])C([H])([H])N(C(C(C1([H])C([H])([H])C([H])([H])C(N(C(=O)N(C([H])([H])[H])C([H])([H])[H])[H])([H])C([H])([H])C1([H])[H])([H])[H])([H])[H])C([H])([H])C2([H])[H])/C([H])=C([H])\\C([H])=C3\\Cl', 'CN(C)C(=O)N[C@@H]3CC[C@H](CCN2CCN(c1cccc(Cl)c1Cl)CC2)CC3', 'Cariprazine', 'RGH-188; Vraylar; MP 214', 'D(2) dopamine receptor', '11154555', 'Phase III Completed', 'Bipolar disorder', '29017067', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(194, '6918474', '6918474', 'NC(=O)OC[C@@H](O)c1ccccc1Cl', '[(2<I>S</I>)-2-(2-chlorophenyl)-2-hydroxy-ethyl] carbamate', 'CYAAFQwAtfwQgm3vex27VVmiSGD9mYxuKrV$RZcFC67QG0xsXbz9iAUE62UDNtC$RLY1S8jpwlsalSyeOKtRtX5Vp5KTFb^QQXmsY061b9kxXXnuD1z1WXQEuLg$^2$LuP$5RMI8hLfMztZQdqv5KHyNNKaN4ZiEKNt$g5BV2qBnqiFqI^YGwTOw84SFerk2wxzqjI$o zwkyzYzTPZ1lvv0M3p6inqinjRjpD0jyNAehR2nJVonW952VDrYXWx8EoyJj6iJiS7sBaoSt9lTHllkJdQBKJn6MetKxSMvSrM3NKpULD5c6iaTKe1K7z4eyHfzj0tnNmK7cpnCAocYnT7mPRyMZX8q^eRzgDFuQn75XyAflFZ1lVfpm3$ycOpeO9ZJhzg5dN^cdu6FF fKU9tb^KH4Ia4B9zYHt50gImtdP5JG8cys^VDtpUHyWcMPdoT2xiEHTsyd8Y9ul07fM0HaV^rjGtWtekVuu3DaV^24zRul4x', 'InChI=1S/C9H10ClNO3/c10-7-4-2-1-3-6(7)8(12)5-14-9(11)13/h1-4,8,12H,5H2,(H2,11,13)/t8-/m1/s1', 'AuxInfo=1/1/N:12,13,10,11,8,7,9,6,14,1,5,2,4,3/it:im/rA:24ClOOONC.eCCCCCCCCHHHHHHHHHH/rB:;;;;s2;s6;s3s6;s1s7;d+7;d+9;s10;s11d-12;s3d4s5;s6;s8;s8;s10;s11;s12;s13;s2;s5;s5;/rC:-1.9272,2.3117,1.1505;.316 ,.8652,-2.3059;1.8717,-.1897,-.1721;3.6693,.4723,1.1044;3.4425,-1.7057,.4031;.0448,1.1942,-.9389;-1.0053,.2737,-.4061;1.3583,1.1347,-.1463;-1.9372,.6968,.5415;-1.0386,-1.0379,-.8799;-2.9025,-.1916,1.0 154;-2.0039,-1.9263,-.4059;-2.9358,-1.5032,.5417;3.0478,-.3942,.4985;-.3154,2.2271,-.9664;2.094,', 'OLBWFRRUHYQABZ-MRVPVSSYSA-N', '1010:N612UB3RQYEKC8NPMJN6CATSW8Y3BH', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[#6](-[#7](-[#1])-[#1])=[#8])-[#8]-[#1]', 'Clc1c([H])c([H])c([H])c([H])c1[C@@]([H])(C([H])([H])OC(N([H])[H])=O)O[H]', '01.548', '1.548', '0', '0', 'TRUE', '-8.4e-002\r\n-0.3859\r\n-0.2975\r\n-0.2428\r\n-0.3048\r\n0.1044\r\n1.4e-003\r\n8.82e-002\r\n4.64e-002\r\n-5.49e-002\r\n-4.32e-002\r\n-6.18e-002\r\n-6.08e-002\r\n0.348\r\n6.77e-002\r\n6.05e-002\r\n6.05e-002\r\n6.27e-002\r\n6.38e-002\r\n6.22e-002\r\n6.23e-002\r\n0.211\r\n0.1479\r\n0.1487', '1', '1.548', 'C9H10ClNO3', '0215.035', '-2.473', '0215.634', '', '2', '2', '1', '7', '06', '1', '14', '14', '14', '4', '004', '03', '10', '0', '1', '004', '0072.55', '213.6', '', '0.46171', '1.2741', '11.17', '2.39', '3.03339', '8.78', '345.818', '150.965', '155.37', '', 'Cl/C1=C([H])/C([H])=C([H])\\C([H])=C1\\C(O[H])(C(OC(=O)N([H])[H])([H])[H])[H]', 'NC(=O)OC[C@@H](O)c1ccccc1Cl', 'Carisbamate', 'RWJ-333369; Comfyde; YKP-509; JNJ-10234094; YKP 509', 'Cytosolic phospholipase A2', '6918474', 'Phase II Completed', 'Epilepsy', '18353614', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(195, '44159258', '44159258', 'CCNC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2', '(4<I>a</I><I>S</I>,6<I>a</I><I>R</I>,6<I>b</I><I>S</I>,8<I>a</I><I>R</I>,12<I>a</I><I>S</I>,14<I>a</I><I>R</I>,14<I>b</I><I>S</I>)-11-cyano-<I>N</I>-ethyl-2,2,6<I>a</I>,6<I>b</I>,9,9,12<I>a</I>-heptam ethyl-10,14-dioxo-1,3,4,5,6,7,8,8<I>a</I>,14<I>a</I>,14<I>b</I>-decahydropicene-4<I>a</I>-carboxamide', 'CYAAFQwA6dwQHzmQKNVjCdHXIaUwm$gSqBoY8QFCKO1Sh7Tbzxsy4IUzH2ZembVwjdW73mmiEZw2SxiVAv7xWLYHtfmgghEeo0SseC0iHXiV48IwmuY$9LXAv^E8lW87CcJu88z5^97^lvmWAKwTg749a4Aa68wi1rBGV5RFvtM24gbZohf7XxN51AIeksTT9hNeNGO2 B^1WtgSI4D4zfOc3witH0lyedMFgMJ8One5yqL2P4^D^0COUwj2qzsIseKkq04uJMasVyfc5lXMT15wGTEh1kXoafqAgLlg7hFfcciWyIadk9M97plDF3NRmY3Dy66X$n8whFEBw3lh$rTBrrK3^W5jAmVrq1XFZ$Op2zC9o24mMtyA7$wePKwqeq4yw3O4ITLdExyvL yNEJKvbT8ln9BuZ4PteKBxFk5$zmkAjUMqfGWjGh1SaNWA1ck9iSKmvne2nY804LlyK1mPGqzJyiy5wDkPLck3P4avZ4$6y0', 'InChI=1S/C33H46N2O3/c1-9-35-27(38)33-14-12-28(2,3)18-21(33)25-22(36)16-24-30(6)17-20(19-34)26(37)29(4,5)23(30)10-11-31(24,7)32(25,8)13-15-33/h16-17,21,23,25H,9-15,18H2,1-8H3,(H,35,38)/t21-,23-,25-,30- ,31+,32+,33-/m0/s1', 'AuxInfo=1/1/N:38,30,31,34,35,28,24,21,36,20,15,23,11,18,12,25,29,16,37,33,9,22,17,13,8,32,27,19,26,14,7,6,10,5,4,1,3,2/E:(2,3)(4,5)/it:im/rA:84OOONNC.eC.eC.eC.eC.eCCCC.eCCC.eCCCCCCCCCCCCCCCCCCCCCHHHHH HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;s6;s6;s8;s9;s6;s10s11;s7;s13;s7;s9;s14;s10;s16;s15s17;s6;d1s8;s18s19;s7;d-13s22;s17;d2s4s10;s14;s14;s19;s19;d3s26;d-29s32;s26;s26;s4;t5s33;s36;s8;s9;s 11;s11;s12;s12;s15;s15;s16;s16;s17;s18;s18;s20;s20;s21;s21;s21;s23;s23;s24;s24;s24;s25;s28;s28;s', 'RZRQJICXYQPEQJ-YKEYHJQHSA-N', '1010:61DXZVUJ33BS3XP6K5A2W696UGKYHX', '[#8]=[#6](-[#6](-[#1])=[#6](-[#6@]1(-[#6](-[#1])(-[#1])-[#1])-[#6@](-[#1])(-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[#6]#[#7])=[#6]1-[#1])=[#8])-[#6](-[#1])(-[#1])-[#6]2(- [#1])-[#1])-[#6@@]23-[#6](-[#1])(-[#1])-[#1])-[#6@](-[#1])(-[#6@@]4(-[#1])-[#6@](-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#6]( -[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6]4(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]5(-[#1])', 'O=C(C([H])=C([C@]1(C([H])([H])[H])[C@]([H])(C(C([H])([H])[H])(C([H])([H])[H])C(C(C#N)=C1[H])=O)C([H])([H])C2([H])[H])[C@@]23C([H])([H])[H])[C@]([H])([C@@]4([H])[C@](C(N([H])C([H])([H])C([H])([H])[H])= O)(C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C4([H])[H])C([H])([H])C5([H])[H])[C@]35C([H])([H])[H]', '05.5', '5.5', '0', '0', 'TRUE', '-0.2945\r\n-0.2771\r\n-0.2928\r\n-0.3153\r\n-0.1923\r\n-1.31e-002\r\n-4.3e-003\r\n3.17e-002\r\n-1.6e-002\r\n5.06e-002\r\n-4.53e-002\r\n-3.81e-002\r\n-5.02e-002\r\n1.27e-002\r\n-4.32e-002\r\n-4.36e-002\r\n-1.62e-002\r\n-3.82e-002\r\n-3.51e-002\r\n-4.76e-002\r\n-5.81e-002\r\n0.1591\r\n-4.71e-002\r\n-5.', '1', '5.5', 'C33H46N2O3', '0518.351', '-9.248', '0518.73', '', '3', '1', '5', '36', '00', '0', '38', '42', '58', '5', '005', '01', '46', '0', '5', '002', '0087.03', '593.5', '', '6.56441', '1.2845', '55.33', '31.01', '4.8535', '24.32', '2,360.51', '142.894', '455.84', '178.94', 'CCNC(=O)C15CCC(C)(C)CC1C4C(=O)/C=C\\3C2(C)/C=C(C#N)\\C(=O)C(C)(C)C2CCC3(C)C4(C)CC5', 'CCNC(=O)[C@]15CCC(C)(C)C[C@H]1[C@H]4C(=O)/C=C\\3[C@@]2(C)/C=C(C#N)\\C(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC5', 'CDDO-EA', '2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid-ethylamide; CS-3079', 'Nuclear factor erythroid 2-related factor 2', '44159258', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '21457778', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(196, '196', 'Not Available', 'CC1(C)CC[C@@]2(CC[C@]3(C)[C@@H]([C@@H]2C1)C(=O)C=C4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)C(=O)NCC(F)(F)F', '(4<I>a</I><I>R</I>,6<I>a</I><I>R</I>,6<I>b</I><I>S</I>,8<I>a</I><I>R</I>,12<I>a</I><I>S</I>,14<I>a</I><I>R</I>,14<I>b</I><I>S</I>)-11-cyano-2,2,6<I>a</I>,6<I>b</I>,9,9,12<I>a</I>-heptamethyl-10,14-dio xo-<I>N</I>-(2,2,2-trifluoroethyl)-1,3,4,5,6,7,8,8<I>a</I>,14<I>a</I>,14<I>b</I>-decahydropicene-4<I>a</I>-carboxamide', 'CYAAFQwAhcwQZQEgdEGhH791VWAroxY2RxXJ14cr5G^qK7p3L4Ac$ZRRphOdwZiZ4CqrRVeW2cPozyxpFcw0jA^8EYbiLZqVqw1NtvLx$amQE2136LD7$^tufe883^xv473iMyD^jP7DvnOax0Yej9njz3$aqwnQ9fN$CfSha^Om4JaC4tO^1z3UNt$BMAKsxf8^E7UR lefy0IWn8ZhK9DIWGH2dXxi6FMJBSdNxKCFsG9cBWsCYx6Rg$QDI2kvfYd6CwwB4zKO5ol8sVcRkkgVrPJdxVI6IuAcwGW4i7Pet$XwmnUqjFsjFn9arPK1mzDJvaySFkTOWBMmv31YRFvn1FmoYy4kzPCwILUQpKCs8YxbZcPNq1yTG166qVMUIXR7CfktdswiX08$Y sgkNHc^fO0$b^t2wUh3vBElyVwKSuL9S9dUtwxhsKUjqrQXv2JZWdrf4Kap1khVbr0wtvI88majlZxv11tlsFLFjLWrkYD$J', 'InChI=1S/C33H43F3N2O3/c1-27(2)10-12-32(26(41)38-18-33(34,35)36)13-11-31(7)24(20(32)16-27)21(39)14-23-29(5)15-19(17-37)25(40)28(3,4)22(29)8-9-30(23,31)6/h14-15,20,22,24H,8-13,16,18H2,1-7H3,(H,38,41)/t2 0-,22-,24-,29-,30+,31+,32-/m0/s1', 'AuxInfo=1/1/N:30,31,34,35,28,24,21,20,15,23,11,18,12,25,29,16,37,36,33,9,22,17,13,8,32,27,19,26,14,7,6,10,38,82,83,84,5,4,1,3,2/E:(1,2)(3,4)(34,35,36)/it:im/rA:84OOONNC.eC.eC.eC.eC.eCCCC.eCCC.eCCCCCCC CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHFFF/rB:;;;;;s6;s6;s8;s9;s6;s10s11;s7;s13;s7;s9;s14;s10;s16;s15s17;s6;d1s8;s18s19;s7;d-13s22;s17;d2s4s10;s14;s14;s19;s19;d3s26;d-29s32;s26;s26;s 4;t5s33;s36;s8;s9;s11;s11;s12;s12;s15;s15;s16;s16;s17;s18;s18;s20;s20;s21;s21;s21;s23;s23;s24;s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r\n-0.2771\r\n-0.2928\r\n-0.3059\r\n-0.1923\r\n-1.31e-002\r\n-4.3e-003\r\n3.17e-002\r\n-1.6e-002\r\n5.06e-002\r\n-4.53e-002\r\n-3.81e-002\r\n-5.02e-002\r\n1.27e-002\r\n-4.32e-002\r\n-4.36e-002\r\n-1.62e-002\r\n-3.82e-002\r\n-3.51e-002\r\n-4.76e-002\r\n-5.81e-002\r\n0.1591\r\n-4.71e-002\r\n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trifluoroethylamide', 'Nuclear factor erythroid 2-related factor 2', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '21457778', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(197, '16016585', '16016585', 'CC(C)Oc1ccc(cc1)C(=O)Nc2cccc3ccc(C)nc23', '4-isopropoxy-<I>N</I>-(2-methyl-8-quinolyl)benzamide', 'CYAAFQwA0dwQ0Tti3bwPMYYT2Sy^dCvSyo3Z66jM9N7pZumXYSLbHBJ1p4kkX7CUZPEJWjfzkqHAvKWa$AgrbjsmLNg42t62Mhkcoc5iIBfLQ^l9tBWnWwXHtKSk8jLF35TvJ81L$JOAVCa$YtdqEXTQVlwg8FKTyPvKC45cT9Yio2oqj41TX0I8d3xeVqk5F5dY$4F0 UlnXHHZTBZVKYvXSNi7IZVxx6tiTgpoRZ7vVHEW7EhQyoIPazXrSjrIpwYt83YRePwrrTJYr1bjn5kBXq2^3RsHTfqVg92GPwa^7W1hKGxnRseFPx7eD2UddDEnVeJNT$u1lpUkWEx$sZUnn8jd^bVgSWieXwFZnjvNv6AuaRRBefkR$2zeuadhRJG^ncaFcuFfkpe^r KqoJ9f2AeWOGwSzBxeR6Zk90vUdvYhIrWWo$2KSFcr$vGSf5u6W4uvJpx6BPPkN2nRLw84eHjuDJkm0D$GTPIX06KYEfjJjp', 'InChI=1S/C20H20N2O2/c1-13(2)24-17-11-9-16(10-12-17)20(23)22-18-6-4-5-15-8-7-14(3)21-19(15)18/h4-13H,1-3H3,(H,22,23)', 'AuxInfo=1/1/N:22,23,24,16,11,9,17,12,18,19,20,21,8,14,7,10,13,6,5,15,4,3,2,1/E:(1,2)(9,10)(11,12)/rA:44OONNCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;s4;s3s5;d+5;s1;d+6;;s7;s7;s1;d-4;d2s3s10;s9d-1 1;d-12s14;d+10;s10;d+13s18;s13d-19;s8;s8;s14;s8;s3;s9;s11;s12;s16;s17;s18;s19;s20;s21;s22;s22;s22;s23;s23;s23;s24;s24;s24;/rC:-5.3287,-.711,.475;-.0249,2.6228,.6209;.8197,.553,-.1058;2.7513,-1.4148,.1 899;3.134,-.1587,-.1077;2.1804,.8442,-.2601;4.4918,.1861,-.2742;-6.0921,-.6591,-.7293;2.5418,2.1', 'GVGVYDCVFBGALZ-UHFFFAOYSA-N', '1010:ZMUPFDH32YXMQMFCMR98UBPRFSUWHZ', '[#8](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#7](-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[n]3):[c]23)=[#8]):[c](-[#1]):[c]1-[#1])-[#6](-[# 1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]', 'O(c(c([H])c([H])c1C(N([H])c2c([H])c([H])c([H])c(c([H])c([H])c(C([H])([H])[H])n3)c23)=O)c([H])c1[H])C([H])(C([H])([H])[H])C([H])([H])[H]', '03.793', '3.793', '0', '0', 'TRUE', '-0.3435\r\n-0.2716\r\n-0.2795\r\n-0.2512\r\n9.18e-002\r\n5.93e-002\r\n2.1e-003\r\n5.85e-002\r\n-3.85e-002\r\n3.75e-002\r\n-5.27e-002\r\n-5.1e-002\r\n7.53e-002\r\n3.8e-002\r\n0.2472\r\n-5.97e-002\r\n-4.03e-002\r\n-4.71e-002\r\n-4.71e-002\r\n-3.1e-002\r\n-3.1e-002\r\n-3.85e-002\r\n-3.85e-002\r\n-2.23e-', '0', '3.794', 'C20H20N2O2', '0320.152', '-5.895', '0320.385', '2.3 4.56', '3', '1', '1', '8', '17', '3', '24', '26', '25', '9', '004', '01', '20', '0', '3', '004', '0051.22', '338.28', '', '2.8232', '1.2642', '47.61', '1.02', '5.00972', '46.59', '1,358.47', '56.101', '262.05', '178.59', 'O(C(C([H])([H])[H])(C([H])([H])[H])[H])/C3=C([H])/C([H])=C(C(=O)N(/C1=C([H])/C([H])=C([H])\\C2=C1\\N=C(C([H])([H])[H])/C([H])=C2/[H])[H])\\C([H])=C3\\[H]', 'Cc3ccc2cccc(NC(=O)c1ccc(OC(C)C)cc1)c2n3', 'CDN1163', 'AK402664', 'Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)', '16016585', 'Under Investigation', 'Parkinson Disease(PARK)', '27776889', 'Parkinson Disease(PARK)', 'PARK'),
(198, '5479530', '5479530', 'CO\\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSC3=NC(=O)C(=O)NN3C)\\c4csc(N)n4', '(6<I>R</I>,7<I>R</I>)-7-[[(2<I>Z</I>)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1<I>H</I>-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene -2-carboxylic acid', 'CYAAFQwAPdwQTaipiVLToKWM2^PR^09$kxVov2OSDvUsFKNFD0$spEraBWoEStxIDcz6PMdvH^FUZBz$IGpY87stR2D7QHdfSa7buoM8ptxMrCKSxCQDHPvmv61nULlozH4S^^8D1$69i4vV^6LghPMvfKNTMFw40dl199FUFP8K7R^6WONUrR0OHYwfGq8IDf$eYlcr 3vTqK4RFOsDrWqwjACV0YNr$yXbKXoxxqo6DFc1AYAOc44JxBb^NrDoylEFwvDn3HFnEKEslu0Qr3JFBM3BnXMACsyHrLPIxPctFDb$kXbzCMRVw1ecdVJ5AlPGRIRZwL8If4ddsiFAeI8sHXrcjR5cvDw8$hT7G637T6tihOAJOiZ6LUV9Ys4^HpFoTKWMvqKylnB^f HkJhOdCsOqNUcOw8N62McTmcHrrKNMU1WyZeIL9C^0wA5Ki4PrQshUnnX0RxqzArb9BqHm5qfTZES4tyc$0cqF2FhoJL9m8a', 'InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9 -,15-/m1/s1', 'AuxInfo=1/1/N:32,36,24,25,31,23,30,28,20,22,27,33,34,21,19,26,35,29,18,17,12,15,16,14,13,11,7,9,10,4,5,6,8,1,3,2/E:(31,32)/it:im/rA:54SSSOOOOOOONNNNNNNNC.eC.eCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH/rB:;;;; ;;;;;;;;s8;;s13;;;s1s11;s12s19;d4s11s20;s11;d-22;s1s23;s2s23;s5d6s22;d7s12;d-14s27;s2s13d+15;s17s28;s3d-30;s13;d9s15;d10s16s33;s3d-17s18;s8;s19;s20;s24;s24;s12;s25;s25;s5;s31;s16;s32;s32;s32;s36;s36;s 36;s18;s18;/rC:-.7324,1.0326,2.2326;3.2959,-.7458,.3114;-3.7694,-3.5773,-1.5035;-1.8066,2.1402,-', 'VAAUVRVFOQPIGI-SPQHTLEESA-N', '1010:2464VU27UD4BB127Q4TWBVR5JFCM8N', '[#16]1-[#6](-[#1])(-[#1])-[#6](-[#6](-[#1])(-[#1])-[#16]-[#6](=[#7]-[#6](-[#6](-[#7]2-[#1])=[#8])=[#8])-[#7]2-[#6](-[#1])(-[#1])-[#1])=[#6](-[#6](=[#8])-[#8]-[#1])-[#7]3-[#6@@]1(-[#1])-[#6@@](-[#1])(- [#6]3=[#8])-[#7](-[#1])-[#6](\\-[#6](\\-[c](:[c]4-[#1]):[n]:[c](-[#7](-[#1])-[#1]):[s]4)=[#7]/-[#8]-[#6](-[#1])(-[#1])-[#1])=[#8]', 'S1C([H])([H])C(C([H])([H])SC(=NC(C(N2[H])=O)=O)N2C([H])([H])[H])=C(C(=O)O[H])N3[C@@]1([H])[C@@]([H])(C3=O)N([H])C(\\C(\\c(c4[H])nc(N([H])[H])s4)=N/OC([H])([H])[H])=O', '-00.956', '-0.576', '0', '0', 'TRUE', '-0.1318\r\n-8.8e-002\r\n-6.4e-002\r\n-0.2748\r\n-0.3269\r\n-0.2594\r\n-0.27\r\n-0.2548\r\n-0.2612\r\n-0.2648\r\n-0.2493\r\n-0.2957\r\n-0.1771\r\n-0.1271\r\n-0.1844\r\n-0.2344\r\n-0.2271\r\n-0.281\r\n0.1038\r\n0.1286\r\n0.2431\r\n0.1104\r\n-2.2e-002\r\n1.94e-002\r\n2.47e-002\r\n0.3047\r\n0.2668\r\n0.1789\r\n0.1', '1', '-2.326', 'C18H18N8O7S3', '0554.046', '-3.982', '0554.58', '1.29 3.01 3.2 3.61 4.79', '9', '3', '8', '26', '05', '1', '36', '39', '29', '10', '015', '05', '18', '0', '4', '008', '0287.82', '514.11', '', '3.15852', '1.3263', '195.22', '117.78', '5.49', '77.44', '3,236.98', '471.174', '383.81', '170.34 -179.88', 'S4[C@H]1N(C(=O)[C@H]1NC(=O)/C(=N\\OC)/C\\2=C/S/C(N)=N2)/C(C(O)=O)=C(CS/C3=N/C(=O)C(=O)NN3C)\\C4', 'CO/N=C(C(=O)N[C@@H]2C(=O)N3/C(C(=O)O)=C(CSc1nc(=O)c(=O)[nH]n1C)\\CS[C@H]23)/c4csc(N)n4', 'Ceftriaxone', 'Biotrakson; Rocephin; Longacef; Rophex; Rocephalin', 'Glutamine synthetase', '5479530', 'Clinical Trail Completed', 'Amyotrophic Lateral Sclerosis (ALS)', '25297012', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(199, '122724', '122724', 'CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O', '(2<I>R</I>,4<I>a</I><I>S</I>,6<I>a</I><I>R</I>,6<I>a</I><I>S</I>,14<I>a</I><I>S</I>,14<I>b</I><I>R</I>)-10-hydroxy-2,4<I>a</I>,6<I>a</I>,6<I>a</I>,9,14<I>a</I>-hexamethyl-11-oxo-1,3,4,5,6,13,14,14<I>b </I>-octahydropicene-2-carboxylic acid', 'CYAAFQwATfwQUCg0tUFbUqLeCaVE3E3mSkKNS06PSEBAI9FHTg0QdHotqjEHMonlh1ke$wjf$p10$B$^FYj8LOfxVmoLEvFmUgdchct6L6wjsQD6^lQd47vq7t^yuy2cxHcr^f8hRcx6C8U7DePgXG1vHvf^4Ss^NO4v9nKgJao1xlj4azD7wiOi6sBS33Y40vVYTsv7 WhsbZpj90N^vZYyEhrj9yJQszr7Ds5mGhtc61NYBQTB8t^k25KuHAYrhiWTraes3fKhDbm0r2FTAbMHVNh5a0VjlbO8XtCVCyXfA^JuENOMfwvPjgmskdNi8VUzzWM7gzT7zBkB4Zmn3qCyMxjLr1xLyvszstf96oTEzaWG4LbM$DH8r0Q^v7cMFszHJjuxKeSf2MvgK 7dHHS9yumyMv94b1cMP^MYUSshJOvOjzt$D2d6axxHlLYBduyZeLVtz9HUZ2KL0zWvltTbc8saA7TZOvwx7H8fd5684u4zcK', 'InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1', 'AuxInfo=1/1/N:33,21,25,24,20,18,28,23,14,19,10,17,9,11,29,12,30,27,22,31,13,6,32,26,8,16,15,7,5,4,3,1,2/E:(32,33)/it:im/rA:71OOOOC.eC.eC.oC.eCCCCCCC.eC.oCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH HHHHHHHH/rB:;;;;s5;s5;s6;s7;s8s9;s5;s6;s7;s8;s13;s12;s11s15;s5;s14s16;s7;s8;s15;d+13;s15;s16;s1d2s16;s22;s23d-27;d+22;s27;d4s29;s3d+30s31;s30;s6;s9;s9;s10;s10;s11;s11;s12;s12;s14;s14;s17;s17;s18;s18;s 18;s19;s19;s20;s20;s20;s21;s21;s21;s23;s24;s24;s24;s25;s25;s25;s28;s29;s1;s33;s33;s33;s3;/rC:3.2', 'KQJSQWZMSAGSHN-JJWQIEBTSA-N', '1010:V7PK6JGP634AXK7ZDS5CTA8E47K3J2', '[#8](-[#1])-[#6](-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6](=[ #6](-[#1])-[#6](-[#1])=[#6]1-[#6]2=[#6](-[#1])-[#6](-[#6](=[#6]1-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1])=[#8])-[#6@@]2(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])-[#6@@]34-[#6](-[#1])( -[#1])-[#1])-[#6@]45-[#1])-[#6]5(-[#1])-[#1])=[#8]', 'O([H])C([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])=C1C2=C([H])C(C(=C1C([H])([H])[H])O[H])=O)[C@@]2(C([H])([H])[H])C([H]) ([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@]45[H])C5([H])[H])=O', '05.475', '5.475', '0', '0', 'TRUE', '-0.3314\r\n-0.2662\r\n-0.357\r\n-0.287\r\n-2.e-002\r\n-2.88e-002\r\n-4.8e-003\r\n-2.91e-002\r\n-4.3e-002\r\n-4.68e-002\r\n-4.56e-002\r\n-3.46e-002\r\n-5.34e-002\r\n-4.66e-002\r\n1.49e-002\r\n5.36e-002\r\n-3.94e-002\r\n-5.86e-002\r\n-3.8e-002\r\n-5.53e-002\r\n-5.94e-002\r\n-2.65e-002\r\n-6.1e-002\r\n-', '1', '3.401', 'C29H38O4', '0450.277', '-7.816', '0450.61', '2.29 5.37', '2', '1', '6', '31', '00', '0', '33', '37', '48', '6', '004', '02', '38', '0', '5', '001', '0074.59', '494.51', '', '4.52742', '1.2866', '55.47', '17.56', '4.4547', '37.91', '1,793.09', '152.883', '393.07', '', 'OC(=O)[C@@]2(C)C[C@H]1[C@@]5(C)[C@](C)(CC[C@@]1(C)CC2)/C4=C/C=C/3\\C(=C/C(=O)/C(O)=C3/C)[C@]4(C)CC5', 'Cc1c(O)c(=O)cc2c1=C/C=C/4[C@@]2(C)CC[C@@]5(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]45C', 'Celastrol', 'Tripterine', 'heat shock transcription factor 1', '122724', 'Under Investigation', 'Parkinson Disease(PARK)', '24214023', 'Parkinson Disease(PARK)', 'PARK');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(200, '2662', '2662', 'Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F', '4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide', 'CYAAFQwABfwQ$7UbkBezG6AXSoFnG3CwDU1b$7wtiWqJFsBZyR^xMi8FQWf6iZ$a6dQ5x5UYmiDN2aqD^tCCKiWZF4b5bBSEKDWaWnKuil^vSA7j8T2S9ufOhSBC5DmUu7zeT4rX7wNApeok$wSaRPE4B^1abpyAGrV$77s5i9BUHOoB3LtgD5pdl^W$EMUyo^KutheY sBA7YPPue6QoPGmmVE5FrIM^GEQ9VgHOAxK9vY5mU55V9E15WP3CKG9prddl2Bd0ZIC8g$gJX9clcOqnJHZfLY6Inr^LfmliHNGtQDB6qh3lKNiDZ3G5vA1Zxz6^Epnob$1HEkMjb97rOHfejs2WNNzWAAc5H5xVn2SzPLVxyDivXtozq2Bnefq7lSMc9iuvXVeIr2xY 8ulaAcNeFQPZsDPggjPe6vowvIDx5Hx04FN0Cu61u79hfHzg1Og7265FihnOh4nkfuVaUr4IquDdq9FZjue3ttC0BCC69ewU', 'InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)', 'AuxInfo=1/1/N:26,23,24,18,19,15,16,20,21,13,22,12,11,17,10,14,25,2,3,4,9,8,7,5,6,1/E:(2,3)(4,5)(6,7)(8,9)(18,19,20)(24,25)/CRV:26.6/rA:40SFFFOONNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;d1;d1;;s7;s1;s7; s7;s10;d-10;d-8s13;d+11;s11;s1;d+12;s12;s15d+17;d-16s17;;s18d-22;d-19s22;s2s3s4s14;s22;s13;s15;s16;s18;s19;s20;s21;s23;s24;s26;s26;s26;s9;s9;/rC:4.7676,-1.6195,-.0537;-5.477,-1.1414,.059;-4.4403,-2.71 98,-1.0181;-4.3905,-2.6771,1.1609;5.0701,-2.506,-1.1686;5.4593,-.3433,.064;-1.0637,-.6091,.0008;', 'RZEKVGVHFLEQIL-UHFFFAOYSA-N', '1010:MSUT5DVJY1XSJ4PG46T3UDPCWWXVH8', '[#16](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[n]2:[c](:[c](-[#1]):[c](-[#6](-[#9])(-[#9])-[#9]):[n]2)-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]3-[#1]):[c](-[#1]):[c]1-[#1])(-[# 7](-[#1])-[#1])(=[#8])=[#8]', 'S(c(c([H])c([H])c1n2c(c([H])c(C(F)(F)F)n2)c3c([H])c([H])c(C([H])([H])[H])c([H])c3[H])c([H])c1[H])(N([H])[H])(=O)=O', '04.428', '4.428', '0', '0', 'TRUE', '1.4112\r\n-0.1645\r\n-0.1645\r\n-0.1645\r\n-0.5686\r\n-0.5686\r\n-0.1375\r\n-0.1847\r\n-0.3846\r\n5.41e-002\r\n4.46e-002\r\n-5.1e-003\r\n-8.9e-003\r\n0.161\r\n-4.3e-002\r\n-4.3e-002\r\n-4.16e-002\r\n-5.31e-002\r\n-5.31e-002\r\n-7.01e-002\r\n-7.01e-002\r\n-5.11e-002\r\n-5.87e-002\r\n-5.87e-002\r\n0.4342\r\n-3.98e-002\r\n6.63e-002\r\n6.39e-002\r\n6.39e-002\r\n6.29e-002\r\n6.29e-002\r\n6.09e-002\r\n6.09e-002\r\n6.25e-002\r\n6.25e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n8.8e-002\r\n9.03000000000003e-002', '0', '4.434', 'C17H14F3N3O2S', '0381.076', '-6.441', '0381.372', '-4.39 8.65', '3', '1', '2', '9', '17', '3', '26', '28', '23', '10', '005', '02', '14', '0', '3', '004', '0086.36', '352.62', '', '2.94967', '1.3074', '62.29', '28.79', '4.17403', '33.5', '1,342.07', '150.129', '262.73', '', 'S(=O)(=O)(N)/C/3=C/C=C(N1/N=C(C(F)(F)F)\\C=C1\\C2=CC=C(C)C=C2)\\C=C3', 'Cc3ccc(c1cc(C(F)(F)F)nn1c2ccc(S(N)(=O)=O)cc2)cc3', 'Celecoxib', 'Celebrex; Onsenal; Xilebao; Solexa; YM-177', 'Prostaglandin G/H synthase 2', '2662', 'Phase II', 'Spinal Muscular Atrophy Type I', '23656793', 'Spinal Muscular Atrophy Type I', 'SPINAL AND BULBAR MUSCULAR ATROPHY; SBMA\nKENNEDY DISEASE; KD\nKENNEDY SPINAL AND BULBAR MUSCULAR ATROPHY\nBULBOSPINAL MUSCULAR ATROPHY, X-LINKED\nBULBOSPINAL NEURONOPATHY, X-LINKED RECESSIVE; XBSN; ; SMA1'),
(201, '9917013', '9917013', 'CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57', 'methyl (28<I>R</I>,31<I>S</I>,32<I>R</I>)-16,17-bis(ethylsulfanylmethyl)-32-hydroxy-31-methyl-29-oxo-39-oxa-33,34,35-triazaoctacyclo[BLAH.BLAH.BLAH.BLAH.BLAH.BLAH.BLAH.BLAH.BLAH]octacosa-4(6),5(7),8(1 6),9(17),18(20),19(21),22(24),23(25),26-nonaene-32-carboxylate', 'CYAAFQwAqdwQUQZNtSDnvwtQM9Ctwzb$x6n42NKmJ06J^zUJmi2Rdu$V8HCg9URJhVG8cn2YDx$sBXkSTAzw4K1Cal4GbLlk^$^4zdLfOwCXXzGI3P1yXnfk$R7jnPv8LJ3ZKLVVd^x9f95^93yanljzf^En1qC7e6Pt5r6rLJqfp7iaqoxeyzluXrxioWb8pw1hLfLe Xtcf9ruz39SiE5f5clxFucv$ud1xpOuqhKqF0X9zhdZL1ubjxq3bvnhNcKLWyio$Cl7Dn6wK057tnX3em66QfNkr0vTJGZbIqs30EdVI22PKcO46Dm^3lDHnw^Z6f5yW03qSpJ3p7qQZlUelc3yBFQuc9hQyp7kqWm2nDfOlFPEP5mkbPkC2LWzeofmbfbQdYH1mIOZM ^j9j2nx7veYYPWiJylJ$iemXbZpZoajDlyKRJvnVJ$Rdpui4FyKR67dSxzFCkhIYJhstWLf1We5RcHdyQxDKWzvLO2zxinvE', 'InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H ,34,37)/t24-,32+,33+/m1/s1', 'AuxInfo=1/1/N:43,42,19,39,41,40,36,34,31,28,32,29,14,27,38,37,35,33,24,22,23,21,20,13,17,18,25,16,15,30,26,11,12,10,9,8,7,6,4,5,3,2,1/it:im/rA:76SSOOOOONNNC.oC.eC.eCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH HHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;s3s8;s4s11;s3s9;s12s13;s8;s9d-15;s15;s16;s11;s8;s9;s17d-20;d-17;s18d-21;d-18s23;s5d6s12;s10s23;s20;s22;d7s10s25;s21;s24;d-29;d-28s33;d-32;d-31s35;s1s33;s2s35;s5 ;s1;s2;s40;s41;s13;s14;s14;s19;s19;s19;s4;s27;s27;s28;s29;s31;s32;s10;s34;s36;s37;s37;s38;s38;s3', 'SCMLRESZJCKCTC-KMYQRJGFSA-N', '1010:ZYP3C6XHBXMYFQV294F5NYX8KC38HG', '[#16](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[c]1-[#1]):[c](-[#1]):[c](:[c]12):[c]3:[c](:[c](:[c](:[c](-[#6](-[#7]4-[#1])=[#8]):[c]3-[#6]4(-[#1])-[#1]):[c](:[c ](-[#1]):[c](-[#6](-[#1])(-[#1])-[#16]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]5-[#1]):[c]56):[n]6-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6@@]7(-[#6](=[#8])-[#8]-[#6](-[#1])(-[#1])-[#1] )-[#8]-[#1])-[#8]-[#6@@]78-[#6](-[#1])(-[#1])-[#1]):[n]28', 'S(C([H])([H])C([H])([H])[H])C([H])([H])c(c([H])c1[H])c([H])c(c12)c3c(c(c(c(C(N4[H])=O)c3C4([H])[H])c(c([H])c(C([H])([H])SC([H])([H])C([H])([H])[H])c([H])c5[H])c56)n6[C@@]([H])(C([H])([H])[C@@]7(C(=O)O C([H])([H])[H])O[H])O[C@@]78C([H])([H])[H])n28', '05.351', '5.351', '0', '0', 'TRUE', '-0.1575\r\n-0.1575\r\n-0.3372\r\n-0.3756\r\n-0.317\r\n-0.263\r\n-0.2719\r\n-0.2096\r\n-0.2148\r\n-0.3071\r\n0.1675\r\n0.197\r\n0.1245\r\n3.09e-002\r\n5.21e-002\r\n5.22e-002\r\n9.1e-003\r\n1.64e-002\r\n-1.76e-002\r\n3.25e-002\r\n3.22e-002\r\n2.5e-003\r\n-8.1e-003\r\n3.e-003\r\n5.2e-002\r\n0.2974\r\n3.8e-002', '1', '4.839', 'C33H33N3O5S2', '0615.186', '-9.396', '0615.762', '6 7.74', '4', '1', '2', '24', '24', '5', '43', '50', '40', '11', '008', '02', '33', '0', '8', '008', '0145.32', '584.9', '', '1.37148', '1.3109', '156.59', '91.77', '6.0661', '64.82', '3,610.17', '206.526', '476.42', '0.32', 'S(C/C/8=C/C/2=C(N1C7(C)OC(N4/C3=C1/C2=C\\6/C(=C3/C/5=C4/C=C\\C(CSCC)=C5)C(=O)NC6)CC7(O)C(OC)=O)\\C=C8)CC', 'CCSCc1ccc6c(c1)c5c2C(=O)NCc2c4c3cc(CSCC)ccc3n7c4c5n6[C@@H]8C[C@](O)(C(=O)OC)[C@]7(C)O8', 'CEP-1347', 'KT 7515', 'c-Jun N-terminal kinase', '9917013', 'Terminated at Phase II/III', 'Parkinson Disease(PARK)', '14745084', 'Parkinson Disease(PARK)', 'PARK'),
(202, '87917606', '87917606', 'CN(CC#C)CC1=Cc2ccccc2Oc3ccccc13', '<I>N</I>-(benzo[b][1]benzoxepin-5-ylmethyl)-<I>N</I>-methyl-prop-2-yn-1-amine', 'CYAAFQwAvdwQcp27m1Vv1jlIDGMcIsr1S^zHAk2INehN9GLo3AokHb44Y48YtUcA9YZtn5MovjxuPtihPFfFYJW8ZPY$Zi2BOBIDIvpALWHASPV1^BvTjt3stKwbc9Rze$zf^iGiyDACBvnf7DdRFNIegh8uQLM4v1XugT8MMrVNbYcPq5CLmZw82ZPnCHM5fDDpmAEz CV9LkT3$jYcYo^mnLMV4ZasgCnzlxZEal$CE4dOCg6waR9UGjiHuPvA2LbMd8VpKLDh5ecyGoCRLs$cpIIp8ckXXCqfvq0q2Xb874KsOAbn8o$tPeV6y5CQWQRx1K^3qHRl^pC7J0PLoZvuy8OVordC1eOzdOnKjPLgiedBv2kmstOwT9ct$LrM$KUHveHW04WCAuuu1 A$GP658MeNYoGASeTf5ksrowKbX$jmzKYWnXS4rbe5kzX3Feu1orNLGiS3^1828FL0FVH0M088EhY1zHTV7TAZYTPnc$SPvM', 'InChI=1S/C19H17NO/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19/h1,4-11,13H,12,14H2,2H3', 'AuxInfo=1/0/N:21,13,20,18,16,19,17,14,10,15,12,11,6,4,8,3,5,9,7,2,1/rA:38ONCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH/rB:;;s2s3;s3;d+3;s1s5;s6;s1s8;d+5;s2;d+7;s2;d+8;d+9;s10;s12d-16;s14;s15d-18;s11;t20;s4;s 4;s6;s10;s11;s11;s12;s13;s13;s13;s14;s15;s16;s17;s18;s19;s21;/rC:-1.4187,-.5744,1.3073;2.6889,.8456,-.12;.325,.6604,-.718;1.6823,1.1898,-1.1059;.1962,-.8048,-.51;-.7102,1.5143,-.5999;-.6562,-1.3528,.4 643;-2.0915,1.1668,-.2442;-2.3979,.1576,.6763;.9632,-1.7017,-1.2749;4.0137,1.3154,-.5389;-.7206,', 'QLMMOGWZCFQAPU-UHFFFAOYSA-N', '1010:RPD7BYJEE5CE8TJZSECKA9Q2BHD58Y', '[#8]1-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#1]):[c]2-[#6](-[#1])=[#6](-[c]3:[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1]) -[#6]#[#6]-[#1]', 'O1c(c([H])c([H])c([H])c2[H])c2C([H])=C(c3c1c([H])c([H])c([H])c3[H])C([H])([H])N(C([H])([H])[H])C([H])([H])C#C[H]', '04.772', '4.772', '0', '0', 'TRUE', '-0.3092\r\n-0.2911\r\n-2.34e-002\r\n2.47e-002\r\n9.8e-003\r\n-4.72e-002\r\n8.96e-002\r\n5.6e-003\r\n8.92e-002\r\n-5.2e-002\r\n5.99e-002\r\n-3.07e-002\r\n-1.21e-002\r\n-5.24e-002\r\n-3.07e-002\r\n-6.15e-002\r\n-5.96e-002\r\n-6.15e-002\r\n-5.96e-002\r\n-9.1e-002\r\n-0.1187\r\n4.81e-002\r\n4.81e-002\r\n', '1', '4.74', 'C19H17NO', '0275.131', '-3.865', '0275.344', '6.3', '1', '0', '1', '9', '12', '2', '21', '23', '19', '7', '002', '00', '17', '0', '3', '003', '0012.47', '293.43', '', '2.15615', '1.2728', '74.37', '39.48', '3.82949', '34.89', '672.63', '12.875', '224.66', '', 'O2/C1=C/C=C\\C=C1\\C(CN(CC#C)C)=C/C/3=C/C=C\\C=C23', 'C#CCN(C)Cc2cc1ccccc1oc3ccccc23', 'CGP 3466B', 'J-012946', 'Glyceraldehyde-3-phosphate dehydrogenase', '87917606', 'Terminated', 'Parkinson Disease(PARK)', '11205142', 'Parkinson Disease(PARK)', 'PARK'),
(203, '203', 'Not Available', 'Clc1c(Cl)c(Cl)c(C2CC(=O)CC(=O)C2)c(Cl)c1Cl', '5-(2,3,4,5,6-pentachlorophenyl)cyclohexane-1,3-dione', 'CYAAFQwABfwQlL8nirYY^oOR3LEMODD81foaz^VQgIgJsokrQGahxvyupqZVrMloneR4IvWiTIxMar4VIWUAzPaFSqbHQWTFaQNESQOIip72xBOwG3o82^XbCKVlEd0Dw8Tes^wohs980NFIMDShXJ4ULsJaBZ4BnrQThXQMEecArNoExYqfDzNdEx1^xpRJ5DDkv0Mp XvEimHUOzx5St^V03G318Pp9cPqpKyr78KlPduHml73aG6gFGEPrdp8v0coPRrpLRdJKzbZxzaqiz8J3yqlLiei5n7yIaDr53E6LOPyzpyIkUkV$CZ$PuvFMf75Il78xdA53YnIuDn6CdgWRqLsL6eBcrIlirKYb42EcEylOFM8rYX2Ci9bCzRWJ099KtA3mQZt6Vqr3 dnOH54m9upL1^oFv$yzA7fOH^YOvyC^cUA', 'InChI=1S/C12H7Cl5O2/c13-8-7(4-1-5(18)3-6(19)2-4)9(14)11(16)12(17)10(8)15/h4H,1-3H2', 'AuxInfo=1/0/N:4,8,5,6,3,7,9,10,11,12,13,14,15,19,16,18,17,1,2/E:(1,2)(5,6)(8,9)(10,11)(13,14)(15,16)(18,19)/rA:19OOCCCCCCCCCCCCClClClClCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s12;s 14;s13;s11;/rC:11.3413,-4.1052,0;8.4786,-3.9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3 505,0;10.6541,-8.1755,0;9.2252,-8.1754,0;9.9396,-8.588,0;11.7687,-6.6795,0;11.5898,-8.6675,0;9.8', 'QBJQRNWUGQGKEA-UHFFFAOYSA-N', '1010:QEYWX6ZE5KZ4V47A9923Q47RQTCZYY', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#17]):[c](-[#17]):[c](-[#17]):[c](-[#17]):[c]2-[#17])-[#6]1', 'O=C1CC(=O)CC(c2c(Cl)c(Cl)c(Cl)c(Cl)c2Cl)C1', '04.919', '4.918', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n6.e-004\r\n0.1403\r\n1.39e-002\r\n-3.6e-003\r\n6.58e-002\r\n6.58e-002\r\n7.97e-002\r\n7.97e-002\r\n8.08e-002\r\n-8.23e-002\r\n-8.1e-002\r\n-8.1e-002\r\n-8.1e-002\r\n-8.23e-002', '0', '5.407', 'C12H7Cl5O2', '0357.889', '-6.338', '0360.448', '1.01', '2', '0', '2', '12', '06', '1', '19', '20', '8', '5', '002', '00', '7', '0', '2', '001', '0034.14', '294.61', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C(Cl)/C(Cl)=C(Cl)\\C(Cl)=C1\\Cl)CC(=O)C2', 'O=C2CC(=O)CC(c1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl)C2', 'CHD_10', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(204, '204', 'Not Available', 'CSc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-methylsulfanylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAZdwQTebCvv^tlAya99kwHbpXiSsaflWkMr0Zlsbt2cqdlmzoC1rgrAtu8yz41a9oSPDTdmIRTt4VR$qDRVQhLZrsdDE7HeqedBhxit3lRt9gbNX74XSKKLiEMC88NHr1DN4uF$iJuwMI0eQwBJc4xcKRi5MFXFocMYCOLnk3dr$ic3Lwqwz5HoR0NNZCcJv2 PTLkeTWB8Sk430e32^Icnm3COc$a0W19mzvnctfu^tyyRCR4Q$T1tn7VGT4ephR$NuwgVh$S07uRyN2n5OWMqjaqcxb^j93JPKsbzRlINrlFqRcWuQo3oNngrKo6kaCkwOrmxwZ1Bx8VrUA20S^h76k8oW7wenJ949eLGYf6$pP859MNZ^Tmmd5v', 'InChI=1S/C13H14O2S/c1-16-13-4-2-9(3-5-13)10-6-11(14)8-12(15)7-10/h2-5,10H,6-8H2,1H3', 'AuxInfo=1/0/N:16,10,11,12,13,4,8,5,9,6,3,7,14,1,2,15/E:(2,3)(4,5)(6,7)(11,12)(14,15)/rA:16OOCCCCCCCCCCCCSC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;/rC:11.3413,-4.1052,0;8.4786,-3. 9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.2252,-8.1754,0;9. 9396,-8.588,0;9.9696,-9.572,0;9.1048,-10.2777,0;', 'QQKNFZFHZOFLHX-UHFFFAOYSA-N', '1010:M2GM229NGQAHFA6YAYBZNUF577AH9Q', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#16]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(SC)cc2)C1', '02.138', '2.138', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.4e-002\r\n-5.77e-002\r\n-5.77e-002\r\n-4.84e-002\r\n-4.84e-002\r\n6.9e-003\r\n-0.1296\r\n-1.37e-002', '0', '2.627', 'C13H14O2S', '0234.071', '-3.498', '0234.314', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '4', '5', '002', '00', '14', '0', '2', '002', '0059.44', '239.17', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(SC)\\C=C1)CC(=O)C2', 'CSc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_11', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(205, '205', 'Not Available', 'Fc1cc(F)cc(c1)C2CC(=O)CC(=O)C2', '5-(3,5-difluorophenyl)cyclohexane-1,3-dione', 'CYAAFQwARewQdkdwtTEzceuJy$uNPM8iJdWCebWO84j9XnAqNLu6RqPNtfPI2^J5TK2W9Y0naL0GlDxKjXvv95F$B^VwmYpJuW4Juwc0MTxILaELiVSEtevTCKVlEd0LwwT$s^woQo$8clEkziQIOA^ShDX7wKGIzXIqyLImEesB1GsKSgGvp7uOodiOcsFR$wEJLscW tJt65FpTON3j53M^e7uOvST$vtKbD91d7SyLz9Wf8^aLENUhjkrN7L3rGD990yYS^eT1pO$F1r6r$^Vfxexv5KpmvqOKcm3cTAH7tug0sSi5IOpmFyV1zJYzEoFaaG$VcWNcm^KhiVIhPLsdymGW9UJpuyxWR76glw2yt7pe5DeF$gT7^rh55mMAUdJ', 'InChI=1S/C12H10F2O2/c13-9-1-7(2-10(14)5-9)8-3-11(15)6-12(16)4-8/h1-2,5,8H,3-4,6H2', 'AuxInfo=1/0/N:10,11,4,8,14,5,9,6,12,13,3,7,15,16,1,2/E:(1,2)(3,4)(9,10)(11,12)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s13;/rC:11.3413,-4.1052,0;8. 4786,-3.9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.2252,-8.1 754,0;9.9396,-8.588,0;11.3711,-8.6675,0;8.578,-8.8563,0;', 'IPXMHIXARNRVBG-UHFFFAOYSA-N', '1010:6QBC366SDU6BJVYQ4QN8PGGRU2NAPB', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#9]):[c]:[c](-[#9]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(F)cc(F)c2)C1', '02.007', '2.008', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.2e-003\r\n0.1403\r\n1.38e-002\r\n-3.83e-002\r\n-2.26e-002\r\n-2.26e-002\r\n0.1259\r\n0.1259\r\n9.5e-003\r\n-0.2069\r\n-0.2069', '0', '2.496', 'C12H10F2O2', '0224.065', '-2.985', '0224.203', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '10', '0', '2', '001', '0034.14', '213.07', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(F)=C\\C(F)=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1cc(F)cc(F)c1)C2', 'CHD_12', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(206, '206', 'Not Available', 'Fc1cccc(F)c1C2CC(=O)CC(=O)C2', '5-(2,6-difluorophenyl)cyclohexane-1,3-dione', 'CYAAFQwARewQdkdwtTEzQ2sJ4FRQmKYAc18tAKjDiHtG28eNf8m$tQDqMNx8ovDjbKYT2^SyslX5PeJ7NiNGXd4WXDbB6aECVEMzG4pjeMrXevJW7LyTzNcxlkSWiIB$Bevyn1ZGHc3lqw0jMDSh7EsLFuMtej4gciiYDQ$wMB3bLRNGmu4yeCufKOnrFTrRkLcQ8Urk tTyHZGwciE3b7bn67h7G5tw$1t1ZNk3heLZnPvLryzbtR4QFOSf2drMv0MinkOmTMqbrtJswrDu371J5MMfGcp$YPXPdlLcu7Ivd0Zi5aGKFqB7iWJiLsKy8h68CcVRahQThEyV1Ca$qOIW$sWnwTnFFtmpyGdtDldRpypYHV0$7tnP4m^DOD8fNXWfwKB', 'InChI=1S/C12H10F2O2/c13-10-2-1-3-11(14)12(10)7-4-8(15)6-9(16)5-7/h1-3,7H,4-6H2', 'AuxInfo=1/0/N:14,12,13,4,8,5,6,3,7,10,11,9,15,16,1,2/E:(2,3)(4,5)(8,9)(10,11)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s11;/rC:11.3413,-4.1052,0;8.4 786,-3.9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.2252,-8.17 54,0;9.9396,-8.588,0;11.2121,-6.6497,0;7.8921,-6.8386,0;', 'QGSUTEMGHLKAAR-UHFFFAOYSA-N', '1010:HVV1AJWNP3CJAFXAMWXY5E7MWSE6CP', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#9]):[c]:[c]:[c]:[c]2-[#9])-[#6]1', 'O=C1CC(=O)CC(c2c(F)cccc2F)C1', '02.007', '2.008', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.4e-002\r\n6.5e-002\r\n3.4e-003\r\n0.1403\r\n1.4e-002\r\n2.74e-002\r\n0.1291\r\n0.1291\r\n-2.59e-002\r\n-2.59e-002\r\n-5.65e-002\r\n-0.2066\r\n-0.2066', '0', '2.496', 'C12H10F2O2', '0224.065', '-2.871', '0224.203', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '10', '0', '2', '001', '0034.14', '213', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C(F)/C=C\\C=C1\\F)CC(=O)C2', 'O=C2CC(=O)CC(c1c(F)cccc1F)C2', 'CHD_13', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(207, '207', 'Not Available', 'Fc1ccccc1C2CC(=O)CC(=O)C2', '5-(2-fluorophenyl)cyclohexane-1,3-dione', 'CYAAFQwAfdwQtVpbzwF5kcadtrC4YP1Rm1XrCC^^O6twOBhWV2DDMkcMDYVuOXugcOxkpUld659tKvuuwTkfpayjKMWCrNp4WE3Yz1K4AbOsYbe0M4tHVyKWvIoU8JaIRjpH5ZXeILfdIIFpSwuw7MEvIiDXG2C6MljwGAvPBR4x8Sbv7oOa^lu7IGtTIhjtyyFmDeul uMGpeMPIuL6JO6Lc$e3u2eFk7eb1TF6r$2t0Lz1xh^1KNFJFri8794P30MuQirtRSMGDNevbR4vrye^MNlrccfnfiYPhSMHVJ1sVuqGxBbmwtQTOQuqgaSqJVD3kfBDn46EzNtSGySrlDv4ZZCVd8A^$Avy25t981wMfnHg^R6oI', 'InChI=1S/C12H11FO2/c13-12-4-2-1-3-11(12)8-5-9(14)7-10(15)6-8/h1-4,8H,5-7H2', 'AuxInfo=1/0/N:12,14,10,13,4,8,5,6,3,7,9,11,15,1,2/E:(5,6)(9,10)(14,15)/rA:15OOCCCCCCCCCCCCF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s11;/rC:11.3413,-4.1052,0;8.4786,-3.9461,0;10.6542,-4.8 754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.2252,-8.1754,0;9.9396,-8.588,0;7.892 1,-6.8386,0;', 'RMEWCTHODLROAM-UHFFFAOYSA-N', '1010:N83FZKTQ8H53QBM5JNBWBWC2NTS5U1', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#9]):[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2c(F)cccc2)C1', '01.802', '1.802', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n5.e-004\r\n0.1403\r\n1.39e-002\r\n-8.3e-003\r\n-5.59e-002\r\n0.1262\r\n-6.18e-002\r\n-2.61e-002\r\n-5.94e-002\r\n-0.2067', '0', '2.291', 'C12H11FO2', '0206.074', '-2.727', '0206.213', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '11', '0', '2', '001', '0034.14', '202.06', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(F)/C=C\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1ccccc1F)C2', 'CHD_14', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(208, '208', 'Not Available', 'CCCCOc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-butoxyphenyl)cyclohexane-1,3-dione', 'CYAAFQwArcwQOlW0vn1v9ki3fXHhKDfOF2XVpq^IJMPbMC3PVKH2No2H9e0nDwRCzJqT6OI6E$cWxPW8iGVbZiqt3J0NbWOQSs4xtNFXcAitOBdJjRw7a^PLCHDiRBxpM^gWYKKmD3poLnJM5UOBYejgOc2F43LDkknwOWT1Z3bCJkLlrDRXP3Hu^8dNOoX9wpmI1o$G a84XrfdW^8fO1v53E0nukRB9JMTnr9JdUA1$fVVomHXQtO37oX8P$bI^NPnb7J91v3biwtTxdFMSXa^5zSK3Zq7baEPMf62lnOBe31HnJRS6nzVLnGg0Zd$mE6F$EylkiQulbSCrIPL0qUcbZiAukTZhJxlIUitLw15kbyyZ5pG1GumTSN6SeT911SsUxRxtB206LrQr ZZ4f8AAvG7RvGTzxwh7XODL', 'InChI=1S/C16H20O3/c1-2-3-8-19-16-6-4-12(5-7-16)13-9-14(17)11-15(18)10-13/h4-7,13H,2-3,8-11H2,1H3', 'AuxInfo=1/0/N:19,18,17,10,11,12,13,16,4,8,5,9,6,3,7,14,1,2,15/E:(4,5)(6,7)(9,10)(14,15)(17,18)/rA:19OOCCCCCCCCCCCCOCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;s16;s17;s18;/rC:11. 0009,-3.6483,0;8.5259,-5.0773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7 .2207,0;11.0009,-7.9352,0;11.826,-7.9352,0;12.2385,-8.6497,0;13.0635,-8.6497,0;13.476,-9.3641,0;', 'ZWSGOXVKTZBIRN-UHFFFAOYSA-N', '1010:XC9P4VFWUSB5VDAF1GVBKW3XTBQ852', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(OCCCC)cc2)C1', '02.909', '2.909', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.39e-002\r\n-5.62e-002\r\n-5.62e-002\r\n-3.16e-002\r\n-3.16e-002\r\n7.49e-002\r\n-0.3462\r\n5.32e-002\r\n-2.94e-002\r\n-5.4e-002\r\n-6.53e-002', '0', '3.397', 'C16H20O3', '0260.141', '-3.975', '0260.328', '1.01', '3', '0', '2', '12', '06', '1', '19', '20', '4', '5', '003', '00', '20', '0', '2', '005', '0043.37', '277.99', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(OCCCC)\\C=C1)CC(=O)C2', 'CCCCOc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_15', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(209, '209', 'Not Available', 'O=C1CC(CC(=O)C1)c2cocc2', '5-(3-furyl)cyclohexane-1,3-dione', 'CYAAFQwApewQD8qkbrmQY3yPUpyreA4dQzAe5Bo$wiPpd$huzyYO3ffWx68OAs6zSGQcV5f$fhf1TOaVFo6FqYiZKuqA5EJd4wIb9PlqRdCX^YtlagObDODTiGyDM^g0WZHWe8gd$h8Y9hWNKA^R1nXrKOKIR$kV5ppU5gKTLU9hkPK6csXwu3Xvo7dTKGWg59g^Fz1$ mzJZ^7VeXf^NcEOviWZEs0LznpLHzNvoVjKxug1S5ZO3NLmZhZ28Knk7Mzr2^^jQeJ9tbIobxiA6kujFQyuWHG3aUFItcZAkwpx0XdWGClbjtg0r1CvdIvByXnD$AeGgjf5pW^lcn0g8s1ny', 'InChI=1S/C10H10O3/c11-9-3-8(4-10(12)5-9)7-1-2-13-6-7/h1-2,6,8H,3-5H2', 'AuxInfo=1/0/N:10,12,4,8,5,11,9,6,3,7,1,2,13/E:(3,4)(9,10)(11,12)/rA:13OOCCCCCCCCCCO/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11s12;/rC:11.0009,-3.6483,0;8.5259,-5.0773,0;10.5884,-4.3628,0;11.0009,-5. 0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.8214,-6.5925,0;10.6654,-7.2599,0;11.9929,-7.3994,0;11.2785,-7.812,0;', 'NMPOXKDKNJQVPU-UHFFFAOYSA-N', '1010:H79VT9K32K5WA1U2B43CEY2HA3VHTN', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[o]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cocc2)C1', '00.7', '0.7', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n-4.e-004\r\n0.1403\r\n1.39e-002\r\n-1.87e-002\r\n-3.33e-002\r\n4.86e-002\r\n4.54e-002\r\n-0.3256', '0', '1.189', 'C10H10O3', '0178.063', '-1.914', '0178.185', '1.01', '3', '0', '2', '7', '05', '1', '13', '14', '3', '4', '003', '00', '10', '0', '2', '001', '0047.28', '178.3', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C\\1=C/O/C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1ccoc1)C2', 'CHD_16', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(210, '210', 'Not Available', 'Clc1ccccc1C2CC(=O)CC(=O)C2', '5-(2-chlorophenyl)cyclohexane-1,3-dione', 'CYAAFQwAjcwQttgl5eOlr0flkVns49Saqrr9EH^J1^tKUJ4kH^2QA0ml8i4yCCNnie2F1c$y2E8ZEc0ifO61Pit0DiUdlDTWoeOdqSmwK3xZsV$29KVGk2XTDCOlWhciFKRhnT28aCVMhphyemgdNfuvuOXhCXKrpofC9CsygcuQWJroCFpTcIO2YZcoTYn24cuifKs9 5dRvvf5IczbE7ddkyNUFPtTY9$H9GO^VUh3eNzr80ZfR3v$mMhMCM27mbEFL7c8diy0Bn$8Vcl7Nm^MmHFuZ5qaENjFiqRaRbGhd4pCkTzlFcFuZVgofFz1cxgk4VEzV0W8coNIm$mbafV$pAM32Z7He8c82$^C7U8IY', 'InChI=1S/C12H11ClO2/c13-12-4-2-1-3-11(12)8-5-9(14)7-10(15)6-8/h1-4,8H,5-7H2', 'AuxInfo=1/0/N:13,15,11,14,5,9,6,7,4,8,10,12,1,2,3/E:(5,6)(9,10)(14,15)/rA:15ClOOCCCCCCCCCCCC/rB:;;d2;s4;s4;s5;d3s6;s7s8;s7;s10;s1d-10;d-11;s12;s13d-14;/rC:9.3832,-6.7094,0;11.0009,-3.6483,0;8.5259,-5. 0773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7.2208,0;11.0009,-7.9352,0 ;11.8259,-7.9352,0;', 'BPFBAVBCEHCMFU-UHFFFAOYSA-N', '1010:UT9UHPRPCEUUMJ87ZBQ6UH7G8J5Z1G', '[#17]-[c](:[c]:[c]:[c]:[c]1):[c]1-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]2=[#8])-[#6]2', 'Clc(cccc1)c1C(CC(=O)CC2=O)C2', '02.261', '2.261', '0', '0', 'TRUE', '-8.41e-002\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n-9.e-004\r\n0.1403\r\n1.39e-002\r\n-2.54e-002\r\n-5.73e-002\r\n4.4e-002\r\n-6.19e-002\r\n-4.33e-002\r\n-6.08e-002', '0', '2.749', 'C12H11ClO2', '0222.045', '-3.325', '0222.668', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '11', '0', '2', '001', '0034.14', '211.83', '', '', '', '', '', '', '', '', '', '', '', 'Cl/C/2=C(C1CC(=O)CC(=O)C1)/C=C\\C=C2', 'O=C2CC(=O)CC(c1ccccc1Cl)C2', 'CHD_17', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(211, '211', 'Not Available', 'Brc1ccccc1C2CC(=O)CC(=O)C2', '5-(2-bromophenyl)cyclohexane-1,3-dione', 'CYAAFQwAjcwQttgl5eOlYdWl78jMaeM0P53IVuygHaduzeOQVLwJCsLr3JEgMpf8V1ptc3Ea2ch9viRVsE$X8MI$RvYCwATySvBw8QwnNgFYoK$DB44zXNdwengSshYmejaVxzfh0gBowIZVPSwuzl35rwZ4hL1^UoOP9Cc^gcOQUBroCBpTcIO24QcoC5WFHwxr^dgb K7v98k7G^B1Rv71QpyQFR6rT^V$5zfRvUkjh3SZhKhcu$k71mB0Rlxu2l$BZcfTckD8c5Le5XqC5ZP^C0xC3aGKFVj4iqSEXxehZF8VCrJ4zcyi2xexyr6oYfxBWMVFzxwVxgYeKuqlW5n278Yf1eyRA$Y^9Ds^LPi0FcA', 'InChI=1S/C12H11BrO2/c13-12-4-2-1-3-11(12)8-5-9(14)7-10(15)6-8/h1-4,8H,5-7H2', 'AuxInfo=1/0/N:13,15,11,14,5,9,6,7,4,8,10,12,1,2,3/E:(5,6)(9,10)(14,15)/rA:15BrOOCCCCCCCCCCCC/rB:;;d2;s4;s4;s5;d3s6;s7s8;s7;s10;s1d-10;d-11;s12;s13d-14;/rC:9.6317,-6.769,0;11.0009,-3.6483,0;8.5259,-5.0 773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7.2208,0;11.0009,-7.9352,0; 11.8259,-7.9352,0;', 'LVDPCSTZFXGYJB-UHFFFAOYSA-N', '1010:JWG2UMFT41JEADPK3CPV4YRF82XYXS', '[#35]-[c](:[c]:[c]:[c]:[c]1):[c]1-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]2=[#8])-[#6]2', 'Brc(cccc1)c1C(CC(=O)CC2=O)C2', '02.345', '2.345', '0', '0', 'TRUE', '-5.06e-002\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-1.3e-003\r\n0.1403\r\n1.38e-002\r\n-2.98e-002\r\n-5.77e-002\r\n2.09e-002\r\n-6.19e-002\r\n-4.77e-002\r\n-6.12e-002', '0', '2.833', 'C12H11BrO2', '0265.994', '-3.736', '0267.119', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '11', '0', '2', '001', '0034.14', '216.47', '', '', '', '', '', '', '', '', '', '', '', 'Br/C/2=C(C1CC(=O)CC(=O)C1)/C=C\\C=C2', 'O=C2CC(=O)CC(c1ccccc1Br)C2', 'CHD_18', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(212, '212', 'Not Available', 'Brc1cccc(c1)C2CC(=O)CC(=O)C2', '5-(3-bromophenyl)cyclohexane-1,3-dione', 'CYAAFQwAOdwQ2SUDtDcCNn6mGmjkdp3FTivaw2UPi3KJ8v6dTy7RiRc7X2SA9V1RmqqL8er$K87of0SV^aDj64^XOdGFbV$i0RW3U1t2QgvYvqBBqYjRY9cS4ZUMKJyEZE45m6y0iGc3NP4W3VOBQ9MBOc2DopqAJTR4O2y$EWTCrMXNhdiWn5u49TtbzdTl7ENEvNyu 0XF121fk^Xtna2b1h38NJnMUEfhNc^d0jOMmW3GCbQRF7MHtjlt71qHtB39PE7fp7sV5C$CpXcgSz6u7Am2cVAHxXtgO8ZCzIsZMCzRxFFydcVBSgrq0e5CViYOMFPimWIMbrF2sRfiN5L30zbWkFT1XDD8IcH90$VmpY9FAE8I', 'InChI=1S/C12H11BrO2/c13-10-3-1-2-8(4-10)9-5-11(14)7-12(15)6-9/h1-4,9H,5-7H2', 'AuxInfo=1/0/N:12,10,14,11,4,8,5,9,6,13,3,7,15,1,2/E:(5,6)(11,12)(14,15)/rA:15OOCCCCCCCCCCCCBr/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;/rC:11.0009,-3.6483,0;8.5259,-5.0773,0;10.5884,-4 .3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7.2208,0;11.0009,-7.9352,0;11.8259,-7.9352, 0;10.5263,-8.5085,0;', 'YZWQTKIZVUKNPW-UHFFFAOYSA-N', '1010:F7A24TYT64W45SH6Y1NJV7RFSCP7XV', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#35]):[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(Br)ccc2)C1', '02.345', '2.345', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.3e-002\r\n-5.87e-002\r\n-4.45e-002\r\n-6.09e-002\r\n1.77e-002\r\n-4.8e-002\r\n-5.09e-002', '0', '2.833', 'C12H11BrO2', '0265.994', '-3.722', '0267.119', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '11', '0', '2', '001', '0034.14', '216.51', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(Br)=C\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1cccc(Br)c1)C2', 'CHD_19', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(213, '213', 'Not Available', 'Clc1cccc(Cl)c1C2CC(=O)CC(=O)C2', '5-(2,6-dichlorophenyl)cyclohexane-1,3-dione', 'CYAAFQwACdwQTD1d088EWy6eSbJ9drGm9H4k$ds66VEh91p2NWdodvCOreI0r7qSvKd6Gtl7t^tJ7R78cil$oE3qRq$uneFRY$sQBurJwRDeaWBi2W$B4hWcpok$QcYwH4ZUxQiFb8VywUdRwI4FPRwuY323UmS1hPG6NmJDmjjVKcpsMHz5c^Q05xwK0UVEy4VtYO$W sMGUMr9pEPI6$fRsI3L78l7G$vwDezrjpi2q12M^^^KPa276jw9NQKFoK5SdctNohe4v23KCPqoC3BnuDfG^qXP5mQf$yBwFhdzJVj4oUlIPYaSzFltq5CrWCnmCmQ71BKPWflhlZmcxWk3izwsW5ooFtUCi0e^1ndNvkuq8DEbVZ7He8esud^C3qg5u', 'InChI=1S/C12H10Cl2O2/c13-10-2-1-3-11(14)12(10)7-4-8(15)6-9(16)5-7/h1-3,7H,4-6H2', 'AuxInfo=1/0/N:16,14,15,6,10,7,8,5,9,12,13,11,1,2,3,4/E:(2,3)(4,5)(8,9)(10,11)(13,14)(15,16)/rA:16ClClOOCCCCCCCCCCCC/rB:;;;d3;s5;s5;s6;d4s7;s8s9;s8;s1s11;s2d-11;d+12;s13;s14d-15;/rC:12.0272,-5.5564,0;9 .2838,-7.117,0;11.0009,-3.6483,0;8.5259,-5.0773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7 .2207,0;12.2385,-7.2208,0;11.0009,-7.9352,0;11.8259,-7.9352,0;', 'XFSFQUOJDRNZIT-UHFFFAOYSA-N', '1010:1C7JRQ9BVUNZBV6CNXN7YZ8Y4T8HAG', '[#17]-[c]1:[c]:[c]:[c]:[c](-[#17]):[c]1-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]2=[#8])-[#6]2', 'Clc1cccc(Cl)c1C(CC(=O)CC2=O)C2', '02.925', '2.925', '0', '0', 'TRUE', '-8.4e-002\r\n-8.4e-002\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n5.e-004\r\n0.1403\r\n1.39e-002\r\n-6.8e-003\r\n4.55e-002\r\n4.55e-002\r\n-4.32e-002\r\n-4.32e-002\r\n-5.93e-002', '0', '3.414', 'C12H10Cl2O2', '0256.006', '-4.088', '0257.113', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '10', '0', '2', '001', '0034.14', '232.53', '', '', '', '', '', '', '', '', '', '', '', 'Cl/C1=C/C=C\\C(Cl)=C1\\C2CC(=O)CC(=O)C2', 'O=C2CC(=O)CC(c1c(Cl)cccc1Cl)C2', 'CHD_20', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(214, '214', 'Not Available', 'Cc1cc(C)cc(c1)C2CC(=O)CC(=O)C2', '5-(3,5-dimethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwACdwQTD1d088EiT6ebmV9Jxk9s2WO3ujJ$orGGw5EEd7CXaO8WR^JXOu5xGFaj1Xf2668fO$DT5TaHY1$sBBFnhFK2VUWBnPDJ25sznhDFZQzatvwgTZpx04iI$Rui9JMW0iP2uYv8bKEOA^MhP3awKKIodCKBAuQlYwRirsaOqH0SffHu32cP71QgLcQ8GY7 wclN7LHpV6ZUd38^uvezMGV4XEzptv^6e0$cNnZAj4CccNy2g9y2gJnsO33v1BCYRh4lx1BvL2pFZbus3NIJ5AgdhYVgqBfvUHhVqKCrYTU2gvKBmCZVyLYrHTHuURFisW9hZpqwMfVMpxmTLxXZb3zytXibrstvtnPwn^DNA8vmX2J4pB', 'InChI=1S/C14H16O2/c1-9-3-10(2)5-11(4-9)12-6-13(15)8-14(16)7-12/h3-5,12H,6-8H2,1-2H3', 'AuxInfo=1/0/N:15,16,14,11,10,4,8,5,13,12,9,6,3,7,1,2/E:(1,2)(4,5)(6,7)(9,10)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s12;/rC:11.0008,-3.6483,0;8.52 58,-5.0772,0;10.5883,-4.3628,0;11.0008,-5.0772,0;9.7633,-4.3628,0;10.5883,-5.7917,0;9.3508,-5.0772,0;9.7633,-5.7917,0;11.0008,-6.5061,0;11.8258,-6.5061,0;10.5883,-7.2207,0;12.2383,-7.2207,0;11.0008,-7 .9351,0;11.8258,-7.9351,0;10.7151,-8.8563,0;13.4485,-7.3952,0;', 'MKXIOMJWYCENJQ-UHFFFAOYSA-N', '1010:RHMX8PGXKBVK3ZXAGS4Z52WPKZ3NV4', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#6]):[c]:[c](-[#6]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(C)cc(C)c2)C1', '02.569', '2.569', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.35e-002\r\n-5.58e-002\r\n-5.58e-002\r\n-5.06e-002\r\n-5.06e-002\r\n-5.64e-002\r\n-3.98e-002\r\n-3.98e-002', '0', '3.057', 'C14H16O2', '0216.115', '-3.581', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '16', '0', '2', '001', '0034.14', '234', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(C)=C\\C(C)=C1)CC(=O)C2', 'Cc2cc(C)cc(C1CC(=O)CC(=O)C1)c2', 'CHD_21', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(215, '215', 'Not Available', 'Clc1cc(Cl)cc(c1)C2CC(=O)CC(=O)C2', '5-(3,5-dichlorophenyl)cyclohexane-1,3-dione', 'CYAAFQwA2fwQ0xCZ2BvcFjAtpbem8tZGfT$M933JF41991jXZStM7LxQceEdjkAkyZjPT5grEGUaLKad^1DiByHzneWPzjmfcbEpcysrDHzipKTX0MegeqBkKJlfEpC8BuOltMfGOvd5RDfYKLYFnI4OLoIWVFxBKKHtFbLZGHaMnvA6JWQ03c3Av3rcRy7jWQ4g5VB3 i$av9LbpT7pV9W^^sfDmpAVEXYDyfDdJD^NX2QIUKqw$yp7inx3V0T$w6xn4odUB3uk5vRUX8td8nPwH12Dkowb$l78^fMfRoXE41IEKqB7mrGhNtWY2QqqQNBXRnTwWMmudRfVMmlKHa66EFPfDaSMH3rtVzyFtSblz9Mrz^wNAbfu7vYOfYS$nOA', 'InChI=1S/C12H10Cl2O2/c13-9-1-7(2-10(14)5-9)8-3-11(15)6-12(16)4-8/h1-2,5,8H,3-4,6H2', 'AuxInfo=1/0/N:10,11,4,8,14,5,9,6,12,13,3,7,16,15,1,2/E:(1,2)(3,4)(9,10)(11,12)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCClCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s12;/rC:11.0009,-3.6483,0; 8.5259,-5.0773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7.2208,0;11.0009 ,-7.9352,0;11.8259,-7.9352,0;10.7748,-8.4787,0;13.1405,-7.4251,0;', 'DGTMFXHOMNISPT-UHFFFAOYSA-N', '1010:FU8XEFF1TB2QHRPWG7G3T2HXAURZBZ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#17]):[c]:[c](-[#17]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(Cl)cc(Cl)c2)C1', '02.925', '2.925', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.11e-002\r\n-3.99e-002\r\n-3.99e-002\r\n4.23e-002\r\n4.23e-002\r\n-2.48e-002\r\n-8.43e-002\r\n-8.43e-002', '0', '3.414', 'C12H10Cl2O2', '0256.006', '-4.094', '0257.113', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '10', '0', '2', '001', '0034.14', '232.6', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(Cl)=C\\C(Cl)=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1cc(Cl)cc(Cl)c1)C2', 'CHD_22', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(216, '216', 'Not Available', 'O=C1CC(CC(=O)C1)c2ccc3ccccc3c2', '5-(2-naphthyl)cyclohexane-1,3-dione', 'CYAAFQwAOfwQFvC3sV3Y4OjHIu7$BQVl4xHCbHnwO8NHCr3CJ42Sl50cRwualS78pNzYJcNLL2lqLCeAz7iouO^wB4M^$8LbsoW6A^oNxPAuqpRkjl1VMaVMF6TE5JNi0aMY3n2iPBN7BJj5B3R$Hy8GGewM4olKhpQRCN2iysZNzH6N33hYtOn08$p7IOonDsbwu2ae cgoYcOvtu^q^34lblc0hcu9L7faijsJXthAoUUh1yp7Z54$B6SHYe852^pF4X6vlvsHuNZOXn4$Nj2p37nf5Xe79SL4lZV$F89CaIsaMCzaxEltiUUIWgPbILajkchFPiYOMFPiqVIMrTJ2s2trNmBoWaNssN^ZHsRYRlhpLLNxsAexopt$8rpEfCUA^8nqk', 'InChI=1S/C16H14O2/c17-15-8-14(9-16(18)10-15)13-6-5-11-3-1-2-4-12(11)7-13/h1-7,14H,8-10H2', 'AuxInfo=1/0/N:18,16,17,15,12,10,11,4,8,5,14,13,9,6,3,7,1,2/E:(8,9)(15,16)(17,18)/rA:18OOCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;d-15;s14;s16d-17;/rC:11.0009,-3.6483,0 ;8.5259,-5.0773,0;10.5884,-4.3628,0;11.0009,-5.0773,0;9.7634,-4.3628,0;10.5884,-5.7917,0;9.3509,-5.0773,0;9.7634,-5.7917,0;11.0009,-6.5062,0;11.826,-6.5062,0;10.5884,-7.2207,0;12.2385,-7.2208,0;11.000 9,-7.9352,0;11.8259,-7.9352,0;10.5884,-8.6497,0;11.001,-9.3641,0;12.2384,-8.6496,0;11.826,-9.364', 'BQKLSCZUTXHPJQ-UHFFFAOYSA-N', '1010:V7ZDQCU171JSQUNWBG5VWHVRXMJ5M5', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]3:[c](:[c]:[c]:[c]:[c]3):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc3c(cccc3)cc2)C1', '02.505', '2.505', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.34e-002\r\n-5.81e-002\r\n-5.09e-002\r\n-5.41e-002\r\n-1.82e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-5.44e-002\r\n-6.17e-002', '0', '2.993', 'C16H14O2', '0238.099', '-4.343', '0238.281', '1.01', '2', '0', '2', '7', '11', '2', '18', '20', '3', '7', '002', '00', '14', '0', '3', '001', '0034.14', '233.56', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/1=C/C/2=C(\\C=C1)/C=C\\C=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2ccc1ccccc1c2)C3', 'CHD_23', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(217, '217', 'Not Available', 'CCCCc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-butylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAvcwQZMrAb^dLT^2AwWH2^u$xrUjCcqIY92QYtCKnsZ19t^V2ymkFJxQ8RPzHDJQiCEpfCmLBe9pBx34wUsktaxDmty9p1B3cOMv3QLGC6tObwrUrrpVSo$gXMYUlZ1D3ylYROy^Bg69C64sLFpMinnlihBfV4fzSNXcOetHq5Jw6npjqo3GNUFPI1xUwX95g dkrx1dnf$7zwleH7tW2QjEq3tVTh9vtkrLnglj^8633Fk52V3ujdP39$PwXN^6A7iuJf5s^nG4s^O635MdzzAwS^W1yngbE4Al9CDQGKdAZsQVAhBQVAKcrFSPOkYZYToOGQY2AkZajQwQezZqhTy0ubMEjv4mtl2U2wngv7FA$r6RP4c9IlAeg8cg6Q', 'InChI=1S/C16H20O2/c1-2-3-4-12-5-7-13(8-6-12)14-9-15(17)11-16(18)10-14/h5-8,14H,2-4,9-11H2,1H3', 'AuxInfo=1/0/N:18,17,16,15,12,13,10,11,4,8,5,14,9,6,3,7,1,2/E:(5,6)(7,8)(9,10)(15,16)(17,18)/rA:18OOCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;s16;s17;/rC:10.0117,-4. 2927,0;8.5828,-6.7677,0;10.0117,-5.1177,0;10.7262,-5.5302,0;9.2973,-5.5302,0;10.7262,-6.3552,0;9.2973,-6.3552,0;10.0117,-6.7677,0;11.4407,-6.7677,0;12.1552,-6.3552,0;11.4407,-7.5927,0;12.8697,-6.7677, 0;12.1552,-8.0052,0;12.8697,-7.5927,0;13.5842,-8.0052,0;14.2986,-7.5927,0;15.0131,-8.0052,0;15.7', 'DNDLMJCBFDAQOH-UHFFFAOYSA-N', '1010:MAZGHVACDPUZR1DGKS96QVGZCQR8WA', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6]-[#6]-[#6]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(CCCC)cc2)C1', '03.451', '3.451', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-4.8e-002\r\n-2.79e-002\r\n-4.95e-002\r\n-5.59e-002\r\n-6.54e-002', '0', '3.94', 'C16H20O2', '0244.146', '-4.545', '0244.329', '1.01', '2', '0', '2', '11', '06', '1', '18', '19', '4', '5', '002', '00', '20', '0', '2', '004', '0034.14', '264.68', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(CCCC)\\C=C1)CC(=O)C2', 'CCCCc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_24', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(218, '218', 'Not Available', 'FC(F)(F)c1ccccc1C2CC(=O)CC(=O)C2', '5-[2-(trifluoromethyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwA9cwQuYOhPpUiKjDdF5CEuMoi2zz3dNkZlzPjQpfCFhhsN8g^66nw3MOqm0Q5jNk1dhCToM0annYg57K87pQiYG141chxires0J92yNkWwJo6y$8S$UBVTiB2icgvS$OVGdwCHAm4KB2wCzbD2HH$OoHDB^8Q0CTY9V96efl6x0$YuBqhazC8PXGYnR2IbtNf Syh$91Ay68WLz^6x0yrr3E7KN6AeP3mi8ofX9VvuTgO^fiv4F7Ru3zmSOZetf^XflN0hev5ye1Xa7anj9Q77bF9lSHf2cA5DXHsGYJHEwaOIwROgDgTgRA$ZNeLKcmGQRphTwJphYvgDNbBH1GWDT2aHmrpu3UavEXjCATqGTD8M^F7y^vKSufiBKhK', 'InChI=1S/C13H11F3O2/c14-13(15,16)12-4-2-1-3-11(12)8-5-9(17)7-10(18)6-8/h1-4,8H,5-7H2', 'AuxInfo=1/0/N:13,14,11,12,4,8,5,6,3,7,9,10,15,16,17,18,1,2/E:(5,6)(9,10)(14,15,16)(17,18)/rA:18OOCCCCCCCCCCCCCFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s15;s15;s15;/rC:11.9549,-2.12 63,0;10.526,-4.6013,0;11.9549,-2.9513,0;12.6694,-3.3638,0;11.2405,-3.3638,0;12.6694,-4.1888,0;11.2405,-4.1888,0;11.9549,-4.6013,0;13.3839,-4.6013,0;14.0983,-4.1888,0;13.3839,-5.4263,0;14.8127,-4.6013, 0;14.0983,-5.8387,0;14.8127,-5.4263,0;14.0983,-3.3638,0;14.9232,-3.3638,0;13.2733,-3.3638,0;14.0', 'YRXUINZCBBZSLH-UHFFFAOYSA-N', '1010:5JJEPF2FX53XME2K7R5E452AKFHA7M', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c]:[c]2-[#6](-[#9])(-[#9])-[#9])-[#6]1', 'O=C1CC(=O)CC(c2ccccc2C(F)(F)F)C1', '02.539', '2.539', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-1.8e-003\r\n0.1403\r\n1.38e-002\r\n-3.19e-002\r\n5.89e-002\r\n-5.82e-002\r\n-4.98e-002\r\n-6.2e-002\r\n-6.17e-002\r\n0.4162\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '3.027', 'C13H11F3O2', '0256.071', '-3.824', '0256.22', '1.01', '2', '0', '2', '11', '06', '1', '18', '19', '6', '5', '002', '00', '11', '0', '2', '002', '0034.14', '239.95', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C/C=C\\C=C1\\C(F)(F)F)CC(=O)C2', 'O=C2CC(=O)CC(c1ccccc1C(F)(F)F)C2', 'CHD_25', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(219, '219', 'Not Available', 'FC(F)(F)c1cc(cc(c1)C(F)(F)F)C2CC(=O)CC(=O)C2', '5-[3,5-bis(trifluoromethyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAsewQi$skFfFrEubjKVip2O3PjSskIDdZwbBNDR0lqoR6hrXlq6PEIx66LAYPgRTpzxy5DskQFzyxvlO056IJ6ACSo3hl7OQh6Ej1j^BxU9ORR4ir2eVg5pu15sIIvxKxZ6xNJohYap$i6JIeTRJ2JnD6MWEyu2jQotQy7aY^CnTbXhMkPfgzi4cPA7TeRkXr DEdtcvXef8Ifw199DzJjN6cA^62eXqp7^zGM8c7x^6evUYi6ddt7qb^8Zknz^^x08u$w7HKy^qgUv195$Y2693sxE6UiPmDd5YulnGdD9cpPZ9dTeUMxuS3F5pKXOZcOe6gnVZk9EbFhi4kYSMXFriZugvISKgrIVlmKTaJkqMSG4KnYwNJmwwZxNp5P6I9Oz2jrmaD9 p3bLWVqNsaF5YHRaaJotwfXM3DHAXLDeXwsuLvwxDB', 'InChI=1S/C14H10F6O2/c15-13(16,17)9-1-7(2-10(5-9)14(18,19)20)8-3-11(21)6-12(22)4-8/h1-2,5,8H,3-4,6H2', 'AuxInfo=1/0/N:10,11,4,8,14,5,9,6,12,13,3,7,16,15,20,21,22,17,18,19,1,2/E:(1,2)(3,4)(9,10)(11,12)(13,14)(15,16,17,18,19,20)(21,22)/rA:22OOCCCCCCCCCCCCCCFFFFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s 11;s12d-13;s13;s12;s15;s15;s15;s16;s16;s16;/rC:10.8568,-4.2167,0;9.4279,-6.6917,0;10.8568,-5.0417,0;11.5714,-5.4542,0;10.1424,-5.4542,0;11.5714,-6.2792,0;10.1424,-6.2792,0;10.8568,-6.6917,0;12.2858,-6 .6917,0;13.0003,-6.2792,0;12.2858,-7.5167,0;13.7148,-6.6917,0;13.0003,-7.9292,0;13.7148,-7.5167,', 'NUQVZPNQASEHFH-UHFFFAOYSA-N', '1010:NU3Q3T1C4WX158HWUZ5WRX1Z8JBU9Z', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1', '03.481', '3.481', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.29e-002\r\n-4.65e-002\r\n-4.65e-002\r\n5.63e-002\r\n5.63e-002\r\n-3.78e-002\r\n0.4159\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '3.97', 'C14H10F6O2', '0324.058', '-5.148', '0324.218', '1.01', '2', '0', '2', '15', '06', '1', '22', '23', '9', '5', '002', '00', '10', '0', '2', '003', '0034.14', '288.86', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(C(F)(F)F)=C\\C(C(F)(F)F)=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2', 'CHD_26', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(220, '220', 'Not Available', 'CCc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-ethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwA2fwQ0xCZ2BvcPuFtCm8Qzof7lHUv$XjYoHHX^2xlBLUiLTZmdeUz^YnU9KwKMt3tj9kxRZLZA9s6Rn8qVDURMpzp8uwStqLzXFcJxZPGlHFJMWljE6dE^IFiwGGMTTqLwKanBtwcCyFmNjyZhenJc$si5dxQ5VHx3lkFP3H3PrVMUH$c48oK5alQ5tmgHXsD OK^KeUPu76$vlQw4M^HW^sczb7ZOazj88vX^sOPyrr5^4pcM7vsbi66eFitqMj0C4YuOuUhKYeDBTr9mRA3Wucht4X1mRYFbEmtskR43wVUICuiT4i70ZxsYyeEVcWcWprYzrbnYp5NxslU0TU6u9s7r8wjAtxcnNMvKX6AZdC', 'InChI=1S/C14H16O2/c1-2-10-3-5-11(6-4-10)12-7-13(15)9-14(16)8-12/h3-6,12H,2,7-9H2,1H3', 'AuxInfo=1/0/N:16,15,12,13,10,11,4,8,5,14,9,6,3,7,1,2/E:(3,4)(5,6)(7,8)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;/rC:10.8568,-4.2166,0;9.4278,-6. 6916,0;10.8568,-5.0416,0;11.5713,-5.4541,0;10.1423,-5.4541,0;11.5713,-6.2791,0;10.1423,-6.2791,0;10.8568,-6.6916,0;12.2857,-6.6916,0;13.0002,-6.2791,0;12.2857,-7.5166,0;13.7147,-6.6916,0;13.0002,-7.92 91,0;13.7147,-7.5166,0;14.4425,-8.0114,0;14.194,-8.8861,0;', 'UWYXYUUAKSBXRP-UHFFFAOYSA-N', '1010:7GE3UB3XNNSSN6MPJG7K5GMA7V38B6', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(CC)cc2)C1', '02.539', '2.539', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-4.83e-002\r\n-3.08e-002\r\n-6.13e-002', '0', '3.027', 'C14H16O2', '0216.115', '-3.535', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '4', '5', '002', '00', '16', '0', '2', '002', '0034.14', '229.84', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(CC)\\C=C1)CC(=O)C2', 'CCc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_27', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(221, '221', 'Not Available', 'CCCc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-propylphenyl)cyclohexane-1,3-dione', 'CYAAFQwACewQmaF5a5hUedtA9MALMtX25y6jeuEuAKYEs1t6w97^7gh9yU0wuOL0X27Ffsbur7y3ZQzn3842H8VoO2xYdkAJQ^xhEikNkNdGem8ezUh2k3O6NFOnqjMiTmQgCb8DwJanBNBCB7CaiR9MQp6VuYRJ8iMY5V3x3kkHP3H3IrfMUX$Yx9$KyxKhyfdBMrkA dR$V9Yp472uflQQ4ZiX$^d6Gvlrcov4yx^$ty$yIvtq^7zCxevVfK6b$nIuqxEiLH7z6ylaWzUYKSp2$tyZrz9XQbitB$WRcYG6FFj4sqUEnxNhZEKVFlEMV2qQrBnndYuImmnSHiZMLOhpzOdjZW0p7dKWb86Wz3Ymz7ZmX4hHBbhrOb4$Og$eNhB', 'InChI=1S/C15H18O2/c1-2-3-11-4-6-12(7-5-11)13-8-14(16)10-15(17)9-13/h4-7,13H,2-3,8-10H2,1H3', 'AuxInfo=1/0/N:17,16,15,12,13,10,11,4,8,5,14,9,6,3,7,1,2/E:(4,5)(6,7)(8,9)(14,15)(16,17)/rA:17OOCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;s16;/rC:10.8568,-4.2166,0;9. 4278,-6.6916,0;10.8568,-5.0416,0;11.5713,-5.4541,0;10.1423,-5.4541,0;11.5713,-6.2791,0;10.1423,-6.2791,0;10.8568,-6.6916,0;12.2857,-6.6916,0;13.0002,-6.2791,0;12.2857,-7.5166,0;13.7147,-6.6916,0;13.00 02,-7.9291,0;13.7147,-7.5166,0;14.4425,-8.0114,0;14.194,-8.8861,0;12.4844,-8.916,0;', 'ANBYWGIMRSJTIR-UHFFFAOYSA-N', '1010:47YKMWQA1W7XEXX36BUKN522K6D9SA', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6]-[#6]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(CCC)cc2)C1', '02.995', '2.995', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-4.8e-002\r\n-2.82e-002\r\n-5.21e-002\r\n-6.51e-002', '0', '3.484', 'C15H18O2', '0230.131', '-4.031', '0230.302', '1.01', '2', '0', '2', '10', '06', '1', '17', '18', '4', '5', '002', '00', '18', '0', '2', '003', '0034.14', '247.26', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(CCC)\\C=C1)CC(=O)C2', 'CCCc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_28', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(222, '222', 'Not Available', 'Cc1cccc(C)c1C2CC(=O)CC(=O)C2', '5-(2,6-dimethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwA2fwQ0xCZ2Bvc0uNt^K$SZPoHnY5oHqp57oPqikJYuLmBlaU3dvIljnGbwSXeYSNnG9SRwAnYdjG6j0gjxmPRFJde^rqmTw$lCZAfK$A2F2L8zwZnRkAvg5XlDRuw39nKSWkDFTokGiXJ1ym2E35CBMHPb10InDJ3Kyfk58xuZ^hRF4cV4c77yZnQ5tOgTXSA 9wbgjntbr471SClTNB8P0m98nf7PrTfRRi^99b9VIy91P3W27lX78e5cx^$oCw91uyCli8owElNqJOLVXYGpEpS8BTVhFYlm5F3lVhZwUfENSJGbuF2srfoNZEN5Pk9oczb0gHR7kle4Zv0blD^bcdJ', 'InChI=1S/C14H16O2/c1-9-4-3-5-10(2)14(9)11-6-12(15)8-13(16)7-11/h3-5,11H,6-8H2,1-2H3', 'AuxInfo=1/0/N:15,16,14,12,13,4,8,5,10,11,6,3,7,9,1,2/E:(1,2)(4,5)(6,7)(9,10)(12,13)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s11;/rC:10.8568,-4.228,0;9.427 9,-6.703,0;10.8568,-5.053,0;11.5714,-5.4655,0;10.1424,-5.4655,0;11.5714,-6.2905,0;10.1424,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528,0;13.7148,-6.703,0;13.0003,-7.940 5,0;13.7148,-7.528,0;13.0003,-5.4655,0;11.5714,-7.9405,0;', 'YBWQRPSSVLQIRT-UHFFFAOYSA-N', '1010:KHJWGV5PAKUMBM2KU9RQ7EN117SGB5', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#6]):[c]:[c]:[c]:[c]2-[#6])-[#6]1', 'O=C1CC(=O)CC(c2c(C)cccc2C)C1', '02.569', '2.569', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-1.9e-003\r\n0.1403\r\n1.38e-002\r\n-3.82e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-5.91e-002\r\n-5.91e-002\r\n-6.18e-002\r\n-3.95e-002\r\n-3.95e-002', '0', '3.057', 'C14H16O2', '0216.115', '-3.563', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '16', '0', '2', '001', '0034.14', '233.93', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C(C)/C=C\\C=C1\\C)CC(=O)C2', 'Cc1cccc(C)c1C2CC(=O)CC(=O)C2', 'CHD_29', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(223, '223', 'Not Available', 'Cc1ccccc1C2CC(=O)CC(=O)C2', '5-(o-tolyl)cyclohexane-1,3-dione', 'CYAAFQwAOdwQ2SUDtDcCoS9msE9PN1DKOUDBF$BM4yMi1XVlKa5b4krzJjcbtIpO$EV7VSO29iTmASiZCaejp2yHuMBwJbSB9MJQE7ZNrr5LL3iovIGa54lQQg^Z9riIJTIwuT1hKyhnJUCJwv0iZXrC6chamnXiaakAhgr15Pyz8cfB$woccuqsv69CsTYcXPAZKJw8 51gpLj792^nHCCXXGwvkfqpbnffTIyr99kvfVWuf18fd2J2N7N3652u3f3T^AtiyVlcmEEF$IuZNRajaiwO1oWoXYpCkgr60f5iMVYGM1ERzUj5mbiJb4Eez6RXe^9MNOUXUXuPAs0XnA8XZOuIHuC', 'InChI=1S/C13H14O2/c1-9-4-2-3-5-13(9)10-6-11(14)8-12(15)7-10/h2-5,10H,6-8H2,1H3', 'AuxInfo=1/0/N:15,14,12,13,10,4,8,5,11,6,3,7,9,1,2/E:(6,7)(11,12)(14,15)/rA:15OOCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s11;/rC:10.8568,-4.228,0;9.4279,-6.703,0;10.8568,-5.05 3,0;11.5714,-5.4655,0;10.1424,-5.4655,0;11.5714,-6.2905,0;10.1424,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528,0;13.7148,-6.703,0;13.0003,-7.9405,0;13.7148,-7.528,0;11. 5714,-7.9405,0;', 'HUPGWYIWIQPTIS-UHFFFAOYSA-N', '1010:PYPW4GN6CGHWVD43JG5AMQNFU1NK2G', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#6]):[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2c(C)cccc2)C1', '02.083', '2.083', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.2e-003\r\n0.1403\r\n1.38e-002\r\n-4.11e-002\r\n-5.85e-002\r\n-4.77e-002\r\n-6.2e-002\r\n-5.91e-002\r\n-6.2e-002\r\n-3.95e-002', '0', '2.571', 'C13H14O2', '0202.099', '-3.057', '0202.249', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '14', '0', '2', '001', '0034.14', '212.52', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(C)/C=C\\C=C1)CC(=O)C2', 'Cc1ccccc1C2CC(=O)CC(=O)C2', 'CHD_30', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(224, '224', 'Not Available', 'CCc1ccccc1C2CC(=O)CC(=O)C2', '5-(2-ethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAgewQirXixUeLCnFPHtMVTZLSO8V6N$MZ^OcHWyqhRnumA7y5geDZ8a80istCeUPgnMwe2RhJUNIcMGqx5hAC7TaygR1xBefk0mnY8ccMM0vhrkmWvTQp5SkQwgpHz^hOiGs7SSFSEsLMKC1LhaVjmAZlgOmzrvYcSyh8PG3WofcPCvtAc^eWIfkFwZnVj$cL RqNJbu4drH^7OtivbLKUT3Yw7iX2Ls8bfbN6vIy4fd^XmMQf329uv3V5z792Mzb9^TaxoQ8SN^v38Aa5hfxGVHueoKCrUVUWwm4shEFCmCbR5GcFxoZXVXhZrWTEsWNGM3JmUzpba2yOZfZgn7o8A4Y2H88TX$5cTEQ$AeJT', 'InChI=1S/C14H16O2/c1-2-10-5-3-4-6-14(10)11-7-12(15)9-13(16)8-11/h3-6,11H,2,7-9H2,1H3', 'AuxInfo=1/0/N:16,15,14,12,13,10,4,8,5,11,6,3,7,9,1,2/E:(7,8)(12,13)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s11;s15;/rC:10.8568,-4.228,0;9.4279,-6.703,0;10.85 68,-5.053,0;11.5714,-5.4655,0;10.1424,-5.4655,0;11.5714,-6.2905,0;10.1424,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528,0;13.7148,-6.703,0;13.0003,-7.9405,0;13.7148,-7.5 28,0;11.5714,-7.9405,0;11.5899,-8.8266,0;', 'PHXDTQMJAVKZDF-UHFFFAOYSA-N', '1010:2ZWB65RG6RKM3TQA41Z22NYVRJD25S', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#6]-[#6]):[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2c(CC)cccc2)C1', '02.539', '2.539', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.1e-003\r\n0.1403\r\n1.38e-002\r\n-4.09e-002\r\n-5.85e-002\r\n-4.48e-002\r\n-6.2e-002\r\n-5.88e-002\r\n-6.2e-002\r\n-3.05e-002\r\n-6.13e-002', '0', '3.027', 'C14H16O2', '0216.115', '-3.494', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '4', '5', '002', '00', '16', '0', '2', '002', '0034.14', '229.81', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(CC)/C=C\\C=C1)CC(=O)C2', 'CCc1ccccc1C2CC(=O)CC(=O)C2', 'CHD_31', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(225, '225', 'Not Available', 'Cc1cccc(c1)C2CC(=O)CC(=O)C2', '5-(m-tolyl)cyclohexane-1,3-dione', 'CYAAFQwAjcwQ1yHRbqQWWaaV8dmqS3MIhi0fh0a3jl4hN^uh3vxNBWrem6V0VhKXBEvCE7XsxZKeeAEzb$WuGBMiP6IkfAzW2Wj^G0weFf5dbojHwbWUSQZPRsAvg5X58huwH8GzxKyiZTIkBiXJLxq2Jo1F8IearJjBnDJ3CyNk5oxeYfhR65sV4Y95yarQ5t$gRXiH twrjj7tbL471iClTZG82sxc651$zy3dAIz^f$v$yA72anfNZtyr9TxVu9GhDvFeCg^nLrOJPwPKciwWxJOLFuwMWI1lwFIVEqQ7lL9IOcZ8MkOHRY2EmMbjYwZuT6QTnZyuZGY37f0DOuMW9d0Q^x6Ic', 'InChI=1S/C13H14O2/c1-9-3-2-4-10(5-9)11-6-12(14)8-13(15)7-11/h2-5,11H,6-8H2,1H3', 'AuxInfo=1/0/N:15,12,14,10,11,4,8,5,13,9,6,3,7,1,2/E:(6,7)(12,13)(14,15)/rA:15OOCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;/rC:10.8568,-4.228,0;9.4279,-6.703,0;10.8568,-5.05 3,0;11.5714,-5.4655,0;10.1424,-5.4655,0;11.5714,-6.2905,0;10.1424,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528,0;13.7148,-6.703,0;13.0003,-7.9405,0;13.7148,-7.528,0;13. 1405,-8.6377,0;', 'PNVNVCYTGLOTGK-UHFFFAOYSA-N', '1010:U55JQHJT6G5WPE7WV1WUZ158Z6D9B1', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#6]):[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(C)ccc2)C1', '02.083', '2.083', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.38e-002\r\n-5.88e-002\r\n-5.58e-002\r\n-6.18e-002\r\n-5.09e-002\r\n-5.93e-002\r\n-3.98e-002', '0', '2.571', 'C13H14O2', '0202.099', '-3.066', '0202.249', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '4', '5', '002', '00', '14', '0', '2', '001', '0034.14', '212.56', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(C)=C\\C=C1)CC(=O)C2', 'Cc2cccc(C1CC(=O)CC(=O)C1)c2', 'CHD_32', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(226, '226', 'Not Available', 'Cc1cccc(C2CC(=O)CC(=O)C2)c1C', '5-(2,3-dimethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwA2fwQ0xCZ2Bvc0uNt^K$SZPoHRY$uJOgg^Q9u4c4AYBb^5AIm3Z$aXGXM7^vkbLJSqPmux2tNdH3wgQWnnLczySDNq45GQOH8KCT3bvcjYd8sleScC9OBekLR6ADmfP^HIJawhRCLelgdrbBoWVoU4opQMH4jkfjG3SSOG5J4FEtjzWpt1kr3tCpj6BO7Jdkn vNCtnv5ivXD$UOhgwZH6zorZ71323CkXPeM3uzDvGo^v9aHTb^8b1ss6RDR5WDxmNE29Rqcx3MfZRexlC7aHXIcjQl4siZCzIsbMFFydcVBSgrq0N7C3RMHGiFZzKGmN7AT2zNcmYiu0NYcs^yT0wxQ7q7je0z3xCW^NhdJ', 'InChI=1S/C14H16O2/c1-9-4-3-5-14(10(9)2)11-6-12(15)8-13(16)7-11/h3-5,11H,6-8H2,1-2H3', 'AuxInfo=1/0/N:15,16,12,14,10,4,8,5,13,11,6,3,7,9,1,2/E:(6,7)(12,13)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s11;/rC:10.8568,-4.228,0;9.4279,-6.703,0;10.85 68,-5.053,0;11.5714,-5.4655,0;10.1424,-5.4655,0;11.5714,-6.2905,0;10.1424,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528,0;13.7148,-6.703,0;13.0003,-7.9405,0;13.7148,-7.5 28,0;13.1405,-8.6377,0;11.4308,-8.0413,0;', 'XSQHNTMUOBNZMO-UHFFFAOYSA-N', '1010:AC3SJ6SNMG7EYMWGRKPAS3TY1C2NFA', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#6]):[c](-[#6]):[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2c(C)c(C)ccc2)C1', '02.569', '2.569', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.1e-003\r\n0.1403\r\n1.38e-002\r\n-4.09e-002\r\n-5.85e-002\r\n-4.47e-002\r\n-6.17e-002\r\n-4.8e-002\r\n-5.91e-002\r\n-3.96e-002\r\n-3.93e-002', '0', '3.057', 'C14H16O2', '0216.115', '-3.577', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '16', '0', '2', '001', '0034.14', '233.93', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(C)/C(C)=C\\C=C1)CC(=O)C2', 'Cc2cccc(C1CC(=O)CC(=O)C1)c2C', 'CHD_33', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(227, '227', 'Not Available', 'O=C1CC(CC(=O)C1)c2cccc(c2)c3ccccc3', '5-(3-phenylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAMcwQlbLlWlwJhfrTqpNAN7KV8ln1sfNPLYdjVL9BLGDw6klqtkpazhrP23CEiT9jtmajR4ckabmDbB2Q05eGVTHQiXMNDpqAF5noaU4A6fHPlXnXDGOn2jUiMVyg5SiPID3ekQJngfJFNbeFhenRng54kCmLr9YcSyj8PC33RfWLOvzRevAnEG37HEn1CM^V OaqccvFvfesMccTeffyIT3Yw664si$SNH753ox7rPxfXZjY3ted71dceHwXnP^WmjnbUyN^cHPmH1pMHedFf11iz5eF9c4^o7wLgfvwOmBqiNHVEaKpIVRcVeqAs0WdhpgVWMfxlFXhWLWTYsUNGMvJmc3pp6UjOryKyUU1Em30JkJvI$xkF2I2HOPtYMYvkyRP8yevM 28Azmtbh', 'InChI=1S/C18H16O2/c19-17-10-16(11-18(20)12-17)15-8-4-7-14(9-15)13-5-2-1-3-6-13/h1-9,16H,10-12H2', 'AuxInfo=1/0/N:20,18,19,13,16,17,14,11,10,4,8,5,15,12,9,6,3,7,1,2/E:(2,3)(5,6)(10,11)(17,18)(19,20)/rA:20OOCCCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;d+15;d-16;s17; s18d-19;/rC:10.8568,-4.228,0;9.4279,-6.703,0;10.8568,-5.053,0;11.5713,-5.4655,0;10.1423,-5.4655,0;11.5713,-6.2905,0;10.1423,-6.2905,0;10.8568,-6.703,0;12.2858,-6.703,0;13.0003,-6.2905,0;12.2858,-7.528 ,0;13.7147,-6.703,0;13.0003,-7.9405,0;13.7147,-7.528,0;14.4292,-6.2905,0;14.4292,-5.4655,0;15.14', 'WSUBJXIZRCNCPO-UHFFFAOYSA-N', '1010:XCKP754XKMNBPCN8CTQW1YSY1Q1GMZ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(c3ccccc3)c2)C1', '03.115', '3.115', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.35e-002\r\n-5.09e-002\r\n-5.87e-002\r\n-1.82e-002\r\n-6.14e-002\r\n-5.44e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-6.17e-002\r\n-6.23e-002', '0', '3.603', 'C18H16O2', '0264.115', '-4.871', '0264.318', '1.01', '2', '0', '2', '8', '12', '2', '20', '22', '4', '8', '002', '00', '16', '0', '3', '002', '0034.14', '264.17', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(\\C\\1=C\\C=C/C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(c1ccccc1)c2)C3', 'CHD_34', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(228, '228', 'Not Available', 'CCCCCc1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-pentylphenyl)cyclohexane-1,3-dione', 'CYAAFQwArcwQOlW0vn1v^pj3b06^CJVKmYK9$2VGHH5S$Npw4E4Fr0DX^pUn5zb3$0tYtJy0QeEHWP3K$levxZ9OJxOQDUbRNuiuM^cluNFjzEMc$S6HOL3wE5C8BuOp8kYGnX3aVKL0dCSmXI4INtIq$UYWFIshtlCjeOUcrY7RN7n7h6cRT5tcIIO3BMdJFcurfENt OvLy8PX9K$eOWT3En5T0y3Vk713$wSsX^$hfwKl8bq$^7SGk7$8bpft3dDxdX7pfDY5enHUe8EowQVaPL$s3$9neB80NVA3qhShfIuImExVxXYmKpkQsgrqQFYlk8v7aXEzgShTsYXEzY6iYh18m0l3OKSretejtN1Ou752KTp40$n2ExT1MwDPB3KDf3wsOwmJsJD', 'InChI=1S/C17H22O2/c1-2-3-4-5-13-6-8-14(9-7-13)15-10-16(18)12-17(19)11-15/h6-9,15H,2-5,10-12H2,1H3', 'AuxInfo=1/0/N:19,18,17,16,15,12,13,10,11,4,8,5,14,9,6,3,7,1,2/E:(6,7)(8,9)(10,11)(16,17)(18,19)/rA:19OOCCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;s16;s17;s18;/rC:11 .0051,-4.3132,0;9.5761,-6.7882,0;11.0051,-5.1382,0;11.7196,-5.5507,0;10.2906,-5.5507,0;11.7196,-6.3757,0;10.2906,-6.3757,0;11.0051,-6.7882,0;12.434,-6.7882,0;13.1485,-6.3757,0;12.434,-7.6132,0;13.863, -6.7882,0;13.1485,-8.0257,0;13.863,-7.6132,0;14.5774,-8.0257,0;15.292,-7.6132,0;16.0064,-8.0257,', 'OAZHUPVMGHKRSC-UHFFFAOYSA-N', '1010:VWMZBSFY1FBMGVCWRRGRRVHQFNYKT3', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6]-[#6]-[#6]-[#6]-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(CCCCC)cc2)C1', '03.908', '3.908', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-4.8e-002\r\n-2.79e-002\r\n-4.93e-002\r\n-5.33e-002\r\n-5.62e-002\r\n-6.54e-002', '0', '4.396', 'C17H22O2', '0258.162', '-5.069', '0258.355', '1.01', '2', '0', '2', '12', '06', '1', '19', '20', '4', '5', '002', '00', '22', '0', '2', '005', '0034.14', '282.1', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(CCCCC)\\C=C1)CC(=O)C2', 'CCCCCc2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_35', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(229, '229', 'Not Available', 'CC(C)c1cccc(c1)C2CC(=O)CC(=O)C2', '5-(3-isopropylphenyl)cyclohexane-1,3-dione', 'CYAAFQwACewQmaF5a5hUiugA4fzImAgk1PRqv9JXbwvq5UEeTvhm1MxHyXHjVFqVsQRpDFBXdLZCngjElO^gH333IDePXWTJH7Kq6aRBK6Yd3VGKsSZNrsuivRQp5RkQRipHvnDSaxh7kIntj8PKoemgMZ6wfZQoh8IO3khxymC53DX3w5yWpqs0xhpUoLJhn7qCBRbe 7g8r7V^zvrL^0NhhlFt17Kiz37C6Ayr9esvfiK^PfS^lkgo3e698X77dSSRYTsu1FhTzUHj8Wv0dTxZ8X26q^ea2BwXuqE$m$SBdE2EmRYjYFl9iUUIWwVVICuaS601cFxcYKeENtQY2cPsZOyR0Hb0krHgjOKf2OhS^Es3ZajHe8udmGcDzhBa5', 'InChI=1S/C15H18O2/c1-10(2)11-4-3-5-12(6-11)13-7-14(16)9-15(17)8-13/h3-6,10,13H,7-9H2,1-2H3', 'AuxInfo=1/0/N:16,17,13,14,11,10,4,8,5,15,12,9,6,3,7,1,2/E:(1,2)(7,8)(14,15)(16,17)/rA:17OOCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;s15;/rC:11.0051,-4.3132,0;9.5761, -6.7882,0;11.0051,-5.1382,0;11.7195,-5.5507,0;10.2905,-5.5507,0;11.7195,-6.3757,0;10.2905,-6.3757,0;11.0051,-6.7882,0;12.434,-6.7882,0;13.1484,-6.3757,0;12.434,-7.6132,0;13.8629,-6.7882,0;13.1484,-8.0 257,0;13.8629,-7.6132,0;14.8202,-6.769,0;15.0687,-5.9341,0;15.5359,-7.1169,0;', 'RKNLRFQOXGTHTA-UHFFFAOYSA-N', '1010:H7YG9BDAWTJ639AHBZTTAEM2Z9WTKG', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#6](-[#6])-[#6]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(C(C)C)c2)C1', '02.791', '2.791', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.38e-002\r\n-5.53e-002\r\n-5.88e-002\r\n-4.52e-002\r\n-6.17e-002\r\n-5.88e-002\r\n-2.19e-002\r\n-5.87e-002\r\n-5.87e-002', '0', '3.279', 'C15H18O2', '0230.131', '-3.8', '0230.302', '1.01', '2', '0', '2', '10', '06', '1', '17', '18', '5', '5', '002', '00', '18', '0', '2', '002', '0034.14', '249.06', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C\\C(C(C)C)=C1)CC(=O)C2', 'CC(C)c2cccc(C1CC(=O)CC(=O)C1)c2', 'CHD_36', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(230, '230', 'Not Available', 'Clc1ccc(cc1)c2cccc(c2)C3CC(=O)CC(=O)C3', '5-[3-(4-chlorophenyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwATewQtpS1G0ZlfXOb5gv3Uwf8$SeHWRXYzkmvpE1d8jzCqQawPiJx70jXXuYvfGNhGU929WaieXQl^4ryDo3XHkz0OKS0XJoaioT^DR9ylwSae$KE8NCGlGBMaANemiTmLewveuhRkLcCCzrEyxqEYqIFUmHz4aPED9pJurTbieeswNrFsHpz2QYcuGAhoNv5 k3Axqb$Om^PHGhT74Q3baww5qfw6Cyn1H9tvkk1xj92nA5Gu62v4Z9dNHHRXUN35vhn7j0uLRxsD3NeuePd5^BE7uvTl3d6zqbXFc$mf3hUBhfBrzGuWkRYWQi4skpSzFw5EnL0LQvIbcxVqz2aMn5AKTiwsZLYzazW2T1ai0t^Ujs5xnQRWqYOzWwm42kGj1G9GHqx4 ea31e5ZA$ouLHUfHEX0VXD', 'InChI=1S/C18H15ClO2/c19-16-6-4-12(5-7-16)13-2-1-3-14(8-13)15-9-17(20)11-18(21)10-15/h1-8,15H,9-11H2', 'AuxInfo=1/0/N:13,14,11,16,17,18,19,10,4,8,5,15,12,9,6,20,3,7,21,1,2/E:(4,5)(6,7)(9,10)(17,18)(20,21)/rA:21OOCCCCCCCCCCCCCCCCCCCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;d+15;d-16; s17;s18d-19;s20;/rC:11.2029,-4.3132,0;9.7739,-6.7882,0;11.2029,-5.1382,0;11.9173,-5.5507,0;10.4883,-5.5507,0;11.9173,-6.3757,0;10.4883,-6.3757,0;11.2029,-6.7882,0;12.6318,-6.7882,0;13.3463,-6.3757,0;1 2.6318,-7.6132,0;14.0607,-6.7882,0;13.3463,-8.0257,0;14.0607,-7.6132,0;14.7752,-6.3757,0;14.7752', 'VTBOFFAQVYSKGC-UHFFFAOYSA-N', '1010:WE573R42KN2ETTUEKQWUMQ81547U4T', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[c]3:[c]:[c]:[c](-[#17]):[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(c3ccc(Cl)cc3)c2)C1', '03.779', '3.779', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.35e-002\r\n-5.09e-002\r\n-5.87e-002\r\n-1.82e-002\r\n-6.14e-002\r\n-5.44e-002\r\n-1.83e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-4.3e-002\r\n-4.3e-002\r\n4.05e-002\r\n-8.44e-002', '0', '4.268', 'C18H15ClO2', '0298.076', '-5.651', '0298.764', '1.01', '2', '0', '2', '9', '12', '2', '21', '23', '5', '8', '002', '00', '15', '0', '3', '002', '0034.14', '284.91', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(\\C\\1=C\\C=C(Cl)/C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(c1ccc(Cl)cc1)c2)C3', 'CHD_37', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(231, '231', 'Not Available', 'Fc1ccc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)cc1', '5-[3-(4-fluorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwA3fwQW^MdiOVZUy23wxN3NtmQMaW4WBQ6SjPEMQzRtfl9jJVeOAJNVkyz7LMm5zxaHj47eN9a6cJSR^S6YZ2vpVXJhMH2jSzFqD5QE9uWn7qnjgRRRoAfA3fpSIEjDut0a2cQYG0M3IIXVtJqeXY25I86sHC9eOUcbYdRLHn7SZfRJvWOEGX7JQoJ5curO5N1 z1B5^5Yf4428ZfaQ0Y$34Puae2tdtF95DP2zXRSG0Zs^kAY37V3$62q3UhiXDZgzgc^eO5dc5uNz1O^4izd6dyLx^57Ov2pLviem9f8c2TeeK0ynwNzBL15zCW3njC7qsVMczehwMDViqwvLpiApatkgKzZFGvSxzREXNhJp2IG6zRGzOeCaD4hjS7t11WeRF5wNmxCN hmwsMZDbdtJOH^GSZnmDzbbu0DvA3Lle^kaaNT0AiA', 'InChI=1S/C18H15FO3/c19-14-4-6-17(7-5-14)22-18-3-1-2-12(10-18)13-8-15(20)11-16(21)9-13/h1-7,10,13H,8-9,11H2', 'AuxInfo=1/0/N:13,11,14,19,20,17,18,4,8,10,5,9,6,21,3,7,16,12,22,1,2,15/E:(4,5)(6,7)(8,9)(15,16)(20,21)/rA:22OOCCCCCCCCCCCCOCCCCCCF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;s16;d+16 ;d-17;s18;s19d-20;s21;/rC:11.2028,-4.3131,0;9.7738,-6.7881,0;11.2028,-5.1381,0;11.9172,-5.5506,0;10.4882,-5.5506,0;11.9172,-6.3756,0;10.4882,-6.3756,0;11.2028,-6.7881,0;12.6317,-6.7881,0;13.3461,-6.37 56,0;12.6317,-7.6131,0;14.0606,-6.7881,0;13.3461,-8.0256,0;14.0606,-7.6131,0;14.7208,-7.584,0;14', 'IDJYDJMMYCZMTQ-UHFFFAOYSA-N', '1010:85F5U4WFP2SV9ET2SZVNN261C66EWS', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[c]3:[c]:[c]:[c](-[#9]):[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(Oc3ccc(F)cc3)c2)C1', '03.362', '3.362', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3105\r\n8.22e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.38e-002\r\n-2.38e-002\r\n0.1229\r\n-0.207', '0', '3.851', 'C18H15FO3', '0298.101', '-4.622', '0298.308', '1.01', '3', '0', '2', '10', '12', '2', '22', '24', '5', '8', '003', '00', '15', '0', '3', '003', '0043.37', '286.43', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(O/C/1=C/C=C(F)\\C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(Oc1ccc(F)cc1)c2)C3', 'CHD_38', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(232, '232', 'Not Available', 'Clc1ccc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)cc1', '5-[3-(4-chlorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAXcwQyE74NPaJ7G3YEZLJGtT1rbmTdokyGKKMoJ28mvmEoYU85HRbe9FXVnlQUSOfd6xNIKQ$wI$R4ERGqpxUA4AmRCPlaCVJdIdD6hD1XjvI6CYBY04qKw3I5XaEKpIwpnuo5GSyBNDaCyFmd$00GhDXZmQIYj2s9eMcgMeQpoqoNcEnrvYYyyh8nGXWZdRN OLXpi^dkI0GCWi7BoG953C5O1V7zvvF^0Phi$UvhYB9Zrf^zFxjtP69vReWFbkHfGs$humNJuL^2hWV1XkDUd2GLpS8geD7Ov3ux7v0rs$gF7H3tn$85HUb^cvm$O8nXh1HIvXIXzZRhYGqEFj4ksICbhQhwJhUV5I4qZAeHilyY2wkczG2ZuMWOd26mlBsLYtgsAMue GTPvKiYszVWCNzpF^vcCFpuJ3d8amkeav82cv$MAxE^5PEfjNTkkRC', 'InChI=1S/C18H15ClO3/c19-14-4-6-17(7-5-14)22-18-3-1-2-12(10-18)13-8-15(20)11-16(21)9-13/h1-7,10,13H,8-9,11H2', 'AuxInfo=1/0/N:14,12,15,20,21,18,19,5,9,11,6,10,7,22,4,8,17,13,1,2,3,16/E:(4,5)(6,7)(8,9)(15,16)(20,21)/rA:22ClOOCCCCCCCCCCCCOCCCCCC/rB:;;d2;s4;s4;s5;d3s6;s7s8;s7;s10;d+10;d-11;s12;s13d-14;s13;s16;s17; d+17;d-18;s19;s1s20d+21;/rC:17.7027,-5.0594,0;11.2028,-4.3131,0;9.7738,-6.7881,0;11.2028,-5.1381,0;11.9172,-5.5506,0;10.4882,-5.5506,0;11.9172,-6.3756,0;10.4882,-6.3756,0;11.2028,-6.7881,0;12.6317,-6. 7881,0;13.3461,-6.3756,0;12.6317,-7.6131,0;14.0606,-6.7881,0;13.3461,-8.0256,0;14.0606,-7.6131,0', 'BOOREBUXFMWSKV-UHFFFAOYSA-N', '1010:KBXNDCMC7MN4KXRS52MHJY3WZJT1GW', '[#17]-[c](:[c]:[c]:[c]1-[#8]-[c](:[c]:[c]:[c]:[c]2-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]3=[#8])-[#6]3):[c]2):[c]:[c]1', 'Clc(ccc1Oc(cccc2C(CC(=O)CC3=O)C3)c2)cc1', '03.821', '3.821', '0', '0', 'TRUE', '-8.44e-002\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3105\r\n8.2e-002\r\n-2.98e-002\r\n-2.98e-002\r\n-4.1e-002\r\n-4.1e-002\r\n4.07e-002', '0', '4.31', 'C18H15ClO3', '0314.071', '-5.159', '0314.763', '1.01', '3', '0', '2', '10', '12', '2', '22', '24', '5', '8', '003', '00', '15', '0', '3', '003', '0043.37', '296.2', '', '', '', '', '', '', '', '', '', '', '', 'Cl/C/3=C/C=C(O/C\\2=C\\C(C1CC(=O)CC(=O)C1)=C/C=C2)\\C=C3', 'O=C3CC(=O)CC(c2cccc(Oc1ccc(Cl)cc1)c2)C3', 'CHD_39', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(233, '233', 'Not Available', 'Clc1cccc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)c1', '5-[3-(3-chlorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAXcwQyE74NPaJJgzYEaJ4MCdD676cUowLblbHUiXFrI3RUfJY71VNzlW$nGpAWE21xus2hfd$fQRjwBLXDjoifE7AE7ArQjhaBkdHqcJr88hhPW9kPgOiVRkRUyHC48DnjFBMQeovvStU87juAv4zNYoJIAxjPXWyzo4A4d^g7nw6o^2YiGy661KhMbMB$2He t4IA3$8HQGz79NxtYyVGwfH2asv9vPFsHtXuNLS99GN7F$e3ziHLd3V8AOH1X6sr$Bvnu^4cr^e7vbAIdp$Z61fvKgjHR^eHiPQP7bM603rXdy0obIIqweZwhhSQCj1gFEmDVAsLrSFqdmKQiWDXh3iAwYjEayWJwEezJyojsuQGIF1sQ86iNRzCAitcNdYMhp8Yj7$B aGLux$H5a9sCc27P60H1T9g6618Z', 'InChI=1S/C18H15ClO3/c19-14-4-2-6-18(10-14)22-17-5-1-3-12(9-17)13-7-15(20)11-16(21)8-13/h1-6,9-10,13H,7-8,11H2', 'AuxInfo=1/0/N:13,20,11,21,14,18,4,8,10,17,5,9,6,19,3,7,12,16,22,1,2,15/E:(7,8)(15,16)(20,21)/rA:22OOCCCCCCCCCCCCOCCCCCCCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;s16;d+16;d-17;s18 ;s19d-20;s19;/rC:9.689,-5.3808,0;9.689,-8.2387,0;10.1015,-6.0953,0;10.9265,-6.0953,0;9.689,-6.8097,0;11.339,-6.8097,0;10.1015,-7.5242,0;10.9265,-7.5242,0;12.164,-6.8097,0;12.5765,-6.0953,0;12.5765,-7. 5242,0;13.4015,-6.0953,0;13.4015,-7.5242,0;13.814,-6.8097,0;13.814,-5.3808,0;14.639,-5.3808,0;15', 'AUKBWFNQYRSCDQ-UHFFFAOYSA-N', '1010:RPDZCUG7BB9VPSJ7E2NN673WNXZ7CX', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[c]3:[c]:[c]:[c]:[c](-[#17]):[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(Oc3cccc(Cl)c3)c2)C1', '03.821', '3.821', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3104\r\n8.34e-002\r\n-1.26e-002\r\n-3.12e-002\r\n4.31e-002\r\n-5.82e-002\r\n-4.34e-002\r\n-8.43e-002', '0', '4.31', 'C18H15ClO3', '0314.071', '-5.156', '0314.763', '1.01', '3', '0', '2', '10', '12', '2', '22', '24', '5', '8', '003', '00', '15', '0', '3', '003', '0043.37', '296.2', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(O/C/1=C/C=C\\C(Cl)=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(Oc1cccc(Cl)c1)c2)C3', 'CHD_40', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(234, '234', 'Not Available', 'Fc1ccc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)cc1', '5-[3-(4-fluorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAdfwQI0^uBhf1XN6xC8fAxjkyVym2vfe8RHaDGWwh8O3eKhHBwyap^BOdBWqySSQcCRUKmwUScdUcjNZsrB0Y8Lmmpb4HXoCkuS^RZ1wnJw5kt$qa8NCGNHhCGGaRH0PmQZyhEuHy4VSywX$gg6yP3AOmkZCO5cpYOrYRjzNdFdRLum7jgKmryfL6Z0IG^pV4 Y1pHv5eOkNxn1NQtf0ZBjfLmasu93PEtjiL3jAMvuRzcw279bUTRmo$75Gyz09bpzVnQtbsjws$zRWNe3uCvoc6nxLfI96DH5c1PP77Sc52eTmi$wt4wiBdvLGuVoUUW$NhZEKVFLJIL4Ii2XtYlImLjxgk6FDzqNjJrOdtZT3B79y6BX8UsQpItiVMRQsqNFbmyZPLh 2RLhWeJX7sWnPBwL5f6r53qPcD$Dc0M', 'InChI=1S/C18H15FO3/c19-14-4-6-17(7-5-14)22-18-3-1-2-12(10-18)13-8-15(20)11-16(21)9-13/h1-7,10,13H,8-9,11H2', 'AuxInfo=1/0/N:13,11,14,19,20,17,18,4,8,10,5,9,6,21,3,7,16,12,22,1,2,15/E:(4,5)(6,7)(8,9)(15,16)(20,21)/rA:22OOCCCCCCCCCCCCOCCCCCCF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;s16;d+16 ;d-17;s18;s19d-20;s21;/rC:9.689,-5.3808,0;9.689,-8.2387,0;10.1015,-6.0953,0;10.9265,-6.0953,0;9.689,-6.8097,0;11.339,-6.8097,0;10.1015,-7.5242,0;10.9265,-7.5242,0;12.164,-6.8097,0;12.5765,-6.0953,0;12 .5765,-7.5242,0;13.4015,-6.0953,0;13.4015,-7.5242,0;13.814,-6.8097,0;13.814,-5.3808,0;14.639,-5.', 'IDJYDJMMYCZMTQ-UHFFFAOYSA-N', '1010:85F5U4WFP2SV9ET2SZVNN261C66EWS', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[c]3:[c]:[c]:[c](-[#9]):[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(Oc3ccc(F)cc3)c2)C1', '03.362', '3.362', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3105\r\n8.22e-002\r\n-2.84e-002\r\n-2.84e-002\r\n-2.38e-002\r\n-2.38e-002\r\n0.1229\r\n-0.207', '0', '3.851', 'C18H15FO3', '0298.101', '-4.622', '0298.308', '1.01', '3', '0', '2', '10', '12', '2', '22', '24', '5', '8', '003', '00', '15', '0', '3', '003', '0043.37', '286.43', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(O/C/1=C/C=C(F)\\C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(Oc1ccc(F)cc1)c2)C3', 'CHD_41', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(235, '235', 'Not Available', 'Clc1ccc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)cc1', '5-[3-(4-chlorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAdfwQI0^uBhf1Fw6xm$yptU0OvM3u6G4RHHnQNOydMHxl3K6kO8CwLW57^Bz7X20Gzp6yCf$Z8jqOxHW6IKHcESFu94PWd^ny5eAmbBkiKgcD6jL5aGTiEb0DICRu^wpxKCLeh8umNTBpPk6qUM^^YpG2BiQ82zHk6BDBPi3Ok51tGef2KKgvVzaM2D7InfNi ZD$C85f8D4x2QvTiHG8lOs^AfZn3Q7$Ce7$el2jX0t3I7N^bidQIr67Veo3m5fN0iMh00t3qft3bEpxD7Stj1vtejgFBR8e7zHLwVNS1v3bG^sUxEpeZIwfFGIsUNQYodQItcJgwQtCgBaVq4trUKgY1LRItWCM2ukGs4M8hszUcZCGW6JUjotQQFbaggZDHTHGzYLHm 4sfgWiqf4s$k8Y8zmzZvmT3$m^0Px1M', 'InChI=1S/C18H15ClO3/c19-14-4-6-17(7-5-14)22-18-3-1-2-12(10-18)13-8-15(20)11-16(21)9-13/h1-7,10,13H,8-9,11H2', 'AuxInfo=1/0/N:13,11,14,19,20,17,18,4,8,10,5,9,6,21,3,7,16,12,22,1,2,15/E:(4,5)(6,7)(8,9)(15,16)(20,21)/rA:22OOCCCCCCCCCCCCOCCCCCCCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;s16;d+1 6;d-17;s18;s19d-20;s21;/rC:9.689,-5.3808,0;9.689,-8.2387,0;10.1015,-6.0953,0;10.9265,-6.0953,0;9.689,-6.8097,0;11.339,-6.8097,0;10.1015,-7.5242,0;10.9265,-7.5242,0;12.164,-6.8097,0;12.5765,-6.0953,0;1 2.5765,-7.5242,0;13.4015,-6.0953,0;13.4015,-7.5242,0;13.814,-6.8097,0;13.814,-5.3808,0;14.639,-5', 'BOOREBUXFMWSKV-UHFFFAOYSA-N', '1010:KBXNDCMC7MN4KXRS52MHJY3WZJT1GW', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[c]3:[c]:[c]:[c](-[#17]):[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(Oc3ccc(Cl)cc3)c2)C1', '03.821', '3.821', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3105\r\n8.2e-002\r\n-2.98e-002\r\n-2.98e-002\r\n-4.1e-002\r\n-4.1e-002\r\n4.07e-002\r\n-8.44e-002', '0', '4.31', 'C18H15ClO3', '0314.071', '-5.159', '0314.763', '1.01', '3', '0', '2', '10', '12', '2', '22', '24', '5', '8', '003', '00', '15', '0', '3', '003', '0043.37', '296.2', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(O/C/1=C/C=C(Cl)\\C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(Oc1ccc(Cl)cc1)c2)C3', 'CHD_42', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(236, '236', 'Not Available', 'Clc1cc(Cl)cc(Oc2cccc(c2)C3CC(=O)CC(=O)C3)c1', '5-[3-(3,5-dichlorophenoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAsewQH2l0dMnjBWPGysb1W85NBHJB^ImRavGoJbaDAaTi7oQ6Alp^J1d^AVIb9CtRdN7xMDk6BiBCvBz8jW$jJJdlbeHL5EYjgv1VthYW3cgj1efWwbWZ0QkLBVoF3vfLS2pHE$n54VSyznXgR50HVYMnZmgjucG23lJIwdfHEmZz74afSC6N8UbxOeuRf1Kc T$CRbfP75Qg5OfATxTfFdwLwu23tQn$wudTP5^0LNyByvw32wFGPq^$Kj8sKflb$CHh2Nyh6X752QY8odRuj82OuGLKgkP3$5lCF8ZY646VSusy7z1qR7PFRAs5neOiUF9ehVYGKVhZsbGDaQuIiWQmImJNX4kewMD2uHRVRFmliFb2K2xmp3xadw$BXYOOdE$lBxElF VY2ysmtQ2AHmWB5mpd^xULrBcxYSJour5HP4m6NNC4fNVbmHcC', 'InChI=1S/C18H14Cl2O3/c19-13-7-14(20)9-18(8-13)23-17-3-1-2-11(6-17)12-4-15(21)10-16(22)5-12/h1-3,6-9,12H,4-5,10H2', 'AuxInfo=1/0/N:13,11,14,4,8,10,21,17,18,5,9,6,19,20,3,7,12,16,22,23,1,2,15/E:(4,5)(8,9)(13,14)(15,16)(19,20)(21,22)/rA:23OOCCCCCCCCCCCCOCCCCCCClCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s 12;s15;s16;d+16;d-17;s18;s19d-20;s19;s20;/rC:9.689,-5.3808,0;9.689,-8.2387,0;10.1015,-6.0953,0;10.9265,-6.0953,0;9.689,-6.8097,0;11.339,-6.8097,0;10.1015,-7.5242,0;10.9265,-7.5242,0;12.164,-6.8097,0;1 2.5765,-6.0953,0;12.5765,-7.5242,0;13.4015,-6.0953,0;13.4015,-7.5242,0;13.814,-6.8097,0;13.814,-', 'UQQGFACXUXLRNC-UHFFFAOYSA-N', '1010:FA11771RKE696QA9CZDFJAQ77UQVSX', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[c]3:[c]:[c](-[#17]):[c]:[c](-[#17]):[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(Oc3cc(Cl)cc(Cl)c3)c2)C1', '04.485', '4.486', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-2.78e-002\r\n-5.86e-002\r\n8.22e-002\r\n-5.94e-002\r\n-3.13e-002\r\n-0.3104\r\n8.49e-002\r\n-1.25e-002\r\n-1.25e-002\r\n4.46e-002\r\n4.46e-002\r\n-2.47e-002\r\n-8.42e-002\r\n-8.42e-002', '0', '4.974', 'C18H14Cl2O3', '0348.032', '-5.926', '0349.208', '1.01', '3', '0', '2', '11', '12', '2', '23', '25', '6', '8', '003', '00', '14', '0', '3', '003', '0043.37', '316.94', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(O/C/1=C/C(Cl)=C\\C(Cl)=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(Oc1cc(Cl)cc(Cl)c1)c2)C3', 'CHD_43', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(237, '237', 'Not Available', 'CC(C)c1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-isopropylphenyl)cyclohexane-1,3-dione', 'CYAAFQwADfwQWmd0Iu^EPD0KA^hANO^U2LTLfFt09Od0AbO6dLKxcT^9uK8dhcOZDS1EQniAz^9yUJfB9^G$1L0H6LRF0pD3baUbB8gl^MuVgxS16Ii6vYoLlS0QhhtH4nFszDaIBtoxBjCWiT7Bkkn6PI0zNNqHF9OtfBB5xAZe3aNpbgBVy^uOYuI3XsvEyMhHHxcj Y3Em$q79ht327PEtbf$W3sE3nZ73DUnC63QffDPOuvtzNE9a1nX7L5t9P8Pv6x8U$gdJwCIRHSNhLEGXOVBTctSgpCsggdtx1DnWYbRttUhlG6aNBiXiCgwcK0yZpfMXihoHY1nznMicz^MgX$bUB8^ogWoxNB', 'InChI=1S/C15H18O2/c1-10(2)11-3-5-12(6-4-11)13-7-14(16)9-15(17)8-13/h3-6,10,13H,7-9H2,1-2H3', 'AuxInfo=1/0/N:2,3,15,16,13,14,7,11,8,1,17,12,9,6,10,4,5/E:(1,2)(3,4)(5,6)(7,8)(14,15)(16,17)/rA:17CCCOOCCCCCCCCCCCC/rB:s1;s1;;;d4;s6;s6;s7;d5s8;s9s10;s9;s12;d+12;d-13;s14;s1s15d+16;/rC:14.639,-6.4525, 0;15.0515,-5.738,0;15.0515,-7.167,0;9.689,-5.0236,0;9.689,-7.8815,0;10.1015,-5.738,0;10.9265,-5.738,0;9.689,-6.4525,0;11.339,-6.4525,0;10.1015,-7.167,0;10.9265,-7.167,0;12.164,-6.4525,0;12.5765,-5.738 ,0;12.5765,-7.167,0;13.4015,-5.738,0;13.4015,-7.167,0;13.814,-6.4525,0;', 'GZEOADDHUHXTCJ-UHFFFAOYSA-N', '1010:DMYHWDRP164AGFESGHN7S91TJFMRM8', '[#6](-[c](:[c]:[c]:[c]1-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]2=[#8])-[#6]2):[c]:[c]1)(-[#6])-[#6]', 'C(c(ccc1C(CC(=O)CC2=O)C2)cc1)(C)C', '02.791', '2.791', '0', '0', 'TRUE', '-2.19e-002\r\n-5.87e-002\r\n-5.87e-002\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-4.55e-002', '0', '3.279', 'C15H18O2', '0230.131', '-3.813', '0230.302', '1.01', '2', '0', '2', '10', '06', '1', '17', '18', '5', '5', '002', '00', '18', '0', '2', '002', '0034.14', '249.06', '', '', '', '', '', '', '', '', '', '', '', 'CC(C)c2ccc(C1CC(=O)CC(=O)C1)cc2', 'C(C)(C)/C/2=C/C=C(C1CC(=O)CC(=O)C1)\\C=C2', 'CHD_44', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(238, '238', 'Not Available', 'O=C1CC(CC(=O)C1)c2ccc(OCCCc3ccccc3)cc2', '5-[4-(3-phenylpropoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAPewQlKJJaxPA78ycRI22ONlSn8FW99ZElDI0nl8kl$rlTuOXcbp78Gz8hVLqjd^jS4YzM4FuW$8M05lDFUZzl8Ic1^E2dy1RClHShTvj5sHyIYVKY5TAPXRKUlyAujjW1ahDElEKXcB^5IEvJMMf^ZhsWNzngffJLXAUUffHsT4cXDQ7Uoj$9zfFG5kePbJu zU2ob$GkkS7Yyo^BZ6hBbH3t6XTfutXo9YH30S$gD^p35DBY6t7nNaxBp9qyD95JEvjZ63VOnmn^Hx5VYf$UXS84dagvfq3cn4828uO6aU^2v01t$HNIgYAHESlMLXY7$UhZIV1mwvpNsA$qKjAugqY1s4C2WEFGsFe1zGqVTGTWO5CzW1J61ooORz9Wu3imW0MaLSyd vXBYUWxZGnaRFxMnuQG6mlEmCo1JOVdav8MAxk^xXkvrdfQ$oD', 'InChI=1S/C21H22O3/c22-19-13-18(14-20(23)15-19)17-8-10-21(11-9-17)24-12-4-7-16-5-2-1-3-6-16/h1-3,5-6,8-11,18H,4,7,12-15H2', 'AuxInfo=1/0/N:24,22,23,17,20,21,18,10,11,12,13,16,4,8,5,19,9,6,3,7,14,1,2,15/E:(2,3)(5,6)(8,9)(10,11)(13,14)(19,20)(22,23)/rA:24OOCCCCCCCCCCCCOCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s1 2d-13;s14;s15;s16;s17;s18;s19;d+19;d-20;s21;s22d-23;/rC:10.0382,-5.3808,0;10.0382,-8.2387,0;10.4507,-6.0952,0;11.2757,-6.0952,0;10.0382,-6.8097,0;11.6882,-6.8097,0;10.4507,-7.5242,0;11.2757,-7.5242,0; 12.5132,-6.8097,0;12.9257,-6.0952,0;12.9257,-7.5242,0;13.7507,-6.0952,0;13.7507,-7.5242,0;14.163', 'XEIQVVGQGKOCAB-UHFFFAOYSA-N', '1010:DU8SENX71ZJRX2N93QCJKQHWW86JSW', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#8]-[#6]-[#6]-[#6]-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(OCCCc3ccccc3)cc2)C1', '03.941', '3.941', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.39e-002\r\n-5.62e-002\r\n-5.62e-002\r\n-3.16e-002\r\n-3.16e-002\r\n7.49e-002\r\n-0.3461\r\n5.35e-002\r\n-2.51e-002\r\n-2.57e-002\r\n-4.8e-002\r\n-5.91e-002\r\n-5.91e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e', '0', '4.43', 'C21H22O3', '0322.157', '-5.745', '0322.398', '1.01', '3', '0', '2', '12', '12', '2', '24', '26', '4', '8', '003', '00', '22', '0', '3', '006', '0043.37', '330.18', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C(OCCC/C/1=C/C=C\\C=C1)\\C=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2ccc(OCCCc1ccccc1)cc2)C3', 'CHD_45', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(239, '239', 'Not Available', 'Fc1ccc(cc1)c2cc(cc(c2)c3ccc(F)cc3)C4CC(=O)CC(=O)C4', '5-[3,5-bis(4-fluorophenyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAzfwQQHnTGqZHAa^h8peLWaCQTZqUBa5oorxQhTjmubh7SGBcxPMbDjzfG6zdzTTpI^Mg9p2XpUUup2PUL6uxa^UElUOO4yKUbNC96a6rqHf23RHcjFRtS^Ah5fqWZ5EgFmo8UM1gCdRnqR$qrTIec$D5xxeVKOfl10OGIt$zVx5246o2O2Na3oh$S8oreI$x hFJWThL7qH2zFr^1L7kP$MeeuIHj1v5udseEbsMXLv07qJ$2zN$HCW2YlGc2hhY31m7xs$KPeFU4^LHQ9eTW$ybEbvsbmfrWHUeByH95wKso6ftn1MXHiD47H^pb7flFp5IEg$YvLfNnzX$3m6hcXz$NcdnP57omyHmEF01Eic65FVDb2wGuGuSYWRTKXE7Bi0MlLaDT 7EDYJYd0KQZWr4EfQiz6ZO1PoM74zChTmhiiLiUwjVZ2Wc$e0RQTM14qhVsFwuaMMblYJkdiQX12tKt02DZV^wXjvozpv$EA', 'InChI=1S/C24H18F2O2/c25-21-5-1-15(2-6-21)17-9-18(16-3-7-22(26)8-4-16)11-19(10-17)20-12-23(27)14-24(28)13-20/h1-11,20H,12-14H2', 'AuxInfo=1/0/N:2,3,22,23,4,5,24,25,20,16,17,10,14,11,1,21,18,19,15,12,6,26,9,13,27,28,7,8/E:(1,2,3,4)(5,6,7,8)(10,11)(12,13)(15,16)(17,18)(21,22)(23,24)(25,26)(27,28)/rA:28CCCCCCOOCCCCCCCCCCCCCCCCCCFF/ rB:s1;d-1;d-2;s3;s4d-5;;;d7;s9;s9;s10;d8s11;s12s13;s12;s15;d+15;s1d+16;s17;s18d-19;s19;s21;d+21;d-22;s23;s24d-25;s6;s26;/rC:16.5271,-6.2967,0;16.5271,-5.4717,0;17.2415,-6.7092,0;17.2415,-5.0592,0;17.9 561,-6.2967,0;17.9561,-5.4717,0;12.9547,-4.2341,0;11.5257,-6.7092,0;12.9547,-5.0592,0;13.6692,-5', 'WJWQLPNTUGOMQD-UHFFFAOYSA-N', '1010:52JA89XFKAVM3ASWWYPVDKEDGWSYMK', '[c]1(-[c](:[c]:[c](-[c]2:[c]:[c]:[c](-[#9]):[c]:[c]2):[c]:[c]3-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]4=[#8])-[#6]4):[c]3):[c]:[c]:[c](-[#9]):[c]:[c]1', 'c1(c(cc(c2ccc(F)cc2)cc3C(CC(=O)CC4=O)C4)c3)ccc(F)cc1', '05.044', '5.044', '0', '0', 'TRUE', '-1.82e-002\r\n-5.15e-002\r\n-5.15e-002\r\n-2.58e-002\r\n-2.58e-002\r\n0.1227\r\n-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.28e-002\r\n-5.09e-002\r\n-5.09e-002\r\n-1.75e-002\r\n-1.75e-002\r\n-4.65e-002\r\n-1.82e-002\r\n-5.15e-002\r\n-5.15e-002\r\n-2', '0', '5.533', 'C24H18F2O2', '0376.127', '-7.494', '0376.395', '2.25', '2', '0', '2', '11', '18', '3', '28', '31', '7', '11', '002', '00', '18', '0', '4', '003', '0034.14', '359.17', '', '', '', '', '', '', '', '', '', '', '', 'C\\4(/C/3=C/C(C1CC(=O)CC(=O)C1)=C\\C(\\C\\2=C\\C=C(F)/C=C2)=C3)=C\\C=C(F)/C=C4', 'O=C4CC(=O)CC(c3cc(c1ccc(F)cc1)cc(c2ccc(F)cc2)c3)C4', 'CHD_46', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(240, '240', 'Not Available', 'O=C1CC(CC(=O)C1)c2ccc(OCCOc3ccccc3)cc2', '5-[4-(2-phenoxyethoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAbcwQ2GFymcFcLbaVGQCaycnQLJ9Oyuk7$uIZRabg4VkOErKs9g6LkLLI5sO$tpfQ7p$GKKffNC5bHYIdu2ZbUqit^FMV6TQv4wrm9QVRYh4CSV5rhcngP0tIwANbe06OEZIDIciJ4US15SrwjhB5zLJlt7NKPri5NduoNHr7xRSWceeKuHiVdRQ5PTtCozbt erC59wVpz^7xbku^$lNL1Fqz5ro9g8iKj9dbIP^kU3tPjC6NV6b^bs$1PnzoHw^2oZq6oyr$ow19Slfnz3vf2MOvHyyFI9kLfV87l^VMSQa6P6h0dPQkucD1h39LrqeXFX52tC3kcWM8mjSRxIGLriwqkJCkoxlEtB2kYY5lzGxccW8ImnShZPLHJZMbRPVrZbtK1JOt 41qNr0UnQsojZdn0xcRBySU0TiQumVSzIm9ssGkOAeGtDf5pr9KemXA^b3tc', 'InChI=1S/C20H20O4/c21-17-12-16(13-18(22)14-17)15-6-8-20(9-7-15)24-11-10-23-19-4-2-1-3-5-19/h1-9,16H,10-14H2', 'AuxInfo=1/0/N:24,22,23,20,21,10,11,12,13,17,16,4,8,5,9,6,3,7,19,14,1,2,18,15/E:(2,3)(4,5)(6,7)(8,9)(12,13)(17,18)(21,22)/rA:24OOCCCCCCCCCCCCOCCOCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d -13;s14;s15;s16;s17;s18;s19;d+19;d-20;s21;s22d-23;/rC:13.3115,-3.7903,0;11.8825,-6.2653,0;13.3115,-4.6153,0;14.0259,-5.0278,0;12.597,-5.0278,0;14.0259,-5.8528,0;12.597,-5.8528,0;13.3115,-6.2653,0;14.7 404,-6.2653,0;15.4549,-5.8528,0;14.7404,-7.0903,0;16.1694,-6.2653,0;15.4549,-7.5028,0;16.1694,-7', 'CEPWZONXXFQAEI-UHFFFAOYSA-N', '1010:NMSPBFNC7ZB9ND4ESX7DY3122XFSNV', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#8]-[#6]-[#6]-[#8]-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(OCCOc3ccccc3)cc2)C1', '03.212', '3.212', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.39e-002\r\n-5.62e-002\r\n-5.62e-002\r\n-3.16e-002\r\n-3.16e-002\r\n7.5e-002\r\n-0.3437\r\n7.72e-002\r\n7.72e-002\r\n-0.3437\r\n7.5e-002\r\n-3.18e-002\r\n-3.18e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002', '0', '3.701', 'C20H20O4', '0324.136', '-4.73', '0324.37', '1.01', '4', '0', '2', '12', '12', '2', '24', '26', '4', '8', '004', '00', '20', '0', '3', '006', '0052.6', '326.08', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C(OCCO/C/1=C/C=C\\C=C1)\\C=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2ccc(OCCOc1ccccc1)cc2)C3', 'CHD_47', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(241, '241', 'Not Available', 'CCCCOc1cccc(C2CC(=O)CC(=O)C2)c1OCCCC', '5-(2,3-dibutoxyphenyl)cyclohexane-1,3-dione', 'CYAAFQwAidwQ1xqYzls0K7o6U$S6bDplU8lZ6hV19Ho9$jy1ulukT3XaZCLav1XY1MKtixhrNRXsmoORmReWPUP5ktf5UxGPPBkgwzyDuZKfX3jT43OIEQU4YgtvD89oeTbWe2KBXKJHoSDrjEIrn9BjwEaHXEUx3iFM9vmq01CJO36zemQoH1pBvG8KTjV662hwQeh6 w7emVb92dz1eu9093LOjd6RdnYHZFp^t3vMdUjOW^RaxMZU532Tcn3m$r$rVugz9tTY^esf7ud$bru07528oWkLzfv1ojr6ldPbYq7imdMOd660c7TyL6uy7tH8pGnw$9bHZqiM1$SAeTGSBZi4EKDEnxWAZA6MAZD0RkSQbLLTcYKDik7MGmwGBbk5JdYKyWnZavpkm pv1gm$fTWtp0IpAlNVNQB0Eg0hbAXWBoiTrDt2hMO7JeLD8K^F62^PN1rItAfuN', 'InChI=1S/C20H28O4/c1-3-5-10-23-19-9-7-8-18(20(19)24-11-6-4-2)15-12-16(21)14-17(22)13-15/h7-9,15H,3-6,10-14H2,1-2H3', 'AuxInfo=1/0/N:24,20,23,19,22,18,13,11,14,21,17,4,8,5,6,3,7,9,12,10,1,2,16,15/E:(12,13)(16,17)(21,22)/rA:24OOCCCCCCCCCCCCOOCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s12;s15;s17; s18;s19;s16;s21;s22;s23;/rC:13.3506,-4.159,0;11.9217,-6.634,0;13.3506,-4.984,0;14.0651,-5.3965,0;12.6361,-5.3965,0;14.0651,-6.2215,0;12.6361,-6.2215,0;13.3506,-6.634,0;14.7795,-6.634,0;15.494,-6.2215, 0;14.7795,-7.459,0;16.2085,-6.634,0;15.494,-7.8715,0;16.2085,-7.459,0;15.494,-5.3965,0;16.923,-6', 'IFHQVTWQZNMGSN-UHFFFAOYSA-N', '1010:T8KJDEBC42DD4EHE5P7TH49T9B9CZT', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c]2-[#8]-[#6]-[#6]-[#6]-[#6])-[#6]1', 'O=C1CC(=O)CC(c2cccc(OCCCC)c2OCCCC)C1', '04.221', '4.221', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n3.e-004\r\n0.1403\r\n1.39e-002\r\n-1.1e-002\r\n0.1086\r\n-5.6e-002\r\n0.1054\r\n-5.92e-002\r\n-2.91e-002\r\n-0.3431\r\n-0.3434\r\n5.34e-002\r\n-2.94e-002\r\n-5.4e-002\r\n-6.53e-002\r\n5.34e-002\r\n-2.94e-002\r\n-5.4e-002\r\n-6.53e-002', '0', '4.71', 'C20H28O4', '0332.199', '-5.082', '0332.434', '1.01', '4', '0', '2', '17', '06', '1', '24', '25', '5', '5', '004', '00', '28', '0', '2', '009', '0052.6', '364.79', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C/C=C\\C(OCCCC)=C1\\OCCCC)CC(=O)C2', 'CCCCOc2cccc(C1CC(=O)CC(=O)C1)c2OCCCC', 'CHD_48', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(242, '242', 'Not Available', 'CCCCOc1ccc(C2CC(=O)CC(=O)C2)c(OCCCC)c1', '5-(2,4-dibutoxyphenyl)cyclohexane-1,3-dione', 'CYAAFQwAWewQEZs2vFhxU7lowPdzz^fw2SM54YRNgnUEuFdbihN9OW1evCwb2d9Lg^mHS^dODyV0$A1$AFWdamP^jKGFOlKzOv^oFMpv8Yvw4oD7tX3YIg4RxELfD8uRkSTWTCMOkY$QgK8dc2gZcibYfKUOCYObMPuR9flGvpBPn^7W5cROzFIp1gbIlEpjX5jyeLY^ v^LIV38tezydcM$O2dkOIN^no^h3Fp^rbwC9akifd^k^WLOi^a16Tqbv^J$32^PnD69223iyFY8bX$T3Mp16H4LtUMWlcPQoz6iY9T0dgJ3W3nkL9bcxdfSOAT30PQ3T5zOO0Nf6Qg2VhUhvRc0JUI3creSKwVEiIwjFD6myn0CIUa0EhjZxFyBnRkczkd^c0640aadm a8mSNleU9qyIpSUazTKiYzdajIETo1hLDUKxMhbjeOyRKMvp2JP81^h6n9L9cvte', 'InChI=1S/C20H28O4/c1-3-5-9-23-18-7-8-19(20(14-18)24-10-6-4-2)15-11-16(21)13-17(22)12-15/h7-8,14-15H,3-6,9-13H2,1-2H3', 'AuxInfo=1/0/N:24,19,23,18,22,17,13,11,21,16,4,8,5,12,6,3,7,14,9,10,1,2,20,15/E:(11,12)(16,17)(21,22)/rA:24OOCCCCCCCCCCCCOCCCCOCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s10;s15;s16;s17; s18;s14;s20;s21;s22;s23;/rC:13.0124,-4.2289,0;11.5834,-6.704,0;13.0124,-5.0539,0;13.7268,-5.4664,0;12.2979,-5.4664,0;13.7268,-6.2915,0;12.2979,-6.2915,0;13.0124,-6.704,0;14.4413,-6.704,0;15.1558,-6.29 15,0;14.4413,-7.529,0;15.8702,-6.704,0;15.1558,-7.9415,0;15.8702,-7.529,0;15.1558,-5.4664,0;15.8', 'NMZWIKDNDMYGAL-UHFFFAOYSA-N', '1010:3AY1XT37NUFKYRZHHYVJPWSZSDG732', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#8]-[#6]-[#6]-[#6]-[#6]):[c]:[c]2-[#8]-[#6]-[#6]-[#6]-[#6])-[#6]1', 'O=C1CC(=O)CC(c2ccc(OCCCC)cc2OCCCC)C1', '04.221', '4.221', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n2.e-004\r\n0.1403\r\n1.39e-002\r\n-1.35e-002\r\n8.1e-002\r\n-5.36e-002\r\n-1.1e-003\r\n-3.14e-002\r\n7.75e-002\r\n-0.3458\r\n5.32e-002\r\n-2.94e-002\r\n-5.4e-002\r\n-6.53e-002\r\n-0.3461\r\n5.32e-002\r\n-2.94e-002\r\n-5.4e-002\r\n-6.53e-002', '0', '4.71', 'C20H28O4', '0332.199', '-5.171', '0332.434', '1.01', '4', '0', '2', '17', '06', '1', '24', '25', '5', '5', '004', '00', '28', '0', '2', '009', '0052.6', '364.82', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C/C=C(OCCCC)\\C=C1\\OCCCC)CC(=O)C2', 'CCCCOc2ccc(C1CC(=O)CC(=O)C1)c(OCCCC)c2', 'CHD_49', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(243, '243', 'Not Available', 'CC(C)(C)OC(=O)N1CCN(CC1)c2ccc(cc2)C3CC(=O)CC(=O)C3', 'tert-butyl 4-[4-(3,5-dioxocyclohexyl)phenyl]piperazine-1-carboxylate', 'CYAAFQwAAewQa33wQylVQxxsMlphYZfg8zkDVHfZoHIztLfr9AXK61LufV$5W3JUps$kGo5KXINhTRMMz2S6aKJmeqtQzY2bglZq880Y3SoMbam2vMVszzmNiUC1t2g5$qftE6RcPsPMkAZACKsZcatuyRPziCR4jU496CB4L2MXDXGYcZbPKKGAtcxEn7x2TPQAzflP HzLC2L^KOWGu3k3svQAXOqg7YkNwWvu94aIP^8YvvnUe6aJ86LJDevWdVX3^yFe9lHr3z5pkyvlkLTiElcsr^9Qv1yRx6Agr82fobq7s^SUOP79K3v6Qi5vhSlu3TNo3qTwNetGcsLk5yton0YYyBcc9KM^uKvECc4Qec4$uaql6Uv0$Pc1mztnTti4kOLGo5sogMT1i VgnKORAW0WpwfQeSMbRQmJSu5s4BM^1CZvQGRqNbRnq1a^PprAn6XYjUcmdI15XhiZjab0xE2d9B4eIdi1MFdrSPUpX4YPsu', 'InChI=1S/C21H28N2O4/c1-21(2,3)27-20(26)23-10-8-22(9-11-23)17-6-4-15(5-7-17)16-12-18(24)14-19(25)13-16/h4-7,16H,8-14H2,1-3H3', 'AuxInfo=1/0/N:25,26,27,10,11,12,13,16,17,18,19,4,8,5,9,6,14,3,7,21,24,15,20,1,2,22,23/E:(1,2,3)(4,5)(6,7)(8,9)(10,11)(12,13)(18,19)(24,25)/rA:27OOCCCCCCCCCCCCNCCCCNCOOCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6 ;s9;d+9;d-10;s11;s12d-13;s14;s15;s15;s16;s17;s18s19;s20;d21;s21;s23;s24;s24;s24;/rC:13.962,-4.2695,0;12.533,-6.7445,0;13.962,-5.0945,0;14.6765,-5.507,0;13.2476,-5.507,0;14.6765,-6.332,0;13.2476,-6.332 ,0;13.962,-6.7445,0;15.391,-6.7445,0;16.1054,-6.332,0;15.391,-7.5695,0;16.82,-6.7445,0;16.1054,-', 'LMOBTCPMDWVRMS-UHFFFAOYSA-N', '1010:SDC8GK4V98PYJVP43VGV5AWXGZUDPG', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#7]3-[#6]-[#6]-[#7](-[#6](-[#8]-[#6](-[#6])(-[#6])-[#6])=[#8])-[#6]-[#6]3):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(N3CCN(C(OC(C)(C)C)=O)CC3)cc2)C1', '02.55', '2.55', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.4e-002\r\n-5.72e-002\r\n-5.72e-002\r\n-4.38e-002\r\n-4.38e-002\r\n1.73e-002\r\n-0.2719\r\n1.9e-002\r\n1.9e-002\r\n2.95e-002\r\n2.95e-002\r\n-0.2751\r\n0.3537\r\n-0.2423\r\n-0.2945\r\n7.11e-002\r\n-3.57e-002\r', '0', '2.915', 'C21H28N2O4', '0372.205', '-3.373', '0372.458', '1.01 6.93', '4', '0', '3', '20', '06', '1', '27', '29', '8', '6', '006', '00', '28', '0', '3', '004', '0066.92', '405.93', '', '', '', '', '', '', '', '', '', '', '', 'CC(C)(C)OC(=O)N3CCN(c2ccc(C1CC(=O)CC(=O)C1)cc2)CC3', 'O=C3CC(/C/2=C/C=C(N1CCN(C(=O)OC(C)(C)C)CC1)\\C=C2)CC(=O)C3', 'CHD_50', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(244, '244', 'Not Available', 'COc1cc(OC)cc(c1)C2CC(=O)CC(=O)C2', '5-(3,5-dimethoxyphenyl)cyclohexane-1,3-dione', 'CYAAFQwAmfwQAiuzTjAl9lqhkz$yjRjOCH72SAL6S050qWvKjmsOf4oB1Aj^5gdenpj36bqJjRB54igjQgia$lOOVLvrM$ZR0PMZ46Hhhh8gyQWCEXgESotYghfEey4YoJ3B9WgEIT3emgkPrpKD1jA4YEOcYe$gRDYuXri0$yn8nm76lcRJcWOUGfLOhQbWXbj8qJg8 yvzeabu^m^LHeAXXdkZPmBEX^O6vRfhlH^9Lxyzj6$q8sWSE5121vW3WfmUerNPuUH03ZW87eM^mr88baaCyJpbtyv13qN^WwtaGX4bFTiZocWMimpCRWE3EXRAXtWSQyJtCIWsccgpikYuLnEDbzWGz6d0anZ^xy5t5byt2cPtbr72mF71TzD8C8F26$VD0WI^AhiK', 'InChI=1S/C14H16O4/c1-17-13-5-10(6-14(8-13)18-2)9-3-11(15)7-12(16)4-9/h5-6,8-9H,3-4,7H2,1-2H3', 'AuxInfo=1/0/N:17,18,4,8,11,10,5,14,6,9,3,7,13,12,1,2,15,16/E:(1,2)(3,4)(5,6)(11,12)(13,14)(15,16)(17,18)/rA:18OOCCCCCCCCCCCCOOCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s12;s15;s16;/r C:14.0816,-4.2569,0;12.6527,-6.7319,0;14.0816,-5.0819,0;14.7961,-5.4944,0;13.3672,-5.4944,0;14.7961,-6.3194,0;13.3672,-6.3194,0;14.0816,-6.7319,0;15.5106,-6.7319,0;16.2251,-6.3194,0;15.5106,-7.5569,0; 16.9396,-6.7319,0;16.2251,-7.9694,0;16.9396,-7.5569,0;16.2251,-8.7945,0;17.654,-6.3194,0;15.5106', 'DVSOUYRRLAEPAO-UHFFFAOYSA-N', '1010:P7XXH3WVMAXNW7X7TPJPE65VGWABN1', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#8]-[#6]):[c]:[c](-[#8]-[#6]):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(OC)cc(OC)c2)C1', '01.564', '1.564', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.2e-003\r\n0.1403\r\n1.38e-002\r\n-3.89e-002\r\n-2.81e-002\r\n-2.81e-002\r\n7.74e-002\r\n7.74e-002\r\n-1.4e-003\r\n-0.3493\r\n-0.3493\r\n4.22e-002\r\n4.22e-002', '0', '2.052', 'C14H16O4', '0248.105', '-2.761', '0248.274', '1.01', '4', '0', '2', '11', '06', '1', '18', '19', '5', '5', '004', '00', '16', '0', '2', '003', '0052.6', '261.92', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(OC)=C\\C(OC)=C1)CC(=O)C2', 'COc2cc(OC)cc(C1CC(=O)CC(=O)C1)c2', 'CHD_51', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(245, '245', 'Not Available', 'CCn1c2ccccc2c3cc(ccc13)C4CC(=O)CC(=O)C4', '5-(9-ethylcarbazol-3-yl)cyclohexane-1,3-dione', 'CYAAFQwAadwQdVDVnHVsQ^R61bLWGur^JzA^btxNXo3Gk8t6Af$balg$aIgBTfeT6v7Ew3g1W^YuH72OhUlfgIjpl6IKeFYNypHYMXLxPIEHRaWkpY0r0nfQ0M2EtS2HGUfTXBaPH8kSYRxDCN8s51qU4WbNEgA$xE^Y4MMi8Wv83ZFA9eqvkm5T0zn$zRuf72J4zf9w 1LNG7is7ztu73pJ^Qsw52CPRiE4j$2u8g8UPm7BBOqfSXV9^4KPI7$8bBfp3$sys2FRBSzz4NfmuHb4b^6mP0WwK71uul8u2f0nS3xbEf6rO3z9wwYBgdjrSna6NgO3am768$nYt4lC97pmYcLjdz56szqNavwdHeealsFCWYvYgYrIQYvIQgaVQBQlAFo1Si3OTgilC VAi1rEYs5PrYp5CLx3KvAlb2kJI2rPQczGVRuEwcErP0gYDLhk6uHKGz14CJWhoY^LfhXUIYP55Yxk^xHkfnXX4WWC', 'InChI=1S/C20H19NO2/c1-2-21-19-6-4-3-5-17(19)18-11-13(7-8-20(18)21)14-9-15(22)12-16(23)10-14/h3-8,11,14H,2,9-10,12H2,1H3', 'AuxInfo=1/0/N:23,22,19,21,18,20,10,12,4,8,11,5,9,6,3,7,15,13,16,14,17,1,2/E:(9,10)(15,16)(22,23)/rA:23OOCCCCCCCCCCCCCCNCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;d+9;s9;s10;d-11;d-12s13;s13;d-15;s14s16;s15;d -18;s16;s19d-20;s17;s22;/rC:14.1482,-4.2568,0;12.7192,-6.7319,0;14.1482,-5.0819,0;14.8627,-5.4944,0;13.4337,-5.4944,0;14.8627,-6.3194,0;13.4337,-6.3194,0;14.1482,-6.7319,0;15.5771,-6.7319,0;16.2916,-6 .3194,0;15.5771,-7.5569,0;17.0061,-6.7319,0;16.2916,-7.9694,0;17.0061,-7.5569,0;16.4631,-8.7763,', 'UBBUYKYRJOJIHE-UHFFFAOYSA-N', '1010:QR6AWG2D8KP51XMAW3CA6CDH5S97TH', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]3:[c](:[n](-[#6]-[#6]):[c](:[c]:[c]:[c]:[c]4):[c]34):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc3c(n(CC)c(cccc4)c34)cc2)C1', '03.644', '3.644', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.33e-002\r\n-5.71e-002\r\n-4.92e-002\r\n-4.28e-002\r\n2.e-003\r\n2.96e-002\r\n1.7e-003\r\n2.96e-002\r\n-0.2441\r\n-5.28e-002\r\n-6.16e-002\r\n-4.31e-002\r\n-6.07e-002\r\n5.2e-003\r\n-5.17e-002', '0', '2.503', 'C20H19NO2', '0305.142', '-5.924', '0305.37', '2.25 9.32', '2', '0', '2', '9', '15', '3', '23', '26', '4', '8', '003', '00', '19', '0', '4', '002', '0039.07', '304.81', '', '', '', '', '', '', '', '', '', '', '', 'O=C4CC(/C/1=C/C=C/2\\C(=C1)\\C\\3=C(N2CC)\\C=C/C=C3)CC(=O)C4', 'CCn4c1ccccc1c3cc(C2CC(=O)CC(=O)C2)ccc34', 'CHD_52', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(246, '246', 'Not Available', 'FC(F)(F)c1ccc(C2CC(=O)CC(=O)C2)c(c1)C(F)(F)F', '5-[2,4-bis(trifluoromethyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAsewQi$skFfFrC$Zj6wZntBSq9GeOLkiawi0y6uFpkvQb1Lp56QiusrA5PJW4TzwlEqEd$faWvO1NTCwaruRbFyLd7B$WEkH2N8wX2oku3nKEp5OUEU6KEx0rc$RuSG3RNtt8TOifYGURPRwqXYDsZOaHIq7LHJuaXYuu0nI09erfxBiL6ucSNOI4hIIde9XJ iw^16Iliad374b$1P$eNsVPXRU35LAdf8ftzZPCFR^E0XtfqvUurt5MNzdqfp^9m8D9$LQ8vGNgc9^b47^r7i2Vszf$aDxEqnESnKM^qO^TR2qS9SEqzXwOZOrai8zwi2Zn8EuCcpImHSBtVlCGr3AE28KA4utigcg7KwZzleYdBYV6xxqUQSxvyFrLPvcsvQNiy$Orv t0pstvzbopXwYGhb9AneHUIcHvLgdyX3Fw^1LvFCmC', 'InChI=1S/C14H10F6O2/c15-13(16,17)8-1-2-11(12(5-8)14(18,19)20)7-3-9(21)6-10(22)4-7/h1-2,5,7H,3-4,6H2', 'AuxInfo=1/0/N:13,11,4,8,12,5,6,14,3,7,9,10,16,15,20,21,22,17,18,19,1,2/E:(3,4)(9,10)(15,16,17)(18,19,20)(21,22)/rA:22OOCCCCCCCCCCCCCCFFFFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;d+9;s9;s10;d-11;d-12s13;s10;s14 ;s15;s15;s15;s16;s16;s16;/rC:14.3139,-4.3083,0;12.8849,-6.7834,0;14.3139,-5.1333,0;15.0283,-5.5458,0;13.5994,-5.5458,0;15.0283,-6.3709,0;13.5994,-6.3709,0;14.3139,-6.7834,0;15.7428,-6.7834,0;16.4573,- 6.3709,0;15.7428,-7.6084,0;17.1718,-6.7834,0;16.4573,-8.0209,0;17.1718,-7.6084,0;16.4573,-5.5458', 'PKENIIVQXQHTBS-UHFFFAOYSA-N', '1010:GY2R6N31E2Z7P65NT31NQZYXKVVC8C', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c]2-[#6](-[#9])(-[#9])-[#9])-[#6]1', 'O=C1CC(=O)CC(c2ccc(C(F)(F)F)cc2C(F)(F)F)C1', '03.481', '3.481', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-1.8e-003\r\n0.1403\r\n1.38e-002\r\n-3.18e-002\r\n5.95e-002\r\n-5.76e-002\r\n-3.75e-002\r\n-4.98e-002\r\n5.61e-002\r\n0.4162\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '3.97', 'C14H10F6O2', '0324.058', '-5.111', '0324.218', '1.01', '2', '0', '2', '15', '06', '1', '22', '23', '9', '5', '002', '00', '10', '0', '2', '003', '0034.14', '288.82', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(C(F)(F)F)/C=C(C(F)(F)F)\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1ccc(C(F)(F)F)cc1C(F)(F)F)C2', 'CHD_53', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(247, '247', 'Not Available', 'Clc1cccc(c1)c2oc(cc2)C3CC(=O)CC(=O)C3', '5-[5-(3-chlorophenyl)-2-furyl]cyclohexane-1,3-dione', 'CYAAFQwA3fwQRaJO$mFrFSW4FiXjWTzo9y$UnfSGgd$fyfalNU3LABtrh2KLywwbFSMDgdZ7vV1Cu7o0EaxZJT7ZL$TGAfwbHur0gHEGpLCmVzyfJu2LwDc8qGa9BUg530KIKslzsJtGgY2lwmAlzVQyxVHMqAd4cxcQkzCtPz1ZRY9C3lXjscxIKfIsk9RBNGpxrjrP L$MX0jhlf7tej^OXf^7RILr6Yi7Pv^pdePHJHj98PJT43dG2CYzxltfTxq$CnDhcbQUflHXx0NMmVz2f77aez6yUxmzXqAIGgh$hqFpz9sxqnmhuA5d6j6paN1VeVDc1CDBvN^FtDtub4zJoQMPhr4bq$sskucj3idVHhVBXYGLFxAXTiB5mbGsdwKCwSflCljsq5wY9 zR0VNjJs2JWoatVgCNAHb6re0WEim7MN2gUWmh5zyAxcnCq736fcgFPVj3PzN1rfC0^Y8mCifB', 'InChI=1S/C16H13ClO3/c17-12-3-1-2-10(6-12)15-4-5-16(20-15)11-7-13(18)9-14(19)8-11/h1-6,11H,7-9H2', 'AuxInfo=1/0/N:18,16,19,13,11,15,4,8,5,14,6,17,3,7,12,9,20,1,2,10/E:(7,8)(13,14)(18,19)/rA:20OOCCCCCCCOCCCCCCCCCCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;s10;s11d-12;s12;s14;d+14;d-15;s16;s17d-18;s17;/rC: 14.3595,-4.3083,0;12.9306,-6.7834,0;14.3595,-5.1333,0;15.074,-5.5458,0;13.6451,-5.5458,0;15.074,-6.3709,0;13.6451,-6.3709,0;14.3595,-6.7834,0;15.7885,-6.7834,0;16.5422,-6.4478,0;15.8748,-7.6038,0;17.0 942,-7.0609,0;16.6817,-7.7754,0;17.9147,-6.9747,0;18.2503,-6.221,0;18.3997,-7.6421,0;19.0708,-6.', 'AWAKUKBVLAWBKN-UHFFFAOYSA-N', '1010:AWXF363TSVTFVX7444F1H1M66KM6ZK', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[c]3:[c]:[c]:[c]:[c](-[#17]):[c]3):[o]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(c3cccc(Cl)c3)o2)C1', '03.255', '3.255', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1404\r\n1.58e-002\r\n6.5e-002\r\n1.98e-002\r\n0.1404\r\n1.58e-002\r\n6.33e-002\r\n-0.3139\r\n-3.26e-002\r\n8.89e-002\r\n-2.84e-002\r\n6.7e-003\r\n-3.37e-002\r\n-5.23e-002\r\n4.12e-002\r\n-6.01e-002\r\n-4.35e-002\r\n-8.44e-002', '0', '3.744', 'C16H13ClO3', '0288.055', '-4.878', '0288.726', '2.25', '3', '0', '2', '9', '11', '2', '20', '22', '5', '7', '003', '00', '13', '0', '3', '002', '0047.28', '270.75', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C2=C/C=C(/C/1=C/C=C\\C(Cl)=C1)\\O2)CC(=O)C3', 'O=C3CC(=O)CC(c2ccc(c1cccc(Cl)c1)o2)C3', 'CHD_54', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(248, '248', 'Not Available', 'O=C1CC(CC(=O)C1)c2cc(cc(c2)c3ccccc3)c4ccccc4', '5-(3,5-diphenylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAQewQpAoGAkgzwMFhbxfhp5QYAUyTrHDWU60KSBKgd2Dur6gmbe1HMP8evsZ$fBD3CrD9wA3qyVZcTIobDBNDa3fcino7JleGXdbf4ozO5mICLmONVGemdGDEV22BTzWc2Rp7m0EGXUCUKnQ4IFeYXGUsC9aOuOFNlmz5u^QzcSub4Cmw66McMOOOeYt8eqH4 gbyV9xbgx^srf59ZMOUdvizBBKNHv0juy$IKLc5$wQniU6erjW36$KkQfdrnLy8dI3h1uV0Yzfin2CuHONJv86s7149WIauT8ObhbcwN3tdHJD8Oy1ZP^0dML^$3O^Lt08XyZgV5^06j5edjS5fvuTfmuFBdM7FFYKoKxQUVNhwuqgAkatkQNlbEtCj3HSVRCzKxxkFi B18mcRLt5fqvaeAdqJCCmzsWbijJMPSF4Bi5lCK71GQEIisdZjBKC7GbDPXZHYDfJZY4Do9Wj3PwN1beG0^axrHMrD', 'InChI=1S/C24H20O2/c25-23-14-22(15-24(26)16-23)21-12-19(17-7-3-1-4-8-17)11-20(13-21)18-9-5-2-6-10-18/h1-13,22H,14-16H2', 'AuxInfo=1/0/N:20,26,18,19,24,25,16,17,22,23,14,11,10,4,8,5,15,21,13,12,9,6,3,7,1,2/E:(1,2)(3,4,5,6)(7,8,9,10)(12,13)(14,15)(17,18)(19,20)(23,24)(25,26)/rA:26OOCCCCCCCCCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4; d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s15;d+15;d-16;s17;s18d-19;s12;s21;d+21;d-22;s23;s24d-25;/rC:14.3594,-4.3083,0;12.9305,-6.7833,0;14.3594,-5.1333,0;15.0739,-5.5458,0;13.6449,-5.5458,0;15.0739,- 6.3708,0;13.6449,-6.3708,0;14.3594,-6.7833,0;15.7884,-6.7833,0;16.5029,-6.3708,0;15.7884,-7.6084', 'GMAAZXCNTVDYDQ-UHFFFAOYSA-N', '1010:S3BTVNS8XQQERD2EG3FJQRRX4FDUUP', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]:[c](-[c]4:[c]:[c]:[c]:[c]:[c]4):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(c3ccccc3)cc(c4ccccc4)c2)C1', '04.633', '4.633', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.28e-002\r\n-5.09e-002\r\n-5.09e-002\r\n-1.75e-002\r\n-1.75e-002\r\n-4.65e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-6.17e-002\r\n-6.23e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002', '0', '5.122', 'C24H20O2', '0340.146', '-7.185', '0340.414', '1.01', '2', '0', '2', '9', '18', '3', '26', '29', '5', '11', '002', '00', '20', '0', '4', '003', '0034.14', '337.23', '', '', '', '', '', '', '', '', '', '', '', 'O=C4CC(/C/3=C/C(/C/1=C/C=C\\C=C1)=C\\C(\\C\\2=C\\C=C/C=C2)=C3)CC(=O)C4', 'O=C4CC(=O)CC(c3cc(c1ccccc1)cc(c2ccccc2)c3)C4', 'CHD_55', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(249, '249', 'Not Available', 'FC(F)(F)c1cc(cc(c1)c2ccccc2)C3CC(=O)CC(=O)C3', '5-[3-phenyl-5-(trifluoromethyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAbcwQ2GFymcFcQFTVp3rrFyzBaBt9cUATXTCfoYyTpzmg^HWuRkd2lQKtPV4WjWoNQui7lBlfSnJSKinW7Y^vwcjRBo8U$sLORKiiOyp01TZfpy2cTyrKs76cQ$xBWYxoSKg7I4Bc1V8hjLA8Ros5ZsjKSQIux5qsRfhl7KY6in7bjAvSP07FjxxaHEnCJk3Z OOdmO3Gv1gv56$47OMvk0FmLuOKvGlQ58Ud4SIfQXN1^6NPU7ucXZelV5UP3$vNj8n7bjR7j2OuDiU57Xf6JuNz$78zu5x4vl4^8z9Xyzt8jDrdYF3VWjyJtnpc4oAvLStiYhcSNExZ1JYqrVVQmwPaQU0WNTTpv9Z$CDNZFEwZ1CP3V2Amwb4kYatly3cmKil6CDusS 6EReWNBmxUl7oF7GYI9xn6Ga1GBvxtlgnoaOnfIgb93QN8vVe^HMgA', 'InChI=1S/C19H15F3O2/c20-19(21,22)16-7-13(12-4-2-1-3-5-12)6-14(8-16)15-9-17(23)11-18(24)10-15/h1-8,15H,9-11H2', 'AuxInfo=1/0/N:20,18,19,16,17,10,14,11,4,8,5,15,12,9,6,13,3,7,21,22,23,24,1,2/E:(2,3)(4,5)(9,10)(17,18)(20,21,22)(23,24)/rA:24OOCCCCCCCCCCCCCCCCCCCFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d- 13;s12;s15;d+15;d-16;s17;s18d-19;s13;s21;s21;s21;/rC:14.3596,-4.2738,0;12.9307,-6.7489,0;14.3596,-5.0989,0;15.0741,-5.5114,0;13.6451,-5.5114,0;15.0741,-6.3364,0;13.6451,-6.3364,0;14.3596,-6.7489,0;15. 7886,-6.7489,0;16.5031,-6.3364,0;15.7886,-7.5739,0;17.2175,-6.7489,0;16.5031,-7.9864,0;17.2175,-', 'PGJDLYXZBXXPPR-UHFFFAOYSA-N', '1010:NU3BYQNWH7H6T8FD5CK4VBBW6Z8XFP', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(C(F)(F)F)cc(c3ccccc3)c2)C1', '04.057', '4.057', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.29e-002\r\n-5.09e-002\r\n-4.65e-002\r\n-1.76e-002\r\n5.63e-002\r\n-4.22e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-6.17e-002\r\n-6.23e-002\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '4.546', 'C19H15F3O2', '0332.102', '-5.941', '0332.316', '1.01', '2', '0', '2', '12', '12', '2', '24', '26', '7', '8', '002', '00', '15', '0', '3', '003', '0034.14', '313.04', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C(C(F)(F)F)=C\\C(\\C\\1=C\\C=C/C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cc(c1ccccc1)cc(C(F)(F)F)c2)C3', 'CHD_56', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(250, '250', 'Not Available', 'FC(F)(F)c1cc(cc(c1)c2cccc(Cl)c2)C3CC(=O)CC(=O)C3', '5-[3-(3-chlorophenyl)-5-(trifluoromethyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwATdwQjvx2u6EYHPEXg85IWaWHBSkwY1wLtw7NXIqGTIyC0IYBotbf5yuETq04xjAYQD1hAgrsvS4czR34SSSLun8SgHRZ38yj5F3I692Mk^4xx2YmWWd3XhJiqbNt5Z8$RBCo8427aOFIqvACkNvWzcp5kByhiIeey$Es8WrxWYFAP3G3evcqwxVzx9qzHGNB LzVHUA0itR$df02c7b^vn6yoLOIttzCEyvNqTLAGD4ha^7gOgscqu1baUt7ytjwV00X57uvbe0fJ$ccc9drGoQgrcnrW2O$Xzv2$2A5Sk^1z3dD9Lw5vu6R4IWR1s03yL2JO$TFxLS^Xq4j^J94pEmV4sRsXZHsFlJCLumwsAPrAcibWnugNMSe5FdZObCTc2AVRnY$C 1MxsfrSbOLq0OrAulSqoLwTyCycmTlf6LOxsaoldtzaGi1B6Xg6LaSVdAe$iuP2Bj^gHx7at2I7G4cO', 'InChI=1S/C19H14ClF3O2/c20-16-3-1-2-11(7-16)12-4-13(6-15(5-12)19(21,22)23)14-8-17(24)10-18(25)9-14/h1-7,14H,8-10H2', 'AuxInfo=1/0/N:19,17,20,10,14,11,16,4,8,5,15,12,9,6,13,18,3,7,21,25,22,23,24,1,2/E:(8,9)(17,18)(21,22,23)(24,25)/rA:25OOCCCCCCCCCCCCCCCCCCCFFFCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12 ;s15;d+15;d-16;s17;s18d-19;s13;s21;s21;s21;s18;/rC:14.3596,-4.2738,0;12.9307,-6.7489,0;14.3596,-5.0989,0;15.0741,-5.5114,0;13.6451,-5.5114,0;15.0741,-6.3364,0;13.6451,-6.3364,0;14.3596,-6.7489,0;15.78 86,-6.7489,0;16.5031,-6.3364,0;15.7886,-7.5739,0;17.2175,-6.7489,0;16.5031,-7.9864,0;17.2175,-7.', 'UXXPYGNIHNTLCJ-UHFFFAOYSA-N', '1010:CAZKQCDZJUNMMUWSWWQ1VARNC1QMTJ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[c]3:[c]:[c]:[c]:[c](-[#17]):[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(C(F)(F)F)cc(c3cccc(Cl)c3)c2)C1', '04.722', '4.722', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.29e-002\r\n-5.09e-002\r\n-4.65e-002\r\n-1.75e-002\r\n5.63e-002\r\n-4.22e-002\r\n-1.69e-002\r\n-3.57e-002\r\n-5.43e-002\r\n4.11e-002\r\n-6.02e-002\r\n-4.35e-002\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-', '0', '5.21', 'C19H14ClF3O2', '0366.063', '-6.688', '0366.761', '1.01', '2', '0', '2', '13', '12', '2', '25', '27', '8', '8', '002', '00', '14', '0', '3', '003', '0034.14', '333.78', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C(C(F)(F)F)=C\\C(\\C\\1=C\\C=C/C(Cl)=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cc(c1cccc(Cl)c1)cc(C(F)(F)F)c2)C3', 'CHD_57', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(251, '251', 'Not Available', 'Clc1cc(cc(c1)c2ccccc2)C3CC(=O)CC(=O)C3', '5-(3-chloro-5-phenyl-phenyl)cyclohexane-1,3-dione', 'CYAAFQwAJfwQ$CJI6yY8SvmeEAWKZp5FeSvPXxhUYQcN6OuH2s6jw2$C8oaTAvEbrHGhsc1RRPoKa0SJa2KOztU6kIl1H01uhG7xPsAP2rpbG047TZvSdRNfIkYbREDvgNf6voFHu^eQPpDHEOhL8Ih6wR^wFjR4cxsU^GGQ8UryXwxjP3H3oTaeFSMzNWGFcixs1C8P eDIv8GI8N7abefW8jV3X4cgS2bUrW2NQuEzFBP29TQWRq^X^hRjJL7Wvrs62^lmltZsjSv17HgQ^cjm5Skr9kFItG^7vXffbJ9zvurXi0a$ce3fH8RCzxI0LFj4qVICr4k4sC6yCKF2JMSi2rMplRwkZiFe1LGmVXGTWM7Uz8lba6twSRYm9ph6iXtZKsmdIv6OmY1pm SPNth4PbRIeTpHO4q7NNA8nGFHSbzA', 'InChI=1S/C18H15ClO2/c19-16-7-13(12-4-2-1-3-5-12)6-14(8-16)15-9-17(20)11-18(21)10-15/h1-8,15H,9-11H2', 'AuxInfo=1/0/N:20,18,19,16,17,10,14,11,4,8,5,15,12,9,6,13,3,7,21,1,2/E:(2,3)(4,5)(9,10)(17,18)(20,21)/rA:21OOCCCCCCCCCCCCCCCCCCCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;d+15;d-16; s17;s18d-19;s13;/rC:14.3596,-4.4504,0;12.9307,-6.9254,0;14.3596,-5.2754,0;15.0741,-5.6879,0;13.6451,-5.6879,0;15.0741,-6.5129,0;13.6451,-6.5129,0;14.3596,-6.9254,0;15.7886,-6.9254,0;16.5031,-6.5129,0; 15.7886,-7.7504,0;17.2175,-6.9254,0;16.5031,-8.1629,0;17.2175,-7.7504,0;17.932,-6.5129,0;17.932,', 'MYLLOOJJLRIXDS-UHFFFAOYSA-N', '1010:UNG89HKNVVZUCHX5M1EZ2A6V7QW41Z', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#17]):[c]:[c](-[c]3:[c]:[c]:[c]:[c]:[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(Cl)cc(c3ccccc3)c2)C1', '03.779', '3.779', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.2e-002\r\n-5.08e-002\r\n-4.e-002\r\n-1.67e-002\r\n4.14e-002\r\n-3.57e-002\r\n-1.84e-002\r\n-5.44e-002\r\n-5.44e-002\r\n-6.17e-002\r\n-6.17e-002\r\n-6.23e-002\r\n-8.43e-002', '0', '4.268', 'C18H15ClO2', '0298.076', '-5.641', '0298.764', '1.01', '2', '0', '2', '9', '12', '2', '21', '23', '5', '8', '002', '00', '15', '0', '3', '002', '0034.14', '284.91', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C(Cl)=C\\C(\\C\\1=C\\C=C/C=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cc(Cl)cc(c1ccccc1)c2)C3', 'CHD_58', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(252, '252', 'Not Available', 'Fc1cc(F)cc(c1)c2cccc(c2)C3CC(=O)CC(=O)C3', '5-[3-(3,5-difluorophenyl)phenyl]cyclohexane-1,3-dione', 'CYAAFQwAifwQLvdu57iTYvWiTtNJiqcUdq^h$hM38evRjOXgoO97yi7lFJfbA57P9yiSjSbIX8B0eu3WdNyx9REVVCxA4o6oL7z4g0P4R17VO8ZGIxdYpzOxhX1QokYnjfQzVqH0OvO9kPfoYGkMXIIXLMJqWi6xEYuQq0fl8M^1whlcOP39nVwIxciKnpB6fzZU8Ufw 49WQ159Rj^ur^531YYI9pC3dOyejX4p3PzCMFE8Y8PBZjo3fvnlGblX7ZqWvRfvtnveu5NtF95Iy67Od0KVv9qrQt5svy$Sr^1PU6xCk5d5HWXtate295$7lx0DN^ogpML1FxIkJFj4mMJC7gvogJxkKkK8qg1rORThxm5CHYa7EZPXDpkIn3fdL3lENhKBdWYJiRk3s G2smQuXpYlJzneKL$CeRf1MHeqSse6BAtN$D3MuGNbgt7C', 'InChI=1S/C18H14F2O2/c19-15-5-13(6-16(20)9-15)11-2-1-3-12(4-11)14-7-17(21)10-18(22)8-14/h1-6,9,14H,7-8,10H2', 'AuxInfo=1/0/N:13,14,11,10,16,17,4,8,20,5,12,9,15,6,18,19,3,7,21,22,1,2/E:(5,6)(7,8)(15,16)(17,18)(19,20)(21,22)/rA:22OOCCCCCCCCCCCCCCCCCCFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15 ;d+15;d-16;s17;s18d-19;s18;s19;/rC:14.3596,-4.4504,0;12.9307,-6.9254,0;14.3596,-5.2754,0;15.0741,-5.6879,0;13.6451,-5.6879,0;15.0741,-6.5129,0;13.6451,-6.5129,0;14.3596,-6.9254,0;15.7886,-6.9254,0;16. 5031,-6.5129,0;15.7886,-7.7504,0;17.2175,-6.9254,0;16.5031,-8.1629,0;17.2175,-7.7504,0;17.932,-6', 'VIBCGHONLAQFFX-UHFFFAOYSA-N', '1010:RCYVMUJAB4SNSCDV6CB5A5DFKTZP55', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[c]3:[c]:[c](-[#9]):[c]:[c](-[#9]):[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(c3cc(F)cc(F)c3)c2)C1', '03.526', '3.526', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.35e-002\r\n-5.09e-002\r\n-5.87e-002\r\n-1.8e-002\r\n-6.14e-002\r\n-5.44e-002\r\n-1.26e-002\r\n-1.83e-002\r\n-1.83e-002\r\n0.1262\r\n0.1262\r\n9.5e-003\r\n-0.2069\r\n-0.2069', '0', '4.014', 'C18H14F2O2', '0300.096', '-5.158', '0300.299', '1.01', '2', '0', '2', '10', '12', '2', '22', '24', '6', '8', '002', '00', '14', '0', '3', '002', '0034.14', '286.12', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(\\C\\1=C\\C(F)=C/C(F)=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(c1cc(F)cc(F)c1)c2)C3', 'CHD_59', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(253, '253', 'Not Available', 'FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2cccc(c2)C3CC(=O)CC(=O)C3', '5-[3-[3,5-bis(trifluoromethyl)phenyl]phenyl]cyclohexane-1,3-dione', 'CYAAFQwAicwQEracpEDcn0tVwnQXRiCPlwGLXAGQJCBpZdXk44T3HO9iCbEig8hyqj5WOjGre91kKwQjldWiV$nm1KAe5K5ju37Be5dHDyZ74Gsmtd10quTdE$uCfYHiEDHfp3OFy6pzDSbXEylzvg5Fc54FT4kREx5laVe2eQnX9z9NgMtlROHO4cPknHtdl7qDhccJ dRudcot5uN^ZShOuc2h8UPZVlfbUbvYi4wWfYgacXNl^$pOn3ZZ3G7WrnfNolzNabXWvMb3hLjb0aX53fhj3x967d2fv$9T^InW5IOXH$rxScvnzoHn5^pV4UIE7IEe2seSHAP8e38Fv5TtcChwOlz5e6SVpL4sMWDn7$lDmtEnFrGjUWJGkZvYkCyChZBqi2IJ$l^2C 5RI91R0XVhJqrEDczZiF0aZJLxXqXC$SUwr3yPdUE6JZFbmTzdCCtbTJMQLtRpN1dUKo820etEmF7CgltkGQO1CZBwTHfwDP', 'InChI=1S/C20H14F6O2/c21-19(22,23)15-5-13(6-16(9-15)20(24,25)26)11-2-1-3-12(4-11)14-7-17(27)10-18(28)8-14/h1-6,9,14H,7-8,10H2', 'AuxInfo=1/0/N:13,14,11,10,16,17,4,8,20,5,12,9,15,6,18,19,3,7,21,22,23,24,25,26,27,28,1,2/E:(5,6)(7,8)(15,16)(17,18)(19,20)(21,22,23,24,25,26)(27,28)/rA:28OOCCCCCCCCCCCCCCCCCCCCFFFFFF/rB:;d1;s3;s3;s4;d 2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s12;s15;d+15;d-16;s17;s18d-19;s18;s19;s21;s21;s21;s22;s22;s22;/rC:14.2325,-4.2828,0;12.8036,-6.7578,0;14.2325,-5.1078,0;14.947,-5.5203,0;13.518,-5.5203,0;14.947,-6. 3453,0;13.518,-6.3453,0;14.2325,-6.7578,0;15.6615,-6.7578,0;16.376,-6.3453,0;15.6615,-7.5828,0;1', 'ZPACAFBFZGSARV-UHFFFAOYSA-N', '1010:CEYA4CPMABPYCR7N2U3CX2F9EWD3EZ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c](-[c]3:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]3):[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cccc(c3cc(C(F)(F)F)cc(C(F)(F)F)c3)c2)C1', '05', '5', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.35e-002\r\n-5.09e-002\r\n-5.87e-002\r\n-1.81e-002\r\n-6.14e-002\r\n-5.44e-002\r\n-1.72e-002\r\n-4.22e-002\r\n-4.22e-002\r\n5.66e-002\r\n5.66e-002\r\n-3.78e-002\r\n0.4159\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0', '0', '5.488', 'C20H14F6O2', '0400.09', '-7.153', '0400.314', '1.01', '2', '0', '2', '16', '12', '2', '28', '30', '10', '8', '002', '00', '14', '0', '3', '004', '0034.14', '361.91', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(/C/2=C/C=C\\C(\\C\\1=C\\C(C(F)(F)F)=C/C(C(F)(F)F)=C1)=C2)CC(=O)C3', 'O=C3CC(=O)CC(c2cccc(c1cc(C(F)(F)F)cc(C(F)(F)F)c1)c2)C3', 'CHD_60', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(254, '254', 'Not Available', 'FC(F)(F)Oc1cccc(c1)C2CC(=O)CC(=O)C2', '5-[3-(trifluoromethoxy)phenyl]cyclohexane-1,3-dione', 'CYAAFQwA9fwQAAn24cQRLkapzADUHerYimNR1uaeV2yKqVGTtqszwv8MKyNYWsBJbBm63w030q9GoCBjcIuhmSouoUE42$xQ3cPEMdNx54tnxZSFgkffSoek0gfE1TKRN6Aw35VNBf4BIkpBJUnQXAjzg58ZmshIzIiL1I3rLM6zUffHiI$cKyVzx1qzn2jFNzVHEhxC tRudOW3c7k3uIMmzLMIvYPGaNfb0$4^ki4iO^nbCo1E9frX3r$mNT08b$4P5P^nzTjeIF5hVAr$p4aJh1vTzJZceFNSmVr8sQB0^c^u$arPcLwjKQq43iJSzItoNiwa2kJsLBbWYW0WOk3OrnFjhTyRUsJSzmvgNRMrJUr9SpZqv2IXzyFf3x1tNqVEbg3Sx5DeF$gT7 ^ph639TAsFL', 'InChI=1S/C13H11F3O3/c14-13(15,16)19-12-3-1-2-8(6-12)9-4-10(17)7-11(18)5-9/h1-3,6,9H,4-5,7H2', 'AuxInfo=1/0/N:12,10,14,4,8,11,5,9,6,3,7,13,16,17,18,19,1,2,15/E:(4,5)(10,11)(14,15,16)(17,18)/rA:19OOCCCCCCCCCCCCOCFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s13;s15;s16;s16;s16;/rC:14.2 325,-4.6369,0;12.8036,-7.1119,0;14.2325,-5.4619,0;14.947,-5.8744,0;13.518,-5.8744,0;14.947,-6.6994,0;13.518,-6.6994,0;14.2325,-7.1119,0;15.6615,-7.1119,0;16.376,-6.6994,0;15.6615,-7.9369,0;17.0904,-7. 1119,0;16.376,-8.3494,0;17.0904,-7.9369,0;16.376,-9.1744,0;15.6615,-9.5869,0;16.074,-10.3014,0;1', 'NNPZPQXHYJQQHW-UHFFFAOYSA-N', '1010:GNH5DHYFWQTK3E74M9ZHZ3JEYBMR9H', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c](-[#8]-[#6](-[#9])(-[#9])-[#9]):[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2cc(OC(F)(F)F)ccc2)C1', '03.716', '3.716', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.3e-003\r\n0.1403\r\n1.38e-002\r\n-4.15e-002\r\n-5.86e-002\r\n-2.8e-002\r\n-5.94e-002\r\n8.49e-002\r\n-3.15e-002\r\n-0.2542\r\n0.527\r\n-0.1435\r\n-0.1435\r\n-0.1435', '0', '4.205', 'C13H11F3O3', '0272.066', '-4.074', '0272.22', '1.01', '3', '0', '2', '12', '06', '1', '19', '20', '6', '5', '003', '00', '11', '0', '2', '003', '0043.37', '252.06', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C(OC(F)(F)F)=C\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1cccc(OC(F)(F)F)c1)C2', 'CHD_61', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(255, '255', 'Not Available', 'O=C1CC(Cc2ccccc2)CC(=O)C1', '5-benzylcyclohexane-1,3-dione', 'CYAAFQwAsfwQULcUkpNwFUsZQbmJT^uIxlgYIeFg4PjIGoAsnmUO3wL4EB7qaSP69fzXaZTrVPJ8B59oxaLFJSwIybulCotDyqNZiZ2YaGC6uXM8$q1DZg5SiIDv$YkuLjpp9E4y6bcMJ1XDg6ZE8y9^IFD7XI68v11k4PL7bsbxPJEP6FqaRdQwKH^24rSv0fztZ$UR 3F9^mvd3vHD$ts3te2OB9JsZgP1Lpnk6z79UxeEyk3LV33UCmAz$G2H77fPmsDjQyZcfS6dZp4ux7tSpaWqFzQtHuz^myKalgo$YWQ6ItAqz3GCndNAcwtRgtp2BZbLvBFhoM8fXrBK34qGFhzKQNkkorh4Bt1Wt3DwD3d0j774WalABB7I', 'InChI=1S/C13H14O2/c14-12-7-11(8-13(15)9-12)6-10-4-2-1-3-5-10/h1-5,11H,6-9H2', 'AuxInfo=1/0/N:15,13,14,11,12,9,4,8,5,10,6,3,7,1,2/E:(2,3)(4,5)(7,8)(12,13)(14,15)/rA:15OOCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;d+10;d-11;s12;s13d-14;/rC:9.4648,-2.1204,0;8.0358,-4.5954,0;9 .4648,-2.9454,0;10.1793,-3.3579,0;8.7503,-3.3579,0;10.1793,-4.1829,0;8.7503,-4.1829,0;9.4648,-4.5954,0;10.9337,-4.781,0;10.8132,-5.5972,0;11.4596,-6.1097,0;10.046,-5.9008,0;11.339,-6.9259,0;9.9254,-6. 7169,0;10.5719,-7.2295,0;', 'WYHYLVFEMYKTNG-UHFFFAOYSA-N', '1010:132KVSYRHFNWS56SFQZDH33MYRS7E4', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]-[c]2:[c]:[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(Cc2ccccc2)C1', '02.053', '2.053', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.14\r\n1.01e-002\r\n6.5e-002\r\n-2.36e-002\r\n0.14\r\n1.01e-002\r\n-2.42e-002\r\n-4.78e-002\r\n-5.91e-002\r\n-5.91e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002', '0', '2.541', 'C13H14O2', '0202.099', '-2.983', '0202.249', '1.01', '2', '0', '2', '8', '06', '1', '15', '16', '3', '5', '002', '00', '14', '0', '2', '002', '0034.14', '208.67', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(C/C/1=C/C=C\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(Cc1ccccc1)C2', 'CHD_62', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(256, '256', 'Not Available', 'Cc1cc(C)cc(CC2CC(=O)CC(=O)C2)c1', '5-[(3,5-dimethylphenyl)methyl]cyclohexane-1,3-dione', 'CYAAFQwAVewQJxPsVfEag1sZgoAJFnYgAD$yE9^ZZHldAFCZ9ox5JC0fwDYqFt73akysv10UnJOkmFiS7exEufSaocgbJewArluQroe0yvvf^x9T$WnFm9VZM$qBNNHikJqTs7kFKHFi5S3OCiXRlHn9fMkkuciKyhBWk^cvXf3GOSYchzH1BNPvlDcbwrRuz76bEPai dA^^5s^c33pfzz1xnuhXMDXicJfJ9BJuOOiyLSAnOuYhsTH0Yn4QYaIfv7jxPvZDcyBOSf7N4VKOB9McnQbqWwcdtMnxOTTq3fEm6fukxlK5gHHp8L6yFi6zYdI0oVyyQeZLHkraXLQ3Q1CwmFftjUxs7Ivg1A8l8xINgcdKxyVpuoMU2aKyFYp3K692b3NY9D8A$m34 $vWzeHrA5AK', 'InChI=1S/C15H18O2/c1-10-3-11(2)5-12(4-10)6-13-7-14(16)9-15(17)8-13/h3-5,13H,6-9H2,1-2H3', 'AuxInfo=1/0/N:16,17,15,11,12,9,4,8,5,13,14,10,6,3,7,1,2/E:(1,2)(4,5)(7,8)(10,11)(14,15)(16,17)/rA:17OOCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;d+10;d-11;s12;s13d-14;s13;s14;/rC:9.4648,-2.12 04,0;8.0358,-4.5954,0;9.4648,-2.9454,0;10.1793,-3.3579,0;8.7503,-3.3579,0;10.1793,-4.1829,0;8.7503,-4.1829,0;9.4648,-4.5954,0;10.9337,-4.781,0;10.8132,-5.5972,0;11.4596,-6.1097,0;10.046,-5.9008,0;11.3 39,-6.9259,0;9.9254,-6.7169,0;10.5719,-7.2295,0;11.9874,-7.922,0;9.3831,-7.1765,0;', 'CVMDGPUVOMWKCU-UHFFFAOYSA-N', '1010:GU2J6WCWS5JB3FBS65S4C629A3B7YY', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]-[c]2:[c]:[c](-[#6]):[c]:[c](-[#6]):[c]2)-[#6]1', 'O=C1CC(=O)CC(Cc2cc(C)cc(C)c2)C1', '03.025', '3.025', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.14\r\n1.01e-002\r\n6.5e-002\r\n-2.36e-002\r\n0.14\r\n1.01e-002\r\n-2.42e-002\r\n-4.72e-002\r\n-5.61e-002\r\n-5.61e-002\r\n-5.06e-002\r\n-5.06e-002\r\n-5.64e-002\r\n-3.98e-002\r\n-3.98e-002', '0', '3.514', 'C15H18O2', '0230.131', '-4.031', '0230.302', '1.01', '2', '0', '2', '10', '06', '1', '17', '18', '5', '5', '002', '00', '18', '0', '2', '002', '0034.14', '251.54', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(C/C/1=C/C(C)=C\\C(C)=C1)CC(=O)C2', 'Cc2cc(C)cc(CC1CC(=O)CC(=O)C1)c2', 'CHD_63', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(257, '257', 'Not Available', 'CC(C1CC(=O)CC(=O)C1)c2ccccc2', '5-(1-phenylethyl)cyclohexane-1,3-dione', 'CYAAFQwAZdwQTebCvv^tdE4agelzBgy5b9ZV2Cp2oWpG2cmNd8sgru7LpzT6aSU41K9bUoFPo$siSN^C4GqBaS$jv2nppyrfPNy6$3Vkpw0T$Gcl4AISys^Clh3MrwJRDBRuncjyYQsd0Njy4VUOyZvgDJZ9LU9LGykTn9tX3tZ4Em318Rtjzzb8wbjoq4r8XfL$HVQ9 R^fitz$day^c$e8920r5hPxTkvE2SiXuHR5$gkrHXsoFpHaHD9AunZNxcnGih175WOz6zl3gnqpG$$AFViysOSK9kTW2OMRsH5M1zZgkz3A5GA6vsOk0aJQ4SVwwQfXDCgbDaD6NbulxRoRr0$NlodFASkvGKBhrSpGuC7gwd1mV1H4WA8Abn^49vaT$qvQ$wd5L', 'InChI=1S/C14H16O2/c1-10(11-5-3-2-4-6-11)12-7-13(15)9-14(16)8-12/h2-6,10,12H,7-9H2,1H3', 'AuxInfo=1/0/N:16,15,13,14,11,12,4,8,5,9,10,6,3,7,1,2/E:(3,4)(5,6)(7,8)(13,14)(15,16)/rA:16OOCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;d+10;d-11;s12;s13d-14;s9;/rC:9.4648,-2.1204,0;8.0358,-4.5 954,0;9.4648,-2.9454,0;10.1793,-3.3579,0;8.7503,-3.3579,0;10.1793,-4.1829,0;8.7503,-4.1829,0;9.4648,-4.5954,0;10.9337,-4.781,0;10.8132,-5.5972,0;11.4596,-6.1097,0;10.046,-5.9008,0;11.339,-6.9259,0;9.9 254,-6.7169,0;10.5719,-7.2295,0;12.5241,-5.1587,0;', 'PHCHXVBFAARFQC-UHFFFAOYSA-N', '1010:6R8T6JS3RCDANEJYY4EXHH43TEBWVT', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6](-[#6])-[c]2:[c]:[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(C(C)c2ccccc2)C1', '02.305', '2.304', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.14\r\n1.03e-002\r\n6.5e-002\r\n-2.1e-002\r\n0.14\r\n1.03e-002\r\n-1.54e-002\r\n-4.49e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n-5.82e-002', '0', '2.793', 'C14H16O2', '0216.115', '-3.286', '0216.276', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '4', '5', '002', '00', '16', '0', '2', '002', '0034.14', '227.81', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(C(/C/1=C/C=C\\C=C1)C)CC(=O)C2', 'CC(c1ccccc1)C2CC(=O)CC(=O)C2', 'CHD_64', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(258, '258', 'Not Available', 'O=C1CC(CC(c2ccccc2)c3ccccc3)CC(=O)C1', '5-(2,2-diphenylethyl)cyclohexane-1,3-dione', 'CYAAFQwAifwQLvdu57iT$RQiT2^lEaGEzawgm8HLfLeUN^KbYKr^Xuedfg7XM4MJ99K3ZtgZV3L50TQ4AK0s5bZyQdBs33zq8W2FHhTfP1dcC$gNkbcJC5rvhAPC3TBR6MxA$6TUyiQPRoy0lENhyWIegHXOPTbULJEn4anSYeKmzncVo$uPfNO39btrydzl7BFEviye xXt19nbz3KHPm3Z1YMXD7FHjoxce7Ovt7Vgxh4IYHozbDp7C6S^cWN382GOy8OvugetX3a30345v5q^5WSNWrv^d5y8cL$p3YP89N3^6pgHuFN8IYHFmC7GbTMXZdtpPkYCuCmyC0q5cwCNtS^LEgKuKo2EzeoMLsms1zSiwZajYNAzgNHzoef7ARRGOkFKMJHsV0DL3 RJ6odhB8B450O5lnc136f9y6Q0cL', 'InChI=1S/C20H20O2/c21-18-11-15(12-19(22)14-18)13-20(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-10,15,20H,11-14H2', 'AuxInfo=1/0/N:16,22,14,15,20,21,12,13,18,19,4,8,9,5,6,11,17,3,7,10,1,2/E:(1,2)(3,4,5,6)(7,8,9,10)(11,12)(16,17)(18,19)(21,22)/rA:22OOCCCCCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;s11;d+11;d -12;s13;s14d-15;s10;s17;d+17;d-18;s19;s20d-21;/rC:10.7238,-2.1743,0;8.2488,-3.6032,0;10.3113,-2.8888,0;10.7238,-3.6032,0;9.4863,-2.8888,0;10.3113,-4.3177,0;9.0738,-3.6032,0;9.4863,-4.3177,0;10.7238,-5 .0322,0;11.5488,-5.0322,0;11.9613,-4.3177,0;11.5488,-3.6032,0;12.7863,-4.3177,0;11.9613,-2.8888,', 'ZMJWSLCBZBZKOO-UHFFFAOYSA-N', '1010:18E6FD57Y9V45Y3S58RBHT1SWZWNBZ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]-[#6](-[c]2:[c]:[c]:[c]:[c]:[c]2)-[c]3:[c]:[c]:[c]:[c]:[c]3)-[#6]1', 'O=C1CC(=O)CC(CC(c2ccccc2)c3ccccc3)C1', '03.793', '3.793', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.14\r\n9.8e-003\r\n6.5e-002\r\n-2.67e-002\r\n0.14\r\n9.8e-003\r\n-3.86e-002\r\n9.2e-003\r\n-4.05e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n-4.05e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002', '0', '4.281', 'C20H20O2', '0292.146', '-5.516', '0292.372', '1.01', '2', '0', '2', '10', '12', '2', '22', '24', '4', '8', '002', '00', '20', '0', '3', '004', '0034.14', '297.29', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(CC(/C/1=C/C=C\\C=C1)\\C\\2=C\\C=C/C=C2)CC(=O)C3', 'O=C3CC(=O)CC(CC(c1ccccc1)c2ccccc2)C3', 'CHD_65', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(259, '259', 'Not Available', 'O=C1CC(COc2ccccc2)CC(=O)C1', '5-(phenoxymethyl)cyclohexane-1,3-dione', 'CYAAFQwAgewQirXixUeLCnFPHtMVTZLSj37Z4VZXYqM9DgJeC8Stz7tn$TerrPkmLS4oeXD3ob7B^mCjsbuELWXOvjdePjdQCIoOIFzY64lHpHYTx$Qa0DPzEO2EU26TgonkNxahTuNkrJmRQFqEHVAXJWMKaD4gZwshorM95dSCUishyBBveWeRan7rvZy9iCC5u6fD XrNv51oy4fqn313f9Y48crEHI8IL$bf3jjrb9dRNhMc2t^zW3G5q5af$jet3dST9FDyz$g7e^v8Hfzv4x1$8YAkFNKsKzdmwNz5EsRYTNFsd0xC6TTZELuEdyvYDQqa1amYRUmFMJLrGlIMr$I2swNYm9MVDgXR7w2e5ZpsPEEwfXepd', 'InChI=1S/C13H14O3/c14-11-6-10(7-12(15)8-11)9-16-13-4-2-1-3-5-13/h1-5,10H,6-9H2', 'AuxInfo=1/0/N:16,14,15,12,13,4,8,5,9,6,3,7,11,1,2,10/E:(2,3)(4,5)(6,7)(11,12)(14,15)/rA:16OOCCCCCCCOCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;s11;d+11;d-12;s13;s14d-15;/rC:10.7238,-2.1743,0;8.2488,-3 .6032,0;10.3113,-2.8888,0;10.7238,-3.6032,0;9.4863,-2.8888,0;10.3113,-4.3177,0;9.0738,-3.6032,0;9.4863,-4.3177,0;10.7238,-5.0322,0;11.5488,-5.0322,0;11.9613,-5.7467,0;12.7863,-5.7467,0;11.5488,-6.4612 ,0;13.1988,-6.4612,0;11.9613,-7.1756,0;12.7863,-7.1756,0;', 'YLQVBDACXWOTBU-UHFFFAOYSA-N', '1010:H8YQYRP715JWQPKWWDG7ZUKJC9PJQ2', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]-[#8]-[c]2:[c]:[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(COc2ccccc2)C1', '01.578', '1.578', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1401\r\n1.2e-002\r\n6.5e-002\r\n-3.5e-003\r\n0.1401\r\n1.2e-002\r\n5.69e-002\r\n-0.3458\r\n7.49e-002\r\n-3.18e-002\r\n-3.18e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002', '0', '2.066', 'C13H14O3', '0218.094', '-2.504', '0218.248', '1.01', '3', '0', '2', '9', '06', '1', '16', '17', '3', '5', '003', '00', '14', '0', '2', '003', '0043.37', '221.98', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(CO/C/1=C/C=C\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(COc1ccccc1)C2', 'CHD_66', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(260, '260', 'Not Available', 'FC(F)(F)c1cc(OCC2CC(=O)CC(=O)C2)cc(c1)C(F)(F)F', '5-[[3,5-bis(trifluoromethyl)phenoxy]methyl]cyclohexane-1,3-dione', 'CYAAFQwAOewQ8Vzd9dAXjRPQCp6Ud8c^emJ4pCF1hqOYX7b8VEjaAqNt2GSvrQqLghfak8VfZcsbW4bBkEb5vebaaiaRHAzU29Bpsy0hHwR^zuy^nZ^wKo^7HAcIiX6KCBif8fpYNZ0OQloQF0FGtB7L4xhTZKMtMi$0OORUyoDFKGns42xgrH5$y^cdC4gR$^herfNk iTjGn5ZZq^P3NYu7kAx55d2pltQkcfmfizfybD7W2RSO1ZK4pLVNr^5ba1Sd$PdxvWHd^0LcX87F$f4$4kr9^KT39rb^V6BH6FuVbDqnlTn3z9iHd5tr5RA5T8rNaHtjYrMfaHznChDzM7q1fLZxHSU4Meuk4jLT4dEWKIzEi08mLaDXsnN8BXjwmAfWxdKKNswSvF^C 4I4qEqttbLmzZayQygUVTa2KphQOTrBmrDkY4XQLQxhJrSAGAQfUjy8DoOK0BwTHfwDP4ut1u8l1KttE', 'InChI=1S/C15H12F6O3/c16-14(17,18)9-3-10(15(19,20)21)5-13(4-9)24-7-8-1-11(22)6-12(23)2-8/h3-5,8H,1-2,6-7H2', 'AuxInfo=1/0/N:4,8,16,12,13,5,9,6,14,15,3,7,11,17,18,19,20,21,22,23,24,1,2,10/E:(1,2)(4,5)(9,10)(11,12)(14,15)(16,17,18,19,20,21)(22,23)/rA:24OOCCCCCCCOCCCCCCCCFFFFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s1 0;s11;d+11;d-12;s13;s14d-15;s14;s15;s17;s17;s17;s18;s18;s18;/rC:11.127,-2.3151,0;8.652,-3.744,0;10.7145,-3.0296,0;11.127,-3.744,0;9.8895,-3.0296,0;10.7145,-4.4585,0;9.477,-3.744,0;9.8895,-4.4585,0;11. 127,-5.173,0;11.952,-5.173,0;12.3645,-5.8875,0;13.1895,-5.8875,0;11.952,-6.602,0;13.602,-6.602,0', 'MCGIWMAVEWETEI-UHFFFAOYSA-N', '1010:ESY55DD7C66JEV22275S8YZWQ4ZSEG', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]-[#8]-[c]2:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]2)-[#6]1', 'O=C1CC(=O)CC(COc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1', '03.462', '3.462', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1401\r\n1.2e-002\r\n6.5e-002\r\n-3.5e-003\r\n0.1401\r\n1.2e-002\r\n5.69e-002\r\n-0.3458\r\n7.61e-002\r\n-1.96e-002\r\n-1.96e-002\r\n5.86e-002\r\n5.86e-002\r\n-3.76e-002\r\n0.416\r\n0.416\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '3.951', 'C15H12F6O3', '0354.069', '-5.076', '0354.244', '1.01', '3', '0', '2', '17', '06', '1', '24', '25', '9', '5', '003', '00', '12', '0', '2', '005', '0043.37', '319.71', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(CO/C/1=C/C(C(F)(F)F)=C\\C(C(F)(F)F)=C1)CC(=O)C2', 'O=C2CC(=O)CC(COc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2', 'CHD_67', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(261, '261', 'Not Available', 'CC1(COc2ccccc2)CC(=O)CC(=O)C1', '5-methyl-5-(phenoxymethyl)cyclohexane-1,3-dione', 'CYAAFQwAYfwQZgW6lSw8FXNhguG2mCBEU5FzQLoTxdWZcjfDuJwc0l8EM0$dXQH2TXJVLvnyPcJHLgPDk18m5T8qtMHc7OSbgllqCJ$5q0pZSlRT2pAoXON$7AMiuL6IDJyB^PLHSaMwgy0phfRUmreByEEzhPXwOnIrHZQ45ICaklzX3PQC9JHOeXl7YGIyGSOlX7Dv TeeGz583z9X8GO^dDh3cl7W0LfSKx1V^ne^FUHyXth3cnfDELNkWu23vm0wz2^GI7v6s7f9Bf1fR93gw9lj9qn0JGxSOz1Z$hbFAowvKXEjQ5uYEMTFiTImLXRAXNWSQ0o5WdTLT1joKwupK9QdR5KL5N^pCZvQFvRIHp5AGWTpOAekbDf$pr9KfmFg^bAq4', 'InChI=1S/C14H16O3/c1-14(8-11(15)7-12(16)9-14)10-17-13-5-3-2-4-6-13/h2-6H,7-10H2,1H3', 'AuxInfo=1/0/N:17,16,14,15,12,13,5,4,8,9,3,7,11,6,1,2,10/E:(3,4)(5,6)(8,9)(11,12)(15,16)/rA:17OOCCCCCCCOCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s10;s11;d+11;d-12;s13;s14d-15;s6;/rC:11.127,-2.3151,0;8.6 52,-3.744,0;10.7145,-3.0296,0;11.127,-3.744,0;9.8895,-3.0296,0;10.7145,-4.4585,0;9.477,-3.744,0;9.8895,-4.4585,0;11.127,-5.173,0;11.952,-5.173,0;12.3645,-5.8875,0;13.1895,-5.8875,0;11.952,-6.602,0;13. 602,-6.602,0;12.3645,-7.3165,0;13.1895,-7.3165,0;10.0989,-5.3079,0;', 'XRBILOBFEYWFQT-UHFFFAOYSA-N', '1010:ST8FSTWVHMXFHTYTAH55NFNZ5W5JZS', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6])(-[#6]-[#8]-[c]2:[c]:[c]:[c]:[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(C)(COc2ccccc2)C1', '01.851', '1.851', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1404\r\n1.45e-002\r\n6.5e-002\r\n5.2e-003\r\n0.1404\r\n1.45e-002\r\n5.95e-002\r\n-0.3456\r\n7.49e-002\r\n-3.18e-002\r\n-3.18e-002\r\n-5.97e-002\r\n-5.97e-002\r\n-6.21e-002\r\n-5.66e-002', '0', '2.34', 'C14H16O3', '0232.11', '-2.977', '0232.275', '-0.75', '3', '0', '2', '10', '06', '1', '17', '18', '4', '5', '003', '00', '16', '0', '2', '003', '0043.37', '252.09', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(CO/C/1=C/C=C\\C=C1)(C)CC(=O)C2', 'CC2(COc1ccccc1)CC(=O)CC(=O)C2', 'CHD_68', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(262, '262', 'Not Available', 'CC1(COc2cc(cc(c2)C(F)(F)F)C(F)(F)F)CC(=O)CC(=O)C1', '5-[[3,5-bis(trifluoromethyl)phenoxy]methyl]-5-methyl-cyclohexane-1,3-dione', 'CYAAFQwAGewQbhlx6UYg61xfM7L2q2iUAUuv^ur6DKny8pmm8AvXQEr6hdPtVtd^zOLpdtOWjIirGU5RL$grA7jsb2S0uhQrD3rxfx3L$jF$ROVKWFA25Cr^qWq1RMo77Yf0yDkYO4u3FFDDEgQn9G9cznnuBYHWNhciYhgjeQ$8WDGPPAH0p4UPEkDd9XcyDf73cDfB OyW52VPH31gvq9ZPQYX6SDEwzczn2YeXAf85D5pf0lII0X754ujoE$Wt7ALk3dzhmf7D5A0S3hM7gOUnXmD1sfRD7k4ez3q8ajsJW7^^xIge9sMSSaeX5Uf3GLWA2k^i4PIHl4MWSfygAdkHuTGmML3Gg6SfFtunO3h8HvPASbRaMjliFj0sctIPkWFzIgrKVWgnryla UXcai4u3q1CiI6bFF$QeEyVyCaOTslcxMQFhWr2m2qGluqVqVrqwYaPOUXRsC5qCWtfHsYFhsP^pLPO33ybcB4fNkjVeED', 'InChI=1S/C16H14F6O3/c1-14(6-11(23)5-12(24)7-14)8-25-13-3-9(15(17,18)19)2-10(4-13)16(20,21)22/h2-4H,5-8H2,1H3', 'AuxInfo=1/0/N:17,16,12,13,5,4,8,9,14,15,3,7,11,6,18,19,20,21,22,23,24,25,1,2,10/E:(3,4)(6,7)(9,10)(11,12)(15,16)(17,18,19,20,21,22)(23,24)/rA:25OOCCCCCCCOCCCCCCCCCFFFFFF/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s 9;s10;s11;d+11;d-12;s13;s14d-15;s6;s14;s15;s18;s18;s18;s19;s19;s19;/rC:12.0133,-2.6769,0;9.1555,-2.6769,0;11.2989,-3.0894,0;11.2989,-3.9144,0;10.5844,-2.6769,0;10.5844,-4.3269,0;9.8699,-3.0894,0;9.869 9,-3.9144,0;10.9969,-5.0415,0;11.8219,-5.0415,0;12.2344,-5.7559,0;13.0594,-5.7559,0;11.8219,-6.4', 'SAXDJPVVQNFQET-UHFFFAOYSA-N', '1010:TGKMAYNM9ATS572GBS22QT2EPREZA8', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6])(-[#6]-[#8]-[c]2:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]2)-[#6]1', 'O=C1CC(=O)CC(C)(COc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1', '03.736', '3.736', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1404\r\n1.45e-002\r\n6.5e-002\r\n5.2e-003\r\n0.1404\r\n1.45e-002\r\n5.95e-002\r\n-0.3455\r\n7.61e-002\r\n-1.96e-002\r\n-1.96e-002\r\n5.86e-002\r\n5.86e-002\r\n-3.76e-002\r\n-5.66e-002\r\n0.416\r\n0.416\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '4.225', 'C16H14F6O3', '0368.085', '-5.388', '0368.271', '-0.75', '3', '0', '2', '18', '06', '1', '25', '26', '10', '5', '003', '00', '14', '0', '2', '005', '0043.37', '349.82', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(CO/C/1=C/C(C(F)(F)F)=C\\C(C(F)(F)F)=C1)(C)CC(=O)C2', 'CC2(COc1cc(C(F)(F)F)cc(C(F)(F)F)c1)CC(=O)CC(=O)C2', 'CHD_69', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(263, '263', 'Not Available', 'Fc1ccc(C2CC(=O)CC(=O)C2)c(F)c1', '5-(2,4-difluorophenyl)cyclohexane-1,3-dione', 'CYAAFQwARewQdkdwtTEzkwlJWEElIx5yQZ8yTE2eE1Tc$N2DGQVhxvzETl0INsXsd4nSR20grwyoq8qk2EA2b1U7vY7IyPXvaG6^bNKr0DbR^aB31xQPLtDT8lBmKLCOMCc$PDrPAN0tFGnJuwMI0uSwBJM5TChwj6sF1UeBJIqLpI8pqvlKHPHuKFaMv1Kc6Ihi^lu7 SAjTgFXri5NaUfxqn6T2FzLy$dSOO67d$c3u4ebzbfr1XI6N$2skry1$r71VjCJkvGF37ttckMOakrdJw8j69LEj^0tvkPOyEytTWJi9pKxcwOpmi4ia5IYzTs3rXrgrm^ChxIELKy0ZwkY2Jn7Y83gUlx5nncFH4KHmFDlrpD8M$gT5^hh5l5fA8dJ', 'InChI=1S/C12H10F2O2/c13-8-1-2-11(12(14)5-8)7-3-9(15)6-10(16)4-7/h1-2,5,7H,3-4,6H2', 'AuxInfo=1/0/N:13,11,5,9,14,6,7,15,4,8,10,12,16,3,1,2/E:(3,4)(9,10)(15,16)/rA:16OOFCCCCCCCCCCCCF/rB:;;d1;s4;s4;s5;d2s6;s7s8;s7;s10;s3d-10;d-11;s12;s13d-14;s15;/rC:11.3413,-4.1052,0;8.4786,-3.9461,0;7.9 518,-6.6198,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.2252,-8.17 54,0;9.9396,-8.588,0;9.9398,-9.7509,0;', 'IPMTVTDPDYIYRN-UHFFFAOYSA-N', '1010:4ANSWHYUHSSN2N2BSEU8EWZB4H6GMP', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#9]):[c]:[c](-[#9]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2c(F)cc(F)cc2)C1', '02.007', '2.008', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n-0.2066\r\n0.1403\r\n1.39e-002\r\n6.5e-002\r\n5.e-004\r\n0.1403\r\n1.39e-002\r\n-8.1e-003\r\n-5.3e-002\r\n0.1291\r\n-2.59e-002\r\n9.8e-003\r\n0.1256\r\n-0.2069', '0', '2.496', 'C12H10F2O2', '0224.065', '-2.962', '0224.203', '1.01', '2', '0', '2', '9', '06', '1', '16', '17', '5', '5', '002', '00', '10', '0', '2', '001', '0034.14', '213.03', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C(F)/C=C(F)\\C=C1)CC(=O)C2', 'O=C2CC(=O)CC(c1ccc(F)cc1F)C2', 'CHD_7', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(264, '264', 'Not Available', 'O=C1CC(CC(=O)C1)C2CC2c3ccccc3', '5-(2-phenylcyclopropyl)cyclohexane-1,3-dione', 'CYAAFQwAbdwQANtcwSIErKZJveiBxgnbUfe4KWjQ0Arw7nv$hVDbvVA8C$NTIj05pRUWrkkfSJpGPQMA48hCtPONidvi5f$KSIkf1wVIcDYzWNrgCVM^L16YdFeVOjMiSswA7e2OmCTSBNDqB7CaDT9CFmzY4KEHjGTyd7JalFSyuvR9pccoH5y$xJHGb79^6wT4WLX6 9e0Iv8dP$8nbbLX18AJF535hKTqYdnQRJyoH8YJV^tbLxFUOA^Wt5pPFoLj1x4YAec5Ci2XEn9lbuFh7h8Sng93ZO3jvjuHAYXEXMjliiRaRXIiLpWxcClSCSCuqN1iJ2b6GCa712J8rOP8qhbjyph6i4ih9cOXRWuSzjMnZ4NsYCsXT$wHe2efjB9hxmKqm', 'InChI=1S/C15H16O2/c16-12-6-11(7-13(17)8-12)15-9-14(15)10-4-2-1-3-5-10/h1-5,11,14-15H,6-9H2', 'AuxInfo=1/0/N:17,15,16,13,14,4,8,5,10,12,6,3,7,11,9,1,2/E:(2,3)(4,5)(6,7)(12,13)(16,17)/rA:17OOCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s9s10;s11;s12;d+12;d-13;s14;s15d-16;/rC:12.0133,-2.6769,0 ;9.1555,-2.6769,0;11.2989,-3.0894,0;11.2989,-3.9144,0;10.5844,-2.6769,0;10.5844,-4.3269,0;9.8699,-3.0894,0;9.8699,-3.9144,0;10.9969,-5.0415,0;10.566,-5.6259,0;11.7092,-5.0992,0;12.2344,-5.7559,0;13.05 94,-5.7559,0;11.8219,-6.4704,0;13.4719,-6.4704,0;12.2344,-7.1849,0;13.0594,-7.1849,0;', 'LSQPOUHSUCSVAD-UHFFFAOYSA-N', '1010:DF7K52WNTZ2ZQ18TGP2SG2GKGBY2NJ', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6]2-[#6](-[c]3:[c]:[c]:[c]:[c]:[c]3)-[#6]2)-[#6]1', 'O=C1CC(=O)CC(C2C(c3ccccc3)C2)C1', '02.185', '2.185', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.14\r\n1.e-002\r\n6.5e-002\r\n-2.42e-002\r\n0.14\r\n1.e-002\r\n-3.03e-002\r\n-4.24e-002\r\n-1.28e-002\r\n-4.47e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002', '0', '2.673', 'C15H16O2', '0228.115', '-3.283', '0228.286', '-8.99', '2', '0', '2', '11', '06', '1', '17', '19', '4', '5', '002', '00', '16', '0', '3', '002', '0034.14', '220.89', '', '', '', '', '', '', '', '', '', '', '', 'O=C3CC(C1CC1/C/2=C/C=C\\C=C2)CC(=O)C3', 'O=C3CC(=O)CC(C1CC1c2ccccc2)C3', 'CHD_70', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(265, '265', 'Not Available', 'FC(F)(F)c1cc(cc(c1)C(F)(F)F)C2CC2C3CC(=O)CC(=O)C3', '5-[2-[3,5-bis(trifluoromethyl)phenyl]cyclopropyl]cyclohexane-1,3-dione', 'CYAAFQwAVdwQS^SvhXZlXOPIG5Ert78xXG0P2T4pEbLU4F$3$gJ2sgLfOvdxUd5CcUlszfwRiNOXYXwo6F3UcqWNA7OdnU7JLEBBCYCPpwTdSwzyrrPA5iqepgk6TcSwH4akFjxId25BTaAHOmyV8Ih64CbwN5AcuXn4YUersjdJpQgnXZiy6wz87vzKzIhJTENcWE3b DQcnL0MXfQMGnvNy^^haw1l$bMgHL85f4wF6QeBkBOKrbS8iamQ907AY9nbUPf19953y^vdl9FhvfprI2X$Xot0641Ry6p$znvq8cLb$Wj4Vl1^zL$Vv3ztsPxqs9zIj8GrWM9Wv95Pv174WjkUm2k45U3GOggeakuiQIOKmFxRxVYmK2aRcE4BCeSzlNxg0y7MmCqag tG8ZnR^4vU4mzgkYTuZIOxGkmxMWGT2ImOJTTbwt4QNgw0KTFiarbDmJKetCXwZqXfOgo$^cD8^omLYspC', 'InChI=1S/C17H14F6O2/c18-16(19,20)10-1-8(2-11(5-10)17(21,22)23)14-7-15(14)9-3-12(24)6-13(25)4-9/h1-2,5,9,14-15H,3-4,6-7H2', 'AuxInfo=1/0/N:14,15,5,9,18,6,12,13,7,16,17,4,8,11,10,1,19,20,21,22,23,24,25,2,3/E:(1,2)(3,4)(10,11)(12,13)(16,17)(18,19,20,21,22,23)(24,25)/rA:25COOCCCCCCCCCCCCCCCCFFFFFF/rB:;;d2;s4;s4;s5;d3s6;s7s8;s7 ;s10;s10s11;s11;s13;d+13;s1d+14;s15;s16d-17;s17;s1;s1;s1;s19;s19;s19;/rC:17.8756,-4.6127,0;14.1926,-4.6127,0;12.7637,-7.0877,0;14.1926,-5.4377,0;14.9071,-5.8502,0;13.4781,-5.8502,0;14.9071,-6.6752,0;1 3.4781,-6.6752,0;14.1926,-7.0877,0;15.6215,-7.0877,0;16.4466,-7.0877,0;16.034,-7.8022,0;17.1611,', 'ZGNWACSWSPOQCW-UHFFFAOYSA-N', '1010:YRPW1ETGCC472SUPD62ENFQU2XAWBH', '[#6](-[#9])(-[#9])(-[#9])-[c](:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c]1-[#6]2-[#6]-[#6]2-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]3=[#8])-[#6]3):[c]1', 'C(F)(F)(F)c(cc(C(F)(F)F)cc1C2CC2C(CC(=O)CC3=O)C3)c1', '04.069', '4.069', '0', '0', 'TRUE', '0.4159\r\n-0.2992\r\n-0.2992\r\n0.14\r\n1.e-002\r\n6.5e-002\r\n-2.42e-002\r\n0.14\r\n1.e-002\r\n-3.03e-002\r\n-1.28e-002\r\n-4.24e-002\r\n-4.35e-002\r\n-4.65e-002\r\n-4.65e-002\r\n5.63e-002\r\n5.63e-002\r\n-3.78e-002\r\n0.4159\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '4.558', 'C17H14F6O2', '0364.09', '-5.864', '0364.282', '-8.99', '2', '0', '2', '19', '06', '1', '25', '27', '10', '5', '002', '00', '14', '0', '3', '004', '0034.14', '318.62', '', '', '', '', '', '', '', '', '', '', '', 'C(/C/3=C/C(C2C(C1CC(=O)CC(=O)C1)C2)=C\\C(C(F)(F)F)=C3)(F)(F)F', 'O=C3CC(=O)CC(C1CC1c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C3', 'CHD_71', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(266, '266', 'Not Available', 'CC(Oc1cc(Cl)cc(Cl)c1)C2CC(=O)CC(=O)C2', '5-[1-(3,5-dichlorophenoxy)ethyl]cyclohexane-1,3-dione', 'CYAAFQwArcwQOlW0vn1vzzp30Xl79b^sUVo^4JHWXzpNGgBXF5j3EzxfIoktMvKQjVxuSWEimILmLjHKMqIK7hfX68p7F59R^cqXAGs019j47VdRoWhBrqfejgRrtiBfPoddkgBR7oLSoSJGasRKDX1Uby8KFmdV4lLHimoFpgnHJrzzGdQK016qWPs3$v^W4ttypVoG a79VgJ21aonHv2fD8W^7H6gdhZozPtpXxhI0^$yI74fBcO^bvnUGMOWy2nzyMWh9P^g3tEZYet9$n$8m3KLZuv75Clftc5g$L1L7kkz55PYCafpmnJJcI1Dcg7SKBG3SNoIUTVAfAxMwU3cJ1iFtq6LmFgmH$Sn4AbrCuAEHQe1F1wFXds4noWNS7t0TXWgQzww^8MAP VzhvqrVfW53B7FL', 'InChI=1S/C14H14Cl2O3/c1-8(9-2-12(17)7-13(18)3-9)19-14-5-10(15)4-11(16)6-14/h4-6,8-9H,2-3,7H2,1H3', 'AuxInfo=1/0/N:10,4,8,17,13,14,5,9,6,15,16,3,7,12,19,18,1,2,11/E:(2,3)(5,6)(10,11)(12,13)(15,16)(17,18)/rA:19OOCCCCCCCCOCCCCCCClCl/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;s9;s11;s12;d+12;d-13;s14;s15d-16;s16;s 15;/rC:11.8686,-2.6901,0;9.3936,-4.119,0;11.4561,-3.4046,0;11.8686,-4.119,0;10.6311,-3.4046,0;11.4561,-4.8336,0;10.2186,-4.119,0;10.6311,-4.8336,0;11.8686,-5.548,0;11.4561,-6.2625,0;12.6936,-5.548,0;1 3.1061,-6.2625,0;13.9311,-6.2625,0;12.6936,-6.977,0;14.3437,-6.977,0;13.1061,-7.6914,0;13.9311,-', 'WSEAUBQOJSFWIC-UHFFFAOYSA-N', '1010:NPQ8G5Y6JZVD9JMRBZPU4F6MHDT575', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[#6](-[#8]-[c]2:[c]:[c](-[#17]):[c]:[c](-[#17]):[c]2)-[#6])-[#6]1', 'O=C1CC(=O)CC(C(Oc2cc(Cl)cc(Cl)c2)C)C1', '03.284', '3.284', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1401\r\n1.22e-002\r\n6.5e-002\r\n-1.e-003\r\n0.1401\r\n1.22e-002\r\n6.5e-002\r\n-3.79e-002\r\n-0.3428\r\n7.82e-002\r\n-1.3e-002\r\n-1.3e-002\r\n4.46e-002\r\n4.46e-002\r\n-2.47e-002\r\n-8.42e-002\r\n-8.42e-002', '0', '3.773', 'C14H14Cl2O3', '0300.032', '-4.437', '0301.165', '1.01', '3', '0', '2', '12', '06', '1', '19', '20', '6', '5', '003', '00', '14', '0', '2', '003', '0043.37', '281.97', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(C(C)O/C/1=C/C(Cl)=C\\C(Cl)=C1)CC(=O)C2', 'CC(Oc1cc(Cl)cc(Cl)c1)C2CC(=O)CC(=O)C2', 'CHD_72', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(267, '267', 'Not Available', 'CC(Oc1cc(cc(c1)C(F)(F)F)C(F)(F)F)C2CC(=O)CC(=O)C2', '5-[1-[3,5-bis(trifluoromethyl)phenoxy]ethyl]cyclohexane-1,3-dione', 'CYAAFQwAGewQbhlx6UYgav1fIHkINKp72AiGkKlJFuAyN9qON$ZcvHUOQOfGqvmig$4o17^$ykVWCxJ3UlKfEnDo8JVmUUaiya6C7rfgY5T5a3B7SmA7XV1vGFTGiIB$BOvS6OYFJLMxRfmoMBinLEsLzMJDjG5ZXOHrUNhm3r3bBhEpSm7NaA953kV3ALvkyeUB0mRx w5gGj$cJgc3Vr85brzff5E8duLM9RfeMe$rWyl1dNwCZZDCXR$Ero^RP7D3oOf1$f43y^vdhdFgvcpHJ2H$Xot46Y7By6Q$5nvqcuuVurT0qb575ge97tftLpUvlvi96bPSUoY463$969Si5yhz4Dimja34SIoDFNvwXChi5RckNEl1sJXImhYgQm2UOJYKN9^0SCpSg THmZLUz^QU8l34Lw9G6JhGWOhuyNVZ8MVprWIqAWUNSlF56CC2SqYrFmlzkW8GAvb^pvaTz5Bd$P3SO', 'InChI=1S/C16H14F6O3/c1-8(9-2-12(23)7-13(24)3-9)25-14-5-10(15(17,18)19)4-11(6-14)16(20,21)22/h4-6,8-9H,2-3,7H2,1H3', 'AuxInfo=1/0/N:12,5,9,18,14,15,6,10,7,16,17,4,8,13,1,19,20,21,22,23,24,25,2,3,11/E:(2,3)(5,6)(10,11)(12,13)(15,16)(17,18,19,20,21,22)(23,24)/rA:25COOCCCCCCCOCCCCCCCCFFFFFF/rB:;;d2;s4;s4;s5;d3s6;s7s8;s7 ;s10;s10;s11;s13;d+13;s1d+14;s15;s16d-17;s17;s1;s1;s1;s19;s19;s19;/rC:17.8756,-4.6127,0;14.1926,-4.6127,0;12.7637,-7.0877,0;14.1926,-5.4377,0;14.9071,-5.8502,0;13.4781,-5.8502,0;14.9071,-6.6752,0;13.4 781,-6.6752,0;14.1926,-7.0877,0;15.6215,-7.0877,0;16.4466,-7.0877,0;16.034,-7.8022,0;17.1611,-6.', 'FVEVQUBFQXFSNY-UHFFFAOYSA-N', '1010:3MXTBSYPAQVKGKKYAWK4T4B14X2R4J', '[#6](-[#9])(-[#9])(-[#9])-[c](:[c]:[c](-[#6](-[#9])(-[#9])-[#9]):[c]:[c]1-[#8]-[#6](-[#6])-[#6](-[#6]-[#6](=[#8])-[#6]-[#6]2=[#8])-[#6]2):[c]1', 'C(F)(F)(F)c(cc(C(F)(F)F)cc1OC(C)C(CC(=O)CC2=O)C2)c1', '03.84', '3.84', '0', '0', 'TRUE', '0.416\r\n-0.2992\r\n-0.2992\r\n0.1401\r\n1.22e-002\r\n6.5e-002\r\n-1.e-003\r\n0.1401\r\n1.22e-002\r\n6.5e-002\r\n-0.3429\r\n-3.79e-002\r\n7.65e-002\r\n-1.96e-002\r\n-1.96e-002\r\n5.86e-002\r\n5.86e-002\r\n-3.76e-002\r\n0.416\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662\r\n-0.1662', '0', '4.328', 'C16H14F6O3', '0368.085', '-5.59', '0368.271', '1.01', '3', '0', '2', '18', '06', '1', '25', '26', '10', '5', '003', '00', '14', '0', '2', '005', '0043.37', '338.22', '', '', '', '', '', '', '', '', '', '', '', 'C(/C/2=C/C(OC(C1CC(=O)CC(=O)C1)C)=C\\C(C(F)(F)F)=C2)(F)(F)F', 'CC(Oc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C2CC(=O)CC(=O)C2', 'CHD_73', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(268, '268', 'Not Available', 'Cc1cc(C)c(C2CC(=O)CC(=O)C2)c(C)c1', '5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAVfwQzL$c62MZvVdoYu5RqAIExwqV6vousOdW$^3^8EoB0m9t7XfGxImodywV8$gylFiCj3UoGF7ELGOkYDXgqvaTk6p06xy^CiT3SGlHj^9usefHgz8yRFx2M^gP7PA6FsDvXJBZsLMCAxnE4w1O0gBS5Jcx5BBtCP2g1GMKSQKvl7uOoeiPcsFR3oJGhkXb mvjOvLjIJ6ccXz$P2^Ycnm3i7O3W6py$dmdI1y8eVIPvZlgT8GY5f3uyOZzItIqUWVuL9ptF3iYx^3q$1TUVVWstybdu7dCLL^5f4aHQFleCkYOrTqJtcVNSC6chtg6cwtqgqhbTXJsTCJ8chvTMMw6ZKLdWc01OdXkrleIPxC8a7u5T8GQvH^pvGz759C3f9^J', 'InChI=1S/C15H18O2/c1-9-4-10(2)15(11(3)5-9)12-6-13(16)8-14(17)7-12/h4-5,12H,6-8H2,1-3H3', 'AuxInfo=1/0/N:17,15,16,13,12,4,8,5,14,11,10,6,3,7,9,1,2/E:(2,3)(4,5)(6,7)(10,11)(13,14)(16,17)/rA:17OOCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s11;s10;s14;/rC:11.3413,-4.10 52,0;8.4786,-3.9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.1755,0;9.22 52,-8.1754,0;9.9396,-8.588,0;8.3594,-6.5901,0;11.3413,-6.7391,0;9.9994,-9.3533,0;', 'RGCPDRWZRFMXHQ-UHFFFAOYSA-N', '1010:K3XA8HQ4UQHYZAH1E1F5AXTRS43NYM', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c](-[#6]):[c]:[c](-[#6]):[c]:[c]2-[#6])-[#6]1', 'O=C1CC(=O)CC(c2c(C)cc(C)cc2C)C1', '03.055', '3.055', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-1.9e-003\r\n0.1403\r\n1.38e-002\r\n-3.82e-002\r\n-4.71e-002\r\n-4.71e-002\r\n-5.61e-002\r\n-5.61e-002\r\n-5.06e-002\r\n-3.95e-002\r\n-3.95e-002\r\n-3.98e-002', '0', '3.544', 'C15H18O2', '0230.131', '-4.09', '0230.302', '1.01', '2', '0', '2', '10', '06', '1', '17', '18', '6', '5', '002', '00', '18', '0', '2', '001', '0034.14', '255.36', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C1=C(C)/C=C(C)\\C=C1\\C)CC(=O)C2', 'Cc2cc(C)c(C1CC(=O)CC(=O)C1)c(C)c2', 'CHD_8', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(269, '269', 'Not Available', 'CC(C)(C)c1ccc(cc1)C2CC(=O)CC(=O)C2', '5-(4-tert-butylphenyl)cyclohexane-1,3-dione', 'CYAAFQwAGewQuAY5SzXAeM6Na2fVSUaDjTfl7NjWdw2gIAyazNWwlrdBponmpHPELBwsmqomi^cxWEUgu$daOouVULJ5DxKPG9eFdR3QNyIQqJehYArqWyd$XIsqNL6IzH5AtzbgIAulCcxIIkbnGC97ZfwCpmcBp5NcBTLSUobE8e7AMEDL^PP3CSHXBWMuqUvOk8SL uMm19IaO6njjD43w^$2dZvDZ4enOfgzre6eM1y8eVIPvIxul51h4^udlcp2R3lBzSWNO1jqsr638X1^nOeFR^6U^YfrlEhVjEnjtnhJeiWDgoIuJXVjUcVdIm7aRVhcTqVIkFQ1FVH8NvWIXFqo5C7gYyF7Xr8ES7Q67ytIVdn$npdEbKKDFXpIv3eJgkx^0D4^anyxA MD', 'InChI=1S/C16H20O2/c1-16(2,3)13-6-4-11(5-7-13)12-8-14(17)10-15(18)9-12/h4-7,12H,8-10H2,1-3H3', 'AuxInfo=1/0/N:16,17,18,10,11,12,13,4,8,5,9,6,14,3,7,15,1,2/E:(1,2,3)(4,5)(6,7)(8,9)(14,15)(17,18)/rA:18OOCCCCCCCCCCCCCCCC/rB:;d1;s3;s3;s4;d2s5;s6s7;s6;s9;d+9;d-10;s11;s12d-13;s14;s15;s15;s15;/rC:11.34 13,-4.1052,0;8.4786,-3.9461,0;10.6542,-4.8754,0;10.6542,-5.7004,0;9.9397,-4.4629,0;9.9397,-6.1129,0;9.2253,-4.8754,0;9.2253,-5.7004,0;9.9397,-6.9379,0;10.6542,-7.3505,0;9.2252,-7.3505,0;10.6541,-8.175 5,0;9.2252,-8.1754,0;9.9396,-8.588,0;9.9994,-9.3533,0;11.3114,-9.3235,0;9.9994,-10.2777,0;9.0054', 'DOBCYMOHKDQMLM-UHFFFAOYSA-N', '1010:5CS1VMEGGDR1YW64GC6JEGHQ9A25SE', '[#8]=[#6]1-[#6]-[#6](=[#8])-[#6]-[#6](-[c]2:[c]:[c]:[c](-[#6](-[#6])(-[#6])-[#6]):[c]:[c]2)-[#6]1', 'O=C1CC(=O)CC(c2ccc(C(C)(C)C)cc2)C1', '02.997', '2.997', '0', '0', 'TRUE', '-0.2992\r\n-0.2992\r\n0.1403\r\n1.38e-002\r\n6.5e-002\r\n-2.4e-003\r\n0.1403\r\n1.38e-002\r\n-4.41e-002\r\n-5.85e-002\r\n-5.85e-002\r\n-5.83e-002\r\n-5.83e-002\r\n-4.27e-002\r\n-1.32e-002\r\n-5.61e-002\r\n-5.61e-002\r\n-5.61e-002', '0', '3.485', 'C16H20O2', '0244.146', '-4.456', '0244.329', '1.01', '2', '0', '2', '11', '06', '1', '18', '19', '6', '5', '002', '00', '20', '0', '2', '002', '0034.14', '278.37', '', '', '', '', '', '', '', '', '', '', '', 'O=C2CC(/C/1=C/C=C(C(C)(C)C)\\C=C1)CC(=O)C2', 'CC(C)(C)c2ccc(C1CC(=O)CC(=O)C1)cc2', 'CHD_9', 'Not Available', 'Superoxide Dismutase 1', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22189273', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT; Lou Gehrig Disease'),
(270, '9996409', '9996409', 'OC(=O)C1(CC1)c2ccc(c(F)c2)c3ccc(Cl)c(Cl)c3', '1-[4-(3,4-dichlorophenyl)-3-fluoro-phenyl]cyclopropanecarboxylic acid', 'CYAAFQwADcwQ6$j9aqOXs7lCrcF$pJiCe3pNmtnUjhtUyOHfnWE5B57C2WgL13irqxvSecI27KyJvfEoSpQl2MR3w0wK68$wg1KqxKomFawQ6cI30xfq9s^0WWSM0DOlw67OJ8rT$IMAsbZfbVmQ3ZRUIjQ3SbFAm990lMHv9nySrHElZcgtlDWxWsIILyZ6KvybTXNx wR31BJXSC08wbD5sZeot9zPMDlDWZaM8VQroKnOszaTcV$if$Mi60Sv5zMh$xcbbctmVLIfVNCw5sB0EUXlny5iVeN$8vEXhfUM0oXvojD3ihgOwaxsP9vXitnKy7kYQ3mjHIhr0nt5QgholTbf4i9Q0M4^7xoM$dvKL516HKwMRAeO18QPtsWKkqYOHHaQllBXZMNXr DRRXKexRIrrz9talCLmSJ0pebovHxww8f1td$rRAc6CR^5AifOMJjhjXH659$zMi$Vr1u3LnEZ8979HRjQ8Pzc53HEzpqvLN', 'InChI=1S/C16H11Cl2FO2/c17-12-4-1-9(7-13(12)18)11-3-2-10(8-14(11)19)16(5-6-16)15(20)21/h1-4,7-8H,5-6H2,(H,20,21)', 'AuxInfo=1/1/N:18,12,14,20,7,8,17,11,16,9,15,21,19,13,10,6,2,1,3,4,5/E:(5,6)(20,21)/rA:32ClClFOOCCCCCCCCCCCCCCCCHHHHHHHHHHH/rB:;;;;;s6;s6s7;s6;s4d5s6;d+9;s9;s3s11;d-12;d+13s14;s15;d+16;s16;s1s17;d-18;s 2d-19s20;s7;s7;s8;s8;s11;s12;s14;s4;s17;s18;s20;/rC:-4.8426,-2.4885,.0076;-6.4665,.3059,-.147;-.4564,.3848,2.2398;4.6171,-1.4287,1.217;4.7108,-1.7514,-1.0375;3.7774,.2698,-.1433;4.4775,1.3197,-.9528;4 .48,1.4011,.5457;2.2874,.265,-.1402;4.4117,-1.0643,-.0723;1.5923,.3282,1.0674;1.5876,.1975,-1.34', 'LIYLTQQDABRNRX-UHFFFAOYSA-N', '1010:BJW3SWJ95Y57PGDDCTS1K6NK5DBPAZ', '[#17]-[c](:[c](:[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[#1]):[c](-[#1]):[c]2-[#6]3(-[#6](=[#8])-[#8]-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]):[c](:[c]2-[#1])-[#9])-[#17]):[c]1-[#1]', 'Clc(c(c([H])c([H])c1c(c([H])c([H])c2C3(C(=O)O[H])C([H])([H])C3([H])[H])c(c2[H])F)Cl)c1[H]', '05.055', '5.055', '0', '0', 'TRUE', '-8.27e-002\r\n-8.28e-002\r\n-0.2063\r\n-0.3311\r\n-0.2658\r\n8.11e-002\r\n-3.27e-002\r\n-3.27e-002\r\n-2.9e-002\r\n0.2689\r\n-2.14e-002\r\n-5.72e-002\r\n0.1308\r\n-5.12e-002\r\n1.75e-002\r\n-1.39e-002\r\n-3.41e-002\r\n-5.27e-002\r\n5.98e-002\r\n-4.14e-002\r\n5.92e-002\r\n2.81e-002\r\n2.81e-002\r\n2.8', '0', '3.583', 'C16H11Cl2FO2', '0324.012', '-6.11', '0325.162', '3.59', '1', '0', '1', '10', '12', '2', '21', '23', '18', '7', '002', '01', '11', '0', '3', '003', '0037.29', '289.1', '', '3.41706', '1.3197', '58.56', '49.64', '3.95169', '8.92', '1,246.07', '82.791', '228.78', '', 'Cl/C/3=C(Cl)/C=C\\C(\\C2=C(F)\\C=C(C1(C(O)=O)CC1)/C=C2)=C3', 'O=C(O)C3(c2ccc(c1ccc(Cl)c(Cl)c1)c(F)c2)CC3', 'CHF 5074', 'CSP-1103; GHF-5074; H50', 'Amyloid beta A4 protein', '9996409', 'Phase II Completed', 'Alzheimer disease (AD)', '25450955', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(271, '2719', '2719', 'CCN(CC)CCC[C@H](C)Nc1ccnc2cc(Cl)ccc12', '(4<I>S</I>)-<I>N</I>4-(7-chloro-4-quinolyl)-<I>N</I>1,<I>N</I>1-diethyl-pentane-1,4-diamine', 'CYAAFQwAMcwQXcREhbtGekw6dkPx909q^ToDpXAvUeBU071dzwDkgiC06O7qgE^056FY8wE1PzsCmoyB3xJuD2qy$PqhuEBpzJ543TOwrHv5utHXqBme39e3svSYzTdp^z5H39zPh93LdXfrqxRkF0nKFL2hzJWs$^FK6EyGOM47xPoJ1CkFBq$r$iFBXcYlyoyzw1R9 NtHmkeoHHcYh4FcM9BwqHEY9FaNOI98F8YEF6veM5qvPLXOLqNly1inOl2kWKru0qf2iEZnOi3LYL6dxuK$F7VZxMi8MrW$alVtCC08joeXNnYmWWtLZKlMJse^NAuoQP84KRRfEVqarI$gBLK821b1ZP3lynMC3j3VIenWxmNDKr6BV7ZqyNaoHOk7xoetf$durAFGy 1cQmjEMp1vdBMedM6xnYR^Jr30DYAtmTsVWmDHLsx7Tgq6MyvTXfKoBNsrC02KS$eKBjJQPwSf$71IRYEeXPr0ze0FKBxnw4', 'InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)/t14-/m0/s1', 'AuxInfo=1/1/N:14,15,9,10,11,6,5,21,18,16,19,8,20,7,22,13,12,17,1,4,3,2/E:(1,2)(4,5)/it:im/rA:48ClNNNCCC.oCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s5;s3s5;s2s6;s7;s2;s2;s3;d+12;s10;s11;s12;d-4s 13;s13;s4d-16;s17;d-18;s1d+20s21;s5;s5;s6;s6;s7;s8;s8;s3;s9;s9;s9;s10;s10;s11;s11;s14;s14;s14;s15;s15;s15;s16;s18;s19;s20;s21;/rC:5.6865,1.6202,1.4891;-3.4381,1.1166,.2312;.0243,-1.899,.2448;2.3431,.6 111,-2.192;-2.3561,-1.5882,-.2345;-2.6376,-1.008,1.157;-1.1696,-2.5616,-.2376;-3.7816,.0041,1.10', 'WHTVZRBIWZFKQO-AWEZNQCLSA-N', '1010:V6P7TDFKY8BFG6TTB9QCDS7VPAVZTG', '[#17]-[c](:[c](-[#1]):[c]1-[#1]):[c](-[#1]):[c]2:[c]1:[c](:[c](-[#1]):[c](-[#1]):[n]2)-[#7](-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7] (-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]', 'Clc(c([H])c1[H])c([H])c2c1c(c([H])c([H])n2)N([H])[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]', '04.345', '4.345', '0', '0', 'TRUE', '-8.43e-002\r\n-0.3039\r\n-0.2853\r\n-0.2561\r\n-3.65e-002\r\n-3.9e-002\r\n8.5e-003\r\n-1.9e-003\r\n-4.95e-002\r\n-4.7e-003\r\n-4.7e-003\r\n2.58e-002\r\n1.82e-002\r\n-5.25e-002\r\n-5.25e-002\r\n-2.52e-002\r\n7.32e-002\r\n-4.98e-002\r\n2.91e-002\r\n-1.71e-002\r\n-4.28e-002\r\n4.27e-002\r\n2.82e-002\r\n', '1', '3.106', 'C18H26ClN3', '0319.182', '-5.857', '0319.872', '7.6 10.17', '1', '1', '0', '12', '11', '2', '22', '23', '30', '5', '003', '01', '26', '0', '2', '008', '0028.16', '357.67', '', '2.49849', '1.2599', '13.91', '6.14', '3.87463', '7.77', '1,015.83', '25.425', '271.31', '', 'Cl/C/2=C/C1=N/C=C\\C(N[C@H](CCCN(CC)CC)C)=C1\\C=C2', 'CCN(CC)CCC[C@H](C)Nc1ccnc2cc(Cl)ccc12', 'Chloroquine', 'Aralen; Capquin; Artrichin; Reumachlor; Bemasulph; Malaquin; Arthrochin', 'Nuclear receptor subfamily 4 group A member 2', '2719', 'Under Investigation', 'Parkinson Disease(PARK)', '26124091', 'Parkinson Disease(PARK)', 'PARK'),
(272, '2726', '2726', 'CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13', '3-(2-chlorophenothiazin-10-yl)-<I>N</I>,<I>N</I>-dimethyl-propan-1-amine', 'CYAAFQwAGdwQMJ45Gh7OlH2jqRCczd2cGozosCqqQz6HBrKxPiRn6^uM^H6azFc17sN4zUPXfBtMLsN4^QcWRSXRPmVbs98tnXQacRs1S^gQ5LmRwxbpb$LfqNBQ^aaDRcx$BsT7v5NQGk$vbRryYGHusZh7tLeoj^z08tn8cPyEGO97L8Q3wt58eo9$jDFPhxksT1JW Evc$hVxSU2PsaouNkf7$TCeQKm3BpGPUIDL4nudF59wJNNKevocITGdBguxhxC$6NkfewnXJcomjVmddpvXi6aUQb0A$NDY1wD3AWVIVMOUPSFQEDH3lVnHGaAx8nhOvOwCfs27Tqe9XscxcXA1yWwevl5id56lj5^Sujbg8y0PNkSViWjrC2J3LQKnhEW4V$9KoGiTP qjpssGROv5xTNUPduqGCXyOHZzM$ZLhaG4vrIr3rYlHU$eFOU7PqFw4kvSEf1VmIV3n7va2AqSIjrJwvHJ7P8GjJNaQKTCLj', 'InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3', 'AuxInfo=1/0/N:16,17,19,21,6,13,15,20,14,7,5,12,18,9,8,11,10,1,4,3,2/E:(1,2)/rA:40ClSNNCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;s3;s5;s4s6;s3;s3;s2d-8;s2s9;s8;d+9;s10;d+11;s4;s4;s1d+12;s13;d-14s18;s1 5d-19;s5;s5;s6;s6;s7;s7;s12;s13;s14;s15;s16;s16;s16;s17;s17;s17;s19;s20;s21;/rC:-5.0532,-1.3975,-.9548;-.4721,2.1681,1.4743;-.0573,-.075,-.6375;2.4307,-2.2659,.6091;.261,-1.3541,-1.2851;.135,-2.509,-. 2922;1.0185,-2.3789,.9524;-1.3932,.1236,-.2059;.9781,.8901,-.5542;-1.7119,1.1264,.7313;.8942,1.9', 'ZPEIMTDSQAKGNT-UHFFFAOYSA-N', '1010:UKKSWWSNFVRJSW83T2RF6XTRQYR17C', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2-[#7](-[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#16]1)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1])-[ #6](-[#1])(-[#1])-[#1]):[c]2-[#1]', 'Clc(c([H])c([H])c1c2N(c3c(c([H])c([H])c([H])c3[H])S1)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c2[H]', '04.739', '4.739', '0', '0', 'TRUE', '-8.43e-002\r\n-8.68e-002\r\n-0.2429\r\n-0.3094\r\n9.3e-003\r\n-2.68e-002\r\n-1.3e-003\r\n3.73e-002\r\n3.58e-002\r\n3.08e-002\r\n3.07e-002\r\n-2.38e-002\r\n-4.25e-002\r\n-4.52e-002\r\n-4.67e-002\r\n-1.37e-002\r\n-1.37e-002\r\n4.22e-002\r\n-6.06e-002\r\n-4.23e-002\r\n-6.11e-002\r\n4.39e-002\r\n4.39e-', '0', '2.81', 'C17H19ClN2S', '0318.096', '-4.848', '0318.864', '7.59 10.16', '0', '0', '0', '11', '12', '2', '21', '23', '22', '6', '002', '00', '19', '0', '3', '004', '0031.78', '326.15', '', '1.11588', '1.2998', '30.12', '4.69', '3.61205', '25.43', '760.577', '37.419', '256.22', '', 'Cl/C/3=C/C2=C(S/C1=C/C=C\\C=C1\\N2CCCN(C)C)\\C=C3', 'CN(C)CCCn3c1ccccc1sc2ccc(Cl)cc23', 'Chlorpromazine', 'Thorazine; Largactil; Contomin; Aminazine; Fenactil; Megaphen; Propaphenin', 'D(2) dopamine receptor', '2726', 'FDA approved', 'Schizophrenia', '24395698', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(273, '5280795', '5280795', 'CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\\C(=C\\C=C\\3/C(CC[C@@H](C3)O)=C)\\CCC[C@]12C', '(1<I>S</I>,3<I>Z</I>)-3-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(1<I>R</I>)-1,5-dimethylhexyl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethyl idene]-4-methylene-cyclohexanol', 'CYAAFQwAPewQ6f1vSZo7uXj^vR2ame0p^VQ$pB3w8ILv$UQ1SlM9SEwVjcv5wC7Pmzkl40JNvZpPGfVsNhT^Jq1qQQrh6$^3kdE9KJ81P6XoX9Ul4tJhjGPZ$^TXZnv9LpJn$D^a^f^w7d9$l8^bzjMAHWW75mes6MsgvIJnNDhOt962ljDqE5hGKUb4g^6eY7Gommt^ LqZKOYYchAZC1BdKFSFrm43fgLWdMEGWkDnPOUd4g^sP8lR06aASM$GjZeN6s0i06QONv1IoeKQ32mncP8wMORLKZfOhfwxhHjtJoCfC0nbF9J3nqEY4X0TFbGKwnHXD4gsGpAIOq3NDC33Xb5907ntjoFBs7AJ^VqZ7qDyTz0Y999wPyRocFoQZVgNdljdNnSIILlR3 8ATzEYW7pD0ePS9yaDZFm95U7bgbOLJzHGkWN^xpo0oDdKs9E$qKe9zTAuRmGEnXgo$qnPe3YddW8qn$OT^I9^TNmlUfvtyS', 'InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1', 'AuxInfo=1/0/N:22,23,28,14,10,16,11,17,13,12,26,15,18,27,5,6,7,21,19,24,8,9,20,25,3,4,2,1/E:(1,2)/it:im/rA:72OC.oC.oC.eCCCC.eCCCCCCCCCCCCCCCCC.oCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;s2 ;s3;s4s5;s2;s3;s4;s2;s7;s9s11;s8;s8;d+9;s13;s16;s15;s17;d+18;s20;s19;s19;s20;s1s21;s24;s25s26;d+24;s3;s4;s5;s5;s6;s6;s7;s7;s8;s10;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s14;s15;s16;s16;s17;s17;s18;s1 9;s21;s21;s22;s22;s22;s23;s23;s23;s25;s26;s26;s27;s27;s28;s28;s1;/r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r\n-2.29e-002\r\n-3.28e-002\r\n-1.43e-002\r\n-4.91e-002\r\n-4.59e-002\r\n-4.67e-002\r\n-4.09e-002\r\n-6.65e-002\r\n-5.88e-002\r\n-4.9e-002\r\n-3.14e-002\r\n-5.04e-002\r\n-6.23e-002\r\n-6.25e-002\r\n-5.28e-002\r\n-5.1e-002\r\n-5.87e-002\r\n-4.71e-002\r\n-4.28e-002\r\n-1.4e-003\r\n-6.28e-00', '1', '7.755', 'C27H44O', '0384.339', '-8.651', '0384.638', '', '0', '1', '3', '27', '00', '0', '28', '30', '51', '3', '001', '01', '44', '0', '3', '006', '0020.23', '446.74', '', '1.46938', '1.2594', '53.12', '32.97', '5.26075', '20.15', '2,125.64', '40.792', '368.38', '', 'OC3C/C(=C/C=C\\2C1C(C)(C(C(CCCC(C)C)C)CC1)CCC2)C(=C)CC3', 'C=C/1CC[C@H](O)CC1=C\\C=C\\2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C', 'Cholecalciferol', 'Vitamin D3; Calciol; Arachitol; Ricketon; Trivitan; Vigorsan', 'Vitamin D3 receptor', '5280795', 'FDA approved', 'Epilepsy', '22503468', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(274, '5280795', '5280795', 'CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\\C(=C\\C=C\\3/C(CC[C@@H](C3)O)=C)\\CCC[C@]12C', '(1<I>S</I>,3<I>Z</I>)-3-[(2<I>E</I>)-2-[(1<I>R</I>,3<I>a</I><I>S</I>,7<I>a</I><I>R</I>)-1-[(1<I>R</I>)-1,5-dimethylhexyl]-7<I>a</I>-methyl-2,3,3<I>a</I>,5,6,7-hexahydro-1<I>H</I>-inden-4-ylidene]ethyl idene]-4-methylene-cyclohexanol', 'CYAAFQwAPewQ6f1vSZo7uXj^vR2ame0p^VQ$pB3w8ILv$UQ1SlM9SEwVjcv5wC7Pmzkl40JNvZpPGfVsNhT^Jq1qQQrh6$^3kdE9KJ81P6XoX9Ul4tJhjGPZ$^TXZnv9LpJn$D^a^f^w7d9$l8^bzjMAHWW75mes6MsgvIJnNDhOt962ljDqE5hGKUb4g^6eY7Gommt^ LqZKOYYchAZC1BdKFSFrm43fgLWdMEGWkDnPOUd4g^sP8lR06aASM$GjZeN6s0i06QONv1IoeKQ32mncP8wMORLKZfOhfwxhHjtJoCfC0nbF9J3nqEY4X0TFbGKwnHXD4gsGpAIOq3NDC33Xb5907ntjoFBs7AJ^VqZ7qDyTz0Y999wPyRocFoQZVgNdljdNnSIILlR3 8ATzEYW7pD0ePS9yaDZFm95U7bgbOLJzHGkWN^xpo0oDdKs9E$qKe9zTAuRmGEnXgo$qnPe3YddW8qn$OT^I9^TNmlUfvtyS', 'InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1', 'AuxInfo=1/0/N:22,23,28,14,10,16,11,17,13,12,26,15,18,27,5,6,7,21,19,24,8,9,20,25,3,4,2,1/E:(1,2)/it:im/rA:72OC.oC.oC.eCCCC.eCCCCCCCCCCCCCCCCC.oCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;s2;s2 ;s3;s4s5;s2;s3;s4;s2;s7;s9s11;s8;s8;d+9;s13;s16;s15;s17;d+18;s20;s19;s19;s20;s1s21;s24;s25s26;d+24;s3;s4;s5;s5;s6;s6;s7;s7;s8;s10;s10;s10;s11;s11;s12;s12;s13;s13;s14;s14;s14;s15;s16;s16;s17;s17;s18;s1 9;s21;s21;s22;s22;s22;s23;s23;s23;s25;s26;s26;s27;s27;s28;s28;s1;/r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r\n-2.29e-002\r\n-3.28e-002\r\n-1.43e-002\r\n-4.91e-002\r\n-4.59e-002\r\n-4.67e-002\r\n-4.09e-002\r\n-6.65e-002\r\n-5.88e-002\r\n-4.9e-002\r\n-3.14e-002\r\n-5.04e-002\r\n-6.23e-002\r\n-6.25e-002\r\n-5.28e-002\r\n-5.1e-002\r\n-5.87e-002\r\n-4.71e-002\r\n-4.28e-002\r\n-1.4e-003\r\n-6.28e-00', '1', '7.755', 'C27H44O', '0384.339', '-8.651', '0384.638', '', '0', '1', '3', '27', '00', '0', '28', '30', '51', '3', '001', '01', '44', '0', '3', '006', '0020.23', '446.74', '', '1.46938', '1.2594', '53.12', '32.97', '5.26075', '20.15', '2,125.64', '40.792', '368.38', '', 'O[C@@H]3C/C(=C/C=C\\2[C@H]1[C@@](C)([C@@H]([C@@H](CCCC(C)C)C)CC1)CCC2)C(=C)CC3', 'C=C/1CC[C@H](O)CC1=C\\C=C\\2CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C', 'Cholecalciferol', 'Vitamin D3; Calciol; Arachitol; Ricketon; Trivitan; Vigorsan', 'Vitamin D3 receptor', '5280795', 'Phase II', 'Multiple Sclerosis', '23767916', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(275, '657272', '657272', 'C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO', '[(2<I>R</I>)-2,3-dihydroxypropyl] 2-(trimethylammonio)ethyl phosphate', 'CYAAFQwA4ewQaKbZP1ROMasrmC9iXl54ZBOa1wriKP^HHwQWIIevWB2C7TDtY9pe04CqP8h5pMFBwSjWnB^rCurMGoawLAsoLDpVq3Lad1OPRcQCzjc2L^sVLglUwmyS2De^cj3$kwfv6gFAEWlg0e^tLCgVW1RxyfOYJyQrNxfZzjazoXFcv2n6yHtNFLeduqy2MV4Y VwebyzrdzjLXGjr7WZjhO3EUCBPvntl6LL2KVSaHk65dxNiH4Tn862zCrsq$$dfkaS77asMVEHOXKd4uuC5ayDkm8yLxv4hDqW6QF5raqFLweSFDK0jZcdeP4IcilbxF8^yMCgZ6ibgrr88Q4QvXOhkaGb7q2cwYFjuvrhVuo2SObdeN86UST4Hm2G^k^QaIobn0aGV7 tDo9XNZHKtqGa7s1fMPHnMalJzuhrVNuYSwTmbqeKKSmcybOyJzz7ktgD61b8E7ZZJy8rQSbcSspkRxMFp$v4QnEkTMiEhRK', 'InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1', 'AuxInfo=1/0/N:10,11,12,9,13,16,15,14,8,7,4,5,6,2,3,1/E:(1,2,3)(12,13)/it:im/CRV:9+1,12-1/rA:36POOOO-OON+CCCCCC.eCCHHHHHHHHHHHHHHHHHHHH/rB:s1;s1;;s1;d1;;;s8;s8;s8;s8;s2s9;s4;s3s14;s7s14;s9;s9;s10;s10;s 10;s11;s11;s11;s12;s12;s12;s13;s13;s14;s15;s15;s16;s16;s4;s7;/rC:.553,2.4007,-.0393;-.6772,1.6035,.6856;1.4596,1.1328,-.5391;1.9536,-1.5968,-1.0475;.0269,3.1186,-1.2643;1.3123,3.1635,1.0256;4.229,-2.7 547,.034;-3.188,-1.085,.0579;-2.4666,.0101,.8302;-2.1893,-2.156,-.3563;-4.2607,-1.7059,.9412;-3.', 'SUHOQUVVVLNYQR-MRVPVSSYSA-N', '1010:UE4NZ1U9WP7PACRE7HF6FPBYUVNYX6', '[#15](=[#8])(-[#8-])(-[#8]-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[#1])-[#8]-[#1])-[#8]-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7+](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1 ])-[#6](-[#1])(-[#1])-[#1]', 'P(=O)([O-])(OC([H])([H])[C@@]([H])(C([H])([H])O[H])O[H])OC([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]', '-04.131', '-2.987', '0', '0', 'TRUE', '0.3933\r\n-0.2984\r\n-0.2993\r\n-0.3883\r\n-0.5973\r\n-0.5973\r\n-0.3936\r\n0.1387\r\n5.94e-002\r\n2.31e-002\r\n2.31e-002\r\n2.31e-002\r\n8.81e-002\r\n0.1009\r\n8.51e-002\r\n7.14e-002\r\n7.06e-002\r\n7.06e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.09e-002\r\n6.09e-002\r\n6.49e-002\r\n6.e-002\r\n6.e-002\r\n5.91e-002\r\n5.91e-002\r\n0.2106\r\n0.211700000000001', '1', '-3.458', 'C8H20NO6P', '0257.103', '-0.323', '0257.221', '6.57', '2', '2', '1', '14', '00', '0', '16', '15', '26', '1', '007', '02', '20', '0', '0', '008', '0108.86', '301.66', '', '26.4323', '1.2652', '21.84', '-2.28', '3.50239', '24.12', '545.94', '193.18', '208.2', '', 'P(OCC[N+](C)(C)C)(OC[C@H](O)CO)([O-])=O', 'C[N+](C)(C)CCO.O=C(O)C(O)C(O)C(=O)[O-]', 'Choline Alfoscerate', 'SN-glycero-3-phosphocholine; Glycerophosphocholine; GPCho; brezal', 'Ganglioside GM2 activator', '657272', 'Under Investigation', 'Alzheimer disease (AD)', '24898643', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(276, '10198924', '10198924', 'C[N+](C)(C)CCO.OC(C(O)C(=O)[O-])C(=O)O', '2-hydroxyethyl(trimethyl)ammonium;2,3,4-trihydroxy-4-oxo-butanoate', 'CYAAFQwAecwQqOrz1O3jiOR8NGX0rqBm1tqXPkyLKOSElfF3l6Ev^badVCNn4Dj3NhhKCQvoe1mVadVbdi2iejEnxVYQihxgNW1L^UWg6X0W0yJEoI^$9EqPPjD^IxSQrHAD7r$iSRZ8G9kwBlHxUjcEBNhlMlaQi9IBWZB$jpci1sCYkCkqnoY5VKKQGA8lVQAPbE1q EHh6xqarsRoX9aViu55c6TEPI4zjeLJ1xDrVeelnE5Lb13TE2G$7kS43En26tA8I4H$7b8YGyD37AfCjphdp6d3H3Z7eTj787f$27euzsZvPx49YeF3jMxihSl06Pln6s57d51Y9xYIBNxjrf7zNuxH8j8su07woWDNVNMLKqOv6etIt6bv88KHEQOk1euvQwnhS$KOy GU0L95e^r7D$$$StvT7pNg5sbji$v3Hfy^VOkxKBvcj$I$u$H53t^hYfPVlpHlRXLD^8lkDdNjHwCj0IwYFuvPg22F^I$WxX', 'InChI=1S/C5H14NO.C4H6O6/c1-6(2,3)4-5-7;5-1(3(7)8)2(6)4(9)10/h7H,4-5H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/q+1;/p-1', 'AuxInfo=1/1/N:10,11,12,9,13,8,1;14,15,16,17,2,3,4,5,6,7/E:(1,2,3);(1,2)(3,4)(5,6)(7,8,9,10)/gE:;(1,2)/CRV:6+1;/rA:36OOOOOO-ON+CCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s8;s8;s8;s8;s1s9;s2;s3s14;s4d5s14;s 6d7s15;s9;s9;s11;s11;s12;s12;s12;s10;s10;s11;s10;s13;s13;s1;s14;s15;s2;s3;s4;/rC:4.1656,1.903,0;2.269,5.1159,0;3.135,7.6159,0;.5369,6.1159,0;1.403,7.6159,0;4.8671,6.6159,0;4.001,5.1159,0;1.5675,1.403, 0;2.4335,1.903,0;.7015,.903,0;1.0675,2.269,0;2.0675,.5369,0;3.2996,1.403,0;2.269,6.1159,0;3.135,', 'QWJSAWXRUVVRLH-UHFFFAOYSA-M', '1010:2AWZGNBKGTFKYDBMFQNKCA36N8ZWCT', '[#8](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7+](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1].[#8](-[#1])-[#6](-[#1])(-[#6](=[#8])-[#8]-[#1])-[#6](-[#1])(-[#6](=[ #8])-[#8-])-[#8]-[#1]', 'O([H])C([H])([H])C([H])([H])[N+](C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H].O([H])C([H])(C(=O)O[H])C([H])(C(=O)[O-])O[H]', '-04.712', '-1.575', '0', '0', 'TRUE', '-0.3928\r\n-0.3796\r\n-0.3814\r\n-0.3296\r\n-0.2637\r\n-0.6366\r\n-0.6366\r\n0.1387\r\n5.85e-002\r\n2.31e-002\r\n2.31e-002\r\n2.31e-002\r\n7.43e-002\r\n0.1728\r\n0.1555\r\n0.2904\r\n0.2174\r\n7.06e-002\r\n7.06e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002', '1', '-6.174', 'C9H19NO7', '0253.116', '-3.219', '0253.25', '3.04 4.37', '1', '3', '2', '13', '00', '0', '17', '15', '27', '2', '008', '04', '19', '0', '0', '005', '0138.12', '315.1', '', '', '', '', '', '', '', '', '', '', '', 'OCC[N+](C)(C)C.OC(C(O)C([O-])=O)C(O)=O', 'C[N+](C)(C)CCO.O=C(O)C(O)C(O)C(=O)[O-]', 'Choline bitartrate', 'holine Hydrogen L-(+)-Tartrate', 'Acetylcholinesterase', '10198924', 'Phase II Completed', 'Fetal alcohol spectrum disorder', '26447156', 'Fetal alcohol spectrum disorder', 'LUJAN-FRYNS SYNDROME'),
(277, '5351560', '5351560', 'CO[C@@H]([C@@H]1Cc2cc3cc(OC4CC(OC5CC(O)C(OC)C(C)O5)C(OC(=O)C)C(C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1OC6CC(OC7CC(OC8CC(C)(O)C(OC(=O)C)C(C)O8)C(O)C(C)O7)C(O)C(C)O6)C(=O)[C@@H](O)[C@@H](C)O', '[6-[[(6<I>S</I>,7<I>S</I>)-6-[4-[4-(5-acetoxy-4-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-7-[(1<I>S</I>,3<I> S</I>,4<I>R</I>)-3,4-dihydroxy-1-methoxy-2-oxo-pentyl]-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6<I>H</I>-anthracen-2-yl]oxy]-4-(4-hydroxy-5-methoxy-6-methyl-tetrahydropyran-2-yl)oxy-2-methyl-tetrahy dropyran-3-yl] acetate', 'CYAAFQwAbewQihoArMNfb62NDyL8xrqN3sQWvMG5Ihl$ujtlvo4GVohj9nJcdMeCaY$2Fi0lhV2mkCL4PtfULE99Md8cUKAdqnXmPENgnUJeJV$^HKkY^9XUNO9^57^PkM58nbWUfkP^3$fnKK1v9O4$788rnc4piD^nCxxm3bdMPFI^VvfvnWRNylDXuMF5MVObp87n nd9t6^udLV7tuAu^o64VHlifRx8RuxpqBrc7nueWWL93jnurCo^djs4aIjdapCeh1KUvPrzwvWZhl^KjKGp4HCt3s$IPZLRRIXJyZV^7TqLHk09Qi3PnxgC6OYi6r29rfxLGhGfyt6vIvkS3c0U5$oJnFUu3iBZfAPyiZa1vhR^rkKlKY9mHjM$62^HRo5TV4f103iAt 67OTybOw^9ZpvpqeXO6nI7lfRzcv294T3uUN5uxSVXuGDW8fl7ly7rsL8dnQGvzpH4N$3c60q5V5Vv8M94m3fs1e3S93aNbl', 'InChI=1S/C57H82O26/c1-21-34(79-40-19-37(53(26(6)75-40)77-28(8)59)82-38-16-33(61)52(70-11)25(5)74-38)15-31-13-30-14-32(54(71-12)51(68)46(63)22(2)58)55(50(67)44(30)49(66)43(31)45(21)62)83-41-18-35(47(64 )24(4)73-41)80-39-17-36(48(65)23(3)72-39)81-42-20-57(10,69)56(27(7)76-42)78-29(9)60/h13,15,22-27,32-33,35-42,46-48,52-56,58,61-66,69H,14,16-20H2,1-12H3/t22-,23?,24?,25?,26?,27?,32+,33?,35?,36?,37?,38? ,39?,40?,41?,42?,46+,47?,48?,52?,53?,54+,55+,56?,57?/m1/s1', 'AuxInfo=1/0/N:79,80,50,52,77,74,51,83,78,48,82,76,55,44,69,64,30,37,58,34,73,75,41,43,68,60,42,81,72,46,59,31,66,70,28,27,53,63,32,62,40,35,61,49,71,65,38,33,57,47,54,67,56,45,39,36,29,24,26,25,21,23, 22,10,9,18,15,19,7,20,11,4,6,14,13,5,17,8,16,2,1,12,3/it:im/rA:165OOOOOOOOOOOOOOOOOOOOOOOOOOCCCCC.eCCCCCCCC.eCCCCCC.eCCCCCCCCCCCCCCCCCCCC.oCCCCCCCCCC.eCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;;;;;;;;;s1;s2;s7;s27;;s2s4s30;s9s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c](:[c](:[c](:[c](:[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c', 'O(C1([H])C([H])([H])C(C([H])([H])[H])(C([H])(C([H])(C([H])([H])[H])O1)OC(C([H])([H])[H])=O)O[H])C([H])(C([H])(C([H])(C([H])([H])[H])O2)O[H])C([H])([H])C2([H])OC([H])(C([H])(C([H])(C([H])([H])[H])O3)O[ H])C([H])([H])C3([H])O[C@]4([H])C(c(c(c(c(c(C([H])([H])[H])c(c5[H])OC([H])(C([H])([H])C([H])(C([H])(C6([H])C([H])([H])[H])OC(C([H])([H])[H])=O)OC7([H])C([H])([H])C([H])(C([H])(C([H])(C([H])([H])[H])O7 )OC([H])([H])[H])O[H])O6)O[H])c5c8[H])O[H])c8C([H])([H])[C@@]4([H])[C@@]([H])(C([C@]([H])([C@@](', '01.486', '1.486', '0', '0', 'TRUE', '-0.3463\r\n-0.3464\r\n-0.3408\r\n-0.3468\r\n-0.3468\r\n-0.3468\r\n-0.3872\r\n-0.3071\r\n-0.3877\r\n-0.3877\r\n-0.3732\r\n-0.3463\r\n-0.3464\r\n-0.3468\r\n-0.2911\r\n-0.3159\r\n-0.3074\r\n-0.3594\r\n-0.2937\r\n-0.3761\r\n-0.3901\r\n-0.3825\r\n-0.3598\r\n-0.3903\r\n-0.267\r\n-0.267\r\n9.39e-002\r\n9.39e-002\r\n9', '1', '1.472', 'C57H82O26', '1182.51', '-6.337', '1183.25', '8.8 10.88', '18', '7', '4', '75', '11', '2', '83', '90', '111', '9', '026', '08', '82', '0', '8', '020', '0359.34', '1,171.61', '', '', '', '', '', '', '', '', '', '', '', 'O(C7CC(OC6CC(O[C@H]1[C@H](C(OC)C(=O)C(O)C(O)C)C/C/2=C(C1=O)/C(O)=C/5\\C(=C2)\\C=C(OC4OC(C)C(OC(=O)C)C(OC3OC(C)C(OC)C(O)C3)C4)/C(C)=C5/O)OC(C)C6O)OC(C)C7O)C8OC(C)C(OC(=O)C)C(O)(C)C8', 'COC(C(=O)C(O)C(C)O)[C@@H]5Cc4cc3cc(OC2CC(OC1CC(O)C(OC)C(C)O1)C(OC(C)=O)C(C)O2)c(C)c(O)c3c(O)c4C(=O)[C@H]5OC8CC(OC7CC(OC6CC(C)(O)C(OC(C)=O)C(C)O6)C(O)C(C)O7)C(O)C(C)O8', 'Chromomycin A3', 'Toyomycin; AmbotzLS-1018', 'DNA', '5351560', 'Under Investigation', 'Huntington Disease (HD)', '17403718', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(278, '1792197', '1792197', 'COc1ccccc1\\C=C\\C(=O)NC(=S)Nc2ccc(cc2)S(=O)(=O)N(C)c3ccccc3', '(<I>E</I>)-3-(2-methoxyphenyl)-<I>N</I>-[[4-[methyl(phenyl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide', 'CYAAFQwAQdwQb9Jnym0qj4yqPmMfec7SGjUAWIhOwDBsRxZz0HD7Y20gC3c7Z225rl^bfCRIhk5UT80ZieGkrkVbgzkFxlEWx7Jh64Woq^2lu^z3h2Uyo33O7t^yi32E5Hcr^^81I$5nj8Ha9TOAHGi9Yn9qIdw7Pg8HTxKOt9Gt4ihuCcoBiHr9xh4AXFk7$A$e0BO9 x70Mi8EIW9zpnb^wtd9ETts$79BCPgQ^aCueiYoH9Tz4pXfijj5LDMciUu$AcNOqLTcgoQ6u06RxJLuVzse$GChXCdRmd9sKlPsYy42u7D9VTmT59Bs$pGN8XS^0zq8q97OSldseZqfPGwc3xDVk$8$GIQHcPHyZCuzdyxhTwhtM1JMhTLgCyb3MP40JvlRwpqhVoHBF lQM86E9KeGXRkBWc4$hx5VFZzVpzbDSM3084KtCyd8CVy^Lg$a36x45m6OVp4jtkmJXcM6VnTdS29QZEho8z4mUlPDm4^dDy', 'InChI=1S/C24H23N3O4S2/c1-27(20-9-4-3-5-10-20)33(29,30)21-15-13-19(14-16-21)25-24(32)26-23(28)17-12-18-8-6-7-11-22(18)31-2/h3-17H,1-2H3,(H2,25,26,28,32)/b17-12+', 'AuxInfo=1/1/N:14,33,22,20,21,31,32,27,18,19,29,26,16,17,12,13,30,24,15,11,10,25,28,23,8,9,7,6,3,4,5,2,1/E:(4,5)(9,10)(13,14)(15,16)(29,30)/CRV:33.6/rA:56SSOOOONNNCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH HHHHHHHHH/rB:;d1;d1;;;s1;;;s1;s7;d+10;s10;s7;s8;s12d+15;d-13s15;d+11;s11;s18;d-19;d-20s21;d2s8s9;;s5s24;s24;d-24;d6s9;d+25;d+26s28;s27;s29d-31;s5;s12;s13;s14;s14;s14;s16;s17;s18;s19;s20;s21;s8;s22;s9; s26;s27;s29;s30;s31;s32;s33;s33;s33;/rC:-5.8677,1.051,-.7139;.6021,4.0342,.0167;-6.4051,2.3856,-', 'XOMQERYBMDFBAG-SFQUDFHCSA-N', '1010:H7R9YXJVSQFD2UYYHJFRYHWW5R4KU2', '[#16](-[c]1:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#6](-[#7](-[#1])-[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#8]-[#6](-[#1])(-[#1]) -[#1])=[#8])=[#16])(-[#7](-[#6](-[#1])(-[#1])-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])(=[#8])=[#8]', 'S(c1c([H])c([H])c(c([H])c1[H])N([H])C(N([H])C(\\C([H])=C([H])\\c2c([H])c([H])c([H])c([H])c2OC([H])([H])[H])=O)=S)(N(C([H])([H])[H])c3c([H])c([H])c([H])c([H])c3[H])(=O)=O', '04.911', '4.438', '0', '0', 'TRUE', '1.4216\r\n-4.91e-002\r\n-0.5684\r\n-0.5684\r\n-0.3488\r\n-0.2722\r\n-0.3306\r\n-0.237\r\n-0.2632\r\n-4.13e-002\r\n-6.5e-003\r\n-7.01e-002\r\n-7.01e-002\r\n-3.22e-002\r\n2.04e-002\r\n-4.51e-002\r\n-4.51e-002\r\n-4.65e-002\r\n-4.65e-002\r\n-6.08e-002\r\n-6.08e-002\r\n-6.22e-002\r\n0.1472\r\n4.8e-003\r\n8.17e-002\r\n-4.71e-002\r\n-5.24e-002\r\n0.2412\r\n-3.12e-002\r\n1.6e-003\r\n-6.15e-002\r\n-5.97e-002\r\n4.22e-002\r\n6.09e-002\r\n6.09e-002\r\n3.71e-002\r\n3.71e-002\r\n3.71e-002\r\n6.38e-002\r\n6.38e-002\r\n6.38e-002\r\n6.38e-002\r\n6.23e-002\r\n6.23e-002\r\n0.1363\r\n6.22e-002\r\n0.1578', '1', '4.476', 'C24H23N3O4S2', '0481.113', '-8.462', '0481.587', '3.79 9.01 12.01', '4', '2', '5', '12', '18', '3', '33', '35', '31', '14', '007', '02', '23', '0', '3', '009', '0128.21', '476.42', '', '4.97021', '1.2924', '88.03', '3.95', '6.09386', '84.08', '3,477.68', '200.249', '359.8', '-179.92', 'S(=O)(=O)(N(/C/1=C/C=C\\C=C1)C)/C/3=C/C=C(NC(=S)NC(=O)/C=C/C2=C/C=C\\C=C2\\OC)\\C=C3', 'COc1ccccc1/C=C/C(=O)NC(=S)Nc3ccc(S(=O)(=O)N(C)c2ccccc2)cc3', 'CID1792197', 'GTPL5563; BB0286089', 'G protein-coupled receptor 55', '1792197', 'Under Investigation', 'Parkinson Disease(PARK)', '28807673', 'Parkinson Disease(PARK)', 'PARK'),
(279, '2440433', '2440433', 'CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(c1)C(=O)N3CCN(CC3)c4cccc(C)c4C', '3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-<I>N</I>,<I>N</I>-dimethyl-4-pyrrolidin-1-yl-benzenesulfonamide', 'CYAAFQwAkdwQYCXlwLjkIYNtJkVd8tAQdwn6kCb$hFJ6hwivtwy$ugUzF57IaIW2je9TLnFgpuA7xJDJnl1kUhj9W^SjGhWBRvowB0O4gIng^dNtA1Hb9^FIVon8QJWt3pvyrp1^C8S5pdNgji2fzyv^$hqHRJsW8hb1lP$Kj7w04KunqHiUwS3V^U5o5sjVN0KwNZmP tBmPwv7TMLi1q4007Jzcoz$2e7JMkFPF2AmhX8VLHi7uglerXhRIUhDcRrtf5jc4ohAlVFDX1hte842bIsm44wnPt7dNOGLGsjAjGRCrlDIzde6lWl3EcIAPEXhf4Z3nzeLNoxnzC2eP5r7r28xGNaHGGIbmhVvoEd^FbNdG63cJ3jct$cRYZQNcD$6DB$QGmRMUJD8Z y1qU2WlXU31pySVR$w2CExA$ayz9loPY8lRZuHPxicoZp2S2XtuP6bfTyrXgO^YoJrP9$chVmDGEp6cgLix$091Jzzy3ULJU', 'InChI=1S/C25H34N4O3S/c1-19-8-7-9-23(20(19)2)28-14-16-29(17-15-28)25(30)22-18-21(33(31,32)26(3)4)10-11-24(22)27-12-5-6-13-27/h7-11,18H,5-6,12-17H2,1-4H3', 'AuxInfo=1/0/N:31,28,32,33,11,12,29,30,26,25,21,9,10,15,16,13,14,22,27,24,23,18,20,17,19,8,5,7,6,2,3,4,1/E:(3,4)(5,6)(12,13)(14,15)(16,17)(31,32)/CRV:33.6/rA:67SOOONNNNCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH HHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;d1;d1;;;;s1;s5;s5;s9;s10s11;s6;s6;s7s13;s7s14;s5;d-17;d2s6s18;s7;s17;s18;s1d+22;s20;d-21s23;d+20;d-24;s24;s26;s27d-29;s27;s8;s8;s9;s9;s10;s10;s11;s11;s12;s12;s13;s13;s14 ;s14;s15;s15;s16;s16;s21;s22;s25;s26;s28;s28;s28;s29;s30;s31;s31;s31;s32;s32;s32;s33;s33;s33;/rC', 'VRSJAHQGJHDACS-UHFFFAOYSA-N', '1010:4AS7G98RUQQMZ44UYJWMXMBT8DRD8R', '[#16](-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1]):[c](-[#1]):[c]1-[#6](-[#7]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[c]4:[c ](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c]4-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1])=[#8])(-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])(=[#8])=[ #8]', 'S(c(c([H])c([H])c1N2C([H])([H])C([H])([H])C([H])([H])C2([H])[H])c([H])c1C(N3C([H])([H])C([H])([H])N(c4c([H])c([H])c([H])c(C([H])([H])[H])c4C([H])([H])[H])C([H])([H])C3([H])[H])=O)(N(C([H])([H])[H])C([ H])([H])[H])(=O)=O', '03.585', '3.585', '0', '0', 'TRUE', '1.4167\r\n-0.2717\r\n-0.5684\r\n-0.5684\r\n-0.2744\r\n-0.2952\r\n-0.2716\r\n-0.3622\r\n3.e-003\r\n3.e-003\r\n-3.88e-002\r\n-3.88e-002\r\n2.76e-002\r\n2.76e-002\r\n1.89e-002\r\n1.89e-002\r\n2.97e-002\r\n5.41e-002\r\n0.2471\r\n2.05e-002\r\n-4.45e-002\r\n-5.75e-002\r\n-4.06e-002\r\n-3.01e-002\r\n-7.01e-002\r\n-4.38e-002\r\n-4.67e-002\r\n-3.8e-002\r\n-6.04e-002\r\n-5.9e-002\r\n-3.95e-002\r\n-3.67e-002\r\n-3.67e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n2.8e-002\r\n2.8e-002\r\n2.8e-002\r\n2.8e-002\r\n4.83e-002\r\n4.83e-002\r\n4.83e-002\r\n4.83e-002\r\n4.51e-002\r\n4.51e-002', '0', '3.585', 'C25H34N4O3S', '0470.235', '-4.373', '0470.627', '0.8 4.16', '3', '0', '3', '21', '12', '2', '33', '36', '44', '9', '007', '00', '34', '0', '4', '005', '0072.55', '500.59', '', '5.15792', '1.2799', '188.55', '50.79', '4.81218', '137.76', '1,981.36', '105.445', '393.07', '-179.93', 'S(=O)(=O)(N(C)C)/C/4=C/C(C(=O)N2CCN(/C1=C/C=C\\C(C)=C1\\C)CC2)=C(N3CCCC3)\\C=C4', 'Cc4cccc(N3CCN(C(=O)c1cc(S(=O)(=O)N(C)C)ccc1N2CCCC2)CC3)c4C', 'CID2440433', 'ML184; GTPL5565; AOB1419', 'G protein-coupled receptor 55', '2440433', 'Under Investigation', 'Parkinson Disease(PARK)', '28807673', 'Parkinson Disease(PARK)', 'PARK'),
(280, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1A', '896', 'FDA approved', 'Delayed Sleep Phase Syndrome', '20044310', 'Delayed Sleep Phase Syndrome', 'DSPD');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(281, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1A', '896', 'Phase II', 'Migraine', '28800342', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(282, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1B', '896', 'Phase III', 'Angelman syndrome', '18539989', 'Angelman syndrome', 'HAPPY PUPPET?SYNDROME'),
(283, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1A', '896', 'Phase III', 'Angelman syndrome', '18539989', 'Angelman syndrome', 'HAPPY PUPPET SYNDROME'),
(284, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1A', '896', 'Phase IV', 'Parkinson Disease(PARK)', '23994935', 'Parkinson Disease(PARK)', 'PARK'),
(285, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1A', '896', 'Phase IV Completed', 'Delayed Sleep Phase Syndrome', '23363423', 'Delayed Sleep Phase Syndrome', 'DSPD'),
(286, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1B', '896', 'Phase IV Completed', 'Delayed Sleep Phase Syndrome', '23363423', 'Delayed Sleep Phase Syndrome', 'DSPD'),
(287, '896', '896', 'COc1ccc2[nH]cc(CCNC(=O)C)c2c1', '<I>N</I>-[2-(5-methoxy-1<I>H</I>-indol-3-yl)ethyl]acetamide', 'CYAAFQwAddwQHtedNGyChomEw5Icqk3MET7AK5xAIqLWtU3zwNGnHaQa3IJ6UGEMPKZON5NKmOXsaakVUYy1shuoTBffZCJGUyBDifSGM5bn5^JJvOigCY5O1^9t5vXuQAQSLs89swibN08$r4OqVgM2Sery595laSiqsJ6pgX4YL09kADabFJWuovC7$Y1qxxn7LvmW BC20rmGXFntOgJiHepqRtq^a5pl3s2enRAW$ybD0tjJEU7mCc7jMyVNTXQ4DDjsvfWiquK1urKEyh^a1EcNyQ7yhdtX92Xl8qfZ4wKBUnoc4eCXkjQrqb753VfBZxvhUIqfgsoyTWHe8ziCXD$GFqFSGrReuSvOudIVFualSe^9MJLeJxri0F9Kq53yUy0mWVbD^WtW0 X0ceS2$oH0Um1XwsudjWkeEJzBDe7jNdicuYE3Q6p6uWv72Rx91sSTlwQjfS7eWhdXlH8Bxqqjjj1Bp1QNqtjDSzRY5k4$Bd', 'InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)', 'AuxInfo=1/1/N:16,17,14,12,7,10,11,9,15,5,13,6,8,4,3,2,1/rA:33OONNCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s3d-6;s3d-5;s4s7;s6;s8;s1d+11;d-12s13;d2s4;s15;s1;s7;s7;s9;s10;s10;s3;s11;s12;s14;s4;s16;s16 ;s16;s17;s17;s17;/rC:-1.3636,3.0246,.297;3.7267,.6738,.6109;-2.0703,-2.3711,-.3715;2.3445,-.61,-.7547;-.1101,-1.7944,.4955;-.859,-.6075,.2605;1.2503,-1.8778,1.0635;-2.0848,-.9972,-.2836;-.8813,-2.8618 ,.097;2.3739,-1.8247,.0151;-.611,.7654,.459;-3.0788,-.0792,-.6406;-1.5962,1.695,.1067;-2.8103,1.', 'DRLFMBDRBRZALE-UHFFFAOYSA-N', '1010:WC2RMGXGNVUYT9XYEE83CVA5TFAVAN', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]1:[c]2:[c](:[c](-[#1]):[n]1-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8]):[c]2-[#1]', 'O(C([H])([H])[H])c(c([H])c([H])c1c2c(c([H])n1[H])C([H])([H])C([H])([H])N([H])C(C([H])([H])[H])=O)c2[H]', '01.555', '1.555', '0', '0', 'TRUE', '-0.3494\r\n-0.2781\r\n-0.2646\r\n-0.3154\r\n-2.67e-002\r\n-6.e-004\r\n-1.06e-002\r\n2.62e-002\r\n-1.45e-002\r\n1.5e-002\r\n-2.27e-002\r\n-4.07e-002\r\n7.52e-002\r\n-3.02e-002\r\n0.2085\r\n1.26e-002\r\n4.22e-002\r\n3.32e-002\r\n3.32e-002\r\n7.56e-002\r\n4.7e-002\r\n4.7e-002\r\n0.1336\r\n6.57e-002\r\n6.4', '0', '1.555', 'C13H16N2O2', '0232.121', '-3.336', '0232.278', '-2.99', '2', '2', '1', '7', '10', '2', '17', '18', '19', '5', '004', '02', '16', '0', '2', '004', '0054.12', '254.52', '', '1.67533', '1.2534', '31.8', '21.59', '3.24197', '10.21', '400.795', '103.735', '190.02', '178.94', 'O(/C/2=C/C1=C(N/C=C1/CCNC(=O)C)\\C=C2)C', 'COc2ccc1[nH]cc(CCNC(C)=O)c1c2', 'Circadin', 'Melatonin; Melatol; Melovine; Melapure; Posidorm; Vivitas', 'Melatonin receptor type 1B', '896', 'Terminated', 'Tardive Dyskinesia', '21950196', 'Tardive Dyskinesia', 'NA'),
(288, '2771', '2771', 'CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3', '(1<I>S</I>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-isobenzofuran-5-carbonitrile', 'CYAAFQwAKewQKNztnFFQaiNWIRXj^bgIwxAwY2NM4QslzjmICGK3BiNlFk4AMH1PmoSWtR8t9On$eH8SAYQLIoT$DiYj^bbZ3c2u0k6Y94z4AiRyaZAxP7J^J2rJ7bQt^7$HEd1XI8Lt^KNAGAdf8gX3Avx7Bcvf7p6GN36$69MEzLoh3FkTUy9D3qd0s15smNQ3uLBZ cN4090HtdXT22cG1sYATc600XKG$wB2z4GVmND^0fz0Oho9Xb6YkYfywhYzKueoFnvsKzmfOmV8adiiVqlP3KUzlOZ4KDNp5LSIdmpSXvOSlFUORa^LDQfZJwyAm4x8G9$VWZu08KWDVFXsLx7KljvCOHUDWOXkL68GBYxKKMGekvRNzJyrdXGp6$9EpT7n7Yx^mBYSr Dvsw0^dnxQkSpLNA8TUQxehl4AkubG4$r3FADR21PUt6VJ7yQP7BK73dvNDwkTOVmKP71R4AHikMUSoU25m2mmT3LWXnpTqq', 'InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1', 'AuxInfo=1/0/N:22,23,9,17,15,16,19,20,13,6,12,14,24,11,18,8,10,21,7,5,1,4,3,2/E:(1,2)(5,6)(7,8)/it:im/rA:45FONNC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s5;s5;d-7;s6;s5;s2s8;s3s9;s7;s8;d+10; s10;d-13;d-14s17;s15;d-16;s1d+19s20;s3;s3;t4s18;s6;s6;s9;s9;s11;s11;s12;s12;s13;s14;s15;s16;s17;s19;s20;s22;s22;s22;s23;s23;s23;/rC:-2.0573,5.0073,-.1688;-.1141,-.6063,1.6317;-4.589,-2.2435,-.2846;6.6 873,-1.0534,-.4823;-.0688,-.2352,.2173;-.9383,-1.2115,-.5664;1.3868,-.336,-.1353;2.0974,-.8278,.', 'WSEQXVZVJXJVFP-FQEVSTJZSA-N', '1010:SD4TUE2UXNJ3JMN8DFVQYKRK1XKTMF', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@]2(-[c]3:[c](:[c](-[#1]):[c](-[#6]#[#7]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#8]2)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[ #1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1[C@]2(c3c(c([H])c(C#N)c([H])c3[H])C([H])([H])O2)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c([H])c1[H]', '03.721', '3.721', '0', '0', 'TRUE', '-0.207\r\n-0.3609\r\n-0.3094\r\n-0.1925\r\n0.1189\r\n-1.41e-002\r\n-6.2e-003\r\n-1.46e-002\r\n-3.71e-002\r\n-1.16e-002\r\n7.37e-002\r\n-2.4e-003\r\n-5.42e-002\r\n-3.85e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-4.4e-002\r\n5.23e-002\r\n-2.6e-002\r\n-2.6e-002\r\n0.1227\r\n-1.37e-002\r\n-1.37e-002\r\n9.91e-0', '1', '2.181', 'C20H21FN2O', '0324.164', '-5.54', '0324.392', '10.26', '1', '0', '0', '13', '12', '2', '24', '26', '26', '6', '003', '00', '21', '0', '3', '005', '0036.26', '352.38', '', '2.66732', '1.2754', '19.54', '12.83', '4.04675', '6.71', '1,017.73', '71.597', '267.53', '', 'F/C/3=C/C=C([C@]1(CCCN(C)C)OC/C/2=C1/C=C\\C(C#N)=C2)\\C=C3', 'CN(C)CCC[C@@]3(c1ccc(F)cc1)OCc2cc(C#N)ccc23', 'Citalopram', 'Nitalapram; Celexa; Bonitrile; Recital; Cytalopram; Oropram; Talohexal', 'Sodium-dependent serotonin transporter', '2771', 'Phase 4 Completed', 'Frontotemporal Dementia', '26001387', 'Frontotemporal Dementia', 'FRONTOTEMPORAL LOBAR DEGENERATION WITH TAU INCLUSIONS\nFTLD WITH TAU INCLUSIONS\nDEMENTIA, FRONTOTEMPORAL, WITH PARKINSONISM\nFRONTOTEMPORAL DEMENTIA WITH PARKINSONISM\nFRONTOTEMPORAL LOBE DEMENTIA; FLDEM\nFTDP17\nMULTIPLE SYSTEM TAUOPATHY WITH PRESENILE DEMENTIA; MSTD\nDISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX; DDPAC\nWILHELMSEN-LYNCH DISEASE; WLD\nPALLIDOPONTONIGRAL DEGENERATION; PPND'),
(289, '2771', '2771', 'CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3', '(1<I>S</I>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-isobenzofuran-5-carbonitrile', 'CYAAFQwAKewQKNztnFFQaiNWIRXj^bgIwxAwY2NM4QslzjmICGK3BiNlFk4AMH1PmoSWtR8t9On$eH8SAYQLIoT$DiYj^bbZ3c2u0k6Y94z4AiRyaZAxP7J^J2rJ7bQt^7$HEd1XI8Lt^KNAGAdf8gX3Avx7Bcvf7p6GN36$69MEzLoh3FkTUy9D3qd0s15smNQ3uLBZ cN4090HtdXT22cG1sYATc600XKG$wB2z4GVmND^0fz0Oho9Xb6YkYfywhYzKueoFnvsKzmfOmV8adiiVqlP3KUzlOZ4KDNp5LSIdmpSXvOSlFUORa^LDQfZJwyAm4x8G9$VWZu08KWDVFXsLx7KljvCOHUDWOXkL68GBYxKKMGekvRNzJyrdXGp6$9EpT7n7Yx^mBYSr Dvsw0^dnxQkSpLNA8TUQxehl4AkubG4$r3FADR21PUt6VJ7yQP7BK73dvNDwkTOVmKP71R4AHikMUSoU25m2mmT3LWXnpTqq', 'InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1', 'AuxInfo=1/0/N:22,23,9,17,15,16,19,20,13,6,12,14,24,11,18,8,10,21,7,5,1,4,3,2/E:(1,2)(5,6)(7,8)/it:im/rA:45FONNC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s5;s5;d-7;s6;s5;s2s8;s3s9;s7;s8;d+10; s10;d-13;d-14s17;s15;d-16;s1d+19s20;s3;s3;t4s18;s6;s6;s9;s9;s11;s11;s12;s12;s13;s14;s15;s16;s17;s19;s20;s22;s22;s22;s23;s23;s23;/rC:-2.0573,5.0073,-.1688;-.1141,-.6063,1.6317;-4.589,-2.2435,-.2846;6.6 873,-1.0534,-.4823;-.0688,-.2352,.2173;-.9383,-1.2115,-.5664;1.3868,-.336,-.1353;2.0974,-.8278,.', 'WSEQXVZVJXJVFP-FQEVSTJZSA-N', '1010:SD4TUE2UXNJ3JMN8DFVQYKRK1XKTMF', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@]2(-[c]3:[c](:[c](-[#1]):[c](-[#6]#[#7]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#8]2)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[ #1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1[C@]2(c3c(c([H])c(C#N)c([H])c3[H])C([H])([H])O2)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c([H])c1[H]', '03.721', '3.721', '0', '0', 'TRUE', '-0.207\r\n-0.3609\r\n-0.3094\r\n-0.1925\r\n0.1189\r\n-1.41e-002\r\n-6.2e-003\r\n-1.46e-002\r\n-3.71e-002\r\n-1.16e-002\r\n7.37e-002\r\n-2.4e-003\r\n-5.42e-002\r\n-3.85e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-4.4e-002\r\n5.23e-002\r\n-2.6e-002\r\n-2.6e-002\r\n0.1227\r\n-1.37e-002\r\n-1.37e-002\r\n9.91e-0', '1', '2.181', 'C20H21FN2O', '0324.164', '-5.54', '0324.392', '10.26', '1', '0', '0', '13', '12', '2', '24', '26', '26', '6', '003', '00', '21', '0', '3', '005', '0036.26', '352.38', '', '2.66732', '1.2754', '19.54', '12.83', '4.04675', '6.71', '1,017.73', '71.597', '267.53', '', 'F/C/3=C/C=C([C@]1(CCCN(C)C)OC/C/2=C1/C=C\\C(C#N)=C2)\\C=C3', 'CN(C)CCC[C@@]3(c1ccc(F)cc1)OCc2cc(C#N)ccc23', 'Citalopram', 'Nitalapram; Celexa; Bonitrile; Recital; Cytalopram; Oropram; Talohexal', 'Sodium-dependent serotonin transporter', '2771', 'Phase I', 'Alzheimer disease (AD)', '28739492', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(290, '2771', '2771', 'CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3', '(1<I>S</I>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-isobenzofuran-5-carbonitrile', 'CYAAFQwAKewQKNztnFFQaiNWIRXj^bgIwxAwY2NM4QslzjmICGK3BiNlFk4AMH1PmoSWtR8t9On$eH8SAYQLIoT$DiYj^bbZ3c2u0k6Y94z4AiRyaZAxP7J^J2rJ7bQt^7$HEd1XI8Lt^KNAGAdf8gX3Avx7Bcvf7p6GN36$69MEzLoh3FkTUy9D3qd0s15smNQ3uLBZ cN4090HtdXT22cG1sYATc600XKG$wB2z4GVmND^0fz0Oho9Xb6YkYfywhYzKueoFnvsKzmfOmV8adiiVqlP3KUzlOZ4KDNp5LSIdmpSXvOSlFUORa^LDQfZJwyAm4x8G9$VWZu08KWDVFXsLx7KljvCOHUDWOXkL68GBYxKKMGekvRNzJyrdXGp6$9EpT7n7Yx^mBYSr Dvsw0^dnxQkSpLNA8TUQxehl4AkubG4$r3FADR21PUt6VJ7yQP7BK73dvNDwkTOVmKP71R4AHikMUSoU25m2mmT3LWXnpTqq', 'InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1', 'AuxInfo=1/0/N:22,23,9,17,15,16,19,20,13,6,12,14,24,11,18,8,10,21,7,5,1,4,3,2/E:(1,2)(5,6)(7,8)/it:im/rA:45FONNC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s5;s5;d-7;s6;s5;s2s8;s3s9;s7;s8;d+10; s10;d-13;d-14s17;s15;d-16;s1d+19s20;s3;s3;t4s18;s6;s6;s9;s9;s11;s11;s12;s12;s13;s14;s15;s16;s17;s19;s20;s22;s22;s22;s23;s23;s23;/rC:-2.0573,5.0073,-.1688;-.1141,-.6063,1.6317;-4.589,-2.2435,-.2846;6.6 873,-1.0534,-.4823;-.0688,-.2352,.2173;-.9383,-1.2115,-.5664;1.3868,-.336,-.1353;2.0974,-.8278,.', 'WSEQXVZVJXJVFP-FQEVSTJZSA-N', '1010:SD4TUE2UXNJ3JMN8DFVQYKRK1XKTMF', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@]2(-[c]3:[c](:[c](-[#1]):[c](-[#6]#[#7]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#8]2)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[ #1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1[C@]2(c3c(c([H])c(C#N)c([H])c3[H])C([H])([H])O2)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c([H])c1[H]', '03.721', '3.721', '0', '0', 'TRUE', '-0.207\r\n-0.3609\r\n-0.3094\r\n-0.1925\r\n0.1189\r\n-1.41e-002\r\n-6.2e-003\r\n-1.46e-002\r\n-3.71e-002\r\n-1.16e-002\r\n7.37e-002\r\n-2.4e-003\r\n-5.42e-002\r\n-3.85e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-4.4e-002\r\n5.23e-002\r\n-2.6e-002\r\n-2.6e-002\r\n0.1227\r\n-1.37e-002\r\n-1.37e-002\r\n9.91e-0', '1', '2.181', 'C20H21FN2O', '0324.164', '-5.54', '0324.392', '10.26', '1', '0', '0', '13', '12', '2', '24', '26', '26', '6', '003', '00', '21', '0', '3', '005', '0036.26', '352.38', '', '2.66732', '1.2754', '19.54', '12.83', '4.04675', '6.71', '1,017.73', '71.597', '267.53', '', 'F/C/3=C/C=C([C@]1(CCCN(C)C)OC/C/2=C1/C=C\\C(C#N)=C2)\\C=C3', 'CN(C)CCC[C@@]3(c1ccc(F)cc1)OCc2cc(C#N)ccc23', 'Citalopram', 'Nitalapram; Celexa; Bonitrile; Recital; Cytalopram; Oropram; Talohexal', 'Sodium-dependent serotonin transporter', '2771', 'Phase II Completed', 'Huntington Disease (HD)', '24375941', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(291, '2771', '2771', 'CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3', '(1<I>S</I>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3<I>H</I>-isobenzofuran-5-carbonitrile', 'CYAAFQwAKewQKNztnFFQaiNWIRXj^bgIwxAwY2NM4QslzjmICGK3BiNlFk4AMH1PmoSWtR8t9On$eH8SAYQLIoT$DiYj^bbZ3c2u0k6Y94z4AiRyaZAxP7J^J2rJ7bQt^7$HEd1XI8Lt^KNAGAdf8gX3Avx7Bcvf7p6GN36$69MEzLoh3FkTUy9D3qd0s15smNQ3uLBZ cN4090HtdXT22cG1sYATc600XKG$wB2z4GVmND^0fz0Oho9Xb6YkYfywhYzKueoFnvsKzmfOmV8adiiVqlP3KUzlOZ4KDNp5LSIdmpSXvOSlFUORa^LDQfZJwyAm4x8G9$VWZu08KWDVFXsLx7KljvCOHUDWOXkL68GBYxKKMGekvRNzJyrdXGp6$9EpT7n7Yx^mBYSr Dvsw0^dnxQkSpLNA8TUQxehl4AkubG4$r3FADR21PUt6VJ7yQP7BK73dvNDwkTOVmKP71R4AHikMUSoU25m2mmT3LWXnpTqq', 'InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1', 'AuxInfo=1/0/N:22,23,9,17,15,16,19,20,13,6,12,14,24,11,18,8,10,21,7,5,1,4,3,2/E:(1,2)(5,6)(7,8)/it:im/rA:45FONNC.oCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s5;s5;d-7;s6;s5;s2s8;s3s9;s7;s8;d+10; s10;d-13;d-14s17;s15;d-16;s1d+19s20;s3;s3;t4s18;s6;s6;s9;s9;s11;s11;s12;s12;s13;s14;s15;s16;s17;s19;s20;s22;s22;s22;s23;s23;s23;/rC:-2.0573,5.0073,-.1688;-.1141,-.6063,1.6317;-4.589,-2.2435,-.2846;6.6 873,-1.0534,-.4823;-.0688,-.2352,.2173;-.9383,-1.2115,-.5664;1.3868,-.336,-.1353;2.0974,-.8278,.', 'WSEQXVZVJXJVFP-FQEVSTJZSA-N', '1010:SD4TUE2UXNJ3JMN8DFVQYKRK1XKTMF', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@]2(-[c]3:[c](:[c](-[#1]):[c](-[#6]#[#7]):[c](-[#1]):[c]3-[#1])-[#6](-[#1])(-[#1])-[#8]2)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[ #1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1[C@]2(c3c(c([H])c(C#N)c([H])c3[H])C([H])([H])O2)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c([H])c1[H]', '03.721', '3.721', '0', '0', 'TRUE', '-0.207\r\n-0.3609\r\n-0.3094\r\n-0.1925\r\n0.1189\r\n-1.41e-002\r\n-6.2e-003\r\n-1.46e-002\r\n-3.71e-002\r\n-1.16e-002\r\n7.37e-002\r\n-2.4e-003\r\n-5.42e-002\r\n-3.85e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-4.4e-002\r\n5.23e-002\r\n-2.6e-002\r\n-2.6e-002\r\n0.1227\r\n-1.37e-002\r\n-1.37e-002\r\n9.91e-0', '1', '2.181', 'C20H21FN2O', '0324.164', '-5.54', '0324.392', '10.26', '1', '0', '0', '13', '12', '2', '24', '26', '26', '6', '003', '00', '21', '0', '3', '005', '0036.26', '352.38', '', '2.66732', '1.2754', '19.54', '12.83', '4.04675', '6.71', '1,017.73', '71.597', '267.53', '', 'F/C/3=C/C=C([C@]1(CCCN(C)C)OC/C/2=C1/C=C\\C(C#N)=C2)\\C=C3', 'CN(C)CCC[C@@]3(c1ccc(F)cc1)OCc2cc(C#N)ccc23', 'Citalopram', 'Nitalapram; Celexa; Bonitrile; Recital; Cytalopram; Oropram; Talohexal', 'Sodium-dependent serotonin transporter', '2771', 'Phase IV Completed', 'Friedreich''s Ataxia', '10463380', 'Friedreich''s Ataxia', 'FRDA1\nFA; Friedreich Ataxia'),
(292, '13804', '13804', 'C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=CC(=NC2=O)N', '[[(2<I>R</I>,3<I>S</I>,4<I>R</I>,5<I>R</I>)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] 2-(trimethylammonio)ethyl phosphate', 'CYAAFQwA^ewQXpcutnIN^OCjhN7GrVvRbUkZJuRR0VJ9CGGAYw2^$pVNsjXIfLV36qBZ70DNmdbKhalEj$ZDKhQI7Nm43W6381NzKnvPH$V$xhuGmfU247^81SBeK4low^PH69P$lvmWAKwLv^C0azK^H^LpnnyJzuWiZsn8nLhJPZtamTL8VeimFOsd8KkLee4iaXdt 0B^T$pFpwH3WfxBJGmQ5dMeXRP6QvfRHcSHgBmuGqs8CFPMe3GzOAeZ4C0fKG1v3EimHcM4QRROeHjW1YcTsrF9Xqa^Gv196k9KRTJOO5thYvrJIKhq9AgTHSPSrL3mhg85QMbvnHPTNSCvKkRzR2fBx1hPZXlelX5x0ayDzjdSngK^3r0wpm4bPi1jmlLv4sej3ImMa sLjiEHfiladcqnsNSGoRjR9BTmdurnNiicA6cbPWV8oIgs71i$6JvkpLzjqtnK3hrJh$D70azPkoeMco60VOpPNdLJX0k4$P', 'InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1', 'AuxInfo=1/2/N:26,27,28,30,24,23,29,22,20,31,18,19,21,25,17,16,14,15,4,5,9,12,13,10,11,7,6,3,8,2,1/E:(1,2,3)(22,23)(24,25)/it:im/CRV:18+1,22-1/rA:57PPOOOOOOOOOO-ONN+NNC.eC.oC.eC.eCCCCCCCCCCHHHHHHHHHHHH HHHHHHHHHHHHHH/rB:;;;;s1;s2;s1s2;;s1;d1;s2;d2;;;;;s4;s5s18;s3s18;s3s14s19;s6s20;s15;s14;d9s14s16;s15;s15;s15;s7s23;d-24;d+16s17s30;s18;s19;s20;s21;s22;s22;s4;s5;s23;s23;s24;s26;s26;s26;s27;s27;s27;s28 ;s28;s28;s29;s29;s30;s10;s17;s17;/r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r\n0.4022\r\n-0.3484\r\n-0.3874\r\n-0.3858\r\n-0.2839\r\n-0.2981\r\n-0.2004\r\n-0.2483\r\n-0.3023\r\n-0.2277\r\n-0.597\r\n-0.597\r\n-0.2289\r\n0.1387\r\n-0.1837\r\n-0.2868\r\n0.1126\r\n0.1257\r\n0.1125\r\n0.1602\r\n8.75e-002\r\n5.94e-002\r\n6.2e-003\r\n0.3425\r\n2.31e-002\r\n2.31e-002\r\n2.31e-002\r\n8.81e-002\r\n-1.08e-002\r\n0.1094\r\n6.58e-002\r\n6.74e-002\r\n6.57e-002\r\n8.54e-002\r\n6.01e-002\r\n6.01e-002\r\n0.2106\r\n0.2107\r\n7.06e-002\r\n7.06e-002\r\n7.95e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.44e-002\r\n6.', '1', '-6.862', 'C14H26N4O11P2', '0488.107', '-0.558', '0488.324', '2.04 4.21 4.55', '6', '3', '5', '27', '00', '0', '31', '32', '38', '5', '015', '05', '26', '0', '2', '010', '0233.12', '484.5', '', '29.747', '1.2958', '103.69', '20.87', '3.9954', '82.82', '1,541.58', '397.322', '354.31', '', 'P(OCC2OC(N1/C=C\\C(N)=N/C1=O)C(O)C2O)(OP(OCC[N+](C)(C)C)([O-])=O)(O)=O', 'C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OC[C@H]2O[C@@H](n1ccc(N)nc1=O)[C@H](O)[C@@H]2O', 'Citicoline', 'Difosfocin; CDP-choline; Haocolin; Recofnan; Somazina; Cereb', 'Acetylcholinesterase', '13804', 'Under Investigation', 'Parkinson Disease(PARK)', '28805762', 'Parkinson Disease(PARK)', 'PARK'),
(293, '20279', '20279', 'Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3', '(2<I>R</I>,3<I>S</I>,5<I>R</I>)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol', 'CYAAFQwANfwQE14K6hj1sxEZ^AyVrv9h0NMgpg9hx4^uGWZR506hPKHekZiVOYlYTs9JnAwHYWWTSkC5YdflNeWGK15Xphaeeu6qSI1gLGt$1UP6OiWqu^1LYS89COFm2Ps9u3zfS4rnrwNAZOkwf4z2uKHXYgzKzPNTR5yr49UetfHFiDwuc0R9pTgr4p1UMCe$YNi2 khgzH1Z4t6c8RJt7XjmCySyK2qV8vMEbeY3K0beUoLvtrTDA$wgyqhGeO8wOSYalcczKDCyKHccnefJFmKUIbeYU8x771jDiypKbwBt87X446XJnHhgihzQvtnD4jVzRogM$ZlJ02tLywDfooj5zYY1a1BaeAoCJxoZAzf$gaRCdgwvM0$P2NoVRuiWoFfmMa3uNTra2 HnRF4rkCVAueK^hQz$Mm7kcNSo2LeuLHFgXfZnViQyHeLgj0GzFp9oZ233A5mqDoTz5v7qEglPl3HAf8dYUWpDgzxVedwbc7', 'InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1', 'AuxInfo=1/1/N:12,14,16,11,13,10,17,18,15,19,1,9,6,8,7,5,4,3,2/it:im/rA:31ClOOONNNNNC.eC.eCC.eCCCCCCHHHHHHHHHHHH/rB:;;;;;;;;s2s5;s3;s10s11;s2s11;s4s13;s5d+7;s5d-6;s6s15;s8s9d+17;s1s7d+8;s10;s11;s12;s12 ;s13;s14;s14;s16;s3;s4;s9;s9;/rC:1.633,3.3744,.3086;-1.7996,.0059,-.962;-4.3416,-1.3596,.1353;-2.1398,2.7706,-.7255;.0048,-1.3461,-.2243;2.0188,-2.3091,-.1868;.6561,.9811,.028;3.0795,1.2132,.1989;4.55 92,-.6652,.1181;-1.4462,-1.2216,-.3011;-3.415,-.4529,.7289;-2.146,-1.2088,1.0502;-2.9596,.5656,-', 'PTOAARAWEBMLNO-KVQBGUIXSA-N', '1010:QTFK1SNP8MPKAZ9GAPBJ3RSZHWV95Y', '[#17]-[c](:[n]:[c](:[c](:[c]12):[n]:[c](-[#1]):[n]1-[#6@@]3(-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[#1])-[#8]3)-[#8]-[#1])-[#7](-[#1])-[#1]):[n]2', 'Clc(nc(c(c12)nc([H])n1[C@@]3([H])C([H])([H])[C@@]([H])([C@@]([H])(C([H])([H])O[H])O3)O[H])N([H])[H])n2', '-00.259', '-0.399', '0', '0', 'TRUE', '-4.08e-002\r\n-0.3539\r\n-0.3902\r\n-0.3936\r\n-0.1897\r\n-0.2377\r\n-0.2032\r\n-0.2042\r\n-0.2849\r\n0.1239\r\n8.63e-002\r\n1.66e-002\r\n0.1086\r\n7.2e-002\r\n0.1481\r\n7.98e-002\r\n0.1384\r\n0.1353\r\n0.2251\r\n7.88e-002\r\n6.3e-002\r\n3.35e-002\r\n3.35e-002\r\n6.55e-002\r\n5.91e-002\r\n5.91e-002\r\n9.79', '1', '-0.259', 'C10H12ClN5O3', '0285.063', '-1.331', '0285.687', '1.28', '4', '3', '0', '11', '10', '2', '19', '21', '17', '4', '008', '04', '12', '0', '3', '002', '0119.3', '266.94', '', '3.08685', '1.294', '74.67', '45.9', '3.35612', '28.77', '569.231', '198.022', '200.65', '', 'Cl/C/3=N/C(N)=C\\2/N=C\\N(C1OC(CO)C(O)C1)C2=N3', 'Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3', 'Cladribine', 'Leustatin; 2-CdA; Chlorodeoxyadenosine; Litak; Mylinax; Leustat', 'ribonucleotide reductase catalytic subunit M1', '20279', 'Phase Iii', 'Multiple Sclerosis', '24502830', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(294, '2782', '2782', 'Clc1ccc(Cn2c(CN3CCCC3)nc4ccccc24)cc1', '1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole', 'CYAAFQwAXdwQSnaxlNSqe7K6nVvWUZB9sk0Sicu125N^PLNHfx7LrdQSsi2yMYkrt7edX0$zFFrs3KUi4B0PY^tVT8UU1E2LArsKhB5P3qhqMX3UcYsdWion^PtA7lr$A4U$oyO8MqibOCf8lanN34g^yLLBY^u^ryB^jTtLNNMvIePBVlAsK^1KNMIxufes3V1qTwrX 591ZvWFuBJrPns8EyL7aGsKe0IKOnx4lvFqpxFb5bo0G$Q6m591MJlrsm9RTIGPlr5c9jclslml4hIuO37IRx9wqEHv866I07UKQ1qxDtIMjFH348eU1yw2AIFuqB8YqT5c6ePWiQn0VpugUhkHrehuoIo9ZoVRJSg^r6O6DNmlpZnhRfzJPKYr8p$aGZyj119ip$lRA FSw4SGx0zSMvILb4c2mhPSNY$4eD51CCZjYN0XRYydYxWceH$tcRcFXQ9yReSkuhTHqo8KwhyjK8xfFihHEOwDLUmPCZFZFz', 'InChI=1S/C19H20ClN3/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22/h1-2,5-10H,3-4,11-14H2', 'AuxInfo=1/0/N:18,17,7,8,16,15,19,20,21,22,5,6,12,9,14,23,13,11,10,1,4,2,3/E:(3,4)(7,8)(9,10)(11,12)/rA:43ClNNNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/rB:;;;s2;s2;s5;s6s7;s2;s3d-4s9;s3;s3;s4s11;s12;d+1 1;d+13;s15;s16d-17;d+14;s14;s19;d-20;s1d+21s22;s5;s5;s6;s6;s7;s7;s8;s8;s9;s9;s12;s12;s15;s16;s17;s18;s19;s20;s21;s22;/rC:5.6431,-2.3962,1.1027;-2.942,-1.441,.4257;-.1146,.561,-.4939;-1.5959,1.0847,1.0 784;-3.5701,-.894,-.7767;-3.3738,-2.8374,.4779;-4.9745,-1.4772,-.7236;-4.8462,-2.7525,.1038;-1.4', 'CJXAEXPPLWQRFR-UHFFFAOYSA-N', '1010:V1NH5KGMR4DTWDS2VQSSAXTK9JUFZN', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6](-[#1])(-[#1])-[n]2:[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1]):[n]:[c]2-[#6](-[#1])(-[#1])-[#7]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])( -[#1])-[#6]4(-[#1])-[#1]):[c](-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c1C([H])([H])n2c3c(c([H])c([H])c([H])c3[H])nc2C([H])([H])N4C([H])([H])C([H])([H])C([H])([H])C4([H])[H])c([H])c1[H]', '04.527', '4.527', '0', '0', 'TRUE', '-8.44e-002\r\n-0.2965\r\n-0.2253\r\n-0.238\r\n-1.4e-003\r\n-1.4e-003\r\n-3.92e-002\r\n-3.92e-002\r\n5.17e-002\r\n0.1043\r\n4.9e-002\r\n3.44e-002\r\n8.3e-002\r\n-3.3e-002\r\n-4.14e-002\r\n-3.48e-002\r\n-6.05e-002\r\n-6.e-002\r\n-5.63e-002\r\n-5.63e-002\r\n-4.32e-002\r\n-4.32e-002\r\n4.05e-002\r\n4.3e-', '0', '3.006', 'C19H20ClN3', '0325.135', '-5.912', '0325.835', '6.1 10.15', '1', '0', '0', '10', '16', '3', '23', '26', '23', '7', '003', '00', '20', '0', '4', '004', '0021.06', '326.65', '', '2.38717', '1.2847', '47.17', '39.71', '4.00787', '7.46', '1,018.34', '20.996', '253.47', '', 'Cl/C/4=C/C=C(CN2/C(CN1CCCC1)=N\\C\\3=C\\C=C/C=C23)\\C=C4', 'Clc4ccc(Cn3c(CN1CCCC1)nc2ccccc23)cc4', 'Clemizole', 'Histacur; Histakool; Lergopenin; Depocural', '5-hydroxytryptamine receptor 1A', '2782', 'Under Investigation', 'Myoclonic Epilepsy (Dravet Syndrome)', '28073790', 'Myoclonic Epilepsy (Dravet Syndrome)', 'EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6; SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI'),
(295, '2788', '2788', 'Oc1c(I)cc(Cl)c2cccnc12', '5-chloro-7-iodo-quinolin-8-ol', 'CYAAFQwAvewQpzPuW6AdZRwPlueUNWFCO31B8fJjaAuem6cGOjLnLF^Oq4OWVGoLYNasnNKYInWgEldjighpwUr$nQx1^v^rG2lsHUl82G5LjP1AdXPoAKQAPe6w8qgU6KSM146HusJIUgx61YZmEhIDVDA8ddNPXihxCnQXHuji$6WBNdnOznZQnDm4OWDJ8kX47Lwj l1pdxVazH^EBTnluR1iVczWdTEZzcsdRPYvYQm^5dpWlGHOJnPSxVKR^Kik6pHXsDeJWdY1YfWqZ1d$h550SIL375$8lrHFmrRCTYx$42KwVtkkf8dvDq9ilvqdw3Vvic81kJxmm32Xcu7f^$z3xzhhqUEZnYovGABdOVrP2X9N1Ew5j1okZpvVAfRcfkuUdleX7n^nx cByIhflvhXDjBVerx^NUD60KdmFIrj4idfhT0I64jackgp58fj^8ooJkKwDQu1T3NBLWxuAej7VCCGNdtLj$B8RRu5p7fsy5', 'InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H', 'AuxInfo=1/0/N:12,9,13,11,5,8,10,6,7,2,1,4,3/rA:18IClONCCCCCCCCCHHHHH/rB:;;;;s4d+5;s3s6;s2s5;s5;s1d-7;d+8s10;d-9;d-4s12;s9;s11;s12;s13;s3;/rC:-4.0284,.4021,-.0011;.2055,-3.324,-.0009;-1.4227,2.3236,-.0 002;1.2323,1.7479,-.0001;.746,-.6123,.0001;.3408,.7388,.0001;-1.0241,1.0132,.0005;-.2119,-1.6405,.0006;2.1198,-.8892,0;-1.9767,-.0088,.0007;-1.5704,-1.3374,.0008;3.0408,.1485,-.0002;2.549,1.438,-.0003 ;2.5083,-1.9036,.0001;-2.3057,-2.1391,.0007;4.1067,-.0469,-.0004;3.2216,2.2895,-.0005;-2.3951,2.', 'QCDFBFJGMNKBDO-UHFFFAOYSA-N', '1010:R1MQXRRZ91TNQZGR5BA67HXJD99YCN', '[#53]-[c](:[c](-[#1]):[c]1-[#17]):[c](:[c]2:[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]2)-[#8]-[#1]', 'Ic(c([H])c1Cl)c(c2c1c([H])c([H])c([H])n2)O[H]', '03.016', '3.016', '0', '0', 'TRUE', '-4.14e-002\r\n-8.36e-002\r\n-0.3577\r\n-0.2534\r\n2.15e-002\r\n0.1027\r\n0.1111\r\n5.12e-002\r\n-4.97e-002\r\n4.67e-002\r\n-2.68e-002\r\n-4.32e-002\r\n2.76e-002\r\n6.3e-002\r\n6.5e-002\r\n6.38e-002\r\n8.39e-002\r\n0.2193', '0', '2.924', 'C9H5ClINO', '0304.91', '-4.009', '0305.5', '3.77 7.9', '1', '1', '0', '3', '11', '2', '13', '14', '8', '5', '002', '01', '5', '0', '2', '000', '0033.12', '199.17', '', '1.79327', '1.3561', '2.45', '-1.62', '2.78115', '4.07', '527.071', '56.743', '156.06', '', 'I/C/1=C(O)/C/2=C(\\C(Cl)=C1)/C=C\\C=N2', 'Oc1c(I)cc(Cl)c2cccnc12', 'Clioquinol', 'PBT1; Chinoform; Vioform; Enteroquinol; Alchloquin; Eczecidin', 'Amyloid beta A4 protein', '2788', 'Under Investigation', 'Alzheimer disease (AD)', '23627708', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(296, '2789', '2789', 'CN1C(=O)CC(=O)N(c2ccccc2)c3cc(Cl)ccc13', '7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione', 'CYAAFQwABfwQcUtKesv8ffDpmNK2g4F4pvy4LVlepmqI3DMFhczJvkPA8FgLAZQTlBx1qgIQEqgc2N6xrxSzjhECHfRFA5xdViuY9fYjBlYEWJ$Hskz7Q0r^SJ5F3TP49yN$AAE^yjPiotBBi77473YjmDsq5pl2C2j^Mdyki^Zt4Aq5KpMe5tW5ppP8rY5siZj1elZs HHLeQpe15hdEOKSsredvvulH5ceZSb$Qwj7Md9oQjnmxPMmp95eOqPvPnZrpgk33YHYGxUOYrwxVjh2R2Reh^VY5nNZ1fmuo6xiKzHFuqEPV0$R6MzPcVoweGkOq2P1o1qOin5rjiPjRAhIcZv31PZAQE3WCfhokFRbe232KEa0AySOWYsC1nSxAz$V0BMKrzee^kL6V MbdNnLSG42xS9IUV5Fm$BT0LN90Kqfu014gk^Wc90MEqDQxqkonHb1udFvHTA$7o1z1$MkaeF84KsSx8ryT517KAceoNYu2e', 'InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3', 'AuxInfo=1/0/N:14,21,19,20,17,18,16,13,12,8,15,11,7,6,10,9,1,5,4,3,2/E:(3,4)(5,6)/rA:34ClOONNCCCCCCCCCCCCCCCCHHHHHHHHHHHHH/rB:;;;;s4;s5d-6;;d2s4s8;d3s5s8;s4;s6;s7;s5;s1d+12;d-13s15;d+11;s11;s17;d-18;d- 19s20;s8;s8;s12;s13;s14;s14;s14;s16;s17;s18;s19;s20;s21;/rC:-.0754,-4.4844,.9755;-.6431,2.9072,.7473;2.9585,2.9475,-.2587;-.4181,.6075,.3481;2.4836,.694,-.6072;.4496,-.5457,.2487;1.7872,-.5066,-.225;1 .4412,1.9205,1.2398;.0192,1.8674,.77;2.3595,1.9162,.0544;-1.8015,.4293,-.0317;-.0883,-1.8016,.63', 'CXOXHMZGEKVPMT-UHFFFAOYSA-N', '1010:7F7P1EK2VMMXVTJ722UMYBUBK9T6M9', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]12)-[#7](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[#1])(-[#1])-[#6](-[#7]1-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])=[#8])=[#8]):[c]2-[#1]', 'Clc(c([H])c([H])c(c12)N(C([H])([H])[H])C(C([H])([H])C(N1c3c([H])c([H])c([H])c([H])c3[H])=O)=O)c2[H]', '02.738', '2.738', '0', '0', 'TRUE', '-8.43e-002\r\n-0.2762\r\n-0.2766\r\n-0.238\r\n-0.2725\r\n6.36e-002\r\n5.72e-002\r\n0.1027\r\n0.2323\r\n0.2275\r\n4.06e-002\r\n-1.95e-002\r\n-3.71e-002\r\n7.9e-003\r\n4.25e-002\r\n-4.16e-002\r\n-4.02e-002\r\n-4.02e-002\r\n-6.04e-002\r\n-6.04e-002\r\n-6.22e-002\r\n4.64e-002\r\n4.64e-002\r\n6.59e-002\r\n6', '0', '2.694', 'C16H13ClN2O2', '0300.067', '-3.607', '0300.74', '-0.52 2.79 7.32', '2', '0', '2', '9', '12', '2', '21', '23', '18', '8', '004', '00', '13', '0', '3', '001', '0040.62', '292.06', '', '3.336', '1.2978', '31.71', '23.19', '3.51536', '8.52', '647.603', '76.76', '224.32', '175.53 -173.76', 'Cl/C/3=C/C1=C(N(C)C(=O)CC(=O)N1/C/2=C/C=C\\C=C2)\\C=C3', 'CN3C(=O)CC(=O)N(c1ccccc1)c2cc(Cl)ccc23', 'Clobazam', 'Chlorepin; Urbanyl; Clorepin; Caastilium; Noiafren; Odipam; Mystan', 'Gamma-aminobutyric acid receptor subunit alpha-1', '2789', 'FDA approved', 'Epilepsy', '25917225', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(297, '2801', '2801', 'CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13', '3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-<I>N</I>,<I>N</I>-dimethyl-propan-1-amine', 'CYAAFQwAkfwQYmAPj4YUPl$i7KTZVM4WWhS9OA34ruF9hCkdnaPGZue8daeSmcCihiPThIppLy3UP2LdJ$pOmQISUeCaUgb4FUfqV6I3ArgXXB7OZahpTy^Yn98LqvSUlDdpLy^^HJPinLaJVTvhesTxFhvP8UnpUiVqH^7zu3S4V61gpOvgeaT1qcHvZo83sgwVmsno TC3r75Y8csV1QJlzd$1Gd3wu6jn7FNPvmFKyucEpx9WjSvGOoOuIzkQ55eP5nqD64HnmfFlpKjGpJdlwj71soWnuEtC84xn7551RzBBnR79PNcgwvy8ssS^SDGNXl5VpVm5qD5cRq^N12MNU3pp4o47z85mnIVXF11qdE6rzG1nL7Ktfq8ApaPSpCnulET3JPCQ4K3qe DdfXPfLwku$dsc$E7Ia0eD6ncHnltZWvKXPGPJxBIr2d1Od41CvXewnn8$^h5zdqRXM9zp0sznUyQ^^WS79$a31znfTMRfOW', 'InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3', 'AuxInfo=1/0/N:21,22,20,18,11,16,14,8,7,15,19,12,4,13,10,9,17,6,5,1,3,2/E:(1,2)/rA:45ClNNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s2;s2;s2;;s7;d-5s7;s6s8;s4;s3s11;s5;d+6;s9;d-10;s1d+13;s14;d-15s 17;s16d-18;s3;s3;s4;s4;s7;s7;s8;s8;s11;s11;s12;s12;s13;s14;s15;s16;s18;s19;s20;s21;s21;s21;s22;s22;s22;/rC:4.8378,-1.0542,-1.4359;-.2091,-.2626,-.788;.0534,3.9753,.1824;-.0906,.7185,-1.8785;.9936,-.75 04,-.2061;-1.5369,-.7066,-.558;-.0715,-1.5197,2.0499;-1.2041,-.5128,1.933;1.0721,-1.3577,1.0709;', 'GDLIGKIOYRNHDA-UHFFFAOYSA-N', '1010:TANE94JR4KYP13GWJMX9ZAMX8P24TN', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1]):[c]1-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[ #6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1]):[c]23):[c]3-[#1]', 'Clc(c([H])c([H])c(C([H])([H])C([H])([H])c(c([H])c([H])c([H])c1[H])c1N2C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])c23)c3[H]', '05.052', '5.052', '0', '0', 'TRUE', '-8.43e-002\r\n-0.2443\r\n-0.3094\r\n9.3e-003\r\n2.64e-002\r\n2.49e-002\r\n-2.22e-002\r\n-2.22e-002\r\n-2.91e-002\r\n-2.92e-002\r\n-2.68e-002\r\n-1.3e-003\r\n-2.47e-002\r\n-4.34e-002\r\n-5.6e-002\r\n-5.75e-002\r\n4.21e-002\r\n-6.07e-002\r\n-4.32e-002\r\n-6.19e-002\r\n-1.37e-002\r\n-1.37e-002\r\n4.39', '0', '3.492', 'C19H23ClN2', '0314.155', '-5.325', '0314.852', '5.86 10.45', '0', '0', '0', '12', '12', '2', '22', '24', '26', '6', '002', '00', '23', '0', '3', '004', '0006.48', '336.86', '', '1.71391', '1.276', '75.39', '22.52', '3.62731', '52.87', '756.68', '6.561', '265.13', '', 'Cl/C/3=C/C2=C(CC/C1=C/C=C\\C=C1\\N2CCCN(C)C)\\C=C3', 'CN(C)CCCN3c1ccccc1CCc2ccc(Cl)cc23', 'Clomipramine', 'Anafranil; Hydiphen; Clomicalm; G 34586', 'Sodium-dependent serotonin transporter', '2801', 'Under Investigation', 'Trichotillomania', '2761586', 'Trichotillomania', 'TTM'),
(298, '2801', '2801', '[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1', '5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one', 'CYAAFQwAkewQCsCTMtbhRbg7ZCjLktVWDD0ZJLjuuHOvgjwlEn4uzPEmLtKr5xpsV8qiTxAn3kwuXiUca5r08nXf3OeYCBnZ3Au$oPAnJKMDdUgfQ9$yhNVQeUQKHfsvPtc3lCoAZq1ITU^GiTCrTjbc4qtid0PPPsRwa76Vink$01PhQUxhWlvad5tDvXnV46e$ZYhV qZKPX$0OVNckqyJeO0BS^YlKsU06nygojzsDAXwNOpl82ws^p299TwIIJKtmVd$d6nGqKv8EyTWkKNPO3ixYnopyljmUPEV6CewoBAc6YO70RgHnvk$61FFlIzAnQx7zDxaaWncpv2yvvUT4d7$A94EckjeozfRi^GdpaaNUepp^LEHe6jDhPPMHDqiTMUfXVYedQ0Dy 6dNbvBwqym7GOZlc$^iV0XEek8KduxWq077lLrlOkNojq4WHnr^7veAU33dWu2Jwa5te^tnbiMCDvfm24ri82qAcjT4be^3e', 'InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)', 'AuxInfo=1/1/N:21,22,19,20,17,13,12,14,15,11,8,18,9,16,10,1,6,5,7,2,3,4/E:(21,22)/CRV:19.5/rA:32ClOO-ONNN+CCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s3d4;;s5d-8;d-6s8;s10;s8;s9;s6;s7d+12;d2s5s14;d-13s15;s1s11;d +11;d+18;s19;s20d-21;s12;s5;s13;s14;s14;s17;s19;s20;s21;s22;/rC:2.3382,.2449,-2.1583;1.3758,4.3718,-.0107;-4.599,-1.7344,-.3276;-2.9543,-2.7447,.7179;-.3114,2.9033,-.5001;1.6649,1.341,1.1652;-3.4285,- 1.7462,.1242;-.483,.535,.2508;-1.0141,1.6901,-.3464;.9649,.4155,.6029;1.6835,-.8444,.2561;-1.301', 'DGBIGWXXNGSACT-UHFFFAOYSA-N', '1010:XD4G6TBS88K76F1ZGU498PU6W25XQR', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[c]2:[c]3:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#1])-[#7+](=[#8])-[#8-])=[#7]-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8]', 'Clc1c([H])c([H])c([H])c([H])c1C(c2c3c([H])c([H])c(c2[H])[N+](=O)[O-])=NC([H])([H])C(N3[H])=O', '02.859', '2.859', '0', '0', 'TRUE', '-8.36e-002\r\n-0.2752\r\n-0.4304\r\n-0.4304\r\n-0.2832\r\n-0.2743\r\n0.5709\r\n2.59e-002\r\n4.22e-002\r\n7.6e-002\r\n1.9e-002\r\n-1.5e-003\r\n-3.59e-002\r\n0.1166\r\n0.1738\r\n0.2376\r\n-1.09e-002\r\n4.99e-002\r\n-5.14e-002\r\n-4.29e-002\r\n-6.15e-002\r\n-6.08e-002\r\n6.74e-002\r\n0.1557\r\n6.44e-002\r\n', '0', '2.756', 'C15H10ClN3O3', '0315.041', '-5.167', '0315.711', '1.5 10.5', '2', '1', '3', '9', '12', '2', '22', '24', '15', '9', '006', '01', '10', '0', '3', '002', '0087.28', '293.63', '', '1.76843', '1.308', '38.27', '28.61', '3.50315', '9.66', '681.692', '176.354', '222.26', '-10.74', 'Cl/C/3=C/C2=C(CC/C1=C/C=C\\C=C1\\N2CCCN(C)C)\\C=C3', 'CN(C)CCCN3c1ccccc1CCc2ccc(Cl)cc23', 'Clomipramine', 'Anafranil; Hydiphen; Clomicalm; G 34586', '5-hydroxytryptamine receptor 2A', '2801', 'Under Investigation', 'Trichotillomania', '2761586', 'Trichotillomania', 'TTM');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(299, '2802', '2802', '[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1', '5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one', 'CYAAFQwAkewQCsCTMtbhRbg7ZCjLktVWDD0ZJLjuuHOvgjwlEn4uzPEmLtKr5xpsV8qiTxAn3kwuXiUca5r08nXf3OeYCBnZ3Au$oPAnJKMDdUgfQ9$yhNVQeUQKHfsvPtc3lCoAZq1ITU^GiTCrTjbc4qtid0PPPsRwa76Vink$01PhQUxhWlvad5tDvXnV46e$ZYhV qZKPX$0OVNckqyJeO0BS^YlKsU06nygojzsDAXwNOpl82ws^p299TwIIJKtmVd$d6nGqKv8EyTWkKNPO3ixYnopyljmUPEV6CewoBAc6YO70RgHnvk$61FFlIzAnQx7zDxaaWncpv2yvvUT4d7$A94EckjeozfRi^GdpaaNUepp^LEHe6jDhPPMHDqiTMUfXVYedQ0Dy 6dNbvBwqym7GOZlc$^iV0XEek8KduxWq077lLrlOkNojq4WHnr^7veAU33dWu2Jwa5te^tnbiMCDvfm24ri82qAcjT4be^3e', 'InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)', 'AuxInfo=1/1/N:21,22,19,20,17,13,12,14,15,11,8,18,9,16,10,1,6,5,7,2,3,4/E:(21,22)/CRV:19.5/rA:32ClOO-ONNN+CCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s3d4;;s5d-8;d-6s8;s10;s8;s9;s6;s7d+12;d2s5s14;d-13s15;s1s11;d +11;d+18;s19;s20d-21;s12;s5;s13;s14;s14;s17;s19;s20;s21;s22;/rC:2.3382,.2449,-2.1583;1.3758,4.3718,-.0107;-4.599,-1.7344,-.3276;-2.9543,-2.7447,.7179;-.3114,2.9033,-.5001;1.6649,1.341,1.1652;-3.4285,- 1.7462,.1242;-.483,.535,.2508;-1.0141,1.6901,-.3464;.9649,.4155,.6029;1.6835,-.8444,.2561;-1.301', 'DGBIGWXXNGSACT-UHFFFAOYSA-N', '1010:XD4G6TBS88K76F1ZGU498PU6W25XQR', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[c]2:[c]3:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#1])-[#7+](=[#8])-[#8-])=[#7]-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8]', 'Clc1c([H])c([H])c([H])c([H])c1C(c2c3c([H])c([H])c(c2[H])[N+](=O)[O-])=NC([H])([H])C(N3[H])=O', '02.859', '2.859', '0', '0', 'TRUE', '-8.36e-002\r\n-0.2752\r\n-0.4304\r\n-0.4304\r\n-0.2832\r\n-0.2743\r\n0.5709\r\n2.59e-002\r\n4.22e-002\r\n7.6e-002\r\n1.9e-002\r\n-1.5e-003\r\n-3.59e-002\r\n0.1166\r\n0.1738\r\n0.2376\r\n-1.09e-002\r\n4.99e-002\r\n-5.14e-002\r\n-4.29e-002\r\n-6.15e-002\r\n-6.08e-002\r\n6.74e-002\r\n0.1557\r\n6.44e-002\r\n', '0', '2.756', 'C15H10ClN3O3', '0315.041', '-5.167', '0315.711', '1.5 10.5', '2', '1', '3', '9', '12', '2', '22', '24', '15', '9', '006', '01', '10', '0', '3', '002', '0087.28', '293.63', '', '1.76843', '1.308', '38.27', '28.61', '3.50315', '9.66', '681.692', '176.354', '222.26', '-10.74', 'Cl/C1=C/C=C\\C=C1\\C2=N\\CC(=O)N/C/3=C2/C=C(N(=O)=O)\\C=C3', 'O=C3C/N=C(c1ccccc1Cl)\\c2cc(N(=O)=O)ccc2N3', 'Clonazepam', 'Klonopin; Rivotril; Antelepsin; Iktorivil; Landsen; Clonex; Solfidin', 'Gamma-aminobutyric acid receptor subunit alpha-1', '2802', 'Phase IV', 'Epilepsy', '18384456', 'Epilepsy', 'LANDAU-KLEFFNER SYNDROME, INCLUDED; LKS, INCLUDED\nCONTINUOUS SPIKE AND WAVES DURING SLOW-WAVE SLEEP SYNDROME, INCLUDED; CSWS, INCLUDED; CSWSS, INCLUDED\nROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT, INCLUDED; RESDAD, INCLUDED; ADRESD, INCLUDED\nBENIGN EPILEPSY OF CHILDHOOD WITH CENTROTEMPORAL SPIKES, INCLUDED; BECTS, INCLUDED'),
(300, '2802', '2802', '[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1', '5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one', 'CYAAFQwAkewQCsCTMtbhRbg7ZCjLktVWDD0ZJLjuuHOvgjwlEn4uzPEmLtKr5xpsV8qiTxAn3kwuXiUca5r08nXf3OeYCBnZ3Au$oPAnJKMDdUgfQ9$yhNVQeUQKHfsvPtc3lCoAZq1ITU^GiTCrTjbc4qtid0PPPsRwa76Vink$01PhQUxhWlvad5tDvXnV46e$ZYhV qZKPX$0OVNckqyJeO0BS^YlKsU06nygojzsDAXwNOpl82ws^p299TwIIJKtmVd$d6nGqKv8EyTWkKNPO3ixYnopyljmUPEV6CewoBAc6YO70RgHnvk$61FFlIzAnQx7zDxaaWncpv2yvvUT4d7$A94EckjeozfRi^GdpaaNUepp^LEHe6jDhPPMHDqiTMUfXVYedQ0Dy 6dNbvBwqym7GOZlc$^iV0XEek8KduxWq077lLrlOkNojq4WHnr^7veAU33dWu2Jwa5te^tnbiMCDvfm24ri82qAcjT4be^3e', 'InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)', 'AuxInfo=1/1/N:21,22,19,20,17,13,12,14,15,11,8,18,9,16,10,1,6,5,7,2,3,4/E:(21,22)/CRV:19.5/rA:32ClOO-ONNN+CCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s3d4;;s5d-8;d-6s8;s10;s8;s9;s6;s7d+12;d2s5s14;d-13s15;s1s11;d +11;d+18;s19;s20d-21;s12;s5;s13;s14;s14;s17;s19;s20;s21;s22;/rC:2.3382,.2449,-2.1583;1.3758,4.3718,-.0107;-4.599,-1.7344,-.3276;-2.9543,-2.7447,.7179;-.3114,2.9033,-.5001;1.6649,1.341,1.1652;-3.4285,- 1.7462,.1242;-.483,.535,.2508;-1.0141,1.6901,-.3464;.9649,.4155,.6029;1.6835,-.8444,.2561;-1.301', 'DGBIGWXXNGSACT-UHFFFAOYSA-N', '1010:XD4G6TBS88K76F1ZGU498PU6W25XQR', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[c]2:[c]3:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#1])-[#7+](=[#8])-[#8-])=[#7]-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8]', 'Clc1c([H])c([H])c([H])c([H])c1C(c2c3c([H])c([H])c(c2[H])[N+](=O)[O-])=NC([H])([H])C(N3[H])=O', '02.859', '2.859', '0', '0', 'TRUE', '-8.36e-002\r\n-0.2752\r\n-0.4304\r\n-0.4304\r\n-0.2832\r\n-0.2743\r\n0.5709\r\n2.59e-002\r\n4.22e-002\r\n7.6e-002\r\n1.9e-002\r\n-1.5e-003\r\n-3.59e-002\r\n0.1166\r\n0.1738\r\n0.2376\r\n-1.09e-002\r\n4.99e-002\r\n-5.14e-002\r\n-4.29e-002\r\n-6.15e-002\r\n-6.08e-002\r\n6.74e-002\r\n0.1557\r\n6.44e-002\r\n', '0', '2.756', 'C15H10ClN3O3', '0315.041', '-5.167', '0315.711', '1.5 10.5', '2', '1', '3', '9', '12', '2', '22', '24', '15', '9', '006', '01', '10', '0', '3', '002', '0087.28', '293.63', '', '1.76843', '1.308', '38.27', '28.61', '3.50315', '9.66', '681.692', '176.354', '222.26', '-10.74', 'Cl/C1=C/C=C\\C=C1\\C2=N\\CC(=O)N/C/3=C2/C=C(N(=O)=O)\\C=C3', 'O=C3C/N=C(c1ccccc1Cl)\\c2cc(N(=O)=O)ccc2N3', 'Clonazepam', 'Klonopin; Rivotril; Antelepsin; Iktorivil; Landsen; Clonex; Solfidin', 'Translocator protein', '2802', 'Under Investigation', 'Tardive Dyskinesia', '16855954', 'Tardive Dyskinesia', 'NA'),
(301, '2802', '2802', '[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1', '5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one', 'CYAAFQwAkewQCsCTMtbhRbg7ZCjLktVWDD0ZJLjuuHOvgjwlEn4uzPEmLtKr5xpsV8qiTxAn3kwuXiUca5r08nXf3OeYCBnZ3Au$oPAnJKMDdUgfQ9$yhNVQeUQKHfsvPtc3lCoAZq1ITU^GiTCrTjbc4qtid0PPPsRwa76Vink$01PhQUxhWlvad5tDvXnV46e$ZYhV qZKPX$0OVNckqyJeO0BS^YlKsU06nygojzsDAXwNOpl82ws^p299TwIIJKtmVd$d6nGqKv8EyTWkKNPO3ixYnopyljmUPEV6CewoBAc6YO70RgHnvk$61FFlIzAnQx7zDxaaWncpv2yvvUT4d7$A94EckjeozfRi^GdpaaNUepp^LEHe6jDhPPMHDqiTMUfXVYedQ0Dy 6dNbvBwqym7GOZlc$^iV0XEek8KduxWq077lLrlOkNojq4WHnr^7veAU33dWu2Jwa5te^tnbiMCDvfm24ri82qAcjT4be^3e', 'InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)', 'AuxInfo=1/1/N:21,22,19,20,17,13,12,14,15,11,8,18,9,16,10,1,6,5,7,2,3,4/E:(21,22)/CRV:19.5/rA:32ClOO-ONNN+CCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s3d4;;s5d-8;d-6s8;s10;s8;s9;s6;s7d+12;d2s5s14;d-13s15;s1s11;d +11;d+18;s19;s20d-21;s12;s5;s13;s14;s14;s17;s19;s20;s21;s22;/rC:2.3382,.2449,-2.1583;1.3758,4.3718,-.0107;-4.599,-1.7344,-.3276;-2.9543,-2.7447,.7179;-.3114,2.9033,-.5001;1.6649,1.341,1.1652;-3.4285,- 1.7462,.1242;-.483,.535,.2508;-1.0141,1.6901,-.3464;.9649,.4155,.6029;1.6835,-.8444,.2561;-1.301', 'DGBIGWXXNGSACT-UHFFFAOYSA-N', '1010:XD4G6TBS88K76F1ZGU498PU6W25XQR', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[c]2:[c]3:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#1])-[#7+](=[#8])-[#8-])=[#7]-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8]', 'Clc1c([H])c([H])c([H])c([H])c1C(c2c3c([H])c([H])c(c2[H])[N+](=O)[O-])=NC([H])([H])C(N3[H])=O', '02.859', '2.859', '0', '0', 'TRUE', '-8.36e-002\r\n-0.2752\r\n-0.4304\r\n-0.4304\r\n-0.2832\r\n-0.2743\r\n0.5709\r\n2.59e-002\r\n4.22e-002\r\n7.6e-002\r\n1.9e-002\r\n-1.5e-003\r\n-3.59e-002\r\n0.1166\r\n0.1738\r\n0.2376\r\n-1.09e-002\r\n4.99e-002\r\n-5.14e-002\r\n-4.29e-002\r\n-6.15e-002\r\n-6.08e-002\r\n6.74e-002\r\n0.1557\r\n6.44e-002\r\n', '0', '2.756', 'C15H10ClN3O3', '0315.041', '-5.167', '0315.711', '1.5 10.5', '2', '1', '3', '9', '12', '2', '22', '24', '15', '9', '006', '01', '10', '0', '3', '002', '0087.28', '293.63', '', '1.76843', '1.308', '38.27', '28.61', '3.50315', '9.66', '681.692', '176.354', '222.26', '-10.74', 'Cl/C1=C/C=C\\C=C1\\C2=N\\CC(=O)N/C/3=C2/C=C(N(=O)=O)\\C=C3', 'O=C3C/N=C(c1ccccc1Cl)\\c2cc(N(=O)=O)ccc2N3', 'Clonazepam', 'Klonopin; Rivotril; Antelepsin; Iktorivil; Landsen; Clonex; Solfidin', 'Gamma-aminobutyric acid receptor subunit alpha-1', '2802', 'Under Investigation', 'Huntington Disease (HD)', '2962291', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(302, '2802', '2802', '[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1', '5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one', 'CYAAFQwAkewQCsCTMtbhRbg7ZCjLktVWDD0ZJLjuuHOvgjwlEn4uzPEmLtKr5xpsV8qiTxAn3kwuXiUca5r08nXf3OeYCBnZ3Au$oPAnJKMDdUgfQ9$yhNVQeUQKHfsvPtc3lCoAZq1ITU^GiTCrTjbc4qtid0PPPsRwa76Vink$01PhQUxhWlvad5tDvXnV46e$ZYhV qZKPX$0OVNckqyJeO0BS^YlKsU06nygojzsDAXwNOpl82ws^p299TwIIJKtmVd$d6nGqKv8EyTWkKNPO3ixYnopyljmUPEV6CewoBAc6YO70RgHnvk$61FFlIzAnQx7zDxaaWncpv2yvvUT4d7$A94EckjeozfRi^GdpaaNUepp^LEHe6jDhPPMHDqiTMUfXVYedQ0Dy 6dNbvBwqym7GOZlc$^iV0XEek8KduxWq077lLrlOkNojq4WHnr^7veAU33dWu2Jwa5te^tnbiMCDvfm24ri82qAcjT4be^3e', 'InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)', 'AuxInfo=1/1/N:21,22,19,20,17,13,12,14,15,11,8,18,9,16,10,1,6,5,7,2,3,4/E:(21,22)/CRV:19.5/rA:32ClOO-ONNN+CCCCCCCCCCCCCCCHHHHHHHHHH/rB:;;;;;s3d4;;s5d-8;d-6s8;s10;s8;s9;s6;s7d+12;d2s5s14;d-13s15;s1s11;d +11;d+18;s19;s20d-21;s12;s5;s13;s14;s14;s17;s19;s20;s21;s22;/rC:2.3382,.2449,-2.1583;1.3758,4.3718,-.0107;-4.599,-1.7344,-.3276;-2.9543,-2.7447,.7179;-.3114,2.9033,-.5001;1.6649,1.341,1.1652;-3.4285,- 1.7462,.1242;-.483,.535,.2508;-1.0141,1.6901,-.3464;.9649,.4155,.6029;1.6835,-.8444,.2561;-1.301', 'DGBIGWXXNGSACT-UHFFFAOYSA-N', '1010:XD4G6TBS88K76F1ZGU498PU6W25XQR', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6](-[c]2:[c]3:[c](-[#1]):[c](-[#1]):[c](:[c]2-[#1])-[#7+](=[#8])-[#8-])=[#7]-[#6](-[#1])(-[#1])-[#6](-[#7]3-[#1])=[#8]', 'Clc1c([H])c([H])c([H])c([H])c1C(c2c3c([H])c([H])c(c2[H])[N+](=O)[O-])=NC([H])([H])C(N3[H])=O', '02.859', '2.859', '0', '0', 'TRUE', '-8.36e-002\r\n-0.2752\r\n-0.4304\r\n-0.4304\r\n-0.2832\r\n-0.2743\r\n0.5709\r\n2.59e-002\r\n4.22e-002\r\n7.6e-002\r\n1.9e-002\r\n-1.5e-003\r\n-3.59e-002\r\n0.1166\r\n0.1738\r\n0.2376\r\n-1.09e-002\r\n4.99e-002\r\n-5.14e-002\r\n-4.29e-002\r\n-6.15e-002\r\n-6.08e-002\r\n6.74e-002\r\n0.1557\r\n6.44e-002\r\n', '0', '2.756', 'C15H10ClN3O3', '0315.041', '-5.167', '0315.711', '1.5 10.5', '2', '1', '3', '9', '12', '2', '22', '24', '15', '9', '006', '01', '10', '0', '3', '002', '0087.28', '293.63', '', '1.76843', '1.308', '38.27', '28.61', '3.50315', '9.66', '681.692', '176.354', '222.26', '-10.74', 'Cl/C1=C/C=C\\C=C1\\C2=N\\CC(=O)N/C/3=C2/C=C(N(=O)=O)\\C=C3', 'O=C3C/N=C(c1ccccc1Cl)\\c2cc(N(=O)=O)ccc2N3', 'Clonazepam', 'Klonopin; Rivotril; Antelepsin; Iktorivil; Landsen; Clonex; Solfidin', 'Gamma-aminobutyric acid receptor subunit alpha-1', '2802', 'Under Investigation', 'Coffin-Lowry syndrome', '25667906', 'Coffin-Lowry syndrome', 'CLS'),
(303, '2803', '2803', 'Clc1cccc(Cl)c1NC2=NCCN2', '<I>N</I>-(2,6-dichlorophenyl)-4,5-dihydro-1<I>H</I>-imidazol-2-amine', 'CYAAFQwAVewQ5FB6$4wDuWZmfYXoE9Zb8Gsptsw^CztlZeJQg$Q3ku2Z62ZwM8Uik3XZR8$HtvzPFOmXmO0ySotaCej$p39EY3MD^ylVAvAmW8gdfRhQFAIvgPAOGuL9vM8u4QsRx81DZfWqMy5ZapdnwLsLdcL9DljP81P15KIcLw6cVt7Fz4OuHFHTzyZaCzrKqEGx 5INaJHsxyElyoy^v0Xjt44Fc97aSTDvtLZ5cVeag$16Yscy7oUedIGeq5z7j53dMxXX7GxPPrjSXUHly2YpqSz6YioCOSw5DYgwtHZQzvexK6SNUV85nfImk66FcgL$nkUOeaQTZGPb9rhSRTBJftRUqrb1tCRdeHLH8RzZmvfzVvgDXSSKnqf$SiIScVfej770R16Yv rg8cWF7xBderkri0xfnoV8fR$G^s9UyZN^wRFSNXHXcrvLXikKKxtx1DnUQU4mT35InuXNqe8H1A0fG7E4Sp^vPh2jRIi8pg', 'InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)', 'AuxInfo=1/1/N:14,12,13,6,7,10,11,9,8,1,2,3,5,4/E:(2,3)(4,5)(6,7)(10,11)(12,13)/rA:23ClClNNNCCCCCCCCCHHHHHHHHH/rB:;;;;s3;s5s6;s3s4d-5;s4;s1d-9;s2s9;s10;d+11;d-12s13;s6;s6;s7;s7;s3;s4;s12;s13;s14;/rC:-. 6943,-2.7291,-.4532;-.7006,2.7304,-.4526;2.8328,.0005,-.9266;.5073,.002,-.9263;1.7928,.0018,1.0905;3.9605,-.0026,-.0455;3.2689,.0018,1.3238;1.6703,.0019,-.2155;-.7949,.0004,-.4146;-1.4585,-1.2083,-.15 33;-1.4612,1.2077,-.1531;-2.7567,-1.2098,.3571;-2.7595,1.206,.3572;-3.4071,-.0027,.6123;4.5811,.', 'GJSURZIOUXUGAL-UHFFFAOYSA-N', '1010:C9SZWXWGQAJVPZTPVQHKWUZ4ZE28AD', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](:[c]1-[#7](-[#1])-[#6](=[#7]-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7]2-[#1])-[#17]', 'Clc1c([H])c([H])c([H])c(c1N([H])C(=NC([H])([H])C2([H])[H])N2[H])Cl', '02.354', '2.354', '0', '0', 'TRUE', '-8.26e-002\r\n-8.26e-002\r\n-0.2615\r\n-0.231\r\n-0.2615\r\n2.2e-002\r\n5.47e-002\r\n0.1515\r\n5.86e-002\r\n6.04e-002\r\n6.04e-002\r\n-4.18e-002\r\n-4.18e-002\r\n-5.92e-002\r\n4.51e-002\r\n4.51e-002\r\n5.28e-002\r\n5.28e-002\r\n0.1306\r\n0.1368\r\n6.38e-002\r\n6.38e-002\r\n6.36e-002', '0', '2.354', 'C9H9Cl2N3', '0229.017', '-3.362', '0230.094', '4.87', '1', '2', '1', '8', '06', '1', '14', '15', '12', '4', '003', '02', '9', '0', '2', '002', '0036.42', '209.39', '', '0.34637', '1.3085', '115.74', '33.33', '3.24537', '82.41', '354.46', '58.838', '161.89', '', 'Cl/C/2=C(N/C1=N/CCN1)/C(Cl)=C\\C=C2', 'Clc1cccc(Cl)c1N/C2=N/CCN2', 'Clonidine', 'Duraclon; Adesipress; Catarpres; Dixarit; Klofelin; Duraclont', 'Alpha-2A adrenergic receptor', '2803', 'Phase II Completed', 'Parkinson Disease (Sialorrhoea)', '20347876', 'Parkinson Disease (Sialorrhoea)', 'PARK'),
(304, '60606', '60606', 'COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl', 'methyl (2<I>S</I>)-2-(2-chlorophenyl)-2-(6,7-dihydro-4<I>H</I>-thieno[3,2-c]pyridin-5-yl)acetate', 'CYAAFQwAeewQnbNvcSo2WeajUVi92ZRxoYOMzBH6XXvyc5rsrX$2RJW8FL^0vEVKBmvOWoBtYy2Rx7QKNukLB153SBD7EhrRqQtaJo3tn$pLEFJidINFOF3ZCOFX3fR^Vd8v^20auDACD^3OdXqQsZcwe$W2FMGa^9sTjT0uWlcPOrZzAz2EFKWFvtUZlAe6zRI3oCAq EcG9HnOaUtsyse1gueFYhXHKVPT$HGnadsfh6FnKQPfP2va3Vt6OxV0YVeevYb8hBeW3mkH3PvgwKbx3Ioc4D$lYGBPf2c6aZlZbZ7i$6k$tF6NYtNQxenjhhrg57rYlsjnW0nUNCdC3adYoe9qVoHWsFvSKPrKlnIq5vGqkv2FqGvU7f0zV11eYDTN$1q9HdI$lTPB3 FiAH8S8Patp16Q8XQM4zYffP$Oc2YEJS9jIqSnuDs$8FuCIFjVIDeykS$u8z4VCockDqdlKGwCV9p4Jdj$6WVLtAKX9XkPZv', 'InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1', 'AuxInfo=1/0/N:21,19,20,17,18,9,13,6,15,7,10,12,16,11,8,14,1,5,4,3,2/it:im/rA:37ClSOONCCC.eCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;s5;s5;s5;s6;s7;s2s9d+10;s8;s10;s3d4s8;s2d-13;s1s12;d+12;d+16;s17;s18d-19; s3;s6;s6;s7;s7;s8;s9;s9;s13;s15;s17;s18;s19;s20;s21;s21;s21;/rC:3.1828,.3367,-2.3503;-4.966,-.039,.3676;1.4377,-2.0054,1.2016;1.7297,-2.8681,-.9149;-.5596,-.5183,-.1523;-1.3355,-1.6995,-.5849;-1.1631, .7407,-.6443;.8271,-.6203,-.6073;-2.7334,-1.7163,.0654;-2.6173,.7905,-.2831;-3.334,-.3502,.0158;', 'GKTWGGQPFAXNFI-HNNXBMFYSA-N', '1010:TK3EQPM8FMWZ9D9VCU7S3J92SZSAPC', '[#17]-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#6@@](-[#1])(-[#6](=[#8])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#7]2-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[s]3):[c]3-[#6](-[#1])(-[#1])-[ #6]2(-[#1])-[#1]', 'Clc1c([H])c([H])c([H])c([H])c1[C@@]([H])(C(=O)OC([H])([H])[H])N2C([H])([H])c(c([H])c([H])s3)c3C([H])([H])C2([H])[H]', '03.735', '3.508', '0', '0', 'TRUE', '-8.4e-002\r\n-0.1022\r\n-0.3179\r\n-0.2644\r\n-0.2831\r\n4.2e-003\r\n2.52e-002\r\n0.1237\r\n-8.4e-003\r\n-2.35e-002\r\n-5.1e-003\r\n-2.1e-003\r\n-5.03e-002\r\n0.2827\r\n-2.42e-002\r\n4.58e-002\r\n-5.55e-002\r\n-4.32e-002\r\n-6.19e-002\r\n-6.08e-002\r\n4.53e-002\r\n4.34e-002\r\n4.34e-002\r\n4.81e-002\r', '1', '3.735', 'C16H16ClNO2S', '0321.059', '-5.109', '0321.822', '3.65', '2', '0', '1', '11', '11', '2', '21', '23', '20', '6', '003', '00', '16', '0', '3', '004', '0057.78', '313.52', '', '1.62735', '1.3116', '31.12', '18.1', '3.58299', '13.02', '798.527', '81.899', '243.18', '', 'Cl/C1=C/C=C\\C=C1\\C(N2CC/C3=C(C2)/C=C\\S3)C(OC)=O', 'COC(=O)[C@H](c1ccccc1Cl)N3CCc2sccc2C3', 'Clopidogrel', 'Plavix; Zyllt; HSDB 7430; CGE', 'P2Y purinoceptor 12', '60606', 'Phase IV', 'Migraine', '24836213', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(305, '2818', '2818', 'CN1CCN(CC1)C2=C3C=CC=CC3=Nc4ccc(Cl)cc4N2', '3-chloro-6-(4-methylpiperazin-1-yl)-5<I>H</I>-benzo[b][1,4]benzodiazepine', 'CYAAFQwAvfwQQ1Yabg3z3MoxBfrhmZT9sME3vF5te0X924fGZUoAl9KiAGP8zTJrIxTPIoINJo6L7eeKC$PkTYppL$MYrS3YZkEcmb7lQG03vqx^mwklKd5aSZbp^aP4e5ufAIi^UfHepTjD4^59zfLAKeAB8nfWuDz749EvNKDC2f2WHsgbybbI4xdvrBS9MziMFcYC DuOsiY7FWPOw4rNj$op18UR^OqKnUHzkWNcwXmR$zosj2KhLBFVYuwHscrzjTyoKZVtiTidEje4xu6nZfMsLdKONVX7VSHS2OKSce8AG69CBrqrO9a6ZHT7fw6RjWgY8$ZWVPBEIUsjXVteIMwZ1G33Vu1X7F2xZPvowWFu^F97RS9iS^MTD7^9EzZ$p1BkH9Zl1Ed99 xUyULwI6LmPtny0bfogSqzXjsroq7yi^4MT02j3JHq8rhab$Q6jJquSI6^hgqDH7uj3LHormG3nA2sVjMpTz59h0BTP6D29C', 'InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,21H,8-11H2,1H3', 'AuxInfo=1/0/N:12,19,20,15,17,23,21,8,9,6,7,18,22,11,13,16,14,10,1,5,4,3,2/E:(8,9)(10,11)/rA:42ClNNNNCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;s2;s2;s3s6;s3s7;s2s4;d+10;s3;d-5s11;s4;s11;s5d-14;s13;s 14;d-15;d-17s19;s16;s1d+18;d-21s22;s6;s6;s7;s7;s8;s8;s9;s9;s12;s12;s12;s4;s15;s17;s18;s19;s21;s20;s23;/rC:5.186,-3.098,-.1688;-1.6132,-.9339,.2115;-4.2856,-1.8921,-.0397;.6603,-.8825,.5575;1.9247,1.83 04,.1543;-2.4356,-1.1215,1.4061;-1.984,-1.7684,-.9308;-3.9173,-.9796,1.0523;-3.4754,-1.6127,-1.2', 'ZUXABONWMNSFBN-UHFFFAOYSA-N', '1010:Z25D2A4YCT5TUTARMKF1JR9EZFEZWC', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]1-[#7]2-[#1])-[#7]=[#6](-[#6](-[#1])=[#6](-[#1])-[#6](-[#1])=[#6]3-[#1])-[#6]3=[#6]2-[#7]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1]) -[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c(c1N2[H])N=C(C([H])=C([H])C([H])=C3[H])C3=C2N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H])c1[H]', '03.476', '3.476', '0', '0', 'TRUE', '-8.43e-002\r\n-0.2624\r\n-0.3038\r\n-0.247\r\n-0.2466\r\n1.68e-002\r\n1.68e-002\r\n1.11e-002\r\n1.11e-002\r\n7.44e-002\r\n2.98e-002\r\n-1.33e-002\r\n7.36e-002\r\n4.72e-002\r\n-5.02e-002\r\n8.2e-002\r\n-3.57e-002\r\n-2.3e-002\r\n-6.15e-002\r\n-6.01e-002\r\n-3.33e-002\r\n4.23e-002\r\n-4.13e-002\r\n4.48', '0', '1.938', 'C18H19ClN4', '0326.13', '-3.432', '0326.823', '3.95 3.99 6.3 9.91', '1', '1', '4', '16', '06', '1', '23', '26', '22', '7', '004', '01', '19', '0', '4', '001', '0030.86', '323.65', '', '1.82329', '1.288', '133.48', '41.87', '3.9875', '91.61', '1,009.63', '24.982', '256.22', '', 'Cl/C/4=C/C2=C(/N=C/3\\C(=C(N1CCN(C)CC1)/N2)\\C=C/C=C3)\\C=C4', 'CN4CCN(c2[nH]c1cc(Cl)ccc1nc3ccccc23)CC4', 'Clozapine', 'Leponex; CLOZARIL; Fazaclo; Iprox; Lepotex; Fazaclo ODT', 'D(4) dopamine receptor', '2818', 'FDA approved', 'Schizophrenia', '24119631', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(306, '2818', '2818', 'CN1CCN(CC1)C2=C3C=CC=CC3=Nc4ccc(Cl)cc4N2', '3-chloro-6-(4-methylpiperazin-1-yl)-5<I>H</I>-benzo[b][1,4]benzodiazepine', 'CYAAFQwAvfwQQ1Yabg3z3MoxBfrhmZT9sME3vF5te0X924fGZUoAl9KiAGP8zTJrIxTPIoINJo6L7eeKC$PkTYppL$MYrS3YZkEcmb7lQG03vqx^mwklKd5aSZbp^aP4e5ufAIi^UfHepTjD4^59zfLAKeAB8nfWuDz749EvNKDC2f2WHsgbybbI4xdvrBS9MziMFcYC DuOsiY7FWPOw4rNj$op18UR^OqKnUHzkWNcwXmR$zosj2KhLBFVYuwHscrzjTyoKZVtiTidEje4xu6nZfMsLdKONVX7VSHS2OKSce8AG69CBrqrO9a6ZHT7fw6RjWgY8$ZWVPBEIUsjXVteIMwZ1G33Vu1X7F2xZPvowWFu^F97RS9iS^MTD7^9EzZ$p1BkH9Zl1Ed99 xUyULwI6LmPtny0bfogSqzXjsroq7yi^4MT02j3JHq8rhab$Q6jJquSI6^hgqDH7uj3LHormG3nA2sVjMpTz59h0BTP6D29C', 'InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,21H,8-11H2,1H3', 'AuxInfo=1/0/N:12,19,20,15,17,23,21,8,9,6,7,18,22,11,13,16,14,10,1,5,4,3,2/E:(8,9)(10,11)/rA:42ClNNNNCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;s2;s2;s3s6;s3s7;s2s4;d+10;s3;d-5s11;s4;s11;s5d-14;s13;s 14;d-15;d-17s19;s16;s1d+18;d-21s22;s6;s6;s7;s7;s8;s8;s9;s9;s12;s12;s12;s4;s15;s17;s18;s19;s21;s20;s23;/rC:5.186,-3.098,-.1688;-1.6132,-.9339,.2115;-4.2856,-1.8921,-.0397;.6603,-.8825,.5575;1.9247,1.83 04,.1543;-2.4356,-1.1215,1.4061;-1.984,-1.7684,-.9308;-3.9173,-.9796,1.0523;-3.4754,-1.6127,-1.2', 'ZUXABONWMNSFBN-UHFFFAOYSA-N', '1010:Z25D2A4YCT5TUTARMKF1JR9EZFEZWC', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]1-[#7]2-[#1])-[#7]=[#6](-[#6](-[#1])=[#6](-[#1])-[#6](-[#1])=[#6]3-[#1])-[#6]3=[#6]2-[#7]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#1]) -[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]):[c]1-[#1]', 'Clc(c([H])c([H])c(c1N2[H])N=C(C([H])=C([H])C([H])=C3[H])C3=C2N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H])c1[H]', '03.476', '3.476', '0', '0', 'TRUE', '-8.43e-002\r\n-0.2624\r\n-0.3038\r\n-0.247\r\n-0.2466\r\n1.68e-002\r\n1.68e-002\r\n1.11e-002\r\n1.11e-002\r\n7.44e-002\r\n2.98e-002\r\n-1.33e-002\r\n7.36e-002\r\n4.72e-002\r\n-5.02e-002\r\n8.2e-002\r\n-3.57e-002\r\n-2.3e-002\r\n-6.15e-002\r\n-6.01e-002\r\n-3.33e-002\r\n4.23e-002\r\n-4.13e-002\r\n4.48', '0', '1.938', 'C18H19ClN4', '0326.13', '-3.432', '0326.823', '3.95 3.99 6.3 9.91', '1', '1', '4', '16', '06', '1', '23', '26', '22', '7', '004', '01', '19', '0', '4', '001', '0030.86', '323.65', '', '1.82329', '1.288', '133.48', '41.87', '3.9875', '91.61', '1,009.63', '24.982', '256.22', '', 'Cl/C/4=C/C2=C(/N=C/3\\C(=C(N1CCN(C)CC1)/N2)\\C=C/C=C3)\\C=C4', 'CN4CCN(c2[nH]c1cc(Cl)ccc1nc3ccccc23)CC4', 'Clozapine', 'Leponex; CLOZARIL; Fazaclo; Iprox; Lepotex; Fazaclo ODT', 'D(4) dopamine receptor', '2818', 'Under Investigation', 'Huntington Disease (HD)', '9221965', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(307, '307', 'Not Available', 'CN1C(=N)NS(=O)(=O)CC1(C)c2cc(NC(=O)c3ccc(F)cn3)ccc2F', '5-fluoro-<I>N</I>-[4-fluoro-3-(3-imino-4,5-dimethyl-1,1-dioxo-1,2,4-thiadiazinan-5-yl)phenyl]pyridine-2-carboxamide', 'CYAAFQwATewQkQdUy5jMcuhMcB0tiipMmXHV38GTF4C7x$2^7QPYzJ4Fzi5Niaa7aQo448okSh4VaAAYbJrhVYAMOx1KVEmBEucfcl9bq$xeomJKtUK3McOfIy4PJHVfM4EWyMCsV2DaIB9^NEOFPUsh4rAXmsIlF2IkYOxQHrzwNMuhcB9dnnCM04fDvQ$t8Q3Gd4$f c23F7^03Gh2k7vKDa4cKBGHzoRxoK6R9Tb8sN6wcBT7itQ83pO2$1d8mbp5fcuJq7njZ54X2LOnzOJU^2su6cPN$D^bny0T7$JfxqkldA5FWu574HXU^ngzG2UZfKPG39N037b$PuFa$5xl$cR5Hz2smy$k3RVaE3M^1pOW1NQyXi8LVx3JbdyFIfJcjEW0gEypG8j5b RaBxKobWyNukFT1E4aIshdkBED3aqkAX5sdYxrYqkzAnha$GRFJvoCKBdM5IyCW20H6kkBSxEZtpQaJ4CplImppyzy^Rmd9U', 'InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)23-16(20)24(17)2)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)', 'AuxInfo=1/1/N:27,28,3,14,12,1,11,6,16,5,13,9,10,2,7,19,15,26,24,23,4,8,20,18,25,21,22,17/E:(26,27)/CRV:28.6/rA:28CCCNCCCNCCCCCCCCSNCNOONFOFCC/rB:s1;d-1;d-2;s3;s4d-5;s2;s7;;s9;d-9;d-10;s8s11;s12d+13;s9 ;s15;s16;s15;s18;s17s19;d17;d17;d19;s10;d7;s5;s15;s18;/rC:8.3282,-11.0351,0;8.3282,-11.8601,0;7.6137,-10.6226,0;7.6137,-12.2726,0;6.8992,-11.0351,0;6.8992,-11.8601,0;9.0427,-12.2726,0;9.7572,-11.8601, 0;11.9006,-12.2726,0;11.9006,-13.0976,0;11.1861,-11.8601,0;11.1861,-13.5101,0;10.4716,-12.2726,0', 'QJMYQMJOIGPMOR-UHFFFAOYSA-N', '1010:8W64X8PAVUF41JF8F5HEP1CA68NMZX', '[c]1:[c]:[c](-[#9]):[c]:[n]:[c]1-[#6](=[#8])-[#7]-[c](:[c]:[c]:[c]2-[#9]):[c]:[c]2-[#6]3(-[#6])-[#7](-[#6])-[#6](=[#7])-[#7]-[#16](=[#8])(=[#8])-[#6]3', 'c1cc(F)cnc1C(=O)Nc(ccc2F)cc2C3(C)N(C)C(=N)NS(=O)(=O)C3', '01.314', '1.314', '0', '0', 'TRUE', '-2.81e-002\r\n0.1259\r\n-2.24e-002\r\n-0.2483\r\n0.141\r\n6.34e-002\r\n0.2657\r\n-0.28\r\n8.9e-003\r\n0.1278\r\n-3.28e-002\r\n-2.41e-002\r\n3.33e-002\r\n-3.78e-002\r\n4.58e-002\r\n-2.9e-003\r\n1.3711\r\n-0.2465\r\n0.123\r\n-0.3189\r\n-0.5709\r\n-0.5709\r\n-0.2812\r\n-0.2067\r\n-0.2698\r\n-0.2053\r\n-4.3e-0', '0', '1.418', 'C17H17F2N5O3S', '0409.102', '-3.549', '0409.41', '2.53 5.24 6.03', '4', '2', '4', '14', '12', '2', '28', '30', '10', '10', '008', '03', '17', '0', '3', '003', '0123.63', '394.68', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(F)=C\\N=C1\\C(N/C/3=C/C=C(F)\\C(C2(C)CS(=O)(=O)NC(=N)N2C)=C3)=O', 'CN1C(=N)NS(=O)(=O)CC1(C)c3cc(NC(=O)c2ccc(F)cn2)ccc3F', 'CNP520', 'CNP-520; AMG-520', 'BACE1 (beta-secretase)', 'Not Available', 'Phase II/III', 'Alzheimer disease (AD)', '28720101', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(308, '308', 'Not Available', 'Oc1ccc(\\C=C\\c2ccc(O)c3ncccc23)cc1', '5-[(<I>E</I>)-2-(4-hydroxyphenyl)vinyl]quinolin-8-ol', 'CYAAFQwA3fwQRaJO$mFrDRW4END$PeJ0mlfj2xiVQJMhWZj7NIk9CqSxQiyEveKcyDoRz6Ov79LODWnSN9FTq4K7^jtM4HIdBqK8yLO8mPMgrr8TNhNOuWbn8JBlZERChAYpwfAO2wownVtilkFh5XIenVc51XSvyLVCHhd8Y3H60lH9jTqN3VNvifMl$4pxC$rSOmVk oD7$UXHx7icfH^N^E5lfxQ9TET4jIPfHzQdKOy63eMWsirQeciP67r7mww55Hwn9d3dTazKv5NXr6s$bRTLtLP$R6iXZ0xOF4OzJeogwBzGYosVVjrQGSsIBQi6imCgmhwVSnvRVK16cGrphdD3IJsrDrWsFoCCWRxGWqbQxuKndoftAXSD1z0y^cGAvzfyL5fJnXt4A JvL', 'InChI=1S/C17H13NO2/c19-14-8-4-12(5-9-14)3-6-13-7-10-16(20)17-15(13)2-1-11-18-17/h1-11,19-20H/b6-3+', 'AuxInfo=1/0/N:8,7,12,15,18,11,3,13,16,5,10,17,1,14,2,6,4,9,19,20/E:(4,5)(8,9)/rA:20CCCCCCCCNCCCCCCCCCOO/rB:s1;d-1;d-2;s3;s4d-5;s2;d-7;s4;s8d-9;s1;d+11;;s13;d-13;d-14;s12s15;s16d+17;s14;s6;/rC:7.7755,- 11.3823,0;7.363,-12.0968,0;7.363,-10.6678,0;6.5379,-12.0968,0;6.5379,-10.6678,0;6.1254,-11.3823,0;7.7755,-12.8112,0;7.363,-13.5258,0;6.1254,-12.8112,0;6.5379,-13.5258,0;8.6005,-11.3823,0;9.013,-12.096 8,0;11.0755,-11.3823,0;11.4879,-12.0968,0;10.2504,-11.3823,0;11.0755,-12.8112,0;9.8379,-12.0968,', 'DWGPFSCAVFASNW-ZZXKWVIFSA-N', '1010:9BXRT5F6SUGAQ6DUFQNBFDDYRG1CMZ', '[c]1(\\-[#6]=[#6]\\-[c](:[c]:[c]:[c]2-[#8]):[c]:[c]2):[c]:[c]:[c](-[#8]):[c](:[n]:[c]:[c]:[c]3):[c]13', 'c1(\\C=C\\c(ccc2O)cc2)ccc(O)c(nccc3)c13', '03.518', '3.518', '0', '0', 'TRUE', '-1.61e-002\r\n1.e-002\r\n-5.17e-002\r\n0.1007\r\n-2.93e-002\r\n9.75e-002\r\n-5.06e-002\r\n-4.32e-002\r\n-0.2535\r\n2.76e-002\r\n-5.37e-002\r\n-5.44e-002\r\n-3.15e-002\r\n7.13e-002\r\n-5.24e-002\r\n-3.15e-002\r\n-2.55e-002\r\n-5.24e-002\r\n-0.3609\r\n-0.3587', '0', '3.523', 'C17H13NO2', '0263.095', '-4.82', '0263.291', '5.32 9.9 9.98', '1', '2', '1', '4', '17', '3', '20', '22', '3', '9', '003', '02', '13', '0', '3', '002', '0053.35', '261.66', '', '', '', '', '', '', '', '', '', '', '', 'C2(/C=C/C/1=C/C=C(O)\\C=C1)=C\\C=C(O)/C/3=C2/C=C\\C=N3', 'Oc3ccc(/C=C/c1ccc(O)c2ncccc12)cc3', 'Compound 10c-24986600', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24986600', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(309, '309', 'Not Available', 'COc1ccccc1C(=O)N2Cc3cc(NC(=O)c4ccccc4)ccc3CC2=O', '<I>N</I>-[2-(2-methoxybenzoyl)-3-oxo-1,4-dihydroisoquinolin-7-yl]benzamide', 'CYAAFQwAgdwQq1CDcYBeaiyU^g4gCZnzE4PQOqWAHGmo0hpflzcSyeC9qW6C5okyWfK2FQeB^hi2WR^yoHa9zYlqBMN4Fr2eHzyylwIePCmBUG1qTTNtZ9GE4VSKaIyFop4sAEngRy2DSWBLC2FUOg5RRH3Xu00uJeHoQfmMHD3SJMEnHz52^0KZn^qrLpu9eHDSC^FU $ILSHP3letWMnIzlVn4832Be5c1mmyeMtZCextt9hN3u$fsQWovh$8rbJ^eQR7oZ5$cb6744hNHqRdHZ9m3382^3CxzSHO9ssdf0HOYl77HipXe^yQmxn9ypa^4pXHx78t0xj8LPxZvr3^G0e^q76tcw7vKvqDOuUzafb$49lNm7cthz2iOwokq3s4bWJnNTZzGJVJcz ftwM4WEzvluh6mTowW1iNtkpTHBciZZGUIszsZ8chtjNhYuG2p2T0ciQVrprcldirInkjtwRodw2DmQtSNBUURJxraDTsmNs', 'InChI=1S/C24H20N2O4/c1-30-21-10-6-5-9-20(21)24(29)26-15-18-13-19(12-11-17(18)14-22(26)27)25-23(28)16-7-3-2-4-8-16/h2-13H,14-15H2,1H3,(H,25,28)', 'AuxInfo=1/1/N:30,6,4,5,23,21,2,3,25,20,10,12,13,16,18,1,9,11,14,24,22,15,7,19,8,17,27,26,28,29/E:(3,4)(7,8)/rA:30CCCCCCCNCCCCCCCCNCCCCCCCCOOOOC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;;s9;d-9;d-10;s11;s8s12d+13; ;s9s15;s15;s11s17;s17;;s20;d-20;d-21;s19s22;s23d+24;d7;d15;d19;s22;s29;/rC:8.3735,-14.04,0;8.3735,-14.865,0;7.659,-13.6275,0;7.659,-15.2775,0;6.9446,-14.04,0;6.9446,-14.865,0;9.088,-13.6275,0;9.8025,- 14.04,0;11.9459,-12.8025,0;11.9459,-13.6275,0;11.2315,-12.39,0;11.2315,-14.04,0;10.5169,-12.8025', 'CDSXZKIEHDOCCP-UHFFFAOYSA-N', '1010:RF95X8NYH1R49N96VFPAPMK4B7PXNX', '[c]1(-[#6](=[#8])-[#7]-[c](:[c]:[c](-[#6]-[#7](-[#6](=[#8])-[c](:[c]:[c]:[c]2):[c](-[#8]-[#6]):[c]2)-[#6]3=[#8]):[c]4-[#6]3):[c]:[c]4):[c]:[c]:[c]:[c]:[c]1', 'c1(C(=O)Nc(cc(CN(C(=O)c(ccc2)c(OC)c2)C3=O)c4C3)cc4)ccccc1', '03.249', '3.773', '0', '0', 'TRUE', '3.73e-002\r\n-4.97e-002\r\n-4.97e-002\r\n-6.15e-002\r\n-6.15e-002\r\n-6.23e-002\r\n0.2471\r\n-0.2814\r\n-3.4e-002\r\n-5.64e-002\r\n-2.45e-002\r\n-4.05e-002\r\n-3.56e-002\r\n3.3e-002\r\n0.2257\r\n5.05e-002\r\n-0.2329\r\n4.77e-002\r\n0.2549\r\n-3.1e-002\r\n-5.97e-002\r\n8.7e-002\r\n-6.13e-002\r\n6.79e-002\r\n-4.7e-002\r\n-0.2716\r\n-0.2767\r\n-0.2711\r\n-0.3486\r\n4.22e-002', '0', '3.249', 'C24H20N2O4', '0400.142', '-5.631', '0400.427', '3.58', '4', '1', '3', '12', '18', '3', '30', '33', '6', '12', '006', '01', '20', '0', '4', '004', '0075.71', '397.01', '', '', '', '', '', '', '', '', '', '', '', 'C\\4(/C(N/C/1=C/C3=C(\\C=C1)/CC(=O)N(C(/C2=C/C=C\\C=C2\\OC)=O)C3)=O)=C\\C=C/C=C4', 'COc1ccccc1C(=O)N4Cc3cc(NC(=O)c2ccccc2)ccc3CC4=O', 'Compound 10d-28728106', 'Not Available', 'BACE1 (beta-secretase)', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28728106', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(310, '310', 'Not Available', 'COc1ccccc1C(=O)N2Cc3cc(NC(=O)c4ccccc4)ccc3CC2=O', '<I>N</I>-[2-(2-methoxybenzoyl)-3-oxo-1,4-dihydroisoquinolin-7-yl]benzamide', 'CYAAFQwAgdwQq1CDcYBeaiyU^g4gCZnzE4PQOqWAHGmo0hpflzcSyeC9qW6C5okyWfK2FQeB^hi2WR^yoHa9zYlqBMN4Fr2eHzyylwIePCmBUG1qTTNtZ9GE4VSKaIyFop4sAEngRy2DSWBLC2FUOg5RRH3Xu00uJeHoQfmMHD3SJMEnHz52^0KZn^qrLpu9eHDSC^FU $ILSHP3letWMnIzlVn4832Be5c1mmyeMtZCextt9hN3u$fsQWovh$8rbJ^eQR7oZ5$cb6744hNHqRdHZ9m3382^3CxzSHO9ssdf0HOYl77HipXe^yQmxn9ypa^4pXHx78t0xj8LPxZvr3^G0e^q76tcw7vKvqDOuUzafb$49lNm7cthz2iOwokq3s4bWJnNTZzGJVJcz ftwM4WEzvluh6mTowW1iNtkpTHBciZZGUIszsZ8chtjNhYuG2p2T0ciQVrprcldirInkjtwRodw2DmQtSNBUURJxraDTsmNs', 'InChI=1S/C24H20N2O4/c1-30-21-10-6-5-9-20(21)24(29)26-15-18-13-19(12-11-17(18)14-22(26)27)25-23(28)16-7-3-2-4-8-16/h2-13H,14-15H2,1H3,(H,25,28)', 'AuxInfo=1/1/N:30,6,4,5,23,21,2,3,25,20,10,12,13,16,18,1,9,11,14,24,22,15,7,19,8,17,27,26,28,29/E:(3,4)(7,8)/rA:30CCCCCCCNCCCCCCCCNCCCCCCCCOOOOC/rB:s1;d-1;d-2;s3;s4d-5;s1;s7;;s9;d-9;d-10;s11;s8s12d+13; ;s9s15;s15;s11s17;s17;;s20;d-20;d-21;s19s22;s23d+24;d7;d15;d19;s22;s29;/rC:8.3735,-14.04,0;8.3735,-14.865,0;7.659,-13.6275,0;7.659,-15.2775,0;6.9446,-14.04,0;6.9446,-14.865,0;9.088,-13.6275,0;9.8025,- 14.04,0;11.9459,-12.8025,0;11.9459,-13.6275,0;11.2315,-12.39,0;11.2315,-14.04,0;10.5169,-12.8025', 'CDSXZKIEHDOCCP-UHFFFAOYSA-N', '1010:RF95X8NYH1R49N96VFPAPMK4B7PXNX', '[c]1(-[#6](=[#8])-[#7]-[c](:[c]:[c](-[#6]-[#7](-[#6](=[#8])-[c](:[c]:[c]:[c]2):[c](-[#8]-[#6]):[c]2)-[#6]3=[#8]):[c]4-[#6]3):[c]:[c]4):[c]:[c]:[c]:[c]:[c]1', 'c1(C(=O)Nc(cc(CN(C(=O)c(ccc2)c(OC)c2)C3=O)c4C3)cc4)ccccc1', '03.249', '3.773', '0', '0', 'TRUE', '3.73e-002\r\n-4.97e-002\r\n-4.97e-002\r\n-6.15e-002\r\n-6.15e-002\r\n-6.23e-002\r\n0.2471\r\n-0.2814\r\n-3.4e-002\r\n-5.64e-002\r\n-2.45e-002\r\n-4.05e-002\r\n-3.56e-002\r\n3.3e-002\r\n0.2257\r\n5.05e-002\r\n-0.2329\r\n4.77e-002\r\n0.2549\r\n-3.1e-002\r\n-5.97e-002\r\n8.7e-002\r\n-6.13e-002\r\n6.79e-002\r\n-4.7e-002\r\n-0.2716\r\n-0.2767\r\n-0.2711\r\n-0.3486\r\n4.22e-002', '0', '3.249', 'C24H20N2O4', '0400.142', '-5.631', '0400.427', '3.58', '4', '1', '3', '12', '18', '3', '30', '33', '6', '12', '006', '01', '20', '0', '4', '004', '0075.71', '397.01', '', '', '', '', '', '', '', '', '', '', '', 'C/3=C/C=C(CN2CCC(COC(/C=C/C/1=C/C=C(O)\\C(OC)=C1)=O)CC2)\\C=C3', 'COc3cc(/C=C/C(=O)OCC2CCN(Cc1ccccc1)CC2)ccc3O', 'Compound 10d-28728106', 'Not Available', 'Acetylcholinesterase', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28728106', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(311, '311', 'Not Available', 'Nc1nc2ccccc2nc1NC(=O)c3ccc(cc3)N4CCCCC4', '<I>N</I>-(3-aminoquinoxalin-2-yl)-4-(1-piperidyl)benzamide', 'CYAAFQwAxdwQhougfR8akeTzL1apUOb0rC6Io9$owTan4Q9PB7DwTBhKP57agf98YH2JhMbX6e^d6BFLjSn^FnapNG4LaR7yJwqDKF^KAyRHLGhPE^gIPRXyCIyWMS2naOZGyUCka4MwpwODoOTf9EorzsJz1h2xi6cJsGzDj5RcqvBcE6btqwtVzH95er^^mf9rLdNU jjL7OeSN9n7lTenMep673eOQhPHnofCYWTO30Wk6FVYwN^nbpHZTCyR8Not37nOXB7Aa4uFS$^ul532^lOn7iwuH$lpMNerjXyxc5i75n2zVHjdV25eZztjDaLsYUueOwdjh857cOz5r9t2SPw35G1bOmNp2bPf4FzURzKITURc2^AZsqzxXmzcRiNZBmArqI10mYLSx fDkWjvNb4Ydwipsd5Mm3EWUmsYBZTMrJW7YNpqa70kAqinpDRFK6uOUjZ6zFJzURTKIL$kY2w3iTyBvCPzIP^YsuxDZTbB', 'InChI=1S/C20H21N5O/c21-18-19(23-17-7-3-2-6-16(17)22-18)24-20(26)14-8-10-15(11-9-14)25-12-4-1-5-13-25/h2-3,6-11H,1,4-5,12-13H2,(H2,21,22)(H,23,24,26)', 'AuxInfo=1/1/N:26,6,5,24,25,4,3,14,15,16,17,22,23,13,18,2,1,10,8,12,20,9,7,11,21,19/E:(4,5)(8,9)(10,11)(12,13)/rA:26CCCCCCNCNCNCCCCCCCONNCCCCC/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s2;s8d-9;s8;s11;s12;s13;d+13 ;d-14;s15;s16d-17;d12;s10;s18;s21;s21;s22;s23;s24s25;/rC:5.6986,-10.7642,0;6.1111,-11.4787,0;4.8736,-10.7642,0;5.6986,-12.1932,0;4.4611,-11.4787,0;4.8736,-12.1932,0;6.1111,-10.0498,0;6.9361,-10.0498,0 ;6.9361,-11.4787,0;7.3486,-10.7642,0;7.3486,-9.3353,0;8.1737,-9.3353,0;8.5862,-10.0498,0;9.4112,', 'XSZAEOSYXLTWAC-UHFFFAOYSA-N', '1010:SZPRBJ6Z965XEZ2U3HVFTFVH2APNPE', '[c]12:[c](:[n]:[c](-[#7]):[c](-[#7]-[#6](=[#8])-[c]3:[c]:[c]:[c](-[#7]4-[#6]-[#6]-[#6]-[#6]-[#6]4):[c]:[c]3):[n]1):[c]:[c]:[c]:[c]2', 'c12c(nc(N)c(NC(=O)c3ccc(N4CCCCC4)cc3)n1)cccc2', '03.489', '3.489', '0', '0', 'TRUE', '9.1e-002\r\n9.07e-002\r\n-3.42e-002\r\n-3.42e-002\r\n-6.e-002\r\n-6.e-002\r\n-0.2277\r\n0.1619\r\n-0.2314\r\n0.1443\r\n-0.2633\r\n0.2484\r\n3.75e-002\r\n-4.81e-002\r\n-4.81e-002\r\n-4.33e-002\r\n-4.33e-002\r\n1.72e-002\r\n-0.2715\r\n-0.2839\r\n-0.275\r\n3.e-003\r\n3.e-003\r\n-4.e-002\r\n-4.e-002\r\n-5.09e-002', '0', '3.34', 'C20H21N5O', '0347.175', '-4.773', '0347.414', '5.51 7.02', '3', '2', '1', '11', '17', '3', '26', '29', '4', '9', '006', '03', '21', '0', '4', '003', '0084.14', '350.75', '', '', '', '', '', '', '', '', '', '', '', 'C/1\\4=C/C=C\\C=C1\\N=C(N)/C(NC(/C/3=C/C=C(N2CCCCC2)\\C=C3)=O)=N4', 'Nc2nc1ccccc1nc2NC(=O)c4ccc(N3CCCCC3)cc4', 'Compound 11a - 22019465', 'Not Available', 'BACE1 (beta-secretase)', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '22019465', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(312, '312', 'Not Available', 'Nc1nc2ccccc2nc1NC(=O)c3ccc(cc3)N4CCCCC4', '<I>N</I>-(3-aminoquinoxalin-2-yl)-4-(1-piperidyl)benzamide', 'CYAAFQwAxdwQhougfR8akeTzL1apUOb0rC6Io9$owTan4Q9PB7DwTBhKP57agf98YH2JhMbX6e^d6BFLjSn^FnapNG4LaR7yJwqDKF^KAyRHLGhPE^gIPRXyCIyWMS2naOZGyUCka4MwpwODoOTf9EorzsJz1h2xi6cJsGzDj5RcqvBcE6btqwtVzH95er^^mf9rLdNU jjL7OeSN9n7lTenMep673eOQhPHnofCYWTO30Wk6FVYwN^nbpHZTCyR8Not37nOXB7Aa4uFS$^ul532^lOn7iwuH$lpMNerjXyxc5i75n2zVHjdV25eZztjDaLsYUueOwdjh857cOz5r9t2SPw35G1bOmNp2bPf4FzURzKITURc2^AZsqzxXmzcRiNZBmArqI10mYLSx fDkWjvNb4Ydwipsd5Mm3EWUmsYBZTMrJW7YNpqa70kAqinpDRFK6uOUjZ6zFJzURTKIL$kY2w3iTyBvCPzIP^YsuxDZTbB', 'InChI=1S/C20H21N5O/c21-18-19(23-17-7-3-2-6-16(17)22-18)24-20(26)14-8-10-15(11-9-14)25-12-4-1-5-13-25/h2-3,6-11H,1,4-5,12-13H2,(H2,21,22)(H,23,24,26)', 'AuxInfo=1/1/N:26,6,5,24,25,4,3,14,15,16,17,22,23,13,18,2,1,10,8,12,20,9,7,11,21,19/E:(4,5)(8,9)(10,11)(12,13)/rA:26CCCCCCNCNCNCCCCCCCONNCCCCC/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s2;s8d-9;s8;s11;s12;s13;d+13 ;d-14;s15;s16d-17;d12;s10;s18;s21;s21;s22;s23;s24s25;/rC:5.6986,-10.7642,0;6.1111,-11.4787,0;4.8736,-10.7642,0;5.6986,-12.1932,0;4.4611,-11.4787,0;4.8736,-12.1932,0;6.1111,-10.0498,0;6.9361,-10.0498,0 ;6.9361,-11.4787,0;7.3486,-10.7642,0;7.3486,-9.3353,0;8.1737,-9.3353,0;8.5862,-10.0498,0;9.4112,', 'XSZAEOSYXLTWAC-UHFFFAOYSA-N', '1010:SZPRBJ6Z965XEZ2U3HVFTFVH2APNPE', '[c]12:[c](:[n]:[c](-[#7]):[c](-[#7]-[#6](=[#8])-[c]3:[c]:[c]:[c](-[#7]4-[#6]-[#6]-[#6]-[#6]-[#6]4):[c]:[c]3):[n]1):[c]:[c]:[c]:[c]2', 'c12c(nc(N)c(NC(=O)c3ccc(N4CCCCC4)cc3)n1)cccc2', '03.489', '3.489', '0', '0', 'TRUE', '9.1e-002\r\n9.07e-002\r\n-3.42e-002\r\n-3.42e-002\r\n-6.e-002\r\n-6.e-002\r\n-0.2277\r\n0.1619\r\n-0.2314\r\n0.1443\r\n-0.2633\r\n0.2484\r\n3.75e-002\r\n-4.81e-002\r\n-4.81e-002\r\n-4.33e-002\r\n-4.33e-002\r\n1.72e-002\r\n-0.2715\r\n-0.2839\r\n-0.275\r\n3.e-003\r\n3.e-003\r\n-4.e-002\r\n-4.e-002\r\n-5.09e-002', '0', '3.34', 'C20H21N5O', '0347.175', '-4.773', '0347.414', '5.51 7.02', '3', '2', '1', '11', '17', '3', '26', '29', '4', '9', '006', '03', '21', '0', '4', '003', '0084.14', '350.75', '', '', '', '', '', '', '', '', '', '', '', 'C/1\\4=C/C=C\\C=C1\\N=C(N)/C(NC(/C/3=C/C=C(N2CCCCC2)\\C=C3)=O)=N4', 'Nc2nc1ccccc1nc2NC(=O)c4ccc(N3CCCCC3)cc4', 'Compound 11a - 22019465', 'Not Available', 'Acetylcholinesterase', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '22019465', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(313, '313', 'Not Available', 'Nc1nc2ccccc2nc1NC(=O)c3ccc(cc3)N4CCCCC4', '<I>N</I>-(3-aminoquinoxalin-2-yl)-4-(1-piperidyl)benzamide', 'CYAAFQwAxdwQhougfR8akeTzL1apUOb0rC6Io9$owTan4Q9PB7DwTBhKP57agf98YH2JhMbX6e^d6BFLjSn^FnapNG4LaR7yJwqDKF^KAyRHLGhPE^gIPRXyCIyWMS2naOZGyUCka4MwpwODoOTf9EorzsJz1h2xi6cJsGzDj5RcqvBcE6btqwtVzH95er^^mf9rLdNU jjL7OeSN9n7lTenMep673eOQhPHnofCYWTO30Wk6FVYwN^nbpHZTCyR8Not37nOXB7Aa4uFS$^ul532^lOn7iwuH$lpMNerjXyxc5i75n2zVHjdV25eZztjDaLsYUueOwdjh857cOz5r9t2SPw35G1bOmNp2bPf4FzURzKITURc2^AZsqzxXmzcRiNZBmArqI10mYLSx fDkWjvNb4Ydwipsd5Mm3EWUmsYBZTMrJW7YNpqa70kAqinpDRFK6uOUjZ6zFJzURTKIL$kY2w3iTyBvCPzIP^YsuxDZTbB', 'InChI=1S/C20H21N5O/c21-18-19(23-17-7-3-2-6-16(17)22-18)24-20(26)14-8-10-15(11-9-14)25-12-4-1-5-13-25/h2-3,6-11H,1,4-5,12-13H2,(H2,21,22)(H,23,24,26)', 'AuxInfo=1/1/N:26,6,5,24,25,4,3,14,15,16,17,22,23,13,18,2,1,10,8,12,20,9,7,11,21,19/E:(4,5)(8,9)(10,11)(12,13)/rA:26CCCCCCNCNCNCCCCCCCONNCCCCC/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s2;s8d-9;s8;s11;s12;s13;d+13 ;d-14;s15;s16d-17;d12;s10;s18;s21;s21;s22;s23;s24s25;/rC:5.6986,-10.7642,0;6.1111,-11.4787,0;4.8736,-10.7642,0;5.6986,-12.1932,0;4.4611,-11.4787,0;4.8736,-12.1932,0;6.1111,-10.0498,0;6.9361,-10.0498,0 ;6.9361,-11.4787,0;7.3486,-10.7642,0;7.3486,-9.3353,0;8.1737,-9.3353,0;8.5862,-10.0498,0;9.4112,', 'XSZAEOSYXLTWAC-UHFFFAOYSA-N', '1010:SZPRBJ6Z965XEZ2U3HVFTFVH2APNPE', '[c]12:[c](:[n]:[c](-[#7]):[c](-[#7]-[#6](=[#8])-[c]3:[c]:[c]:[c](-[#7]4-[#6]-[#6]-[#6]-[#6]-[#6]4):[c]:[c]3):[n]1):[c]:[c]:[c]:[c]2', 'c12c(nc(N)c(NC(=O)c3ccc(N4CCCCC4)cc3)n1)cccc2', '03.489', '3.489', '0', '0', 'TRUE', '9.1e-002\r\n9.07e-002\r\n-3.42e-002\r\n-3.42e-002\r\n-6.e-002\r\n-6.e-002\r\n-0.2277\r\n0.1619\r\n-0.2314\r\n0.1443\r\n-0.2633\r\n0.2484\r\n3.75e-002\r\n-4.81e-002\r\n-4.81e-002\r\n-4.33e-002\r\n-4.33e-002\r\n1.72e-002\r\n-0.2715\r\n-0.2839\r\n-0.275\r\n3.e-003\r\n3.e-003\r\n-4.e-002\r\n-4.e-002\r\n-5.09e-002', '0', '3.34', 'C20H21N5O', '0347.175', '-4.773', '0347.414', '5.51 7.02', '3', '2', '1', '11', '17', '3', '26', '29', '4', '9', '006', '03', '21', '0', '4', '003', '0084.14', '350.75', '', '', '', '', '', '', '', '', '', '', '', 'C/1\\4=C/C=C\\C=C1\\N=C(N)/C(NC(/C/3=C/C=C(N2CCCCC2)\\C=C3)=O)=N4', 'Nc2nc1ccccc1nc2NC(=O)c4ccc(N3CCCCC3)cc4', 'Compound 11a - 22019465', 'Not Available', 'Histamine H3 receptor', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '22019465', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(314, '314', 'Not Available', 'COc1cc(\\C=C\\C(=O)OCC2CCN(Cc3ccccc3)CC2)ccc1O', '(1-benzyl-4-piperidyl)methyl (<I>E</I>)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate', 'CYAAFQwA9cwQMeHxQfBwY8iDFHPaL77YkHZRIvM05^MrdsE8IvP$DvSFv2i7ZyH3FvJ4ZR$NSpx7fljCB6UmkkjNqqNXD5hZrKfe0e1^G08DniEaFgK^gTks1yang6j$t65NAh3Aj4oM1U4Z4plyl3OhsOupBO0YcqurTjeSJfm5OmbpjgYT8qVHT^VIBNfDDJOM1pPm fkpupLcOdvTegyL8YYafam^5vwpb8Wjay8VIfyLntXx124^s9OR9Zf3X^W67nv6NfkLkPavoUl^597zJ882y9T6zmvxodU9rzP3z3P1$YtO2INy7zvY9DC0$d3nIQ$sv$ezv^$HPO1GdDEXn9Z^v4NCOk$XrPlyJ2xlBXFAtgfmdDKzdGgMUpVJfZgFmjBWKybB0QCLD pywm02AkbGFBGkBXAXNdd9d6gxTZAACqoQg1HkGgAuHZBwdmHIXZOkMnLWHUyEYva8QfUhD0nL6GNbZosVtAdPqugnR7YhX6', 'InChI=1S/C23H27NO4/c1-27-22-15-18(7-9-21(22)25)8-10-23(26)28-17-20-11-13-24(14-12-20)16-19-5-3-2-4-6-19/h2-10,15,20,25H,11-14,16-17H2,1H3/b10-8+', 'AuxInfo=1/0/N:28,1,2,3,4,5,9,13,11,14,19,20,21,22,8,24,17,7,6,18,12,10,15,23,26,25,27,16/E:(3,4)(5,6)(11,12)(13,14)/rA:28CCCCCCCCCCCCCCCOCCCCCCNCOOOC/rB:s1;d-1;d-2;s3;s4d-5;;s7;d-7;d-8;s9;s10d-11;s7;d +13;s14;s15;s16;s17;s18;s18;s19;s20;s21s22;s6s23;d15;s12;s10;s27;/rC:15.5304,-12.4373,0;15.5303,-13.2623,0;14.8158,-12.0248,0;14.8158,-13.6748,0;14.1014,-12.4373,0;14.1014,-13.2623,0;6.9566,-12.4373,0 ;6.9566,-13.2623,0;6.2421,-12.0248,0;6.2421,-13.6748,0;5.5277,-12.4373,0;5.5277,-13.2623,0;7.671', 'QJDRBHVMOOPIGE-CSKARUKUSA-N', '1010:WCR3TXJ2CNZKU2VP12MPZ7DC9M5C82', '[c]1:[c]:[c]:[c](-[#6]-[#7](-[#6]-[#6]-[#6]2-[#6]-[#8]-[#6](=[#8])\\-[#6]=[#6]\\-[c]3:[c]:[c]:[c](-[#8]):[c](-[#8]-[#6]):[c]3)-[#6]-[#6]2):[c]:[c]1', 'c1ccc(CN(CCC2COC(=O)\\C=C\\c3ccc(O)c(OC)c3)CC2)cc1', '04.167', '4.167', '0', '0', 'TRUE', '-6.23e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-5.78e-002\r\n-5.78e-002\r\n-3.4e-002\r\n-2.27e-002\r\n-2.19e-002\r\n-5.22e-002\r\n0.105\r\n-2.88e-002\r\n0.1015\r\n-4.89e-002\r\n1.11e-002\r\n0.2853\r\n-0.3123\r\n5.95e-002\r\n-1.48e-002\r\n-3.53e-002\r\n-3.53e-002\r\n-1.2e-003\r\n-1.2e-003\r\n-0.2991\r\n2.33e', '0', '3.658', 'C23H27NO4', '0381.194', '-5.352', '0381.465', '7.78 9.88', '3', '1', '2', '16', '12', '2', '28', '30', '5', '8', '005', '01', '27', '0', '3', '008', '0059', '403.55', '', '', '', '', '', '', '', '', '', '', '', 'C/3=C/C=C(CN2CCC(COC(/C=C/C/1=C/C=C(O)\\C(OC)=C1)=O)CC2)\\C=C3', 'COc3cc(/C=C/C(=O)OCC2CCN(Cc1ccccc1)CC2)ccc3O', 'Compound 12a - 28282613', 'Not Available', 'Acetylcholinesterase', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28282613', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(315, '315', 'Not Available', 'Oc1cc(OCCCN2CCN(CCCNc3c4CCCCc4nc5ccccc35)CC2)cc6OC(=CC(=O)c16)c7ccccc7', '5-hydroxy-2-phenyl-7-[3-[4-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]piperazin-1-yl]propoxy]chromen-4-one', 'CYAAFQwAnfwQkz2ruPStsSPiTjzs8lFflA4opHl4lnLKt^Q7F$WPMAIBhjZfQrKHL1zRaFPxWUAhC^zh$v5kjPLf3YZ1IwYLJ5vGmizaIRZkY8ShTz2t83TnSNp$R9rUL07adCkI3IlohGyoNJvNaN7AjhavZZdcWEJseQAdOrY0ccLgOkI5VUYIH$cXtkCYWvL5ayX9 02dnlorrnuLYP2rf3$7Bzw3sPp5vEKS38MM4NTwX5b2S94nZfW73wK6AD$K0ObF6fcQl11cKKQXAv8DNLxYCJ43CzBMX$s7v7ilIX^qk^5Tv$0VgSf^VZP1jwmblFquLuwRuEozCdfUTwP3hX414vw5yxu57ckPgH5OTy380cjZEvy87$Zu66flDTqLq3Y3$7e8F15sG 6e2LH0VW03awXW32Iz39tT$FP4TabzurW^KzvtR5dOV7$Q5haf^V9Y9r7$d27je^PC3$^3hBDEb8yDoHuGwW8JgkwtjJybRT', 'InChI=1S/C38H42N4O4/c43-33-24-28(25-36-37(33)34(44)26-35(46-36)27-10-2-1-3-11-27)45-23-9-18-42-21-19-41(20-22-42)17-8-16-39-38-29-12-4-6-14-31(29)40-32-15-7-5-13-30(32)38/h1-4,6,10-12,14,24-26,43H,5,7 -9,13,15-23H2,(H,39,40)', 'AuxInfo=1/1/N:44,42,43,5,12,6,14,17,26,40,41,3,11,4,13,16,18,25,21,24,19,22,27,31,30,38,39,29,1,8,2,10,33,37,36,32,34,7,15,9,23,20,46,45,28,35/E:(2,3)(10,11)(19,20)(21,22)/rA:46CCCCCCCCNCCCCCNCCCCNCCN CCCCOCCCCCCOCCCCCCCCCOO/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s2;s8d-9;s8;s11;s10;s12s13;s7;s15;s16;s17;;s19;s19;s20;s18s21;s22s23;s20;s25;s26;s27;s28;s29;d+29;d-30;s31;s32d-33;s32;s35;s34;d-36s37;s36;s39;d+3 9;d-40;s41;s42d-43;d37;s33;/rC:4.2098,-10.9201,0;3.3848,-10.9201,0;4.6223,-11.6346,0;2.9723,-11.', 'VBAJECZQEAYMJO-UHFFFAOYSA-N', '1010:B5876BYFNGXCEHVCMJ1G81QWQBPABT', '[c]12:[c](:[n]:[c](-[#6]-[#6]-[#6]-[#6]3):[c]3:[c]1-[#7]-[#6]-[#6]-[#6]-[#7](-[#6]-[#6]-[#7]4-[#6]-[#6]-[#6]-[#8]-[c]5:[c]:[c](-[#8]):[c](-[#6](=[#8])-[#6]=[#6](-[c]6:[c]:[c]:[c]:[c]:[c]6)-[#8]7):[c]7 :[c]5)-[#6]-[#6]4):[c]:[c]:[c]:[c]2', 'c12c(nc(CCCC3)c3c1NCCCN(CCN4CCCOc5cc(O)c(C(=O)C=C(c6ccccc6)O7)c7c5)CC4)cccc2', '06.262', '6.262', '0', '0', 'TRUE', '1.84e-002\r\n7.21e-002\r\n-5.13e-002\r\n-3.58e-002\r\n-6.15e-002\r\n-6.01e-002\r\n2.9e-002\r\n-7.9e-003\r\n-0.2525\r\n4.58e-002\r\n-2.45e-002\r\n-4.88e-002\r\n-1.01e-002\r\n-4.74e-002\r\n-0.2878\r\n1.1e-003\r\n-2.75e-002\r\n-6.e-004\r\n1.1e-002\r\n-0.3007\r\n1.1e-002\r\n1.1e-002\r\n-0.3008\r\n1.1e-002\r\n4.e-004\r\n-1.63e-002\r\n5.45e-002\r\n-0.3459\r\n8.01e-002\r\n1.e-004\r\n-8.e-004\r\n9.84e-002\r\n8.77e-002\r\n8.29e-002\r\n-0.3087\r\n9.31e-002\r\n0.1932\r\n1.77e-002\r\n5.4e-003\r\n-5.24e-002\r\n-5.24e-002\r\n-6.16e-002\r\n-6.16e-002\r\n-6.23e-002\r\n-0.289\r\n-0.36', '0', '6.232', 'C38H42N4O4', '0618.321', '-9.103', '0618.764', '2.69 6.28 7.16 10.09', '4', '2', '2', '27', '23', '4', '46', '52', '5', '13', '008', '02', '42', '0', '7', '011', '0087.16', '617.95', '', '', '', '', '', '', '', '', '', '', '', 'C/12=C/C=C\\C=C1\\N=C\\7/C(=C2/NCCCN6CCN(CCCO/C/3=C/C(O)=C/5\\C(=C3)O/C(/C/4=C/C=C\\C=C4)=C\\C5=O)CC6)CCCC7', 'O=c6cc(c1ccccc1)oc7cc(OCCCN5CCN(CCCNc3c2CCCCc2nc4ccccc34)CC5)cc(O)c67', 'Compound 13K-24095756', 'Not Available', 'Acetylcholinesterase', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24095756', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(316, '66720098', '66720098', 'NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c2cccnc2n3ccc(n3)c4ccccc4', '<I>N</I>-[(1<I>S</I>)-3-amino-1-benzyl-2,3-dioxo-propyl]-2-(3-phenylpyrazol-1-yl)pyridine-3-carboxamide', 'CYAAFQwA8ewQxruEKo$7IqLcL5n6ZKrAy^jWiLOtANJel5OGJxmu^vKd6EPXhstSyv$HdDn6QJePOLNVRXB6ca17MMwCXu8IE^S2ULKs^GXPrgWdWE$cfd8vb$zPePtS^zpG^zP8IuY9asn9h8MgMEewf9hkwCB$ocGmX2uIM0kN8cJ3361wjLeEm4AjueQ9REa4x7GN TdIEdF3ILlI8cZ4virr3eEM9d7r0RIe^ahX6cGSQgxmG6gzbxjx8FjWAPxOrNoPXTG4tpB1gQQnadEn2lZKVIgaV^MKgvkJcEjOgvsVo2z5HPjmfdyiEvsVwnJw2LNsTd2iKHe8Ebhqdb^iAeSSXLyDucsZeqUcxt5ZeWaAOaVTGqty5H1RhjgjiFreV8oXp84Y^CvaS V9Zk5Hczc45wdQFSl5xQhT9DSdWDFEQFThjnOcyxi$zkHARyiH^UlRM$0P0RJ0uPOUvSX5eyZI7DHKfVU3FWOufULT8Yu0sC', 'InChI=1S/C25H21N5O3/c26-23(32)22(31)21(16-17-8-3-1-4-9-17)28-25(33)19-12-7-14-27-24(19)30-15-13-20(29-30)18-10-5-2-6-11-18/h1-15,21H,16H2,(H2,26,32)(H,28,33)/t21-/m0/s1', 'AuxInfo=1/1/N:26,33,20,21,31,32,27,16,17,29,30,18,24,28,23,10,11,25,14,19,9,12,22,15,13,8,7,4,6,5,1,3,2/E:(3,4)(5,6)(8,9)(10,11)/it:im/rA:54OOONNNNNC.eCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH/rB: ;;;;s5;;;s4;s9;s10;d1s9;d2s4;s13;s5s7d-14;d+11;s11;s14;d-6;s16;d-17;d3s8s12;s5;s19d-23;s19;d-20s21;d-18;d-7s27;d+25;s25;s29;d-30;d-31s32;s9;s10;s10;s4;s16;s17;s18;s23;s20;s21;s24;s26;s27;s28;s29;s30;s 8;s8;s31;s32;s33;/rC:.8304,-3.4069,.1444;-.1179,.9948,-2.3258;1.5992,-1.4809,2.3741;.8613,.1751,', 'YAJUREDVHDQEOI-NRFANRHFSA-N', '1010:HFP6D7A8FXCTCSDN26FJHKU6HC2HSX', '[#8]=[#6](-[#6](-[#7](-[#1])-[#1])=[#8])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#7](-[#1])-[#6](-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]2):[c]2 -[n]3:[c](-[#1]):[c](-[#1]):[c](-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1]):[n]3)=[#8]', 'O=C(C(N([H])[H])=O)[C@]([H])(C([H])([H])c1c([H])c([H])c([H])c([H])c1[H])N([H])C(c(c([H])c([H])c([H])n2)c2n3c([H])c([H])c(c4c([H])c([H])c([H])c([H])c4[H])n3)=O', '03.37', '3.37', '0', '0', 'TRUE', '-0.2868\r\n-0.2718\r\n-0.2687\r\n-0.3004\r\n-0.1261\r\n-0.1883\r\n-0.2418\r\n-0.3225\r\n9.5e-002\r\n-1.7e-003\r\n-4.57e-002\r\n0.2374\r\n0.2468\r\n7.62e-002\r\n0.1445\r\n-5.9e-002\r\n-5.9e-002\r\n-4.49e-002\r\n8.67e-002\r\n-6.2e-002\r\n-6.2e-002\r\n0.2784\r\n1.24e-002\r\n-2.13e-002\r\n1.4e-003\r\n-6.23e-', '1', '3.37', 'C25H21N5O3', '0439.164', '-7.219', '0439.466', '0.43 3.48', '5', '2', '3', '10', '23', '4', '33', '36', '28', '14', '008', '03', '21', '0', '4', '008', '0119.97', '437.9', '', '2.77153', '1.2752', '72.82', '49.45', '4.31895', '23.37', '1,351.48', '134.747', '333.05', '-178.85', 'O=C([C@@H](NC(=O)/C/3=C(N/2/N=C(/C/1=C/C=C\\C=C1)\\C=C2)/N=C\\C=C3)C/C/4=C/C=C\\C=C4)C(=O)N', 'NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c2cccnc2n4ccc(c3ccccc3)n4', 'Compound 19-28759231', 'A-933548', 'Calpain 3', '66720098', 'Under Investigation', 'Alzheimer disease (AD)', '28759231', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(317, '66720197', '66720197', 'NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c2cccnc2n3ccc(n3)c4ccc(F)cc4', '<I>N</I>-[(1<I>S</I>)-3-amino-1-benzyl-2,3-dioxo-propyl]-2-[3-(4-fluorophenyl)pyrazol-1-yl]pyridine-3-carboxamide', 'CYAAFQwA8ewQxruEKo$7vsGcd2le^y$9soSgoJoC$FDEAN6d9DFXe$YxiiNmcvLQVhcVJ8S4XUgG06dx8WBwDNlYenoSYHc5U8BoA2WJTZS62Uxdfn7Zatnq8n^HTXielWDZo5PP$8L^0Xbrce$J96TciEy272f^9WMH5^m9WqO8JRqvS1e0VToP41ppZMfK8z^GjQr9 ^16LbMyoB^Te5xW^hGt2^JXr5d4SM6^0CV6DW01ucGsaTg$a$q5pAze3D2kw2qVxFzG0zsjdZNprknsCyb6IevBsoDLbDKVosB7romPfCMvP0wcBPDYFW6rdddYKakRGku5ZZl$TGUnqVoDPtFl09^AcMvuokPBsYrVzgbfe^cm7YWTPVkJZZ^ZIK6oQX5W6mnGzHpIi KTNd35zB5gs4bB^121ABzO8td6Ij4FtSprqu1yxe67JWFjiW9GUW6ZnHJIHs5Y$bLVk4y3^PwudUwH36PSGyfS4lkzHfVIjp', 'InChI=1S/C25H20FN5O3/c26-18-10-8-17(9-11-18)20-12-14-31(30-20)24-19(7-4-13-28-24)25(34)29-21(22(32)23(27)33)15-16-5-2-1-3-6-16/h1-14,21H,15H2,(H2,27,33)(H,29,34)/t21-/m0/s1', 'AuxInfo=1/1/N:27,22,23,28,17,18,20,30,31,32,33,25,29,21,11,12,26,34,15,19,10,13,24,16,14,1,9,8,5,7,6,2,4,3/E:(2,3)(5,6)(8,9)(10,11)/it:im/rA:54FOOONNNNNC.eCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH/ rB:;;;;;s6;;;s5;s10;s11;d2s10;d3s5;s14;s6s8d-15;d+12;s12;d-7;s15;s6;s17;d-18;d4s9s13;s19d-21;s19;d-22s23;d-20;d-8s28;d+26;s26;s30;d-31;s1d+32s33;s10;s11;s11;s5;s17;s18;s20;s21;s22;s23;s25;s27;s28;s29; s30;s31;s9;s9;s32;s33;/rC:-5.333,-3.6887,-.8785;.3245,-3.3866,.2557;.1869,1.0518,-2.3246;1.4972,', 'CJFKGISBMQMNDQ-NRFANRHFSA-N', '1010:CZA9177X9PTKX8EJGEVHDS7H4CXNFU', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[c](:[c](-[#1]):[c](-[#1]):[n]2-[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]3)-[#6](-[#7](-[#1])-[#6@](-[#1])(-[#6](-[#6](-[#7](-[#1])-[#1])=[#8])=[#8])-[#6](-[# 1])(-[#1])-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]4-[#1])=[#8]):[n]2):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1c(c([H])c([H])n2c3c(c([H])c([H])c([H])n3)C(N([H])[C@]([H])(C(C(N([H])[H])=O)=O)C([H])([H])c4c([H])c([H])c([H])c([H])c4[H])=O)n2)c([H])c1[H]', '03.575', '3.575', '0', '0', 'TRUE', '-0.207\r\n-0.2868\r\n-0.2718\r\n-0.2687\r\n-0.3004\r\n-0.1261\r\n-0.1883\r\n-0.2418\r\n-0.3225\r\n9.5e-002\r\n-1.7e-003\r\n-4.57e-002\r\n0.2374\r\n0.2468\r\n7.62e-002\r\n0.1445\r\n-5.9e-002\r\n-5.9e-002\r\n8.67e-002\r\n-4.49e-002\r\n1.24e-002\r\n-6.2e-002\r\n-6.2e-002\r\n0.2784\r\n-2.13e-002\r\n1.6e-003\r', '1', '3.575', 'C25H20FN5O3', '0457.155', '-7.463', '0457.456', '0.43 3.48', '5', '2', '3', '11', '23', '4', '34', '37', '28', '14', '008', '03', '20', '0', '4', '008', '0119.97', '448.87', '', '4.48355', '1.2797', '73.96', '37.17', '4.32512', '36.79', '1,511.63', '135.244', '336.13', '-178.85', 'F/C/4=C/C=C(/C\\3=N/N(/C/2=C(C(=O)N[C@@H](C/C/1=C/C=C\\C=C1)C(=O)C(=O)N)/C=C\\C=N2)/C=C3)\\C=C4', 'NC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c2cccnc2n4ccc(c3ccc(F)cc3)n4', 'Compound 38-28759231', 'A-953227; SCHEMBL541498', 'Calpain 3', '66720197', 'Under Investigation', 'Alzheimer disease (AD)', '28759231', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(318, '318', '', 'COC1CCC2(C)C(CCC3C2CCC4(C)C3CC5OC(CCC(C)C(=O)NC(Cc6ccccc6)C(=O)OC)C(C)C45)C1', 'methyl 2-[[4-(25-methoxy-23,36,37-trimethyl-41-oxapentacyclo[BLAH.BLAH.BLAH.BLAH.BLAH.BLAH]icosan-30-yl)-2-methyl-butanoyl]amino]-3-phenyl-propanoate', 'CYAAFQwAvdwQu7$HM4MZXWlDx6VxyeUzb2AuQp1g7esCpWBX7jgwL2DXE9K^oF5Id8fyODBNiS3hkDepXJxDwDEkDNchPqdAi9JVy1eMFP$lcj4vLxF4UGrHsuPYSz8xAKwN1c0ea26YyNh0WjiNsP4fPQKL5zfasUJ0ojWhigFxTKf3hyAr1e2Xc^U^iHlkvvMuaydc 3M8WpHX1afNKK3tQuF77yUY9ehblKXczRb$G8OiMl7Youjz9ctn8ta2hwgueHQ7ipWqfX1hDOHrq4$MijUJifVWn$OW2CvBkyfv7YdmWlQMe9zoYNiLVQAMuaxT6nZQrRZK3q5cH0RTK0XDUgz1wTqN6YB8Z31pIPsyQaI8P1NczDDgxXV7r59^evH71wrcgap14ZeC5 151CI$NcKt$flxmBWqA6yffXKdqWo2xZPZvFPDnsBd9r5rBYsSb$Pv6Tah7F6NPp98cEubRxFdcleeebCjt$7XseedOTNeRM', 'InChI=1S/C38H57NO5/c1-23(35(40)39-31(36(41)43-6)20-25-10-8-7-9-11-25)12-15-32-24(2)34-33(44-32)22-30-28-14-13-26-21-27(42-5)16-18-37(26,3)29(28)17-19-38(30,34)4/h7-11,23-24,26-34H,12-22H2,1-6H3,(H,39, 40)', 'AuxInfo=1/1/N:42,41,39,40,44,29,38,36,37,34,35,22,9,10,21,5,11,3,12,32,4,15,23,20,33,2,6,8,7,13,26,19,16,17,24,27,1,14,25,31,30,43,28,18/E:(8,9)(10,11)/rA:44CCCCCCCCCCCCCCCCCOCCCCCCNCCOCOOCCCCCCCCCCCO C/rB:s1;s1;s2;s3;s4s5;s1;s7;s2;s8s9;s7;s11;s8;s12s13;s13;s15;s14s16;s16;s18;s17s19;s19;s21;s22;s23;s24;s25;s26;s27;s28;d27;d24;s26;s32;s33;d+33;d-34;s35;s36d-37;s1;s14;s20;s23;s6;s43;/rC:6.1667,-13.90 59,0;5.4522,-13.4934,0;6.1667,-14.7309,0;4.7378,-13.9059,0;5.4522,-15.1434,0;4.7378,-14.7309,0;6', 'SRDVTEHUZJTHJA-UHFFFAOYSA-N', '1010:ZHWGXQKFK2ZCM7Q4181TTCA75V59QY', '[#6]12(-[#6])-[#6](-[#6]-[#6]-[#6](-[#6]3-[#6](-[#6])(-[#6](-[#6](-[#6])-[#6](-[#6]-[#6]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6](-[#6]-[c]4:[c]:[c]:[c]:[c]:[c]4)-[#6](=[#8])-[#8]-[#6])-[#8]5)-[#6]5-[#6]3)-[ #6]-[#6]6)-[#6]16)-[#6]-[#6](-[#8]-[#6])-[#6]-[#6]2', 'C12(C)C(CCC(C3C(C)(C(C(C)C(CCC(C)C(=O)NC(Cc4ccccc4)C(=O)OC)O5)C5C3)CC6)C16)CC(OC)CC2', '06.72', '6.72', '0', '0', 'TRUE', '-2.65e-002\r\n-3.33e-002\r\n-4.49e-002\r\n-2.34e-002\r\n-2.62e-002\r\n5.74e-002\r\n-3.26e-002\r\n-3.46e-002\r\n-4.96e-002\r\n-4.96e-002\r\n-4.91e-002\r\n-4.7e-002\r\n-3.01e-002\r\n-2.38e-002\r\n-2.28e-002\r\n6.18e-002\r\n-4.3e-003\r\n-0.3744\r\n6.08e-002\r\n-1.2e-002\r\n-2.57e-002\r\n-3.97e-002\r\n', '0', '6.72', 'C38H57NO5', '0607.424', '-10.556', '0607.863', '', '5', '1', '2', '41', '06', '1', '44', '49', '9', '5', '006', '01', '57', '0', '6', '010', '0073.86', '643.45', '', '', '', '', '', '', '', '', '', '', '', 'C12(C)CCC(OC)CC1CCC3C2CCC5(C)C3CC6OC(CCC(C(NC(C(OC)=O)C/C/4=C/C=C\\C=C4)=O)C)C(C)C56', 'COC(=O)C(Cc1ccccc1)NC(=O)C(C)CCC6OC5CC4C3CCC2CC(OC)CCC2(C)C3CCC4(C)C5C6C', 'compound 5h-28687235', 'Not Available', 'Not Available', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '28687235', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(319, '319', 'Not Available', 'Oc1ccc(cc1)\\N=C\\2/Oc3ccccc3C=C2C(=O)Nc4cc(Br)ccc4N5CCN(CCC6C(=O)c7ccccc7C6=O)CC5', '(2<I>Z</I>)-<I>N</I>-[5-bromo-2-[4-[2-(1,3-dioxoindan-2-yl)ethyl]piperazin-1-yl]phenyl]-2-(4-hydroxyphenyl)imino-chromene-3-carboxamide', 'CYAAFQwAbfwQRgjc9zc^JoDkND2$xY1s4yf3nBu7uyVEYBCr7mvo0UyA8nvUQlMOyCUFqfdanVhRioisnDGausgwYvhTKCxTsZPvqQ6yFVXrFYvtRmYxND$MW75OiyrGX759OiwQAHCscA5pERp$z2R4A7rHXjXsCcVe66$2fqKHfYY69iVuftT9vGv$uPDecbX$eqF6 $1xxtG3VnLjDdr9VOyoOOhyvznYd3S3iXa0fz1UXWnbH5Pg660dDCI$v5PQ462dDOO6f329Kb1^2j3ozfQp1XWF0dDPO0VWfbq36qr5wP6T^6aN^vdX4v1tH1tRrLfPrVuNmvPv7D^ZSpzdZR7P35RfX0NA737cJni9yT63VcVRfNy8WU$Muuci^th034fnHGNer^fgn nV$uZd8$PUZcIfF33i68Lk87FTcniy^B0n2y9zUumrBO85ofogOX0b3p5XRuqlumETXqT3czP9DPAl^xiq1l48fW3vubTjwc', 'InChI=1S/C37H31BrN4O5/c38-24-9-14-32(42-19-17-41(18-20-42)16-15-29-34(44)27-6-2-3-7-28(27)35(29)45)31(22-24)40-36(46)30-21-23-5-1-4-8-33(23)47-37(30)39-25-10-12-26(43)13-11-25/h1-14,21-22,29,43H,15-20 H2,(H,40,46)/b39-37-', 'AuxInfo=1/1/N:10,45,47,12,8,44,46,11,24,29,30,31,32,22,36,35,1,5,2,6,13,21,7,23,28,33,40,41,37,14,19,20,9,38,39,17,16,25,27,18,3,4,34,42,43,26,15/E:(2,3)(6,7)(10,11)(12,13)(17,18)(19,20)(27,28)(34,35) (44,45)/rA:47CCNNCCCCCCCCCCOCCNCCCCCCBrONCCCCCCOCCCCCCCOOCCCC/rB:s1;s1;s2;s3;s4s5;;s7;d-7;d-8;s9;s10d-11;s7;d-13;s9;s14s15;s14;s17;s18;s4s19;d+19;d+20;s21;s22d-23;s23;d17;d+16;s27;s28;d+28;d-29;s30;s3 1d-32;s33;s3;s35;s36;s37;s37;s38;s39d-40;d38;d39;s40;d-44;s41;s45d-46;/rC:11.4292,-15.2055,0;10.', 'NYDOMQVMPCWJLU-XENYIEROSA-N', '1010:Y2G5UNXJP35UPAZKVFU42R6RE9V88V', '[#6]1-[#7](-[#6]-[#6]-[#6]2-[#6](=[#8])-[c](:[c]:[c]:[c]:[c]3):[c]3-[#6]2=[#8])-[#6]-[#6]-[#7](-[c]4:[c]:[c]:[c](-[#35]):[c]:[c]4-[#7]-[#6](=[#8])-[#6](\\-[#6](=[#7]\\-[c]5:[c]:[c]:[c](-[#8]):[c]:[c]5)\\ -[#8]-[c](:[c]67):[c]:[c]:[c]:[c]6)=[#6]7)-[#6]1', 'C1N(CCC2C(=O)c(cccc3)c3C2=O)CCN(c4ccc(Br)cc4NC(=O)C(\\C(=N\\c5ccc(O)cc5)\\Oc(c67)cccc6)=C7)C1', '06.483', '6.483', '0', '0', 'TRUE', '1.13e-002\r\n1.59e-002\r\n-0.3008\r\n-0.2709\r\n1.13e-002\r\n1.59e-002\r\n6.2e-003\r\n-5.24e-002\r\n9.12e-002\r\n-6.15e-002\r\n-3.06e-002\r\n-5.96e-002\r\n-3.54e-002\r\n8.81e-002\r\n-0.2903\r\n0.185\r\n0.2515\r\n-0.2798\r\n5.22e-002\r\n3.91e-002\r\n-2.49e-002\r\n-4.1e-002\r\n1.94e-002\r\n-4.63e-002\r\n-5.08e-002\r\n-0.2714\r\n-0.2238\r\n6.61e-002\r\n-3.38e-002\r\n-3.38e-002\r\n-3.e-002\r\n-3.e-002\r\n7.14e-002\r\n-0.361\r\n-7.e-004\r\n-2.29e-002\r\n8.69e-002\r\n0.1739\r\n0.1739\r\n2.91e-002\r\n2.91e-002\r\n-0.2934\r\n-0.2934\r\n-5.07e-002\r\n-6.15e-002\r\n-5.07e-002\r\n-6.15e-002', '0', '6.169', 'C37H31BrN4O5', '0690.148', '-8.946', '0691.57', '-2.65 6.56 7.37 7.56 7.67 10.22', '5', '2', '5', '24', '24', '4', '47', '53', '9', '17', '009', '02', '31', '0', '7', '007', '0111.54', '612.77', '', '', '', '', '', '', '', '', '', '', '', 'C5CN(/C1=C/C=C(Br)\\C=C1\\NC(/C/3=C/C/2=C(/C=C\\C=C2)\\OC3=N/C/4=C/C=C(O)\\C=C4)=O)CCN5CCC6C(=O)/C/7=C(C6=O)/C=C\\C=C7', 'O=C(Nc1cc(Br)ccc1N4CCN(CCC3C(=O)c2ccccc2C3=O)CC4)c6cc5ccccc5oc6=Nc7ccc(O)cc7', 'Compound 9e-23480856', 'Not Available', 'BACE1 (beta-secretase)', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '23480856', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(320, '7687685', '7687685', 'Fc1ccc(OCC(=O)Nc2cccc(c2)N3CCCCC3=O)cc1', '2-(4-fluorophenoxy)-<I>N</I>-[3-(2-oxo-1-piperidyl)phenyl]acetamide', 'CYAAFQwAQcwQ7ii5f3XsKhWf$ZsFYNj1SE201k8qlb4l74oa7OZF^BY6ftsjH12VwZBHXkv2UDZ2edyjtz8nVVAak8hPXgCY7C0Kw^Fk4LaIgMUi370XRaCTSYJJ7^LLmWbqAkwfV2gn6VKTuE2WWUDzGh8LfNdFu9RqndBvmL^waZcUKMftf1EUK41FZUmXtW4u9sQv 5ldBgWFmo0b62N7EvjpHkdJv9x6BpS9l4O4Kr$SpESmHXURGO6vpjjWlDxTv7$eU63gU4Ely5hVfpGglq2LDA5OPn3J1KnVGg8ByqgPzNzT7SMv3SMZ$$1e28wRviYQyY$cXm81hH3p8tmdWto27IN$IXQsc6Uf2LL^o9I0h0xa9VycFrwdbzjrT67MMAsK042nNqe^n VafG474GORFVQbQPwnaE5BCq8$KKLYAyC4HlX3K9Huh6k51dV40tqrD5259Gyl0vD$WubW6d11hHV71Cw1qXyDjL7awZ5S63', 'InChI=1S/C19H19FN2O3/c20-14-7-9-17(10-8-14)25-13-18(23)21-15-4-3-5-16(12-15)22-11-2-1-6-19(22)24/h3-5,7-10,12H,1-2,6,11,13H2,(H,21,23)', 'AuxInfo=1/1/N:9,7,16,17,14,10,23,24,21,22,8,13,19,25,15,12,20,18,11,1,6,5,4,2,3/E:(7,8)(9,10)/rA:44FOOONNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s5s7;s7;s9;d2s5s10;s5;s12;d+12;s6d+13;s14;s15d- 16;d4s6;s3s18;s3;d+20;s20;s21;d-22;s1d+23s24;s7;s7;s8;s8;s9;s9;s10;s10;s13;s14;s16;s17;s6;s19;s19;s21;s22;s23;s24;/rC:8.2897,1.8339,-.6291;-3.6187,2.1995,-.8029;3.6934,-.8836,.6504;1.5407,-2.2335,.067 4;-4.7019,.2572,-.0476;.1095,-.3832,.3522;-7.0857,.496,.7143;-6.0128,-.3953,.1115;-7.1348,1.801,', 'AKNVSHJDMGMSOK-UHFFFAOYSA-N', '1010:YJBKPDCNR8JWKS4B4P3A8WBXJARMV4', '[#9]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#8]-[#6](-[#1])(-[#1])-[#6](-[#7](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#7]3-[#6](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[# 1])-[#1])=[#8]):[c]2-[#1])=[#8]):[c](-[#1]):[c]1-[#1]', 'Fc(c([H])c([H])c1OC([H])([H])C(N([H])c(c([H])c([H])c([H])c2N3C(C([H])([H])C([H])([H])C([H])([H])C3([H])[H])=O)c2[H])=O)c([H])c1[H]', '02.693', '2.693', '0', '0', 'TRUE', '-0.207\r\n-0.2772\r\n-0.3365\r\n-0.2747\r\n-0.2716\r\n-0.2834\r\n-3.65e-002\r\n1.92e-002\r\n-4.32e-002\r\n2.49e-002\r\n0.2185\r\n3.72e-002\r\n-1.91e-002\r\n-4.04e-002\r\n3.43e-002\r\n-5.86e-002\r\n-4.06e-002\r\n0.2424\r\n0.1301\r\n7.58e-002\r\n-2.89e-002\r\n-2.89e-002\r\n-2.38e-002\r\n-2.38e-002\r\n0.1', '0', '2.691', 'C19H19FN2O3', '0342.138', '-4.214', '0342.364', '0.68 5.61', '3', '1', '2', '13', '12', '2', '25', '27', '24', '8', '005', '01', '19', '0', '3', '005', '0058.64', '340.54', '', '4.95748', '1.2754', '27.52', '-0.21', '5.3709', '27.73', '2,031.81', '90.64', '261.7', '-166.93 -180', 'F/C/3=C/C=C(OCC(=O)N/C/2=C/C(N1CCCCC1=O)=C\\C=C2)\\C=C3', 'O=C(COc1ccc(F)cc1)Nc3cccc(N2CCCCC2=O)c3', 'Compound ID 7687685', '1. 2-(4-fluorophenoxy)-N-(3-(2-oxopiperidin-1-yl)phenyl)acetamide, AC1OQM9V', 'Superoxide Dismutase 1', '7687685', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '22652679', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(321, '321', 'Not Available', 'CNc1nc(NC2=C(Cl)N(CC(C)(C)O)NC2)ncc1C(F)(F)F', '1-[3-chloro-4-[[4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-1,5-dihydropyrazol-2-yl]-2-methyl-propan-2-ol', 'CYAAFQwAmdwQV2GmIV1yPtmcqFJ^qGndzj1rfylypdjim7jrHrZX2POsKn5nCa5twPjWszbR^shdZDKrTgCcGQ22DGSb4UpY$VNRm^l^UghuvDiy^ehAu1NyoZ8KAggPD2n0BXAbns2JFTslNBITPAjX$7lpLUwwOPkqc24W2uTvviuyyE8cDjLbFPklbs$^rfJcIv$E 8W^6Rqnzjo$GkL2GVlKzKfDRpJ$2GCkqWEXf3dJ2RtMR7JM4uWeXQUd5Xj4b5Jn$jwmbcsqk7nuONSL^Yx1FCbs5N5yQlU8y6dnn5d3ATTmv2TLsbnXhN8$5nL5xIPkt4r2^RIrXHKDGALXKleYMzl5a8EGTVH2DUclmRycZxn6B$AoQjvk3lFJKKG$Z4XVRC2iYs48z biDpLVB49g$RYahezUs0EjlhiHq4rQIXoZizdYajc5glWg0Kk$icc26FtAHYHX6JCIQtSv2Q1HBZiWvw8VcJnpYrP4xY$k^$', 'InChI=1S/C13H18ClF3N6O/c1-12(2,24)6-23-9(14)8(5-20-23)21-11-19-4-7(13(15,16)17)10(18-3)22-11/h4,20,24H,5-6H2,1-3H3,(H2,18,19,21,22)', 'AuxInfo=1/1/N:22,23,18,3,12,20,1,10,9,2,6,21,14,19,15,16,17,7,5,13,8,4,11,24/E:(1,2)(15,16,17)/rA:24CCCNNCNNCCNCNCFFFCClCCCCO/rB:s1;d-1;d-2;s3;s4d-5;s2;s6;;s8d+9;s9;s10;s11s12;s1;s14;s14;s14;s7;s9;s11 ;s20;s21;s21;s21;/rC:15.6104,-6.2639,0;15.6104,-7.0889,0;14.8959,-5.8514,0;14.8959,-7.5014,0;14.1814,-6.2639,0;14.1814,-7.0889,0;16.3248,-7.5014,0;13.4669,-7.5014,0;12.7995,-8.8113,0;13.4669,-8.3264,0 ;13.0544,-9.596,0;14.1344,-8.8113,0;13.8794,-9.596,0;16.3248,-5.8514,0;15.9123,-5.1369,0;16.7374', 'NQCPNBJSGRWTKK-UHFFFAOYSA-N', '1010:4RTZDD6FB97W4UQEHAE2EVQGY36KBW', '[c]1(-[#6](-[#9])(-[#9])-[#9]):[c]:[n]:[c](-[#7]-[#6](-[#6]-[#7]-[#7]2-[#6]-[#6](-[#8])(-[#6])-[#6])=[#6]2-[#17]):[n]:[c]1-[#7]-[#6]', 'c1(C(F)(F)F)cnc(NC(CNN2CC(O)(C)C)=C2Cl)nc1NC', '01.361', '2.138', '2', '0', 'TRUE', '0.1107\r\n0.1225\r\n4.58e-002\r\n-0.2056\r\n-0.2257\r\n0.2058\r\n-0.2755\r\n-0.2266\r\n0.1141\r\n4.51e-002\r\n-0.1985\r\n4.86e-002\r\n-0.2443\r\n0.4204\r\n-0.166\r\n-0.166\r\n-0.166\r\n-1.02e-002\r\n-6.82e-002\r\n4.76e-002\r\n7.36e-002\r\n-3.51e-002\r\n-3.51e-002\r\n-0.3891', '0', '1.009', 'C13H18ClF3N6O', '0366.118', '-3.487', '0366.77', '4.19 7.64', '2', '3', '1', '18', '06', '1', '24', '25', '9', '4', '007', '04', '18', '0', '2', '006', '0085.34', '366.78', '', '', '', '', '', '', '', '', '', '', '', 'C2(/C(F)(F)F)=C\\N=C(N/C1=C(Cl)/N(CC(C)(C)O)NC1)/N=C2/NC', 'CNc2nc(N/C1=C(Cl)/N(CC(C)(C)O)NC1)ncc2C(F)(F)F', 'Compund 18_24900567', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '24900567', 'Parkinson Disease(PARK)', 'PARK'),
(322, '322', 'Not Available', 'Cc1ccc(NC(=O)c2cncc(Br)c2)c(O)c1', '5-bromo-<I>N</I>-(2-hydroxy-4-methyl-phenyl)pyridine-3-carboxamide', 'CYAAFQwAicwQ14Oh^x6bmTvkbFSLBbDVgP6TfymjXlo6W9T9Hcd0Bc9rNK1sKlnPXWLBKWk0A92lUH0ZYOfIcAo69^7oFPqKtYidpQHcMKvFvu6vbo5$TC08ZqpXgcWwP8pIxgErPtgOCVVAChA62nwd$^E0KmwxjnlJQpoIjdN7fSntNy0EcuWt6OMYh^VIDYubGlwQ zz9i9Q2zCjpxFynhWg6iCnzVy1OpOXR3mx5TOHH39SRUw96n5P^tNXbbtsvh9VN350Mv$41I$k9vrdP1L59GK$eW1T9m7xJOPSyJi9iQC1gHnY2LWwmmmPSovw22WMlDcOcvEGUzY6AbIOLZlRjUxTdMWozDPGR9RvTRMJOTnOAB3jWUxvXyyBvCPSNP^ou3o6fhlB', 'InChI=1S/C13H11BrN2O2/c1-8-2-3-11(12(17)4-8)16-13(18)9-5-10(14)7-15-6-9/h2-7,17H,1H3,(H,16,18)', 'AuxInfo=1/1/N:17,2,4,3,10,9,13,1,8,12,6,5,14,7,11,16,18,15/rA:18CCCCCCBrCCCNCCCONCO/rB:s1;d-1;d-2;s3;s4d-5;;;s8;d-8;d-9;s7s10;s11d+12;s8;d14;s6s14;s1;s5;/rC:15.0449,-2.5322,0;15.0449,-3.3573,0;14.3304 ,-2.1197,0;14.3304,-3.7698,0;13.6159,-2.5322,0;13.6159,-3.3573,0;9.329,-3.3573,0;11.4724,-3.7698,0;11.4724,-4.5948,0;10.758,-3.3573,0;10.758,-5.0073,0;10.0435,-3.7698,0;10.0435,-4.5948,0;12.1869,-3.35 73,0;12.1869,-2.5322,0;12.9014,-3.7698,0;15.7594,-2.1197,0;12.9014,-2.1197,0;', 'UKTAVCOVENHZKB-UHFFFAOYSA-N', '1010:3UZG6K12P3QBD1F5EVM8HKJ5D7N5PV', '[c]1(-[#6]):[c]:[c](-[#8]):[c](-[#7]-[#6](=[#8])-[c]2:[c]:[c](-[#35]):[c]:[n]:[c]2):[c]:[c]1', 'c1(C)cc(O)c(NC(=O)c2cc(Br)cnc2)cc1', '02.456', '2.456', '0', '0', 'TRUE', '-4.84e-002\r\n-5.73e-002\r\n-2.72e-002\r\n-3.78e-002\r\n9.29e-002\r\n6.31e-002\r\n-4.92e-002\r\n5.68e-002\r\n3.93e-002\r\n-3.23e-002\r\n-0.2628\r\n3.66e-002\r\n4.1e-002\r\n0.2488\r\n-0.2715\r\n-0.2791\r\n-3.97e-002\r\n-0.359', '0', '2.446', 'C13H11BrN2O2', '0306', '-4.101', '0307.143', '-0.16 2.41 8.93', '2', '2', '1', '6', '12', '2', '18', '19', '5', '7', '004', '02', '11', '0', '2', '002', '0062.22', '263.25', '', '', '', '', '', '', '', '', '', '', '', 'C\\2(/C)=C\\C(O)=C(NC(/C/1=C/C(Br)=C\\N=C1)=O)/C=C2', 'Cc2ccc(NC(=O)c1cncc(Br)c1)c(O)c2', 'Compund A-24367508', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24367508', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(323, '323', 'Not Available', 'Clc1ccc(OCC(=O)Nc2ccncc2)cc1', '2-(4-chlorophenoxy)-<I>N</I>-(4-pyridyl)acetamide', 'CYAAFQwAicwQ14Oh^x6bfzlkYjh3XnF$kmbttdzSfqnaReiPqDhBphPXGmiR1z3N4dZ4^oxpBn8sqVmouUZhXusYddvqIEXxmF9uQJhKvP^mQOGe$lEnL3cDBnCSiUyus9Q3RZUMT4hFQKqR1JUCw6YC44tbp49JeSox42evXqR5Giy8x4YXIrBetz9qvvDPzFN1HCJk $el7OGXD3kTbswi4ydfH3ufnRBxzeAkwtaKCc^j3zvp8eDqdtPhjyxOukWWA31xLG^8K8oTk$2ruN$FL4O20mzCzrKrs1WGcN^VCxIEL3I8LJ$ATVFdz$6oa2r$L0LEdCy6VP03ZigbT2Dg1iwa2iNLZO1skxZIh5byni^akpDeGegJe^wEdo2IJcB', 'InChI=1S/C13H11ClN2O2/c14-10-1-3-12(4-2-10)18-9-13(17)16-11-5-7-15-8-6-11/h1-8H,9H2,(H,15,16,17)', 'AuxInfo=1/1/N:15,16,13,14,4,5,2,3,7,17,6,12,8,18,1,10,9,11/E:(1,2)(3,4)(5,6)(7,8)/rA:18NCCCCCCCONOCCCCCCCl/rB:s1;d-1;d-2;s3;s4d-5;;s7;d8;s6s8;s7;s11;s12;d+12;d-13;s14;s15d-16;s17;/rC:12.8879,-9.8006,0 ;12.4754,-10.5152,0;12.4754,-9.0862,0;11.6504,-10.5152,0;11.6504,-9.0862,0;11.2379,-9.8006,0;9.1754,-9.0862,0;10.0004,-9.0862,0;10.4129,-8.3717,0;10.4129,-9.8006,0;8.7629,-8.3717,0;7.9379,-8.3717,0;7. 5254,-9.0862,0;7.5254,-7.6572,0;6.7004,-9.0862,0;6.7004,-7.6572,0;6.2879,-8.3717,0;5.4629,-8.371', 'YSGYLLRPKPGMSY-UHFFFAOYSA-N', '1010:U99E28W6W7PSM4R91XT44WNJJPK1CV', '[n]1:[c]:[c]:[c](-[#7]-[#6](=[#8])-[#6]-[#8]-[c]2:[c]:[c]:[c](-[#17]):[c]:[c]2):[c]:[c]1', 'n1ccc(NC(=O)COc2ccc(Cl)cc2)cc1', '01.963', '1.963', '0', '0', 'TRUE', '-0.2646\r\n2.86e-002\r\n2.86e-002\r\n-2.24e-002\r\n-2.24e-002\r\n3.55e-002\r\n0.1301\r\n0.2424\r\n-0.2747\r\n-0.2833\r\n-0.3365\r\n7.57e-002\r\n-3.03e-002\r\n-3.03e-002\r\n-4.1e-002\r\n-4.1e-002\r\n4.07e-002\r\n-8.44e-002', '0', '1.994', 'C13H11ClN2O2', '0262.051', '-3.736', '0262.692', '5.87', '3', '1', '1', '6', '12', '2', '18', '19', '3', '7', '004', '01', '11', '0', '2', '004', '0051.22', '257.05', '', '', '', '', '', '', '', '', '', '', '', 'N/2=C/C=C(NC(CO/C/1=C/C=C(Cl)\\C=C1)=O)\\C=C2', 'O=C(COc1ccc(Cl)cc1)Nc2ccncc2', 'Compund C-24367508', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24367508', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(324, '324', 'Not Available', 'CCN(CC)Cc1ccc(NC(=O)c2cncc(Br)c2)cc1', '5-bromo-<I>N</I>-[4-(diethylaminomethyl)phenyl]pyridine-3-carboxamide', 'CYAAFQwAwfwQBBJ3jdg3XZ8ORjDcv128InSzDDQuYhFgK$LlICqlW072aRHw8l6Mx5HbYFuVdD8yAoTkjD4s6EWqU0^FvAl$lD^8OYPhAT5VJNqjl9kz7Wl6FWFLiGydY9BeWvB0CoOe^shKRTIEEiXJfIf83HtTROsuWPDeDSxsdAHHdL7E7hh5yvhl34WFYj^HqE^1 VB^9srYcm7B1qD3WXYS^7iF0Ven3Ja467Iowwf$LxxthbrpvYc6yjHqg7XIfe9z9B9v6sWDa697fj7uDG6Ov4I19542jeK6xUYfQc7kRpsn9zOEnn75$f97dHG3LsJW9QsnTJrTf6wEKOLcTcBi5wuoMxuYGwwuw6ETJcmMzzRChkpvwaGlFmSi$$FiPZwYo0xN4K6KE GkwUOlv9yaFraqWxQJYhOiU5y80EGg3JfqDe4uv2C9l20u8d', 'InChI=1S/C17H20BrN3O/c1-3-21(4-2)12-13-5-7-16(8-6-13)20-17(22)14-9-15(18)11-19-10-14/h5-11H,3-4,12H2,1-2H3,(H,20,22)', 'AuxInfo=1/1/N:20,22,19,21,2,3,4,5,10,9,13,17,1,8,12,6,14,7,11,16,18,15/E:(1,2)(3,4)(5,6)(7,8)/rA:22CCCCCCBrCCCNCCCONCNCCCC/rB:s1;d-1;d-2;s3;s4d-5;;;s8;d-8;d-9;s7s10;s11d+12;s8;d14;s6s14;s1;s17;s18;s19 ;s18;s21;/rC:12.7419,-8.9147,0;12.7419,-9.7397,0;12.0274,-8.5022,0;12.0274,-10.1522,0;11.3129,-8.9147,0;11.3129,-9.7397,0;7.0261,-9.7397,0;9.1695,-10.1522,0;9.1695,-10.9772,0;8.4551,-9.7397,0;8.4551,- 11.3897,0;7.7406,-10.1522,0;7.7406,-10.9772,0;9.884,-9.7397,0;9.884,-8.9147,0;10.5985,-10.1522,0', 'LPEWLWGXSFFTAR-UHFFFAOYSA-N', '1010:FMMJ6EQSZ3SV2E79W3YJPVAESGXGEV', '[c]1(-[#6]-[#7](-[#6]-[#6])-[#6]-[#6]):[c]:[c]:[c](-[#7]-[#6](=[#8])-[c]2:[c]:[c](-[#35]):[c]:[n]:[c]2):[c]:[c]1', 'c1(CN(CC)CC)ccc(NC(=O)c2cc(Br)cnc2)cc1', '02.983', '2.983', '0', '0', 'TRUE', '-3.38e-002\r\n-5.59e-002\r\n-5.59e-002\r\n-4.04e-002\r\n-4.04e-002\r\n3.27e-002\r\n-4.92e-002\r\n5.68e-002\r\n3.93e-002\r\n-3.23e-002\r\n-0.2628\r\n3.66e-002\r\n4.1e-002\r\n0.2487\r\n-0.2715\r\n-0.2813\r\n2.33e-002\r\n-0.2997\r\n-4.4e-003\r\n-5.25e-002\r\n-4.4e-003\r\n-5.25e-002', '0', '1.55', 'C17H20BrN3O', '0361.079', '-5.223', '0362.264', '-0.16 2.19 9.41', '2', '1', '1', '10', '12', '2', '22', '23', '5', '7', '004', '01', '20', '0', '2', '006', '0045.23', '346.8', '', '', '', '', '', '', '', '', '', '', '', 'C\\2(/CN(CC)CC)=C\\C=C(NC(/C/1=C/C(Br)=C\\N=C1)=O)/C=C2', 'CCN(CC)Cc2ccc(NC(=O)c1cncc(Br)c1)cc2', 'Compund D-24367508', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24367508', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(325, '325', 'Not Available', 'Fc1ccc(cc1)c2oc(CNCc3ccccc3)cc2', '<I>N</I>-[[5-(4-fluorophenyl)-2-furyl]methyl]-1-phenyl-methanamine', 'CYAAFQwATewQtpS1G0ZlxmDbLm17LFaB3juSradnKSor2CMPfG$tZN5mdbqOvR2G1qssXWOBJUkv4ZnhBjDYU9tvWUildbUHddz9vr3BwaRuSybN^mfI$Y$08VNVsCAErUUWUVsz1hIPJsgEglrNd1kHxiDXqEoGC75B2sIjmrmElUko5cumv0C9J^FEcBwwYj18TlcX d2nbusyLDqmcXYJh9ZGS5xSEBqMp3NydpuM^v2q$y7MKzJD0U^2OntLM9sOJh2vt42xFek11NNB1YQp8jfuKH2H9jwmvxxpcApkzPvzdnQ2WE$UN7knpL^^l81D^K8n$bn8^5tOuArXwcsPeEkIbPL3Lec5OMvsAKWpwlCvqsJiacZhZE2FzGVijqOpuqWE2IOBd1df6 UXUQ$QPgDeL2DupPP2LccGgjLQq7lKaKuxWxZPrQsJIMHLkDBTYH70Wo8Y8Lr^QHrrRfpHxLrRM', 'InChI=1S/C18H16FNO/c19-16-8-6-15(7-9-16)18-11-10-17(21-18)13-20-12-14-4-2-1-3-5-14/h1-11,20H,12-13H2', 'AuxInfo=1/0/N:4,2,6,1,5,16,17,18,19,12,14,7,9,3,15,20,10,13,21,8,11/E:(2,3)(4,5)(6,7)(8,9)/rA:21CCCCCCCNCCOCCCCCCCCCF/rB:s1;d-1;d-2;s3;s4d-5;s3;s7;s8;s9;s10;d+10;s11;s12d-13;s13;s15;d+15;d-16;s17;s18d -19;s20;/rC:8.7338,-7.378,0;7.9802,-7.0425,0;8.8219,-8.1922,0;7.3142,-7.5265,0;8.1506,-8.6763,0;7.3969,-8.3406,0;9.5756,-8.5275,0;10.2412,-8.0435,0;10.9949,-8.3791,0;11.6662,-7.895,0;12.4416,-8.1479,0 ;11.6662,-7.0756,0;12.926,-7.488,0;12.4416,-6.8168,0;13.7513,-7.488,0;14.1637,-6.7728,0;14.1637,', 'OKIAFLBYBKHZSA-UHFFFAOYSA-N', '1010:QCWVVECH6E97EZR4WA2B67XPCFV1R6', '[c]1:[c](-[#6]-[#7]-[#6]-[c]2:[c]:[c]:[c](-[c]3:[c]:[c]:[c](-[#9]):[c]:[c]3):[o]2):[c]:[c]:[c]:[c]1', 'c1c(CNCc2ccc(c3ccc(F)cc3)o2)cccc1', '04.148', '4.148', '0', '0', 'TRUE', '-5.78e-002\r\n-6.2e-002\r\n-3.42e-002\r\n-6.23e-002\r\n-5.78e-002\r\n-6.2e-002\r\n2.09e-002\r\n-0.3067\r\n4.31e-002\r\n7.32e-002\r\n-0.3128\r\n-3.16e-002\r\n8.89e-002\r\n-2.84e-002\r\n5.4e-003\r\n-4.95e-002\r\n-4.95e-002\r\n-2.57e-002\r\n-2.57e-002\r\n0.1227\r\n-0.207', '0', '2.925', 'C18H16FNO', '0281.122', '-5.995', '0281.324', '10.34', '1', '1', '0', '6', '17', '3', '21', '23', '3', '8', '002', '01', '16', '0', '3', '005', '0025.17', '286.88', '', '', '', '', '', '', '', '', '', '', '', 'C/3=C(CNC/C2=C/C=C(/C/1=C/C=C(F)\\C=C1)\\O2)/C=C\\C=C3', 'Fc3ccc(c2ccc(CNCc1ccccc1)o2)cc3', 'Compund E-24367508', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24367508', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(326, '326', 'Not Available', 'Cc1nc2ccccc2n1Cc3nc4ccccc4[nH]3', '1-(1<I>H</I>-benzimidazol-2-ylmethyl)-2-methyl-benzimidazole', 'CYAAFQwAcewQXsVsT6Shl756DDOdqc0snybfbyLcz2680COZw7iANGHOyLSs$APbIwb7803HERaMqz9wzMOAspsG8dRqxZSgNhjRFIdsoHivMFL8UcBp7jJAwfPc4goxoVwNH0vXei6gE2z64Jm4h3PDwlhx4sh0Ug4hBf5KIqMJ862KXvdhYE4l6rf7ccu^VJhkSEoz 7E4$ChzHrfFEnrR^qof07Yxhsh5hAdElrzN6ohvsPXSfvLVmOM6QSXQOu2LyRQ^SiByJLSvs5dcWkjrihRaUZzwvpKs0TA56qXDMxQUfoOnHL3JxvyHO55vyr^ronrt^umEjIFz55wtlc2hZIlyWhYVb7qY71aH0aiLimRaVuJi7m6DWLOdWAc84Ga$bc4REKLg2vFRE ovpQzWea3euqNTFiVtcFV54rsDu85uqwfVOY1lnQNAvq801o0B^h33sP^wcZ9WoxmB', 'InChI=1S/C16H14N4/c1-11-17-14-8-4-5-9-15(14)20(11)10-16-18-12-6-2-3-7-13(12)19-16/h2-9H,10H2,1H3,(H,18,19)', 'AuxInfo=1/1/N:10,12,14,4,6,13,16,2,5,11,8,15,17,1,3,19,7,18,20,9/E:(2,3)(6,7)(12,13)(18,19)/rA:20CCCCCCNCNCCCCCCCCNCN/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s3s8;s8;s9;;s12;d-12;d-13;s14;s15d-16;s15;s11d+18;s1 7s19;/rC:9.089,-8.5497,0;8.264,-8.5497,0;9.5015,-7.8353,0;7.8515,-7.8353,0;9.089,-7.1208,0;8.264,-7.1208,0;9.6411,-9.1629,0;10.3948,-8.8273,0;10.3085,-8.0068,0;11.1092,-9.2398,0;10.9216,-7.4548,0;14.1 452,-8.9359,0;13.3383,-9.1074,0;14.4002,-8.1513,0;12.7862,-8.4943,0;13.8481,-7.5382,0;13.0412,-7', 'LUWYIVFCZASTHJ-UHFFFAOYSA-N', '1010:M9S2TJ8J9AAXKD7M6D8D4EDCH5QUGA', '[c]12:[c](:[n](-[#6]-[c](:[n]:[c](:[c]3:[c]4):[c]:[c]:[c]4):[n]3):[c](-[#6]):[n]1):[c]:[c]:[c]:[c]2', 'c12c(n(Cc([nH]c(c3c4)ccc4)n3)c(C)n1)cccc2', '03.104', '3.104', '0', '0', 'TRUE', '8.3e-002\r\n-3.48e-002\r\n4.9e-002\r\n-6.e-002\r\n-4.14e-002\r\n-6.05e-002\r\n-0.2397\r\n8.71e-002\r\n-0.224\r\n-1.11e-002\r\n6.24e-002\r\n-6.e-002\r\n-3.48e-002\r\n-6.06e-002\r\n8.28e-002\r\n-4.17e-002\r\n4.59e-002\r\n-0.2382\r\n0.1021\r\n-0.2438', '0', '3.167', 'C16H14N4', '0262.122', '-4.727', '0262.309', '6.19 7.03', '2', '1', '0', '3', '20', '4', '20', '23', '2', '8', '004', '01', '14', '0', '4', '002', '0046.5', '267.06', '', '', '', '', '', '', '', '', '', '', '', 'C/1/4=C(/C=C\\C=C1)\\N(C/C3=N/C2=C/C=C\\C=C2\\N3)\\C(C)=N4', 'Cc2nc1ccccc1n2Cc4nc3ccccc3[nH]4', 'Compund F-24367508', 'Not Available', 'Amyloid beta A4 protein', 'Not Available', 'Under Investigation', 'Alzheimer disease (AD)', '24367508', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(327, '3081884', '3081884', 'C[C@H](N)C(=O)O.CC(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O', 'acetic acid;(2<I>S</I>)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2<I>S</I>)-2-aminopentanedioic acid;(2<I>S</I>)-2-aminopropanoic acid;(2<I>S</I>)-2,6-diaminohexanoic acid', 'CYAAFQwAncwQlEWkiw^YORLyyIg7K7lNqlWiYhKDIQBgnh9mPr0EiHxPfGZPgpvP$VLtxTKHYdCcEI0SUtl36WLLnlrizESym6iPBEk7NuResz^wOhrburvO$co$O95P0lExfYvDP$H3FnyTAsU^QxN8jBJ9u^v30S5YvOQf$C$qipmuPVw5PsBIFcZwcg^rvdbmCMA7 ijHzXPSA4dd1Yu3Su9G1ECSck4TmaKxTvURvkHhev8iGpDYejs3Yvo2L8WVpVBsI4xSKxObRRG6xF3$rpkLmQDfXr24K5vc5emlv3NgZd5SfNX$6veRvljtVPwC3Yd8gL9tm2^knkJvsvOwj4xZc854IPNejfMyyRGvIvlToXMO263d7dAO6OhfrpmnLeffoOxW^rENv fx5tG3KevfCla528w2$h63ms97aQdHOMmWn$KRdwKbtve5bKqo3Kug^kViXe8a5lfdR4RcPt5g87zDpfuvqNiTXPxzfjd^nM', 'InChI=1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2.C2H4O2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6;1-2(3)4/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1 -2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6);1H3,(H,3,4)/t8-;5-;3-;2-;/m0000./s1', 'AuxInfo=1/1/N:31,32,34,35,25,27,36,26,33,16,4,3,5;19,21,20,23,22,24,15,14,1,2;28,30,29,38,37,17,7,9,6,8;40,39,41,18,10,11;42,43,12,13/E:(1,2)(3,4)(12,13);(9,10);(7,8)(9,10);(5,6);(3,4)/it:4im;/rA:88OO OOOOOOOOOOONNNNNCCCC.eCCCC.eCCC.eCCCCCCCCCC.eCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;;s19;s19;n14s20;s15s21;s1d2s22;;p16s25;s25;;n17s28;s28;d+27;s27;s3d5s26;s31;d-32;s4d+ 34s35;s6d8s29;s7d9s30;n18;s39;s10d11s39;;s12d13s42;s19;s19;s20;s20;s21;s21;s22;s23;s23;s14;s14;s', 'FHEAIOHRHQGZPC-KIWGSFCNSA-N', '1010:BBFSQ88KD3CSXUWZDXCBYHBKAJM7Y2', '[#8](-[#1])-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1])-[#7](-[#1])-[#1])=[#8].[#8](-[#1])-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])- [c]1:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]1-[#1])-[#8]-[#1])-[#7](-[#1])-[#1])=[#8].[#8](-[#1])-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](=[#8])-[#8]-[#1])-[#7](-[#1])-[#1])=[ #8].[#8](-[#1])-[#6](-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#1])=[#8].[#8](-[#1])-', 'O([H])C([C@]([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])N([H])[H])=O.O([H])C([C@]([H])(C([H])([H])c1c([H])c([H])c(c([H])c1[H])O[H])N([H])[H])=O.O([H])C([C@]([H])(C([H])([H])C([H])([H]) C(=O)O[H])N([H])[H])=O.O([H])C([C@]([H])(C([H])([H])[H])N([H])[H])=O.O([H])C(C([H])([H])[H])=O', '-14.39', '-0.762', '0', '0', 'TRUE', '-0.3306\r\n-0.265\r\n-0.3306\r\n-0.361\r\n-0.265\r\n-0.3306\r\n-0.3318\r\n-0.265\r\n-0.2669\r\n-0.3306\r\n-0.265\r\n-0.332\r\n-0.2672\r\n-0.3195\r\n-0.3305\r\n-0.3192\r\n-0.3194\r\n-0.3197\r\n-5.01e-002\r\n-2.83e-002\r\n-4.09e-002\r\n9.12e-002\r\n-7.8e-003\r\n0.2752\r\n-3.e-003\r\n9.52e-002\r\n-4.58e-002\r\n', '1', '-15.78', 'C25H45N5O13', '0623.301', '-8.228', '0623.65', '2.16 2.18 2.25 2.34 4.36 4.76 9.21 9.52 9.86 9.98 10.47 10.51', '6', '6', '6', '27', '06', '1', '43', '39', '61', '9', '018', '17', '45', '0', '1', '013', '0374.12', '711.05', '', '', '', '', '', '', '', '', '', '', '', 'OC(=O)C(N)CCCCN.OC(=O)C(N)C/C/1=C/C=C(O)\\C=C1.OC(=O)C(N)CCC(O)=O.OC(=O)C(N)C.OC(=O)C', 'NCCCCC(N)C(=O)O.NC(Cc1ccc(O)cc1)C(=O)O.NC(CCC(=O)O)C(=O)O.CC(N)C(=O)O.CC(=O)O', 'Copaxone (Glatiramer acetate)', 'Glatiramer acetate; Copolymer 1; COP-1; Protiramer; Glatopa', 'HLA class II histocompatibility antigen, DRB1-1 beta chain', '3081884', 'Terminated at Phase IV', 'Relapsing Remitting Multiple Sclerosis (RRMS)', '25924547', 'Relapsing Remitting Multiple Sclerosis (RRMS)', 'DISSEMINATED SCLEROSIS'),
(328, '20784468', '20784468', 'C1CCN(CC1)c2ccnc3[nH]ccc23', '4-(1-piperidyl)-1<I>H</I>-pyrrolo[2,3-b]pyridine', 'CYAAFQwARdwQ32t^9L8KZlnaTGuPzU4QTFXfMmP8o86KsO7xJ4CJYTwre31XOBXUy5wOaNrC5d58meqbjdeNqDS7EMRtOnH5FVyyUtFuP$z3RICx590Zf3rnhN0COVgKxN$vLK^9eDOAk6WEKoP1KKmNCIPqCB6GjsSeeNPuKjHObUYfvfFSIjdEt5hVHmgVpPiMhME0 FinXfogN4FQmuCiZc6rW1gbeqycsmlVgxGBQTgH8Kx80YFco6VbuUGU5Ig6bKnhV7GhyDSG882myMTTF1Sju9edh8UbQqr2tFKfgiuxhLj38iIjbveieILue5k7wHF719cBZbRo2RXg$Q$BrzdKt^20aFunBToOqrT0z6xA6R57y6wXFGn91jstCjB9v6GKjA0M9a5wc xI5n1yWEnvFfyzAQmNZrljch3uowLMbjONGqs$0YAkXX^OrXX8ZdvaqjnhJv7idcFvn6lzWTV8bSK9mPNrkZnoa9qrDq1IlA', 'InChI=1S/C12H15N3/c1-2-8-15(9-3-1)11-5-7-14-12-10(11)4-6-13-12/h4-7H,1-3,8-9H2,(H,13,14)', 'AuxInfo=1/1/N:8,6,7,13,11,15,14,4,5,10,9,12,2,3,1/E:(2,3)(8,9)/rA:30NNNCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:;;s1;s1;s4;s5;s6s7;s1;d+9;s9;s2d+3s10;s10;s3d-11;s2d-13;s4;s4;s5;s5;s6;s6;s7;s7;s8;s8;s11;s13;s2;s 14;s15;/rC:1.2527,.2322,-.015;-3.2553,-1.0432,.1728;-2.8621,1.3125,-.1423;2.2207,1.2097,.4955;1.7482,-.7088,-1.0297;3.4852,.507,.9876;3.0078,-1.4164,-.5352;4.0637,-.4181,-.0758;-.1068,.5654,-.0538;-1. 1193,-.3984,.0784;-.4913,1.8936,-.2288;-2.4372,.0457,.0247;-1.1668,-1.8052,.2657;-1.8456,2.1975,', 'QTWWJUWXADSYNH-UHFFFAOYSA-N', '1010:GRC4G39E7ENUMDRJXY2FJASN116QHJ', '[#7]1(-[c](:[c](-[#1]):[c](-[#1]):[n]2):[c](:[c](-[#1]):[c](-[#1]):[n]3-[#1]):[c]23)-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]1(-[#1])-[#1]', 'N1(c(c([H])c([H])n2)c(c([H])c([H])n3[H])c23)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]', '02.251', '2.111', '0', '0', 'TRUE', '-0.2743\r\n-0.2492\r\n-0.2439\r\n3.e-003\r\n3.e-003\r\n-4.e-002\r\n-4.e-002\r\n-5.09e-002\r\n2.93e-002\r\n3.08e-002\r\n-2.49e-002\r\n0.1181\r\n-3.93e-002\r\n3.03e-002\r\n-1.62e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n2.67e-002\r\n2.', '0', '2.478', 'C12H15N3', '0201.127', '-2.498', '0201.268', '-2.37 9.79', '1', '1', '0', '7', '10', '2', '15', '17', '16', '4', '003', '01', '15', '0', '3', '001', '0031.92', '210.71', '', '1.88851', '1.2677', '71.3', '31.26', '3.19109', '40.04', '336.079', '58.428', '166.35', '', 'N3(/C/1=C\\2/C(=N\\C=C1)NC=C2)CCCCC3', 'c3cc(N1CCCCC1)c2cc[nH]c2n3', 'Coumpound 1_26403521', 'HE043492; KB-65546', 'Leucine-rich repeat serine/threonine-protein kinase 2', '20784468', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(329, '329', 'Not Available', 'CCN(C(C)C)c1ccnc2[nH]ccc12', '<I>N</I>-ethyl-<I>N</I>-isopropyl-1<I>H</I>-pyrrolo[2,3-b]pyridin-4-amine', 'CYAAFQwAGfwQQLA17zeUnvn0b75mZUQX7IyZkDN32I2mo9DhRwLKZK^LRVymqu0tszItWMAfD5Q$lbnSt76rz4Ww6LoVLpn6mbbax2VSeHjxSqXve4AaqulkM$uC8kPiYoLEqVOJMlzNApCVIs7lHi2eUk$fOo54omK1y1FFaWrQRdad1x$xQf3MX9S^PnXHYe$DE6im M3DO6uZTLfr7aTSlWvN94mT5dYS6$hl5nLyP2lfJ1H8PnOyd0xNL3foGl^P2jK3VePPDSZU5L^ua5uCrqDZOzAiLViwF7A$bYjM5gXVIbqlBrhQDIm8sDNraPIXaE7W7KAe1qnvUGcp5nTjv5D3GcoxiO5VAcu^BB0^lP6$0UA', 'InChI=1S/C12H17N3/c1-4-15(9(2)3)11-6-8-14-12-10(11)5-7-13-12/h5-9H,4H2,1-3H3,(H,13,14)', 'AuxInfo=1/1/N:4,1,15,5,12,8,13,10,2,7,6,9,14,11,3/E:(2,3)/rA:15CCNCCCCCCCNCCNC/rB:s1;s2;;s3s4;s3;s6;d+6;d-7;s8;s9d-10;s7;d-12;s9s13;s2;/rC:10.6538,-7.0818,0;10.6538,-7.9068,0;9.9393,-8.3193,0;9.2249,- 7.0818,0;9.2249,-7.9068,0;9.9393,-9.1442,0;10.6537,-9.5567,0;9.2248,-9.5567,0;10.6537,-10.3817,0;9.2248,-10.3817,0;9.9392,-10.7942,0;11.4384,-9.3018,0;11.9232,-9.9693,0;11.4384,-10.6367,0;11.6191,-8.2 298,0;', 'STAYGEDQLUAQDM-UHFFFAOYSA-N', '1010:51Q3KP3PHMTW2DP3GKDAJE5FWQQM2E', '[#6]-[#6](-[#6])-[#7](-[c]1:[c]:[c]:[n]:[c](:[n]:[c]:[c]2):[c]12)-[#6]-[#6]', 'CC(C)N(c1ccnc([nH]cc2)c12)CC', '02.409', '2.269', '0', '0', 'TRUE', '-4.95e-002\r\n8.6e-003\r\n-0.2721\r\n-5.21e-002\r\n4.e-004\r\n2.96e-002\r\n3.08e-002\r\n-2.49e-002\r\n0.1181\r\n3.03e-002\r\n-0.2439\r\n-3.93e-002\r\n-1.62e-002\r\n-0.2492\r\n-4.95e-002', '0', '2.41', 'C12H17N3', '0203.142', '-2.411', '0203.283', '1.98 4.8', '1', '1', '0', '6', '10', '2', '15', '16', '3', '4', '003', '01', '17', '0', '2', '003', '0031.92', '238', '', '', '', '', '', '', '', '', '', '', '', 'CC(N(CC)/C1=C/C=N\\C2=C1\\C=C/N2)C', 'CCN(c1ccnc2[nH]ccc12)C(C)C', 'Coumpound 2_26403521', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(330, '330', 'Not Available', 'COCCCNC(=O)c1cc2cc(C)cnc2nn1', '<I>N</I>-(3-methoxypropyl)-6-methyl-pyrido[2,3-c]pyridazine-3-carboxamide', 'CYAAFQwAmcwQSsOw5LHJp951r87iMMPMSr1iz2rh2SYOXEI4jrfqOl9xEDINnBqivc^mssOOn2H4TopKKtXWvhrTGfJxdrlLTj$ty7YWUweo0lEow6J3V$fAvIoURz4aGA08ohYyUABdEI3mrVjBmXA4LV5wz1uzkCDkXKD432LkIU^WE$Xndw^WsILNf^cc1fjC9Rt^ 6fApKTqWxLRCl5YHm6143nX9WGt69m2vvR0b7aOzK3cOddjOnL2cDGgvreKFGyT99dsOwHtjxcJ30rdR1hyxuvhjCcevvqv238NW73v$XH^urNd1zKbpyWCcFB$sAExZ4$CfErcY6nklBZRrZgopJpyINTzuGrXyTQ2lYmamtCB6p5pmiSjdjckZYZi4Ji6L8SNASTUa sv1VcGAv4Pup8vGrVDzALFL', 'InChI=1S/C13H16N4O2/c1-9-6-10-7-11(16-17-12(10)15-8-9)13(18)14-4-3-5-19-2/h6-8H,3-5H2,1-2H3,(H,14,18)', 'AuxInfo=1/1/N:7,18,15,14,16,1,10,5,3,2,8,4,12,13,6,9,11,19,17/rA:19CCCCCNCCNCNCNCCCOCO/rB:s1;d-1;d-2;s3;s4d-5;s3;;s8;s2d-8;s4d-9;s8;s12;s13;s14;s15;s16;s17;d12;/rC:10.1088,-8.8298,0;10.9338,-8.8298,0; 9.6963,-9.5442,0;11.3463,-9.5442,0;10.1088,-10.2587,0;10.9338,-10.2587,0;8.8713,-9.5442,0;12.1713,-8.1152,0;12.5838,-8.8298,0;11.3463,-8.1152,0;12.1713,-9.5442,0;12.5838,-7.4008,0;13.4088,-7.4008,0;13 .8213,-6.6863,0;14.6463,-6.6863,0;15.0588,-5.9718,0;15.8838,-5.9718,0;16.2963,-5.2574,0;12.1713,', 'IMSNNAKJWPTGKK-UHFFFAOYSA-N', '1010:UUJPDMXV3HRYXBR8NKS7ENJH6P526D', '[c]1:[c](-[#6]):[c]:[n]:[c](:[c]1:[c]:[c]2-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#8]-[#6]):[n]:[n]2', 'c1c(C)cnc(c1cc2C(=O)NCCCOC)nn2', '00.648', '0.909', '0', '0', 'TRUE', '-4.66e-002\r\n2.37e-002\r\n-3.2e-002\r\n0.1812\r\n3.23e-002\r\n-0.2348\r\n-3.83e-002\r\n0.1487\r\n-0.1433\r\n-1.8e-002\r\n-0.1293\r\n0.2634\r\n-0.3099\r\n1.35e-002\r\n-1.4e-002\r\n4.76e-002\r\n-0.3847\r\n3.54e-002\r\n-0.2701', '0', '0.708', 'C13H16N4O2', '0260.127', '-3.211', '0260.292', '1.5 6.41', '5', '1', '1', '8', '11', '2', '19', '20', '3', '6', '006', '01', '16', '0', '2', '005', '0077', '285.51', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C(C)/C=N\\C\\2=C1\\C=C(C(NCCCOC)=O)/N=N2', 'COCCCNC(=O)c2cc1cc(C)cnc1nn2', 'Coumpound 3_26403521', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(331, '331', 'Not Available', 'Brc1ccc2c(n[nH]c2n1)N3CCOCC3', '4-(6-bromo-1<I>H</I>-pyrazolo[3,4-b]pyridin-3-yl)morpholine', 'CYAAFQwAldwQGPBNQqNE$Ucl20euL^jdUpI06UqGXhPVvmrzHBrrk3Ypv2d49rtyXiVvOA2OdbGB$ShD0EGGXCkX4jsLHKzpfLR$1e5BRZqheMNMYR0Ab76JmV2lOrM88wfuyNEkwsbKsxUJHKQJgveODrtHic2sw0z1kaBDqbIeVzWv^TxIp^2HRo8bXr4aDvv$84^O dey1KA25YU^mbyUWyq8pR$YVbyHVvLyQUtCniw5pbemelPkne0sms^dq4A9jC4v170oJaKy9inHuC3zt1EMqbn6zId$uF7Vd7pNa$$7TYH6AZeo3dfOaexafqzob1AiL6ag4AEIcQvH41MfVuEimkuQBYtQhqB8XRFgsFkmHKFk7fFgcotgkwZXS72RKLnrA28B^4RAe G7BOGz72uu7bLpJ', 'InChI=1S/C10H11BrN4O/c11-8-2-1-7-9(12-8)13-14-10(7)15-3-5-16-6-4-15/h1-2H,3-6H2,(H,12,13,14)', 'AuxInfo=1/1/N:1,3,11,12,13,14,2,5,4,7,16,6,9,8,10,15/E:(3,4)(5,6)/rA:16CCCCCNCNNNCCCCOBr/rB:s1;d-1;d-2;s3;s4d-5;s2;d-7;s4s8;s7;s10;s10;s11;s12;s13s14;s5;/rC:10.1088,-8.8298,0;10.9338,-8.8298,0;9.6963, -9.5443,0;11.3463,-9.5443,0;10.1088,-10.2587,0;10.9338,-10.2587,0;11.4858,-8.2167,0;12.2395,-8.5523,0;12.1534,-9.3727,0;11.3143,-7.4097,0;10.5297,-7.1547,0;11.9275,-6.8577,0;10.3582,-6.3477,0;11.756,- 6.0507,0;10.9714,-5.7957,0;9.6317,-10.9935,0;', 'UNJIOWCWRWGKAM-UHFFFAOYSA-N', '1010:ZXPJT3TCK3HPQPYRFNJ4HHYV6V9AFB', '[c]1:[c]:[c](-[#35]):[n]:[c](:[n]:[n]:[c]2-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]3):[c]12', 'c1cc(Br)nc([nH]nc2N3CCOCC3)c12', '01.893', '1.754', '0', '0', 'TRUE', '-4.58e-002\r\n5.16e-002\r\n-2.84e-002\r\n0.1369\r\n0.1076\r\n-0.2271\r\n0.1337\r\n-0.1831\r\n-0.1633\r\n-0.2531\r\n2.81e-002\r\n2.81e-002\r\n5.98e-002\r\n5.98e-002\r\n-0.3787\r\n-2.87e-002', '0', '1.893', 'C10H11BrN4O', '0282.012', '-2.052', '0283.125', '-0.78 0.51', '3', '1', '0', '8', '10', '2', '16', '18', '2', '4', '005', '01', '11', '0', '3', '001', '0054.04', '231.28', '', '', '', '', '', '', '', '', '', '', '', 'C/1=C/C(Br)=N\\C3=C1\\C(N2CCOCC2)=N/N3', 'Brc3ccc2c(N1CCOCC1)n[nH]c2n3', 'Coumpound 4_26403521', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(332, '332', 'Not Available', 'CC1CNCCN1S(=O)(=O)c2cccc3cncc(C)c23', '4-methyl-5-(2-methylpiperazin-1-yl)sulfonyl-isoquinoline', 'CYAAFQwA9dwQdfxWjk3GWPr1R6Rh3lbXf$V7QhUGoQNsDOAQubzRe4w$YW38fgSL1Jgo5^hoyXqxuVGGDSougRQZaCzpr5IBUkuS1E88GmIIgGaC0YasSsu8khfELyORHbsSnAAIsNkQDl9YE21kOg5FEP$^XYSpsrQTJ1s8iTCTJy9RwhNyLGJxGm^$UenFLwwTslfr yO6gyP95YRH3s7zzvM1Youz5d07ZGK855DtYeorL5c657yFrJ28DprOb0Xe$fmYw$io$x9UmMhj1X5u0P^Nr4S7N3z3uws43My1T^qH3J9RJccOnz9t2J^mfPkqpVgucl7793ckkxR4cxu8n79fKjD3k8xS3IsYNKk7oxB2vd4J3NKi1Jxo5gMbNV1MHoJMiHBZKZs$T vU4phWhZEXFmRoiYKFkFoYG5iKd6aYMM6g4pAeTncH$1Vf$PSEw^mTcj', 'InChI=1S/C15H19N3O2S/c1-11-8-17-10-13-4-3-5-14(15(11)13)21(19,20)18-7-6-16-9-12(18)2/h3-5,8,10,12,16H,6-7,9H2,1-2H3', 'AuxInfo=1/0/N:18,19,8,7,10,15,17,6,12,3,4,14,1,9,2,13,5,16,20,21,11/E:(19,20)/CRV:21.6/rA:21CCCCNCCCCCSCNCCNCCCOO/rB:s1;d-1;d-2;s3;s4d-5;s1;d-7;s2;s8d-9;s9;;s12;s12;s13;s11s14;s15s16;s4;s14;d11;d11;/r C:8.5769,-10.1237,0;8.5769,-10.9487,0;7.8624,-9.7112,0;7.8624,-11.3612,0;7.1479,-10.1237,0;7.1479,-10.9487,0;9.2914,-9.7113,0;10.0058,-10.1238,0;9.2913,-11.3612,0;10.0058,-10.9488,0;9.3534,-12.1763,0; 12.364,-12.1713,0;12.364,-12.9963,0;11.6495,-11.7588,0;11.6495,-13.4089,0;10.935,-12.1713,0;10.9', 'TZMWPNOFFYPOEV-UHFFFAOYSA-N', '1010:QK2B8MGSK7C7VTA4FPN4QJ3T6GX9BS', '[c]12:[c](:[c](-[#16](=[#8])(=[#8])-[#7](-[#6]-[#6]-[#7]3)-[#6](-[#6])-[#6]3):[c]:[c]:[c]1):[c](-[#6]):[c]:[n]:[c]2', 'c12c(c(S(=O)(=O)N(CCN3)C(C)C3)ccc1)c(C)cnc2', '00.989', '0.989', '0', '0', 'TRUE', '-1.e-003\r\n-2.18e-002\r\n3.45e-002\r\n-2.62e-002\r\n-0.2638\r\n3.02e-002\r\n-5.3e-002\r\n-6.28e-002\r\n-3.33e-002\r\n-7.11e-002\r\n1.418\r\n8.3e-003\r\n-0.3141\r\n-2.6e-003\r\n5.7e-003\r\n-0.3523\r\n-1.14e-002\r\n-3.77e-002\r\n-5.06e-002\r\n-0.5684\r\n-0.5684', '0', '0.466', 'C15H19N3O2S', '0305.12', '-3.256', '0305.395', '5.99 7.92', '3', '1', '2', '10', '11', '2', '21', '23', '5', '7', '005', '01', '19', '0', '3', '002', '0070.68', '305.98', '', '', '', '', '', '', '', '', '', '', '', 'C/1\\3=C/N=C\\C(C)=C1\\C(S(N2C(C)CNCC2)(=O)=O)=C/C=C3', 'Cc2cncc3cccc(S(=O)(=O)N1CCNCC1C)c23', 'Coumpound 5_26403521', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(333, '333', 'Not Available', 'CCN(CC)c1cc(C)nn2cnnc12', '<I>N</I>,<I>N</I>-diethyl-6-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-amine', 'CYAAFQwA5fwQ8HKk16zYIrMWTE273sRvU8fnMtbxHifKtJYS1WytAjwKg7ySo3wgiKuBiwQMPiLdh19nKfPW8bat5hSU4BSuTUWNVvtm^v7s9PUVZEp^oWmVJwnKimZETQFkGD2ekzK4kLcPBxrEAzfPQobCc7$etFxczLF94KNxwdrleHjg5dXcxY4I1v3uTxdL99Qf shOxxNbzm8QtnGEt7js$Wqf1RFMP3^OLoh$Se^6KUwxMfffV8O3I89e05t3LVebP9B1F$$Pslc8WMvMgvWqwflgsikKTkYOzGPMfcopsiPd6haGbWQbfKY$UnYGmFgbrLVBpmg97Xnh0$Lk04o6ifybA1Y$jDMXDPSHTWA', 'InChI=1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-15-7-11-12-10(9)15/h6-7H,4-5H2,1-3H3', 'AuxInfo=1/0/N:12,14,15,11,13,5,9,6,3,1,8,7,4,10,2/E:(1,2)(4,5)/rA:15CNCNCCNNCNCCCCC/rB:s1;s1;s2;d-3;d-4s5;d-1;s7;s2d-8;s3;s10;s11;s10;s13;s6;/rC:9.0996,-11.6432,0;9.0996,-12.4682,0;8.3852,-11.2307,0;8 .3852,-12.8807,0;7.6707,-11.6432,0;7.6707,-12.4682,0;9.8843,-11.3882,0;10.3692,-12.0557,0;9.8843,-12.7231,0;8.3852,-10.4057,0;9.0996,-9.9932,0;9.0996,-9.1682,0;7.6707,-9.9932,0;7.6707,-9.1682,0;6.9563 ,-12.8807,0;', 'WJNHXUKNOCPMOR-UHFFFAOYSA-N', '1010:6T5NNEVCXDS81WCK1H1R6V6FV2DB19', '[c]12:[n](:[c]:[n]:[n]1):[n]:[c](-[#6]):[c]:[c]2-[#7](-[#6]-[#6])-[#6]-[#6]', 'c12n(cnn1)nc(C)cc2N(CC)CC', '01.3', '1.561', '0', '0', 'TRUE', '0.1747\r\n-0.1036\r\n6.08e-002\r\n-0.192\r\n-1.8e-002\r\n5.45e-002\r\n-0.1338\r\n-0.1429\r\n0.1213\r\n-0.2727\r\n2.e-004\r\n-5.21e-002\r\n2.e-004\r\n-5.21e-002\r\n-2.09e-002', '0', '1.295', 'C10H15N5', '0205.133', '-1.117', '0205.26', '5.56', '3', '0', '0', '6', '10', '2', '15', '16', '3', '4', '005', '00', '15', '0', '2', '003', '0046.32', '236.54', '', '', '', '', '', '', '', '', '', '', '', 'C/12=N/N=C\\N1/N=C(C)\\C=C2\\N(CC)CC', 'CCN(CC)c1cc(C)nn2cnnc12', 'Coumpound 6_26403521', 'Not Available', 'Leucine-rich repeat serine/threonine-protein kinase 2', 'Not Available', 'Under Investigation', 'Parkinson Disease(PARK)', '26403521', 'Parkinson Disease(PARK)', 'PARK'),
(334, '4011297', '4011297', 'Cc1cc(C)c(OCC(=O)Nc2nc(cs2)c3ccccn3)c(C)c1', '<I>N</I>-[4-(2-pyridyl)thiazol-2-yl]-2-(2,4,6-trimethylphenoxy)acetamide', 'CYAAFQwArewQEJ4jlf^5GSNLWupRdguEvkYINHPkjvZcRR4DlC88Y2m5e3aRJCTfWcTSMWFpCeWpr^RAMlw^UVAGMtq9I$FZlrCyacEP^$6YV$BRlXHYP7JlkIJJLTwpqp377kerfCYA092TtbGqab2bw9GmJtGAfk67ExrbpZwRHRAv6LllRB4Ghfm$iPbtg7^aoRVA FiP8OZ05Qi3bzyYVvyL59^8K$WuF1A0yRAOe5jH3cQKYm3qlqfR44fZjWrCqZX0dj8sBlvW^yscSUlrdBgUjHVZ4PxjEOdGp42C6RJf84NEMPI587o4vCj8DIrhHwvE8wOuyYK25LnnflO^wn2py9wBCv48BMSDPWCou1Pn384OESB7O1vAds9q6KyDPeWXCJnl4scj1 g11WXsZ6XTfbj7XBs2Qev5OcGyFTeanXwE15MIF986lpeezMtAlHguo$8dwUN9$jEfLfyDKfcPVpsURedx89pEDO6WC4vx78', 'InChI=1S/C19H19N3O2S/c1-12-8-13(2)18(14(3)9-12)24-10-17(23)22-19-21-16(11-25-19)15-6-4-5-7-20-15/h4-9,11H,10H2,1-3H3,(H,21,22,23)', 'AuxInfo=1/1/N:15,13,14,23,24,22,25,11,12,16,21,10,8,9,20,19,17,7,18,6,5,4,3,2,1/E:(2,3)(8,9)(13,14)/rA:44SOONNNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;;;;s2;d+7;s7;;s8d-10;d-9s10;s8;s9;s10;s2;d3s4 s16;s1s4d-5;s5;s6s19;s1d-19;d-20;s22;d-23;d-6s24;s11;s12;s13;s13;s13;s14;s14;s14;s15;s15;s15;s16;s16;s4;s21;s22;s23;s24;s25;/rC:-2.5565,-2.885,-.0357;2.6045,.6477,.0082;-.0482,1.0272,.0032;-.477,-1.28 91,-.0232;-2.6753,-.3029,-.0077;-6.3126,-.4896,.0009;3.9548,.4538,.0072;4.6478,.3795,-1.201;4.64', 'GFIBBYANFXZDMS-UHFFFAOYSA-N', '1010:7BXSGQWFVDTVNUAZAPB7QQ5X56HK3B', '[s]1:[c](-[#1]):[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[n]2):[n]:[c]1-[#7](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#8]-[c]3:[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1 ]):[c](-[#1]):[c]3-[#6](-[#1])(-[#1])-[#1])=[#8]', 's1c([H])c(c2c([H])c([H])c([H])c([H])n2)nc1N([H])C(C([H])([H])Oc3c(C([H])([H])[H])c([H])c(C([H])([H])[H])c([H])c3C([H])([H])[H])=O', '04.13', '4.323', '0', '0', 'TRUE', '-5.99e-002\r\n-0.336\r\n-0.2746\r\n-0.2622\r\n-0.2237\r\n-0.2546\r\n8.14e-002\r\n-2.03e-002\r\n-2.03e-002\r\n-5.05e-002\r\n-5.38e-002\r\n-5.38e-002\r\n-3.72e-002\r\n-3.72e-002\r\n-3.98e-002\r\n0.1302\r\n0.244\r\n0.1639\r\n9.81e-002\r\n8.92e-002\r\n6.7e-003\r\n-3.42e-002\r\n-5.86e-002\r\n-4.38e-002\r\n2', '0', '4.177', 'C19H19N3O2S', '0353.12', '-6.032', '0353.438', '4.65 7.34', '4', '1', '1', '9', '17', '3', '25', '27', '25', '9', '005', '01', '19', '0', '3', '005', '0092.35', '370.75', '', '3.09585', '1.2825', '68.64', '24.82', '5.45438', '43.82', '1,915.32', '122.002', '282.28', '179.97', 'S/3/C(NC(=O)COC1=C(C)C=C(C)C=C1C)=N\\C(\\C\\2=C\\C=C/C=N2)=C3', 'Cc3cc(C)c(OCC(=O)Nc2nc(c1ccccn1)cs2)c(C)c3', 'CPN-9', 'AC1N1UIO; KB-271985', 'Nuclear factor erythroid 2-related factor 2', '4011297', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '23000247', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(335, '146782', '146782', 'CCN(CC)S(=O)(=O)N[C@H]1C[C@@H]2[C@@H](Cc3cn(CC)c4cccc2c34)N(C)C1', '(6<I>a</I><I>R</I>,9<I>S</I>,10<I>a</I><I>S</I>)-9-(diethylsulfamoylamino)-4-ethyl-7-methyl-6,6<I>a</I>,8,9,10,10<I>a</I>-hexahydroindolo[4,3-fg]quinoline', 'CYAAFQwADfwQgzgBdBmGd1tKxS50WENJn8bbycVzj0^05FYWVc$TXq21$tac2fZrnzXWkKzaRFMhlojTY6nl1V7qk0I^hoIY1XcLMWMumop34UZ8GKzYnf6JUgysgLV5zPM^jv$^vUu74CoAq7zXaDQwRF8v8xWxrE1Qwo83KybkpYclf35OgAF8s^XKEbIv4paeDZoe OTvwV8xCj$Hs0XzoUvZ8rXuyDNqyeL0mhRLQgR5j6V54NKCG$55U3KeHc4Zz51CyZ4s56W9HjO42dRWmPuKRNgEjl92y82$LYewg0F81dDXqp^vVN5VnJK$uerktm7daweenx1LKLm25QK^T74mfqGj4b4GOu31n4PZWQvrZKXWEdGjiuq33xpXLSF4i9SRIiiLMb7rJ Ya88ZA6p$mxKqT^8aWbrMgWVqNvssPPeflKv62mGOhy1PkYohJSFYUhqs^H$Gla5WNKC5GVIyc0xhWINZHdq9zFy36Rzo3YU', 'InChI=1S/C21H32N4O2S/c1-5-24-13-15-11-20-18(17-9-8-10-19(24)21(15)17)12-16(14-23(20)4)22-28(26,27)25(6-2)7-3/h8-10,13,16,18,20,22H,5-7,11-12,14H2,1-4H3/t16-,18-,20+/m0/s1', 'AuxInfo=1/0/N:24,27,28,18,23,25,26,22,20,21,12,10,19,14,16,11,13,8,17,9,15,5,4,6,7,2,3,1/E:(2,3)(6,7)(26,27)/it:im/CRV:28.6/rA:60SOONNNNC.eC.eCC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:d 1;d1;;s1;;s1;;s4s8;s8;s5s10;s9;s8;s4s11;d-13;s12s15;s6s15;s4;s6d+16;s13;d+17;d-20s21;s6;s23;s7;s7;s25;s26;s8;s9;s10;s10;s11;s12;s12;s14;s14;s5;s18;s18;s18;s19;s20;s21;s22;s23;s23;s24;s24;s24;s25;s25;s 26;s26;s27;s27;s27;s28;s28;s28;/rC:-4.3006,-.4588,-.1568;-4.4142,-.3922,-1.6025;-4.7123,-1.661,.', 'ARTRTLXKTHJPRW-XKGZKEIXSA-N', '1010:3SBUYMTM3VCB5GGS7NN3CY5YZCNGH3', '[#16](-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])(-[#7](-[#1])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#6 @]2(-[#1])-[#6@@]1(-[#1])-[#6](-[#1])(-[#1])-[c](:[c](-[#1]):[n]3-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](:[c]3:[c](-[#1]):[c](-[#1]):[c]4-[#1]):[c]24)(=[#8])=[#8]', 'S(N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])(N([H])[C@]([H])(C([H])([H])N1C([H])([H])[H])C([H])([H])[C@]2([H])[C@@]1([H])C([H])([H])c(c([H])n3C([H])([H])C([H])([H])[H])c(c3c([H])c([H])c4[H ])c24)(=O)=O', '02.384', '2.384', '0', '0', 'TRUE', '1.529\r\n-0.5611\r\n-0.5611\r\n-0.3011\r\n-0.3586\r\n-0.2511\r\n-0.349\r\n1.8e-003\r\n2.03e-002\r\n-3.03e-002\r\n-7.e-004\r\n-1.e-002\r\n-3.41e-002\r\n1.14e-002\r\n6.e-004\r\n-2.62e-002\r\n2.9e-002\r\n-1.3e-002\r\n-1.14e-002\r\n-5.8e-002\r\n-4.31e-002\r\n-6.04e-002\r\n4.6e-003\r\n-5.17e-002\r\n-2.67e-002\r\n-2.67e-002\r\n-5.48e-002\r\n-5.48e-002\r\n3.69e-002\r\n4.76e-002\r\n2.88e-002\r\n2.88e-002\r\n4.54e-002\r\n3.32e-002\r\n3.32e-002\r\n4.45e-002\r\n4.45e-002\r\n9.21e-002\r\n3.94e-002\r\n3.94e-002\r\n3.94e-002\r\n7.58e-002\r\n6.25e-002\r\n6.39e-002\r\n6.23e-002\r\n4.35e-002\r\n4.35e-0', '1', '1.158', 'C21H32N4O2S', '0404.225', '-4.572', '0404.569', '3.14 8.86', '2', '1', '2', '19', '10', '2', '28', '31', '38', '6', '006', '01', '32', '0', '4', '006', '0065.96', '422.34', '', '3.1798', '1.2836', '60.23', '30.75', '4.87034', '29.48', '1,681.37', '73.397', '337.16', '', 'S(=O)(=O)(NC1CC/2C(N(C)C1)C/C3=C/N(CC)/C/4=C/C=C\\C2=C34)N(CC)CC', 'CCN(CC)S(=O)(=O)N[C@H]4C[C@H]3c1cccc2c1c(cn2CC)C[C@H]3N(C)C4', 'CQA-206-291', 'AC1L3TWB', 'D(2) dopamine receptor', '146782', 'Under Investigation', 'Parkinson Disease(PARK)', '2208182', 'Parkinson Disease(PARK)', 'PARK');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(336, '586', '586', 'CN(CC(=O)O)C(=N)N', '2-[carbamimidoyl(methyl)amino]acetic acid', 'CYAAFQwA0ewQddHu4kKOSUMQjhQese9Ql7weadzXnHaSCZwI6r7XOkrXshFaDZlbXT9$shf78VSX80HbM9MGrh14E1TbJs2386l2meCky9ISSCaARzDwAQ$rOnHewHRExFxmvVR3ZoUotOMfIyIS$Fxwu9EQF3GHIcPjizyNU4UflR86qpirsS55xlj97iHFZxrchEc5 M8YoXuBjXi5eUlrHE5^HyIObGW51lp6PMHFc2nW4OH95D5$mcsPn9pTcVdvmaFrowiI9YjD3RXZXWQbNM6Q7R4M6Vb^CjpMiB86D5M^rU3HzYI7c8WBnbm7cUvR9wlPbTEsige^tw5r9bhsOk4A6xFzzSlJtXxR6BO8wxzMyq3iVG7Qc2P3wkJOdqz9KTURZHFXivGnF $S9xpbxqW^B6yewGxVda6Y4qiwpvZGnOd3uHH4fR2C$hk1lwxy$FvKskpws49CysAOriPwoN1cWQxo9uKwLIHigeOZY^RdVI', 'InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)', 'AuxInfo=1/1/N:7,6,9,8,4,5,3,1,2/E:(5,6)(8,9)/rA:18OONNNCCCCHHHHHHHHH/rB:;;;;s3;s3;s3s4d+5;s1d2s6;s6;s6;s7;s7;s7;s4;s4;s5;s1;/rC:2.9551,-.4391,-.297;1.4662,.0437,1.3508;-.5505,.5168,-.3703;-2.6825,.010 7,.5093;-1.3674,-1.7387,-.2336;.7512,.1847,-.9467;-.7951,1.9372,-.1268;-1.5112,-.4512,-.0468;1.7341,-.0641,.1611;1.123,.9982,-1.5789;.6771,-.7169,-1.564;.0646,2.555,-.4092;-.9812,2.1203,.9368;-1.6514, 2.286,-.7133;-2.8698,.992,.6751;-3.4214,-.6339,.7699;-2.2162,-2.2151,.0899;3.5857,-.6055,.4359;', 'CVSVTCORWBXHQV-UHFFFAOYSA-N', '1010:HPAANMTA44QBRHTFN9VS5U7MT157HF', '[#8](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#7](-[#6](=[#7]-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]', 'O([H])C(C([H])([H])N(C(=N[H])N([H])[H])C([H])([H])[H])=O', '-01.095', '-1.095', '0', '0', 'TRUE', '-0.3308\r\n-0.2653\r\n-0.2435\r\n-0.2775\r\n-0.2794\r\n9.11e-002\r\n-5.6e-003\r\n0.1441\r\n0.2729\r\n5.44e-002\r\n5.44e-002\r\n3.99e-002\r\n3.99e-002\r\n3.99e-002\r\n0.1267\r\n0.1267\r\n0.1899\r\n0.2222', '0', '-2.671', 'C4H9N3O2', '0131.069', '0.759', '0131.133', '2.63 9.46', '1', '1', '2', '6', '00', '0', '9', '8', '13', '2', '005', '04', '9', '0', '0', '003', '0090.41', '163.52', '', '1.61426', '1.2119', '11.97', '0.03', '2.46795', '11.94', '124.844', '187.322', '103.58', '', 'OC(=O)CN(C)C(N)=N', 'CN(CC(=O)O)C(=N)N', 'Creatine', 'Krebiozon; Kreatin; N-amidinosarcosine; Pyrolysate; PhosphagenW-105270', 'Creatine kinase M-type', '586', 'Phase II Completed', 'Amyotrophic Lateral Sclerosis (ALS)', '28980128', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(337, '586', '586', 'CN(CC(=O)O)C(=N)N', '2-[carbamimidoyl(methyl)amino]acetic acid', 'CYAAFQwA0ewQddHu4kKOSUMQjhQese9Ql7weadzXnHaSCZwI6r7XOkrXshFaDZlbXT9$shf78VSX80HbM9MGrh14E1TbJs2386l2meCky9ISSCaARzDwAQ$rOnHewHRExFxmvVR3ZoUotOMfIyIS$Fxwu9EQF3GHIcPjizyNU4UflR86qpirsS55xlj97iHFZxrchEc5 M8YoXuBjXi5eUlrHE5^HyIObGW51lp6PMHFc2nW4OH95D5$mcsPn9pTcVdvmaFrowiI9YjD3RXZXWQbNM6Q7R4M6Vb^CjpMiB86D5M^rU3HzYI7c8WBnbm7cUvR9wlPbTEsige^tw5r9bhsOk4A6xFzzSlJtXxR6BO8wxzMyq3iVG7Qc2P3wkJOdqz9KTURZHFXivGnF $S9xpbxqW^B6yewGxVda6Y4qiwpvZGnOd3uHH4fR2C$hk1lwxy$FvKskpws49CysAOriPwoN1cWQxo9uKwLIHigeOZY^RdVI', 'InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)', 'AuxInfo=1/1/N:7,6,9,8,4,5,3,1,2/E:(5,6)(8,9)/rA:18OONNNCCCCHHHHHHHHH/rB:;;;;s3;s3;s3s4d+5;s1d2s6;s6;s6;s7;s7;s7;s4;s4;s5;s1;/rC:2.9551,-.4391,-.297;1.4662,.0437,1.3508;-.5505,.5168,-.3703;-2.6825,.010 7,.5093;-1.3674,-1.7387,-.2336;.7512,.1847,-.9467;-.7951,1.9372,-.1268;-1.5112,-.4512,-.0468;1.7341,-.0641,.1611;1.123,.9982,-1.5789;.6771,-.7169,-1.564;.0646,2.555,-.4092;-.9812,2.1203,.9368;-1.6514, 2.286,-.7133;-2.8698,.992,.6751;-3.4214,-.6339,.7699;-2.2162,-2.2151,.0899;3.5857,-.6055,.4359;', 'CVSVTCORWBXHQV-UHFFFAOYSA-N', '1010:HPAANMTA44QBRHTFN9VS5U7MT157HF', '[#8](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#7](-[#6](=[#7]-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]', 'O([H])C(C([H])([H])N(C(=N[H])N([H])[H])C([H])([H])[H])=O', '-01.095', '-1.095', '0', '0', 'TRUE', '-0.3308\r\n-0.2653\r\n-0.2435\r\n-0.2775\r\n-0.2794\r\n9.11e-002\r\n-5.6e-003\r\n0.1441\r\n0.2729\r\n5.44e-002\r\n5.44e-002\r\n3.99e-002\r\n3.99e-002\r\n3.99e-002\r\n0.1267\r\n0.1267\r\n0.1899\r\n0.2222', '0', '-2.671', 'C4H9N3O2', '0131.069', '0.759', '0131.133', '2.63 9.46', '1', '1', '2', '6', '00', '0', '9', '8', '13', '2', '005', '04', '9', '0', '0', '003', '0090.41', '163.52', '', '1.61426', '1.2119', '11.97', '0.03', '2.46795', '11.94', '124.844', '187.322', '103.58', '', 'OC(=O)CN(C)C(N)=N', 'CN(CC(=O)O)C(=N)N', 'Creatine', 'Krebiozon; Kreatin; N-amidinosarcosine; Pyrolysate; PhosphagenW-105270', 'Creatine kinase M-type', '586', 'Phase III Completed', 'Parkinson Disease(PARK)', '24934384', 'Parkinson Disease(PARK)', 'PARK'),
(338, '80116', '80116', 'CN(CC(=O)O)C(=N)N', '2-[carbamimidoyl(methyl)amino]acetic acid', 'CYAAFQwA0ewQddHu4kKOSUMQjhQese9Ql7weadzXnHaSCZwI6r7XOkrXshFaDZlbXT9$shf78VSX80HbM9MGrh14E1TbJs2386l2meCky9ISSCaARzDwAQ$rOnHewHRExFxmvVR3ZoUotOMfIyIS$Fxwu9EQF3GHIcPjizyNU4UflR86qpirsS55xlj97iHFZxrchEc5 M8YoXuBjXi5eUlrHE5^HyIObGW51lp6PMHFc2nW4OH95D5$mcsPn9pTcVdvmaFrowiI9YjD3RXZXWQbNM6Q7R4M6Vb^CjpMiB86D5M^rU3HzYI7c8WBnbm7cUvR9wlPbTEsige^tw5r9bhsOk4A6xFzzSlJtXxR6BO8wxzMyq3iVG7Qc2P3wkJOdqz9KTURZHFXivGnF $S9xpbxqW^B6yewGxVda6Y4qiwpvZGnOd3uHH4fR2C$hk1lwxy$FvKskpws49CysAOriPwoN1cWQxo9uKwLIHigeOZY^RdVI', 'InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)', 'AuxInfo=1/1/N:7,6,9,8,4,5,3,1,2/E:(5,6)(8,9)/rA:18OONNNCCCCHHHHHHHHH/rB:;;;;s3;s3;s3s4d+5;s1d2s6;s6;s6;s7;s7;s7;s4;s4;s5;s1;/rC:2.9551,-.4391,-.297;1.4662,.0437,1.3508;-.5505,.5168,-.3703;-2.6825,.010 7,.5093;-1.3674,-1.7387,-.2336;.7512,.1847,-.9467;-.7951,1.9372,-.1268;-1.5112,-.4512,-.0468;1.7341,-.0641,.1611;1.123,.9982,-1.5789;.6771,-.7169,-1.564;.0646,2.555,-.4092;-.9812,2.1203,.9368;-1.6514, 2.286,-.7133;-2.8698,.992,.6751;-3.4214,-.6339,.7699;-2.2162,-2.2151,.0899;3.5857,-.6055,.4359;', 'CVSVTCORWBXHQV-UHFFFAOYSA-N', '1010:HPAANMTA44QBRHTFN9VS5U7MT157HF', '[#8](-[#1])-[#6](-[#6](-[#1])(-[#1])-[#7](-[#6](=[#7]-[#1])-[#7](-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]', 'O([H])C(C([H])([H])N(C(=N[H])N([H])[H])C([H])([H])[H])=O', '-01.095', '-1.095', '0', '0', 'TRUE', '-0.3308\r\n-0.2653\r\n-0.2435\r\n-0.2775\r\n-0.2794\r\n9.11e-002\r\n-5.6e-003\r\n0.1441\r\n0.2729\r\n5.44e-002\r\n5.44e-002\r\n3.99e-002\r\n3.99e-002\r\n3.99e-002\r\n0.1267\r\n0.1267\r\n0.1899\r\n0.2222', '0', '-2.671', 'C4H9N3O2', '0131.069', '0.759', '0131.133', '2.63 9.46', '1', '1', '2', '6', '00', '0', '9', '8', '13', '2', '005', '04', '9', '0', '0', '003', '0090.41', '163.52', '', '1.61426', '1.2119', '11.97', '0.03', '2.46795', '11.94', '124.844', '187.322', '103.58', '', 'OC(=O)CN(C)C(N)=N', 'CN(CC(=O)O)C(=N)N', 'Creatine Monohydrate', 'Creatine hydrate; N-amidinosarcosine; AK158914; GE9561', 'Creatine kinase M-type', '80116', 'Terminated at Phase III', 'Huntington Disease (HD)', '24510496', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(339, '27503', '27503', 'OC(COc1cccc2OC(=CC(=O)c12)C(=O)O)COc3cccc4OC(=CC(=O)c34)C(=O)O', '5-[3-(2-carboxy-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylic acid', 'CYAAFQwAmfwQd51cBpAbsvlM8CnzWoNJ$P87RAS9ZTrfI3KYHC9J1Ki8MFkFCOxt^wz1pwJYcl5fLQhtMNHdXUNjfxwXkD0mlgSVIAl4aEcZgUlsQNjXrvM8KSRVwlic$s7$yXbrAFwNf$CnaBAd2dSzB458hW1hJfk8v2zwaFA4aOfL7^cSSNKhnnL1ewTD0IXe84sF WyvrUr8JJNekdbGkZFuVi^wlBIp2ET9KdH2cUxY8wMl$8BeB2PtYDOKx$rnqWai6VJKymwrdSCbdmB4w$SyHDNZ8yoWpIDVZBDhP8hnn^eGCNhHfxJUXjLLbMBcWyDbXtzA5ndc2rp01dxs6XEVj^en$wPv32YOQgBQGCtk9Lws$YLjz265RJPlRH3mK1VxaPcqIcQm$ XHZ4oVRNod$Uo$JJx^TI9cjoE8wpQ^wpHlY^Ya1BCD3UX0vN41uY97DanwmQ2a2vdmy4kfmbIzZ6f17kZ7TbND3oOZ0sg^7e', 'InChI=1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)', 'AuxInfo=1/1/N:27,28,21,22,25,26,29,30,13,14,12,23,24,15,16,19,20,31,32,17,18,33,34,3,6,7,8,10,9,11,1,2,4,5/E:(1,2)(3,4)(5,6)(7,8)(9,10)(12,13)(14,15)(16,17)(18,19)(20,21)(22,23)(25,26)(27,28,29,30)(31 ,32)(33,34)/gE:(1,2)/rA:50OOOOOOOOOOOCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;s3;s1s12;s2s12;s1;s2;s15;s16;s4d+17;s5d+18;d+15;d+16;d6s17;d7s18;s19;s20;s21d-25;s22d-26;s23;s24;s4d-29;s5d-30 ;s8d10s31;s9d11s32;s12;s13;s13;s14;s14;s21;s22;s25;s26;s27;s28;s3;s29;s30;s8;s9;/rC:-2.0176,-2.3', 'IMZMKUWMOSJXDT-UHFFFAOYSA-N', '1010:SZTVM6JYDKJ72BW3S94MP1T8BXAY87', '[#8](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2:[c]1-[#6](-[#6](-[#1])=[#6](-[#6](=[#8])-[#8]-[#1])-[#8]2)=[#8])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#8]-[c]3:[c](-[#1]):[c](-[#1]):[c] (-[#1]):[c]4:[c]3-[#6](-[#6](-[#1])=[#6](-[#6](=[#8])-[#8]-[#1])-[#8]4)=[#8])-[#8]-[#1]', 'O(c1c([H])c([H])c([H])c2c1C(C([H])=C(C(=O)O[H])O2)=O)C([H])([H])C([H])(C([H])([H])Oc3c([H])c([H])c([H])c4c3C(C([H])=C(C(=O)O[H])O4)=O)O[H]', '01.77', '1.77', '0', '0', 'TRUE', '-0.3425\r\n-0.3425\r\n-0.3883\r\n-0.3031\r\n-0.3031\r\n-0.289\r\n-0.289\r\n-0.3263\r\n-0.3263\r\n-0.2585\r\n-0.2585\r\n0.1016\r\n8.15e-002\r\n8.15e-002\r\n8.88e-002\r\n8.88e-002\r\n8.3e-002\r\n8.3e-002\r\n9.61e-002\r\n9.61e-002\r\n-3.09e-002\r\n-3.09e-002\r\n0.1935\r\n0.1935\r\n-3.03e-002\r\n-3.03e-002\r\n', '0', '-1.178', 'C23H16O11', '0468.069', '-4.243', '0468.367', '1.73 1.73', '8', '1', '6', '19', '12', '2', '34', '37', '24', '12', '011', '03', '16', '0', '4', '008', '0165.89', '422.4', '', '2.02228', '1.2921', '46.03', '-3.47', '4.16282', '49.5', '1,433.65', '312.077', '332.7', '', 'O(CC(O)CO/C1=C/C=C\\C2=C1\\C(=O)\\C=C(C(O)=O)/O2)/C3=C/C=C\\C4=C3\\C(=O)\\C=C(C(O)=O)/O4', 'O=C(O)c4cc(=O)c3c(OCC(O)COc1cccc2oc(C(=O)O)cc(=O)c12)cccc3o4', 'cromolyn sodium', 'Sodium cromoglycate; Gastrocrom; Nasalcrom; Lomudal; Aarane; Gastrofrenal', 'Calcium-activated potassium channel subunit alpha-1', '27503', 'Phase III', 'Alzheimer disease (AD)', '25468905', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(340, '11371290', '11371290', 'Cc1ccc(CCCC(=O)c2ccc(CC[C@@](C)(N)CO)n2C)cc1', '1-[5-[(3<I>R</I>)-3-amino-4-hydroxy-3-methyl-butyl]-1-methyl-pyrrol-2-yl]-4-(p-tolyl)butan-1-one', 'CYAAFQwArdwQeJ$a2aXd4L6ndqfqWbEptMQo9eiMp0FiEKF92fvg2Lht6hHYFX0drNscL8Na$hjzUZYF$k0H^8NLMkfAYmLumbzofeC5axK3i820dszSfk1c6Jv$iEZF6RZr5Hs^4q^^bk^e23$aRAfpDr4RGxxJzoP1VDLPo4vWnX0wDYdfMmPFVhIcIey7DG9Ea88F t5bWL6k1DXHsOXv8aO4kfim9HRFegkRG5xTG2AJfAzzH$HRY8TLhEZqUhdInJF6QENy0GOsOZ3XjSaKvmdHiegBSI55Te80asxh9hKIaGiXK84ZFjUSC0izVLsUQ4eb0M2uBImhFXB^y^dTRAhW9gJDOLxI5$tFhplTUStCN1$WI$^uOnmMFMHoI8ILtG2DeSrhj2BXA yg9R55TqqteY9Oee2Ibrf6J8n0hW5NltA7w7I79pnpSWZh772pl1TFcH7mXxpic0GreDlu9iQ2SWe97M7NXawhv8egER9y0K', 'InChI=1S/C21H30N2O2/c1-16-7-9-17(10-8-16)5-4-6-20(25)19-12-11-18(23(19)3)13-14-21(2,22)15-24/h7-12,24H,4-6,13-15,22H2,1-3H3/t21-/m1/s1', 'AuxInfo=1/0/N:25,10,16,17,18,15,23,24,20,21,12,13,7,6,9,22,19,8,11,14,5,4,3,1,2/E:(7,8)(9,10)/it:im/rA:55OONNC.oCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;s4;s5;s6;s3s7;s1s5;s5;s3;d-8;d- 11s12;d2s11;s14;s3;s15;s17;s18;d+19;s19;;s20d-22;d-21s22;s22;s6;s6;s7;s7;s9;s9;s10;s10;s10;s4;s4;s12;s13;s15;s15;s17;s17;s16;s16;s16;s18;s18;s1;s20;s21;s23;s24;s25;s25;s25;/rC:4.2003,-1.8336,2.26;-.17 24,3.5809,1.5833;1.6389,1.6864,.1982;5.3676,-2.0925,-1.2381;4.3769,-2.1276,-.1537;3.2075,-1.1638', 'YXEQXPNSBUIRDZ-OAQYLSRUSA-N', '1010:KU29H4GUMEDC3MJUC9522CWJSHC3KM', '[#8](-[#1])-[#6](-[#1])(-[#1])-[#6@@](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[c ]2:[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c](-[#1]):[c]2-[#1])=[#8]):[n]1-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])-[#1]', 'O([H])C([H])([H])[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])c1c([H])c([H])c(C(C([H])([H])C([H])([H])C([H])([H])c2c([H])c([H])c(C([H])([H])[H])c([H])c2[H])=O)n1C([H])([H])[H])N([H])[H]', '03.706', '3.706', '0', '0', 'TRUE', '-0.3945\r\n-0.2931\r\n-0.2487\r\n-0.3234\r\n3.63e-002\r\n-2.81e-002\r\n-1.56e-002\r\n-1.4e-003\r\n6.08e-002\r\n-4.49e-002\r\n6.47e-002\r\n-4.62e-002\r\n-3.88e-002\r\n0.1735\r\n1.21e-002\r\n-3.6e-003\r\n-4.2e-002\r\n-2.75e-002\r\n-4.8e-002\r\n-5.88e-002\r\n-5.88e-002\r\n-5.12e-002\r\n-5.91e-002\r\n-5.', '1', '2.702', 'C21H30N2O2', '0342.231', '-6.052', '0342.475', '1.87 11.03', '1', '2', '1', '14', '11', '2', '25', '26', '37', '6', '004', '03', '30', '0', '2', '009', '0068.25', '402.91', '', '2.83327', '1.2512', '37.69', '25.35', '4.62696', '12.34', '1,313.18', '115.248', '305.26', '', 'OCC(N)(CCC2=C/C=C(C(=O)CCC/C/1=C/C=C(C)\\C=C1)\\N2C)C', 'Cc2ccc(CCCC(=O)c1ccc(CCC(C)(N)CO)n1C)cc2', 'CS-0777', 'CS 0777', 'Sphingosine 1-phosphate 1 (S1PR1)receptor', '11371290', 'Phase I Completed', 'Multiple Sclerosis', '22465063', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(341, '11646823', '11646823', 'Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1c3ccc(OC(F)(F)F)cc3', '2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine', 'CYAAFQwAhewQIj5q2bYrueG$SLk5iFPurRAydvPeiP1QDf$OXBxh2evztn$EtWfJshSAPz0H$15Va4ycKf4oAWKYW^J8xdCQVJsqwQNuTerUYQamKZN2^IjL8xv^iEoFsoAVP^$fftc3xCABaz7vZtSUhF8HzQaVOiK897jU7spGDT9rw3HCeUgWWH4Il9uyDWb4fsFA EEcwRakOzas7aUEW1DZ0GlDPOXvwIewqFjT$MCWnLHMTXU5tnFQWaqqfQGSFL8Klca$L0eUHHjlJWXBXd86OKWOUHN2CqeOnMm3$UkXLR8Y6qDNtfo50niYHU2vuhIl27QIRz48LsyPyUtTX86GgTWGW9KFrk2RZednZlmNzuW0cqY4If5J2T1MhHXBWk6qDJ^6OA2bl OZQZedny9UA77IRX9vkW5zmmAmTF1IFWfRv13FFlkphHNYu94Gr08IR68v8U2JmK3UgReJa^1uU9nluZ4ltEchLfCCQXTfwa', 'InChI=1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3', 'AuxInfo=1/0/N:13,16,21,14,15,17,18,20,25,27,24,9,11,22,10,19,12,26,23,1,2,3,4,8,7,6,5/E:(4,5)(6,7)(21,22,23)/rA:40ClFFFONNNCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH/rB:;;;;;;;s6;s6;s6d-7;s7d-9;s9;d+10;s10;s11; s14;d-15;s5d+17s18;s12;t20;s21;s2s3s4s5;d+22;s22;s1d+8s24;s8d-25;s13;s13;s13;s14;s15;s16;s16;s16;s17;s18;s24;s25;s27;/rC:-8.6627,-.7644,1.6914;6.7219,-.8603,-.4088;8.2018,.3205,.6828;7.3212,1.1359,-1. 1436;6.0479,.992,.7509;.8039,-.5557,-.1024;-.9391,-1.8416,-.6435;-8.0649,.9091,-.1955;-.3189,.21', 'GOHCTCOGYKAJLZ-UHFFFAOYSA-N', '1010:U1U2WACTWSU9BB7VAF7ZQH9ES3YCRA', '[#17]-[c]1:[c](-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n]1)-[#6]#[#6]-[c](:[c]2-[#6](-[#1])(-[#1])-[#1]):[n]:[c](-[#6](-[#1])(-[#1])-[#1]):[n]2-[c]3:[c](-[#1]):[c](-[#1]):[c](:[c](-[#1]):[c]3-[#1])-[#8]-[# 6](-[#9])(-[#9])-[#9]', 'Clc1c([H])c(c([H])c([H])n1)C#Cc(c2C([H])([H])[H])nc(C([H])([H])[H])n2c3c([H])c([H])c(c([H])c3[H])OC(F)(F)F', '06.286', '6.286', '0', '0', 'TRUE', '-6.23e-002\r\n-0.1435\r\n-0.1435\r\n-0.1435\r\n-0.2542\r\n-0.2033\r\n-0.2306\r\n-0.2445\r\n3.63e-002\r\n2.77e-002\r\n9.17e-002\r\n0.1289\r\n-2.59e-002\r\n-4.07e-002\r\n-4.07e-002\r\n-1.08e-002\r\n-2.99e-002\r\n-2.99e-002\r\n8.47e-002\r\n-4.e-002\r\n-5.98e-002\r\n2.95e-002\r\n0.5271\r\n-9.e-003\r\n-2.8e', '0', '6.299', 'C19H13ClF3N3O', '0391.07', '-8.426', '0391.774', '1.49 6.05', '3', '0', '0', '11', '17', '3', '27', '29', '21', '8', '004', '00', '13', '0', '3', '005', '0039.94', '378.75', '', '1.5917', '1.299', '84.5', '34.44', '5.05285', '50.06', '2,879.30', '57.431', '280.91', '', 'Cl/C/3=N/C=C\\C(C#C/C\\2=C(C)/N(/C/1=C/C=C(OC(F)(F)F)\\C=C1)/C(C)=N2)=C3', 'Cc2nc(C#Cc1ccnc(Cl)c1)c(C)n2c3ccc(OC(F)(F)F)cc3', 'CTEP', 'EX-A095', 'Metabotropic glutamate receptor 5', '11646823', 'Under Investigation', 'Alzheimer disease (AD)', '27210751', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(342, '10311918', '10311918', 'CCCCCCCCCCCCCCCc1cccc(OCC)c1C(=O)Nc2ccc(Cl)c(c2)C(F)(F)F', '<I>N</I>-[4-chloro-3-(trifluoromethyl)phenyl]-2-ethoxy-6-pentadecyl-benzamide', 'CYAAFQwAPdwQzETWGBM$ok0zSKxonaY1qSnca9AmRSAcqs8e$DEXgfE34QGQ^vviFwF30veo2G$XucyKHNKUeo8wiFC^rx2Alp6xAMufENtgzYim^hNYF$XKHCe8UVz6DVBCvZOS12qPTNB8FctSNxccUqf6tmDK1RBz3XYNHv^fK571eZFl7ncfPxAFc9kBJ7jXaE1a 0^4Yb^eBo9lfRVeZXdIR4ryYX7tucxXfvnIeO^eC2xbJDpsL1fzheQK6joHus^0b5as83VCPXm63pn$zTdsqpS4l7n364znz92U89pz$c9QXaZsHnoqya8orsb1G8i3XPdVqV3t634Y6R6^6dX^jH^quup3mKGU^eMoan35$PbFf4tW9vv$Z4$KLXnNvBrv7nxXQ6wf9 g3fHJ^Ygvv7O99TX5eYoMOy3NQIUlP77ZyacVfucELHLzHzKLcgWcA7jnox8lZf2eNCp6Vkj1J2vlkO5PWV40HnYoTgSJ3Wf', 'InChI=1S/C31H43ClF3NO2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-18-24-19-17-20-28(38-4-2)29(24)30(37)36-25-21-22-27(32)26(23-25)31(33,34)35/h17,19-23H,3-16,18H2,1-2H3,(H,36,37)', 'AuxInfo=1/1/N:25,34,22,30,20,18,16,14,12,10,8,9,11,13,15,17,27,19,24,29,33,36,32,21,31,35,37,26,23,28,38,1,2,3,4,7,6,5/E:(33,34,35)/rA:81ClFFFOONCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHH HHHHHHHHHHHHHHHHHHH/rB:;;;;;;;s8;s8;s9;s10;s11;s12;s13;s14;s15;s16;s17;s18;s19;s20;d+21;s21;s22;s5s23;d-24;d6s7s23;d+26s27;s5;s7;d+31;s31;s30;s32;d-33;s1d+35s36;s2s3s4s35;s8;s8;s9;s9;s10;s10;s11;s11;s 12;s12;s13;s13;s14;s14;s15;s15;s16;s16;s17;s17;s18;s18;s19;s19;s20;s20;s22;s22;s24;s25;s25;s25;s', 'OYBMVMAXKOGYDC-UHFFFAOYSA-N', '1010:98D2ASMZYDG8NXMDZXMH66GD7FF4M7', '[#17]-[c](:[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[#6](-[c]2:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[ #6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])-[#8]- [#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1])=[#8]):[c](-[#6](-[#9])(-[#9])-[#9]):[c]1-[#1]', 'Clc(c([H])c([H])c1N([H])C(c2c(c([H])c([H])c([H])c2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])( [H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])=O)c(C(F)(F)F)c1[H]', '11.426', '11.426', '0', '0', 'TRUE', '-8.37e-002\r\n-0.1661\r\n-0.1661\r\n-0.1661\r\n-0.3456\r\n-0.2715\r\n-0.2813\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.34e-002\r\n-5.33e-002\r\n-5.34e-002\r\n-5.3e-002\r\n-5.34e-002\r\n-4.93e-002\r\n-5.34e-002\r\n-2.7e-002\r\n-5.36e-002\r\n-3.28e-002\r\n-5.62e-002\r\n7.08e-002\r\n', '0', '11.426', 'C31H43ClF3NO2', '0553.293', '-13.248', '0554.127', '-5.1', '2', '1', '1', '26', '12', '2', '38', '39', '51', '7', '003', '01', '43', '0', '2', '019', '0038.33', '590.05', '', '', '', '', '', '', '', '', '', '', '', 'Cl/C/2=C(C(F)(F)F)/C=C(NC(=O)/C1=C(CCCCCCCCCCCCCCC)/C=C\\C=C1\\OCC)\\C=C2', 'CCCCCCCCCCCCCCCc1cccc(OCC)c1C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2', 'CTPB', 'N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide; RT-012107', 'p300/CBP histone acetyltransferase', '10311918', 'Under Investigation', 'Parkinson Disease(PARK)', '27256286', 'Parkinson Disease(PARK)', 'PARK'),
(343, '10064708', '10064708', 'CNC(=S)N\\N=C(\\C)/C(=N\\NC(=S)NC)/C', '1-methyl-3-[(Z)-[(2<I>Z</I>)-1-methyl-2-(methylcarbamothioylhydrazono)propylidene]amino]thiourea', 'CYAAFQwAQdwQXwAtGxf3PFUrgrV^8YzTIOG10HTKWrSbOmSbpj22t171xewM8MDuKwu918vOdT5ApppEr0c3VsmmgUEzTqTukal$^gXyxewbd^JER3Y3IuHCGKCFvPNAOLnfBcS4U4Fw5YaneWRl9VUi5BWctE$JFOMtLx5OXcAks0aocySIAO2vA7EWqHda1gTCXbYo y9a2WHHdIopV97sFaHEFqhhL5FzW^8gEij^5r3Nr$xKnYSe8a2Oq4Tfk$9BRLOblf6xw$9KKvbEcA9YR^enM$SBKV6HzXfxiuc3MQkTPxZlgvpZxEhTqQhbWDiCuOj2AviTCK8OnH4ZxX$bSLb0SbUZv3LR$pGnCHLO0Ni5pfrFqNlgyVpPsXagjN93evEZ9YikncSgW i$Uphja5vo52rrlstbEjuzEX4AO^rk61WjifeD0a7k58k$limfT4JYpPKx^W8TDfDupco^pEv^80vEX5p86Wj7TG7n5ygNKF', 'InChI=1S/C8H16N6S2/c1-5(11-13-7(15)9-3)6(2)12-14-8(16)10-4/h1-4H3,(H2,9,13,15)(H2,10,14,16)/b11-5-,12-6-', 'AuxInfo=1/1/N:11,12,15,16,9,10,13,14,7,8,3,4,5,6,1,2/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)/gE:(1,2)/rA:32SSNNNNNNCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;s3;s4;;;d-3;d-4s9;s9;s10;d1s5s7;d2s6s8;s7;s8 ;s11;s11;s11;s12;s12;s12;s5;s6;s7;s8;s15;s15;s15;s16;s16;s16;/rC:2.8697,1.7456,-1.8695;-2.8709,1.743,1.871;1.4003,-.8389,.6716;-1.4002,-.8388,-.672;1.6105,-.0816,-.4299;-1.6104,-.0818,.4295;3.4372,.88 25,.6569;-3.4378,.8821,-.6564;.3995,-1.6594,.6352;-.3993,-1.6592,-.6357;-.052,-2.6116,1.7035;.05', 'UTPYTEWRMXITIN-CBIKUMSCSA-N', '1010:XRSHD3XZN6E6W97MYVJYAF85UWH2WR', '[#16]=[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#1])-[#7](-[#1])\\-[#7]=[#6](\\-[#6](-[#1])(-[#1])-[#1])/-[#6](/-[#6](-[#1])(-[#1])-[#1])=[#7]\\-[#7](-[#1])-[#6](-[#7](-[#1])-[#6](-[#1])(-[#1])-[#1])=[#16]', 'S=C(N([H])C([H])([H])[H])N([H])\\N=C(\\C([H])([H])[H])/C(/C([H])([H])[H])=N\\N([H])C(N([H])C([H])([H])[H])=S', '01.056', '0.421', '0', '0', 'TRUE', '-5.18e-002\r\n-5.18e-002\r\n-0.1988\r\n-0.1988\r\n-0.1622\r\n-0.1622\r\n-0.2718\r\n-0.2718\r\n7.46e-002\r\n7.46e-002\r\n-1.91e-002\r\n-1.91e-002\r\n0.1432\r\n0.1432\r\n-9.9e-003\r\n-9.9e-003\r\n2.96e-002\r\n2.96e-002\r\n2.96e-002\r\n2.96e-002\r\n2.96e-002\r\n2.96e-002\r\n0.1579\r\n0.1579\r\n0.1296\r\n0.1', '0', '1.056', 'C8H16N6S2', '0260.088', '-4.869', '0260.383', '', '2', '4', '4', '11', '00', '0', '16', '15', '21', '4', '006', '04', '16', '0', '0', '007', '0137.02', '298.21', '', '1.29646', '1.2503', '42.08', '6.13', '3.72014', '35.95', '577.233', '188.75', '205.79', '', 'S=C(N/N=C(\\C(=N/NC(=S)NC)C)/C)NC', 'CNC(=S)N/N=C(C)\\C(C)=N/NC(=S)NC', 'Cu(II)ATSM', '0YDK1H9L3A', 'Superoxide Dismutase 1', '10064708', 'Phase I/II', 'Amyotrophic Lateral Sclerosis (ALS)', '24899723', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(344, '969516', '969516', 'COc1cc(\\C=C\\C(=O)CC(=O)\\C=C\\c2ccc(O)c(OC)c2)ccc1O', '(1<I>E</I>,6<I>E</I>)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione', 'CYAAFQwAFcwQr8BzSe64a8OrKX$6h0UBSEUW5ytWQpuR^8EIlWS5YGBDmnwF0HiJ1gOB3wty$hXEfpeRtZHTxNMn9Mq62kv$z9I4jKsUummZ25rmBtw^^$DlsW03FsCS3^jHL39xAKwNsf7dPCCEecww9rMTMjzOvepq3jTZ29xdcMDcNC97IlgxFdn1ua0DPYZ^$BpF 3zjCJOuu5JOc9ZdhxDV8RLutyZWA4YnVPwstKGNoYGzFQ1TLXBCbxvVcsCC5QBFNDNfK$ZVxJL$feKegZBb0FDme^2V5joaZGWrrFsz47uOqyioedwuzwkkxcvkT5lvGRl1G^MZbx7lArCE9w0vkCSGTRUtuzAe^4Aqb2lZntCNZ06jDb7oOnQpxszx7TjCvKUOumoPM HTXF5o3isG$bueFqxbNtbfYQIUM5Q56MjzH91m6TtFY422q99$RrpWsX1jzZgkxFXY46FmVWWdb0aY3a8fb2QMogKp$Ron^z', 'InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+', 'AuxInfo=1/0/N:26,27,16,17,14,15,24,25,22,23,10,11,9,7,8,20,21,18,19,12,13,5,6,3,4,1,2/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(14,15)(16,17)(18,19)(20,21)(22,23)(24,25)(26,27)/rA:47OOOOOOCCCCCCCCCCCCCCCCCC CCCHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;d-7;d-8;s1s10;s2s11;s7;s8;s7;s8;s3d-12;s4d-13;d5s9;d6s9;d-14s18;d-15s19;d+16s20;d+17s21;s1;s2;s9;s9;s10;s11;s14;s15;s16;s17;s22;s23;s24;s25;s3;s4;s26;s26;s26;s27;s27 ;s27;/rC:7.4029,-1.3263,.7759;-7.3871,-1.1972,-1.0249;6.3135,-3.3404,-.7995;-7.4431,-1.9508,1.64', 'VFLDPWHFBUODDF-FCXRPNKRSA-N', '1010:WAQRP6456DQGWZEKBU8R491GQZTFHS', '[#8](-[#6](-[#1])(-[#1])-[#1])-[c](:[c](:[c](-[#1]):[c](-[#1]):[c]1\\-[#6](-[#1])=[#6](-[#1])\\-[#6](-[#6](-[#1])(-[#1])-[#6](\\-[#6](-[#1])=[#6](-[#1])\\-[c]2:[c](-[#1]):[c](-[#1]):[c](:[c](:[c]2-[#1])-[ #8]-[#6](-[#1])(-[#1])-[#1])-[#8]-[#1])=[#8])=[#8])-[#8]-[#1]):[c]1-[#1]', 'O(C([H])([H])[H])c(c(c([H])c([H])c1\\C([H])=C([H])\\C(C([H])([H])C(\\C([H])=C([H])\\c2c([H])c([H])c(c(c2[H])OC([H])([H])[H])O[H])=O)=O)O[H])c1[H]', '03.554', '3.554', '0', '0', 'TRUE', '-0.3466\r\n-0.3466\r\n-0.3582\r\n-0.3582\r\n-0.2944\r\n-0.2944\r\n-2.28e-002\r\n-2.28e-002\r\n7.32e-002\r\n-2.19e-002\r\n-2.19e-002\r\n0.105\r\n0.105\r\n-5.22e-002\r\n-5.22e-002\r\n-5.14e-002\r\n-5.14e-002\r\n0.1015\r\n0.1015\r\n0.1629\r\n0.1629\r\n-2.88e-002\r\n-2.88e-002\r\n-1.8e-002\r\n-1.8e-002\r\n4.', '0', '3.553', 'C21H20O6', '0368.126', '-5.084', '0368.38', '9 9.88 9.88', '4', '2', '4', '12', '12', '2', '27', '28', '27', '10', '006', '02', '20', '0', '2', '008', '0093.06', '386.66', '', '4.2217', '1.2639', '18.54', '1.23', '5.70265', '17.31', '2,455.72', '204.586', '296.69', '', 'O(/C/2=C(O)/C=C\\C(\\C=C\\C(=O)CC(=O)/C=C/C/1=C/C(OC)=C(O)\\C=C1)=C2)C', 'COc2cc(/C=C/C(=O)CC(=O)/C=C/c1ccc(O)c(OC)c1)ccc2O', 'Curcumin', 'Diferuloylmethane; Gelbwurz; Halad; Golden seal; diferuloylmethan', 'Peroxisome proliferator-activated receptor gamma', '969516', 'Unknown after phase II', 'Alzheimer disease (AD)', '23931272', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(345, '2907', '2907', 'ClCCN(CCCl)[P@@]1(=O)NCCCO1', '(2<I>R</I>)-<I>N</I>,<I>N</I>-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine', 'CYAAFQwA3ewQJ7NmzD$bH5G3NJwVvEHPZbXkEoH4y9oE4Sily0ESOUTAXpC5uoa9N9bZOlQFVjDWMc$12znhHCKG40XOAjrUBQ40ovT^iK^9n6O8QQuF5tQBcvwf^x7X7$4HE85l7cNAhMyftZh7hhiJNJIfc3LlJ6g^EGI5yz$YwAuhSFKes61FqPSNSFqHldYR$SFj lWTl3cwwx218dvWcQfzBXrs2Lims7zrR4LjLwqByXUY1Rhd8HO0MdkArUybvj6WJQz9epj2E1pVQmGd5WpVVH2ogZN6L80cuVjr3WGBVXxKtpvDdQhdIOXRE5FJTWVU4H1Mp0fCXQPH1gxzdoqXHDmtbyjrpQoHKeN6abwz5rEjqY4xJk1v1XtPKX$0e^JqOjCS1omei KxaD77Ve7xmQalxndKo$hILeZ5TyWYJZ9sz6jZ050n31VeTBe1H8RP58Ii656YP1ZtNmPr1LSu3IP96O9a0Lz1zJ5EWl95eA', 'InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/t14-/m1/s1', 'AuxInfo=1/1/N:9,13,14,8,11,12,10,1,2,7,6,5,4,3/E:(2,3)(5,6)(8,9)/it:im/rA:29ClClP.eOONNCCCCCCCHHHHHHHHHHHHHHH/rB:;;s3;d3;s3;s3;s7;s8;s4s9;s6;s6;s1s11;s2s12;s8;s8;s9;s9;s7;s10;s10;s11;s11;s12;s12;s13;s 13;s14;s14;/r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lC([H])([H])C([H])([H])N(C([H])([H])C([H])([H])Cl)[P@]1(N([H])C([H])([H])C([H])([H])C([H])([H])O1)=O', '00.144', '0.33', '0', '0', 'TRUE', '-0.1253\r\n-0.1253\r\n0.343\r\n-0.306\r\n-0.2557\r\n-0.2168\r\n-0.2324\r\n7.1e-003\r\n-1.59e-002\r\n5.77e-002\r\n2.17e-002\r\n2.17e-002\r\n3.56e-002\r\n3.56e-002\r\n4.34e-002\r\n4.34e-002\r\n3.03e-002\r\n3.03e-002\r\n0.1334\r\n5.72e-002\r\n5.72e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n', '1', '0.144', 'C7H15Cl2N2O2P', '0260.025', '-1.098', '0261.086', '', '2', '1', '1', '13', '00', '0', '14', '14', '18', '1', '004', '01', '15', '0', '1', '005', '0051.38', '247.65', '', '4.40757', '1.32', '26.94', '3.65', '2.93288', '23.29', '464.809', '75.449', '186.93', '', 'ClCCN(P1(=O)OCCCN1)CCCl', 'O=P1(N(CCCl)CCCl)NCCCO1', 'Cyclophosphamide', 'Clafen; Procytox; Endoxan; Cytoxan; Neosar; Sendoxan', 'DNA', '2907', 'Phase II Completed', 'Neuro-Behcet''s Disease', '27750273', 'Neuro-Behcet''s Disease', 'BEHCET DISEASE; BD'),
(346, '2907', '2907', 'ClCCN(CCCl)[P@@]1(=O)NCCCO1', '(2<I>R</I>)-<I>N</I>,<I>N</I>-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine', 'CYAAFQwA3ewQJ7NmzD$bH5G3NJwVvEHPZbXkEoH4y9oE4Sily0ESOUTAXpC5uoa9N9bZOlQFVjDWMc$12znhHCKG40XOAjrUBQ40ovT^iK^9n6O8QQuF5tQBcvwf^x7X7$4HE85l7cNAhMyftZh7hhiJNJIfc3LlJ6g^EGI5yz$YwAuhSFKes61FqPSNSFqHldYR$SFj lWTl3cwwx218dvWcQfzBXrs2Lims7zrR4LjLwqByXUY1Rhd8HO0MdkArUybvj6WJQz9epj2E1pVQmGd5WpVVH2ogZN6L80cuVjr3WGBVXxKtpvDdQhdIOXRE5FJTWVU4H1Mp0fCXQPH1gxzdoqXHDmtbyjrpQoHKeN6abwz5rEjqY4xJk1v1XtPKX$0e^JqOjCS1omei KxaD77Ve7xmQalxndKo$hILeZ5TyWYJZ9sz6jZ050n31VeTBe1H8RP58Ii656YP1ZtNmPr1LSu3IP96O9a0Lz1zJ5EWl95eA', 'InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/t14-/m1/s1', 'AuxInfo=1/1/N:9,13,14,8,11,12,10,1,2,7,6,5,4,3/E:(2,3)(5,6)(8,9)/it:im/rA:29ClClP.eOONNCCCCCCCHHHHHHHHHHHHHHH/rB:;;s3;d3;s3;s3;s7;s8;s4s9;s6;s6;s1s11;s2s12;s8;s8;s9;s9;s7;s10;s10;s11;s11;s12;s12;s13;s 13;s14;s14;/r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lC([H])([H])C([H])([H])N(C([H])([H])C([H])([H])Cl)[P@]1(N([H])C([H])([H])C([H])([H])C([H])([H])O1)=O', '00.144', '0.33', '0', '0', 'TRUE', '-0.1253\r\n-0.1253\r\n0.343\r\n-0.306\r\n-0.2557\r\n-0.2168\r\n-0.2324\r\n7.1e-003\r\n-1.59e-002\r\n5.77e-002\r\n2.17e-002\r\n2.17e-002\r\n3.56e-002\r\n3.56e-002\r\n4.34e-002\r\n4.34e-002\r\n3.03e-002\r\n3.03e-002\r\n0.1334\r\n5.72e-002\r\n5.72e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n', '1', '0.144', 'C7H15Cl2N2O2P', '0260.025', '-1.098', '0261.086', '', '2', '1', '1', '13', '00', '0', '14', '14', '18', '1', '004', '01', '15', '0', '1', '005', '0051.38', '247.65', '', '4.40757', '1.32', '26.94', '3.65', '2.93288', '23.29', '464.809', '75.449', '186.93', '', 'ClCCN(P1(=O)OCCCN1)CCCl', 'O=P1(N(CCCl)CCCl)NCCCO1', 'Cyclophosphamide', 'Clafen; Procytox; Endoxan; Cytoxan; Neosar; Sendoxan', 'DNA', '2907', 'Phase III', 'Opsoclonus-myoclonus ataxia', '17625938', 'Opsoclonus-myoclonus ataxia', 'Not Available'),
(347, '2907', '2907', 'ClCCN(CCCl)[P@@]1(=O)NCCCO1', '(2<I>R</I>)-<I>N</I>,<I>N</I>-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine', 'CYAAFQwA3ewQJ7NmzD$bH5G3NJwVvEHPZbXkEoH4y9oE4Sily0ESOUTAXpC5uoa9N9bZOlQFVjDWMc$12znhHCKG40XOAjrUBQ40ovT^iK^9n6O8QQuF5tQBcvwf^x7X7$4HE85l7cNAhMyftZh7hhiJNJIfc3LlJ6g^EGI5yz$YwAuhSFKes61FqPSNSFqHldYR$SFj lWTl3cwwx218dvWcQfzBXrs2Lims7zrR4LjLwqByXUY1Rhd8HO0MdkArUybvj6WJQz9epj2E1pVQmGd5WpVVH2ogZN6L80cuVjr3WGBVXxKtpvDdQhdIOXRE5FJTWVU4H1Mp0fCXQPH1gxzdoqXHDmtbyjrpQoHKeN6abwz5rEjqY4xJk1v1XtPKX$0e^JqOjCS1omei KxaD77Ve7xmQalxndKo$hILeZ5TyWYJZ9sz6jZ050n31VeTBe1H8RP58Ii656YP1ZtNmPr1LSu3IP96O9a0Lz1zJ5EWl95eA', 'InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/t14-/m1/s1', 'AuxInfo=1/1/N:9,13,14,8,11,12,10,1,2,7,6,5,4,3/E:(2,3)(5,6)(8,9)/it:im/rA:29ClClP.eOONNCCCCCCCHHHHHHHHHHHHHHH/rB:;;s3;d3;s3;s3;s7;s8;s4s9;s6;s6;s1s11;s2s12;s8;s8;s9;s9;s7;s10;s10;s11;s11;s12;s12;s13;s 13;s14;s14;/r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lC([H])([H])C([H])([H])N(C([H])([H])C([H])([H])Cl)[P@]1(N([H])C([H])([H])C([H])([H])C([H])([H])O1)=O', '00.144', '0.33', '0', '0', 'TRUE', '-0.1253\r\n-0.1253\r\n0.343\r\n-0.306\r\n-0.2557\r\n-0.2168\r\n-0.2324\r\n7.1e-003\r\n-1.59e-002\r\n5.77e-002\r\n2.17e-002\r\n2.17e-002\r\n3.56e-002\r\n3.56e-002\r\n4.34e-002\r\n4.34e-002\r\n3.03e-002\r\n3.03e-002\r\n0.1334\r\n5.72e-002\r\n5.72e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n4.48e-002\r\n', '1', '0.144', 'C7H15Cl2N2O2P', '0260.025', '-1.098', '0261.086', '', '2', '1', '1', '13', '00', '0', '14', '14', '18', '1', '004', '01', '15', '0', '1', '005', '0051.38', '247.65', '', '4.40757', '1.32', '26.94', '3.65', '2.93288', '23.29', '464.809', '75.449', '186.93', '', 'ClCCN(P1(=O)OCCCN1)CCCl', 'O=P1(N(CCCl)CCCl)NCCCO1', 'Cyclophosphamide', 'Clafen; Procytox; Endoxan; Cytoxan; Neosar; Sendoxan', 'DNA', '2907', 'Phase III', 'Relapsing Remitting Multiple Sclerosis (RRMS)', '21547093', 'Relapsing Remitting Multiple Sclerosis (RRMS)', 'DISSEMINATED SCLEROSIS'),
(348, '2911', '2911', 'O[C@@](CCN1CCCCC1)(C2CCCC2)c3ccccc3', '(1<I>S</I>)-1-cyclopentyl-1-phenyl-3-(1-piperidyl)propan-1-ol', 'CYAAFQwAYdwQ8y05uL8FqeKfVZKo$Y$8E9^ZXug8mRNAmiYYoGDx$P2KrGQ5XVfwyWYQmoN7NxW5wjMOKz0220MM0ouRAvGQewiGLeuJFjSAxW7W1q0EXfNSUgyqgLVpzPM^p1^^^WZreBAChHeHtEsgwB3nPxedzRDeX$bL5FdIYS3ne$AAftmGSewC$mPQeoL8V8wG 8kpd^10iQKfeeYYyAzY2e9GzOcVKI04cGjI$jWSz1jo9d1cogaccGKD0k7vRuFS04Pft11GM1gK8MVP3fJH288RUHc4cSf8rh6kZpOOjiTvaDOcwbNPSPOjliNB0ksW30rqc2miarIQsytfbnOw7NjmiSnafWOhzFFFVsp8Ge$EIArNHgohsGLmNL4s9cL^FuuTreH86 9806PpJxewwJiAKHm47ejw3ZMjsKftabsOFvwQXdjXDnde7A0h31ry9P0UJm69GaOSaFBuoTy$STB4X75QOhcbFYdzqWcjN9', 'InChI=1S/C19H29NO/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2/t19-/m1/s1', 'AuxInfo=1/0/N:21,16,19,20,7,8,14,15,17,18,5,6,9,12,13,10,11,3,4,2,1/E:(3,4)(5,6)(7,8)(9,10)(11,12)(14,15)/it:im/rA:50ONCC.oCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s1s3;s3;s3;s5;s6s7;s4;s2s 9;s4;s2;s2;s12;s13;s14s15;d+11;s11;s17;d-18;d-19s20;s3;s5;s5;s6;s6;s7;s7;s8;s8;s9;s9;s10;s10;s12;s12;s13;s13;s1;s14;s14;s15;s15;s16;s16;s17;s18;s19;s20;s21;/rC:1.7412,-.3871,-1.9675;-2.6403,-.5635,.12 4;1.7363,-1.3745,.1699;1.1326,-.2612,-.6679;1.4407,-2.7674,-.3775;3.2613,-1.3509,.1927;2.4768,-3', 'SWRUZBWLEWHWRI-LJQANCHMSA-N', '1010:S4DGAS6TY39GGQ6XN388NS3ECBZRZX', '[#8](-[#1])-[#6@@](-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7]2-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1]) -[#6]2(-[#1])-[#1])-[#6]3(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6]3(-[#1])-[#1]', 'O([H])[C@@](c1c([H])c([H])c([H])c([H])c1[H])(C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H])C3([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H]', '03.961', '3.961', '0', '0', 'TRUE', '-0.3847\r\n-0.3032\r\n-8.2e-003\r\n9.37e-002\r\n-4.74e-002\r\n-4.74e-002\r\n-5.29e-002\r\n-5.29e-002\r\n-6.8e-003\r\n1.2e-003\r\n-1.62e-002\r\n-1.8e-003\r\n-1.8e-003\r\n-4.04e-002\r\n-4.04e-002\r\n-5.09e-002\r\n-5.62e-002\r\n-5.62e-002\r\n-6.19e-002\r\n-6.19e-002\r\n-6.22e-002\r\n3.35e-002\r\n2.7e-', '1', '2.8', 'C19H29NO', '0287.225', '-4.883', '0287.44', '8.75', '0', '0', '0', '17', '06', '1', '21', '23', '32', '3', '002', '01', '29', '0', '3', '005', '0023.47', '313.84', '', '1.68959', '1.2625', '20.07', '11.93', '3.91697', '8.14', '735.348', '27.247', '258.27', '', 'O[C@](C1CCCC1)(CCN2CCCCC2)/C/3=C/C=C\\C=C3', 'O[C@](CCN1CCCCC1)(c2ccccc2)C3CCCC3', 'Cycrimine', 'Pagitane; Cicrimina; LS-187213;', 'Muscarinic acetylcholine receptor M1', '2911', 'Under Investigation', 'Parkinson Disease(PARK)', '13477721', 'Parkinson Disease(PARK)', 'PARK'),
(349, '24883453', '24883453', 'O[C@@H]([C@H](O)C(=O)O)C(=O)O', '(2<I>S</I>,3<I>S</I>)-2,3-dihydroxybutanedioic acid', 'CYAAFQwAqewQJs1nA7C3US0UqELUCL$nj2yjFTGWy4zYoUzVcl1dSISjWb5cIULSkDXm3LGKalziSiSVrpctCOdCj6AY8F5g5FZ9ZmHiS1krSEl^637PgI1U9DcA$3voCIStEZj^FeDXWb6lji7MGF7Cz1aRo8Cw7aOxw$1SuQaVSXOv5DVR2NI5zLbaL0i8QU9ezvDF Keq0uPS5ujcv59WD8Wn1oGfN4TCiscmlGe6w7UnWunb4mcptGFBWAhM6CjrYmic$NWg3RdoKc5pjJ3svaJkrZcyLQHXYXTzcp^deDr86V955OVNkX2rvcrIictqe4dnVJ$MP0dcXgUsmPT2R8ezjUQlLjb$l^iCHetxmlb21BF^E8puJ2Fn5eOW62sauzptdedisNKq$ POw7zSeHyvvNRWdsHKi7Sky8gOJ70jof2SCxIC2HzSoDIPE0KNtnb4G66YuwNMqNh7AiFpzMJI$G5HO4Z2vfA0^aYO56kA', 'InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m0/s1', 'AuxInfo=1/1/N:7,8,9,10,1,2,3,5,4,6/E:(1,2)(3,4)(5,6)(7,8,9,10)/gE:(1,2)/it:im/rA:16OOOOOOC.eC.eCCHHHHHH/rB:;;;;;s1;s2s7;s3d5s7;s4d6s8;s7;s8;s1;s2;s3;s4;/r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r\n-0.3796\r\n-0.3296\r\n-0.3296\r\n-0.2637\r\n-0.2637\r\n0.1747\r\n0.1747\r\n0.2905\r\n0.2905\r\n7.45e-002\r\n7.45e-002\r\n0.2113\r\n0.2113\r\n0.2214\r\n0.2224', '1', '-4.6', 'C4H6O6', '0150.016', '-0.832', '0150.087', '3.04 4.37', '2', '2', '2', '7', '00', '0', '10', '9', '11', '2', '006', '04', '6', '0', '0', '003', '0115.06', '147.61', '', '1.9373', '1.2444', '20.68', '6.52', '2.29231', '14.16', '151.009', '254.842', '102.89', '', 'OC(C(O)C(O)=O)C(O)=O', 'O=C(O)C(O)C(O)C(=O)O', 'Cystagon', '2 Aminoethanethiol; Becaptan; Cysteamine Bitartrate; Mercamine; Mercaptamine; RP103', 'Neuropeptide Y receptor type 2', '24883453', 'Phase II/III', 'Huntington Disease (HD)', '21111020', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(350, '24883453', '24883453', 'O[C@@H]([C@H](O)C(=O)O)C(=O)O', '(2<I>S</I>,3<I>S</I>)-2,3-dihydroxybutanedioic acid', 'CYAAFQwAqewQJs1nA7C3US0UqELUCL$nj2yjFTGWy4zYoUzVcl1dSISjWb5cIULSkDXm3LGKalziSiSVrpctCOdCj6AY8F5g5FZ9ZmHiS1krSEl^637PgI1U9DcA$3voCIStEZj^FeDXWb6lji7MGF7Cz1aRo8Cw7aOxw$1SuQaVSXOv5DVR2NI5zLbaL0i8QU9ezvDF Keq0uPS5ujcv59WD8Wn1oGfN4TCiscmlGe6w7UnWunb4mcptGFBWAhM6CjrYmic$NWg3RdoKc5pjJ3svaJkrZcyLQHXYXTzcp^deDr86V955OVNkX2rvcrIictqe4dnVJ$MP0dcXgUsmPT2R8ezjUQlLjb$l^iCHetxmlb21BF^E8puJ2Fn5eOW62sauzptdedisNKq$ POw7zSeHyvvNRWdsHKi7Sky8gOJ70jof2SCxIC2HzSoDIPE0KNtnb4G66YuwNMqNh7AiFpzMJI$G5HO4Z2vfA0^aYO56kA', 'InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m0/s1', 'AuxInfo=1/1/N:7,8,9,10,1,2,3,5,4,6/E:(1,2)(3,4)(5,6)(7,8,9,10)/gE:(1,2)/it:im/rA:16OOOOOOC.eC.eCCHHHHHH/rB:;;;;;s1;s2s7;s3d5s7;s4d6s8;s7;s8;s1;s2;s3;s4;/r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r\n-0.3796\r\n-0.3296\r\n-0.3296\r\n-0.2637\r\n-0.2637\r\n0.1747\r\n0.1747\r\n0.2905\r\n0.2905\r\n7.45e-002\r\n7.45e-002\r\n0.2113\r\n0.2113\r\n0.2214\r\n0.2224', '1', '-4.6', 'C4H6O6', '0150.016', '-0.832', '0150.087', '3.04 4.37', '2', '2', '2', '7', '00', '0', '10', '9', '11', '2', '006', '04', '6', '0', '0', '003', '0115.06', '147.61', '', '1.9373', '1.2444', '20.68', '6.52', '2.29231', '14.16', '151.009', '254.842', '102.89', '', 'OC(C(O)C(O)=O)C(O)=O', 'O=C(O)C(O)C(O)C(=O)O', 'Cystagon', '2 Aminoethanethiol; Becaptan; Cysteamine; Mercamine; Mercaptamine; RP103', 'Neuropeptide Y receptor type 2', '24883453', 'FDA approved', 'Neuronal Ceroid Lipofuscinosis', '24997880', 'Neuronal Ceroid Lipofuscinosis', 'CEROID LIPOFUSCINOSIS, NEURONAL, 1,'),
(351, '2915', '2915', 'NCCSSCCN', '2-(2-aminoethyldisulfanyl)ethanamine', 'CYAAFQwA3ewQJn$ELAIWBJkRwvnAVgBP5e4G6nYOep9K1GdGNj7tIbyRnNjmyHshPq5cJQH7tS0vt4lm7xwqd92rCp2uH0KDVHmRvxu4W0UsQAqVsm4d4B3^uXurRsJ8hLeMTfVCdgIO2ydrqCeHvrg6vcAsVl5$PegLV^YZj4jGWl07eE9dpuSQH3pleXh7O3rR4tzY C6rkvMhQ5yE3Ipi7ecozYwfCeaT93$YJzDK^eZCmYdM5V6v2OZuCsuNn8l31tTq8FJuyK2zZ51CnZSuLPuwXXk516kcfzkFhNpoV6hOPPKlXDja^86OVOlGalJWQ^TErZ9lJMX0WYNaSatt1wOfuf5emum4SFpXbffGzZfkr2ZejcXa9agdeW5ppNu$2dLuRtF7Viyrb ^bmox3raNpmyt518n890Q^$0WtF564sI5ZLzmhI9v$sc6vHGI2sSUBOGGTyRBuz2OCinikw6AYzmdCom6YMIc7pgXKeCOCYP', 'InChI=1S/C4H12N2S2/c5-1-3-7-8-4-2-6/h1-6H2', 'AuxInfo=1/0/N:7,8,5,6,3,4,1,2/E:(1,2)(3,4)(5,6)(7,8)/rA:20SSNNCCCCHHHHHHHHHHHH/rB:s1;;;s1;s2;s3s5;s4s6;s5;s5;s6;s6;s7;s7;s8;s8;s3;s3;s4;s4;/r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e-002\r\n-9.28e-002\r\n-0.3296\r\n-0.3296\r\n1.6e-002\r\n1.6e-002\r\n2.2e-003\r\n2.2e-003\r\n4.02e-002\r\n4.02e-002\r\n4.02e-002\r\n4.02e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n4.34e-002\r\n0.1184\r\n0.1184\r\n0.1184\r\n0.1188', '0', '-2.137', 'C4H12N2S2', '0152.044', '-1.281', '0152.281', '9.09 9.09', '0', '2', '0', '7', '00', '0', '8', '7', '13', '0', '002', '04', '12', '0', '0', '005', '0102.64', '178.75', '', '1.48721', '1.289', '5.05', '-0.53', '3.26915', '5.58', '246.574', '202.838', '123.13', '', 'S(SCCN)CCN', 'NCCSSCCN', 'Cystamine', 'Decarboxycystine; Mercamine disulfide; Becaptan disulfure; BRN 1736027', 'Transglutaminase 1', '2915', 'Under Investigation', 'Huntington Disease (HD)', '24008831', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(352, '6058', '6058', 'NCCS', '2-aminoethanethiol', 'CYAAFQwALdwQoHNiP$Uhxpvw4uEmaGgmooCMSUv7eaDccD6zVj3AWr8UTf8i0AAsfeTntFocIABxKyb2oEFFsb^L1iCeNieWfzYx93Zp5ikli04HDZLeewb^FuWVIS4zpYVYirtESS6Yyt3cMA$lmnXrrRhD7kp5qeIOac3AKxYOV0sJtmLLLzdLbmLw5Wbh9TiUu18w utsKTmCFz4Vt7h3UZJn55teO3kpZyePnTomanoVJ0jr8Ps8l9dtj7bbRShope9EreoHRTo9$UL8plSjUCGo38nz2VpEPt4mbef3wBFOz3kbe9ee4l9nCdUkHPxPxjFMdZsAgF6dhUU2M7Us1pvOweZPG6fR4Yn24', 'InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2', 'AuxInfo=1/0/N:3,4,2,1/rA:11SNCCHHHHHHH/rB:;s2;s1s3;s3;s3;s4;s4;s2;s2;s1;/rC:2.108,.1744,.0001;-1.943,-.1066,.0001;-.6185,.5074,-.0001;.4536,-.5752,-.0001;-.5276,1.1418,.8886;-.5247,1.1482,-.8843;.3662 ,-1.213,-.8862;.3642,-1.2133,.8855;-2.0578,-.6755,-.8378;-2.6531,.6228,-.0506;2.7963,-.9766,.0003;', 'UFULAYFCSOUIOV-UHFFFAOYSA-N', '1010:ANE274WC7HQZJ6YEBJKUHE4SJ1NTK9', '[#16](-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#1])-[#1]', 'S([H])C([H])([H])C([H])([H])N([H])[H]', '-00.216', '-0.216', '0', '0', 'TRUE', '-0.178\r\n-0.3297\r\n1.2e-003\r\n2.6e-003\r\n4.33e-002\r\n4.33e-002\r\n3.9e-002\r\n3.9e-002\r\n0.1183\r\n0.1183\r\n0.1027', '0', '-1.212', 'C2H7NS', '0077.0299', '0.929', '0077.1487', '10.04 10.53', '0', '1', '0', '3', '00', '0', '4', '3', '8', '0', '001', '02', '7', '0', '0', '001', '0064.81', '102.3', '', '0.69968', '1.2561', '4.12', '-0.15', '1.90478', '4.27', '50.6736', '147.117', '65.16', '', 'NCCS', 'NCCS', 'Cysteamine', 'Lambratene; Riacon; beta-MEA; WR 347', 'Transglutaminase 1', '6058', 'Unknown Statur after Phase II/III', 'Huntington Disease (HD)', '25475049', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(353, '10235', '10235', 'O=C1C=CC=C2[C@H]3CNC[C@H](C3)CN12', '(9<I>S</I>,10<I>R</I>)-11,12-diazatricyclo[BLAH.BLAH.BLAH.BLAH]trideca-(2),1(7)-dien-8-one', 'CYAAFQwApewQ9d2HycLNU0HFQfKNN$D5BYAsg0gm2CJfeG5iNuNXZdzx5F0LcJS0UR8WueJf85ZUrH3oGIQLvBtpztnbt4CeSBqR^peSXyj0C9ENWqosBtE1LRVLsfRijd$7nUuZ9ol1hzjvcoiitq6p6yYbpclYIt0X6yL7bptt4SAnakgxdmXUVVMeUhDiPXHQUtKD ecFa0qErKE865gJr8BLA0NqKRcIH00xAQhgTm01RRt4^1jZ6kFHo6YAZ4apYS4cpVL9trupQHWpy5tsfWg0av3RsaAreJa8GynUoLctawW1ztacm4fvE9Dtj2Dvu3Nrjy70H0xIfWlx5ArfyObna586kHl2dUSWfOCPPjyjbZbuOFtPJ777AzHuQ3EgVKmczyJ^$rUQ9 AgI9BErtd772YSMeBE$WQWLFeRW$VlnritaL65B0^tbrr65F5jOUkohhbD6jWfYnBNbLJ78z55OT7mSB^pNVNvVQXEB6N2qH', 'InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1', 'AuxInfo=1/0/N:13,11,14,6,8,9,7,4,5,10,12,3,2,1/it:im/rA:28ONNC.oC.oCCCCCCCCCHHHHHHHHHHHHHH/rB:;;;;s4s5;s2s4;s3s4;s3s5;s2s5;d-10;d1s2;s11;s12d-13;s4;s5;s6;s6;s7;s7;s8;s8;s9;s9;s3;s11;s13;s14;/r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r\n-0.2713\r\n-0.3158\r\n-1.19e-002\r\n1.01e-002\r\n-3.84e-002\r\n2.33e-002\r\n-5.e-004\r\n3.2e-003\r\n1.71e-002\r\n-4.42e-002\r\n0.2422\r\n-5.55e-002\r\n1.2e-003\r\n3.32e-002\r\n3.78e-002\r\n2.77e-002\r\n2.77e-002\r\n4.77e-002\r\n4.77e-002\r\n4.31e-002\r\n4.31e-002\r\n4.34e-002\r\n4.34e-002\r\n', '1', '-1.017', 'C11H14N2O', '0190.111', '-0.873', '0190.242', '8.11', '1', '1', '3', '13', '00', '0', '14', '16', '15', '3', '003', '01', '14', '0', '3', '000', '0032.34', '185.4', '', '2.97008', '1.2823', '10.77', '4.01', '2.78453', '6.76', '223.361', '69.301', '153.66', '-0.24', 'O=C/3N/2CC1CC(CNC1)C2=C\\C=C3', 'O=c3cccc2[C@@H]1CNC[C@@H](C1)Cn23', 'cytisine', 'Baptitoxine; Sophorine; Laburnin; Tabex; Cytitone; Tsitizin', 'Neuronal acetylcholine receptor subunit alpha-4', '10235', 'Under Investigation', 'Parkinson Disease(PARK)', '18589414', 'Parkinson Disease(PARK)', 'PARK'),
(354, '44252884', '44252884', 'COc1cc(ccc1Nc2ncc(F)c(Nc3ccccc3NS(=O)(=O)C)n2)N4CCOCC4', '<I>N</I>-[2-[[5-fluoro-2-(2-methoxy-4-morpholino-anilino)pyrimidin-4-yl]amino]phenyl]methanesulfonamide', 'CYAAFQwAPewQYm9^lQyY0yGw6Rrh40gS^04kND8URFppbitEpc5zTijTv5alr6OSck4VBDEY^2DbawO2wwWIyxF3qo$ul5cKWSZpuA^qc1xE7sgaXwuaDNPDv61XVUDJvkCTTd$3^10a57sY5CV1q3qcw95DsVSVKn^T9hTGy3^SXccb7FVCWuqwJ3uY^oa7YLb^raZf 2vJuBeBRA$ThvLtUd1xq2zeRZZ35rcrSdtLq5ug0P^sQeYJuOQ11Mn7OPbHsfOMYuPslL^ykf0NQdrn9XL5H1Wn9Xsyge1bL2Zxq3kJV$88O9r85qRMVMeC870xu6m9LOE2Z8ys^u0stpW5XBPS9aDWpFOwfCtzdB4J687ItteOP46rD^vOSs61J^0DKpLU4v17p9zKS EpBtUScRxvzdJWlbdInDvGleXBf7HjaT5rRRjYeqvknLXobwvEFxdTtKU0vjSOfrcDUq2lFyky7O1rj3kaxUEsGisy1Z^2rA', 'InChI=1S/C22H25FN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)', 'AuxInfo=1/1/N:27,34,31,32,28,29,19,22,13,14,15,16,18,33,17,30,24,25,21,20,26,23,2,12,9,8,11,10,7,5,6,4,3,1/E:(9,10)(11,12)(30,31)/CRV:34.6/rA:59SFOOOONNNNNNCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH HHH/rB:;;;d1;d1;;;;s1;;;s7;s7;s3s13;s3s14;s7;d+17;s17;s4s18;s8d-20;d-19s21;s8s11d+12;s9;s10s24;s9d+11;s4;d+24;d+25;s2s26;s28;s29d-31;s12d+30;s1;s13;s13;s14;s14;s15;s15;s16;s16;s18;s19;s22;s8;s9;s10;s2 7;s27;s27;s28;s29;s31;s32;s33;s34;s34;s34;/rC:6.0997,-1.9732,-.0014;4.3533,2.9668,.0968;-6.6973,', 'XXHHOTZUJIXPJX-UHFFFAOYSA-N', '1010:134CYZGMANMYREEN754PVP224BZU9B', '[#16](-[#6](-[#1])(-[#1])-[#1])(-[#7](-[#1])-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#7](-[#1])-[c](:[c](:[c](-[#1]):[n]:[c]2-[#7](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c]3-[#7](-[#6](-[#1 ])(-[#1])-[#6](-[#1])(-[#1])-[#8]4)-[#6](-[#1])(-[#1])-[#6]4(-[#1])-[#1]):[c](:[c]3-[#1])-[#8]-[#6](-[#1])(-[#1])-[#1])-[#9]):[n]2)(=[#8])=[#8]', 'S(C([H])([H])[H])(N([H])c1c([H])c([H])c([H])c([H])c1N([H])c(c(c([H])nc2N([H])c(c([H])c([H])c3N(C([H])([H])C([H])([H])O4)C([H])([H])C4([H])[H])c(c3[H])OC([H])([H])[H])F)n2)(=O)=O', '03.161', '3.161', '0', '0', 'TRUE', '1.3632\r\n-0.2018\r\n-0.3788\r\n-0.3477\r\n-0.571\r\n-0.571\r\n-0.2703\r\n-0.2242\r\n-0.2392\r\n-0.3434\r\n-0.2027\r\n-0.2232\r\n2.66e-002\r\n2.66e-002\r\n5.97e-002\r\n5.97e-002\r\n2.e-002\r\n-1.2e-002\r\n-4.23e-002\r\n9.44e-002\r\n5.21e-002\r\n-3.96e-002\r\n0.2062\r\n3.59e-002\r\n9.5e-003\r\n0.151\r\n4.22e-002\r\n-4.24e-002\r\n-4.5e-002\r\n0.1782\r\n-6.06e-002\r\n-6.07e-002\r\n6.94e-002\r\n-3.78e-002\r\n4.58e-002\r\n4.58e-002\r\n4.58e-002\r\n4.58e-002\r\n5.8e-002\r\n5.8e-002\r\n5.8e-002\r\n5.8e-002\r\n6.67e-002\r\n6.4e-002\r\n6.41e-002\r\n0.1374\r\n0.1359\r\n9.6e-002\r\n5.35e-002\r\n5.35e-0', '0', '3.159', 'C22H25FN6O4S', '0488.164', '-4.771', '0488.535', '1.77 3.71 4.66 5.58 8.85', '6', '3', '2', '17', '18', '3', '34', '37', '33', '11', '010', '03', '25', '0', '4', '008', '0126.09', '475.54', '', '3.12917', '1.2871', '170', '33.83', '5.0562', '136.17', '2,490.01', '174.129', '363.92', '', 'S(=O)(=O)(N/C1=C/C=C\\C=C1\\N\\C4=N\\C(N/C/3=C(OC)/C=C(N2CCOCC2)\\C=C3)=N/C=C4/F)C', 'COc2cc(N1CCOCC1)ccc2Nc4ncc(F)c(Nc3ccccc3NS(C)(=O)=O)n4', 'CZC-25146', 'EX-A1072; J-690054', 'Leucine-rich repeat serine/threonine-protein kinase 2', '44252884', 'Under Investigation', 'Parkinson Disease(PARK)', '21812418', 'Parkinson Disease(PARK)', 'PARK');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(355, '355', '355', 'N.NC(=N)Nc1ccc(cc1)C(=O)Oc2cccc(NC(=N)N)c2', 'ammonia;(3-guanidinophenyl) 4-guanidinobenzoate', 'CYAAFQwANfwQ97THyQ7P2DcrrQBXn9OSqdEvTUlCswQYnQANbT9MKZn7HW0jOJsn^af3IoTQSDC5nZgkK0szU1wVJl5sQ5^WcLiFYuzyoHob2h4KUlhrpgUnC8Qmr6DgAOKayOgsG6SjYtB^8GcdfuNmD54JzlJTCXg1t4Yby9KMHpXwmJ^OPsib$8deJ7nyspkMLPHu g3Qi7m7lBQGvXbRBm71ddMJUNXerKGcf6^DpdMuifNXe9jBsucqG^^eefd30Smhn0$i3leaeIODPgvl3s0XrlfKc3LqvWLbgeu11hnvzxxdvarkzm7^83fIvPsi8P6r1gOulhLx5g1n9cuicO$jHeswMJo7KTa1NMXM8mzoIFzHLVnIlqqU0VoC0PFFDIhTucg5oRYmz FspLsl98NtKhT1UpRQ1JlbNDSXIacoriVLQ3o2KAWhoHg8MVCK7iOO2V^P0p^PKrYgZAumN', 'InChI=1S/C15H16N6O2.H3N/c16-14(17)20-10-6-4-9(5-7-10)13(22)23-12-3-1-2-11(8-12)21-15(18)19;/h1-8H,(H4,16,17,20)(H4,18,19,21);1H3', 'AuxInfo=1/1/N:2,4,1,11,12,13,14,5,10,15,6,3,8,17,21,18,19,22,23,16,20,9,7;24/E:(4,5)(6,7)(16,17)(18,19);/rA:24CCCCCCOCOCCCCCCNCNNNCNNN/rB:s1;d-1;d-2;s3;s4d-5;s3;s7;d8;s8;s10;d+10;d-11;s12;s13d-14;s15; s16;s17;d17;s6;s20;d21;s21;;/rC:7.7804,-13.7476,0;7.3679,-14.4621,0;7.3679,-13.0331,0;6.5429,-14.4621,0;6.5429,-13.0331,0;6.1304,-13.7476,0;7.7804,-12.3187,0;8.6054,-12.3187,0;9.018,-13.0331,0;9.018,- 11.6042,0;8.6054,-10.8897,0;9.843,-11.6042,0;9.018,-10.1752,0;10.2555,-10.8897,0;9.843,-10.1752,', 'JVFKIWFOIJZDPQ-UHFFFAOYSA-N', '1010:W6HGCJQAZ73NEY4RTS7RWE9C4A84YQ', '[c]1:[c](-[#8]-[#6](-[c]2:[c]:[c]:[c](-[#7]-[#6](=[#7])-[#7]):[c]:[c]2)=[#8]):[c]:[c](-[#7]-[#6](-[#7])=[#7]):[c]:[c]1.[#7]', 'c1c(OC(c2ccc(NC(=N)N)cc2)=O)cc(NC(N)=N)cc1.N', '00.881', '1.192', '0', '0', 'TRUE', '-3.1e-002\r\n-5.81e-002\r\n8.72e-002\r\n-4.37e-002\r\n-1.27e-002\r\n2.35e-002\r\n-0.2743\r\n0.2977\r\n-0.2603\r\n4.75e-002\r\n-4.73e-002\r\n-4.73e-002\r\n-4.3e-002\r\n-4.3e-002\r\n2.09e-002\r\n-0.234\r\n0.1456\r\n-0.2774\r\n-0.2793\r\n-0.2339\r\n0.1456\r\n-0.2793\r\n-0.2774\r\n-0.344', '0', '-0.461', 'C15H19N7O2', '0329.16', '-1.946', '0329.357', '8.19 9.25 9.74', '2', '4', '3', '9', '12', '2', '24', '24', '7', '9', '009', '11', '19', '0', '2', '007', '0185.1', '358.86', '', '', '', '', '', '', '', '', '', '', '', 'C/2=C(OC(=O)/C/1=C/C=C(NC(N)=N)\\C=C1)/C=C(NC(=N)N)\\C=C2.N', 'N=C(N)Nc2ccc(C(=O)Oc1cccc(NC(=N)N)c1)cc2', 'D6', 'Not Available', 'd(CAG)n huntingtin', '355', 'Under Investigation', 'Spinocerebellar Ataxia 3', '22252896', 'Spinocerebellar Ataxia 3', 'MACHADO-JOSEPH DISEASE; MJD\nSPINOCEREBELLAR ATROPHY III\nAZOREAN NEUROLOGIC DISEASE\nSPINOPONTINE ATROPHY\nNIGROSPINODENTATAL DEGENERATION (SCA3)'),
(356, '356', '356', 'N.NC(=N)Nc1ccc(cc1)C(=O)Oc2cccc(NC(=N)N)c2', 'ammonia;(3-guanidinophenyl) 4-guanidinobenzoate', 'CYAAFQwANfwQ97THyQ7P2DcrrQBXn9OSqdEvTUlCswQYnQANbT9MKZn7HW0jOJsn^af3IoTQSDC5nZgkK0szU1wVJl5sQ5^WcLiFYuzyoHob2h4KUlhrpgUnC8Qmr6DgAOKayOgsG6SjYtB^8GcdfuNmD54JzlJTCXg1t4Yby9KMHpXwmJ^OPsib$8deJ7nyspkMLPHu g3Qi7m7lBQGvXbRBm71ddMJUNXerKGcf6^DpdMuifNXe9jBsucqG^^eefd30Smhn0$i3leaeIODPgvl3s0XrlfKc3LqvWLbgeu11hnvzxxdvarkzm7^83fIvPsi8P6r1gOulhLx5g1n9cuicO$jHeswMJo7KTa1NMXM8mzoIFzHLVnIlqqU0VoC0PFFDIhTucg5oRYmz FspLsl98NtKhT1UpRQ1JlbNDSXIacoriVLQ3o2KAWhoHg8MVCK7iOO2V^P0p^PKrYgZAumN', 'InChI=1S/C15H16N6O2.H3N/c16-14(17)20-10-6-4-9(5-7-10)13(22)23-12-3-1-2-11(8-12)21-15(18)19;/h1-8H,(H4,16,17,20)(H4,18,19,21);1H3', 'AuxInfo=1/1/N:2,4,1,11,12,13,14,5,10,15,6,3,8,17,21,18,19,22,23,16,20,9,7;24/E:(4,5)(6,7)(16,17)(18,19);/rA:24CCCCCCOCOCCCCCCNCNNNCNNN/rB:s1;d-1;d-2;s3;s4d-5;s3;s7;d8;s8;s10;d+10;d-11;s12;s13d-14;s15; s16;s17;d17;s6;s20;d21;s21;;/rC:7.7804,-13.7476,0;7.3679,-14.4621,0;7.3679,-13.0331,0;6.5429,-14.4621,0;6.5429,-13.0331,0;6.1304,-13.7476,0;7.7804,-12.3187,0;8.6054,-12.3187,0;9.018,-13.0331,0;9.018,- 11.6042,0;8.6054,-10.8897,0;9.843,-11.6042,0;9.018,-10.1752,0;10.2555,-10.8897,0;9.843,-10.1752,', 'JVFKIWFOIJZDPQ-UHFFFAOYSA-N', '1010:W6HGCJQAZ73NEY4RTS7RWE9C4A84YQ', '[c]1:[c](-[#8]-[#6](-[c]2:[c]:[c]:[c](-[#7]-[#6](=[#7])-[#7]):[c]:[c]2)=[#8]):[c]:[c](-[#7]-[#6](-[#7])=[#7]):[c]:[c]1.[#7]', 'c1c(OC(c2ccc(NC(=N)N)cc2)=O)cc(NC(N)=N)cc1.N', '00.881', '1.192', '0', '0', 'TRUE', '-3.1e-002\r\n-5.81e-002\r\n8.72e-002\r\n-4.37e-002\r\n-1.27e-002\r\n2.35e-002\r\n-0.2743\r\n0.2977\r\n-0.2603\r\n4.75e-002\r\n-4.73e-002\r\n-4.73e-002\r\n-4.3e-002\r\n-4.3e-002\r\n2.09e-002\r\n-0.234\r\n0.1456\r\n-0.2774\r\n-0.2793\r\n-0.2339\r\n0.1456\r\n-0.2793\r\n-0.2774\r\n-0.344', '0', '-0.461', 'C15H19N7O2', '0329.16', '-1.946', '0329.357', '8.19 9.25 9.74', '2', '4', '3', '9', '12', '2', '24', '24', '7', '9', '009', '11', '19', '0', '2', '007', '0185.1', '358.86', '', '', '', '', '', '', '', '', '', '', '', 'C/2=C(OC(=O)/C/1=C/C=C(NC(N)=N)\\C=C1)/C=C(NC(=N)N)\\C=C2.N', 'N=C(N)Nc2ccc(C(=O)Oc1cccc(NC(=N)N)c1)cc2', 'D6', 'Not Available', 'd(CAG)n huntingtin', '356', 'Under Investigation', 'Huntington Disease (HD)', '22252896', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(357, '1727', '1727', 'Nc1ccncc1', 'pyridin-4-amine', 'CYAAFQwAzdwQNYUOzsb1sGOqRyPLQh5eWebiLO5plc2LkSCdioFemjMHJEgfVaV8iuo^TIM4o98TkBplmXTzzyBA8ff8DZB06JsPbYXaZ0COsCDVZctORIRfERG$xWFtNj88uf1R1SjaMEOiylbPMm7ERqMLhTrcCviivDnfPzQGF74WI7wV8LXM2t5l42GH0Lq4ITub Mxz54SOc3twRdJ^^Rx43Rtg$GiDGXOw1d0rauuxR5uIdaNp^ON0DHx3w6dvzlC3feBminmj3vXL43sA^mO5LzTJEec1In5mbjS8Fy1JW5udHORKi6wbY1RQRZtMfRYVRWFgWEpeIRSFIRgGgvAwb9N55$vsKf9EApsH', 'InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)', 'AuxInfo=1/1/N:4,5,6,7,3,1,2/E:(1,2)(3,4)/rA:13NNCCCCCHHHHHH/rB:;s1;d+3;s3;d-2s4;s2d-5;s4;s5;s6;s7;s1;s1;/rC:2.402,0,-.0002;-1.8029,.0001,-.0001;.9924,-.0001,.0002;.2944,1.2026,.0002;.2944,-1.2026,.000 1;-1.0901,1.1488,-.0001;-1.0902,-1.1488,0;.8069,2.1588,.0002;.8067,-2.1588,.0001;-1.6813,2.0587,-.0001;-1.6814,-2.0587,-.0001;2.9084,-.8754,.0003;2.9083,.8755,.0004;', 'NUKYPUAOHBNCPY-UHFFFAOYSA-N', '1010:78H9FMV71HP6HGKRU837SSBMPXEAD5', '[#7](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[n]1):[c](-[#1]):[c]1-[#1]', 'N([H])([H])c(c([H])c([H])n1)c([H])c1[H]', '-00.068', '-0.068', '0', '0', 'TRUE', '-0.3026\r\n-0.2646\r\n1.48e-002\r\n-2.61e-002\r\n-2.61e-002\r\n2.83e-002\r\n2.83e-002\r\n6.55e-002\r\n6.55e-002\r\n8.39e-002\r\n8.39e-002\r\n0.1242\r\n0.125', '0', '0.476', 'C5H6N2', '0094.0531', '-0.64', '0094.1145', '9.11', '1', '1', '0', '1', '06', '1', '7', '7', '7', '3', '002', '02', '6', '0', '1', '000', '0038.9', '109.92', '', '1.12418', '1.2329', '8.22', '5.48', '2.14865', '2.74', '57.999', '88.129', '73.74', '', 'N(/C1=C([H])/C([H])=N\\C([H])=C1\\[H])([H])[H]', 'Nc1ccncc1', 'Dalfampridine', '4 Aminopyridine; Fampridine SR; Pymadine; VMI 103', 'Potassium voltage-gated channel subfamily A member 1', '1727', 'FDA approved', 'Spinocerebellar Ataxia 1', '27381005', 'Spinocerebellar Ataxia 1', 'SPINOCEREBELLAR ATROPHY I\nOLIVOPONTOCEREBELLAR ATROPHY I; OPCA1\nOPCA I\nCEREBELLOPARENCHYMAL DISORDER I; CPD1\nMENZEL TYPE OPCA\nOLIVOPONTOCEREBELLAR ATROPHY IV; OPCA4\nOPCA IV\nSCHUT-HAYMAKER TYPE OPCA'),
(358, '1727', '1727', 'Nc1ccncc1', 'pyridin-4-amine', 'CYAAFQwAzdwQNYUOzsb1sGOqRyPLQh5eWebiLO5plc2LkSCdioFemjMHJEgfVaV8iuo^TIM4o98TkBplmXTzzyBA8ff8DZB06JsPbYXaZ0COsCDVZctORIRfERG$xWFtNj88uf1R1SjaMEOiylbPMm7ERqMLhTrcCviivDnfPzQGF74WI7wV8LXM2t5l42GH0Lq4ITub Mxz54SOc3twRdJ^^Rx43Rtg$GiDGXOw1d0rauuxR5uIdaNp^ON0DHx3w6dvzlC3feBminmj3vXL43sA^mO5LzTJEec1In5mbjS8Fy1JW5udHORKi6wbY1RQRZtMfRYVRWFgWEpeIRSFIRgGgvAwb9N55$vsKf9EApsH', 'InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)', 'AuxInfo=1/1/N:4,5,6,7,3,1,2/E:(1,2)(3,4)/rA:13NNCCCCCHHHHHH/rB:;s1;d+3;s3;d-2s4;s2d-5;s4;s5;s6;s7;s1;s1;/rC:2.402,0,-.0002;-1.8029,.0001,-.0001;.9924,-.0001,.0002;.2944,1.2026,.0002;.2944,-1.2026,.000 1;-1.0901,1.1488,-.0001;-1.0902,-1.1488,0;.8069,2.1588,.0002;.8067,-2.1588,.0001;-1.6813,2.0587,-.0001;-1.6814,-2.0587,-.0001;2.9084,-.8754,.0003;2.9083,.8755,.0004;', 'NUKYPUAOHBNCPY-UHFFFAOYSA-N', '1010:78H9FMV71HP6HGKRU837SSBMPXEAD5', '[#7](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[n]1):[c](-[#1]):[c]1-[#1]', 'N([H])([H])c(c([H])c([H])n1)c([H])c1[H]', '-00.068', '-0.068', '0', '0', 'TRUE', '-0.3026\r\n-0.2646\r\n1.48e-002\r\n-2.61e-002\r\n-2.61e-002\r\n2.83e-002\r\n2.83e-002\r\n6.55e-002\r\n6.55e-002\r\n8.39e-002\r\n8.39e-002\r\n0.1242\r\n0.125', '0', '0.476', 'C5H6N2', '0094.0531', '-0.64', '0094.1145', '9.11', '1', '1', '0', '1', '06', '1', '7', '7', '7', '3', '002', '02', '6', '0', '1', '000', '0038.9', '109.92', '', '1.12418', '1.2329', '8.22', '5.48', '2.14865', '2.74', '57.999', '88.129', '73.74', '', 'N(/C1=C([H])/C([H])=N\\C([H])=C1\\[H])([H])[H]', 'Nc1ccncc1', 'Dalfampridine', '4 Aminopyridine; Fampridine SR; Pymadine; VMI 103', 'Potassium voltage-gated channel subfamily A member 1', '1727', 'Under Investigation', 'Multiple Sclerosis', '23184313', 'Multiple Sclerosis', 'DISSEMINATED SCLEROSIS'),
(359, '1727', '1727', 'Nc1ccncc1', 'pyridin-4-amine', 'CYAAFQwAzdwQNYUOzsb1sGOqRyPLQh5eWebiLO5plc2LkSCdioFemjMHJEgfVaV8iuo^TIM4o98TkBplmXTzzyBA8ff8DZB06JsPbYXaZ0COsCDVZctORIRfERG$xWFtNj88uf1R1SjaMEOiylbPMm7ERqMLhTrcCviivDnfPzQGF74WI7wV8LXM2t5l42GH0Lq4ITub Mxz54SOc3twRdJ^^Rx43Rtg$GiDGXOw1d0rauuxR5uIdaNp^ON0DHx3w6dvzlC3feBminmj3vXL43sA^mO5LzTJEec1In5mbjS8Fy1JW5udHORKi6wbY1RQRZtMfRYVRWFgWEpeIRSFIRgGgvAwb9N55$vsKf9EApsH', 'InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)', 'AuxInfo=1/1/N:4,5,6,7,3,1,2/E:(1,2)(3,4)/rA:13NNCCCCCHHHHHH/rB:;s1;d+3;s3;d-2s4;s2d-5;s4;s5;s6;s7;s1;s1;/rC:2.402,0,-.0002;-1.8029,.0001,-.0001;.9924,-.0001,.0002;.2944,1.2026,.0002;.2944,-1.2026,.000 1;-1.0901,1.1488,-.0001;-1.0902,-1.1488,0;.8069,2.1588,.0002;.8067,-2.1588,.0001;-1.6813,2.0587,-.0001;-1.6814,-2.0587,-.0001;2.9084,-.8754,.0003;2.9083,.8755,.0004;', 'NUKYPUAOHBNCPY-UHFFFAOYSA-N', '1010:78H9FMV71HP6HGKRU837SSBMPXEAD5', '[#7](-[#1])(-[#1])-[c](:[c](-[#1]):[c](-[#1]):[n]1):[c](-[#1]):[c]1-[#1]', 'N([H])([H])c(c([H])c([H])n1)c([H])c1[H]', '-00.068', '-0.068', '0', '0', 'TRUE', '-0.3026\r\n-0.2646\r\n1.48e-002\r\n-2.61e-002\r\n-2.61e-002\r\n2.83e-002\r\n2.83e-002\r\n6.55e-002\r\n6.55e-002\r\n8.39e-002\r\n8.39e-002\r\n0.1242\r\n0.125', '0', '0.476', 'C5H6N2', '0094.0531', '-0.64', '0094.1145', '9.11', '1', '1', '0', '1', '06', '1', '7', '7', '7', '3', '002', '02', '6', '0', '1', '000', '0038.9', '109.92', '', '1.12418', '1.2329', '8.22', '5.48', '2.14865', '2.74', '57.999', '88.129', '73.74', '', 'N(/C1=C([H])/C([H])=N\\C([H])=C1\\[H])([H])[H]', 'Nc1ccncc1', 'Dalfampridine', '4 Aminopyridine; Fampridine SR; Pymadine; VMI 103', 'Potassium voltage-gated channel subfamily A member 1', '1727', 'Under Investigation', 'Hereditary spastic paraplegia', '25808501', 'Hereditary spastic paraplegia', 'SPG3\nSTRUMPELL DISEASE\nFAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1'),
(360, '1697', '1697', 'O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc4ccccc4)cc12', '5,6-dianilinoisoindoline-1,3-dione', 'CYAAFQwAxcwQu^QhayMVbBSoYy$qIsYP$NKv$hPG97qKwKSBI4piEyPcaiKIMXHhZajDIyoueo^C^FX1uD2mRE0yga$p1NNgSrV3KTwxyRPZd65^vVhtgcfZDRIE3lOgWXbXAsI8HeNQk0xB5yOlRCBHO6Q7FOCGtE67Y4iNjN4BG7x4czSiO^wA7QbpNJkKmn7jrbD8 PfaGYPOnyhN9$wJzsB0AmXSe0RP2c909bLhySmhTT5ANLHOL4cNnrOoTm2SbOfBl4qI90g0S$oA9pWR6hOcnqO$VL43pOO3YXvKHuwfxRZsefzV7mvwHR$QXx31zgPbosMafDddZ5KNxP1kg17VO6gM6500E6UfSW5w6kH$HKduS8$rd1$41NBkuIWcOi$aTwwFr6yp7 Vs$kUJ$fFrwTgehlKOuU1zNSduClX61Kh4$JCL2RYygpZ8bvfuaea3Wc$sUjhr8pQdlrB8jYHwHmXXmENb$KtiYOpByR6s40', 'InChI=1S/C20H15N3O2/c24-19-15-11-17(21-13-7-3-1-4-8-13)18(12-16(15)20(25)23-19)22-14-9-5-2-6-10-14/h1-12,21-22H,(H,23,24,25)', 'AuxInfo=1/1/N:24,25,20,22,21,23,16,18,17,19,10,11,14,15,6,7,8,9,12,13,3,4,5,1,2/E:(1,2)(3,4,5,6)(7,8,9,10)(11,12)(13,14)(15,16)(17,18)(19,20)(21,22)(24,25)/rA:40OONNNCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH H/rB:;;;;;s6;s3;s4d-8;d-6s8;d-7s9;d1s5s6;d2s5s7;s3;s4;d+14;d+15;s14;s15;s16;s17;d-18;d-19;d-20s22;d-21s23;s10;s11;s3;s4;s5;s16;s17;s18;s19;s20;s21;s22;s23;s24;s25;/rC:-2.2426,4.0513,.5552;2.2406,4.053 3,-.5544;-1.3788,-1.2842,.3397;1.3797,-1.2835,-.3406;-.0011,4.4575,.0006;-.6745,2.3064,.1658;.67', 'AAALVYBICLMAMA-UHFFFAOYSA-N', '1010:U9887G352ET88S1GV14JMQEKJC4BXG', '[#8]=[#6]1-[c]2:[c](-[#6](-[#7]1-[#1])=[#8]):[c](-[#1]):[c](:[c](:[c]2-[#1])-[#7](-[#1])-[c]3:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#7](-[#1])-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#1]):[ c](-[#1]):[c]4-[#1]', 'O=C1c2c(C(N1[H])=O)c([H])c(c(c2[H])N([H])c3c([H])c([H])c([H])c([H])c3[H])N([H])c4c([H])c([H])c([H])c([H])c4[H]', '03.756', '3.951', '0', '0', 'TRUE', '-0.2715\r\n-0.2715\r\n-0.2577\r\n-0.2577\r\n-0.2475\r\n5.17e-002\r\n5.17e-002\r\n3.82e-002\r\n3.82e-002\r\n-2.89e-002\r\n-2.89e-002\r\n0.2504\r\n0.2504\r\n1.89e-002\r\n1.89e-002\r\n-4.39e-002\r\n-4.39e-002\r\n-4.39e-002\r\n-4.39e-002\r\n-6.07e-002\r\n-6.07e-002\r\n-6.07e-002\r\n-6.07e-002\r\n-6.22e-0', '0', '3.769', 'C20H15N3O2', '0329.116', '-5.209', '0329.352', '-4.27 -1.31 8.3', '2', '3', '2', '8', '18', '3', '25', '28', '19', '11', '005', '03', '15', '0', '4', '004', '0070.23', '307.29', '', '1.94799', '1.2774', '132.29', '38.41', '4.32603', '93.88', '1,070.58', '146.574', '245.93', '-1.e-002 0', 'O=C4NC(=O)/C/3=C/C(N/C/1=C/C=C\\C=C1)=C(N/C/2=C/C=C\\C=C2)\\C=C34', 'O=c3[nH]c(=O)c4cc(Nc1ccccc1)c(Nc2ccccc2)cc34', 'DAPH', '4,5-dianilinophthalimide; Cgp 52411; LP00236', 'Amyloid beta A4 protein', '1697', 'Under Investigation', 'Alzheimer disease (AD)', '15388848', 'Alzheimer disease (AD)', 'PRESENILE AND SENILE DEMENTIA'),
(361, '9947999', '9947999', 'N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13', '(1<I>R</I>,4<I>S</I>)-4-(3,4-dichlorophenyl)tetralin-1-amine', 'CYAAFQwAZcwQ2O^DXSV9Au7BuiNeITZFL60tu2WPia0h^BDcN3u7MWx54Nq5pXC8UR6qwwzmnxDyVZ9mm967fO9EZQppsKD9M^GE27lBj1cicy1fh454XGO0w27$SZNFh^PY49v^5fmYwBgTbm^34VNsNKYeftVDq16o8Lf5YT4aTUXe4Bza9huAQZTDvvAgrJeSV4fp RoytJceZvuyUFKeZbYlmA1wXTr1x5WuRpbNH2nDe6wGN4KCHgVzjPP3kNOqzwHGkMEJu0KiHNfelliHYu5Bk9jKVuNw3ZKNHmhRgwhYRF2VjI5ls2MCTr^aclvAxZVK859aJwVlE2kQyhT9NXqAIBOCPD^4KBfbF8k9Ctq6pVprrJWXLoNpjybrQdTC3Gl3iyht14Uc1 jYYxta88Y5RZ18z6sS5NMmKEMhOyg39VXdWojRJQ8zF80^mm9M3LAtoqgu4wzos84tMIWkviXLVbiflOZWBdmY$cfaUcBxzr', 'InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1', 'AuxInfo=1/0/N:15,16,11,12,14,5,18,6,13,10,4,8,9,19,17,7,2,1,3/it:im/rA:34ClClNC.oCCC.oCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:;;;s4;s5;s3s6;s4;s7s8;s4;d+8;d+9;d+10;s10;s11;s12d-15;s1s13;d-14;s2d-17s18;s4;s5;s5 ;s6;s6;s7;s11;s12;s3;s3;s13;s14;s15;s16;s18;/rC:3.4385,-.3817,2.5653;5.487,-.4019,.06;-4.4052,1.5453,.4327;-.3658,.8006,-.7672;-.7176,2.1099,-.0384;-2.213,2.3724,-.1107;-2.978,1.2767,.6427;-1.3109,-.3 481,-.4221;-2.542,-.1232,.2353;1.1106,.4955,-.5414;-.9816,-1.6585,-.824;-3.3437,-1.2329,.5675;1.', 'SRPXSILJHWNFMK-MEDUHNTESA-N', '1010:R655Y2V6RSRR4WC38FSVZV8HZKHG4F', '[#17]-[c](:[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@@]2(-[#1])-[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7](-[#1])-[#1])-[#17]):[c]1-[#1]', 'Clc(c(c([H])c([H])c1[C@@]2([H])c3c(c([H])c([H])c([H])c3[H])[C@@]([H])(C([H])([H])C2([H])[H])N([H])[H])Cl)c1[H]', '04.564', '4.564', '0', '0', 'TRUE', '-8.27e-002\r\n-8.27e-002\r\n-0.3239\r\n9.4e-003\r\n-4.05e-002\r\n-3.29e-002\r\n2.98e-002\r\n-3.57e-002\r\n-2.74e-002\r\n-3.89e-002\r\n-5.81e-002\r\n-5.72e-002\r\n-3.82e-002\r\n-5.69e-002\r\n-6.19e-002\r\n-6.19e-002\r\n5.94e-002\r\n-4.18e-002\r\n5.92e-002\r\n4.01e-002\r\n2.76e-002\r\n2.76e-002\r\n2.', '1', '3.568', 'C16H15Cl2N', '0291.058', '-6.328', '0292.203', '10.03', '0', '1', '0', '9', '12', '2', '19', '21', '19', '6', '001', '02', '15', '0', '3', '001', '0026.02', '271.56', '', '2.10254', '1.3081', '14.74', '9.35', '3.43441', '5.39', '779.089', '56.765', '222.94', '', 'Cl/C/3=C(Cl)/C=C\\C(C1CCC(N)/C/2=C/C=C\\C=C12)=C3', 'NC3CCC(c1ccc(Cl)c(Cl)c1)c2ccccc23', 'Dasotraline', 'Not Available', 'Sodium-dependent dopamine transporter', '9947999', 'Phase III Completed', 'Attention Deficit Hyperactivity Disorder (ADHD)', '25948101', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD'),
(362, '9947999', '9947999', 'N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13', '(1<I>R</I>,4<I>S</I>)-4-(3,4-dichlorophenyl)tetralin-1-amine', 'CYAAFQwAZcwQ2O^DXSV9Au7BuiNeITZFL60tu2WPia0h^BDcN3u7MWx54Nq5pXC8UR6qwwzmnxDyVZ9mm967fO9EZQppsKD9M^GE27lBj1cicy1fh454XGO0w27$SZNFh^PY49v^5fmYwBgTbm^34VNsNKYeftVDq16o8Lf5YT4aTUXe4Bza9huAQZTDvvAgrJeSV4fp RoytJceZvuyUFKeZbYlmA1wXTr1x5WuRpbNH2nDe6wGN4KCHgVzjPP3kNOqzwHGkMEJu0KiHNfelliHYu5Bk9jKVuNw3ZKNHmhRgwhYRF2VjI5ls2MCTr^aclvAxZVK859aJwVlE2kQyhT9NXqAIBOCPD^4KBfbF8k9Ctq6pVprrJWXLoNpjybrQdTC3Gl3iyht14Uc1 jYYxta88Y5RZ18z6sS5NMmKEMhOyg39VXdWojRJQ8zF80^mm9M3LAtoqgu4wzos84tMIWkviXLVbiflOZWBdmY$cfaUcBxzr', 'InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1', 'AuxInfo=1/0/N:15,16,11,12,14,5,18,6,13,10,4,8,9,19,17,7,2,1,3/it:im/rA:34ClClNC.oCCC.oCCCCCCCCCCCCHHHHHHHHHHHHHHH/rB:;;;s4;s5;s3s6;s4;s7s8;s4;d+8;d+9;d+10;s10;s11;s12d-15;s1s13;d-14;s2d-17s18;s4;s5;s5 ;s6;s6;s7;s11;s12;s3;s3;s13;s14;s15;s16;s18;/rC:3.4385,-.3817,2.5653;5.487,-.4019,.06;-4.4052,1.5453,.4327;-.3658,.8006,-.7672;-.7176,2.1099,-.0384;-2.213,2.3724,-.1107;-2.978,1.2767,.6427;-1.3109,-.3 481,-.4221;-2.542,-.1232,.2353;1.1106,.4955,-.5414;-.9816,-1.6585,-.824;-3.3437,-1.2329,.5675;1.', 'SRPXSILJHWNFMK-MEDUHNTESA-N', '1010:R655Y2V6RSRR4WC38FSVZV8HZKHG4F', '[#17]-[c](:[c](:[c](-[#1]):[c](-[#1]):[c]1-[#6@@]2(-[#1])-[c]3:[c](:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]3-[#1])-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7](-[#1])-[#1])-[#17]):[c]1-[#1]', 'Clc(c(c([H])c([H])c1[C@@]2([H])c3c(c([H])c([H])c([H])c3[H])[C@@]([H])(C([H])([H])C2([H])[H])N([H])[H])Cl)c1[H]', '04.564', '4.564', '0', '0', 'TRUE', '-8.27e-002\r\n-8.27e-002\r\n-0.3239\r\n9.4e-003\r\n-4.05e-002\r\n-3.29e-002\r\n2.98e-002\r\n-3.57e-002\r\n-2.74e-002\r\n-3.89e-002\r\n-5.81e-002\r\n-5.72e-002\r\n-3.82e-002\r\n-5.69e-002\r\n-6.19e-002\r\n-6.19e-002\r\n5.94e-002\r\n-4.18e-002\r\n5.92e-002\r\n4.01e-002\r\n2.76e-002\r\n2.76e-002\r\n2.', '1', '3.568', 'C16H15Cl2N', '0291.058', '-6.328', '0292.203', '10.03', '0', '1', '0', '9', '12', '2', '19', '21', '19', '6', '001', '02', '15', '0', '3', '001', '0026.02', '271.56', '', '2.10254', '1.3081', '14.74', '9.35', '3.43441', '5.39', '779.089', '56.765', '222.94', '', 'Cl/C/3=C(Cl)/C=C\\C(C1CCC(N)/C/2=C/C=C\\C=C12)=C3', 'NC3CCC(c1ccc(Cl)c(Cl)c1)c2ccccc23', 'Dasotraline', 'Not Available', 'Sodium-dependent noradrenaline transporter', '9947999', 'Phase III Completed', 'Attention Deficit Hyperactivity Disorder (ADHD)', '25948101', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'HYPERACTIVITY OF CHILDHOOD'),
(363, '9832404', '9832404', 'CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O', '(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-car bonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid', 'CYAAFQwAZcwQrWWVDI98VahrUqdPvS7oUuZDQ1L9p^i2PqsKSN0Oh7SO$YTUoUh85VTVpJllO7P0pm4JU9V$H6IdiKnpPdy48ACmQHd45riaFtZACwUb7zPl6sW7zXuPkZU7S5JRR^v35^v^0ffc5k8dqpz3Sl6W9We81Zlbbw8t6PnVX0wIi35uXR9drW23aXffGruj trNZKat8HRmaeOyWKSrXZYXRbEVUZkY8taXx77BFJWlutCv8drSNibrjVqNH9iVTrm$2jNBfj^cd$3Wv55io6E9YbAnn8763o2a147^7R0ZZaMyXMN2Jt5RY1Z5aMHu5X29iv9R1XXLRmGdJY7hyU5Xozz4myVMKs9K5domWqG85TmvEyjVjp$Oi$^gfyoFcnVo92yCU 2Y7cMyl6QwjoCN5XsL4ML4b0c6zD^O4xzqjz8EXUDrfEjmWa^w3yWecpx7ZX4ojRA7vZr$U7qt9bsbT9w9jCOEM721JTLxth', 'InChI=1S/C36H60N10O12/c1-6-18(4)28(35(56)46-14-8-9-23(46)31(52)41-21(36(57)58)11-12-25(38)48)44-30(51)22(16-47)42-33(54)27(17(2)3)43-32(53)24-10-7-13-45(24)34(55)19(5)40-29(50)20(37)15-26(39)49/h17-24 ,27-28,47H,6-16,37H2,1-5H3,(H2,38,48)(H2,39,49)(H,40,50)(H,41,52)(H,42,54)(H,43,53)(H,44,51)(H,57,58)/t18-,19-,20-,21-,22-,23-,24-,27-,28-/m0/s1', 'AuxInfo=1/1/N:45,49,50,39,48,36,31,26,24,29,47,53,33,25,57,51,41,32,40,55,44,43,23,27,56,58,38,28,54,42,34,35,46,37,30,52,20,21,22,19,17,18,16,15,14,13,7,11,12,10,5,2,3,6,4,1,8,9/E:(2,3)(57,58)/it:im/ rA:118OOOOOOOOOOOONNNNNNNNNNC.eCCCC.eC.oCCCC.oCCCCCC.eCC.oCCC.oC.eCCCCCCCCCCC.oCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;;;;;s13;s23;s13;s24s25;s14;p15;s27;d1 s13s28;s29;s28;s14s31;d2s17P23;d3s16P27;s32;d4s14;p16;N32;n19s37;s38;d5s15;n18s42;n17;s36;d6s18s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r\n-0.2756\r\n-0.2756\r\n-0.2753\r\n-0.2755\r\n-0.2756\r\n-0.3939\r\n-0.3303\r\n-0.2647\r\n-0.2759\r\n-0.278\r\n-0.2779\r\n-0.2884\r\n-0.2884\r\n-0.3018\r\n-0.3019\r\n-0.3014\r\n-0.3001\r\n-0.3027\r\n-0.3197\r\n-0.3292\r\n-0.3291\r\n0.1021\r\n-2.41e-002\r\n1.5e-002\r\n-3.51e-002\r\n0.1021\r\n0.102\r\n-', '1', '-5.745', 'C36H60N10O12', '0824.439', '-5.827', '0824.921', '3.42 6.94', '10', '9', '10', '49', '00', '0', '58', '59', '81', '10', '022', '13', '60', '0', '2', '022', '0355.84', '876.87', '', '', '', '', '', '', '', '', '', '', '', 'O=C(N1[C@H](C(=O)NC(CCC(=O)N)C(O)=O)CCC1)C(NC(=O)C(NC(=O)C(NC(=O)[C@H]2N(C(=O)C(NC(=O)C(N)CC(=O)N)C)CCC2)C(C)C)CO)C(CC)C', 'CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)[C@@H]1CCCN1C(=O)C(C)NC(=O)C(N)CC(N)=O)C(C)C)C(=O)N2CCC[C@H]2C(=O)NC(CCC(N)=O)C(=O)O', 'Davunetide', 'AL-108; J-013876', 'Microtubule-associated protein RP/EB family member 3', '9832404', 'Failed in Phase II/III', 'Progressive Supranuclear Palsy(PSP)', '24873720', 'Progressive Supranuclear Palsy(PSP)', 'PSP\nSTEELE-RICHARDSON-OLSZEWSKI SYNDROME'),
(364, '9832404', '9832404', 'CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)N)C(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)O', '(2<I>S</I>)-5-amino-2-[[(2<I>S</I>)-1-[(2<I>S</I>,3<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-2-[[(2<I>S</I>)-1-[(2<I>S</I>)-2-[[(2<I>S</I>)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-car bonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid', 'CYAAFQwAZcwQrWWVDI98VahrUqdPvS7oUuZDQ1L9p^i2PqsKSN0Oh7SO$YTUoUh85VTVpJllO7P0pm4JU9V$H6IdiKnpPdy48ACmQHd45riaFtZACwUb7zPl6sW7zXuPkZU7S5JRR^v35^v^0ffc5k8dqpz3Sl6W9We81Zlbbw8t6PnVX0wIi35uXR9drW23aXffGruj trNZKat8HRmaeOyWKSrXZYXRbEVUZkY8taXx77BFJWlutCv8drSNibrjVqNH9iVTrm$2jNBfj^cd$3Wv55io6E9YbAnn8763o2a147^7R0ZZaMyXMN2Jt5RY1Z5aMHu5X29iv9R1XXLRmGdJY7hyU5Xozz4myVMKs9K5domWqG85TmvEyjVjp$Oi$^gfyoFcnVo92yCU 2Y7cMyl6QwjoCN5XsL4ML4b0c6zD^O4xzqjz8EXUDrfEjmWa^w3yWecpx7ZX4ojRA7vZr$U7qt9bsbT9w9jCOEM721JTLxth', 'InChI=1S/C36H60N10O12/c1-6-18(4)28(35(56)46-14-8-9-23(46)31(52)41-21(36(57)58)11-12-25(38)48)44-30(51)22(16-47)42-33(54)27(17(2)3)43-32(53)24-10-7-13-45(24)34(55)19(5)40-29(50)20(37)15-26(39)49/h17-24 ,27-28,47H,6-16,37H2,1-5H3,(H2,38,48)(H2,39,49)(H,40,50)(H,41,52)(H,42,54)(H,43,53)(H,44,51)(H,57,58)/t18-,19-,20-,21-,22-,23-,24-,27-,28-/m0/s1', 'AuxInfo=1/1/N:45,49,50,39,48,36,31,26,24,29,47,53,33,25,57,51,41,32,40,55,44,43,23,27,56,58,38,28,54,42,34,35,46,37,30,52,20,21,22,19,17,18,16,15,14,13,7,11,12,10,5,2,3,6,4,1,8,9/E:(2,3)(57,58)/it:im/ rA:118OOOOOOOOOOOONNNNNNNNNNC.eCCCC.eC.oCCCC.oCCCCCC.eCC.oCCC.oC.eCCCCCCCCCCC.oCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;;;;;;;;;;;;;;;;s13;s23;s13;s24s25;s14;p15;s27;d1 s13s28;s29;s28;s14s31;d2s17P23;d3s16P27;s32;d4s14;p16;N32;n19s37;s38;d5s15;n18s42;n17;s36;d6s18s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r\n-0.2756\r\n-0.2756\r\n-0.2753\r\n-0.2755\r\n-0.2756\r\n-0.3939\r\n-0.3303\r\n-0.2647\r\n-0.2759\r\n-0.278\r\n-0.2779\r\n-0.2884\r\n-0.2884\r\n-0.3018\r\n-0.3019\r\n-0.3014\r\n-0.3001\r\n-0.3027\r\n-0.3197\r\n-0.3292\r\n-0.3291\r\n0.1021\r\n-2.41e-002\r\n1.5e-002\r\n-3.51e-002\r\n0.1021\r\n0.102\r\n-', '1', '-5.745', 'C36H60N10O12', '0824.439', '-5.827', '0824.921', '3.42 6.94', '10', '9', '10', '49', '00', '0', '58', '59', '81', '10', '022', '13', '60', '0', '2', '022', '0355.84', '876.87', '', '', '', '', '', '', '', '', '', '', '', 'O=C(N1[C@H](C(=O)NC(CCC(=O)N)C(O)=O)CCC1)C(NC(=O)C(NC(=O)C(NC(=O)[C@H]2N(C(=O)C(NC(=O)C(N)CC(=O)N)C)CCC2)C(C)C)CO)C(CC)C', 'CCC(C)C(NC(=O)C(CO)NC(=O)C(NC(=O)[C@@H]1CCCN1C(=O)C(C)NC(=O)C(N)CC(N)=O)C(C)C)C(=O)N2CCC[C@H]2C(=O)NC(CCC(N)=O)C(=O)O', 'Davunetide', 'AL-108; J-013876', 'Microtubule-associated protein RP/EB family member 1', '9832404', 'Failed in Phase II/III', 'Progressive Supranuclear Palsy(PSP)', '24873720', 'Progressive Supranuclear Palsy(PSP)', 'PSP\nSTEELE-RICHARDSON-OLSZEWSKI SYNDROME'),
(365, '23156961', '23156961', 'NC(=N)c1ccc(nc1)c2oc(cc2)c3oc(cc3)c4ccc(cn4)C(=N)N', '6-[5-[5-(5-carbamimidoyl-2-pyridyl)-2-furyl]-2-furyl]pyridine-3-carboxamidine', 'CYAAFQwAncwQ2K^UAr2VmrSckBPcYoLaYC^IaaZHeJrAkRq0VgjotXV^QrLUkm0RkeenAI3f^XMmOId0UP9A8cH1EgTfddO$Yj1HCcTigraxU9ypJNsRfewfF3st2JG6^ykLIiY8hU4$h0Kh5SxTPXgvq3LXDq1m66$$xO$cVywlkD79IjXAKUNggPpn$sHxBsgxP0la cGO5lg$BrVFEjYMX1OwHesEes8MkW0D163Re3wCRZP36cT5STIx$3n4lKOPOpS8p8c1WzUo9vjH1gfn$k8Yi5f^HfhV8COf2FR8JXHXfXuYcvHHMEDNUzl35f1WCxyr1^h^Bec2nh8EB79cYd^$H55A3KdwkfaX4We0o0f^jVdFkd6rUfozdefGdR6dtbm8dz7C9tduT 48dXeu2bZSP6q0r9efSm$O$1snIIgr7eSkT6v0lznz4ZIRS8b1v6vTU8PL7gBJ^I3E4xgu07049Ug15Xn$oPhDx9E^qHuI^e', 'InChI=1S/C20H16N6O2/c21-19(22)11-1-3-13(25-9-11)15-5-7-17(27-15)18-8-6-16(28-18)14-4-2-12(10-26-14)20(23)24/h1-10H,(H3,21,22)(H3,23,24)', 'AuxInfo=1/1/N:23,24,19,20,15,16,13,14,25,26,22,21,18,17,12,11,10,9,27,28,5,7,6,8,3,4,1,2/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)(17,18)(19,20)(21,22,23,24)(25,26)(27,28)/gE:(1,2)/rA:44OONNNN NNCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;;;;s2;s1s9;s2;s1;d-10;d-9;d-12s13;d-11s14;d+4s11;d+3s12;s18;s17;;;d-19s22;d-20s21;s3d-22;s4d-21;s5d-7s22;s6d-8s21;s14;s13;s15;s16;s19;s20;s23;s24;s26;s25; s5;s5;s6;s6;s7;s8;/rC:9.3346,.6647,0;6.9716,-.6647,0;11.1712,1.6592,0;6.001,-3.1592,0;12.9033,4.', 'FAOLLIBMTHLUNT-UHFFFAOYSA-N', '1010:24AAJ8GR9SV6EFCBH6DZTB68J48JG9', '[o]1:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#6](=[#7]-[#1])-[#7](-[#1])-[#1]):[c](-[#1]):[n]2):[c](-[#1]):[c](-[#1]):[c]1-[c]3:[c](-[#1]):[c](-[#1]):[c](-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#6](=[#7]-[#1] )-[#7](-[#1])-[#1]):[c](-[#1]):[n]4):[o]3', 'o1c(c2c([H])c([H])c(C(=N[H])N([H])[H])c([H])n2)c([H])c([H])c1c3c([H])c([H])c(c4c([H])c([H])c(C(=N[H])N([H])[H])c([H])n4)o3', '02.427', '2.427', '0', '0', 'TRUE', '-0.3054\r\n-0.3054\r\n-0.2534\r\n-0.2534\r\n-0.287\r\n-0.287\r\n-0.2892\r\n-0.2892\r\n0.1129\r\n0.1129\r\n0.1078\r\n0.1078\r\n-2.59e-002\r\n-2.59e-002\r\n-2.63e-002\r\n-2.63e-002\r\n9.37e-002\r\n9.37e-002\r\n-3.3e-002\r\n-3.3e-002\r\n2.88e-002\r\n2.88e-002\r\n-4.81e-002\r\n-4.81e-002\r\n3.8e-002\r\n3.8e-', '0', '2.224', 'C20H16N6O2', '0372.133', '-4.552', '0372.38', '3.65 3.65 8.82 8.82', '4', '2', '2', '7', '22', '4', '28', '31', '23', '12', '008', '06', '16', '0', '4', '005', '0151.79', '380.19', '', '', '', '', '', '', '', '', '', '', '', 'O3/C(/C2=C/C=C(/C/1=N/C=C(C(N)=N)\\C=C1)\\O2)=C\\C=C3\\C\\4=N\\C=C(C(N)=N)/C=C4', 'N=C(N)c4ccc(c3ccc(c2ccc(c1ccc(C(=N)N)cn1)o2)o3)nc4', 'DB1246', 'SCHEMBL3505298', 'r(GGGGCC)exp C9ORF72 RNA', '23156961', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '29113975', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(366, '89354054', '89354054', 'NC(=N)c1ccc(nc1)c2ccc(s2)c3ccc(s3)c4ccc(cn4)C(=N)N', '6-[5-[5-(5-carbamimidoyl-2-pyridyl)-2-thienyl]-2-thienyl]pyridine-3-carboxamidine', 'CYAAFQwAufwQb6vSBfy^XvjZ^pLTsG9dLIJuw66SPLDZISbZ4Hsl85EtJWOnL78OEm7^thTQxiTEkGRGSsMH4UnJrunACiKXR$ltBr835zsv6Yg73fGMPFuGRc2zKJdKvvcg7hb^AEU$LPPEA7wiN0viGomjE3w4rwXsnL3Y4fuSclO1JX80k3rxtpGcWpBjs82HrXuR z9aVPPkziHOseNOcjgkfKxJHaOTnpzF7qdOHTqmK1v9YXBH749W60oGVgwKOn71uKzqzylWyX3m6oq2iYoEpCf$TPWOwn71qoYMk^PaNAi^4KbpZnlFrzxrqMA$rZVZP4GXYBE$68zDwUPvawiyauW36hip6xxXzRvOttBeIWhGzFPTJxNntJTgrz4lhtXct5Vc$6caE jgAfqm753SYcnsTdIo2qlv7iIe0pi6HZDvjm6frRg5YdceB5W6uL9s4XVm5hpz94$utWmfubO1QO3d1FUrXvukrq8IsG7YX2', 'InChI=1S/C20H16N6S2/c21-19(22)11-1-3-13(25-9-11)15-5-7-17(27-15)18-8-6-16(28-18)14-4-2-12(10-26-14)20(23)24/h1-10H,(H3,21,22)(H3,23,24)', 'AuxInfo=1/1/N:23,24,20,19,16,15,14,13,25,26,21,22,17,18,12,11,9,10,27,28,5,7,6,8,3,4,1,2/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)(17,18)(19,20)(21,22,23,24)(25,26)(27,28)/gE:(1,2)/rA:44SSNNNN NNCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;;;;;;s1;s2s9;s2;s1;d-10;d-9;d-11s13;d-12s14;d+3s12;d+4s11;s18;s17;;;d-20s21;d-19s22;s3d-21;s4d-22;s5d-7s21;s6d-8s22;s14;s13;s15;s16;s19;s20;s23;s24;s26;s25; s6;s6;s5;s5;s7;s8;/rC:-2.0161,-.688,-.0491;2.013,.6875,-.0494;-4.9277,-.8169,-.3482;4.9293,.8171', 'QGJLULBHLAQZEK-UHFFFAOYSA-N', '1010:5FFSBDGEWYTQBZQ6XXJK71HTK6DXKM', '[s]1:[c](-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#6](=[#7]-[#1])-[#7](-[#1])-[#1]):[c](-[#1]):[n]2):[c](-[#1]):[c](-[#1]):[c]1-[c]3:[c](-[#1]):[c](-[#1]):[c](-[c]4:[c](-[#1]):[c](-[#1]):[c](-[#6](=[#7]-[#1] )-[#7](-[#1])-[#1]):[c](-[#1]):[n]4):[s]3', 's1c(c2c([H])c([H])c(C(=N[H])N([H])[H])c([H])n2)c([H])c([H])c1c3c([H])c([H])c(c4c([H])c([H])c(C(=N[H])N([H])[H])c([H])n4)s3', '03.544', '3.363', '0', '0', 'TRUE', '-8.67e-002\r\n-8.67e-002\r\n-0.255\r\n-0.255\r\n-0.287\r\n-0.287\r\n-0.2892\r\n-0.2892\r\n2.62e-002\r\n2.62e-002\r\n3.79e-002\r\n3.79e-002\r\n-4.59e-002\r\n-4.59e-002\r\n-4.49e-002\r\n-4.49e-002\r\n7.69e-002\r\n7.69e-002\r\n-3.46e-002\r\n-3.46e-002\r\n2.88e-002\r\n2.88e-002\r\n-4.81e-002\r\n-4.81e-00', '0', '3.341', 'C20H16N6S2', '0404.088', '-6.184', '0404.511', '3.65 3.65 8.82 8.82', '2', '2', '2', '7', '22', '4', '28', '31', '23', '12', '006', '06', '16', '0', '4', '005', '0182', '402.24', '', '1.04509', '1.3044', '54.11', '21.38', '6.57462', '32.73', '3,149.76', '296.897', '288.8', '', 'S3/C(/C2=C/C=C(/C/1=N/C=C(C(N)=N)\\C=C1)\\S2)=C\\C=C3\\C\\4=N\\C=C(C(N)=N)/C=C4', 'N=C(N)c4ccc(c3ccc(c2ccc(c1ccc(C(=N)N)cn1)s2)s3)nc4', 'DB1247', 'SCHEMBL14507287', 'r(GGGGCC)exp C9ORF72 RNA', '89354054', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '29113975', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(367, '367', 'Not Available', 'NC(=N)c1ccc(nc1)c2ccc([se]2)c3ccc([se]3)c4ccc(cn4)C(=N)N', '6-[5-[5-(5-carbamimidoyl-2-pyridyl)selenophen-2-yl]selenophen-2-yl]pyridine-3-carboxamidine', 'CYAAFQwAUcwQGvb0^9g^JJGM6mbXdb9gI032uceiOa63hA9ClLLz8UwckwZuRXBPyKaKX7I4ptE0U8erBCJYMjNgSIaEVjzSPmElhb221KjKMbUV82EYHLgb8RDAMfsjI2E4H8KKKhqd9$nkkbMGYm0KfLYXXYB0qKgDxY58cQnFOPG3PuSIknH3hZEPjyRLzuUkzNIv 90P68gijg^e07WvvyKi46fypXQRRoMuQ5tTutqsRTjzn8tbgCxFDzflU51ICC9mubHY9mHkvKpx8FtP3n^jF9Rqk3vpDJzwMUljt8yu4$YP55tWicTU$CTd486l^LX^nhIWKk1fbAfsOFLbEIdSKzKHzWk^3$B$9K6CZfL6ft3dwnr5BPkCKw1vzaNxfckOoz$sm7vpx L3tXMtFv$jP9U0vHpzUXXepNc725hYFhdjfTUJCLiN8cR8QNvapOFodbNUxUm76YaSqJeA$haMOIdLThVwnJoQ3WE7u5i6gY', 'InChI=1S/C20H16N6Se2/c21-19(22)11-1-3-13(25-9-11)15-5-7-17(27-15)18-8-6-16(28-18)14-4-2-12(10-26-14)20(23)24/h1-10H,(H3,21,22)(H3,23,24)', 'AuxInfo=1/1/N:6,21,4,19,9,17,11,15,5,22,7,23,2,18,8,16,12,13,24,1,27,28,25,26,3,20,10,14/E:(1,2)(3,4)(5,6)(7,8)(9,10)(11,12)(13,14)(15,16)(17,18)(19,20)(21,22,23,24)(25,26)(27,28)/gE:(1,2)/rA:28CCNCCC CCCSeCCCSeCCCCCNCCCCNNNN/rB:;s2;d-2;d-3;s4;s5d-6;s2;d+8;s8;s9;s10d-11;s12;s13;d+13;s14;s15d-16;s16;s18;d+18;d-19;s20;s1s21d+22;s7;d1;s1;d24;s24;/rC:13.4402,-9.785,0;6.4359,-12.3163,0;6.4359,-13.1413,0 ;5.7214,-11.9038,0;5.7214,-13.5538,0;5.0069,-12.3163,0;5.0069,-13.1413,0;7.1504,-11.9038,0;7.236', 'HBRACTFMQJALNR-UHFFFAOYSA-N', '1010:Q2YTFRF8VU6ZV96H4E2CFTK39EH32Q', '[#6](-[#7])(=[#7])-[c](:[c]:[n]:[c]1-[c](:[c]:[c]:[c]2-[c](:[c]:[c]3):[se]:[c]3-[c]4:[c]:[c]:[c](-[#6](-[#7])=[#7]):[c]:[n]4):[se]2):[c]:[c]1', 'C(N)(=N)c(cnc1c(ccc2c(cc3)[se]c3c4ccc(C(N)=N)cn4)[se]2)cc1', '03.502', '1.422', '0', '0', 'TRUE', '0.1029\r\n7.09e-002\r\n-0.2555\r\n-3.51e-002\r\n3.79e-002\r\n-4.81e-002\r\n2.88e-002\r\n9.5e-003\r\n-5.15e-002\r\n0\r\n-5.31e-002\r\n-9.9e-003\r\n-9.9e-003\r\n0\r\n-5.31e-002\r\n9.5e-003\r\n-5.15e-002\r\n7.09e-002\r\n-3.51e-002\r\n-0.2555\r\n-4.81e-002\r\n3.79e-002\r\n2.88e-002\r\n0.1029\r\n-0.2892\r\n-0.287\r\n-0.2892\r\n-0.287', '0', '3.299', 'C20H16N6Se2', '0499.977', '-3.119', '0498.301', '3.65 3.65 8.82 8.82', '2', '2', '2', '7', '22', '4', '28', '31', '7', '12', '006', '06', '16', '0', '4', '005', '0125.52', '397.59', '', '', '', '', '', '', '', '', '', '', '', 'C(/C/4=C/N=C(/C3=C/C=C(/C2=C/C=C(/C/1=C/C=C(C(=N)N)\\C=N1)\\[Se]2)\\[Se]3)\\C=C4)(=N)N', 'N=C(N)c4ccc(c3ccc(c2ccc(c1ccc(C(=N)N)cn1)[se]2)[se]3)nc4', 'DB1273', 'Not Available', 'r(GGGGCC)exp C9ORF72 RNA', 'Not Available', 'Under Investigation', 'Amyotrophic Lateral Sclerosis (ALS)', '29113975', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(368, '6234', '6234', 'N[C@@H]1CONC1=O', '(4<I>R</I>)-4-aminoisoxazolidin-3-one', 'CYAAFQwA5ewQyg0^fm0UMGMCWWO5zMer1EIPwBj3yMKfB^TNGpvshDubQ4juU^L9qYpvhgBT1xYXbfYNwEwx7p2q9gkNEsfOJoMcvLOotpn9MvW8XkeH3rP8VQltRkhve$RrK1Sa4qu2ZIlICwSUUA$H0eQDVroxYm0Ih^6Wx1BOKPlVqd4AG17pnLggo95IgclJxFNm PSFzjyFOpAm0rlMzwjswVstAmuQeHQlhHl4NlEopJ7pzjdQX5qb4uTEkpJRcTQDKnUPxv1lMPe3d$Fc3mv5J8RtCMD$OnL9yaQqWTtbdcsX5$oyaHWZTWJ0CaO$29J4l5erLb2vu48okRPnbmFbmUlr9fGk89XR2SiX1NI2ZO0cxmPVH30bipnomEuLTc^JeeONqZ3uO zkKLuzYMvohEDwrOP5JvWlc4GdA$p4Hb', 'InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1', 'AuxInfo=1/1/N:6,5,7,4,3,2,1/it:im/rA:13OONNC.oCCHHHHHH/rB:;s1;;s4;s1s5;d2s3s5;s5;s6;s6;s3;s4;s4;/rC:-1.7919,.0017,.0374;1.3808,1.4506,-.0254;-.9168,1.0954,-.1404;1.4961,-1.406,-.2218;.3914,-.7225,.420 2;-.9581,-1.1481,-.1243;.3985,.7289,.0544;.431,-.8084,1.5114;-.9317,-1.4043,-1.1908;-1.3785,-1.9939,.4282;-1.2957,1.9924,-.4157;1.4407,-2.4049,-.0276;2.378,-1.0862,.1768;', 'DYDCUQKUCUHJBH-UWTATZPHSA-N', '1010:RMCQDB63JBMTQZC9AFXT4GAUA4NTJX', '[#8]1-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#7]1-[#1])=[#8])-[#7](-[#1])-[#1]', 'O1C([H])([H])[C@]([H])(C(N1[H])=O)N([H])[H]', '-01.788', '-1.788', '0', '0', 'TRUE', '-0.2796\r\n-0.2736\r\n-0.1937\r\n-0.3181\r\n0.1101\r\n9.64e-002\r\n0.2539\r\n5.9e-002\r\n6.14e-002\r\n6.14e-002\r\n0.1839\r\n0.1192\r\n0.1197', '1', '-1.807', 'C3H6N2O2', '0102.043', '0.597', '0102.092', '2.34 6.09', '2', '2', '1', '6', '00', '0', '7', '7', '8', '1', '004', '03', '6', '0', '1', '000', '0064.34', '100.92', '', '2.35644', '1.2493', '30', '19.45', '1.93707', '10.55', '57.3665', '173.012', '75.45', '', 'O1NC(=O)C(N)C1', 'N[C@@H]1CONC1=O', 'D-cycloserine', 'Seromycin; orientomycin; Farmiserina; Miroseryn; Tisomycin; Closina; Wasserina', 'Dopa decarboxylase', '6234', 'Phase III Completed', 'Bipolar disorder', '25566387', 'Bipolar disorder', 'MAJOR DEPRESSIVE DISORDER; MDD'),
(369, '6234', '6234', 'N[C@@H]1CONC1=O', '(4<I>R</I>)-4-aminoisoxazolidin-3-one', 'CYAAFQwA5ewQyg0^fm0UMGMCWWO5zMer1EIPwBj3yMKfB^TNGpvshDubQ4juU^L9qYpvhgBT1xYXbfYNwEwx7p2q9gkNEsfOJoMcvLOotpn9MvW8XkeH3rP8VQltRkhve$RrK1Sa4qu2ZIlICwSUUA$H0eQDVroxYm0Ih^6Wx1BOKPlVqd4AG17pnLggo95IgclJxFNm PSFzjyFOpAm0rlMzwjswVstAmuQeHQlhHl4NlEopJ7pzjdQX5qb4uTEkpJRcTQDKnUPxv1lMPe3d$Fc3mv5J8RtCMD$OnL9yaQqWTtbdcsX5$oyaHWZTWJ0CaO$29J4l5erLb2vu48okRPnbmFbmUlr9fGk89XR2SiX1NI2ZO0cxmPVH30bipnomEuLTc^JeeONqZ3uO zkKLuzYMvohEDwrOP5JvWlc4GdA$p4Hb', 'InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1', 'AuxInfo=1/1/N:6,5,7,4,3,2,1/it:im/rA:13OONNC.oCCHHHHHH/rB:;s1;;s4;s1s5;d2s3s5;s5;s6;s6;s3;s4;s4;/rC:-1.7919,.0017,.0374;1.3808,1.4506,-.0254;-.9168,1.0954,-.1404;1.4961,-1.406,-.2218;.3914,-.7225,.420 2;-.9581,-1.1481,-.1243;.3985,.7289,.0544;.431,-.8084,1.5114;-.9317,-1.4043,-1.1908;-1.3785,-1.9939,.4282;-1.2957,1.9924,-.4157;1.4407,-2.4049,-.0276;2.378,-1.0862,.1768;', 'DYDCUQKUCUHJBH-UWTATZPHSA-N', '1010:RMCQDB63JBMTQZC9AFXT4GAUA4NTJX', '[#8]1-[#6](-[#1])(-[#1])-[#6@](-[#1])(-[#6](-[#7]1-[#1])=[#8])-[#7](-[#1])-[#1]', 'O1C([H])([H])[C@]([H])(C(N1[H])=O)N([H])[H]', '-01.788', '-1.788', '0', '0', 'TRUE', '-0.2796\r\n-0.2736\r\n-0.1937\r\n-0.3181\r\n0.1101\r\n9.64e-002\r\n0.2539\r\n5.9e-002\r\n6.14e-002\r\n6.14e-002\r\n0.1839\r\n0.1192\r\n0.1197', '1', '-1.807', 'C3H6N2O2', '0102.043', '0.597', '0102.092', '2.34 6.09', '2', '2', '1', '6', '00', '0', '7', '7', '8', '1', '004', '03', '6', '0', '1', '000', '0064.34', '100.92', '', '2.35644', '1.2493', '30', '19.45', '1.93707', '10.55', '57.3665', '173.012', '75.45', '', 'O1NC(=O)C(N)C1', 'N[C@@H]1CONC1=O', 'D-cycloserine', 'Seromycin; orientomycin; Farmiserina; Miroseryn; Tisomycin; Closina; Wasserina', 'Dopa decarboxylase', '6234', 'Withdrawn at Phase IV', 'Schizophrenia', '22368237', 'Schizophrenia', 'SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER'),
(370, '2972', '2972', 'CN1C=CC(=O)C(=C1C)O', '3-hydroxy-1,2-dimethyl-pyridin-4-one', 'CYAAFQwAWewQofPbT^3^Dxi8aqLbUQJeBuNrasv2mNoR9bxtHVj8A0YCBXiFHazNSKOSZWnJGy$^XVWkvxlEJcARU0LJIzSm7QtA41lKmvvWm3JFK9msfIDyh39wiNyNf9gPCrA6ubF24VQdGaSIOA9Hf5xVtxuiXa0NdOZwvk1BdbboqnGxrPcqLNsyRNG1ZukxQ0aq TD8owfrWcBPZLC94KFvtp$UNzARO5r3HuPNxoF5Lnc17aL2jZwXeN5VhdZEi^djCVWEdRMH0fMcDP0r2NbUDjbUgncTUHNvfcYt68uESgDl8X^eZdnbz1nKjRPEn7n9ehKICHVTObn9Hn$STbGUQLWiHSRQ7jjmTJuYhz2u$9SNx7AKaeT6jPm7W1nKYlPSkiR^^E^Kn pj70RePuFDbvRvYkxVIyOf19$DvW2niYGV8dlXea$l63yhyGIReHL4XvFnLyBOZumAMrNWFi5C9Jap6kEKwBBY5kF0RzEWh4', 'InChI=1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3', 'AuxInfo=1/0/N:7,8,10,6,4,9,5,3,2,1/rA:19OONCCCCCCCHHHHHHHHH/rB:;;s3;s1d+4;s3;s4;s3;d2s5;d-6s9;s6;s7;s7;s7;s8;s8;s8;s10;s1;/rC:-1.362,-1.992,.0052;-2.7029,.4496,.0062;1.3507,.525,.0079;.6794,-.7221,-.0 046;-.6764,-.7974,.0048;.5955,1.6889,-.0074;1.5167,-1.9789,-.0145;2.8134,.6114,.0136;-1.4763,.4673,.0008;-.7381,1.7482,-.012;1.1798,2.6029,-.0106;.9892,-2.878,.312;2.3603,-1.8909,.6786;1.9137,-2.1584, -1.0189;3.2116,.2645,.9731;3.1664,1.6385,-.1342;3.244,.0095,-.794;-1.2848,2.6819,-.0209;-.7839,-', 'TZXKOCQBRNJULO-UHFFFAOYSA-N', '1010:94SKVH5P1J3H8C9CENKEVFUAPQE2PF', '[#8](-[#1])-[#6](-[#6](-[#6](-[#1])=[#6](-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#1])=[#8])=[#6]1-[#6](-[#1])(-[#1])-[#1]', 'O([H])C(C(C([H])=C([H])N1C([H])([H])[H])=O)=C1C([H])([H])[H]', '-00.139', '-0.139', '0', '0', 'TRUE', '-0.3563\r\n-0.287\r\n-0.2559\r\n2.91e-002\r\n0.1332\r\n-1.19e-002\r\n-2.65e-002\r\n-4.3e-003\r\n0.2102\r\n-8.e-004\r\n7.56e-002\r\n2.9e-002\r\n2.9e-002\r\n2.9e-002\r\n4.02e-002\r\n4.02e-002\r\n4.02e-002\r\n6.75e-002\r\n0.2195', '0', '-0.717', 'C7H9NO2', '0139.063', '-0.36', '0139.152', '3.6 6.35', '1', '1', '3', '7', '00', '0', '10', '10', '13', '3', '003', '01', '9', '0', '1', '000', '0040.54', '158.23', '', '4.11356', '1.2502', '17.32', '6.97', '2.50473', '10.35', '131.2', '91.049', '113.18', '', 'O/C1=C(C)/N(C)/C=C\\C1=O', 'Cc1c(O)c(=O)ccn1C', 'Deferiprone', 'Ferriprox; CP20; APO-66; Deferum; CGP-37391', 'UDP-glucuronosyltransferase 1-6', '2972', 'Phase I/II Completed', 'Friedreich''s Ataxia', '23668357', 'Friedreich''s Ataxia', 'FRDA1\nFA; Friedreich Ataxia'),
(371, '2972', '2972', 'CN1C=CC(=O)C(=C1C)O', '3-hydroxy-1,2-dimethyl-pyridin-4-one', 'CYAAFQwAWewQofPbT^3^Dxi8aqLbUQJeBuNrasv2mNoR9bxtHVj8A0YCBXiFHazNSKOSZWnJGy$^XVWkvxlEJcARU0LJIzSm7QtA41lKmvvWm3JFK9msfIDyh39wiNyNf9gPCrA6ubF24VQdGaSIOA9Hf5xVtxuiXa0NdOZwvk1BdbboqnGxrPcqLNsyRNG1ZukxQ0aq TD8owfrWcBPZLC94KFvtp$UNzARO5r3HuPNxoF5Lnc17aL2jZwXeN5VhdZEi^djCVWEdRMH0fMcDP0r2NbUDjbUgncTUHNvfcYt68uESgDl8X^eZdnbz1nKjRPEn7n9ehKICHVTObn9Hn$STbGUQLWiHSRQ7jjmTJuYhz2u$9SNx7AKaeT6jPm7W1nKYlPSkiR^^E^Kn pj70RePuFDbvRvYkxVIyOf19$DvW2niYGV8dlXea$l63yhyGIReHL4XvFnLyBOZumAMrNWFi5C9Jap6kEKwBBY5kF0RzEWh4', 'InChI=1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3', 'AuxInfo=1/0/N:7,8,10,6,4,9,5,3,2,1/rA:19OONCCCCCCCHHHHHHHHH/rB:;;s3;s1d+4;s3;s4;s3;d2s5;d-6s9;s6;s7;s7;s7;s8;s8;s8;s10;s1;/rC:-1.362,-1.992,.0052;-2.7029,.4496,.0062;1.3507,.525,.0079;.6794,-.7221,-.0 046;-.6764,-.7974,.0048;.5955,1.6889,-.0074;1.5167,-1.9789,-.0145;2.8134,.6114,.0136;-1.4763,.4673,.0008;-.7381,1.7482,-.012;1.1798,2.6029,-.0106;.9892,-2.878,.312;2.3603,-1.8909,.6786;1.9137,-2.1584, -1.0189;3.2116,.2645,.9731;3.1664,1.6385,-.1342;3.244,.0095,-.794;-1.2848,2.6819,-.0209;-.7839,-', 'TZXKOCQBRNJULO-UHFFFAOYSA-N', '1010:94SKVH5P1J3H8C9CENKEVFUAPQE2PF', '[#8](-[#1])-[#6](-[#6](-[#6](-[#1])=[#6](-[#1])-[#7]1-[#6](-[#1])(-[#1])-[#1])=[#8])=[#6]1-[#6](-[#1])(-[#1])-[#1]', 'O([H])C(C(C([H])=C([H])N1C([H])([H])[H])=O)=C1C([H])([H])[H]', '-00.139', '-0.139', '0', '0', 'TRUE', '-0.3563\r\n-0.287\r\n-0.2559\r\n2.91e-002\r\n0.1332\r\n-1.19e-002\r\n-2.65e-002\r\n-4.3e-003\r\n0.2102\r\n-8.e-004\r\n7.56e-002\r\n2.9e-002\r\n2.9e-002\r\n2.9e-002\r\n4.02e-002\r\n4.02e-002\r\n4.02e-002\r\n6.75e-002\r\n0.2195', '0', '-0.717', 'C7H9NO2', '0139.063', '-0.36', '0139.152', '3.6 6.35', '1', '1', '3', '7', '00', '0', '10', '10', '13', '3', '003', '01', '9', '0', '1', '000', '0040.54', '158.23', '', '4.11356', '1.2502', '17.32', '6.97', '2.50473', '10.35', '131.2', '91.049', '113.18', '', 'O/C1=C(C)/N(C)/C=C\\C1=O', 'Cc1c(O)c(=O)ccn1C', 'Deferiprone', 'Ferriprox; CP20; APO-66; Deferum; CGP-37391', 'UDP-glucuronosyltransferase 1-6', '2972', 'Phase III Completed', 'Pantothenate Kinase-Associated Neurodegeneration (PKAN)', '23370589', 'Pantothenate Kinase-Associated Neurodegeneration (PKAN)', 'PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN\nPKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET\nHALLERVORDEN-SPATZ DISEASE'),
(372, '5881', '5881', 'C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O', '(3<I>S</I>,8<I>R</I>,9<I>S</I>,10<I>R</I>,13<I>S</I>,14<I>S</I>)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one', 'CYAAFQwAucwQMQnp73p9P5UYWA2F6qNuzQwnGZuRRqsGXFgk7ZpiMhONL^3bkQOzaylZVhQO^NCQo7kCMbaEHnPHUmoQ6OhL8EJR5F7VHcanOMzueEcX^eoNF5FvqQFv^4cBf^PPvc3HAMxfqqDvVj0BHQo^4VLsDdIe8jaFIaUUvunzmX7hY2y4igX8kb^qSHYwwhnz FjPi$R1aJ9ULww08ZiSVT3crcXD15h$Zo5ghGmnJRVJK88PCG0xD0bE3O2qq$z6J35ZexRJPAMt1tt1U2mL$VcAqNfqhiUVKn5Fqe3gZclHOKt^04HPshpFg$EDqc8YvPAC4M$uXq^KWbISPVZuWPeihr^rQktOe04jln058bkjCmnqUWANbBi8rKmq5HPJ0OrdVfc1Y JBZdQwk94x7n1k1WJBx6IC4^c$vdebUXVmD8YPlaJl64uOn6f3BOz3r4Mrf0AeSnFeCInzWm5tTebWYEdrXzyx7tNnKiOhkz', 'InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1', 'AuxInfo=1/0/N:18,17,16,11,10,15,20,8,13,9,19,12,21,4,5,3,14,7,6,2,1/it:im/rA:49OOC.eC.oC.eC.oC.oCCCCCCCCCCCCCC.oHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s5;s3;s3;s6s8;s5;s4;s7;s7;d1s6;s10s14;s11d-12;s6 ;s7;s12;s13;s2s19s20;s3;s4;s5;s8;s8;s9;s9;s10;s10;s11;s11;s13;s13;s15;s15;s16;s17;s17;s17;s18;s18;s18;s19;s19;s20;s20;s21;s2;/r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r\n-0.3928\r\n-2.88e-002\r\n-3.05e-002\r\n-2.53e-002\r\n2.92e-002\r\n-8.4e-003\r\n-4.84e-002\r\n-4.04e-002\r\n-4.23e-002\r\n-3.14e-002\r\n-6.55e-002\r\n-4.14e-002\r\n0.1385\r\n6.9e-003\r\n-8.44e-002\r\n-5.24e-002\r\n-5.56e-002\r\n-5.3e-003\r\n-2.59e-002\r\n5.77e-002\r\n3.14e-002\r\n3.12e-00', '1', '3.338', 'C19H28O2', '0288.209', '-4.485', '0288.424', '', '1', '1', '2', '22', '00', '0', '21', '24', '32', '2', '002', '01', '28', '0', '4', '000', '0037.29', '299.85', '', '2.59138', '1.2844', '26.48', '14.54', '3.62532', '11.94', '765.632', '91.558', '258.96', '', 'O=C4C3(C)C(C1C(C2(C)/C(=C\\C1)CC(O)CC2)CC3)CC4', 'CC34CCC2C(C/C=C\\1CC(O)CCC12C)C3CCC4=O', 'Dehydroepiandrosterone', 'DHEA; PRASTERONE; Diandron; Psicosterone; Andrestenol; Intrarosa; EM-760', 'Androgen receptor', '5881', 'Terminated in Preclincal trail', 'Amyotrophic Lateral Sclerosis (ALS)', '22409357', 'Amyotrophic Lateral Sclerosis (ALS)', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL; FALS\nAMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT'),
(373, '23241800', '23241800', 'CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5cocc5', '[(1<I>R</I>,4<I>b</I><I>R</I>,5<I>R</I>,6<I>a</I><I>R</I>,10<I>a</I><I>R</I>,10<I>b</I><I>R</I>,12<I>a</I><I>R</I>)-1-(3-furyl)-4<I>b</I>,7,7,10<I>a</I>,12<I>a</I>-pentamethyl-3,8-dioxo-5,6,6<I>a</I>, 10<I>b</I>,11,12-hexahydro-1<I>H</I>-naphtho[2,1-f]isochromen-5-yl] acetate', 'CYAAFQwALcwQFvzNj3FIqdavPC7XGyqr4uySoDRxw9TG9X1did9ifNLxQejgxEPX9jWAk5sGVRdbvYjlHE5d0CDFXaNcf2u9A2TkIZ0S1iXKDKHTXT2Ob1^S6^RmVon8YJW9^3jS^xP4rp1fs$U5y7^5IcgDqhH0y3tqi7RvvtMV4hbZP6XnDbgxippje46^fkc1y9ud abMtwF$Vtr3w9vNY3jSkErTV^cITPpMxA0zO3$bqNEC4DAPb^eSlrcIei^nS1L3oY8Q4XlW4rVzDxU7YzTLw5Nl8sbrSwYegKiqnT5G5Pw3$a5pxk7whIzHnf^DgnH6QI2QxWXDLv^phMBdgxyTb98oGZHhpTD3^znpJ52iK7UaNyflnbIVjwPg25xUxVt4sSS1xebrR W$2OEmzTtgkKon2sItVy7EO8plhsiUST$iZXt7Ts5^pw4pMqFtkwP1mR^G8fv0kqzhvP0q^8Q$$iLiPZ0bvi7SIbchbn2yqX', 'InChI=1S/C28H34O6/c1-16(29)33-22-13-19-25(2,3)21(30)8-11-26(19,4)18-7-10-27(5)20(28(18,22)6)14-23(31)34-24(27)17-9-12-32-15-17/h8-9,11-12,14-15,18-19,22,24H,7,10,13H2,1-6H3/t18-,19+,22-,24+,26-,27-,28 -/m1/s1', 'AuxInfo=1/0/N:33,26,27,19,23,18,13,25,31,17,20,34,12,24,32,30,28,7,10,15,22,11,29,21,16,9,14,8,6,3,4,5,1,2/E:(2,3)/it:im/rA:68OOOOOOC.eC.eC.eC.eC.eCCC.eCCCCCCC.oCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH HHHHHHHH/rB:;;;;;;s7;s7;s9;s1s8;s10s11;s7;;s8s14;s10;s13s14;s8;s9;s9;s2s14;d3s16;s14;d+15;d-20s22;s16;s16;s21;s2d4s24;s1d6;s28;s5d+28;s30;s5d-31;s7;s10;s11;s12;s12;s13;s13;s17;s17;s18;s18;s18;s19;s19; s19;s20;s21;s23;s23;s23;s24;s25;s26;s26;s26;s27;s27;s27;s31;s32;s33;s33;s33;s34;/rC:-1.1513,-1.9', 'VOUDTVRGPAGHGA-SQIPALKSSA-N', '1010:NVSHB3MX73H1VCMXWB4UBXSS7VSHM5', '[#8](-[#6](-[#6](-[#1])(-[#1])-[#1])=[#8])-[#6@](-[#1])(-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[#6](-[#6](-[#1])(-[#1])-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6](-[#1])=[#6]1-[#1])=[#8])-[#6@]12-[#6](-[# 1])(-[#1])-[#1])-[#6@@](-[#6](-[#1])(-[#1])-[#1])(-[#6](=[#6](-[#1])-[#6](=[#8])-[#8]3)-[#6@](-[#6](-[#1])(-[#1])-[#1])(-[#6@]3(-[#1])-[c](:[c]4-[#1]):[c](-[#1]):[c](-[#1]):[o]4)-[#6](-[#1])(-[#1])-[# 6]5(-[#1])-[#1])-[#6@@]25-[#1]', 'O(C(C([H])([H])[H])=O)[C@]([H])(C([H])([H])[C@@]([H])(C(C([H])([H])[H])(C([H])([H])[H])C(C([H])=C1[H])=O)[C@]12C([H])([H])[H])[C@@](C([H])([H])[H])(C(=C([H])C(=O)O3)[C@](C([H])([H])[H])([C@]3([H])c(c4 [H])c([H])c([H])o4)C([H])([H])C5([H])[H])[C@@]25[H]', '04.217', '4.217', '0', '0', 'TRUE', '-0.312\r\n-0.3034\r\n-0.2943\r\n-0.2614\r\n-0.3255\r\n-0.267\r\n-2.05e-002\r\n2.01e-002\r\n-6.6e-003\r\n-1.74e-002\r\n7.69e-002\r\n-2.06e-002\r\n-4.78e-002\r\n2.07e-002\r\n-4.65e-002\r\n3.11e-002\r\n-4.09e-002\r\n-5.31e-002\r\n-5.56e-002\r\n-7.45e-002\r\n0.1036\r\n0.1607\r\n-5.3e-002\r\n1.11e-002\r\n-2', '1', '4.217', 'C28H34O6', '0466.236', '-7.338', '0466.566', '', '6', '0', '5', '28', '05', '1', '34', '38', '44', '7', '006', '00', '34', '0', '5', '003', '0082.81', '493.6', '', '1.98334', '1.2912', '65.07', '37.04', '4.23985', '28.03', '1,695.37', '158.576', '395.13', '', 'O(C1C/3(C)C(C\\2(C)C(C1)C(C)(C)C(=O)/C=C2)CCC4(C)C3=C/C(=O)OC4/C\\5=C/O/C=C5)C(=O)C', 'C[C@]34CC[C@H]2[C@@H](C/C=C\\1C[C@@H](O)CC[C@@]12C)[C@@H]3CCC4=O', 'Deoxygedunin', '14,15-deoxygedunin', 'Neurotrophic receptor tyrosine kinase 2', '23241800', 'Under Investigation', 'Parkinson Disease(PARK)', '26282118', 'Parkinson Disease(PARK)', 'PARK');
INSERT INTO `alldrug` (`osr1`, `osr2`, `osr3`, `osr4`, `osr5`, `osr6`, `osr7`, `osr8`, `osr9`, `osr10`, `osr11`, `osr12`, `osr13`, `osr14`, `osr15`, `osr16`, `osr17`, `osr18`, `osr19`, `osr20`, `osr21`, `osr22`, `osr23`, `osr24`, `osr25`, `osr26`, `osr27`, `osr28`, `osr29`, `osr30`, `osr31`, `osr32`, `osr33`, `osr34`, `osr35`, `osr36`, `osr37`, `osr38`, `osr39`, `osr40`, `osr41`, `osr42`, `osr43`, `osr44`, `osr45`, `osr46`, `osr47`, `osr48`, `osr49`, `osr50`, `osr51`, `osr52`, `osr53`, `osr54`, `osr55`, `osr56`, `osr57`, `osr58`, `osr59`, `osr60`, `osr61`, `osr62`, `osr63`, `osr64`, `osr65`) VALUES
(374, '72035', '72035', 'CCN(CC)CC[n+]1ccc2c(C)c3[nH]c4ccc(O)cc4c3c(C)c2c1', '2-[2-(diethylamino)ethyl]-5,11-dimethyl-6<I>H</I>-pyrido[4,3-b]carbazol-2-ium-9-ol', 'CYAAFQwATdwQGXeH3wVA46aaNTZ1Ed4vd5xl1tGFMksuAtDd50AQ3Njo1Z6Suyk7oEkKB4hNvCWQQ3xhlOWr2^ZrrhtoZRtFS3NvgbFHFGa4c5pkwA3A3f5raJ69CYJtX^72WV7rAIi^LfPiq27JTYfIxy1XcNR9WWLq4t83KMfuQrYXuUQe1N7BtJv09hP8aHLWF^ra RT6yGeEsDnHNVgvXrFnsEOvXDueFuk49DrqQnB6GVDFBnc$yhV1jmWO$IdQm55NWhYf5aR84EwZeHOoQagbPRpVcNMPqtzDFOgbAY66v53d8hzuPb7XRpVyCfzN6nYZZnN0jrRv9HmJD55jsylgcVIi6coObEvXdEd5hdJVQv1hRzkNGRJsvLk6jlTqqwznJ4SNJXeXe J4MjpqdXI51C5kt5qkX19khH3EFensxdfmK4zWpe35kHSS4HMbdrgz0QamF1RGZ1Ix8qO51YGBQ^VF$1$d6K^3IEVkO5ZlQz', 'InChI=1S/C23H27N3O/c1-5-25(6-2)11-12-26-10-9-18-16(4)23-22(15(3)20(18)14-26)19-13-17(27)7-8-21(19)24-23/h7-10,13-14,27H,5-6,11-12H2,1-4H3/p+1', 'AuxInfo=1/5/N:26,27,18,19,22,23,25,21,16,17,15,14,20,13,8,10,24,9,11,7,12,5,6,3,4,2,1/E:(1,2)(5,6)/rA:55ON+NNCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;s3d+5;;s5d-7;s7;s6d-9;s5;s3d-11; d+2s7;s2;s4s14;s9;s2d-16;s8;s10;s11;s12;s4;s4;s1d+20;d-21s24;s22;s23;s3;s14;s14;s13;s15;s15;s16;s17;s18;s18;s18;s19;s19;s19;s20;s21;s22;s22;s23;s23;s25;s26;s26;s26;s27;s27;s27;s1;/rC:-5.8611,-3.3819,- .1588;2.5101,.7066,.7065;-3.6898,1.6492,-.2612;5.8426,-.6786,-.1818;-2.2128,.0171,.0857;-2.355,1', 'NGOHTJBYABHJKF-UHFFFAOYSA-O', '1010:YH6E75F174UJV5S2PN4613K51PDNNZ', '[#8](-[#1])-[c](:[c](-[#1]):[c](-[#1]):[c](:[c]1:[c]2:[c]3:[c](-[#6](-[#1])(-[#1])-[#1]):[c](:[c](-[#1]):[c](-[#1]):[n+]4-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#7](-[#6](-[#1])(-[#1])-[#6](-[#1])(-[# 1])-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#1]):[c](:[c]4-[#1]):[c]2-[#6](-[#1])(-[#1])-[#1]):[n]3-[#1]):[c]1-[#1]', 'O([H])c(c([H])c([H])c(c1c2c3c(C([H])([H])[H])c(c([H])c([H])[n+]4C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])c(c4[H])c2C([H])([H])[H])n3[H])c1[H]', '05.403', '4.75', '0', '1', 'TRUE', '-0.3609\r\n0.2945\r\n-0.2577\r\n-0.3003\r\n5.5e-003\r\n3.07e-002\r\n2.17e-002\r\n-3.04e-002\r\n-7.e-003\r\n-2.41e-002\r\n4.4e-003\r\n2.71e-002\r\n8.07e-002\r\n8.6e-002\r\n3.33e-002\r\n-1.77e-002\r\n7.3e-002\r\n-3.84e-002\r\n-3.76e-002\r\n-2.26e-002\r\n-4.07e-002\r\n-4.6e-003\r\n-4.6e-003\r\n7.2e-002\r', '0', '4.019', 'C23H28N3O', '0362.223', '-7.06', '0362.488', '7.75 8.59 10.46', '0', '2', '0', '10', '20', '4', '27', '30', '33', '8', '004', '02', '28', '0', '4', '005', '0043.14', '399.55', '', '13.0039', '1.2589', '31.13', '22.79', '5.08535', '8.34', '1,716.56', '77.361', '310.07', '', 'O/C/4=C/C1=C(N/C2=C1/C(C)=C/3\\C(=C2\\C)\\C=C/[N+](CCN(CC)CC)=C3)\\C=C4', 'CCN(CC)CC[n+]4ccc3c(C)c2[nH]c1ccc(O)cc1c2c(C)c3c4', 'Detalliptinium', '1b; SR-95156B', 'd(CGG)n FMR1 (fragile X mental retardation 1)', '72035', 'Under Investigation', 'Fragile X syndrome', '22948243', 'Fragile X syndrome', 'FRAGILE X MENTAL RETARDATION SYNDROME\nMENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28\nX-LINKED MENTAL RETARDATION AND MACROORCHIDISM\nMARKER X SYNDROME\nMARTIN-BELL SYNDROME'),
(375, '73442840', '73442840', '[2H]C([2H])([2H])Oc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC([2H])([2H])[2H]', '(3<I>S</I>,11<I>b</I><I>S</I>)-3-isobutyl-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11<I>b</I>-hexahydrobenzo[a]quinolizin-2-one', 'CYAAFQwAMfwQecre4JLhSh05Qysu5mRblSe3gGwlNQt4JKOnG8YUJfDPF9RZ$G6cx3oZA8o0udHqHSsMdhsxruemiww2NB7kS3cHOslSzZbUuiqE2Rhjh3vcre9jlSBK8DuU^P^w3H38Bch8lPP9q7Yn3vPUqRd8D77ZSJQgD9ifKOvogyEHPkQ^Dm2F5V1xBle5$pjb zAaNzdtcvjHW1ACeHxjGg2zTbXupYsIzUpDqHTBSVL2dl9qy$EfTaewwGFH180HB9rXM0Nz^ZcDKcXl6i5wMk$8ugZ0ni7wormDfPtjLokWnMX9oZvBVVsgwDZCb0JaBNc0gK0jNjj0^qVNh1IaeSknXacVVWr5vOME1cv0LiILyRW2DQG42M7v7d0xasO5IDjxCPclG XpeapKo5FD7hcPQpDiCePV98u4Mig6DPxhhNyDfx6r75je7efTWOfCDGtjKlyRr^NGg5QZ3W4afTPmgEZ1KapWizz58wEaav', 'InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m0/s1/i3D3,4D3', 'AuxInfo=1/0/N:18,19,23,22,13,9,12,17,16,8,7,15,14,6,10,5,11,21,20,4,1,3,2/E:(1,2)/it:im/I:/E:m/rA:50OOONC.eC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH.i2H.i2H.i2H.i2H.i2H.i2/rB:;;;s4;;s4s6;s5;s4;s5;d1s 6s8;s6;s9;s10s13;s12;d+10;d-14;s15;s15;s2s16;s3s17d-20;s2;s3;s5;s6;s7;s7;s8;s8;s9;s9;s12;s12;s13;s13;s15;s16;s17;s18;s18;s18;s19;s19;s19;s22;s22;s22;s23;s23;s23;/rC:-2.7907,2.787,-.1404;4.3205,1.9448, -.3753;5.2965,-.602,.149;-1.1282,-.9198,-.0285;-.3155,.2451,-.4676;-3.1647,.4419,.3197;-2.5384,-', 'MKJIEFSOBYUXJB-WEZHFFAMSA-N', '1010:6GF4WZGEHXEY69A1D2BX6TEED85D2X', '[#8]=[#6](-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[c]1:[c](:[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7]23)-[ #6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6]3(-[#1])-[#1]', 'O=C(C([H])([H])[C@@]([H])(c1c(c([H])c(c(c1[H])OC([2H])([2H])[2H])OC([2H])([2H])[2H])C([H])([H])C2([H])[H])N23)[C@@]([H])(C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C3([H])[H]', '03.365', '3.365', '0', '0', 'TRUE', '-0.2993\r\n-0.3466\r\n-0.3466\r\n-0.2949\r\n4.2e-002\r\n3.06e-002\r\n8.5e-003\r\n2.62e-002\r\n2.8e-003\r\n-2.44e-002\r\n0.1386\r\n-4.e-002\r\n-1.46e-002\r\n-3.92e-002\r\n-4.64e-002\r\n-2.41e-002\r\n-2.55e-002\r\n-6.28e-002\r\n-6.28e-002\r\n0.105\r\n0.105\r\n4.23e-002\r\n4.23e-002\r\n5.22e-002\r\n3.96e-', '1', '3.261', 'C19H21D6NO3', '0323.237', '-2.436', '0323.46', '6.84', '3', '0', '1', '18', '06', '1', '23', '25', '30', '4', '004', '00', '27', '0', '3', '006', '0038.77', '334.67', '', '', '1.269', '57.76', '10.17', '', '47.59', '', '72.064', '271.31', '', 'O=C1C(CC(C)C)CN3C(C1)/C2=C/C(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])\\C=C2\\CC3', 'COc3cc2CCN1C[C@H](CC(C)C)C(=O)C[C@H]1c2cc3OC', 'Deutetrabenazine', 'SD-809; Austedo; Dutetrabenazine', 'Vesicular monoamine transporter 2 (VMAT2)', '73442840', 'Phase III', 'Tardive Dyskinesia', '28446646', 'Tardive Dyskinesia', 'NA'),
(376, '73442840', '73442840', '[2H]C([2H])([2H])Oc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC([2H])([2H])[2H]', '(3<I>S</I>,11<I>b</I><I>S</I>)-3-isobutyl-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11<I>b</I>-hexahydrobenzo[a]quinolizin-2-one', 'CYAAFQwAMfwQecre4JLhSh05Qysu5mRblSe3gGwlNQt4JKOnG8YUJfDPF9RZ$G6cx3oZA8o0udHqHSsMdhsxruemiww2NB7kS3cHOslSzZbUuiqE2Rhjh3vcre9jlSBK8DuU^P^w3H38Bch8lPP9q7Yn3vPUqRd8D77ZSJQgD9ifKOvogyEHPkQ^Dm2F5V1xBle5$pjb zAaNzdtcvjHW1ACeHxjGg2zTbXupYsIzUpDqHTBSVL2dl9qy$EfTaewwGFH180HB9rXM0Nz^ZcDKcXl6i5wMk$8ugZ0ni7wormDfPtjLokWnMX9oZvBVVsgwDZCb0JaBNc0gK0jNjj0^qVNh1IaeSknXacVVWr5vOME1cv0LiILyRW2DQG42M7v7d0xasO5IDjxCPclG XpeapKo5FD7hcPQpDiCePV98u4Mig6DPxhhNyDfx6r75je7efTWOfCDGtjKlyRr^NGg5QZ3W4afTPmgEZ1KapWizz58wEaav', 'InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m0/s1/i3D3,4D3', 'AuxInfo=1/0/N:18,19,23,22,13,9,12,17,16,8,7,15,14,6,10,5,11,21,20,4,1,3,2/E:(1,2)/it:im/I:/E:m/rA:50OOONC.eC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH.i2H.i2H.i2H.i2H.i2H.i2/rB:;;;s4;;s4s6;s5;s4;s5;d1s 6s8;s6;s9;s10s13;s12;d+10;d-14;s15;s15;s2s16;s3s17d-20;s2;s3;s5;s6;s7;s7;s8;s8;s9;s9;s12;s12;s13;s13;s15;s16;s17;s18;s18;s18;s19;s19;s19;s22;s22;s22;s23;s23;s23;/rC:-2.7907,2.787,-.1404;4.3205,1.9448, -.3753;5.2965,-.602,.149;-1.1282,-.9198,-.0285;-.3155,.2451,-.4676;-3.1647,.4419,.3197;-2.5384,-', 'MKJIEFSOBYUXJB-WEZHFFAMSA-N', '1010:6GF4WZGEHXEY69A1D2BX6TEED85D2X', '[#8]=[#6](-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[c]1:[c](:[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7]23)-[ #6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6]3(-[#1])-[#1]', 'O=C(C([H])([H])[C@@]([H])(c1c(c([H])c(c(c1[H])OC([2H])([2H])[2H])OC([2H])([2H])[2H])C([H])([H])C2([H])[H])N23)[C@@]([H])(C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C3([H])[H]', '03.365', '3.365', '0', '0', 'TRUE', '-0.2993\r\n-0.3466\r\n-0.3466\r\n-0.2949\r\n4.2e-002\r\n3.06e-002\r\n8.5e-003\r\n2.62e-002\r\n2.8e-003\r\n-2.44e-002\r\n0.1386\r\n-4.e-002\r\n-1.46e-002\r\n-3.92e-002\r\n-4.64e-002\r\n-2.41e-002\r\n-2.55e-002\r\n-6.28e-002\r\n-6.28e-002\r\n0.105\r\n0.105\r\n4.23e-002\r\n4.23e-002\r\n5.22e-002\r\n3.96e-', '1', '3.261', 'C19H21D6NO3', '0323.237', '-2.436', '0323.46', '6.84', '3', '0', '1', '18', '06', '1', '23', '25', '30', '4', '004', '00', '27', '0', '3', '006', '0038.77', '334.67', '', '', '1.269', '57.76', '10.17', '', '47.59', '', '72.064', '271.31', '', 'O=C1C(CC(C)C)CN3C(C1)/C2=C/C(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])\\C=C2\\CC3', 'COc3cc2CCN1C[C@H](CC(C)C)C(=O)C[C@H]1c2cc3OC', 'Deutetrabenazine', 'SD-809; Austedo; Dutetrabenazine', 'Vesicular monoamine transporter 2 (VMAT2)', '73442840', 'Phase III Completed', 'Huntington Disease (HD)', '27380342', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(377, '73442840', '73442840', '[2H]C([2H])([2H])Oc1cc2CCN3C[C@H](CC(C)C)C(=O)C[C@H]3c2cc1OC([2H])([2H])[2H]', '(3<I>S</I>,11<I>b</I><I>S</I>)-3-isobutyl-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11<I>b</I>-hexahydrobenzo[a]quinolizin-2-one', 'CYAAFQwAMfwQecre4JLhSh05Qysu5mRblSe3gGwlNQt4JKOnG8YUJfDPF9RZ$G6cx3oZA8o0udHqHSsMdhsxruemiww2NB7kS3cHOslSzZbUuiqE2Rhjh3vcre9jlSBK8DuU^P^w3H38Bch8lPP9q7Yn3vPUqRd8D77ZSJQgD9ifKOvogyEHPkQ^Dm2F5V1xBle5$pjb zAaNzdtcvjHW1ACeHxjGg2zTbXupYsIzUpDqHTBSVL2dl9qy$EfTaewwGFH180HB9rXM0Nz^ZcDKcXl6i5wMk$8ugZ0ni7wormDfPtjLokWnMX9oZvBVVsgwDZCb0JaBNc0gK0jNjj0^qVNh1IaeSknXacVVWr5vOME1cv0LiILyRW2DQG42M7v7d0xasO5IDjxCPclG XpeapKo5FD7hcPQpDiCePV98u4Mig6DPxhhNyDfx6r75je7efTWOfCDGtjKlyRr^NGg5QZ3W4afTPmgEZ1KapWizz58wEaav', 'InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m0/s1/i3D3,4D3', 'AuxInfo=1/0/N:18,19,23,22,13,9,12,17,16,8,7,15,14,6,10,5,11,21,20,4,1,3,2/E:(1,2)/it:im/I:/E:m/rA:50OOONC.eC.eCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH.i2H.i2H.i2H.i2H.i2H.i2/rB:;;;s4;;s4s6;s5;s4;s5;d1s 6s8;s6;s9;s10s13;s12;d+10;d-14;s15;s15;s2s16;s3s17d-20;s2;s3;s5;s6;s7;s7;s8;s8;s9;s9;s12;s12;s13;s13;s15;s16;s17;s18;s18;s18;s19;s19;s19;s22;s22;s22;s23;s23;s23;/rC:-2.7907,2.787,-.1404;4.3205,1.9448, -.3753;5.2965,-.602,.149;-1.1282,-.9198,-.0285;-.3155,.2451,-.4676;-3.1647,.4419,.3197;-2.5384,-', 'MKJIEFSOBYUXJB-WEZHFFAMSA-N', '1010:6GF4WZGEHXEY69A1D2BX6TEED85D2X', '[#8]=[#6](-[#6](-[#1])(-[#1])-[#6@@](-[#1])(-[c]1:[c](:[c](-[#1]):[c](:[c](:[c]1-[#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#8]-[#6](-[2#1])(-[2#1])-[2#1])-[#6](-[#1])(-[#1])-[#6]2(-[#1])-[#1])-[#7]23)-[ #6@@](-[#1])(-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[#6](-[#1])(-[#1])-[#1])-[#6]3(-[#1])-[#1]', 'O=C(C([H])([H])[C@@]([H])(c1c(c([H])c(c(c1[H])OC([2H])([2H])[2H])OC([2H])([2H])[2H])C([H])([H])C2([H])[H])N23)[C@@]([H])(C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C3([H])[H]', '03.365', '3.365', '0', '0', 'TRUE', '-0.2993\r\n-0.3466\r\n-0.3466\r\n-0.2949\r\n4.2e-002\r\n3.06e-002\r\n8.5e-003\r\n2.62e-002\r\n2.8e-003\r\n-2.44e-002\r\n0.1386\r\n-4.e-002\r\n-1.46e-002\r\n-3.92e-002\r\n-4.64e-002\r\n-2.41e-002\r\n-2.55e-002\r\n-6.28e-002\r\n-6.28e-002\r\n0.105\r\n0.105\r\n4.23e-002\r\n4.23e-002\r\n5.22e-002\r\n3.96e-', '1', '3.261', 'C19H21D6NO3', '0323.237', '-2.436', '0323.46', '6.84', '3', '0', '1', '18', '06', '1', '23', '25', '30', '4', '004', '00', '27', '0', '3', '006', '0038.77', '334.67', '', '', '1.269', '57.76', '10.17', '', '47.59', '', '72.064', '271.31', '', 'O=C1C(CC(C)C)CN3C(C1)/C2=C/C(OC([2H])([2H])[2H])=C(OC([2H])([2H])[2H])\\C=C2\\CC3', 'COc3cc2CCN1C[C@H](CC(C)C)C(=O)C[C@H]1c2cc3OC', 'Deutetrabenazine', 'SD-809; Austedo; Dutetrabenazine', 'Vesicular monoamine transporter 2 (VMAT2)', '73442840', 'Phase III Completed', 'Huntington Disease (HD)', '27380339', 'Huntington Disease (HD)', 'HUNTINGTON CHOREA'),
(378, '5743', '5743', 'C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO', '(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>R</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phen anthren-3-one', 'CYAAFQwABdwQz2WkRrB16EP7vNb4pH^J7cfyTccoj6Q1LQatdc1mWdystuXDyEF3ZQemZTc42yuWVovP7PteLArZis$sX4EW0L90VSVK5a2bgEBNbI6HnHfUoN6xKVxK49XG$9L^$7l74BgJPRId9vmJg7ZC7cMUlToaMJzl3lLdzonew^U7aQGJKbkcF9Y5QyqLeMc1 8GZPj37Pkz9UuevJyceI6GI7Qeaju214wKvIi36xUGN836O4JGtPEc1xvGMx7erCMCevnmCBiKTjTdv7sdauTDs6ohXAPVyQ1Jk1bGa0xmuT66HHGPkNEv1VfGJ^wcnnMr9GHbGeM^nmaNSjwqbyf3EYfIUvzCu6RFcNGKdVSvXmKv1iklQIZi9lGC2$OmzdsCqjzFDt 9bi83eHmZZygZiaJ$z2HSz5g7o1sdz5I^lIWYeC4MO9YWrWFi5lT$jOoOuRa0sHWTqHoN5wCGRqGfw$8DX4lhdcIzKTR5Qpp', 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1', 'AuxInfo=1/0/N:22,23,18,19,17,27,24,12,25,13,26,14,20,28,9,8,15,21,16,7,10,11,1,5,6,3,4,2/it:im/rA:57FOOOOOC.eC.oC.eC.eC.eCCC.eC.oC.eCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s8;s1s9;s2s7;s 8;s7;s11s12;s3s10s13;s10;s9;s7;s17;s16s19;d4s11;s14;s16;s16;d-20;s5s21;d-24;d6s25s27;s8;s9;s12;s12;s13;s13;s14;s15;s17;s17;s18;s18;s18;s19;s19;s22;s22;s22;s23;s23;s23;s2;s24;s3;s25;s26;s26;s27;s5;/r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r\n-0.3811\r\n-0.3897\r\n-0.2938\r\n-0.3885\r\n-0.29\r\n9.5e-003\r\n-2.63e-002\r\n4.e-004\r\n0.1517\r\n0.1332\r\n-4.37e-002\r\n-1.49e-002\r\n-7.2e-003\r\n9.01e-002\r\n4.41e-002\r\n-4.32e-002\r\n-5.61e-002\r\n-3.02e-002\r\n-5.34e-002\r\n0.1899\r\n-5.93e-002\r\n-4.91e-002\r\n-6.75e-002\r\n-1.45e-', '1', '1.708', 'C22H29FO5', '0392.2', '-3.784', '0392.461', '', '2', '2', '4', '27', '00', '0', '28', '31', '38', '4', '005', '03', '29', '0', '4', '002', '0094.83', '394.35', '', '2.58393', '1.2904', '62.85', '34.81', '3.86992', '28.04', '1,202.04', '182.649', '320.01', '', 'FC23C(C1C(C)(C(O)(C(=O)CO)C(C)C1)CC2O)CC/C4=C/C(=O)/C=C\\C34C', 'C[C@@H]4C[C@H]3[C@@H]2CC/C1=C/C(=O)/C=C\\[C@]1(C)[C@@]2(F)[C@@H](O)C[C@]3(C)[C@@]4(O)C(=O)CO', 'Dexamethasone', 'Decadron; Maxidex; Hexadecadrol; Decaspray; Hexadrol; Millicorten', 'Glucocorticoid receptor', '5743', 'FDA approved', 'Migraine', '24031104', 'Migraine', 'MGR1\nMGAU; MA\nMIGRAINE'),
(379, '5743', '5743', 'C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO', '(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>R</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phen anthren-3-one', 'CYAAFQwABdwQz2WkRrB16EP7vNb4pH^J7cfyTccoj6Q1LQatdc1mWdystuXDyEF3ZQemZTc42yuWVovP7PteLArZis$sX4EW0L90VSVK5a2bgEBNbI6HnHfUoN6xKVxK49XG$9L^$7l74BgJPRId9vmJg7ZC7cMUlToaMJzl3lLdzonew^U7aQGJKbkcF9Y5QyqLeMc1 8GZPj37Pkz9UuevJyceI6GI7Qeaju214wKvIi36xUGN836O4JGtPEc1xvGMx7erCMCevnmCBiKTjTdv7sdauTDs6ohXAPVyQ1Jk1bGa0xmuT66HHGPkNEv1VfGJ^wcnnMr9GHbGeM^nmaNSjwqbyf3EYfIUvzCu6RFcNGKdVSvXmKv1iklQIZi9lGC2$OmzdsCqjzFDt 9bi83eHmZZygZiaJ$z2HSz5g7o1sdz5I^lIWYeC4MO9YWrWFi5lT$jOoOuRa0sHWTqHoN5wCGRqGfw$8DX4lhdcIzKTR5Qpp', 'InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1', 'AuxInfo=1/0/N:22,23,18,19,17,27,24,12,25,13,26,14,20,28,9,8,15,21,16,7,10,11,1,5,6,3,4,2/it:im/rA:57FOOOOOC.eC.oC.eC.eC.eCCC.eC.oC.eCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH/rB:;;;;;;s7;s8;s1s9;s2s7;s 8;s7;s11s12;s3s10s13;s10;s9;s7;s17;s16s19;d4s11;s14;s16;s16;d-20;s5s21;d-24;d6s25s27;s8;s9;s12;s12;s13;s13;s14;s15;s17;s17;s18;s18;s18;s19;s19;s22;s22;s22;s23;s23;s23;s2;s24;s3;s25;s26;s26;s27;s5;/r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r\n-0.3811\r\n-0.3897\r\n-0.2938\r\n-0.3885\r\n-0.29\r\n9.5e-003\r\n-2.63e-002\r\n4.e-004\r\n0.1517\r\n0.1332\r\n-4.37e-002\r\n-1.49e-002\r\n-7.2e-003\r\n9.01e-002\r\n4.41e-002\r\n-4.32e-002\r\n-5.61e-002\r\n-3.02e-002\r\n-5.34e-002\r\n0.1899\r\n-5.93e-002\r\n-4.91e-002\r\n-6.75e-002\r\n-1.45e-', '1', '1.708', 'C22H29FO5', '0392.2', '-3.784', '0392.461', '', '2', '2', '4', '27', '00', '0', '28', '31', '38', '4', '005', '03', '29', '0', '4', '002', '0094.83', '394.35', '', '2.58393', '1.2904', '62.85', '34.81', '3.86992', '28.04', '1,202.04', '182.649', '320.01', '', 'FC23C(C1C(C)(C(O)(C(=O)CO)C(C)C1)CC2O)CC/C4=C/C(=O)/C=C\\C34C', 'C[C@@H]4C[C@H]3[C@@H]2CC/C1=C/C(=O)/C=C\\[C@]1(C)[C@@]2(F)[C@@H](O)C[C@]3(C)[C@@]4(O)C(=O)CO', 'Dexamethasone', 'Decadron; Maxidex; Hexadecadrol; Decaspray; Hexadrol; Millicorten', 'Glucocorticoid receptor', '5743', 'Phase III', 'Opsoclonus-myoclonus ataxia', '21531096', 'Opsoclonus-myoclonus ataxia', 'Not Available'),
(380, '45357793', '45357793', 'C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O', '[2-[(8<I>S</I>,9<I>R</I>,10<I>S</I>,11<I>S</I>,13<I>S</I>,14<I>S</I>,16<I>R</I>,17<I>R</I>)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17- yl]-2-oxo-ethyl] dihydrogen phosphate', 'CYAAFQwA1dwQog0sYAj30fzFyN3CVhAtWZq7XGTw4p2nPI6BNhwKTJCuHIzJmqWNGrMg1kfayT5n3^mYiTx$78zCi3k5WE^Q6VjE90ZQtK9wtok2ZflszjvBMW96rlmmDzPc7^^4vt31cExfns95^B23w$Uk9faUGEcq$htqLe6bR7a3W5iJafiWGB$T$JdEyzum5DRX ceca35oXanQn^M7bwTI3GLN0$GX4$R0Qi3H2odHxK$8ddjkXnmG8ea0mhQbPTcubnfKWx6bvk6BDkyDX9^zmR7dezQb685lipVeD^s1ZdWa8JP$heS1gK639LXUDNsyC2LMBvsEteWIofoS0tDIqMZ^hpUc6F6U9IueonLkP9wQ6mC$z7us04p$m4jvkUwsn2QRCOo45 85Ho9^sZkUVVpduFjzYpSc2hjG2RjSMrsYvS33Nsg^GFBVpbtJP9wqPTDpwyZhzId51WvFe8rjNYPl501b13QemnYOe4dYu8', 'InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15+,16+,17+,19+,20 +,21+,22+/m1/s1', 'AuxInfo=1/1/N:26,27,22,23,21,31,28,16,29,17,30,18,24,32,13,12,19,25,20,11,14,15,2,7,4,5,3,8,9,10,6,1/E:(28,29,30)/it:im/rA:62PFOOOOOOOOC.eC.oC.eC.eC.eCCC.eC.oC.eCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH HHH/rB:;;;;s1;;s1;s1;d1;;s11;s12;s2s13;s3s11;s12;s11;s15s16;s4s14s17;s14;s13;s11;s21;s20s23;d5s15;s18;s20;s20;d-24;s6s25;d-28;d7s29s31;s12;s13;s16;s16;s17;s17;s18;s19;s21;s21;s22;s22;s22;s23;s23;s26;s 26;s26;s27;s27;s27;s3;s28;s4;s29;s30;s30;s31;s8;s9;/r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r\n-0.2394\r\n-0.3811\r\n-0.3897\r\n-0.2938\r\n-0.2791\r\n-0.29\r\n-0.3027\r\n-0.3027\r\n-0.2284\r\n9.5e-003\r\n-2.63e-002\r\n4.e-004\r\n0.1517\r\n0.1333\r\n-4.37e-002\r\n-1.49e-002\r\n-7.2e-003\r\n9.01e-002\r\n4.41e-002\r\n-4.32e-002\r\n-5.61e-002\r\n-3.02e-002\r\n-5.34e-002\r\n0.1908\r\n-5.93e-002\r\n-4.91e-002\r\n-6.75e-002\r\n-1.45e-002\r\n0.1201\r\n-1.77e-002\r\n0.1778\r\n3.13e-002\r\n3.4e-002\r\n2.73e-002\r\n2.73e-002\r\n3.01e-002\r\n3.01e-002\r\n3.34e-002\r\n6.35e-002\r\n2.73e-002\r\n2.73e-002\r\n2.37e-002\r\n2.37e-002\r\n2.37e-002\r\n3.13e-002\r\n3.13e-002\r\n2.34e-002\r\n2.', '1', '-0.473', 'C22H30FO8P', '0472.166', '-2.91', '0472.441', '2.54 6.04', '3', '1', '5', '30', '00', '0', '32', '35', '41', '5', '008', '04', '30', '0', '4', '004', '0151.17', '451.28', '', '4.74003', '1.3042', '83.18', '36.24', '4.48188', '46.94', '2,338.64', '281.593', '365.63', '', 'P(OCC(=O)C4(O)C1(C)C(C3C(F)(C(O)C1)C/2(C)/C(=C\\C(=O)\\C=C2)CC3)CC4C)(O)(O)=O', 'C[C@@H]4C[C@H]3[C@@H]2CC/C1=C/C(=O)/C=C\\[C@]1(C)[C@@]2(F)[C@@H](O)C[C@]3(C)[C@@]4(O)C(=O)COP(=O)(O)O', 'Dexamethasone sodium phosphate', 'Decadron phosphate; Solu- Decadron; Spersadox', 'Glucocorticoid receptor', '45357793', 'FDA approved', 'Ataxia telangiectasia', '24405665', 'Ataxia telangiectasia', 'AT1\nLOUIS-BAR SYNDROME'),
(381, '5311068', '5311068', 'C[C@H](c1cnc[nH]1)c2cccc(C)c2C', '5-[(1<I>S</I>)-1-(2,3-dimethylphenyl)ethyl]-1<I>H</I>-imidazole', 'CYAAFQwAJewQ3wy$B805t1w$^hK7wSL67VXdoZd8iU2TPG6lNgqPefkf9EtzJcOcL1^917udJ5ZokqyrjxKDrMnrmD5Ji5$2Cu^PqFOcoZD07f5uP02tn9sxMxSY$Dcpvv^h7hb9AEU$IyO8QnmN3og$ypAItGYe5NlqiN0KGH^5XptRpGKsVORjeYGxSZEbQo4hvgc9 IzdoycqyOrzWBPFBA8MIKk$5ZeuxhB95R5xZdYDtmYPP89yEaMUN7D6uhiVi5tlabcUU23kyKTsKO2Gzyt5SuMSpRgl48^^tqKWgBLPq4h1IsnDsOpeNPjTnMLsGbi64BX3HvVtl67rKPDyY6aDuRzTG9eRmsKvZWSrhNxl^Vjr1fOdBlasYkGtnDn31SSVVPZQzrHNe OuWVMy$xmHuv$qFZA4PzhtaJ5KJKzoStOo3Ls71uMOio11aV5tY0ZnWI6kTQtpUDZVv4bE7sYE8tq$tMaJvu8^jd0BfVozLI', 'InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1', 'AuxInfo=1/1/N:14,10,7,12,11,9,13,15,8,5,3,4,6,2,1/it:im/rA:31NNC.eCCCCCCCCCCCCHHHHHHHHHHHHHHHH/rB:;;s3;s4;s1s3;s3;d-5;d+4;s5;s8;s9d-11;s2d-6;s8;s1d-2;s3;s7;s7;s7;s9;s10;s10;s10;s11;s12;s1;s13;s14;s14; s14;s15;/rC:2.5808,1.0221,-.4692;3.3726,.1767,1.4257;.7254,-.522,-1.0827;-.607,-.5034,-.4073;-1.3933,.6486,-.3985;1.8712,-.0633,-.1668;1.1107,-1.8508,-1.7797;-2.6342,.6411,.2383;-1.0618,-1.6631,.2203; -.9054,1.8923,-1.071;-3.089,-.5186,.8659;-2.3029,-1.6708,.8569;2.3293,-.5881,.9675;-3.4951,1.861', 'CUHVIMMYOGQXCV-NSHDSACASA-N', '1010:8ZBJYANBJ82XB3VAS8NTGHVZ7WAR8K', '[n]1(-[#1]):[c](-[#1]):[n]:[c](-[#1]):[c]1-[#6@@](-[#1])(-[#6](-[#1])(-[#1])-[#1])-[c]2:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#6](-[#1])(-[#1])-[#1]):[c]2-[#6](-[#1])(-[#1])-[#1]', 'n1([H])c([H])nc([H])c1[C@@]([H])(C([H])([H])[H])c2c([H])c([H])c([H])c(C([H])([H])[H])c2C([H])([H])[H]', '02.996', '2.996', '0', '0', 'TRUE', '-0.2512\r\n-0.2513\r\n1.82e-002\r\n-3.66e-002\r\n-4.44e-002\r\n2.23e-002\r\n-5.33e-002\r\n-4.79e-002\r\n-5.81e-002\r\n-3.93e-002\r\n-5.91e-002\r\n-6.17e-002\r\n4.27e-002\r\n-3.95e-002\r\n7.24e-002\r\n4.1e-002\r\n2.4e-002\r\n2.4e-002\r\n2.4e-002\r\n6.25e-002\r\n2.79e-002\r\n2.79e-002\r\n2.79e-002\r\n6', '1', '4.131', 'C13H16N2', '0200.131', '-3.913', '0200.28', '9.71', '1', '1', '0', '5', '11', '2', '15', '16', '20', '5', '002', '01', '16', '0', '2', '002', '0028.68', '233.98', '', '1.49102', '1.2512', '35.04', '24.44', '3.16269', '10.6', '323.746', '49.822', '174.24', '', 'N/2/C(C(/C1=C/C=C\\C(C)=C1\\C)C)=C\\N=C2', 'COC(=O)[C@H](c1ccccc1)[C@H]2CCCCN2', 'Dexmedetomidine', 'Dexmedetomidina; MPV 1440; Dexdor; Dexmedetomidin', 'Alpha-2A adrenergic receptor', '5311068', 'Under Investigation', 'Riley-Day syndrome', '27752785', 'Riley-Day syndrome', 'HSAN III\nDYSAUTONOMIA, FAMILIAL; DYS; FD\nRILEY-DAY SYNDROME'),
(382, '154100', '154100', 'COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2', 'methyl (2<I>R</I>)-2-phenyl-2-[(2<I>R</I>)-2-piperidyl]acetate', 'CYAAFQwABcwQEHu4XoG6N1nsZpzN38uQxKz$lWEe9w1MRNJ^YpAUhvQNLPSdMR4XAXsMHa1yFYLN2NA^b9TzAI2e2oS3xaPoSlBQhKdkXMq0iRDL1GKG1kIpJkUce9hrP^8^PJNz3CgA48wTPTA0QqTfXljSqhBcS9dTvF3cZj4eo$qGHwLnETlHd4hVbWpkITVhLaQL 6QflWy98wfxmN3cV5gpA9oUfLqediMsbXIi0fvgU28Jln6$9iZr18o2U7LTL3UtxCnbHDefmV5sDMpxw899VQrKVihscQNQkPtTqcqUuwbqFLgwhwK97QhOclJHIr9Po2tqgaH6Vz^Zl3VFB5IyfRRBvW5HiHVpk0n6BrTh7QTV^ZcanzR54YyQiv3MeUcYwPbOxQzKb 88WPIHdV6zFtUobn3VpolGkq9mZKXHRn15VhzMQwI3xRnX0VOnnHea1XWYOgOq0tzSgiXzjrFDJtWCAHy3jrKPszefeMXBfw', 'InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1', 'AuxInfo=1/0/N:17,16,14,15,7,8,12,13,5,9,10,4,6,11,3,2,1/E:(3,4)(7,8)/it:im/rA:36OONC.oCC.eCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH/rB:;;s3;s4;s4;s5;s7;s3s8;s6;s1d2s6;d+10;s10;s12;d-13;d-14s15;s1;s4;s5;s5;s6;s7; s7;s8;s8;s3;s9;s9;s12;s13;s14;s15;s16;s17;s17;s17;/rC:-.1941,2.1277,.9168;.1159,2.7647,-1.2749;2.4563,.4805,-.3497;1.2347,-.2385,.0333;1.3444,-1.7269,-.3253;.0388,.3962,-.6743;2.5803,-2.3586,.3096;3.8 28,-1.5499,-.0278;3.6384,-.0732,.311;-1.2773,-.2702,-.3023;.0044,1.8986,-.4166;-1.4452,-.746,.98', 'DUGOZIWVEXMGBE-CHWSQXEVSA-N', '1010:XBDVF34G1NES7VSUXGKVUMWMR1QSN4', '[#8](-[#6](-[#1])(-[#1])-[#1])-[#6](-[#6@](-[#1])(-[c]1:[c](-[#1]):[c](-[#1]):[c](-[#1]):[c](-[#1]):[c]1-[#1])-[#6@@]2(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1])-[#6](-[#1])(-[#1] )-[#7]2-[#1])=[#8]', 'O(C([H])([H])[H])C([C@]([H])(c1c([H])c([H])c([H])c([H])c1[H])[C@@]2([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N2[H])=O', '02.18', '2.18', '0', '0', 'TRUE', '-0.3189\r\n-0.2659\r\n-0.3129\r\n2.3e-002\r\n-3.66e-002\r\n8.54e-002\r\n-5.06e-002\r\n-4.06e-002\r\n-4.6e-003\r\n-3.35e-002\r\n0.2697\r\n-5.82e-002\r\n-5.82e-002\r\n-6.2e-002\r\n-6.2e-002\r\n-6.23e-002\r\n4.52e-002\r\n4.76e-002\r\n2.82e-002\r\n2.82e-002\r\n4.76e-002\r\n2.67e-002\r\n2.67e-002\r\n2.79e', '1', '1.168', 'C14H19NO2', '0233.142', '-3.449', '0233.306', '8.77', '2', '1', '1', '11', '06', '1', '17', '18',